data_2ks0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ks0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -73.95 143.04 45.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.311 -0.868 . . . . 0.0 109.142 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.486 ' NE2' ' OG1' ' B' ' 27' ' ' THR . 79.1 mt-30 -144.65 158.02 43.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.2 -0.938 . . . . 0.0 109.803 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -114.91 132.7 56.45 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.6 tt -121.68 130.27 53.35 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.3 p -127.04 147.43 50.15 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.527 -0.733 . . . . 0.0 109.745 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.2 tp -158.56 160.47 36.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.402 -0.811 . . . . 0.0 109.162 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t -151.52 -165.94 2.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.42 -0.8 . . . . 0.0 108.972 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.48 28.35 55.57 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.0 t -66.4 137.83 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.512 -0.993 . . . . 0.0 109.839 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.4 ' HG ' ' C ' ' A' ' 26' ' ' GLU . 53.4 p -72.63 -37.0 68.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 0.0 109.261 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -170.37 163.59 8.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.0 109.451 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.1 t -98.5 96.5 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.23 -0.919 . . . . 0.0 109.3 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.23 -38.83 88.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.148 -0.97 . . . . 0.0 108.977 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 t -170.26 161.54 8.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.823 . . . . 0.0 109.294 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -146.6 105.49 3.86 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.93 151.62 78.82 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.543 -0.723 . . . . 0.0 109.186 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.87 -16.82 32.84 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.159 1.906 . . . . 0.0 111.086 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -104.97 -10.59 17.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.524 -0.735 . . . . 0.0 109.475 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -169.28 131.4 1.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.413 -0.805 . . . . 0.0 109.209 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.79 129.33 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.695 -0.628 . . . . 0.0 109.496 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 mt -120.48 118.41 30.2 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -133.39 127.93 34.49 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.4 ' C ' ' HG ' ' A' ' 13' ' ' SER . 38.7 tt0 -91.01 123.8 34.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.923 -1.11 . . . . 0.0 109.692 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.611 ' O ' ' N ' ' A' ' 29' ' ' GLN . 1.9 t -119.39 149.24 42.16 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.7 mt 50.46 -80.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.3 pt20 -153.45 -18.19 0.14 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.967 -1.083 . . . . 0.0 110.67 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.67 168.94 26.81 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.36 131.95 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.447 -1.031 . . . . 0.0 109.598 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.0 tp -108.23 128.79 55.03 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.465 0.65 . . . . 0.0 109.445 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.5 t -111.42 126.25 54.74 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.403 HG22 HD12 ' A' ' 34' ' ' ILE . 24.3 mm -106.54 127.53 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.798 -0.564 . . . . 0.0 109.551 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -122.94 135.08 54.35 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.17 -156.5 19.53 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -135.84 146.44 47.49 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.417 -1.049 . . . . 0.0 108.825 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt 55.79 56.45 6.09 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.626 -0.672 . . . . 0.0 110.193 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.49 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 7.6 mp -93.64 68.84 4.05 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.946 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -179.075 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.88 139.16 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.47 -0.769 . . . . 0.0 108.937 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -114.82 160.11 19.84 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -137.43 138.15 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.31 -0.869 . . . . 0.0 109.121 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -120.68 124.79 46.06 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.47 172.78 31.39 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.99 127.64 44.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.492 -1.005 . . . . 0.0 108.817 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -83.01 117.1 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.058 -1.027 . . . . 0.0 109.284 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -96.96 -12.18 23.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.327 -0.858 . . . . 0.0 109.284 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -173.86 154.27 2.35 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.177 -0.952 . . . . 0.0 110.196 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.41 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 13.6 mt -137.17 134.7 36.61 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.2 t -133.23 123.83 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.234 -0.916 . . . . 0.0 109.708 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.54 ' CE1' ' O ' ' A' ' 63' ' ' PRO . 15.3 t80 -139.72 120.72 9.51 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.54 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 31.5 Cg_exo -56.86 127.86 27.58 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 CA-C-N 120.641 1.265 . . . . 0.0 111.109 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.557 ' CD1' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.077 0 O-C-N 121.19 -0.944 . . . . 0.0 109.005 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.464 ' N ' ' OD1' ' B' ' 3' ' ' ASN . 13.7 p-10 . . . . . 0 N--CA 1.498 1.959 0 CA-C-O 121.321 0.581 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -68.84 141.04 55.22 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.313 -0.867 . . . . 0.0 109.436 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . 0.516 ' NE2' ' OG1' ' A' ' 27' ' ' THR . 26.5 mt-30 -146.74 158.27 43.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.183 -0.948 . . . . 0.0 109.782 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -103.81 135.63 44.99 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 7.2 tt -138.41 125.48 21.39 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.396 -0.815 . . . . 0.0 108.841 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -129.41 149.31 51.25 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.4 tp -145.96 146.52 31.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.225 -0.922 . . . . 0.0 109.302 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -132.74 171.33 14.02 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.547 -0.72 . . . . 0.0 109.192 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.75 23.21 70.33 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -77.61 137.17 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -1.158 . . . . 0.0 109.612 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 41.2 t -71.03 -44.31 66.09 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.061 -1.024 . . . . 0.0 109.882 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.68 151.81 4.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.899 -1.126 . . . . 0.0 110.36 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 70.4 t -85.55 130.35 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.458 -0.776 . . . . 0.0 109.349 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -98.54 -42.15 7.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.176 -0.953 . . . . 0.0 109.919 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -157.57 118.7 3.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.111 -0.993 . . . . 0.0 109.261 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -111.86 106.39 15.1 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.472 -0.768 . . . . 0.0 109.133 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -132.42 151.08 77.61 Favored Pre-proline 0 N--CA 1.498 1.971 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.36 -20.27 48.75 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.12 1.88 . . . . 0.0 112.18 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -110.89 6.9 21.56 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.366 -0.834 . . . . 0.0 109.408 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -170.46 137.94 1.47 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.346 -0.846 . . . . 0.0 109.172 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.403 HG23 HD11 ' B' ' 23' ' ' ILE . 91.3 mt -137.92 128.37 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.17 -0.956 . . . . 0.0 109.478 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 mt -124.21 109.83 13.91 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 86.7 mt -113.77 124.2 51.69 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -83.36 104.89 13.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.285 -0.884 . . . . 0.0 109.15 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.621 ' HG1' ' H ' ' B' ' 28' ' ' ILE . 13.8 t -123.95 -178.92 4.21 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.397 0.618 . . . . 0.0 109.548 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.621 ' H ' ' HG1' ' B' ' 27' ' ' THR . 8.6 mm -34.31 157.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.908 0.861 . . . . 0.0 110.629 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 64.94 -57.76 0.27 Allowed 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.961 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' B' ' 28' ' ' ILE . . . -171.36 -131.61 1.37 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.214 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -121.47 134.43 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.718 -0.872 . . . . 0.0 110.175 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 29.3 tp -100.0 126.58 46.21 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -106.34 135.33 48.03 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.541 -0.724 . . . . 0.0 109.619 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 79.7 mt -124.71 132.39 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -124.82 141.53 52.05 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.546 0.689 . . . . 0.0 109.85 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.23 -153.23 21.65 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -130.95 143.74 50.95 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.204 -1.174 . . . . 0.0 109.421 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 55.66 57.0 5.61 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.695 . . . . 0.0 109.704 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' B' ' 39' ' ' LEU . 9.1 mp -97.5 72.29 2.35 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.432 -0.792 . . . . 0.0 109.194 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.002 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.499 1.978 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -125.91 132.83 52.05 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.99 135.21 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -124.38 133.32 53.45 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.436 -0.79 . . . . 0.0 108.967 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.51 -178.38 39.08 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.13 120.64 35.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.412 -1.052 . . . . 0.0 108.927 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.3 mt -91.79 110.27 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.078 -1.014 . . . . 0.0 108.762 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -97.88 -16.43 19.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.373 -0.829 . . . . 0.0 109.997 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.96 147.33 23.98 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.823 -1.173 . . . . 0.0 110.884 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.412 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 13.1 mt -139.15 132.16 29.51 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 54.2 t -130.64 127.01 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.308 -0.87 . . . . 0.0 109.318 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 14.6 t80 -138.71 141.44 30.77 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . 0.531 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 71.9 Cg_endo -76.6 112.41 3.45 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.867 1.711 . . . . 0.0 111.908 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.568 ' CD1' ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.138 0 O-C-N 121.187 -0.946 . . . . 0.0 109.022 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 . . . . . 0 N--CA 1.497 1.903 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 43.2 mmm-85 -59.77 142.47 53.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.559 -0.713 . . . . 0.0 110.525 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -154.34 162.12 41.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.477 -0.764 . . . . 0.0 109.579 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 9.7 m-85 -106.66 130.86 54.33 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.552 -0.718 . . . . 0.0 109.469 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.64 146.83 39.16 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.143 0.973 . . . . 0.0 109.267 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.0 t -139.44 143.2 37.49 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.374 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.4 tp -155.22 139.47 16.62 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.342 -0.848 . . . . 0.0 109.743 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 t -145.33 164.9 30.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.397 -0.814 . . . . 0.0 109.376 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.61 11.55 77.18 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -66.82 159.78 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.769 -0.842 . . . . 0.0 110.633 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 14' ' ' LYS . 22.1 p -74.68 -53.09 9.95 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.4 ' N ' ' OG ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -171.7 158.09 4.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.261 -0.9 . . . . 0.0 109.706 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 t -83.8 108.18 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.86 . . . . 0.0 110.099 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -66.89 -41.57 86.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.426 -0.796 . . . . 0.0 109.094 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.8 t -172.62 143.62 1.34 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.414 -0.804 . . . . 0.0 109.18 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -127.61 116.72 20.76 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.55 -0.719 . . . . 0.0 109.227 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.0 147.87 67.11 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.84 -16.82 46.53 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.835 1.69 . . . . 0.0 110.77 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -98.39 -7.86 27.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.621 -0.675 . . . . 0.0 109.198 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 23' ' ' ILE . 9.5 tm-20 -174.61 150.84 1.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.366 -0.833 . . . . 0.0 109.082 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.479 ' N ' ' CD ' ' A' ' 22' ' ' GLU . 96.5 mt -133.44 130.86 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.299 -0.875 . . . . 0.0 109.991 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.2 mt -115.52 128.11 55.76 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.2 mt -128.54 132.48 48.27 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.393 -0.817 . . . . 0.0 109.155 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -98.81 110.22 22.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 108.709 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.611 ' O ' ' N ' ' A' ' 29' ' ' GLN . 12.3 t -113.43 149.06 34.73 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.411 0.624 . . . . 0.0 109.97 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.8 mm 43.26 -80.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.652 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' A' ' 27' ' ' THR . 9.0 mt-30 -143.58 -24.65 0.58 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.11 -0.994 . . . . 0.0 109.836 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.01 174.78 36.01 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.76 130.31 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.849 -0.795 . . . . 0.0 109.019 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.1 tp -103.75 126.59 50.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.582 -0.699 . . . . 0.0 109.42 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.7 t -113.35 128.11 56.35 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.409 HD11 HG21 ' A' ' 34' ' ' ILE . 90.5 mt -107.27 130.33 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -124.42 138.6 54.34 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.477 0.656 . . . . 0.0 109.416 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.71 -144.92 8.65 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -133.93 144.46 48.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.317 -1.108 . . . . 0.0 108.939 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 54' ' ' GLU . 71.1 mmtt 58.3 57.69 3.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 0.0 109.351 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 9.1 mp -95.56 72.79 3.18 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.601 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.0 t -113.79 132.23 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -125.95 141.02 52.16 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.1 t -131.0 133.67 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.508 ' OE1' ' CD2' ' A' ' 6' ' ' PHE . 27.1 tp10 -117.69 143.13 46.48 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.71 -172.7 30.4 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.93 126.95 54.42 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.632 -0.922 . . . . 0.0 109.218 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.31 118.96 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.033 -1.042 . . . . 0.0 109.552 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -98.7 -19.5 17.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.414 -0.804 . . . . 0.0 108.855 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -168.25 154.33 7.18 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.131 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.9 mt -133.32 139.48 46.89 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.2 t -134.58 122.41 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.526 -0.734 . . . . 0.0 109.796 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.439 ' CD1' ' C ' ' A' ' 62' ' ' TYR . 10.0 t80 -136.23 139.79 30.97 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.16 87.71 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.472 1.448 . . . . 0.0 112.245 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.613 ' CD2' ' H ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' B' ' 3' ' ' ASN . 8.9 p-10 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -79.53 139.11 37.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.586 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -148.14 158.43 44.07 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.138 -0.976 . . . . 0.0 109.734 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -113.94 134.35 54.88 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.483 -0.76 . . . . 0.0 109.021 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.8 mt -116.06 147.3 41.41 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 43.1 t -141.04 131.67 25.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.497 -0.752 . . . . 0.0 109.577 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 25.1 tp -142.82 145.25 33.02 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.501 ' O ' ' N ' ' B' ' 12' ' ' VAL . 14.1 p -68.25 165.64 18.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.208 -0.933 . . . . 0.0 110.649 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.19 92.87 0.01 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' B' ' 10' ' ' THR . 9.3 p -48.2 168.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.51 -0.994 . . . . 0.0 110.26 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 15.7 m -72.86 -39.8 66.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.665 -0.647 . . . . 0.0 110.528 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -148.98 147.66 28.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.883 -1.136 . . . . 0.0 109.949 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 78.6 t -103.32 97.48 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -65.13 -41.83 94.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.851 . . . . 0.0 109.83 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 31.1 t -174.43 147.0 1.1 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.886 . . . . 0.0 109.07 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -128.88 112.46 14.13 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -130.7 148.14 68.91 Favored Pre-proline 0 N--CA 1.498 1.93 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.6 -10.33 28.37 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.792 1.662 . . . . 0.0 111.496 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -118.38 3.86 11.86 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.768 -0.582 . . . . 0.0 109.64 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -172.07 129.76 0.61 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.261 -0.899 . . . . 0.0 109.382 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 50.8 mm -122.03 121.65 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.347 -0.845 . . . . 0.0 109.214 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 58.4 mt -119.21 114.53 22.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 46.3 mt -131.35 127.11 36.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.394 -0.816 . . . . 0.0 108.883 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -87.39 111.34 21.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.021 -1.049 . . . . 0.0 109.414 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.618 ' O ' ' N ' ' B' ' 29' ' ' GLN . 9.6 t -105.74 150.06 25.86 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.475 -0.766 . . . . 0.0 109.96 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 57.5 mt 38.26 -84.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 121.06 0.457 . . . . 0.0 110.485 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.618 ' N ' ' O ' ' B' ' 27' ' ' THR . 15.9 pt20 -139.4 -19.47 0.96 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.338 -0.851 . . . . 0.0 110.26 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.58 166.24 23.91 Favored Glycine 0 N--CA 1.496 2.654 0 O-C-N 121.077 -1.015 . . . . 0.0 110.665 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 69.1 t -114.97 131.31 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.725 -0.868 . . . . 0.0 108.668 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 52.7 tp -109.77 127.61 54.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.613 -0.679 . . . . 0.0 109.24 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.5 t -117.23 124.2 48.48 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.409 HD13 HG23 ' B' ' 34' ' ' ILE . 74.1 mt -110.18 131.38 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.387 -0.821 . . . . 0.0 108.997 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -124.84 139.56 53.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.546 -0.721 . . . . 0.0 109.365 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.67 -144.69 8.05 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.566 ' OE1' ' N ' ' B' ' 37' ' ' GLU . 7.5 mp0 -138.65 147.44 42.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.522 -0.987 . . . . 0.0 109.204 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' B' ' 54' ' ' GLU . 68.8 mmtt 62.54 49.75 3.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.667 -0.646 . . . . 0.0 109.94 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 10.0 mp -93.01 71.17 4.63 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.005 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -178.736 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.497 1.906 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -136.97 149.93 47.84 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 23.8 t -130.62 159.16 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.311 -0.868 . . . . 0.0 109.623 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' B' ' 38' ' ' LYS . 7.5 pt-20 -143.38 144.33 32.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.332 -0.855 . . . . 0.0 109.244 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.46 -175.53 31.82 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.54 113.85 27.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.442 -1.034 . . . . 0.0 109.208 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.535 ' CD1' ' N ' ' B' ' 57' ' ' ILE . 1.5 mp -81.14 127.07 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.156 -0.965 . . . . 0.0 109.759 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -101.78 -23.0 14.26 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.07 155.01 15.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.043 -1.036 . . . . 0.0 110.655 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 14.0 mt -130.82 142.56 50.4 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 71.3 t -134.19 119.77 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.421 -0.8 . . . . 0.0 109.177 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -133.71 102.86 12.32 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.66 97.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.829 1.686 . . . . 0.0 112.745 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.604 HD11 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.483 -0.761 . . . . 0.0 109.22 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.478 0.656 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.3 mmm-85 -69.4 138.3 53.48 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.5 -0.75 . . . . 0.0 109.693 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -150.44 155.75 40.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.454 -0.779 . . . . 0.0 109.139 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -114.34 131.93 56.37 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.0 tt -120.3 123.73 43.87 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.3 t -109.93 132.24 54.34 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.498 -0.751 . . . . 0.0 109.601 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.6 tp -146.92 147.29 30.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.785 . . . . 0.0 109.232 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.9 t -148.43 177.74 9.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.306 -0.871 . . . . 0.0 109.187 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.3 20.98 76.51 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 p -62.46 144.37 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.586 -0.949 . . . . 0.0 110.001 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 t -72.38 -42.7 64.93 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.543 -0.723 . . . . 0.0 109.573 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -165.12 160.65 18.95 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.983 -1.073 . . . . 0.0 110.179 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -94.85 108.89 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -81.9 -56.3 4.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -0.816 . . . . 0.0 110.024 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 t -162.18 127.16 3.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.304 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -109.66 117.43 33.91 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -131.05 148.41 70.14 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 121.309 -0.869 . . . . 0.0 109.466 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.66 -11.8 31.73 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.508 1.472 . . . . 0.0 110.515 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -105.71 -14.52 15.23 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.791 -0.568 . . . . 0.0 110.094 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -167.82 145.89 4.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.232 -0.917 . . . . 0.0 109.306 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.2 mm -121.74 125.29 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.561 -0.712 . . . . 0.0 109.079 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.4 mt -118.39 115.56 24.92 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.4 mt -133.38 133.56 42.59 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -75.7 116.33 16.3 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.312 -0.867 . . . . 0.0 109.3 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.499 ' O ' ' C ' ' A' ' 28' ' ' ILE . 13.3 t -114.51 146.96 40.06 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.499 ' C ' ' O ' ' A' ' 27' ' ' THR . 10.0 mm -1.97 -75.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 123.557 0.743 . . . . 0.0 112.932 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.469 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 99.4 mm-40 -59.35 -71.01 0.13 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.438 -0.789 . . . . 0.0 111.749 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.55 -128.24 1.9 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.2 t -116.72 131.81 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.916 0.865 . . . . 0.0 110.711 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.4 tp -100.71 129.86 46.67 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.7 m -110.21 120.69 43.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.6 mt -105.32 124.04 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -118.41 141.32 48.66 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.754 0.788 . . . . 0.0 109.35 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.58 -138.56 3.36 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.401 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.78 132.35 43.71 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.48 -1.012 . . . . 0.0 108.353 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp 39.72 86.13 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.642 0.734 . . . . 0.0 110.646 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.462 ' N ' ' CD1' ' A' ' 39' ' ' LEU . 8.2 mp -96.8 72.12 2.58 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.686 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.539 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.7 t -122.22 133.08 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.539 ' N ' ' OE1' ' A' ' 52' ' ' GLU . 13.3 mp0 -131.67 146.68 52.31 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.501 0.667 . . . . 0.0 109.428 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.1 t -129.06 134.41 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -117.32 134.76 54.43 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.694 0.759 . . . . 0.0 109.243 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.83 -176.05 34.21 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.71 120.92 41.91 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.9 mt -83.76 116.9 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.056 -1.028 . . . . 0.0 109.772 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -96.99 -15.42 21.09 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.481 -0.762 . . . . 0.0 109.81 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.6 152.96 8.67 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.083 -1.011 . . . . 0.0 110.446 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.401 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 8.8 mt -138.63 134.97 34.41 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 49.7 t -130.86 124.91 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.496 -0.753 . . . . 0.0 109.421 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.556 ' O ' ' N ' ' A' ' 64' ' ' LEU . 33.7 t80 -133.63 111.54 12.55 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.12 78.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.413 1.409 . . . . 0.0 112.326 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 62' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.304 -1.402 0 O-C-N 120.528 -1.358 . . . . 0.0 108.667 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' B' ' 3' ' ' ASN . 10.7 p-10 . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 121.246 0.546 . . . . 0.0 109.809 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 38.6 mmm-85 -72.18 141.22 49.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.295 -0.878 . . . . 0.0 109.166 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -146.61 150.78 36.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.359 -0.838 . . . . 0.0 109.477 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -98.49 144.82 27.42 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 7.0 tt -127.79 125.9 40.71 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -122.17 145.44 48.19 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.533 -0.73 . . . . 0.0 110.126 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.6 tp -153.17 149.29 27.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.4 t -151.15 159.06 44.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.089 -1.007 . . . . 0.0 109.885 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.49 15.07 72.13 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.6 p -62.3 153.03 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -1.079 . . . . 0.0 110.378 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 67.1 m -73.71 -54.07 8.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.15 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.41 153.34 4.3 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.2 -0.937 . . . . 0.0 109.614 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 79.8 t -86.22 130.12 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.416 -0.802 . . . . 0.0 109.886 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -92.8 -23.82 18.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.291 -0.88 . . . . 0.0 109.378 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 21.5 t -171.55 158.16 5.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.133 -0.98 . . . . 0.0 109.893 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -147.52 112.27 5.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.401 -0.812 . . . . 0.0 109.492 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . 0.458 ' OD2' ' O ' ' B' ' 22' ' ' GLU . 1.1 m-20 -133.18 152.88 80.35 Favored Pre-proline 0 N--CA 1.5 2.067 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.58 -12.61 36.23 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.654 1.569 . . . . 0.0 111.556 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -125.88 2.48 7.37 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.574 -0.704 . . . . 0.0 109.563 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.458 ' O ' ' OD2' ' B' ' 19' ' ' ASP . 55.1 tt0 -160.85 119.63 2.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.334 -0.853 . . . . 0.0 109.256 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.6 mt -129.02 127.87 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.173 -0.955 . . . . 0.0 109.416 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 79.3 mt -108.77 134.92 50.82 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 93.7 mt -135.05 123.42 23.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.349 -0.845 . . . . 0.0 109.7 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -93.93 123.17 37.11 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.566 ' O ' ' N ' ' B' ' 29' ' ' GLN . 7.0 t -123.58 149.45 45.28 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.606 0.717 . . . . 0.0 109.886 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 16.7 mt 45.04 -85.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.922 -0.486 . . . . 0.0 110.218 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' B' ' 27' ' ' THR . 17.1 pt20 -142.88 -20.62 0.65 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.08 -1.013 . . . . 0.0 110.201 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.98 171.59 35.88 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -116.54 131.4 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.879 -0.777 . . . . 0.0 109.125 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 31.8 tp -112.76 127.17 56.08 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.42 0.629 . . . . 0.0 109.485 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 40.5 t -108.94 123.46 49.13 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 39.3 mm -99.71 128.15 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -133.06 125.64 30.08 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.83 -139.5 2.65 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -137.94 136.93 37.47 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.349 -1.089 . . . . 0.0 109.99 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 54.84 57.84 5.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.467 -0.771 . . . . 0.0 110.09 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.497 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 8.8 mp -85.15 72.15 10.8 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.791 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -178.716 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.498 1.954 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -146.45 159.6 43.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.236 -0.915 . . . . 0.0 110.131 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.15 159.38 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.691 -0.63 . . . . 0.0 109.513 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -127.81 142.11 51.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.435 -0.79 . . . . 0.0 109.139 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.27 -177.76 31.49 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.66 128.81 52.82 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.406 HG23 HD13 ' B' ' 57' ' ' ILE . 30.6 mm -78.61 125.34 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.073 -1.017 . . . . 0.0 109.656 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -110.09 -9.85 14.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.658 -0.652 . . . . 0.0 109.478 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -174.24 149.29 1.38 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.096 -1.002 . . . . 0.0 110.095 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 13.0 mt -138.34 137.5 37.42 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 t -134.42 122.74 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.491 -0.755 . . . . 0.0 109.982 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.401 ' CG ' ' HB2' ' A' ' 60' ' ' LEU . 26.9 t80 -140.33 106.08 6.6 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -50.59 113.05 0.89 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.302 1.334 . . . . 0.0 112.336 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.606 ' CD1' ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.098 0 O-C-N 121.187 -0.946 . . . . 0.0 108.922 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 . . . . . 0 N--CA 1.501 2.081 0 CA-C-O 121.434 0.635 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -71.18 146.67 48.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 109.649 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -150.2 160.12 43.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.37 -0.831 . . . . 0.0 109.174 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -100.08 141.56 32.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.377 -0.827 . . . . 0.0 109.053 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 tt -133.76 123.85 25.61 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.4 t -131.88 139.62 48.84 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.736 -0.603 . . . . 0.0 109.556 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.8 tp -133.3 147.62 51.9 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p -130.71 159.12 38.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.526 -0.734 . . . . 0.0 109.544 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.95 21.05 69.04 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.35 137.05 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -1.154 . . . . 0.0 109.898 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.5 m -73.12 -44.35 60.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.206 -0.934 . . . . 0.0 109.796 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.56 163.2 5.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.163 -0.961 . . . . 0.0 109.564 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.0 t -93.99 127.71 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.282 -0.886 . . . . 0.0 109.433 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -85.19 -30.92 23.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.046 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.509 ' HG ' ' H ' ' A' ' 18' ' ' PHE . 47.8 t -174.01 167.26 4.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.516 -0.74 . . . . 0.0 109.293 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.509 ' H ' ' HG ' ' A' ' 17' ' ' SER . 9.7 t80 -149.77 106.54 3.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.344 -0.847 . . . . 0.0 108.856 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.62 126.02 19.81 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -47.24 -24.21 3.58 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.361 1.374 . . . . 0.0 112.228 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -90.7 -8.15 50.67 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.985 -1.072 . . . . 0.0 109.98 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -176.65 141.58 0.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.472 -0.767 . . . . 0.0 109.081 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mt -130.76 130.58 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.105 -0.997 . . . . 0.0 109.085 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.1 mt -114.35 125.0 53.36 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.8 mt -124.33 131.35 53.51 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.566 -0.709 . . . . 0.0 109.624 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -95.28 122.59 38.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.401 -0.812 . . . . 0.0 109.162 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 29' ' ' GLN . 2.9 t -124.18 148.67 47.08 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.44 0.638 . . . . 0.0 110.348 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' A' ' 27' ' ' THR . 60.0 mt 38.09 -90.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.971 -0.455 . . . . 0.0 110.5 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.525 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.1 pt20 -136.47 -15.79 1.62 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.227 -0.921 . . . . 0.0 109.786 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.21 153.82 20.06 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.1 t -111.13 131.05 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.553 -0.969 . . . . 0.0 108.39 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.8 tp -107.34 124.07 49.27 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.693 -0.629 . . . . 0.0 109.633 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.1 m -107.49 120.36 41.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.1 mt -104.73 127.11 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.52 127.64 52.37 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.96 -148.61 5.38 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -142.79 139.23 30.91 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm 57.25 63.3 1.92 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.524 -0.735 . . . . 0.0 110.315 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 39' ' ' LEU . 9.0 mp -94.73 72.06 3.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.268 -0.895 . . . . 0.0 109.023 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.367 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.533 -179.087 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 . . . . . 0 N--CA 1.5 2.047 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.58 135.47 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.509 -0.744 . . . . 0.0 109.422 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -126.93 137.9 53.2 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.5 t -137.48 141.08 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -0.799 . . . . 0.0 108.951 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -114.96 125.21 53.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.497 -0.752 . . . . 0.0 109.033 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.49 166.17 27.12 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.592 ' CD1' ' H ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -86.77 151.42 23.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.52 -0.988 . . . . 0.0 110.772 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.9 mt -103.46 119.28 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.832 -1.167 . . . . 0.0 109.168 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -112.5 -11.94 13.55 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.405 -0.81 . . . . 0.0 108.995 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.78 149.03 6.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.105 -0.997 . . . . 0.0 110.086 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.5 mt -138.08 141.46 40.26 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.62 123.4 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.419 -0.801 . . . . 0.0 109.792 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.548 ' O ' ' N ' ' A' ' 64' ' ' LEU . 13.1 t80 -145.69 136.66 12.48 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -44.67 88.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.288 0 CA-C-N 120.22 1.114 . . . . 0.0 111.492 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 62' ' ' TYR . 1.7 tt . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.245 -0.909 . . . . 0.0 109.33 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 . . . . . 0 N--CA 1.5 2.025 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.3 mmm-85 -77.25 141.84 39.8 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.407 -0.808 . . . . 0.0 109.12 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -147.63 161.3 41.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.213 -0.93 . . . . 0.0 109.591 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -116.52 130.77 56.93 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.4 tt -123.12 121.81 36.91 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 97.8 p -114.0 145.76 41.1 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.7 -0.625 . . . . 0.0 109.695 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 34.1 tp -148.09 144.2 27.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.357 -0.839 . . . . 0.0 109.259 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 46.0 p -130.93 170.07 14.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.616 -0.677 . . . . 0.0 109.577 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.02 11.04 77.3 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 83.4 t -72.24 133.75 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -1.166 . . . . 0.0 109.684 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.8 t -72.28 -45.37 60.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.313 -0.867 . . . . 0.0 109.605 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.21 163.06 8.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.077 -1.014 . . . . 0.0 109.658 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 98.1 t -84.67 110.55 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.869 . . . . 0.0 109.979 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -66.35 -41.05 90.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 0.0 109.16 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 5.5 p -160.19 163.96 33.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.338 -0.851 . . . . 0.0 108.963 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -151.21 110.68 3.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.006 -1.058 . . . . 0.0 110.073 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.25 150.0 74.76 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.01 -16.5 49.66 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.612 1.541 . . . . 0.0 111.479 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -111.67 -1.97 15.53 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.557 -0.714 . . . . 0.0 109.517 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -170.86 130.63 0.81 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.169 -0.957 . . . . 0.0 109.286 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -129.73 132.07 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.231 -0.918 . . . . 0.0 109.847 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 89.5 mt -111.4 125.57 54.01 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 76.4 mt -121.73 124.83 45.16 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.667 -0.646 . . . . 0.0 109.357 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -93.32 113.52 25.72 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.576 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.7 t -124.95 154.04 41.79 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.447 0.641 . . . . 0.0 110.028 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 18.5 mm 42.22 -86.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.883 -0.51 . . . . 0.0 110.339 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' B' ' 27' ' ' THR . 18.7 pt20 -143.51 -17.0 0.63 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.018 -1.051 . . . . 0.0 110.232 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.94 178.05 30.6 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.84 134.35 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 54.8 tp -105.42 127.28 52.9 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.368 -0.833 . . . . 0.0 109.463 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.7 m -116.55 120.69 39.52 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.716 . . . . 0.0 109.645 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 92.1 mt -109.85 129.91 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -127.92 143.22 51.1 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.627 -0.67 . . . . 0.0 109.423 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.61 -142.53 7.58 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.523 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -123.0 143.72 49.74 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.627 -0.925 . . . . 0.0 109.069 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' B' ' 54' ' ' GLU . 49.5 mtmt 51.77 63.32 2.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.341 -0.849 . . . . 0.0 111.184 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 8.7 mp -94.88 70.7 3.41 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.979 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.347 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -120.07 143.24 48.23 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.422 -0.799 . . . . 0.0 108.941 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.7 t -124.17 135.59 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.629 -0.669 . . . . 0.0 109.513 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' B' ' 38' ' ' LYS . 44.0 tt0 -125.94 135.05 51.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.62 -177.1 27.09 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.67 127.2 45.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.347 -1.09 . . . . 0.0 108.556 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.497 ' N ' ' CD1' ' B' ' 57' ' ' ILE . 1.3 mp -79.8 128.06 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.925 . . . . 0.0 109.752 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -108.93 -39.54 5.29 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.29 149.66 32.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 110.094 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.69 131.21 42.9 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.09 128.77 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' B' ' 62' ' ' TYR . 19.8 t80 -143.53 140.06 17.07 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.57 85.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 120.986 1.124 . . . . 0.0 112.051 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.558 ' CD2' ' H ' ' B' ' 64' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -88.84 132.1 34.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.104 -0.997 . . . . 0.0 108.87 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -147.75 161.07 41.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.994 -1.066 . . . . 0.0 109.346 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -108.52 131.17 55.09 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.3 tt -117.82 121.77 41.63 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.8 t -116.04 132.34 56.68 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.538 -0.726 . . . . 0.0 109.657 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.5 tp -147.31 153.72 40.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.361 -0.837 . . . . 0.0 109.317 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.463 ' OG1' ' N ' ' A' ' 11' ' ' GLY . 6.1 t -149.85 -164.54 2.05 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.36 -0.838 . . . . 0.0 109.847 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.463 ' N ' ' OG1' ' A' ' 10' ' ' THR . . . 65.24 19.38 66.2 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.5 t -70.25 141.66 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.677 -0.896 . . . . 0.0 110.617 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.3 m -71.78 -43.5 65.6 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.91 160.36 3.55 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.234 -0.916 . . . . 0.0 109.918 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.2 t -88.66 129.96 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.4 -0.812 . . . . 0.0 109.852 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -97.34 -35.1 10.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.386 -0.821 . . . . 0.0 109.23 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.8 t -169.67 145.61 3.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.566 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -137.61 113.94 10.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.513 -0.742 . . . . 0.0 109.132 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -133.24 153.56 80.73 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.03 -20.08 44.82 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.295 1.997 . . . . 0.0 111.605 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -102.07 -4.56 25.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.539 -0.726 . . . . 0.0 109.318 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -172.87 142.04 1.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.444 -0.785 . . . . 0.0 109.045 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.421 HD12 HG22 ' A' ' 23' ' ' ILE . 95.8 mt -132.48 130.24 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.427 -0.796 . . . . 0.0 109.725 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.5 mt -118.06 121.44 40.59 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.6 mt -124.37 125.09 43.73 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -81.76 114.75 20.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.347 -0.846 . . . . 0.0 109.924 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 28' ' ' ILE . 14.5 t -124.68 -179.52 4.54 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.659 0.742 . . . . 0.0 110.215 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.492 ' O ' ' O ' ' A' ' 27' ' ' THR . 1.3 mt -36.51 161.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 121.736 0.779 . . . . 0.0 110.414 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.414 ' OE1' ' OD1' ' B' ' 58' ' ' ASP . 78.6 mm-40 65.12 -61.9 0.22 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.139 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 27' ' ' THR . . . -165.94 -127.26 0.88 Allowed Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.093 -1.527 . . . . 0.0 109.962 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.6 t -122.37 135.18 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.593 -0.945 . . . . 0.0 110.338 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.8 tp -105.55 125.41 50.96 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.8 m -103.61 123.0 46.16 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -107.75 125.02 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -116.57 140.83 48.95 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.47 -151.38 9.43 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -143.32 146.39 33.51 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.337 -1.096 . . . . 0.0 109.024 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 54' ' ' GLU . 67.5 mttm 58.33 55.22 5.14 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.486 0.66 . . . . 0.0 109.68 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.435 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 10.7 mp -92.9 72.64 4.81 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.849 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -179.125 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.015 0.435 . . . . 0.0 109.859 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.4 t -115.05 131.97 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -131.16 136.56 48.42 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.76 135.01 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 38' ' ' LYS . 5.1 tm-20 -116.89 126.55 53.16 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.0 -174.61 41.62 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.211 -1.471 . . . . 0.0 110.032 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.42 118.21 36.06 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.809 -0.818 . . . . 0.0 109.387 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.52 ' CD1' ' N ' ' A' ' 57' ' ' ILE . 1.4 mp -74.05 128.08 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.337 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -105.73 -21.9 13.07 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.89 158.28 12.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.991 -1.068 . . . . 0.0 110.834 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.64 135.34 40.1 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.8 t -133.96 119.94 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.436 -0.79 . . . . 0.0 109.63 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.402 ' O ' ' N ' ' A' ' 64' ' ' LEU . 29.2 t80 -133.46 140.06 35.85 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.77 68.4 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.602 1.535 . . . . 0.0 111.924 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.537 ' H ' HD23 ' A' ' 64' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.734 -0.604 . . . . 0.0 109.689 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 47.2 mmm-85 -88.66 137.77 32.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.657 -1.277 . . . . 0.0 109.451 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -139.05 149.92 45.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.295 -0.878 . . . . 0.0 109.502 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -109.46 129.55 55.55 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.9 tt -122.69 122.49 38.88 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 41.6 t -123.14 137.26 54.95 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.6 tp -145.25 151.59 38.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.221 -0.924 . . . . 0.0 109.835 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -140.49 159.74 41.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.708 -0.62 . . . . 0.0 109.629 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.47 24.19 26.86 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 p -62.62 141.37 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.166 -1.197 . . . . 0.0 110.034 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 10.0 m -92.28 -21.35 20.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.411 -0.806 . . . . 0.0 109.26 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -171.8 154.2 3.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.555 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 75.5 t -102.67 99.16 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -67.36 -40.55 85.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 109.07 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 25.8 t -170.76 167.97 7.49 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.408 -0.808 . . . . 0.0 109.523 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -149.7 105.2 3.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.532 -0.73 . . . . 0.0 109.123 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -132.77 147.82 67.04 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.59 -14.59 39.9 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 121.7 1.6 . . . . 0.0 111.735 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -104.05 -8.01 19.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.548 -0.72 . . . . 0.0 109.534 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -173.18 113.19 0.23 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.371 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.401 HG23 HD11 ' B' ' 23' ' ' ILE . 97.3 mt -109.35 127.14 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.235 -0.916 . . . . 0.0 109.221 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 68.4 mt -117.69 123.43 46.06 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 88.5 mt -131.22 129.49 41.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.465 -0.772 . . . . 0.0 109.391 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.2 111.47 17.65 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.604 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.487 ' O ' ' O ' ' B' ' 28' ' ' ILE . 12.9 t -124.39 -176.94 3.64 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.571 0.7 . . . . 0.0 110.29 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' B' ' 27' ' ' THR . 1.9 mt -32.62 157.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.886 0.85 . . . . 0.0 110.951 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 64.6 -62.45 0.18 Allowed 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.939 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' B' ' 28' ' ' ILE . . . -166.34 -120.09 0.5 Allowed Glycine 0 N--CA 1.486 1.968 0 C-N-CA 119.225 -1.464 . . . . 0.0 110.202 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 53.1 t -119.4 135.03 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.676 -0.897 . . . . 0.0 110.539 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 59.0 tp -109.33 123.38 49.22 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.4 t -107.4 123.66 48.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.792 -0.567 . . . . 0.0 109.989 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 94.6 mt -108.52 122.37 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -117.6 142.44 47.2 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.599 -0.688 . . . . 0.0 109.457 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.61 -146.74 8.71 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -139.1 142.06 38.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.365 -1.08 . . . . 0.0 109.489 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 88.9 mttt 56.21 57.1 5.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.668 -0.645 . . . . 0.0 109.798 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.479 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 8.6 mp -92.99 71.53 4.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.345 -0.847 . . . . 0.0 108.912 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . 0.41 ' O ' ' OE1' ' B' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -126.35 127.96 46.32 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.92 140.68 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.46 -0.775 . . . . 0.0 109.91 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.41 ' OE1' ' O ' ' B' ' 40' ' ' GLY . 5.3 mp0 -114.99 139.58 49.73 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.92 170.66 26.97 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.16 131.33 38.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.242 -1.152 . . . . 0.0 109.469 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 44.2 mm -87.66 113.98 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.099 -1.001 . . . . 0.0 108.862 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . 0.414 ' OD1' ' OE1' ' A' ' 29' ' ' GLN . 18.2 t0 -97.68 -7.0 31.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.593 -0.692 . . . . 0.0 109.222 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -177.19 154.85 1.09 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.048 -1.032 . . . . 0.0 110.823 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 mt -139.93 138.46 35.61 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.3 t -134.14 129.8 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.507 -0.746 . . . . 0.0 109.216 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.666 ' O ' ' N ' ' B' ' 64' ' ' LEU . 65.1 t80 -143.2 123.0 7.71 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -48.44 71.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 121.983 1.788 . . . . 0.0 111.91 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.666 ' N ' ' O ' ' B' ' 62' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.298 -1.642 0 CA-C-O 121.886 0.851 . . . . 0.0 109.975 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 121.307 0.575 . . . . 0.0 109.705 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.6 mmm-85 -81.61 148.0 29.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.241 -0.912 . . . . 0.0 110.121 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -155.83 160.13 39.96 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.46 -0.775 . . . . 0.0 109.264 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -108.92 138.37 45.36 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.7 tt -126.82 124.72 40.3 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 t -127.81 149.12 50.41 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.0 tp -142.5 146.25 34.53 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.344 -0.848 . . . . 0.0 109.402 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -124.73 167.77 14.11 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.641 -0.662 . . . . 0.0 109.534 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.37 14.96 69.8 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.3 p -68.93 136.76 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -1.12 . . . . 0.0 109.685 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.5 m -73.18 -46.5 50.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.307 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.96 163.1 4.0 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.346 -0.846 . . . . 0.0 109.882 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.2 t -95.18 117.55 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.412 -0.805 . . . . 0.0 109.823 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -68.84 -35.9 77.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.373 -0.83 . . . . 0.0 109.184 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -167.31 161.61 14.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.294 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -151.29 111.47 4.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.394 -0.816 . . . . 0.0 108.97 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -126.9 156.63 73.7 Favored Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.436 -0.79 . . . . 0.0 108.888 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.19 -29.78 84.81 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.776 1.651 . . . . 0.0 112.514 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -117.17 17.71 14.72 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.469 -0.769 . . . . 0.0 110.589 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -171.24 132.36 0.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 0.0 109.168 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.42 HG22 HD11 ' A' ' 23' ' ' ILE . 96.7 mt -133.17 129.94 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.366 -0.834 . . . . 0.0 109.54 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.459 ' CD2' ' OG ' ' A' ' 33' ' ' SER . 64.4 mt -112.93 126.86 55.94 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.1 mt -121.53 132.43 54.7 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.666 -0.647 . . . . 0.0 109.763 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -101.68 113.94 27.54 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 28' ' ' ILE . 9.9 t -124.61 -162.84 1.12 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.396 0.617 . . . . 0.0 110.037 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.462 ' O ' ' C ' ' A' ' 29' ' ' GLN . 63.2 mt -33.48 99.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 28' ' ' ILE . 5.6 pt20 29.58 53.83 0.12 Allowed 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 121.294 0.569 . . . . 0.0 111.558 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.02 145.46 8.16 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.53 131.22 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.516 -0.991 . . . . 0.0 108.908 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.7 tp -108.05 118.31 36.41 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.459 ' OG ' ' CD2' ' A' ' 24' ' ' LEU . 22.8 t -104.64 123.58 47.83 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.1 mt -105.81 129.18 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.438 -0.789 . . . . 0.0 109.433 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -120.38 139.19 53.15 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.78 -149.3 8.82 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -133.19 142.54 48.66 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.373 -1.075 . . . . 0.0 109.456 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.5 mttp 54.63 59.9 3.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.565 -0.71 . . . . 0.0 110.545 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 39' ' ' LEU . 9.0 mp -91.38 74.19 6.08 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.95 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.098 -177.313 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 . . . . . 0 N--CA 1.5 2.061 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.36 161.48 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.611 -0.681 . . . . 0.0 109.408 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -139.35 137.84 36.11 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.458 -0.776 . . . . 0.0 109.487 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 52.1 t -130.6 136.53 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -123.34 129.58 51.51 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.374 -0.829 . . . . 0.0 108.902 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.4 177.48 33.54 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.79 133.7 39.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.283 -1.128 . . . . 0.0 109.273 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.8 mt -90.54 111.7 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.148 -0.97 . . . . 0.0 109.727 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -99.31 -17.06 18.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.498 -0.751 . . . . 0.0 109.39 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.59 153.22 16.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.074 -1.016 . . . . 0.0 110.248 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.04 136.5 42.13 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.89 127.44 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.496 -0.752 . . . . 0.0 109.564 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.426 ' C ' ' CD1' ' A' ' 62' ' ' TYR . 9.2 t80 -144.06 139.86 16.39 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -64.19 79.92 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.002 1.135 . . . . 0.0 113.379 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 64' ' ' LEU . 1.4 tm? . . . . . 0 C--N 1.304 -1.375 0 O-C-N 120.989 -1.07 . . . . 0.0 108.7 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 . . . . . 0 N--CA 1.501 2.091 0 CA-C-O 120.847 0.356 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -71.44 143.41 50.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.047 -1.033 . . . . 0.0 109.315 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -146.45 152.76 39.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.431 -0.793 . . . . 0.0 109.598 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.598 ' N ' ' CD1' ' B' ' 6' ' ' PHE . 1.5 m-85 -124.18 145.38 49.36 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 7.0 tt -130.7 125.77 34.79 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 31.1 t -107.24 137.65 44.89 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.651 -0.656 . . . . 0.0 109.264 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.2 tp -149.32 155.27 40.26 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.044 -1.035 . . . . 0.0 109.652 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.7 t -149.95 157.86 43.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.131 -0.98 . . . . 0.0 109.273 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.33 12.95 57.99 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 87.0 t -67.29 135.15 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.997 -1.296 . . . . 0.0 109.28 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 33.2 m -71.87 -45.28 61.89 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.641 -0.823 . . . . 0.0 109.809 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.39 159.47 5.68 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.099 -1.001 . . . . 0.0 109.474 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 87.5 t -92.23 129.7 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.309 -0.869 . . . . 0.0 109.747 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -86.71 -26.69 24.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.421 -0.799 . . . . 0.0 109.795 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 32.7 t -171.88 160.74 5.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -0.896 . . . . 0.0 109.05 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -148.37 108.12 4.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.816 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -132.62 131.16 22.01 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.37 -24.73 9.07 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 CA-C-N 119.991 1.032 . . . . 0.0 111.829 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -93.63 -6.53 46.24 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.337 -0.852 . . . . 0.0 110.157 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -171.86 133.2 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.228 -0.92 . . . . 0.0 109.155 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.421 HD13 HG23 ' B' ' 23' ' ' ILE . 94.0 mt -128.12 131.13 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.4 -0.813 . . . . 0.0 109.469 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 17.2 mt -111.86 125.48 54.07 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 80.8 mt -122.34 118.49 28.59 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -89.55 116.5 27.75 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.576 ' O ' ' N ' ' B' ' 29' ' ' GLN . 2.9 t -123.73 149.04 46.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 109.771 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 59.3 mt 46.95 -85.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.079 0.466 . . . . 0.0 110.028 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' B' ' 27' ' ' THR . 28.1 pt20 -143.07 -23.39 0.62 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.089 -1.007 . . . . 0.0 110.786 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.6 171.56 32.04 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 54.9 t -119.92 130.22 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.848 -0.795 . . . . 0.0 108.883 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 48.6 tp -111.23 128.04 55.8 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.78 127.69 56.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 90.4 mt -105.71 126.53 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -119.49 130.63 55.32 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.7 -147.83 6.34 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -133.59 144.25 49.18 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.344 -1.091 . . . . 0.0 109.447 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 53.34 57.02 6.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.523 -0.735 . . . . 0.0 110.584 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 9.3 mp -84.11 73.39 10.4 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.562 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.694 -178.001 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.5 2.052 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -141.13 119.46 12.18 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.22 153.85 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.334 -0.854 . . . . 0.0 108.888 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -123.66 133.21 53.94 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.456 0.646 . . . . 0.0 109.49 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.14 163.78 14.79 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.13 140.93 28.98 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.02 -1.282 . . . . 0.0 109.643 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 45.5 mm -84.31 126.17 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.322 -0.861 . . . . 0.0 109.481 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -113.53 -34.71 5.47 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -167.99 146.11 4.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.158 -0.964 . . . . 0.0 110.323 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.31 135.96 53.47 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.12 118.05 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.803 0.811 . . . . 0.0 108.97 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.524 ' O ' ' N ' ' B' ' 64' ' ' LEU . 55.8 t80 -138.66 100.98 8.11 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -46.13 84.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 121.473 1.449 . . . . 0.0 112.341 -177.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' B' ' 62' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.306 -1.288 0 O-C-N 120.884 -1.135 . . . . 0.0 108.883 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.405 HD21 ' CB ' ' A' ' 56' ' ' LEU . 8.5 p-10 . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 121.554 0.692 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.538 ' NH1' ' N ' ' A' ' 55' ' ' GLY . 7.6 mmm180 -54.08 148.33 11.14 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.322 -0.861 . . . . 0.0 109.743 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -155.16 159.09 39.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.529 -0.732 . . . . 0.0 110.167 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -99.62 148.94 23.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.629 -0.67 . . . . 0.0 109.366 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.0 tt -138.5 126.63 22.75 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.176 -0.952 . . . . 0.0 108.457 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.0 m -123.77 141.67 51.81 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.436 -0.79 . . . . 0.0 109.563 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.4 tp -150.76 145.64 25.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.386 -0.821 . . . . 0.0 109.354 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 p -137.92 172.14 13.37 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.462 -0.774 . . . . 0.0 109.09 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.62 20.85 59.19 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.91 134.84 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.028 -1.278 . . . . 0.0 110.067 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.1 m -74.71 -53.6 8.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.885 . . . . 0.0 109.841 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.14 156.19 28.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.042 -1.036 . . . . 0.0 109.835 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.1 t -88.92 129.5 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.348 -0.845 . . . . 0.0 109.841 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -97.98 -36.34 10.17 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.163 -0.961 . . . . 0.0 109.316 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.7 t -170.8 148.24 2.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.887 . . . . 0.0 108.907 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -141.49 110.78 6.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.343 -0.848 . . . . 0.0 109.142 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -133.48 144.58 52.83 Favored Pre-proline 0 N--CA 1.503 2.189 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.73 -35.67 48.62 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.027 1.152 . . . . 0.0 111.565 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -63.15 -45.09 93.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.2 -0.938 . . . . 0.0 110.0 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -156.83 156.15 32.72 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.393 -0.817 . . . . 0.0 109.089 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.5 mt -120.25 131.47 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.639 -0.663 . . . . 0.0 109.966 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.3 mt -112.93 116.62 30.27 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 mt -127.03 135.54 50.95 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.389 -0.819 . . . . 0.0 109.292 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -97.48 119.26 35.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.146 -0.971 . . . . 0.0 109.216 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.563 ' OG1' ' NE2' ' B' ' 5' ' ' GLN . 8.9 t -124.57 158.99 31.66 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.301 0.572 . . . . 0.0 110.348 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 27' ' ' THR . 44.8 mt 32.26 -86.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 CA-C-O 121.125 0.488 . . . . 0.0 111.261 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 27' ' ' THR . 24.9 pt20 -150.33 47.71 0.9 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.191 -0.943 . . . . 0.0 109.943 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -171.45 142.31 6.92 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.6 t -90.19 132.64 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.4 -1.059 . . . . 0.0 109.559 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.9 tp -106.95 125.09 50.55 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.6 t -113.05 124.46 52.66 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.6 mt -108.31 123.88 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -112.91 137.34 51.44 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.577 0.703 . . . . 0.0 109.558 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.92 -149.52 10.03 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -137.31 144.56 42.67 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.337 -1.096 . . . . 0.0 109.492 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp 56.1 59.01 3.94 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.726 0.774 . . . . 0.0 109.438 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.497 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 8.1 mp -92.23 73.86 5.39 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.572 0 C-N-CA 119.939 -1.124 . . . . 0.0 110.528 -178.355 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.98 135.46 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.472 -0.768 . . . . 0.0 109.397 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -126.49 131.7 51.57 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.455 0.645 . . . . 0.0 109.588 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -120.58 136.25 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -130.08 146.33 51.74 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.538 ' N ' ' NH1' ' A' ' 4' ' ' ARG . . . 149.1 -175.57 28.27 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.405 ' CB ' HD21 ' A' ' 3' ' ' ASN . 2.4 pp -97.06 127.42 43.01 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.058 -1.26 . . . . 0.0 109.667 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.4 mm -87.32 120.91 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.273 -0.892 . . . . 0.0 109.837 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -105.7 -12.4 15.93 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.524 -0.735 . . . . 0.0 109.592 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -174.07 156.66 2.74 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.084 -1.01 . . . . 0.0 110.259 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.9 mt -138.7 135.48 34.83 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.7 t -128.08 128.88 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.554 -0.716 . . . . 0.0 109.248 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.434 ' CE1' ' O ' ' A' ' 63' ' ' PRO . 29.9 t80 -145.03 140.09 15.8 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.434 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 90.0 Cg_endo -80.3 113.01 2.85 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.442 1.428 . . . . 0.0 112.129 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.131 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.535 0.683 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -69.37 142.45 53.94 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.372 -0.83 . . . . 0.0 109.121 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . 0.563 ' NE2' ' OG1' ' A' ' 27' ' ' THR . 76.1 mt-30 -144.63 153.11 41.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.274 -0.891 . . . . 0.0 109.857 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -114.66 129.16 56.64 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.8 tt -120.63 124.63 45.73 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.386 -0.821 . . . . 0.0 109.102 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 7.6 m -118.98 138.37 52.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.664 -0.647 . . . . 0.0 109.338 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 53.7 tp -146.64 140.87 26.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 0.0 109.23 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' B' ' 10' ' ' THR . 1.0 OUTLIER -134.22 106.34 7.09 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.79 48.35 0.03 OUTLIER Glycine 0 N--CA 1.495 2.571 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.6 p -104.49 131.54 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.542 -0.975 . . . . 0.0 109.67 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 6.3 t -71.21 -43.86 66.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.261 -0.899 . . . . 0.0 109.005 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.81 159.27 5.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.29 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 88.0 t -91.09 127.36 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.131 -0.981 . . . . 0.0 109.59 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -88.35 -23.32 23.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.253 -0.904 . . . . 0.0 109.364 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 32.9 t -172.52 159.78 4.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.322 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -146.09 104.01 3.78 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.054 -1.029 . . . . 0.0 109.73 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.74 150.76 74.34 Favored Pre-proline 0 N--CA 1.497 1.887 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.44 -9.09 22.63 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.449 1.433 . . . . 0.0 111.095 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -99.43 -16.96 18.19 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.388 -0.82 . . . . 0.0 109.437 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.41 ' OE2' ' C ' ' B' ' 23' ' ' ILE . 2.1 tm-20 -173.74 125.04 0.37 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.41 ' C ' ' OE2' ' B' ' 22' ' ' GLU . 77.9 mt -116.04 129.27 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.331 -0.855 . . . . 0.0 109.371 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 86.9 mt -105.18 125.5 51.05 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 88.2 mt -124.06 122.18 37.18 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.659 -0.651 . . . . 0.0 109.697 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -89.65 110.76 21.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.571 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.9 t -124.45 148.91 47.33 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.659 0.742 . . . . 0.0 109.842 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 6.1 mm 51.95 -80.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.839 -0.538 . . . . 0.0 110.024 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' B' ' 27' ' ' THR . 15.3 pt20 -152.1 -21.46 0.18 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.195 -0.94 . . . . 0.0 109.825 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.99 177.87 32.96 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 47.7 t -119.93 132.42 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 38.5 tp -105.86 128.01 53.48 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.411 -0.806 . . . . 0.0 109.363 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 37.0 t -114.39 120.1 39.18 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 86.2 mt -107.19 123.39 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -114.44 140.67 48.51 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.47 0.652 . . . . 0.0 109.489 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.47 -154.46 24.69 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -130.97 149.92 52.37 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.389 -1.065 . . . . 0.0 109.321 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' B' ' 54' ' ' GLU . 26.1 mmtp 61.88 48.08 5.6 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.558 0.694 . . . . 0.0 109.382 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.439 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 10.1 mp -91.85 72.89 5.71 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.242 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 121.613 0.72 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -130.46 126.39 36.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 69.6 t -116.58 136.56 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' B' ' 38' ' ' LYS . 29.6 mt-10 -123.42 144.43 49.5 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.99 177.41 23.98 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.18 144.11 26.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.093 -1.239 . . . . 0.0 109.283 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 35.5 mm -93.62 112.87 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.316 -0.865 . . . . 0.0 109.72 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -101.15 -21.55 14.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.335 -0.853 . . . . 0.0 109.249 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -167.06 152.65 7.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.744 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.99 133.06 39.08 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 53.3 t -134.95 127.07 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.547 -0.721 . . . . 0.0 110.0 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.571 ' O ' ' N ' ' B' ' 64' ' ' LEU . 16.0 t80 -141.46 122.49 8.8 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -43.87 84.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.214 1.276 . . . . 0.0 112.376 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.623 ' H ' ' CD2' ' B' ' 64' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -82.26 122.31 27.77 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -142.14 163.57 32.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.188 -0.945 . . . . 0.0 109.625 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 1.1 m-85 -111.33 134.29 53.02 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.0 tt -120.28 121.91 39.7 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.5 m -115.3 146.74 41.22 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.526 -0.734 . . . . 0.0 109.409 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 tp -152.83 149.65 28.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 109.288 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.461 ' HG1' ' N ' ' A' ' 11' ' ' GLY . 3.1 t -140.76 165.81 26.47 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.368 -0.833 . . . . 0.0 109.651 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.461 ' N ' ' HG1' ' A' ' 10' ' ' THR . . . 86.35 20.87 53.75 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -67.68 136.81 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -1.126 . . . . 0.0 110.333 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t -73.08 -41.36 64.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.379 -0.826 . . . . 0.0 109.542 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -168.89 167.56 10.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.097 -1.002 . . . . 0.0 109.655 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.1 t -98.82 99.61 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.276 -0.89 . . . . 0.0 109.871 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -65.93 -40.68 91.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 108.886 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -168.5 153.44 6.3 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -149.33 107.08 3.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 108.621 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 21' ' ' LYS . 9.2 m-20 -132.76 152.92 80.75 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.82 5.96 0.91 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.025 1.817 . . . . 0.0 111.438 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 19' ' ' ASP . 55.8 mtpt -133.25 -2.27 3.15 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.461 -0.774 . . . . 0.0 109.5 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -171.92 130.1 0.64 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.918 . . . . 0.0 108.856 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.408 HD13 HG22 ' A' ' 23' ' ' ILE . 96.7 mt -130.85 128.73 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.329 -0.857 . . . . 0.0 109.979 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.2 mt -123.25 121.25 35.42 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.8 mt -129.39 131.63 46.86 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.536 -0.728 . . . . 0.0 109.203 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -96.43 119.42 34.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.985 -1.072 . . . . 0.0 109.582 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.569 ' O ' ' N ' ' A' ' 29' ' ' GLN . 5.2 t -124.2 148.61 47.15 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.538 0.685 . . . . 0.0 110.098 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.9 mm 54.81 -79.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.783 -0.573 . . . . 0.0 109.541 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 27' ' ' THR . 13.5 pt20 -154.52 -20.61 0.12 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 0.0 110.074 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.06 177.18 32.42 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.0 t -123.0 132.84 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.779 -0.836 . . . . 0.0 109.203 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.7 tp -105.12 126.51 52.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.487 -0.758 . . . . 0.0 108.971 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.3 t -113.6 123.43 49.93 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.426 HD12 HG22 ' A' ' 34' ' ' ILE . 96.5 mt -112.95 130.2 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.73 139.0 53.9 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.3 -153.24 16.09 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -131.25 153.6 49.35 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.503 -0.998 . . . . 0.0 109.312 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt 57.81 56.54 4.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.493 -0.754 . . . . 0.0 109.82 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.448 ' N ' ' CD1' ' A' ' 39' ' ' LEU . 9.8 mp -93.0 71.91 4.68 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.713 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.114 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 . . . . . 0 N--CA 1.499 1.989 0 CA-C-O 121.206 0.526 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.2 t -127.67 135.97 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -129.79 144.36 51.26 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.298 -0.876 . . . . 0.0 109.844 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.2 t -135.93 160.0 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.632 -0.667 . . . . 0.0 109.79 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -137.79 142.35 40.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.321 -0.862 . . . . 0.0 109.319 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.24 177.23 29.22 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.77 142.48 27.42 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.434 -1.039 . . . . 0.0 108.859 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.4 mm -89.4 121.38 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.292 -0.88 . . . . 0.0 109.692 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -106.58 -29.59 9.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.457 -0.777 . . . . 0.0 109.429 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.42 147.88 10.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.006 . . . . 0.0 109.933 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -130.36 131.18 45.22 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 54.4 t -131.99 132.95 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.612 0.72 . . . . 0.0 109.638 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.467 ' O ' ' N ' ' A' ' 64' ' ' LEU . 34.2 t80 -144.47 139.33 15.49 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.98 78.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 120.844 1.03 . . . . 0.0 111.596 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.536 ' CD2' ' H ' ' A' ' 64' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.4 mmm-85 -63.12 138.65 58.62 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.22 -0.925 . . . . 0.0 108.651 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -146.35 161.17 40.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.252 -0.905 . . . . 0.0 109.491 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -108.95 136.03 49.15 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 5.7 tt -122.56 120.68 34.53 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 9.2 p -111.42 140.52 45.94 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.576 -0.702 . . . . 0.0 109.303 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.3 tp -148.21 146.49 28.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.259 -0.901 . . . . 0.0 109.505 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.9 t -146.12 117.79 8.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.449 -0.782 . . . . 0.0 109.293 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.24 22.57 0.37 Allowed Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 79.3 t -76.82 132.14 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.084 -1.245 . . . . 0.0 109.775 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -72.83 -43.18 62.98 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.128 -0.983 . . . . 0.0 109.774 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.77 157.89 22.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.961 -1.087 . . . . 0.0 110.088 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 69.6 t -93.17 127.22 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.41 -0.806 . . . . 0.0 109.153 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -96.29 -35.56 11.2 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.97 -1.081 . . . . 0.0 109.368 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 36.4 t -173.06 150.22 1.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 108.85 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -143.24 113.44 7.27 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.106 -0.996 . . . . 0.0 109.147 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -126.34 152.73 74.32 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.18 -17.06 54.04 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.669 1.579 . . . . 0.0 111.446 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -114.47 8.21 16.44 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.567 -0.708 . . . . 0.0 109.447 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -171.74 133.37 0.76 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 109.252 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.65 129.31 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.194 -0.941 . . . . 0.0 109.784 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 72.6 mt -120.88 119.19 31.94 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 87.9 mt -133.46 131.96 40.51 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.476 -0.765 . . . . 0.0 109.49 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -94.28 118.39 31.52 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.016 -1.052 . . . . 0.0 109.156 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.546 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.9 t -124.39 154.25 40.68 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.421 ' C ' ' O ' ' B' ' 27' ' ' THR . 44.3 mt 37.87 -89.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.901 -0.499 . . . . 0.0 110.456 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.546 ' N ' ' O ' ' B' ' 27' ' ' THR . 15.0 pt20 -151.6 46.2 0.79 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.004 -1.06 . . . . 0.0 109.515 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.95 132.28 2.57 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 90.4 t -84.3 131.32 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -1.09 . . . . 0.0 109.262 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 48.9 tp -104.18 125.22 50.3 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 28.7 t -112.35 120.75 42.77 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 83.7 mt -107.3 130.77 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -124.27 138.86 54.35 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.23 -147.89 8.54 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -135.99 143.27 44.72 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.226 -1.161 . . . . 0.0 109.319 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 54.9 61.2 3.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.956 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.421 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 10.5 mp -92.95 72.31 4.74 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.187 -0.946 . . . . 0.0 108.805 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.492 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.636 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -144.68 148.07 33.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.27 -0.894 . . . . 0.0 109.508 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 53.8 t -127.08 135.58 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -120.79 131.14 54.31 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.537 -0.727 . . . . 0.0 109.185 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.98 179.19 29.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.95 133.78 41.96 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.404 -1.056 . . . . 0.0 109.187 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 90.4 mt -90.15 115.3 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.053 . . . . 0.0 109.706 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -99.49 -14.95 18.86 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.4 -0.813 . . . . 0.0 109.676 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.4 152.43 8.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.977 -1.077 . . . . 0.0 110.365 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.93 134.73 40.92 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 67.5 t -130.03 123.61 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.455 -0.778 . . . . 0.0 109.05 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.444 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 44.2 t80 -146.02 136.85 12.44 Favored Pre-proline 0 N--CA 1.494 1.753 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . 0.444 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 70.9 Cg_endo -74.45 113.73 3.86 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.328 1.352 . . . . 0.0 112.001 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.64 ' CD1' ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.475 HD21 ' CB ' ' A' ' 56' ' ' LEU . 1.3 p-10 . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -77.91 144.46 36.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.725 -1.235 . . . . 0.0 108.233 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.426 ' NE2' ' CD2' ' B' ' 9' ' ' LEU . 39.7 tt0 -146.66 156.23 43.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.121 -0.987 . . . . 0.0 110.263 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -109.13 114.02 27.38 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 tt -113.28 126.47 55.44 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 t -132.1 140.28 48.77 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.0 tp -131.03 148.14 52.71 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 p -125.26 153.38 43.28 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.48 8.54 87.1 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.52 143.84 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.144 -1.209 . . . . 0.0 109.927 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.2 m -73.34 -47.51 41.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.513 -0.742 . . . . 0.0 109.982 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -172.59 172.91 4.13 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.042 -1.036 . . . . 0.0 110.483 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.7 t -101.21 103.83 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -64.1 -40.43 96.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 109.796 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.4 t -158.17 151.87 23.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.341 -0.85 . . . . 0.0 109.323 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -131.14 112.0 12.46 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.57 150.99 77.36 Favored Pre-proline 0 N--CA 1.501 2.114 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.59 -10.63 25.46 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.962 1.775 . . . . 0.0 111.615 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -129.24 11.45 5.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.598 -0.689 . . . . 0.0 109.61 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -169.3 123.2 0.8 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mm -123.2 130.14 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.188 -0.945 . . . . 0.0 109.695 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.2 mt -113.87 129.85 56.55 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.75 124.29 33.11 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.496 -0.753 . . . . 0.0 110.346 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -96.16 123.36 39.75 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' GLN . 2.6 t -125.64 154.04 42.91 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.231 0.539 . . . . 0.0 109.746 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 27' ' ' THR . 46.7 mt 29.3 -85.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-O 121.16 0.505 . . . . 0.0 111.507 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' THR . 13.1 pt20 -144.05 59.54 1.36 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.16 -0.963 . . . . 0.0 110.148 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.9 160.69 28.93 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.0 t -116.35 130.68 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.655 -0.909 . . . . 0.0 109.06 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.3 tp -110.04 126.34 53.88 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.537 -0.727 . . . . 0.0 109.148 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.8 t -110.34 123.13 49.27 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.4 HG23 HD11 ' A' ' 34' ' ' ILE . 96.2 mt -112.39 129.72 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -116.63 140.69 49.11 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.87 -153.98 12.89 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -133.75 146.71 50.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.535 -0.979 . . . . 0.0 109.338 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 55.83 54.98 7.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.72 -0.613 . . . . 0.0 110.159 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.457 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 9.0 mp -90.45 69.15 6.87 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.895 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -178.752 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.223 0.535 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.87 141.19 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.64 148.41 50.38 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.468 0.652 . . . . 0.0 110.085 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 75.4 t -136.97 136.3 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.43 128.86 47.65 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.05 -1.032 . . . . 0.0 108.379 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.67 174.84 32.04 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.475 ' CB ' HD21 ' A' ' 3' ' ' ASN . 0.2 OUTLIER -98.32 128.13 44.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.556 -0.967 . . . . 0.0 109.467 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.512 ' CD1' ' N ' ' A' ' 57' ' ' ILE . 1.7 mp -77.5 133.43 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 0.0 109.76 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -112.82 -26.11 8.72 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.88 154.01 9.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.417 -0.802 . . . . 0.0 110.034 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -131.1 130.36 43.05 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.5 t -134.56 130.95 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.733 0.777 . . . . 0.0 109.788 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.652 ' O ' ' N ' ' A' ' 64' ' ' LEU . 12.6 t80 -144.7 143.24 20.62 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -49.4 76.33 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.636 0 CA-C-N 120.405 1.18 . . . . 0.0 111.915 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.652 ' N ' ' O ' ' A' ' 62' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--N 1.297 -1.703 0 O-C-N 121.363 -0.836 . . . . 0.0 109.034 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' B' ' 3' ' ' ASN . 9.4 p-10 . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.58 HH21 ' CD ' ' B' ' 54' ' ' GLU . 10.7 mmm180 -49.66 143.63 6.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.519 -0.738 . . . . 0.0 110.031 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -149.8 162.03 41.07 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.348 0.594 . . . . 0.0 109.476 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -118.18 141.88 48.03 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.1 tt -131.07 120.26 23.15 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 5.5 m -110.73 146.09 36.91 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.426 ' CD2' ' NE2' ' A' ' 5' ' ' GLN . 5.4 tp -146.92 139.1 24.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.298 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.15 107.57 7.79 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 146.42 -5.81 1.21 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.57 142.18 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.419 -1.048 . . . . 0.0 110.066 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -72.72 -51.56 18.75 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.665 -0.647 . . . . 0.0 109.629 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.15 160.31 6.29 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.124 -0.985 . . . . 0.0 110.297 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 20.6 t -81.39 133.07 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.654 -0.654 . . . . 0.0 109.891 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -88.79 -23.78 22.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.4 -0.813 . . . . 0.0 110.121 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 30.3 t -172.42 151.52 2.5 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.101 -0.999 . . . . 0.0 109.899 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -121.93 104.64 9.68 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.628 -0.67 . . . . 0.0 109.886 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.39 139.34 31.11 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.32 -17.4 35.07 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.815 1.677 . . . . 0.0 111.97 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -95.62 -10.75 28.62 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.322 -0.861 . . . . 0.0 109.472 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -174.75 130.01 0.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.66 129.49 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 62.0 mt -110.07 123.53 49.86 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 68.6 mt -119.07 131.12 55.91 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.577 -0.702 . . . . 0.0 109.704 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -83.64 104.97 14.18 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.463 ' O ' ' O ' ' B' ' 28' ' ' ILE . 12.9 t -124.87 169.95 11.55 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.73 0.776 . . . . 0.0 110.751 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' B' ' 27' ' ' THR . 8.0 mt -33.0 154.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.344 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 65.38 -60.51 0.26 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.18 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' B' ' 27' ' ' THR . . . -166.71 -168.13 28.43 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.459 -1.353 . . . . 0.0 109.795 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 15.5 t -86.88 135.37 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.405 -1.056 . . . . 0.0 110.146 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 43.0 tp -101.05 119.99 39.55 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 11.5 m -99.6 127.27 45.69 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 86.8 mt -103.95 126.84 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -118.98 144.47 46.47 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.536 0.684 . . . . 0.0 110.075 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.89 -138.05 4.74 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -138.83 139.58 38.23 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.246 -1.149 . . . . 0.0 109.766 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 46.98 73.8 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.686 -0.634 . . . . 0.0 109.834 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.488 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 9.1 mp -91.89 71.25 5.61 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.068 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.497 1.906 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -130.26 149.6 51.88 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.45 0.643 . . . . 0.0 109.387 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.32 135.42 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.58 ' CD ' HH21 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -116.83 125.39 51.49 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . 0.535 ' N ' ' OE1' ' B' ' 54' ' ' GLU . . . 154.77 176.13 26.66 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.14 132.79 46.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.679 -0.895 . . . . 0.0 109.475 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.533 ' CD1' ' N ' ' B' ' 57' ' ' ILE . 1.5 mp -87.12 118.81 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.191 -0.943 . . . . 0.0 108.965 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . 0.444 ' OD2' ' NE2' ' A' ' 29' ' ' GLN . 2.2 t70 -112.8 -5.64 13.88 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -169.05 156.55 7.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.419 -0.801 . . . . 0.0 110.338 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.28 135.87 34.3 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 t -129.97 124.18 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.575 0.702 . . . . 0.0 109.308 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -146.29 138.16 13.36 Favored Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -70.13 104.66 1.41 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.295 1.33 . . . . 0.0 112.167 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.667 ' CD1' ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -64.0 140.06 58.83 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.389 -0.819 . . . . 0.0 108.868 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -154.25 165.44 36.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 0.0 109.881 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -106.09 144.58 32.6 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.6 tt -132.33 121.54 23.69 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -114.24 140.97 48.14 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.593 -0.692 . . . . 0.0 109.903 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.508 ' CD2' ' NE2' ' B' ' 5' ' ' GLN . 4.8 tp -144.79 145.92 31.88 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.8 p -137.23 173.1 12.05 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.371 -0.831 . . . . 0.0 110.102 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 73.51 24.78 74.16 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.5 p -72.24 130.5 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.254 -1.145 . . . . 0.0 109.817 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -73.03 -43.25 62.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.09 -1.006 . . . . 0.0 109.195 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.25 153.52 4.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 109.591 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.5 t -92.28 117.02 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.848 . . . . 0.0 109.676 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -68.05 -37.44 81.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.48 -0.763 . . . . 0.0 109.508 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.7 t -169.04 169.47 9.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.825 . . . . 0.0 109.456 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -145.62 107.18 4.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 109.217 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -130.03 122.78 20.46 Favored Pre-proline 0 N--CA 1.5 2.035 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -45.66 -30.9 6.79 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.037 1.158 . . . . 0.0 111.618 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -92.97 -6.37 48.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.28 -0.888 . . . . 0.0 109.969 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.525 ' OE2' ' NZ ' ' A' ' 35' ' ' LYS . 34.2 tt0 -163.82 128.28 2.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 109.549 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.6 mm -120.44 130.21 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.482 -0.761 . . . . 0.0 109.57 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.3 mt -117.63 130.56 56.45 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.6 mt -133.36 134.53 43.88 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.476 -0.765 . . . . 0.0 109.851 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -108.9 113.17 25.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.602 -0.686 . . . . 0.0 109.166 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 29' ' ' GLN . 2.6 t -125.24 167.38 14.95 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.411 0.624 . . . . 0.0 110.152 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.7 mm 44.95 -87.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.805 -0.56 . . . . 0.0 110.134 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 27' ' ' THR . 27.8 pt20 -158.77 19.54 0.21 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.974 -1.078 . . . . 0.0 108.837 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.02 169.82 21.96 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.3 t -110.89 130.53 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.748 -0.854 . . . . 0.0 109.267 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.1 tp -110.8 123.15 49.52 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.0 m -110.18 120.31 42.04 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.8 mt -102.9 127.27 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.525 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 68.9 mttm -118.22 138.79 52.09 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.656 0.741 . . . . 0.0 109.318 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.98 -147.15 7.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -140.7 143.73 35.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.304 -1.115 . . . . 0.0 108.864 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.7 mttp 55.86 60.27 3.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.603 -0.685 . . . . 0.0 109.904 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' A' ' 39' ' ' LEU . 10.2 mp -92.59 72.21 5.05 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.493 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -178.811 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.491 ' OE1' ' N ' ' A' ' 50' ' ' GLN . 24.0 mp0 . . . . . 0 N--CA 1.498 1.958 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.66 158.76 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.372 -0.83 . . . . 0.0 109.667 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -141.16 149.28 41.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.296 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -124.88 133.41 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -119.07 125.46 49.36 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.36 -175.52 35.48 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.11 130.87 45.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.996 . . . . 0.0 109.225 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.1 mt -86.46 117.45 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.074 -1.016 . . . . 0.0 109.161 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -96.77 -23.82 16.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.456 -0.777 . . . . 0.0 109.143 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -170.1 157.49 6.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.986 . . . . 0.0 110.522 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.4 mt -133.01 139.22 47.12 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.2 t -132.07 115.14 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.511 -0.743 . . . . 0.0 109.628 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 62' ' ' TYR . 25.1 t80 -134.34 113.71 12.3 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.52 123.7 14.37 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 CA-C-N 120.06 1.057 . . . . 0.0 111.03 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.574 ' CD1' ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.062 0 O-C-N 121.128 -0.982 . . . . 0.0 108.712 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 33.2 mmm-85 -74.08 141.35 45.7 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . 0.508 ' NE2' ' CD2' ' A' ' 9' ' ' LEU . 40.1 tt0 -141.36 147.11 37.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.305 -0.872 . . . . 0.0 109.375 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -117.23 131.55 56.82 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 tt -118.08 124.44 48.07 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 78.3 p -115.57 134.67 54.84 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.537 0.684 . . . . 0.0 109.625 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 tp -146.43 143.66 29.16 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -131.26 156.86 44.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.436 -0.79 . . . . 0.0 109.277 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.75 53.9 3.24 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -92.51 139.21 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.088 -1.242 . . . . 0.0 109.833 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -71.7 -42.38 67.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.952 . . . . 0.0 109.136 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -171.73 166.2 6.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.149 -0.969 . . . . 0.0 110.113 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 73.3 t -93.59 99.01 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.331 -0.856 . . . . 0.0 109.13 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -65.5 -40.0 92.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -0.868 . . . . 0.0 109.419 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -169.69 145.48 3.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.13 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -134.52 108.33 8.04 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.533 -0.73 . . . . 0.0 109.672 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -133.81 148.85 70.05 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.61 -12.4 31.22 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 121.706 1.604 . . . . 0.0 111.147 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -104.67 -7.84 19.31 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.522 -0.736 . . . . 0.0 109.539 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.489 ' OE2' ' NZ ' ' B' ' 35' ' ' LYS . 37.2 tt0 -173.74 140.63 0.78 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.463 -0.773 . . . . 0.0 109.158 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.2 130.1 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.383 -0.823 . . . . 0.0 110.438 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.405 ' CD2' ' OG ' ' B' ' 33' ' ' SER . 13.5 mt -122.03 125.41 46.21 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 65.4 mt -132.18 131.62 42.38 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.504 -0.748 . . . . 0.0 109.135 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -88.75 118.75 28.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.895 -1.128 . . . . 0.0 108.602 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.566 ' O ' ' N ' ' B' ' 29' ' ' GLN . 2.2 t -123.8 153.66 40.66 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.709 -0.619 . . . . 0.0 109.974 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' B' ' 27' ' ' THR . 54.8 mt 34.01 -86.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.168 0.509 . . . . 0.0 110.665 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' B' ' 27' ' ' THR . 18.9 pt20 -150.61 39.41 0.72 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.046 -1.034 . . . . 0.0 109.615 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -161.22 130.38 2.33 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 69.7 t -83.42 132.96 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.438 -1.037 . . . . 0.0 109.481 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 43.5 tp -107.48 128.54 54.59 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.405 ' OG ' ' CD2' ' B' ' 24' ' ' LEU . 25.1 m -111.16 125.49 53.84 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.3 0.572 . . . . 0.0 109.582 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 93.2 mt -106.77 129.86 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' LYS . . . . . 0.489 ' NZ ' ' OE2' ' B' ' 22' ' ' GLU . 68.4 mttm -124.72 138.3 54.3 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.467 0.651 . . . . 0.0 109.453 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.57 -146.37 11.29 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -140.51 157.45 45.48 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.281 -1.129 . . . . 0.0 109.624 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.48 57.0 5.17 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.552 0.691 . . . . 0.0 109.783 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 8.8 mp -91.7 70.62 5.75 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 C-N-CA 120.305 -0.95 . . . . 0.0 110.941 -178.544 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t . . . . . 0 N--CA 1.499 1.991 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -128.74 148.87 50.88 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 76.3 t -122.64 134.1 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -120.79 134.97 55.27 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.602 -0.686 . . . . 0.0 109.287 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.97 171.84 18.79 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.07 126.13 34.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.368 -1.078 . . . . 0.0 108.768 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.0 mt -88.56 113.08 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.078 -1.014 . . . . 0.0 109.184 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -94.26 -13.82 26.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.453 -0.78 . . . . 0.0 109.559 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -172.14 155.83 3.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.026 -1.046 . . . . 0.0 110.55 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.4 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 14.2 mt -138.62 142.77 39.11 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 54.1 t -135.72 126.91 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.415 -0.803 . . . . 0.0 109.382 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' B' ' 64' ' ' LEU . 12.0 t80 -141.07 135.89 15.6 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -42.89 82.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.69 1.593 . . . . 0.0 112.722 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' B' ' 62' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--N 1.3 -1.545 0 O-C-N 121.181 -0.95 . . . . 0.0 108.485 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 121.772 0.796 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.4 mmm-85 -81.26 139.42 35.47 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -139.74 163.33 32.89 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.02 -1.05 . . . . 0.0 110.436 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -108.73 127.07 53.68 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.301 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.2 tt -125.71 119.88 29.17 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 51' ' ' VAL . 34.9 t -129.31 151.43 49.97 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.572 0.701 . . . . 0.0 109.927 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.4 tp -142.91 155.72 44.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.429 -0.794 . . . . 0.0 109.549 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.4 p -69.21 170.24 10.53 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.732 0.777 . . . . 0.0 110.804 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -40.07 117.11 0.82 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.412 ' CG2' ' N ' ' A' ' 13' ' ' SER . 9.1 p -83.51 165.84 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.693 -0.886 . . . . 0.0 110.417 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.412 ' N ' ' CG2' ' A' ' 12' ' ' VAL . 69.7 m -72.82 -45.43 58.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.0 109.313 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.17 145.12 1.71 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.069 -1.019 . . . . 0.0 109.831 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 80.6 t -89.88 128.24 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.195 -0.941 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -86.55 -22.42 26.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.464 -0.772 . . . . 0.0 110.033 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 t -172.26 157.16 4.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.968 -1.082 . . . . 0.0 109.837 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.484 ' CD1' ' C ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -145.9 105.2 3.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 109.566 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -134.61 147.47 63.37 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.8 -13.68 34.91 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.372 2.048 . . . . 0.0 110.807 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -100.88 -4.63 27.4 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.407 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -178.81 143.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.421 HD11 HG21 ' A' ' 23' ' ' ILE . 95.6 mt -134.53 131.44 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.092 -1.005 . . . . 0.0 109.407 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.3 mt -112.08 127.97 56.06 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.4 mt -124.88 128.05 48.06 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.614 -0.679 . . . . 0.0 109.626 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -103.46 117.0 33.45 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 29' ' ' GLN . 5.5 t -124.03 150.09 45.33 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.945 0.879 . . . . 0.0 110.705 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.4 mt 47.52 -83.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.359 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.4 pt20 -144.6 -23.04 0.52 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.118 -0.989 . . . . 0.0 109.691 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.6 170.15 32.11 Favored Glycine 0 N--CA 1.498 2.816 0 O-C-N 120.912 -1.118 . . . . 0.0 111.156 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.1 t -120.04 133.5 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.769 -0.842 . . . . 0.0 109.525 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.8 tp -110.12 124.5 51.64 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.4 m -110.64 124.04 51.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.546 -0.721 . . . . 0.0 109.737 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.5 mt -107.75 131.55 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -126.81 139.49 53.07 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.673 0.749 . . . . 0.0 109.456 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.92 -155.71 25.83 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -132.06 148.34 52.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.622 -0.928 . . . . 0.0 109.118 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 61.72 54.6 2.9 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.939 0.876 . . . . 0.0 109.403 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 10.1 mp -93.2 71.94 4.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.334 -0.854 . . . . 0.0 108.836 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.622 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.643 0.735 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.42 ' O ' ' OG ' ' A' ' 8' ' ' SER . 55.6 t -120.63 136.98 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.433 0.635 . . . . 0.0 109.359 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -111.86 146.7 37.25 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.4 t -134.11 136.02 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -125.05 134.75 52.41 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.126 0.965 . . . . 0.0 109.535 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.549 ' N ' ' OE1' ' A' ' 54' ' ' GLU . . . 155.37 174.41 25.22 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.44 139.47 31.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.607 -0.937 . . . . 0.0 109.643 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.472 ' CD1' ' N ' ' A' ' 57' ' ' ILE . 1.5 mp -93.2 111.92 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 108.768 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -98.54 -22.83 15.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.588 -0.695 . . . . 0.0 109.403 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.27 149.45 11.97 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.829 -1.169 . . . . 0.0 110.705 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.407 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 67.4 mt -133.29 135.34 44.82 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 49.2 t -135.55 123.35 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.75 0.786 . . . . 0.0 109.303 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.455 ' O ' ' CD1' ' A' ' 64' ' ' LEU . 22.8 t80 -137.24 142.13 36.72 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.49 111.65 2.85 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.708 1.605 . . . . 0.0 112.432 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.589 ' CD1' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 121.497 0.665 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 34.1 mmm-85 -77.59 139.6 39.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.065 -1.022 . . . . 0.0 109.869 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -139.16 156.65 46.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.474 -0.766 . . . . 0.0 109.468 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -112.04 133.91 53.92 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 tt -118.25 125.03 49.3 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 96.2 p -112.71 145.47 40.44 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.829 0.823 . . . . 0.0 109.988 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.2 tp -156.88 156.33 32.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.515 -0.741 . . . . 0.0 109.358 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.9 t -150.44 158.5 44.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.5 -0.75 . . . . 0.0 110.138 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.68 15.21 73.85 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.0 p -54.75 149.53 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -1.188 . . . . 0.0 110.254 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 3.2 t -73.06 -44.01 61.16 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -172.5 166.59 5.64 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.131 -0.981 . . . . 0.0 110.37 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 88.2 t -96.67 99.75 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.543 -0.723 . . . . 0.0 109.145 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -65.28 -48.39 73.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.509 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 32.1 t -168.82 129.26 1.16 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.05 -1.031 . . . . 0.0 109.409 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -112.34 117.27 32.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.51 -0.744 . . . . 0.0 109.276 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.02 151.16 77.43 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.66 -13.41 29.79 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.31 2.006 . . . . 0.0 111.62 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -115.5 -0.38 13.1 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.431 -0.793 . . . . 0.0 109.197 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.83 138.91 1.86 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 109.078 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.417 HD13 HG21 ' B' ' 23' ' ' ILE . 96.7 mt -131.56 130.91 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.332 -0.855 . . . . 0.0 110.297 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 19.0 mt -122.2 123.3 41.18 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.479 0.657 . . . . 0.0 109.567 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 94.6 mt -132.41 132.6 42.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.684 -0.635 . . . . 0.0 110.121 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -89.06 121.69 31.65 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.562 ' O ' ' N ' ' B' ' 29' ' ' GLN . 6.8 t -124.89 154.89 40.39 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.479 0.657 . . . . 0.0 110.191 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.438 HG21 HD11 ' B' ' 28' ' ' ILE . 24.8 mm 30.77 -84.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.578 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' B' ' 27' ' ' THR . 26.2 pt20 -147.03 48.65 1.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.873 -1.142 . . . . 0.0 109.191 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.06 167.31 39.37 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 53.4 t -117.09 134.6 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.384 -1.068 . . . . 0.0 110.155 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 48.1 tp -106.07 125.91 51.57 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 18.4 t -111.67 127.55 55.8 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.579 0.704 . . . . 0.0 109.313 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.405 HD11 HG22 ' B' ' 34' ' ' ILE . 81.8 mt -106.84 131.28 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.372 0.606 . . . . 0.0 109.387 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -123.64 142.1 51.37 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.554 0.692 . . . . 0.0 109.463 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.38 -148.56 18.34 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -130.58 147.98 52.32 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.475 -1.015 . . . . 0.0 110.048 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt 61.07 52.11 4.17 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.807 0.813 . . . . 0.0 109.495 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.525 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 7.5 mp -91.41 72.02 6.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.874 . . . . 0.0 109.287 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . 0.421 ' O ' ' OE1' ' B' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -118.25 136.89 53.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.762 -0.586 . . . . 0.0 109.569 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 53.9 t -127.88 132.03 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' B' ' 54' ' ' GLU . 2.6 mp0 -116.17 145.69 42.89 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.854 0.835 . . . . 0.0 110.205 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.39 170.28 22.1 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.79 110.8 23.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.533 -0.98 . . . . 0.0 108.956 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.42 ' CD1' ' N ' ' B' ' 57' ' ' ILE . 2.1 mp -75.93 122.33 29.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.059 -1.026 . . . . 0.0 108.957 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -105.04 -22.38 13.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.541 -0.725 . . . . 0.0 109.131 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.22 150.82 16.86 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.75 -1.219 . . . . 0.0 110.659 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 17.2 mt -132.99 146.77 52.07 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.422 -0.799 . . . . 0.0 109.677 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 55.9 t -137.7 115.69 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.364 -0.835 . . . . 0.0 110.233 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.407 ' CG ' ' HB2' ' A' ' 60' ' ' LEU . 59.1 t80 -138.26 104.11 7.94 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -43.32 105.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.209 1.939 . . . . 0.0 112.428 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.702 ' CD1' ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.503 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.519 HD21 ' HB3' ' A' ' 56' ' ' LEU . 2.8 p-10 . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.5 mmm-85 -69.21 142.58 54.21 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.291 -0.88 . . . . 0.0 108.916 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.497 ' NE2' ' CD2' ' B' ' 9' ' ' LEU . 50.1 tt0 -145.94 150.32 35.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.0 109.674 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.527 ' CD2' ' OE1' ' A' ' 54' ' ' GLU . 77.1 m-85 -103.12 145.25 30.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.565 -0.71 . . . . 0.0 109.3 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.0 tt -140.8 124.25 16.8 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.3 t -128.98 135.36 48.87 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.28 -0.887 . . . . 0.0 108.742 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.0 tp -146.48 154.34 41.46 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.077 -1.014 . . . . 0.0 109.336 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 t -144.0 164.24 31.19 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.256 -0.903 . . . . 0.0 109.383 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.68 18.53 51.43 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.9 t -66.25 137.71 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.284 -1.127 . . . . 0.0 110.236 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 m -72.19 -42.93 65.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.549 -0.719 . . . . 0.0 109.929 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.92 160.65 10.31 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.881 -1.137 . . . . 0.0 110.343 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.6 t -93.08 129.15 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.499 -0.75 . . . . 0.0 110.222 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -100.06 -35.69 9.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.436 -0.79 . . . . 0.0 108.939 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.0 t -173.02 144.3 1.24 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 0.0 109.559 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -129.81 107.83 9.7 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -133.67 148.99 70.8 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.94 -11.71 31.13 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.839 1.693 . . . . 0.0 111.792 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -108.97 -5.63 16.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.343 -0.848 . . . . 0.0 110.149 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -172.01 127.4 0.59 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.977 -1.077 . . . . 0.0 108.936 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.47 126.83 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.259 -0.901 . . . . 0.0 109.459 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.9 mt -118.79 110.76 17.62 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.1 mt -129.81 132.56 46.54 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.256 -0.903 . . . . 0.0 109.143 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -94.12 113.58 25.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.237 -0.914 . . . . 0.0 109.899 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 28' ' ' ILE . 4.4 t -124.36 147.67 48.05 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.835 0.826 . . . . 0.0 109.615 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.457 ' C ' ' O ' ' A' ' 27' ' ' THR . 37.4 mt 21.0 -96.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.238 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.411 ' CG ' ' O ' ' B' ' 57' ' ' ILE . 77.0 mm-40 -46.62 -73.76 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.494 -0.754 . . . . 0.0 111.596 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.96 -143.83 3.78 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 119.573 -1.298 . . . . 0.0 111.473 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 t -89.31 134.97 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.65 -0.912 . . . . 0.0 111.39 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.0 tp -112.82 120.46 41.54 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.1 m -108.73 124.55 50.73 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.6 mt -112.45 130.41 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -117.47 143.72 45.76 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.578 -0.701 . . . . 0.0 109.65 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.94 -148.34 13.59 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -136.29 152.05 50.28 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.316 -1.108 . . . . 0.0 109.517 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 54' ' ' GLU . 53.5 mtmt 56.16 52.11 10.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.552 -0.718 . . . . 0.0 110.142 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.465 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 8.5 mp -92.32 72.49 5.3 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.104 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.369 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.9 t -116.15 131.86 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -118.86 130.51 55.78 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.8 t -127.34 133.89 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.501 -0.749 . . . . 0.0 109.068 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.527 ' OE1' ' CD2' ' A' ' 6' ' ' PHE . 17.3 tp10 -122.05 137.31 54.85 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 155.0 173.37 23.69 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.519 ' HB3' HD21 ' A' ' 3' ' ' ASN . 0.2 OUTLIER -96.91 140.55 31.29 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.416 -1.049 . . . . 0.0 109.599 -179.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.414 ' N ' ' CD1' ' A' ' 57' ' ' ILE . 1.7 mp -97.24 116.48 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.372 -0.83 . . . . 0.0 108.953 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -95.12 -18.97 20.5 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -171.42 151.45 3.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 0.0 109.764 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 mt -126.7 137.29 53.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.505 -0.747 . . . . 0.0 109.11 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.3 t -133.94 127.22 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.366 -0.834 . . . . 0.0 109.088 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.565 ' O ' ' N ' ' A' ' 64' ' ' LEU . 48.0 t80 -138.22 107.96 8.06 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -45.26 81.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.739 1.626 . . . . 0.0 112.479 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 O-C-N 120.371 -1.456 . . . . 0.0 108.958 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.499 HD21 ' CB ' ' B' ' 56' ' ' LEU . 6.0 p-10 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -72.41 134.39 45.38 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.212 -0.93 . . . . 0.0 109.393 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -148.89 163.44 37.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.239 -0.913 . . . . 0.0 109.769 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -104.31 148.74 26.03 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.1 tt -135.64 118.66 16.4 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 28.6 t -111.49 131.08 55.48 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.428 -0.795 . . . . 0.0 109.335 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.497 ' CD2' ' NE2' ' A' ' 5' ' ' GLN . 3.1 tp -148.85 153.86 38.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.96 -1.088 . . . . 0.0 110.059 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.609 ' HG1' ' H ' ' B' ' 11' ' ' GLY . 12.7 t -154.45 -167.03 2.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.829 . . . . 0.0 109.529 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . 0.609 ' H ' ' HG1' ' B' ' 10' ' ' THR . . . 63.59 19.52 62.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.4 145.26 13.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.283 -1.128 . . . . 0.0 110.15 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 24.1 m -71.97 -43.13 65.67 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.27 -0.893 . . . . 0.0 108.941 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . 0.56 ' CB ' ' HZ3' ' B' ' 14' ' ' LYS . 0.0 OUTLIER -171.17 159.6 5.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.349 -0.844 . . . . 0.0 109.501 179.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.15 107.33 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.162 -0.961 . . . . 0.0 109.935 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -66.14 -40.57 90.71 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.239 -0.913 . . . . 0.0 109.067 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.445 ' HG ' ' N ' ' B' ' 18' ' ' PHE . 23.1 t -172.26 162.42 5.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.09 -1.006 . . . . 0.0 109.147 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . 0.445 ' N ' ' HG ' ' B' ' 17' ' ' SER . 3.7 t80 -140.25 110.41 6.57 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.327 -0.858 . . . . 0.0 109.76 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.97 148.01 67.72 Favored Pre-proline 0 N--CA 1.495 1.779 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.67 -9.81 27.07 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.851 1.701 . . . . 0.0 111.996 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -118.19 7.52 12.14 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.547 -0.721 . . . . 0.0 109.776 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -171.05 132.45 0.84 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.932 . . . . 0.0 109.194 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 47.0 mm -121.75 125.88 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.475 -0.765 . . . . 0.0 109.279 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 74.5 mt -119.89 113.14 20.12 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -131.64 140.31 49.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.329 -0.857 . . . . 0.0 109.303 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -107.63 117.77 34.98 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.569 ' O ' ' N ' ' B' ' 29' ' ' GLN . 3.7 t -125.01 153.01 43.48 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.417 0.627 . . . . 0.0 110.041 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.401 HD12 HG21 ' B' ' 28' ' ' ILE . 5.4 mm 53.39 -78.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.872 -0.518 . . . . 0.0 110.193 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' B' ' 27' ' ' THR . 22.0 pt20 -169.5 52.4 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -171.53 140.08 5.69 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 92.4 t -84.27 132.48 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.378 -1.072 . . . . 0.0 109.515 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 47.6 tp -111.26 123.12 49.56 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 24.0 m -109.87 119.63 39.96 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.325 -0.859 . . . . 0.0 109.076 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 95.9 mt -109.91 129.31 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -117.86 137.46 52.76 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.92 -152.72 10.4 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -134.22 145.37 49.11 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.307 -1.114 . . . . 0.0 109.608 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' B' ' 54' ' ' GLU . 72.4 mmtt 59.43 52.02 6.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.568 -0.707 . . . . 0.0 110.058 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.445 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 10.4 mp -88.45 72.04 8.91 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.952 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -178.547 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -122.04 147.35 46.2 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -126.69 135.33 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' B' ' 38' ' ' LYS . 47.7 tt0 -119.2 133.03 55.99 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.86 -178.69 34.04 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.499 ' CB ' HD21 ' B' ' 3' ' ' ASN . 0.2 OUTLIER -103.03 126.43 50.2 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.451 -1.029 . . . . 0.0 109.806 -179.625 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.528 ' CD1' ' N ' ' B' ' 57' ' ' ILE . 1.4 mp -76.9 126.1 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.962 . . . . 0.0 109.198 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -104.95 -23.28 13.0 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -169.26 153.28 5.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.055 -1.028 . . . . 0.0 110.019 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.19 134.16 46.22 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 4.1 t -135.43 124.72 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.786 -0.571 . . . . 0.0 110.033 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.463 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 17.9 t80 -144.19 140.32 16.77 Favored Pre-proline 0 N--CA 1.493 1.712 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . 0.463 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 72.6 Cg_endo -74.46 108.48 2.7 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.538 1.492 . . . . 0.0 112.082 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.678 ' CD1' ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.535 -0.728 . . . . 0.0 109.164 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 41.5 mmm-85 -60.48 141.29 56.65 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.327 -0.858 . . . . 0.0 108.785 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -152.19 161.93 41.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.125 -0.984 . . . . 0.0 109.917 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 1.2 m-85 -117.89 139.62 50.87 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.2 tt -115.8 126.06 53.52 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.393 -0.817 . . . . 0.0 108.996 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.4 t -115.25 126.75 54.9 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.4 tp -144.63 151.77 39.5 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 t -143.15 166.84 23.56 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.278 -0.889 . . . . 0.0 109.631 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.4 10.95 67.33 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -69.97 145.23 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -1.219 . . . . 0.0 110.028 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 m -73.87 -51.97 14.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.361 -0.837 . . . . 0.0 109.529 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.591 ' HZ1' ' CB ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -167.37 158.69 11.88 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.067 -1.021 . . . . 0.0 109.619 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.7 t -89.27 116.01 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.268 -0.895 . . . . 0.0 109.403 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -69.19 -40.89 77.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 109.7 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.1 t -161.83 125.28 3.14 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.369 -0.832 . . . . 0.0 109.844 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -109.25 110.19 21.32 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -133.61 148.05 67.07 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.16 -20.1 50.14 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.715 1.61 . . . . 0.0 111.604 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -100.14 -5.44 27.79 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.341 -0.849 . . . . 0.0 109.671 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.547 ' OE2' ' NZ ' ' A' ' 35' ' ' LYS . 36.2 tt0 -171.32 142.91 1.77 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.208 -0.932 . . . . 0.0 109.603 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.8 mt -131.2 130.04 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.715 -0.616 . . . . 0.0 109.497 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.8 mt -117.28 125.75 51.61 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.3 mt -121.1 130.09 53.59 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.591 -0.693 . . . . 0.0 109.647 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -97.68 103.54 15.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.357 -0.839 . . . . 0.0 110.011 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 28' ' ' ILE . 6.6 t -127.18 -172.47 2.66 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.951 0.882 . . . . 0.0 110.562 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' THR . 4.2 mt -31.84 154.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.924 0.868 . . . . 0.0 111.244 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 64.49 -56.17 0.26 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.646 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -173.4 -129.48 1.16 Allowed Glycine 0 N--CA 1.487 2.059 0 C-N-CA 119.234 -1.46 . . . . 0.0 109.944 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 52.7 t -120.72 136.14 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.778 0.799 . . . . 0.0 110.862 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.9 tp -104.61 126.85 52.09 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -100.8 125.51 47.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.632 -0.668 . . . . 0.0 109.512 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.3 mt -111.3 128.54 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-O 121.294 0.569 . . . . 0.0 109.513 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.547 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 68.5 mttm -128.27 144.24 51.11 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.453 0.644 . . . . 0.0 109.629 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.9 -137.69 4.31 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -132.57 153.3 51.13 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.193 -1.181 . . . . 0.0 110.232 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 54' ' ' GLU . 98.9 mttt 49.72 40.64 20.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.619 -0.676 . . . . 0.0 110.135 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.3 mp -68.51 72.23 0.21 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 0.0 109.244 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.676 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.869 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.6 t -131.44 161.16 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.56 -0.712 . . . . 0.0 109.231 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -132.83 160.03 38.1 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.529 0.681 . . . . 0.0 109.673 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 t -128.84 157.82 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 38' ' ' LYS . 32.1 tt0 -135.37 134.56 39.89 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.6 172.14 13.18 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 pp -97.46 134.94 40.03 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.438 -1.037 . . . . 0.0 109.169 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 57' ' ' ILE . 1.3 mp -84.95 113.69 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.845 -1.16 . . . . 0.0 108.664 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -98.74 -22.19 16.0 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -159.47 148.57 18.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.315 -0.866 . . . . 0.0 110.298 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.463 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 51.5 mt -133.97 146.36 50.38 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.5 t -146.53 114.83 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.059 -1.025 . . . . 0.0 109.869 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.532 ' O ' ' N ' ' A' ' 64' ' ' LEU . 13.8 t80 -130.28 142.52 45.73 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.87 85.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.34 1.36 . . . . 0.0 111.916 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 62' ' ' TYR . 2.1 tt . . . . . 0 N--CA 1.492 1.653 0 O-C-N 120.817 -1.177 . . . . 0.0 108.525 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.465 HD21 ' CB ' ' B' ' 56' ' ' LEU . 2.7 p-10 . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 43.5 mmm-85 -89.39 131.46 35.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.964 -1.085 . . . . 0.0 109.128 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -144.52 159.01 43.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.288 -0.882 . . . . 0.0 109.903 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.9 115.17 29.65 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 7.6 tt -113.8 126.77 55.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.407 -0.808 . . . . 0.0 109.061 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 40.7 t -132.47 143.76 50.0 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 52.0 tp -133.64 150.09 51.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.527 -0.733 . . . . 0.0 109.154 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.6 p -129.3 171.12 12.8 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.704 -0.623 . . . . 0.0 109.35 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.52 5.46 63.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.04 135.32 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.339 -1.095 . . . . 0.0 109.695 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.3 t -72.56 -46.12 55.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 109.55 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.03 160.78 5.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.179 -0.95 . . . . 0.0 109.55 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 90.4 t -93.6 121.27 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.189 -0.944 . . . . 0.0 109.218 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -66.7 -40.03 88.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 109.545 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 47.7 t -162.43 149.77 13.75 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.43 -0.794 . . . . 0.0 108.889 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -136.24 117.85 14.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.377 -0.827 . . . . 0.0 109.491 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -132.45 150.81 76.94 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.06 -13.81 41.19 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.502 1.468 . . . . 0.0 111.07 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -118.2 3.12 12.01 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.749 -0.594 . . . . 0.0 109.603 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -170.03 134.43 1.27 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.269 -0.894 . . . . 0.0 109.409 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.414 HD13 HG22 ' B' ' 23' ' ' ILE . 96.2 mt -132.24 129.54 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.279 -0.888 . . . . 0.0 109.46 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 74.8 mt -112.34 125.64 54.41 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 87.1 mt -113.21 132.44 55.5 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.53 -0.731 . . . . 0.0 110.121 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -104.66 101.12 10.77 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.567 ' O ' ' N ' ' B' ' 29' ' ' GLN . 0.0 OUTLIER -108.73 148.86 29.84 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.822 -0.549 . . . . 0.0 110.447 -178.353 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' B' ' 27' ' ' THR . 39.9 mt 34.2 -86.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 122.151 -0.343 . . . . 0.0 110.83 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.567 ' N ' ' O ' ' B' ' 27' ' ' THR . 18.5 pt20 -137.49 -16.05 1.38 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.382 -0.824 . . . . 0.0 109.738 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.32 167.85 29.21 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 54.6 t -123.1 131.51 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 43.5 tp -110.76 126.18 54.32 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 19.1 t -106.69 122.8 47.08 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 94.9 mt -105.73 129.29 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -124.13 141.39 52.09 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.628 -0.67 . . . . 0.0 109.379 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.23 -153.42 22.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -121.45 150.85 40.95 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.571 -0.958 . . . . 0.0 109.847 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' B' ' 54' ' ' GLU . 95.3 mttt 51.93 61.68 3.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -0.8 . . . . 0.0 110.124 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 9.2 mp -93.05 71.56 4.63 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.764 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -179.11 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 121.563 0.696 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -122.1 149.78 43.1 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 10.2 t -141.45 138.22 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.163 -0.961 . . . . 0.0 109.545 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' B' ' 38' ' ' LYS . 16.0 tt0 -127.62 137.59 52.59 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.61 178.36 26.29 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.465 ' CB ' HD21 ' B' ' 3' ' ' ASN . 0.2 OUTLIER -99.82 124.46 45.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.572 -0.958 . . . . 0.0 108.929 179.312 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.522 ' CD1' ' N ' ' B' ' 57' ' ' ILE . 1.5 mp -82.82 119.25 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.181 -0.949 . . . . 0.0 108.895 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -95.26 -21.46 18.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.386 -0.821 . . . . 0.0 109.488 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -170.29 153.5 4.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.117 -0.989 . . . . 0.0 109.8 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 96.2 mt -134.04 136.58 44.11 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 56.7 t -132.64 124.81 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.554 -0.716 . . . . 0.0 109.459 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.463 ' CG ' ' HB2' ' A' ' 60' ' ' LEU . 19.4 t80 -133.01 139.71 35.3 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . 0.477 ' O ' ' C ' ' B' ' 64' ' ' LEU . 71.6 Cg_exo -44.5 -65.49 0.19 Allowed 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 122.026 1.818 . . . . 0.0 115.294 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' B' ' 63' ' ' PRO . 2.0 tm? . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.622 0.725 . . . . 0.0 111.002 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.343 0.592 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.431 ' NE ' ' OE2' ' A' ' 54' ' ' GLU . 40.1 mmm-85 -71.23 147.89 47.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 109.126 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -141.37 156.86 45.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.187 -0.945 . . . . 0.0 109.996 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.51 ' CE1' ' OE1' ' A' ' 54' ' ' GLU . 69.6 m-85 -107.21 125.74 51.51 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 tt -117.92 124.97 49.56 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 t -115.94 135.1 54.3 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.639 -0.663 . . . . 0.0 109.633 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.4 tp -145.4 148.95 33.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.442 -0.786 . . . . 0.0 109.565 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.476 ' HG1' ' N ' ' A' ' 11' ' ' GLY . 2.4 p -142.76 -163.14 1.56 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.81 . . . . 0.0 109.717 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.476 ' N ' ' HG1' ' A' ' 10' ' ' THR . . . 53.62 17.97 7.2 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.65 141.72 16.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.165 -1.197 . . . . 0.0 109.939 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.2 m -71.43 -45.16 63.39 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.53 154.68 0.8 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.186 -0.946 . . . . 0.0 110.384 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.0 t -77.2 132.32 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.544 -0.722 . . . . 0.0 110.382 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -98.5 -34.66 10.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.49 -0.756 . . . . 0.0 108.968 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 p -161.54 163.28 30.27 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.016 -1.053 . . . . 0.0 109.683 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -148.96 104.77 3.47 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -133.85 125.85 18.5 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -47.14 -22.51 2.29 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.857 1.705 . . . . 0.0 111.868 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -94.25 -9.01 37.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.578 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -174.32 143.28 0.85 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 109.315 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.1 mt -128.38 131.35 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.353 -0.842 . . . . 0.0 109.007 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.1 mt -116.69 115.71 26.18 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.2 mt -117.79 130.43 56.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.569 -0.707 . . . . 0.0 109.637 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.07 103.16 11.5 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 28' ' ' ILE . 7.0 t -124.28 -177.96 3.95 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.586 0.708 . . . . 0.0 110.132 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 27' ' ' THR . 3.8 mt -31.91 153.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.765 0.793 . . . . 0.0 110.847 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 64.05 -63.26 0.15 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.504 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -161.85 -123.18 0.65 Allowed Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.191 -1.48 . . . . 0.0 110.014 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.8 t -120.58 135.88 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.668 -0.901 . . . . 0.0 109.727 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.7 tp -100.27 125.23 46.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.603 -0.685 . . . . 0.0 109.205 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.1 m -104.47 121.57 43.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 0.0 108.94 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.9 mt -110.73 127.42 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -117.48 147.96 42.27 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.453 0.644 . . . . 0.0 110.1 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.95 -149.65 12.14 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -136.38 145.92 45.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.346 -1.09 . . . . 0.0 109.472 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 54.99 57.65 5.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.545 -0.722 . . . . 0.0 110.092 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 8.6 mp -89.65 71.73 7.8 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.132 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.038 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.2 t -126.94 134.66 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.574 -0.704 . . . . 0.0 109.261 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -118.41 153.01 34.79 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.716 -0.615 . . . . 0.0 109.624 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.7 t -124.66 135.56 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.51 ' OE1' ' CE1' ' A' ' 6' ' ' PHE . 16.4 tp10 -113.38 127.12 56.02 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.56 169.06 21.58 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.408 HD21 ' H ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -90.91 140.8 29.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.415 -1.05 . . . . 0.0 109.744 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.412 HD13 HG23 ' A' ' 57' ' ' ILE . 92.9 mt -93.82 115.17 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.991 -1.068 . . . . 0.0 109.714 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -98.64 -24.21 15.17 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.82 151.81 18.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.903 -1.123 . . . . 0.0 111.091 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.1 131.7 45.84 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 54.9 t -129.75 128.88 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.682 0.753 . . . . 0.0 109.588 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 64' ' ' LEU . 12.0 t80 -144.9 142.13 18.27 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -49.08 78.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.589 1.526 . . . . 0.0 111.968 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 62' ' ' TYR . 0.6 OUTLIER . . . . . 0 C--N 1.302 -1.472 0 O-C-N 121.38 -0.825 . . . . 0.0 109.193 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -85.31 138.54 32.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.087 -1.008 . . . . 0.0 109.458 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -141.8 153.22 44.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 109.898 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -108.12 119.23 38.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.4 tt -108.09 121.67 45.3 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 8.2 p -114.78 137.25 52.17 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.354 0.597 . . . . 0.0 109.995 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.8 tp -149.3 148.31 29.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.546 -0.721 . . . . 0.0 109.306 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -142.42 164.59 29.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.274 -0.891 . . . . 0.0 110.256 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.98 21.02 58.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 p -59.5 142.29 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.117 -1.225 . . . . 0.0 110.432 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 15.1 m -72.86 -39.99 66.04 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -172.26 163.91 5.83 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.12 -0.988 . . . . 0.0 110.01 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 85.7 t -96.84 99.8 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.425 -0.797 . . . . 0.0 109.555 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -65.53 -39.22 91.52 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.313 -0.867 . . . . 0.0 109.128 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 47.0 t -172.67 152.33 2.52 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.27 -0.893 . . . . 0.0 109.318 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -133.81 107.98 8.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.557 -0.714 . . . . 0.0 109.259 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.93 145.79 57.32 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.6 -19.13 42.58 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.973 1.782 . . . . 0.0 111.426 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -98.52 -7.0 29.1 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.515 ' OE2' ' NZ ' ' B' ' 35' ' ' LYS . 29.9 tt0 -173.38 131.98 0.47 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.368 -0.833 . . . . 0.0 109.352 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.72 128.69 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.447 -0.783 . . . . 0.0 109.28 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 62.9 mt -118.45 121.88 41.38 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 88.8 mt -132.28 130.58 41.07 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -93.62 127.86 39.51 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.211 -0.931 . . . . 0.0 109.101 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.59 ' O ' ' N ' ' B' ' 29' ' ' GLN . 5.4 t -124.39 149.05 47.13 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.373 0.606 . . . . 0.0 109.47 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.4 HG21 HD11 ' B' ' 28' ' ' ILE . 5.9 mm 48.05 -81.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.049 0.452 . . . . 0.0 110.321 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' B' ' 27' ' ' THR . 11.4 pt20 -149.03 -21.21 0.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.052 -1.03 . . . . 0.0 109.359 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.67 165.14 25.7 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 120.987 -1.071 . . . . 0.0 110.509 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.63 130.6 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.609 -0.936 . . . . 0.0 109.488 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 50.9 tp -106.98 126.04 51.8 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 71.0 m -111.27 117.31 32.8 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.413 HD11 HG22 ' B' ' 34' ' ' ILE . 89.6 mt -100.77 128.04 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' LYS . . . . . 0.515 ' NZ ' ' OE2' ' B' ' 22' ' ' GLU . 67.3 mttm -124.68 136.82 54.23 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.51 -149.01 9.79 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -133.83 148.63 51.33 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.513 -0.992 . . . . 0.0 109.813 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 56.23 57.96 4.63 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.732 0.777 . . . . 0.0 109.747 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 9.9 mp -91.34 72.03 6.12 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.386 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.72 159.88 40.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.658 -0.652 . . . . 0.0 109.381 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 99.3 t -127.73 138.25 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -117.96 138.47 52.15 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.17 -179.49 30.33 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.58 124.45 43.36 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.399 -1.059 . . . . 0.0 109.793 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.52 ' CD1' ' N ' ' B' ' 57' ' ' ILE . 1.3 mp -77.83 126.41 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.488 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -109.38 -19.14 13.38 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.15 152.25 9.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.927 -1.108 . . . . 0.0 110.305 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.19 129.56 35.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.569 -0.707 . . . . 0.0 109.176 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.0 t -126.59 128.41 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.416 ' O ' ' N ' ' B' ' 64' ' ' LEU . 45.4 t80 -144.02 101.47 4.9 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -46.62 89.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.111 1.874 . . . . 0.0 112.582 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.613 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.4 0 O-C-N 121.311 -0.868 . . . . 0.0 109.292 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.829 0.823 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -71.4 138.62 49.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.172 -0.955 . . . . 0.0 109.911 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -146.27 154.99 42.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.293 -0.88 . . . . 0.0 110.005 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 8.1 m-85 -110.75 121.1 44.5 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.9 tt -114.08 124.58 52.46 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.509 -0.744 . . . . 0.0 109.223 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.8 p -125.41 149.56 48.07 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.778 0.799 . . . . 0.0 109.558 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.6 tp -147.8 144.45 28.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.45 -0.781 . . . . 0.0 109.511 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -125.99 164.38 20.94 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.714 0.768 . . . . 0.0 110.169 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.54 17.04 71.94 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.34 134.78 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -1.168 . . . . 0.0 110.438 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -72.68 -45.08 60.69 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.543 -0.723 . . . . 0.0 109.074 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.12 160.46 4.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.445 -0.785 . . . . 0.0 109.976 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.8 t -91.62 110.93 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.578 0.704 . . . . 0.0 109.873 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -68.55 -38.32 80.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.45 -0.781 . . . . 0.0 109.595 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.2 t -162.61 156.17 20.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.876 -1.14 . . . . 0.0 110.383 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -141.66 105.57 4.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.98 147.74 66.61 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.74 -18.0 42.16 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.447 2.098 . . . . 0.0 111.274 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -102.16 -9.12 20.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.43 -0.794 . . . . 0.0 109.344 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -171.83 133.68 0.76 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.212 -0.93 . . . . 0.0 109.704 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.1 mt -126.45 130.07 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.428 -0.795 . . . . 0.0 110.135 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.0 mt -116.27 125.89 52.82 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.7 mt -121.15 130.42 53.71 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.715 0.769 . . . . 0.0 109.466 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -98.01 113.69 25.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.6 -0.688 . . . . 0.0 109.556 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.549 ' O ' ' N ' ' A' ' 29' ' ' GLN . 9.0 t -124.65 157.6 35.14 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.941 0.877 . . . . 0.0 110.097 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.6 mm 38.2 -85.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.287 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.549 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.8 pp0? -142.62 -17.02 0.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.95 -1.094 . . . . 0.0 108.873 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.06 175.24 24.91 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.1 t -125.6 133.45 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.781 -0.835 . . . . 0.0 109.602 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.1 tp -102.76 128.31 49.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.621 -0.675 . . . . 0.0 109.51 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -112.85 126.79 55.83 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.823 0.82 . . . . 0.0 110.166 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.6 mt -108.98 130.25 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -124.84 140.49 52.88 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.575 0.703 . . . . 0.0 109.446 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.06 -145.75 9.42 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -134.53 144.52 48.06 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.463 -1.021 . . . . 0.0 109.362 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.8 mttp 55.48 61.22 2.95 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.834 0.826 . . . . 0.0 109.695 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.441 ' N ' ' CD1' ' A' ' 39' ' ' LEU . 10.5 mp -92.56 71.64 5.05 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.912 0.863 . . . . 0.0 109.062 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.221 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.1 m -117.0 158.37 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.618 0.723 . . . . 0.0 109.848 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -141.52 140.11 33.4 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.9 t -125.81 134.89 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.591 -0.693 . . . . 0.0 109.423 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -117.18 125.88 51.89 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.04 174.6 30.03 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.164 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.35 128.76 37.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.667 -0.902 . . . . 0.0 110.092 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.473 ' N ' ' CD1' ' A' ' 57' ' ' ILE . 1.4 mp -78.74 125.96 38.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.435 -0.791 . . . . 0.0 109.126 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -112.19 -29.97 7.38 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.38 137.84 3.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.028 -1.045 . . . . 0.0 110.812 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.14 135.51 53.7 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.78 129.48 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.867 0.841 . . . . 0.0 110.075 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -145.47 137.84 13.51 Favored Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.02 108.42 2.12 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.788 1.658 . . . . 0.0 112.543 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.638 ' CD1' ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.245 -0.909 . . . . 0.0 109.095 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' B' ' 4' ' ' ARG . 52.8 p-10 . . . . . 0 N--CA 1.5 2.037 0 CA-C-O 121.549 0.69 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.543 ' N ' ' OD1' ' B' ' 3' ' ' ASN . 45.0 mmm-85 -50.46 136.78 20.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.192 -0.942 . . . . 0.0 110.682 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -146.37 155.81 42.87 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.335 -0.853 . . . . 0.0 109.551 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' B' ' 6' ' ' PHE . 30.3 m-85 -115.04 121.64 43.71 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.4 tt -118.43 122.79 43.63 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 29.8 t -119.01 134.76 55.0 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.511 0.672 . . . . 0.0 109.825 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 48.9 tp -131.61 144.91 51.4 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.8 p -128.09 164.0 23.39 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.701 0.762 . . . . 0.0 110.26 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.33 20.06 61.19 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 p -67.39 135.71 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.187 -1.184 . . . . 0.0 110.01 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 56.2 m -72.45 -43.65 63.47 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.421 -0.8 . . . . 0.0 109.25 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.98 162.28 3.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.385 -0.822 . . . . 0.0 110.278 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.2 t -89.98 111.24 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.519 0.676 . . . . 0.0 110.066 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -67.2 -38.91 86.13 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.881 0.848 . . . . 0.0 108.791 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 30.1 t -168.89 166.37 11.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 0.0 109.655 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -145.48 104.7 3.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.37 -0.831 . . . . 0.0 109.513 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' B' ' 22' ' ' GLU . 13.7 m-20 -133.92 125.94 18.48 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.62 -26.27 16.63 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.824 1.683 . . . . 0.0 111.503 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -88.59 -5.05 58.42 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.708 0.766 . . . . 0.0 109.379 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' B' ' 19' ' ' ASP . 32.9 tt0 -176.35 132.99 0.23 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.517 -0.74 . . . . 0.0 109.399 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 93.5 mt -123.09 128.1 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.45 -0.781 . . . . 0.0 109.481 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 mt -117.84 129.07 55.44 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.361 0.601 . . . . 0.0 109.463 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 86.3 mt -131.03 131.87 44.58 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.665 0.745 . . . . 0.0 109.873 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -95.4 114.46 26.24 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.616 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.3 t -125.53 153.77 43.13 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.439 0.638 . . . . 0.0 110.114 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.428 HD11 HG21 ' B' ' 28' ' ' ILE . 14.0 mm 46.3 -78.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-O 121.558 0.694 . . . . 0.0 110.91 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.616 ' N ' ' O ' ' B' ' 27' ' ' THR . 13.3 pt20 -151.89 -22.84 0.19 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.161 -0.962 . . . . 0.0 109.118 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.94 176.17 29.29 Favored Glycine 0 N--CA 1.5 2.944 0 O-C-N 120.993 -1.067 . . . . 0.0 110.624 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 56.0 t -121.13 134.65 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.6 -0.941 . . . . 0.0 109.442 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 51.2 tp -104.88 128.27 53.03 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.473 0.654 . . . . 0.0 109.655 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 46.4 t -112.26 121.27 44.42 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 93.9 mt -106.05 130.95 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.551 0.691 . . . . 0.0 110.202 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -127.71 141.21 51.66 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.83 -141.47 4.7 Favored Glycine 0 N--CA 1.485 1.928 0 C-N-CA 119.655 -1.26 . . . . 0.0 110.235 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -129.42 135.62 48.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.708 -0.878 . . . . 0.0 109.544 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? 43.23 80.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.91 0.862 . . . . 0.0 110.08 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 8.7 mp -95.06 71.59 3.35 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.073 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -179.156 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 121.682 0.753 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -127.15 129.3 47.61 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.27 136.43 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.648 -0.657 . . . . 0.0 109.25 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -121.06 134.5 55.27 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.713 0.768 . . . . 0.0 109.373 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.55 -179.82 29.57 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.52 126.87 43.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.667 -0.902 . . . . 0.0 109.52 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.498 ' N ' ' CD1' ' B' ' 57' ' ' ILE . 1.4 mp -83.78 121.65 36.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.418 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -106.95 -19.24 13.69 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.14 150.03 14.5 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.647 -1.283 . . . . 0.0 110.984 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.11 139.36 41.19 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.372 0.606 . . . . 0.0 109.386 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 54.7 t -141.03 131.61 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.454 -0.779 . . . . 0.0 110.198 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.505 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 11.9 t80 -145.73 140.16 15.47 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . 0.505 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 68.4 Cg_endo -76.06 108.82 2.76 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.282 1.988 . . . . 0.0 112.336 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.538 ' CD1' ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.961 0 O-C-N 121.364 -0.835 . . . . 0.0 109.157 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 121.305 0.574 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.7 mmm-85 -53.67 140.41 29.34 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.268 -0.895 . . . . 0.0 109.46 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -146.97 160.82 41.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.32 -0.862 . . . . 0.0 109.534 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -111.35 131.89 54.83 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.0 tt -118.2 139.83 50.71 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 m -121.79 146.69 46.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.509 -0.745 . . . . 0.0 109.262 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tp -156.1 149.0 24.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.113 -0.992 . . . . 0.0 109.868 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.3 163.76 34.51 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.582 -0.699 . . . . 0.0 109.562 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.14 18.96 56.77 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.14 140.22 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.171 -1.194 . . . . 0.0 109.798 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 t -73.44 -51.79 15.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.118 -0.989 . . . . 0.0 109.585 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -155.87 160.42 40.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.026 -1.046 . . . . 0.0 109.917 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.4 t -92.54 102.33 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -65.82 -39.22 90.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 109.445 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -167.74 164.36 14.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.156 -0.965 . . . . 0.0 109.513 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -147.06 108.07 4.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.186 -0.946 . . . . 0.0 108.863 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -132.26 146.97 63.89 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.91 -18.37 46.75 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 121.814 1.676 . . . . 0.0 111.367 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -100.12 -3.58 31.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.408 -0.808 . . . . 0.0 109.502 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.457 ' OE1' ' NZ ' ' A' ' 35' ' ' LYS . 29.8 tt0 -174.29 151.03 1.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.222 -0.924 . . . . 0.0 109.441 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.431 HG23 HD12 ' A' ' 23' ' ' ILE . 95.7 mt -133.98 129.76 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.27 -0.894 . . . . 0.0 109.733 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.0 mt -117.8 120.55 38.26 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.8 mt -134.09 133.23 40.88 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.25 -0.906 . . . . 0.0 109.413 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -102.53 118.56 37.11 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.244 -0.91 . . . . 0.0 108.974 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 29' ' ' GLN . 5.0 t -125.15 153.69 42.66 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.681 0.753 . . . . 0.0 110.143 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 28' ' ' ILE . 10.0 mm 53.8 -82.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.635 -0.665 . . . . 0.0 109.879 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' THR . 20.9 pt20 -164.04 51.05 0.14 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.976 -1.078 . . . . 0.0 109.748 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -171.43 155.12 23.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.2 t -95.99 130.38 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.329 -1.101 . . . . 0.0 109.942 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.4 tp -107.2 121.71 45.06 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.9 t -107.71 118.06 35.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.3 mt -103.89 127.14 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.457 ' NZ ' ' OE1' ' A' ' 22' ' ' GLU . 68.7 mttm -121.43 129.54 53.06 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.553 0.692 . . . . 0.0 109.153 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.67 -141.42 3.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -144.53 151.67 39.45 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.989 -1.301 . . . . 0.0 110.168 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 54' ' ' GLU . 45.6 mmtm 56.65 43.53 25.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.574 -0.704 . . . . 0.0 109.726 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 9.7 mp -73.77 71.99 1.5 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.706 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.093 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.65 159.7 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.294 -0.879 . . . . 0.0 109.193 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.15 146.35 42.67 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.8 t -123.07 135.24 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 38' ' ' LYS . 19.8 pt-20 -116.38 132.09 56.77 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.31 173.34 25.61 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 pp -96.84 124.51 40.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.252 -1.146 . . . . 0.0 109.745 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.7 mt -79.67 129.03 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.238 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -118.72 -27.63 5.81 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.77 146.88 25.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.025 -1.047 . . . . 0.0 110.532 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.93 134.1 42.2 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.5 t -130.68 123.29 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.243 -0.91 . . . . 0.0 109.937 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.41 ' CE1' ' O ' ' A' ' 63' ' ' PRO . 46.4 t80 -146.66 138.01 13.05 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.41 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 61.6 Cg_endo -75.03 116.41 4.57 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.454 1.436 . . . . 0.0 111.442 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.648 ' H ' ' CD1' ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.196 -0.94 . . . . 0.0 108.473 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' B' ' 3' ' ' ASN . 7.2 p-10 . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -80.36 140.33 36.12 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.364 -0.835 . . . . 0.0 109.319 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -152.02 161.77 42.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 109.38 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' B' ' 6' ' ' PHE . 23.6 m-85 -104.2 146.03 29.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.628 -0.67 . . . . 0.0 109.412 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.2 tt -132.66 122.27 24.41 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 80.0 p -114.71 144.75 42.96 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.35 -0.844 . . . . 0.0 109.835 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.9 tp -150.67 150.72 31.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.295 -0.878 . . . . 0.0 109.323 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.6 160.76 41.76 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.476 -0.765 . . . . 0.0 109.472 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.37 14.3 60.36 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.31 135.11 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.235 -1.156 . . . . 0.0 109.689 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t -73.15 -43.41 61.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 109.857 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.56 165.03 10.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.941 -1.099 . . . . 0.0 109.798 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 71.4 t -98.31 129.68 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.22 -0.925 . . . . 0.0 109.917 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -83.57 -29.03 28.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 109.272 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 34.7 t -172.01 168.7 5.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.254 -0.904 . . . . 0.0 109.032 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -150.41 107.63 3.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.137 -0.977 . . . . 0.0 109.771 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -132.12 149.61 73.73 Favored Pre-proline 0 N--CA 1.497 1.923 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.19 -3.25 11.93 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.694 1.596 . . . . 0.0 111.606 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -122.26 -12.59 8.24 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.532 -0.73 . . . . 0.0 109.974 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.42 ' CD ' ' HZ3' ' B' ' 35' ' ' LYS . 80.2 tt0 -158.82 109.57 2.07 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.097 -1.002 . . . . 0.0 109.242 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 95.8 mt -111.67 128.74 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.403 ' CD2' ' OG ' ' B' ' 33' ' ' SER . 15.0 mt -111.6 125.05 53.52 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 80.0 mt -121.69 128.97 52.41 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.571 -0.706 . . . . 0.0 109.853 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -96.75 113.75 25.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.185 -0.947 . . . . 0.0 108.707 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.547 ' O ' ' N ' ' B' ' 29' ' ' GLN . 5.1 t -124.17 156.44 36.71 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.364 0.602 . . . . 0.0 110.514 -178.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.423 ' C ' ' O ' ' B' ' 27' ' ' THR . 45.4 mt 34.71 -87.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 CA-C-O 121.123 0.487 . . . . 0.0 110.639 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.547 ' N ' ' O ' ' B' ' 27' ' ' THR . 17.1 pt20 -150.73 45.19 0.85 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 0.0 109.682 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.68 136.69 4.29 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 74.7 t -91.55 132.73 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.391 -1.064 . . . . 0.0 109.751 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 53.0 tp -107.02 125.27 50.8 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.403 ' OG ' ' CD2' ' B' ' 24' ' ' LEU . 21.0 m -107.61 120.42 42.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.479 -0.763 . . . . 0.0 109.422 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 87.5 mt -106.78 127.5 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' LYS . . . . . 0.42 ' HZ3' ' CD ' ' B' ' 22' ' ' GLU . 68.5 mttm -124.78 139.89 53.43 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.581 0.705 . . . . 0.0 109.355 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.8 -139.97 5.46 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -143.63 152.72 41.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.996 -1.296 . . . . 0.0 109.52 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' B' ' 54' ' ' GLU . 68.1 mttm 56.15 51.23 12.12 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.301 0.572 . . . . 0.0 110.201 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.439 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 9.8 mp -85.56 71.65 10.72 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -178.701 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.498 1.968 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . 0.429 ' CD ' ' N ' ' B' ' 52' ' ' GLU . 18.3 mp0 -138.68 153.86 48.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.347 -0.845 . . . . 0.0 109.508 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 55.4 t -131.42 156.25 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.403 ' O ' ' O ' ' B' ' 38' ' ' LYS . 31.3 tt0 -138.68 134.55 33.77 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.49 178.91 32.95 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.03 139.24 32.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.338 -1.095 . . . . 0.0 109.119 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 43.3 mm -86.38 118.07 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 109.257 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -107.69 -31.77 7.93 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.447 -0.783 . . . . 0.0 109.682 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.76 147.21 15.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.16 -0.963 . . . . 0.0 110.265 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -129.84 135.85 48.88 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 95.0 t -135.28 129.36 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.294 -0.879 . . . . 0.0 109.515 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' B' ' 64' ' ' LEU . 42.4 t80 -144.89 123.18 6.63 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -42.34 86.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.464 1.443 . . . . 0.0 112.224 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.588 ' H ' ' CD2' ' B' ' 64' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.493 1.725 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.3 mmm-85 -69.97 145.32 51.93 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.223 -0.923 . . . . 0.0 109.03 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.543 ' NE2' ' OG1' ' B' ' 27' ' ' THR . 83.2 mt-30 -135.56 146.65 48.21 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.676 0.751 . . . . 0.0 110.005 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -110.19 114.71 28.42 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.9 tt -111.27 125.08 53.45 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.424 -0.797 . . . . 0.0 108.867 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.7 t -119.58 148.04 43.78 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.477 0.656 . . . . 0.0 109.555 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 tp -149.07 -179.46 7.04 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.631 0.729 . . . . 0.0 109.717 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -175.13 158.18 2.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.344 -0.848 . . . . 0.0 109.378 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.12 20.63 57.04 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -66.48 139.88 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -1.078 . . . . 0.0 110.217 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.0 t -72.68 -43.36 63.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.429 -0.794 . . . . 0.0 109.598 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.99 159.12 9.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 0.0 109.93 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.5 t -91.61 106.61 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.472 -0.768 . . . . 0.0 109.959 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -69.09 -38.22 78.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 109.395 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -168.87 164.15 11.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.832 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -149.02 105.16 3.5 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -132.79 150.43 75.71 Favored Pre-proline 0 N--CA 1.498 1.957 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.64 -19.29 36.89 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.134 1.889 . . . . 0.0 111.231 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -100.02 -3.34 32.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.4 -0.813 . . . . 0.0 109.078 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -174.49 146.97 1.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.541 -0.724 . . . . 0.0 109.435 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.413 HD12 HG21 ' A' ' 23' ' ' ILE . 97.0 mt -133.04 129.81 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.335 -0.853 . . . . 0.0 109.614 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.8 mt -117.13 124.9 50.32 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.3 mt -136.64 129.36 30.61 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.56 -0.712 . . . . 0.0 109.192 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -104.7 123.05 46.94 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.526 -0.734 . . . . 0.0 109.444 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 29' ' ' GLN . 8.9 t -123.82 154.71 39.2 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.528 0.68 . . . . 0.0 109.72 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.6 mt 42.97 -84.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.999 -0.438 . . . . 0.0 110.623 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.578 ' N ' ' O ' ' A' ' 27' ' ' THR . 12.9 pt20 -154.9 57.24 0.67 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.932 -1.105 . . . . 0.0 109.85 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.71 141.65 6.15 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.187 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.4 t -86.34 132.2 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.487 -1.007 . . . . 0.0 109.518 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.9 tp -111.26 123.55 50.43 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 t -115.7 126.69 54.42 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.572 -0.705 . . . . 0.0 109.992 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.402 HG21 HD12 ' A' ' 34' ' ' ILE . 92.0 mt -112.59 130.74 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.36 144.67 50.74 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 121.499 0.666 . . . . 0.0 109.662 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.83 -140.1 5.52 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -135.93 143.06 44.74 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.421 -1.046 . . . . 0.0 108.885 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 54.44 62.21 2.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.523 -0.736 . . . . 0.0 110.171 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 39' ' ' LEU . 10.3 mp -91.71 73.04 5.84 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.148 -0.97 . . . . 0.0 108.548 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.013 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 121.475 0.655 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -113.71 136.34 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -136.43 131.0 33.52 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.849 -0.796 . . . . 0.0 108.849 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.1 t -125.1 148.88 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.565 -0.709 . . . . 0.0 109.174 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -133.1 127.97 35.15 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.6 173.64 23.71 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.413 HD22 ' H ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -95.44 128.3 42.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.371 -1.076 . . . . 0.0 109.343 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.1 mt -81.46 121.31 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.868 . . . . 0.0 109.639 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -103.37 -23.76 13.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.545 -0.722 . . . . 0.0 109.085 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.02 151.17 13.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.167 -0.958 . . . . 0.0 109.98 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.95 126.98 37.48 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.6 t -123.04 123.89 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.303 -0.873 . . . . 0.0 109.773 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -146.3 139.76 14.76 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.97 110.01 2.82 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.27 1.313 . . . . 0.0 111.769 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.65 ' CD1' ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.36 -0.838 . . . . 0.0 109.17 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -87.56 137.25 32.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.154 -0.966 . . . . 0.0 109.296 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -146.13 163.75 34.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.409 -0.807 . . . . 0.0 109.299 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -108.96 129.79 55.45 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 7.5 tt -113.41 135.44 53.87 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 12.4 t -130.99 139.8 50.05 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.726 0.774 . . . . 0.0 110.226 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 45.6 tp -151.03 146.06 25.95 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.604 -0.685 . . . . 0.0 109.319 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.4 p -130.11 177.77 7.05 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.61 -0.681 . . . . 0.0 109.414 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.1 18.55 69.23 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 79.3 t -74.55 130.86 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.14 -1.212 . . . . 0.0 109.771 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 38.9 t -73.4 -42.37 62.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.355 -0.841 . . . . 0.0 109.114 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.2 160.29 9.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.155 -0.966 . . . . 0.0 109.946 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 10.1 t -82.08 104.15 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.435 -0.79 . . . . 0.0 109.506 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -67.53 -35.81 79.8 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.164 -0.96 . . . . 0.0 109.352 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 7.5 t -165.46 153.26 11.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.922 . . . . 0.0 109.223 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -140.27 104.54 4.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.278 -0.889 . . . . 0.0 109.455 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . 0.411 ' OD2' ' O ' ' B' ' 22' ' ' GLU . 0.4 OUTLIER -133.26 150.32 74.98 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.97 -16.69 32.46 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.846 1.697 . . . . 0.0 111.953 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -107.93 -8.54 15.91 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.353 -0.842 . . . . 0.0 109.743 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.411 ' O ' ' OD2' ' B' ' 19' ' ' ASP . 50.0 tt0 -167.33 126.78 1.39 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 109.435 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.2 mt -125.11 130.7 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.438 -0.789 . . . . 0.0 109.683 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 60.7 mt -112.95 128.43 56.48 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 94.7 mt -127.02 126.74 43.63 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.629 -0.67 . . . . 0.0 109.658 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -94.03 112.34 24.16 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.543 ' OG1' ' NE2' ' A' ' 5' ' ' GLN . 15.0 t -124.7 164.93 18.87 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.524 0.678 . . . . 0.0 110.488 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' B' ' 27' ' ' THR . 22.2 mm 33.21 -86.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.415 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' B' ' 27' ' ' THR . 27.2 pt20 -148.98 27.2 0.87 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.933 -1.104 . . . . 0.0 109.728 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.84 165.96 31.25 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 55.7 t -112.51 132.4 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.655 -0.909 . . . . 0.0 109.143 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 46.8 tp -104.52 124.33 49.1 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' B' ' 61' ' ' VAL . 5.4 p -107.52 122.59 46.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.591 -0.693 . . . . 0.0 109.48 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 mp -108.6 129.08 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' LYS . . . . . 0.406 ' HZ1' ' CD ' ' B' ' 22' ' ' GLU . 68.5 mttm -123.27 133.3 54.18 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.565 0.698 . . . . 0.0 109.459 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.68 -147.72 8.62 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -136.61 153.76 50.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.357 -1.084 . . . . 0.0 109.767 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 67.8 mttm 55.96 57.41 5.16 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.539 0.685 . . . . 0.0 110.557 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.457 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 9.0 mp -92.35 70.09 5.13 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.557 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.3 t . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 121.616 0.722 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -144.11 127.67 17.03 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 t -118.17 162.55 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.655 -0.653 . . . . 0.0 109.678 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -123.46 132.93 54.08 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.89 179.71 37.62 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.68 138.84 33.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.301 -1.117 . . . . 0.0 109.201 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.457 ' N ' ' CD1' ' B' ' 57' ' ' ILE . 1.4 mp -91.31 117.6 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.247 -0.908 . . . . 0.0 109.061 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -108.13 -25.23 11.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.514 -0.741 . . . . 0.0 109.8 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.59 135.59 4.22 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.74 -1.225 . . . . 0.0 111.146 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.83 135.43 54.87 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . 0.426 ' O ' ' OG ' ' B' ' 33' ' ' SER . 46.6 t -132.58 122.75 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.543 0.687 . . . . 0.0 109.823 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' B' ' 64' ' ' LEU . 28.2 t80 -144.54 128.39 8.88 Favored Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -41.21 88.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.427 1.418 . . . . 0.0 111.785 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' B' ' 62' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 120.783 -1.198 . . . . 0.0 108.678 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 121.092 0.472 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -69.95 140.92 53.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 108.742 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -142.3 162.0 36.59 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.124 -0.985 . . . . 0.0 110.088 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -108.99 142.07 40.18 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.2 tt -142.11 124.01 15.26 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.8 t -132.34 140.45 48.55 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.461 -0.774 . . . . 0.0 109.152 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.5 tp -144.65 142.54 30.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.305 -0.872 . . . . 0.0 109.008 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.5 p -130.61 112.68 13.37 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.548 -0.72 . . . . 0.0 109.468 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 143.33 31.87 0.1 Allowed Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.4 t -81.16 133.47 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -1.125 . . . . 0.0 110.238 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.1 m -72.65 -41.6 65.28 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.56 153.45 4.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.771 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 81.6 t -84.93 106.0 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.509 -0.745 . . . . 0.0 110.285 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -67.96 -42.01 81.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.96 . . . . 0.0 108.86 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.3 t -171.89 136.54 0.91 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.407 -0.808 . . . . 0.0 108.89 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.411 ' CE1' ' CD1' ' A' ' 23' ' ' ILE . 6.9 t80 -123.77 106.46 10.51 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.428 -0.795 . . . . 0.0 109.143 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.22 150.45 74.04 Favored Pre-proline 0 N--CA 1.498 1.968 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.1 -19.57 39.08 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.272 1.981 . . . . 0.0 111.364 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -97.47 -7.12 32.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.466 -0.771 . . . . 0.0 108.978 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -172.86 140.36 0.94 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.411 ' CD1' ' CE1' ' A' ' 18' ' ' PHE . 27.0 mm -127.12 127.51 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.323 -0.861 . . . . 0.0 109.437 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.8 mt -120.51 120.55 36.18 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.1 mt -131.31 125.61 33.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.419 -0.801 . . . . 0.0 108.849 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -92.4 120.83 33.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 29' ' ' GLN . 6.1 t -122.37 154.0 38.28 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.674 0.749 . . . . 0.0 110.271 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.3 mm 46.08 -82.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.085 0.469 . . . . 0.0 110.764 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.578 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.8 pp0? -147.71 -21.36 0.37 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.102 -0.999 . . . . 0.0 109.898 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.485 ' N ' ' CD ' ' A' ' 29' ' ' GLN . . . -97.45 173.77 28.91 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.7 t -118.95 132.67 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.753 -0.851 . . . . 0.0 109.107 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.3 tp -109.62 127.81 54.79 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.6 t -113.22 122.4 47.37 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.7 mt -108.12 130.14 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.403 -0.811 . . . . 0.0 109.264 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -129.16 141.17 51.25 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.488 -0.757 . . . . 0.0 109.37 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.07 -138.1 4.91 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -133.03 150.03 52.16 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.492 -1.005 . . . . 0.0 110.711 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 54' ' ' GLU . 55.0 mmtt 54.08 66.36 1.25 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.492 178.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.1 mp -98.39 71.18 2.03 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.138 0 O-C-N 121.128 -0.982 . . . . 0.0 110.793 -178.146 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 . . . . . 0 N--CA 1.495 1.821 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.0 t -122.65 131.8 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.529 -0.732 . . . . 0.0 109.103 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -130.64 130.98 44.63 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 t -136.36 138.36 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.496 -0.753 . . . . 0.0 109.097 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.491 ' O ' ' O ' ' A' ' 38' ' ' LYS . 24.0 tt0 -118.42 145.98 44.79 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.15 166.14 15.6 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 pp -88.69 128.83 35.62 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.391 -1.064 . . . . 0.0 109.656 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.3 mm -80.12 135.31 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.85 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -125.26 -31.05 3.1 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.02 143.4 16.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.064 -1.023 . . . . 0.0 110.598 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.1 mt -129.73 143.31 50.76 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 54.3 t -139.23 118.22 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.102 -0.999 . . . . 0.0 110.165 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -139.72 108.97 7.17 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.96 109.36 0.23 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.406 1.404 . . . . 0.0 112.426 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.688 ' CD1' ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.323 -0.861 . . . . 0.0 109.588 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.8 mmm-85 -69.25 142.71 54.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.97 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . 0.498 ' NE2' ' OG1' ' A' ' 27' ' ' THR . 86.3 mt-30 -140.15 148.29 41.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.517 -0.739 . . . . 0.0 109.577 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -103.95 119.5 39.06 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.2 tt -119.16 121.24 39.29 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.262 -0.899 . . . . 0.0 108.638 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 70.1 m -132.53 151.37 51.94 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.509 -0.744 . . . . 0.0 109.163 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 tp -147.29 149.3 32.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.193 -0.942 . . . . 0.0 109.5 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.2 p -128.67 163.7 24.53 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.588 -0.695 . . . . 0.0 109.612 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.43 29.27 56.17 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.41 131.37 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -1.174 . . . . 0.0 109.901 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' SER . . . . . 0.54 ' HG ' ' N ' ' B' ' 28' ' ' ILE . 58.2 m -73.83 -40.07 63.58 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.615 -0.678 . . . . 0.0 110.613 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -158.91 158.38 33.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.983 -1.073 . . . . 0.0 109.914 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 76.3 t -103.63 99.96 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -68.96 -49.25 59.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 110.532 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 31.8 t -170.4 146.58 2.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.924 -1.11 . . . . 0.0 110.211 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.71 110.18 17.53 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.673 -0.642 . . . . 0.0 109.882 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' B' ' 22' ' ' GLU . 0.3 OUTLIER -133.76 119.89 15.16 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.431 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -50.19 -27.14 16.7 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.476 1.45 . . . . 0.0 111.443 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -94.52 -5.4 46.13 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' B' ' 19' ' ' ASP . 40.2 tt0 -170.8 115.57 0.45 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 97.0 mt -114.45 126.33 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.203 -0.936 . . . . 0.0 109.194 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 57.9 mt -119.35 126.53 51.63 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 87.0 mt -135.58 123.76 23.04 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.256 -0.902 . . . . 0.0 108.988 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -81.73 118.32 22.76 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.128 -0.982 . . . . 0.0 108.84 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.562 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.8 t -109.54 149.19 30.0 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.472 -0.767 . . . . 0.0 110.201 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.54 ' N ' ' HG ' ' B' ' 13' ' ' SER . 58.7 mt 38.47 -87.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.037 0.446 . . . . 0.0 110.798 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' B' ' 27' ' ' THR . 24.0 pt20 -133.68 -22.52 1.89 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.38 -0.825 . . . . 0.0 110.198 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.6 173.99 30.21 Favored Glycine 0 N--CA 1.498 2.769 0 O-C-N 121.139 -0.976 . . . . 0.0 110.724 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -119.34 131.57 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.79 -0.829 . . . . 0.0 109.401 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 48.7 tp -111.92 128.79 56.25 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.3 t -110.2 120.41 42.37 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 84.3 mt -99.81 125.56 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -130.53 139.06 50.48 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.502 -0.749 . . . . 0.0 109.52 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.66 -138.28 3.28 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -131.86 136.81 47.73 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.348 -1.089 . . . . 0.0 109.836 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt 46.92 75.38 0.12 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 110.283 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.522 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 8.5 mp -93.24 72.12 4.54 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.18 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 121.539 0.685 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -126.62 131.58 51.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.9 t -125.96 137.54 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.499 -0.751 . . . . 0.0 109.721 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -117.24 131.42 56.84 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.7 174.21 28.11 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.99 127.04 40.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.066 -1.256 . . . . 0.0 109.429 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.538 ' N ' ' CD1' ' B' ' 57' ' ' ILE . 1.4 mp -85.63 113.4 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 108.684 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.37 -10.29 16.4 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -159.9 146.28 15.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.904 -1.123 . . . . 0.0 110.522 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 52.8 mt -141.3 138.49 33.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.469 -0.769 . . . . 0.0 108.972 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 53.4 t -133.2 128.23 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.194 -0.941 . . . . 0.0 109.89 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -145.37 137.88 13.59 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.34 109.28 2.86 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.384 1.39 . . . . 0.0 111.74 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.676 ' CD1' ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.479 -0.763 . . . . 0.0 108.981 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.445 ' NE ' ' OE2' ' A' ' 54' ' ' GLU . 46.4 mmm-85 -88.39 138.43 31.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.344 -0.848 . . . . 0.0 109.13 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.444 HE22 ' HG1' ' B' ' 27' ' ' THR . 4.4 pt20 -145.19 161.88 38.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.181 -0.949 . . . . 0.0 109.187 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -119.8 146.4 45.72 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.505 0.669 . . . . 0.0 109.916 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.4 tt -132.51 122.7 25.26 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.3 t -113.8 133.04 55.63 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.49 -0.756 . . . . 0.0 109.283 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.6 tp -144.76 151.5 38.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.35 -0.844 . . . . 0.0 109.444 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.4 t -146.48 162.88 37.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.399 -0.813 . . . . 0.0 108.944 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.27 24.99 41.51 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.45 138.14 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -1.1 . . . . 0.0 109.652 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.5 m -73.57 -38.36 65.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.232 -0.918 . . . . 0.0 109.257 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -169.89 166.71 9.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.177 -0.952 . . . . 0.0 109.499 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.5 t -98.32 96.19 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.329 -0.857 . . . . 0.0 109.063 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -65.21 -39.39 92.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.146 -0.971 . . . . 0.0 109.463 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 t -168.82 152.85 5.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 109.256 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -146.89 107.73 4.16 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.247 -0.908 . . . . 0.0 109.422 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.3 158.68 75.11 Favored Pre-proline 0 N--CA 1.502 2.161 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.83 -26.07 67.67 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 121.672 1.581 . . . . 0.0 112.142 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -106.04 3.43 28.2 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.372 -0.83 . . . . 0.0 110.276 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -171.54 133.46 0.8 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.031 -1.043 . . . . 0.0 109.46 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.9 mt -130.84 126.83 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.421 -0.799 . . . . 0.0 109.184 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.2 mt -117.5 122.18 43.03 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.711 . . . . 0.0 109.271 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.9 mt -133.37 124.56 27.4 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.375 -0.828 . . . . 0.0 108.839 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -91.73 124.74 36.1 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.679 -1.263 . . . . 0.0 109.72 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 29' ' ' GLN . 6.1 t -124.5 153.33 42.2 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.462 0.649 . . . . 0.0 109.755 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.413 HD12 HG21 ' A' ' 28' ' ' ILE . 20.4 mm 44.74 -88.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.868 -0.52 . . . . 0.0 110.094 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.544 ' N ' ' O ' ' A' ' 27' ' ' THR . 25.7 pt20 -143.19 -17.4 0.65 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.965 -1.084 . . . . 0.0 110.213 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.29 173.67 30.32 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.2 t -121.25 131.21 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.779 -0.836 . . . . 0.0 108.909 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -107.56 126.12 52.15 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.37 -0.831 . . . . 0.0 109.554 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -116.9 124.03 48.46 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.639 -0.663 . . . . 0.0 109.417 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.2 mt -107.77 130.0 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.521 -0.737 . . . . 0.0 109.238 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -124.69 138.79 54.27 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.493 -0.754 . . . . 0.0 109.657 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.58 -146.36 9.41 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -140.61 151.87 44.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.036 -1.273 . . . . 0.0 109.802 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 54' ' ' GLU . 73.7 mmtt 58.34 55.24 5.12 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.681 -0.637 . . . . 0.0 109.939 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.503 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 7.9 mp -93.75 70.6 4.12 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.38 0 C-N-CA 120.247 -0.978 . . . . 0.0 110.732 -178.898 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 m -131.43 156.1 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.265 -0.897 . . . . 0.0 109.964 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -142.8 150.37 39.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.425 -0.797 . . . . 0.0 109.107 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.7 t -126.65 134.92 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.458 -0.776 . . . . 0.0 110.109 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.473 ' OE1' ' N ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -114.57 126.08 54.51 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.473 ' N ' ' OE1' ' A' ' 54' ' ' GLU . . . 163.72 176.44 35.64 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.158 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.17 121.44 37.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.527 -0.984 . . . . 0.0 108.885 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.535 ' CD1' ' N ' ' A' ' 57' ' ' ILE . 1.7 mp -90.43 113.3 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.018 -1.051 . . . . 0.0 108.937 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -99.94 -10.77 21.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.452 -0.78 . . . . 0.0 109.988 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.94 145.74 13.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.816 -1.178 . . . . 0.0 110.428 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 mt -135.19 134.53 40.2 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.61 -0.681 . . . . 0.0 109.297 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.8 t -129.81 126.0 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.527 -0.733 . . . . 0.0 109.571 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.558 ' O ' ' N ' ' A' ' 64' ' ' LEU . 10.8 t80 -141.0 127.61 11.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -45.68 84.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.247 1.298 . . . . 0.0 112.206 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.609 ' CD2' ' H ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 O-C-N 121.363 -0.836 . . . . 0.0 109.207 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 31.7 mmm-85 -73.0 142.14 47.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.318 -0.863 . . . . 0.0 109.425 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -147.04 156.09 42.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.272 -0.893 . . . . 0.0 109.025 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -98.79 141.37 31.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.328 -0.858 . . . . 0.0 109.393 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 tt -139.95 126.47 20.31 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 69.8 m -128.53 150.96 49.95 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.442 -0.786 . . . . 0.0 109.594 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.8 tp -146.91 153.21 39.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.35 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.4 t -143.48 164.44 30.32 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.299 -0.876 . . . . 0.0 109.189 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.07 14.95 59.85 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 p -69.14 137.41 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.341 -1.094 . . . . 0.0 109.443 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 4.5 t -73.96 -52.18 13.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.213 -0.929 . . . . 0.0 108.938 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.18 150.6 13.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.253 -0.904 . . . . 0.0 109.646 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 93.0 t -82.58 131.46 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.199 -0.938 . . . . 0.0 110.058 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -95.59 -32.25 12.9 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.314 -0.866 . . . . 0.0 109.247 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 47.3 t -169.04 153.97 5.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.89 . . . . 0.0 108.981 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -145.65 112.49 5.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.004 -1.06 . . . . 0.0 109.408 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' B' ' 19' ' ' ASP . 0.3 OUTLIER -132.6 151.73 78.68 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.59 -18.21 48.52 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.658 1.572 . . . . 0.0 111.382 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -107.7 -3.29 19.32 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.491 -0.756 . . . . 0.0 109.581 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -169.98 127.85 0.88 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.284 -0.885 . . . . 0.0 109.227 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.8 mt -127.74 129.65 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.241 -0.912 . . . . 0.0 109.921 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 70.0 mt -115.06 124.15 50.85 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.336 -0.853 . . . . 0.0 109.639 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 41.5 mt -126.31 131.26 51.88 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.303 -0.873 . . . . 0.0 109.138 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -90.91 119.87 31.45 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.556 ' O ' ' N ' ' B' ' 29' ' ' GLN . 3.1 t -123.53 148.36 46.36 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.669 0.747 . . . . 0.0 110.186 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 68.5 mt 39.05 -88.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.145 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' B' ' 27' ' ' THR . 29.7 pt20 -139.0 -18.17 1.03 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.392 -0.817 . . . . 0.0 109.999 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.19 144.5 17.17 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 18.6 t -94.15 129.64 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.343 -1.092 . . . . 0.0 108.848 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 37.5 tp -106.21 126.02 51.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.445 -0.784 . . . . 0.0 109.415 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 70.9 m -109.34 124.4 50.89 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . 0.425 HD12 HG23 ' B' ' 34' ' ' ILE . 90.8 mt -106.13 129.41 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.534 -0.729 . . . . 0.0 109.178 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -125.25 141.74 51.91 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.507 -0.746 . . . . 0.0 109.414 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.04 -151.52 17.93 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -140.07 150.26 44.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.226 -1.161 . . . . 0.0 108.93 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt 60.27 51.24 5.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.553 -0.717 . . . . 0.0 109.668 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 9.0 mp -91.24 72.99 6.23 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.386 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -178.706 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.2 t . . . . . 0 N--CA 1.499 2.016 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -119.5 137.29 53.9 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.516 -0.74 . . . . 0.0 109.077 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -128.39 160.84 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.411 -0.806 . . . . 0.0 110.086 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.32 146.87 47.06 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.26 176.02 23.68 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.0 136.44 38.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.357 -1.084 . . . . 0.0 108.545 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 36.1 mm -93.49 111.53 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.884 -1.135 . . . . 0.0 109.186 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -100.38 -24.48 14.5 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.399 -0.813 . . . . 0.0 109.799 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.04 147.05 12.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.937 -1.102 . . . . 0.0 110.632 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 9.5 mt -132.48 141.17 48.68 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 77.9 t -133.91 118.97 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.578 -0.701 . . . . 0.0 109.154 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' B' ' 62' ' ' TYR . 18.2 t80 -135.86 140.81 34.57 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -79.84 105.78 1.87 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.491 1.461 . . . . 0.0 112.485 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.589 ' CD1' ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.925 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.592 0.71 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 41.8 mmm-85 -65.16 141.31 58.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.92 -1.112 . . . . 0.0 109.145 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.541 ' NE2' ' OG1' ' B' ' 27' ' ' THR . 85.3 mt-30 -135.38 147.78 49.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.205 -0.934 . . . . 0.0 110.557 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -112.99 113.28 25.26 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.5 tt -111.68 123.11 49.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 108.89 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.3 t -115.22 133.72 55.78 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.48 0.657 . . . . 0.0 109.662 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 tp -141.02 139.11 34.09 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.725 0.774 . . . . 0.0 109.345 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -130.51 168.4 17.1 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.723 -0.61 . . . . 0.0 109.44 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.4 14.09 74.8 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.0 t -67.94 133.94 30.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 109.761 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.6 t -71.15 -43.25 67.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 109.189 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.68 163.82 3.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 0.0 110.026 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.3 t -88.81 111.45 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.432 -0.792 . . . . 0.0 110.086 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -67.46 -31.23 71.26 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.476 -0.765 . . . . 0.0 109.097 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.1 t -167.91 159.34 11.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.099 -1.0 . . . . 0.0 109.537 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.443 ' CD1' ' C ' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -138.77 107.09 5.79 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.342 -0.849 . . . . 0.0 109.31 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.84 145.03 54.29 Favored Pre-proline 0 N--CA 1.495 1.799 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.61 -13.69 32.76 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.444 2.096 . . . . 0.0 111.609 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -115.5 -1.74 12.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.28 -0.887 . . . . 0.0 108.967 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -169.07 111.61 0.51 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.149 -0.97 . . . . 0.0 109.157 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.5 mt -112.51 129.7 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.152 -0.967 . . . . 0.0 109.475 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.3 mt -113.41 123.54 50.32 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.531 -0.73 . . . . 0.0 109.039 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.3 mt -120.95 126.87 51.07 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.587 0.708 . . . . 0.0 109.112 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.81 118.25 31.45 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.35 -0.844 . . . . 0.0 108.974 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.579 ' O ' ' N ' ' A' ' 29' ' ' GLN . 3.4 t -116.95 154.49 30.76 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.345 0.593 . . . . 0.0 110.392 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.523 ' N ' ' HG1' ' A' ' 27' ' ' THR . 27.1 mm 34.09 -85.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-O 121.451 0.643 . . . . 0.0 110.933 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 27' ' ' THR . 24.0 pt20 -138.82 -17.48 1.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.927 . . . . 0.0 108.944 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.58 167.51 25.93 Favored Glycine 0 N--CA 1.497 2.735 0 O-C-N 120.855 -1.153 . . . . 0.0 110.797 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -120.43 132.94 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.513 -0.992 . . . . 0.0 109.305 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.7 tp -112.23 131.92 55.21 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.7 t -115.79 129.9 56.63 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.453 0.644 . . . . 0.0 109.358 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.7 mt -112.8 132.23 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 121.315 0.578 . . . . 0.0 109.457 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -131.33 146.65 52.38 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.575 0.702 . . . . 0.0 109.488 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' OE1' ' A' ' 37' ' ' GLU . . . 168.63 -148.21 12.18 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 36' ' ' GLY . 0.7 OUTLIER -118.89 137.36 53.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.866 -0.785 . . . . 0.0 109.83 -178.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt 50.94 71.3 0.44 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.018 0.913 . . . . 0.0 110.179 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 8.4 mp -98.75 72.55 1.98 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.982 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 -178.869 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 121.513 0.673 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.9 m -133.42 163.0 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.538 -0.726 . . . . 0.0 109.731 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -135.45 160.78 37.38 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.701 0.762 . . . . 0.0 109.688 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.08 135.17 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -122.04 125.52 46.43 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.838 0.827 . . . . 0.0 109.322 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.4 178.47 24.43 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.82 129.83 44.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -1.081 . . . . 0.0 109.297 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.48 122.52 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.282 -0.887 . . . . 0.0 109.519 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -102.22 -24.43 13.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.482 -0.761 . . . . 0.0 109.036 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.93 149.7 14.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.843 -1.161 . . . . 0.0 110.749 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.7 mt -131.2 144.74 51.57 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.24 122.0 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.763 0.792 . . . . 0.0 110.3 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.557 ' O ' ' N ' ' A' ' 64' ' ' LEU . 19.6 t80 -139.73 115.77 8.16 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.54 78.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.43 1.42 . . . . 0.0 111.419 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 62' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.505 0 CA-C-O 122.338 1.066 . . . . 0.0 109.498 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 121.65 0.738 . . . . 0.0 109.098 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -69.72 144.65 52.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.107 -0.995 . . . . 0.0 109.9 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . 0.529 ' NE2' ' OG1' ' A' ' 27' ' ' THR . 75.5 mt-30 -140.71 150.06 42.97 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.785 0.802 . . . . 0.0 109.691 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -110.58 127.25 55.14 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.5 tt -122.33 122.25 38.63 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.229 -0.92 . . . . 0.0 108.876 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 18.2 p -121.19 147.89 44.99 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.726 0.774 . . . . 0.0 109.994 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 32.0 tp -148.83 143.78 26.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.568 -0.707 . . . . 0.0 109.102 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -130.25 161.39 31.3 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.651 0.739 . . . . 0.0 109.933 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.41 20.75 61.6 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.83 134.63 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.834 -1.392 . . . . 0.0 109.78 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 34.0 m -72.92 -41.84 64.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.193 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.02 164.83 4.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.819 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 77.1 t -99.29 128.22 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.429 -0.794 . . . . 0.0 109.66 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -84.0 -29.65 26.8 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.686 0.755 . . . . 0.0 109.187 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 35.6 t -169.3 155.5 6.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.121 -0.987 . . . . 0.0 109.289 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -137.42 108.86 6.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 0.0 109.779 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' ASP . . . . . 0.42 ' OD2' ' O ' ' B' ' 22' ' ' GLU . 0.8 OUTLIER -132.91 149.12 72.01 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.293 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.5 -7.76 19.89 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.327 2.018 . . . . 0.0 111.607 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -114.47 -20.96 10.56 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.781 0.8 . . . . 0.0 109.03 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.447 ' CD ' ' HZ2' ' B' ' 35' ' ' LYS . 74.6 tt0 -153.46 115.62 4.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.142 -0.974 . . . . 0.0 109.078 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 81.3 mt -115.88 130.22 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.217 -0.927 . . . . 0.0 109.959 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 14.5 mt -112.39 126.34 55.17 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 81.1 mt -120.57 125.91 48.97 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.808 0.813 . . . . 0.0 109.148 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -95.12 110.4 22.35 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.583 ' O ' ' N ' ' B' ' 29' ' ' GLN . 0.1 OUTLIER -113.92 151.74 31.82 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.313 0.578 . . . . 0.0 110.031 -178.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' B' ' 27' ' ' THR . 55.0 mt 34.51 -85.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-O 121.161 0.505 . . . . 0.0 110.765 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.583 ' N ' ' O ' ' B' ' 27' ' ' THR . 20.5 pt20 -138.51 -14.91 1.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.127 -0.983 . . . . 0.0 109.638 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.01 165.19 20.76 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.971 -1.081 . . . . 0.0 110.807 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 53.1 t -122.32 132.93 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.253 -1.145 . . . . 0.0 109.107 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 53.9 tp -115.58 137.57 51.93 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.335 0.588 . . . . 0.0 109.926 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.11 138.15 53.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.607 -0.683 . . . . 0.0 109.167 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 5.0 mp -115.25 130.89 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.591 -0.693 . . . . 0.0 109.426 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' LYS . . . . . 0.447 ' HZ2' ' CD ' ' B' ' 22' ' ' GLU . 68.3 mttm -128.57 140.99 51.51 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.518 0.675 . . . . 0.0 109.837 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.99 -139.27 5.46 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.452 ' CD ' ' HZ3' ' B' ' 38' ' ' LYS . 0.4 OUTLIER -117.59 138.31 52.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.627 -0.925 . . . . 0.0 109.059 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' LYS . . . . . 0.452 ' HZ3' ' CD ' ' B' ' 37' ' ' GLU . 32.3 mtmm 36.42 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.996 0.903 . . . . 0.0 110.754 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.446 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 9.1 mp -100.14 71.6 1.61 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.633 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.898 -178.4 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 121.691 0.757 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -120.71 147.16 45.66 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.94 135.06 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.432 -0.793 . . . . 0.0 109.308 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.12 126.12 49.93 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.63 0.729 . . . . 0.0 109.744 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.02 171.2 23.66 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.04 111.94 23.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.29 -1.123 . . . . 0.0 108.805 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.416 HD13 HG23 ' B' ' 57' ' ' ILE . 96.7 mt -74.24 112.18 10.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.311 -0.868 . . . . 0.0 109.564 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -101.53 -11.46 19.26 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.58 143.17 6.93 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.726 -1.234 . . . . 0.0 110.744 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 15.0 mt -127.1 144.64 50.98 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.36 128.27 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.534 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -140.14 137.37 17.96 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -36.52 -39.62 0.42 Allowed 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.414 2.076 . . . . 0.0 112.506 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' LEU . . . . . 0.498 ' O ' ' CD2' ' B' ' 64' ' ' LEU . 2.2 tt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.9 mtp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.344 0.592 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -86.35 109.5 19.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.883 . . . . 0.0 109.587 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -104.95 5.86 33.1 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -73.95 143.04 45.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.311 -0.868 . . . . 0.0 109.142 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.486 ' NE2' ' OG1' ' B' ' 27' ' ' THR . 79.1 mt-30 -144.65 158.02 43.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.2 -0.938 . . . . 0.0 109.803 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -114.91 132.7 56.45 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.6 tt -121.68 130.27 53.35 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.3 p -127.04 147.43 50.15 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.527 -0.733 . . . . 0.0 109.745 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.2 tp -158.56 160.47 36.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.402 -0.811 . . . . 0.0 109.162 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t -151.52 -165.94 2.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.42 -0.8 . . . . 0.0 108.972 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.48 28.35 55.57 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.0 t -66.4 137.83 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.512 -0.993 . . . . 0.0 109.839 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.4 ' HG ' ' C ' ' A' ' 26' ' ' GLU . 53.4 p -72.63 -37.0 68.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 0.0 109.261 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -170.37 163.59 8.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.0 109.451 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.1 t -98.5 96.5 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.23 -0.919 . . . . 0.0 109.3 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.23 -38.83 88.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.148 -0.97 . . . . 0.0 108.977 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 t -170.26 161.54 8.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.823 . . . . 0.0 109.294 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -146.6 105.49 3.86 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.93 151.62 78.82 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.543 -0.723 . . . . 0.0 109.186 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.87 -16.82 32.84 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.159 1.906 . . . . 0.0 111.086 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -104.97 -10.59 17.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.524 -0.735 . . . . 0.0 109.475 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -169.28 131.4 1.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.413 -0.805 . . . . 0.0 109.209 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.79 129.33 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.695 -0.628 . . . . 0.0 109.496 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 mt -120.48 118.41 30.2 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -133.39 127.93 34.49 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.4 ' C ' ' HG ' ' A' ' 13' ' ' SER . 38.7 tt0 -91.01 123.8 34.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.923 -1.11 . . . . 0.0 109.692 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.611 ' O ' ' N ' ' A' ' 29' ' ' GLN . 1.9 t -119.39 149.24 42.16 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.7 mt 50.46 -80.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.3 pt20 -153.45 -18.19 0.14 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.967 -1.083 . . . . 0.0 110.67 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.67 168.94 26.81 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.36 131.95 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.447 -1.031 . . . . 0.0 109.598 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.0 tp -108.23 128.79 55.03 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.465 0.65 . . . . 0.0 109.445 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.5 t -111.42 126.25 54.74 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.403 HG22 HD12 ' A' ' 34' ' ' ILE . 24.3 mm -106.54 127.53 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.798 -0.564 . . . . 0.0 109.551 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -122.94 135.08 54.35 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.17 -156.5 19.53 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -135.84 146.44 47.49 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.417 -1.049 . . . . 0.0 108.825 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt 55.79 56.45 6.09 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.626 -0.672 . . . . 0.0 110.193 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.49 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 7.6 mp -93.64 68.84 4.05 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.946 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -179.075 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 47' ' ' LYS . 42.0 tp . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.572 ' C ' ' H ' ' A' ' 49' ' ' GLY . 52.7 mmtt 55.93 152.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.201 1.0 . . . . 0.0 111.311 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 57.52 -4.04 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.741 -0.599 . . . . 0.0 110.159 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.572 ' H ' ' C ' ' A' ' 47' ' ' LYS . . . 63.85 24.39 68.26 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -111.98 153.09 27.31 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.563 -0.963 . . . . 0.0 109.174 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.88 139.16 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.47 -0.769 . . . . 0.0 108.937 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -114.82 160.11 19.84 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -137.43 138.15 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.31 -0.869 . . . . 0.0 109.121 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -120.68 124.79 46.06 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.47 172.78 31.39 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.99 127.64 44.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.492 -1.005 . . . . 0.0 108.817 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -83.01 117.1 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.058 -1.027 . . . . 0.0 109.284 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -96.96 -12.18 23.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.327 -0.858 . . . . 0.0 109.284 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -173.86 154.27 2.35 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.177 -0.952 . . . . 0.0 110.196 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.41 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 13.6 mt -137.17 134.7 36.61 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.2 t -133.23 123.83 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.234 -0.916 . . . . 0.0 109.708 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.54 ' CE1' ' O ' ' A' ' 63' ' ' PRO . 15.3 t80 -139.72 120.72 9.51 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.54 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 31.5 Cg_exo -56.86 127.86 27.58 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 CA-C-N 120.641 1.265 . . . . 0.0 111.109 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.611 ' O ' ' N ' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -103.59 49.76 0.82 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.19 -0.944 . . . . 0.0 109.005 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -51.11 84.5 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.162 -0.961 . . . . 0.0 110.374 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.611 ' N ' ' O ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER -175.98 -30.39 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.403 ' CD2' ' O ' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -70.39 134.0 47.43 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.618 -0.676 . . . . 0.0 109.849 -179.415 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 69' ' ' HIS . 0.1 OUTLIER -127.57 -39.72 1.82 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 68' ' ' HIS . 2.2 t-80 57.38 151.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.665 0.745 . . . . 0.0 110.432 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -76.58 -68.39 0.6 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -0.929 . . . . 0.0 109.844 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.6 t60 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.522 -179.32 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' B' ' 3' ' ' ASN . 21.6 t70 60.11 -176.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.501 -0.749 . . . . 0.0 110.176 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.489 ' H ' ' CG ' ' B' ' 2' ' ' ASP . 13.7 p-10 -126.57 -18.55 4.79 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.643 -0.661 . . . . 0.0 109.476 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -68.84 141.04 55.22 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.313 -0.867 . . . . 0.0 109.436 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . 0.516 ' NE2' ' OG1' ' A' ' 27' ' ' THR . 26.5 mt-30 -146.74 158.27 43.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.183 -0.948 . . . . 0.0 109.782 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -103.81 135.63 44.99 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 7.2 tt -138.41 125.48 21.39 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.396 -0.815 . . . . 0.0 108.841 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -129.41 149.31 51.25 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.4 tp -145.96 146.52 31.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.225 -0.922 . . . . 0.0 109.302 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -132.74 171.33 14.02 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.547 -0.72 . . . . 0.0 109.192 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.75 23.21 70.33 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -77.61 137.17 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -1.158 . . . . 0.0 109.612 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 41.2 t -71.03 -44.31 66.09 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.061 -1.024 . . . . 0.0 109.882 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.68 151.81 4.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.899 -1.126 . . . . 0.0 110.36 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 70.4 t -85.55 130.35 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.458 -0.776 . . . . 0.0 109.349 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -98.54 -42.15 7.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.176 -0.953 . . . . 0.0 109.919 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -157.57 118.7 3.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.111 -0.993 . . . . 0.0 109.261 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -111.86 106.39 15.1 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.472 -0.768 . . . . 0.0 109.133 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -132.42 151.08 77.61 Favored Pre-proline 0 N--CA 1.498 1.971 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.36 -20.27 48.75 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.12 1.88 . . . . 0.0 112.18 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -110.89 6.9 21.56 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.366 -0.834 . . . . 0.0 109.408 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -170.46 137.94 1.47 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.346 -0.846 . . . . 0.0 109.172 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.403 HG23 HD11 ' B' ' 23' ' ' ILE . 91.3 mt -137.92 128.37 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.17 -0.956 . . . . 0.0 109.478 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 mt -124.21 109.83 13.91 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 86.7 mt -113.77 124.2 51.69 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -83.36 104.89 13.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.285 -0.884 . . . . 0.0 109.15 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.621 ' HG1' ' H ' ' B' ' 28' ' ' ILE . 13.8 t -123.95 -178.92 4.21 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.397 0.618 . . . . 0.0 109.548 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.621 ' H ' ' HG1' ' B' ' 27' ' ' THR . 8.6 mm -34.31 157.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.908 0.861 . . . . 0.0 110.629 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 64.94 -57.76 0.27 Allowed 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.961 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' B' ' 28' ' ' ILE . . . -171.36 -131.61 1.37 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.214 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -121.47 134.43 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.718 -0.872 . . . . 0.0 110.175 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 29.3 tp -100.0 126.58 46.21 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -106.34 135.33 48.03 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.541 -0.724 . . . . 0.0 109.619 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 79.7 mt -124.71 132.39 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -124.82 141.53 52.05 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.546 0.689 . . . . 0.0 109.85 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.23 -153.23 21.65 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -130.95 143.74 50.95 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.204 -1.174 . . . . 0.0 109.421 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 55.66 57.0 5.61 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.695 . . . . 0.0 109.704 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' B' ' 39' ' ' LEU . 9.1 mp -97.5 72.29 2.35 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.432 -0.792 . . . . 0.0 109.194 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.002 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 2.5 tt . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.638 ' C ' ' H ' ' B' ' 49' ' ' GLY . 18.0 ptpt -108.59 -161.92 0.79 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.346 -0.846 . . . . 0.0 109.261 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . 63.73 -20.83 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.442 -0.786 . . . . 0.0 109.838 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . 0.638 ' H ' ' C ' ' B' ' 47' ' ' LYS . . . 78.0 25.5 62.0 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -101.9 160.04 14.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.472 -1.016 . . . . 0.0 109.393 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.03 132.99 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.491 -0.756 . . . . 0.0 109.149 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -125.91 132.83 52.05 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.99 135.21 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -124.38 133.32 53.45 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.436 -0.79 . . . . 0.0 108.967 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.51 -178.38 39.08 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.13 120.64 35.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.412 -1.052 . . . . 0.0 108.927 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.3 mt -91.79 110.27 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.078 -1.014 . . . . 0.0 108.762 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -97.88 -16.43 19.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.373 -0.829 . . . . 0.0 109.997 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.96 147.33 23.98 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.823 -1.173 . . . . 0.0 110.884 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.412 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 13.1 mt -139.15 132.16 29.51 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 54.2 t -130.64 127.01 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.308 -0.87 . . . . 0.0 109.318 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 14.6 t80 -138.71 141.44 30.77 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.531 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 71.9 Cg_endo -76.6 112.41 3.45 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.867 1.711 . . . . 0.0 111.908 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.568 ' CD1' ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -98.98 48.46 0.96 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.187 -0.946 . . . . 0.0 109.022 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' B' ' 67' ' ' HIS . 5.7 mm-40 -76.34 -95.97 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 109.784 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.639 ' ND1' ' N ' ' B' ' 66' ' ' HIS . 0.1 OUTLIER 61.48 -70.57 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.477 -0.765 . . . . 0.0 109.884 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.538 ' N ' ' O ' ' B' ' 65' ' ' GLU . 2.5 m-70 -118.53 158.15 25.94 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.452 ' ND1' ' N ' ' B' ' 68' ' ' HIS . 8.0 m80 -77.01 136.96 38.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.166 -0.959 . . . . 0.0 110.111 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -154.88 95.46 1.76 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -140.57 149.81 42.86 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.38 -0.825 . . . . 0.0 109.968 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 117.952 -1.023 . . . . 0.0 108.943 179.511 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ptp . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -93.57 106.52 18.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.066 -1.021 . . . . 0.0 108.399 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -152.16 -19.1 0.18 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.515 -0.741 . . . . 0.0 109.533 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 43.2 mmm-85 -59.77 142.47 53.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.559 -0.713 . . . . 0.0 110.525 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -154.34 162.12 41.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.477 -0.764 . . . . 0.0 109.579 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 9.7 m-85 -106.66 130.86 54.33 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.552 -0.718 . . . . 0.0 109.469 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.64 146.83 39.16 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.143 0.973 . . . . 0.0 109.267 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.0 t -139.44 143.2 37.49 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.374 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.4 tp -155.22 139.47 16.62 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.342 -0.848 . . . . 0.0 109.743 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 t -145.33 164.9 30.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.397 -0.814 . . . . 0.0 109.376 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.61 11.55 77.18 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.6 t -66.82 159.78 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.769 -0.842 . . . . 0.0 110.633 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 14' ' ' LYS . 22.1 p -74.68 -53.09 9.95 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.4 ' N ' ' OG ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -171.7 158.09 4.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.261 -0.9 . . . . 0.0 109.706 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 t -83.8 108.18 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.86 . . . . 0.0 110.099 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -66.89 -41.57 86.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.426 -0.796 . . . . 0.0 109.094 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.8 t -172.62 143.62 1.34 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.414 -0.804 . . . . 0.0 109.18 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -127.61 116.72 20.76 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.55 -0.719 . . . . 0.0 109.227 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.0 147.87 67.11 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.84 -16.82 46.53 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.835 1.69 . . . . 0.0 110.77 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -98.39 -7.86 27.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.621 -0.675 . . . . 0.0 109.198 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 23' ' ' ILE . 9.5 tm-20 -174.61 150.84 1.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.366 -0.833 . . . . 0.0 109.082 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.479 ' N ' ' CD ' ' A' ' 22' ' ' GLU . 96.5 mt -133.44 130.86 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.299 -0.875 . . . . 0.0 109.991 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.2 mt -115.52 128.11 55.76 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.2 mt -128.54 132.48 48.27 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.393 -0.817 . . . . 0.0 109.155 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -98.81 110.22 22.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 108.709 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.611 ' O ' ' N ' ' A' ' 29' ' ' GLN . 12.3 t -113.43 149.06 34.73 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.411 0.624 . . . . 0.0 109.97 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.8 mm 43.26 -80.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.652 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' A' ' 27' ' ' THR . 9.0 mt-30 -143.58 -24.65 0.58 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.11 -0.994 . . . . 0.0 109.836 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.01 174.78 36.01 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.76 130.31 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.849 -0.795 . . . . 0.0 109.019 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.1 tp -103.75 126.59 50.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.582 -0.699 . . . . 0.0 109.42 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.7 t -113.35 128.11 56.35 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.409 HD11 HG21 ' A' ' 34' ' ' ILE . 90.5 mt -107.27 130.33 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -124.42 138.6 54.34 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.477 0.656 . . . . 0.0 109.416 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.71 -144.92 8.65 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -133.93 144.46 48.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.317 -1.108 . . . . 0.0 108.939 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 54' ' ' GLU . 71.1 mmtt 58.3 57.69 3.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 0.0 109.351 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 9.1 mp -95.56 72.79 3.18 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.601 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' A' ' 48' ' ' ALA . 10.2 mp . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 120.655 0.264 . . . . 0.0 110.775 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.0 tttt 59.91 -70.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.243 0.544 . . . . 0.0 109.862 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . -72.21 0.95 8.48 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.454 -0.778 . . . . 0.0 109.446 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.82 28.94 74.09 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -134.11 161.05 35.94 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.441 -1.035 . . . . 0.0 109.338 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.0 t -113.79 132.23 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -125.95 141.02 52.16 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.1 t -131.0 133.67 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.508 ' OE1' ' CD2' ' A' ' 6' ' ' PHE . 27.1 tp10 -117.69 143.13 46.48 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.71 -172.7 30.4 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.93 126.95 54.42 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.632 -0.922 . . . . 0.0 109.218 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.31 118.96 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.033 -1.042 . . . . 0.0 109.552 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -98.7 -19.5 17.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.414 -0.804 . . . . 0.0 108.855 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -168.25 154.33 7.18 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.131 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.9 mt -133.32 139.48 46.89 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.2 t -134.58 122.41 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.526 -0.734 . . . . 0.0 109.796 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.439 ' CD1' ' C ' ' A' ' 62' ' ' TYR . 10.0 t80 -136.23 139.79 30.97 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.16 87.71 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.472 1.448 . . . . 0.0 112.245 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.613 ' CD2' ' H ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER -99.18 7.82 45.42 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 64' ' ' LEU . 3.0 pp20? -37.33 154.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.576 0.703 . . . . 0.0 110.771 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.655 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 0.3 OUTLIER -158.09 75.47 0.75 Allowed 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 179.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.571 ' C ' ' O ' ' A' ' 66' ' ' HIS . 5.7 m-70 -18.39 -92.14 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.671 -0.643 . . . . 0.0 110.88 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.496 ' ND1' ' N ' ' A' ' 69' ' ' HIS . 16.2 p80 -176.46 -156.15 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.496 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 1.7 t60 73.7 162.69 0.26 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.505 0.669 . . . . 0.0 110.296 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -157.07 -3.28 0.11 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.511 0.672 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' B' ' 2' ' ' ASP . 0.0 OUTLIER -166.92 -171.31 1.77 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.738 -179.321 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' B' ' 3' ' ' ASN . 8.9 p-10 -86.36 -1.05 57.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.462 -0.774 . . . . 0.0 110.088 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -79.53 139.11 37.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.586 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -148.14 158.43 44.07 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.138 -0.976 . . . . 0.0 109.734 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -113.94 134.35 54.88 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.483 -0.76 . . . . 0.0 109.021 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.8 mt -116.06 147.3 41.41 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 43.1 t -141.04 131.67 25.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.497 -0.752 . . . . 0.0 109.577 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 25.1 tp -142.82 145.25 33.02 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.501 ' O ' ' N ' ' B' ' 12' ' ' VAL . 14.1 p -68.25 165.64 18.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.208 -0.933 . . . . 0.0 110.649 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.19 92.87 0.01 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.501 ' N ' ' O ' ' B' ' 10' ' ' THR . 9.3 p -48.2 168.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.51 -0.994 . . . . 0.0 110.26 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 15.7 m -72.86 -39.8 66.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.665 -0.647 . . . . 0.0 110.528 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -148.98 147.66 28.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.883 -1.136 . . . . 0.0 109.949 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 78.6 t -103.32 97.48 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -65.13 -41.83 94.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.851 . . . . 0.0 109.83 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 31.1 t -174.43 147.0 1.1 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.886 . . . . 0.0 109.07 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -128.88 112.46 14.13 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -130.7 148.14 68.91 Favored Pre-proline 0 N--CA 1.498 1.93 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.6 -10.33 28.37 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.792 1.662 . . . . 0.0 111.496 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -118.38 3.86 11.86 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.768 -0.582 . . . . 0.0 109.64 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -172.07 129.76 0.61 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.261 -0.899 . . . . 0.0 109.382 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 50.8 mm -122.03 121.65 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.347 -0.845 . . . . 0.0 109.214 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 58.4 mt -119.21 114.53 22.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 46.3 mt -131.35 127.11 36.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.394 -0.816 . . . . 0.0 108.883 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -87.39 111.34 21.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.021 -1.049 . . . . 0.0 109.414 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.618 ' O ' ' N ' ' B' ' 29' ' ' GLN . 9.6 t -105.74 150.06 25.86 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.475 -0.766 . . . . 0.0 109.96 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 57.5 mt 38.26 -84.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 121.06 0.457 . . . . 0.0 110.485 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.618 ' N ' ' O ' ' B' ' 27' ' ' THR . 15.9 pt20 -139.4 -19.47 0.96 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.338 -0.851 . . . . 0.0 110.26 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.58 166.24 23.91 Favored Glycine 0 N--CA 1.496 2.654 0 O-C-N 121.077 -1.015 . . . . 0.0 110.665 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 69.1 t -114.97 131.31 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.725 -0.868 . . . . 0.0 108.668 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 52.7 tp -109.77 127.61 54.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.613 -0.679 . . . . 0.0 109.24 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.5 t -117.23 124.2 48.48 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.409 HD13 HG23 ' B' ' 34' ' ' ILE . 74.1 mt -110.18 131.38 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.387 -0.821 . . . . 0.0 108.997 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -124.84 139.56 53.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.546 -0.721 . . . . 0.0 109.365 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.67 -144.69 8.05 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.566 ' OE1' ' N ' ' B' ' 37' ' ' GLU . 7.5 mp0 -138.65 147.44 42.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.522 -0.987 . . . . 0.0 109.204 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' B' ' 54' ' ' GLU . 68.8 mmtt 62.54 49.75 3.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.667 -0.646 . . . . 0.0 109.94 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 10.0 mp -93.01 71.17 4.63 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.005 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -178.736 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.416 ' N ' ' CD1' ' B' ' 46' ' ' LEU . 10.8 mp . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.573 0.701 . . . . 0.0 109.647 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -92.47 -80.39 0.37 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.411 -0.805 . . . . 0.0 109.459 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.05 6.38 25.62 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.83 15.78 69.51 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -90.63 160.31 15.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.439 -1.036 . . . . 0.0 109.683 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.18 144.02 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.405 -0.809 . . . . 0.0 109.252 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -136.97 149.93 47.84 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 23.8 t -130.62 159.16 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.311 -0.868 . . . . 0.0 109.623 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' B' ' 38' ' ' LYS . 7.5 pt-20 -143.38 144.33 32.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.332 -0.855 . . . . 0.0 109.244 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.46 -175.53 31.82 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.54 113.85 27.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.442 -1.034 . . . . 0.0 109.208 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.535 ' CD1' ' N ' ' B' ' 57' ' ' ILE . 1.5 mp -81.14 127.07 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.156 -0.965 . . . . 0.0 109.759 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -101.78 -23.0 14.26 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.07 155.01 15.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.043 -1.036 . . . . 0.0 110.655 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 14.0 mt -130.82 142.56 50.4 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 71.3 t -134.19 119.77 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.421 -0.8 . . . . 0.0 109.177 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -133.71 102.86 12.32 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.66 97.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.829 1.686 . . . . 0.0 112.745 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.604 HD11 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -88.23 11.78 15.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.483 -0.761 . . . . 0.0 109.22 179.183 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' B' ' 64' ' ' LEU . 1.6 pm0 44.22 178.68 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 122.25 1.024 . . . . 0.0 112.082 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -174.84 73.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 109.138 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -68.24 -60.01 2.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.263 -0.898 . . . . 0.0 109.189 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.55 -178.76 6.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 110.483 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.537 ' O ' ' N ' ' B' ' 71' ' ' HIS . 0.1 OUTLIER -176.39 -120.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.443 ' CD2' ' N ' ' B' ' 70' ' ' HIS . 1.0 OUTLIER -45.66 -16.3 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.508 -1.37 . . . . 0.0 109.873 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' B' ' 69' ' ' HIS . 27.4 t60 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 118.113 -0.946 . . . . 0.0 109.874 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.4 mmm . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.458 0.647 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.2 t70 63.34 114.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.459 -0.776 . . . . 0.0 109.921 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -100.88 -14.2 18.05 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.445 -0.784 . . . . 0.0 109.594 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.3 mmm-85 -69.4 138.3 53.48 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.5 -0.75 . . . . 0.0 109.693 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -150.44 155.75 40.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.454 -0.779 . . . . 0.0 109.139 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -114.34 131.93 56.37 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.0 tt -120.3 123.73 43.87 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.3 t -109.93 132.24 54.34 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.498 -0.751 . . . . 0.0 109.601 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.6 tp -146.92 147.29 30.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.785 . . . . 0.0 109.232 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.9 t -148.43 177.74 9.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.306 -0.871 . . . . 0.0 109.187 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.3 20.98 76.51 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 p -62.46 144.37 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.586 -0.949 . . . . 0.0 110.001 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 t -72.38 -42.7 64.93 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.543 -0.723 . . . . 0.0 109.573 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -165.12 160.65 18.95 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.983 -1.073 . . . . 0.0 110.179 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -94.85 108.89 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -81.9 -56.3 4.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -0.816 . . . . 0.0 110.024 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 t -162.18 127.16 3.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.304 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -109.66 117.43 33.91 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -131.05 148.41 70.14 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 121.309 -0.869 . . . . 0.0 109.466 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.66 -11.8 31.73 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.508 1.472 . . . . 0.0 110.515 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -105.71 -14.52 15.23 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.791 -0.568 . . . . 0.0 110.094 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -167.82 145.89 4.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.232 -0.917 . . . . 0.0 109.306 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.2 mm -121.74 125.29 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.561 -0.712 . . . . 0.0 109.079 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.4 mt -118.39 115.56 24.92 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.4 mt -133.38 133.56 42.59 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -75.7 116.33 16.3 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.312 -0.867 . . . . 0.0 109.3 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.499 ' O ' ' C ' ' A' ' 28' ' ' ILE . 13.3 t -114.51 146.96 40.06 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.499 ' C ' ' O ' ' A' ' 27' ' ' THR . 10.0 mm -1.97 -75.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 123.557 0.743 . . . . 0.0 112.932 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.469 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 99.4 mm-40 -59.35 -71.01 0.13 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.438 -0.789 . . . . 0.0 111.749 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.55 -128.24 1.9 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.2 t -116.72 131.81 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.916 0.865 . . . . 0.0 110.711 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.4 tp -100.71 129.86 46.67 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.7 m -110.21 120.69 43.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.6 mt -105.32 124.04 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -118.41 141.32 48.66 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.754 0.788 . . . . 0.0 109.35 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.58 -138.56 3.36 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.401 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.78 132.35 43.71 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.48 -1.012 . . . . 0.0 108.353 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp 39.72 86.13 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.642 0.734 . . . . 0.0 110.646 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 8.2 mp -96.8 72.12 2.58 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.686 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.539 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 46' ' ' LEU . 9.5 mp . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.506 0.67 . . . . 0.0 109.584 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -63.35 -51.12 67.23 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.495 -0.753 . . . . 0.0 109.542 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.06 49.31 0.78 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.457 -0.777 . . . . 0.0 109.872 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.99 20.31 79.92 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -104.23 159.68 15.5 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.294 -1.121 . . . . 0.0 109.032 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.7 t -122.22 133.08 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.539 ' N ' ' OE1' ' A' ' 52' ' ' GLU . 13.3 mp0 -131.67 146.68 52.31 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.501 0.667 . . . . 0.0 109.428 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.1 t -129.06 134.41 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -117.32 134.76 54.43 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.694 0.759 . . . . 0.0 109.243 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.83 -176.05 34.21 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.71 120.92 41.91 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.9 mt -83.76 116.9 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.056 -1.028 . . . . 0.0 109.772 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -96.99 -15.42 21.09 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.481 -0.762 . . . . 0.0 109.81 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.6 152.96 8.67 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.083 -1.011 . . . . 0.0 110.446 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.401 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 8.8 mt -138.63 134.97 34.41 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 49.7 t -130.86 124.91 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.496 -0.753 . . . . 0.0 109.421 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.556 ' O ' ' N ' ' A' ' 64' ' ' LEU . 33.7 t80 -133.63 111.54 12.55 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.12 78.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.413 1.409 . . . . 0.0 112.326 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -75.08 84.14 2.31 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.528 -1.358 . . . . 0.0 108.667 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -163.47 126.63 2.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.562 -0.711 . . . . 0.0 109.555 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.627 ' CE1' ' ND1' ' A' ' 67' ' ' HIS . 14.9 p-80 -88.23 11.04 17.53 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.627 ' ND1' ' CE1' ' A' ' 66' ' ' HIS . 27.8 p-80 -152.44 165.07 36.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.582 -0.699 . . . . 0.0 109.659 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -153.97 41.36 0.51 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -167.48 -177.92 3.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.393 -0.817 . . . . 0.0 109.68 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.467 ' O ' ' OXT' ' A' ' 71' ' ' HIS . 1.4 p-80 -153.86 -55.49 0.11 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.193 -0.942 . . . . 0.0 109.29 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.467 ' OXT' ' O ' ' A' ' 70' ' ' HIS . 71.3 m-70 . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 117.903 -1.046 . . . . 0.0 109.838 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 78.8 mtm . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.444 0.64 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 13.7 t0 62.88 33.44 15.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.529 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' B' ' 3' ' ' ASN . 10.7 p-10 -90.2 -5.73 56.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.378 -0.826 . . . . 0.0 109.809 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 38.6 mmm-85 -72.18 141.22 49.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.295 -0.878 . . . . 0.0 109.166 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -146.61 150.78 36.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.359 -0.838 . . . . 0.0 109.477 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -98.49 144.82 27.42 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 7.0 tt -127.79 125.9 40.71 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -122.17 145.44 48.19 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.533 -0.73 . . . . 0.0 110.126 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.6 tp -153.17 149.29 27.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.4 t -151.15 159.06 44.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.089 -1.007 . . . . 0.0 109.885 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.49 15.07 72.13 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.6 p -62.3 153.03 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -1.079 . . . . 0.0 110.378 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 67.1 m -73.71 -54.07 8.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.15 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.41 153.34 4.3 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.2 -0.937 . . . . 0.0 109.614 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 79.8 t -86.22 130.12 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.416 -0.802 . . . . 0.0 109.886 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -92.8 -23.82 18.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.291 -0.88 . . . . 0.0 109.378 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 21.5 t -171.55 158.16 5.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.133 -0.98 . . . . 0.0 109.893 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -147.52 112.27 5.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.401 -0.812 . . . . 0.0 109.492 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . 0.458 ' OD2' ' O ' ' B' ' 22' ' ' GLU . 1.1 m-20 -133.18 152.88 80.35 Favored Pre-proline 0 N--CA 1.5 2.067 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.58 -12.61 36.23 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.654 1.569 . . . . 0.0 111.556 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -125.88 2.48 7.37 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.574 -0.704 . . . . 0.0 109.563 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.458 ' O ' ' OD2' ' B' ' 19' ' ' ASP . 55.1 tt0 -160.85 119.63 2.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.334 -0.853 . . . . 0.0 109.256 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.6 mt -129.02 127.87 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.173 -0.955 . . . . 0.0 109.416 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 79.3 mt -108.77 134.92 50.82 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 93.7 mt -135.05 123.42 23.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.349 -0.845 . . . . 0.0 109.7 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -93.93 123.17 37.11 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.566 ' O ' ' N ' ' B' ' 29' ' ' GLN . 7.0 t -123.58 149.45 45.28 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.606 0.717 . . . . 0.0 109.886 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 16.7 mt 45.04 -85.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.922 -0.486 . . . . 0.0 110.218 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' B' ' 27' ' ' THR . 17.1 pt20 -142.88 -20.62 0.65 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.08 -1.013 . . . . 0.0 110.201 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.98 171.59 35.88 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -116.54 131.4 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.879 -0.777 . . . . 0.0 109.125 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 31.8 tp -112.76 127.17 56.08 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.42 0.629 . . . . 0.0 109.485 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 40.5 t -108.94 123.46 49.13 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 39.3 mm -99.71 128.15 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -133.06 125.64 30.08 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.83 -139.5 2.65 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -137.94 136.93 37.47 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.349 -1.089 . . . . 0.0 109.99 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 54.84 57.84 5.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.467 -0.771 . . . . 0.0 110.09 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.497 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 8.8 mp -85.15 72.15 10.8 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.791 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -178.716 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 66.3 mt . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.696 0.76 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -82.6 133.67 35.18 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.313 0.578 . . . . 0.0 109.479 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . 51.3 16.42 0.4 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.32 -0.862 . . . . 0.0 110.261 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.24 25.23 37.47 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 120.823 -1.173 . . . . 0.0 110.185 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -137.24 159.71 41.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.257 -1.143 . . . . 0.0 109.089 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 5.8 p -127.86 136.88 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -146.45 159.6 43.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.236 -0.915 . . . . 0.0 110.131 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.15 159.38 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.691 -0.63 . . . . 0.0 109.513 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -127.81 142.11 51.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.435 -0.79 . . . . 0.0 109.139 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.27 -177.76 31.49 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.66 128.81 52.82 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.406 HG23 HD13 ' B' ' 57' ' ' ILE . 30.6 mm -78.61 125.34 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.073 -1.017 . . . . 0.0 109.656 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -110.09 -9.85 14.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.658 -0.652 . . . . 0.0 109.478 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -174.24 149.29 1.38 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.096 -1.002 . . . . 0.0 110.095 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 13.0 mt -138.34 137.5 37.42 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 t -134.42 122.74 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.491 -0.755 . . . . 0.0 109.982 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.401 ' CG ' ' HB2' ' A' ' 60' ' ' LEU . 26.9 t80 -140.33 106.08 6.6 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -50.59 113.05 0.89 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.302 1.334 . . . . 0.0 112.336 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.606 ' CD1' ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -93.61 5.79 50.44 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.187 -0.946 . . . . 0.0 108.922 179.066 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.05 123.9 32.63 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.547 -0.721 . . . . 0.0 110.119 -179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -88.25 -70.02 0.66 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.411 -0.805 . . . . 0.0 109.655 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.51 ' C ' ' H ' ' B' ' 69' ' ' HIS . 54.1 m80 -110.57 120.34 42.11 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' B' ' 70' ' ' HIS . 28.8 m80 -71.99 14.55 0.21 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.55 -0.719 . . . . 0.0 110.006 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.51 ' H ' ' C ' ' B' ' 67' ' ' HIS . 75.5 m80 59.04 -68.76 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.281 0.562 . . . . 0.0 110.397 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.644 ' ND1' ' N ' ' B' ' 70' ' ' HIS . 0.1 OUTLIER -57.04 -165.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.905 . . . . 0.0 110.52 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.037 -179.624 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.2 mtp . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.929 0.871 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 54.5 p-10 -146.61 -157.01 0.76 Allowed 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.778 -0.576 . . . . 0.0 109.499 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -107.66 1.84 23.42 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.305 -0.872 . . . . 0.0 109.934 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -71.18 146.67 48.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 109.649 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -150.2 160.12 43.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.37 -0.831 . . . . 0.0 109.174 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -100.08 141.56 32.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.377 -0.827 . . . . 0.0 109.053 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 tt -133.76 123.85 25.61 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.4 t -131.88 139.62 48.84 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.736 -0.603 . . . . 0.0 109.556 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.8 tp -133.3 147.62 51.9 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p -130.71 159.12 38.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.526 -0.734 . . . . 0.0 109.544 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.95 21.05 69.04 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.35 137.05 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -1.154 . . . . 0.0 109.898 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.5 m -73.12 -44.35 60.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.206 -0.934 . . . . 0.0 109.796 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.56 163.2 5.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.163 -0.961 . . . . 0.0 109.564 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.0 t -93.99 127.71 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.282 -0.886 . . . . 0.0 109.433 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -85.19 -30.92 23.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.046 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.509 ' HG ' ' H ' ' A' ' 18' ' ' PHE . 47.8 t -174.01 167.26 4.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.516 -0.74 . . . . 0.0 109.293 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.509 ' H ' ' HG ' ' A' ' 17' ' ' SER . 9.7 t80 -149.77 106.54 3.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.344 -0.847 . . . . 0.0 108.856 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.62 126.02 19.81 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -47.24 -24.21 3.58 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.361 1.374 . . . . 0.0 112.228 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -90.7 -8.15 50.67 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.985 -1.072 . . . . 0.0 109.98 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -176.65 141.58 0.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.472 -0.767 . . . . 0.0 109.081 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mt -130.76 130.58 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.105 -0.997 . . . . 0.0 109.085 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.1 mt -114.35 125.0 53.36 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.8 mt -124.33 131.35 53.51 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.566 -0.709 . . . . 0.0 109.624 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -95.28 122.59 38.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.401 -0.812 . . . . 0.0 109.162 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 29' ' ' GLN . 2.9 t -124.18 148.67 47.08 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.44 0.638 . . . . 0.0 110.348 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' A' ' 27' ' ' THR . 60.0 mt 38.09 -90.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.971 -0.455 . . . . 0.0 110.5 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.525 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.1 pt20 -136.47 -15.79 1.62 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.227 -0.921 . . . . 0.0 109.786 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.21 153.82 20.06 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.1 t -111.13 131.05 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.553 -0.969 . . . . 0.0 108.39 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.8 tp -107.34 124.07 49.27 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.693 -0.629 . . . . 0.0 109.633 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.1 m -107.49 120.36 41.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.1 mt -104.73 127.11 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.52 127.64 52.37 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.96 -148.61 5.38 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -142.79 139.23 30.91 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm 57.25 63.3 1.92 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.524 -0.735 . . . . 0.0 110.315 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.488 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 9.0 mp -94.73 72.06 3.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.268 -0.895 . . . . 0.0 109.023 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.367 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.533 -179.087 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 47.8 tp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.216 0.532 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.566 ' C ' ' H ' ' A' ' 49' ' ' GLY . 63.2 pttt -172.39 -175.45 1.38 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.324 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.439 ' O ' ' OE1' ' A' ' 50' ' ' GLN . . . 65.78 -15.51 0.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.415 -0.803 . . . . 0.0 110.204 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 47' ' ' LYS . . . 82.49 20.4 62.16 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 48' ' ' ALA . 20.9 mp0 -122.49 151.63 41.13 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.397 -1.061 . . . . 0.0 108.974 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.58 135.47 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.509 -0.744 . . . . 0.0 109.422 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -126.93 137.9 53.2 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.5 t -137.48 141.08 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -0.799 . . . . 0.0 108.951 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -114.96 125.21 53.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.497 -0.752 . . . . 0.0 109.033 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.49 166.17 27.12 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.592 ' CD1' ' H ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -86.77 151.42 23.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.52 -0.988 . . . . 0.0 110.772 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.9 mt -103.46 119.28 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.832 -1.167 . . . . 0.0 109.168 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -112.5 -11.94 13.55 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.405 -0.81 . . . . 0.0 108.995 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.78 149.03 6.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.105 -0.997 . . . . 0.0 110.086 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.5 mt -138.08 141.46 40.26 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.62 123.4 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.419 -0.801 . . . . 0.0 109.792 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.548 ' O ' ' N ' ' A' ' 64' ' ' LEU . 13.1 t80 -145.69 136.66 12.48 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -44.67 88.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.288 0 CA-C-N 120.22 1.114 . . . . 0.0 111.492 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 62' ' ' TYR . 1.7 tt -58.88 -14.01 7.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.245 -0.909 . . . . 0.0 109.33 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -159.91 -118.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.111 -0.993 . . . . 0.0 108.854 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.34 146.42 34.41 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.395 -0.815 . . . . 0.0 109.615 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.584 ' ND1' ' C ' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -75.93 141.33 42.3 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.447 ' O ' ' C ' ' A' ' 69' ' ' HIS . 48.1 m170 -116.95 139.93 50.07 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.683 ' ND1' ' N ' ' A' ' 69' ' ' HIS . 0.1 OUTLIER -38.91 111.01 0.15 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.491 ' O ' ' CD2' ' A' ' 70' ' ' HIS . 0.1 OUTLIER -42.04 144.61 0.43 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.563 -0.711 . . . . 0.0 110.777 -177.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.386 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.28 0.562 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -148.51 99.98 3.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.259 -0.901 . . . . 0.0 110.088 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -106.52 4.83 28.61 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.458 -0.776 . . . . 0.0 109.335 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.3 mmm-85 -77.25 141.84 39.8 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.407 -0.808 . . . . 0.0 109.12 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -147.63 161.3 41.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.213 -0.93 . . . . 0.0 109.591 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -116.52 130.77 56.93 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.4 tt -123.12 121.81 36.91 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 97.8 p -114.0 145.76 41.1 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.7 -0.625 . . . . 0.0 109.695 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 34.1 tp -148.09 144.2 27.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.357 -0.839 . . . . 0.0 109.259 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 46.0 p -130.93 170.07 14.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.616 -0.677 . . . . 0.0 109.577 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.02 11.04 77.3 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 83.4 t -72.24 133.75 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -1.166 . . . . 0.0 109.684 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.8 t -72.28 -45.37 60.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.313 -0.867 . . . . 0.0 109.605 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.21 163.06 8.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.077 -1.014 . . . . 0.0 109.658 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 98.1 t -84.67 110.55 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.869 . . . . 0.0 109.979 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -66.35 -41.05 90.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 0.0 109.16 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 5.5 p -160.19 163.96 33.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.338 -0.851 . . . . 0.0 108.963 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -151.21 110.68 3.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.006 -1.058 . . . . 0.0 110.073 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.25 150.0 74.76 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.01 -16.5 49.66 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.612 1.541 . . . . 0.0 111.479 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -111.67 -1.97 15.53 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.557 -0.714 . . . . 0.0 109.517 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -170.86 130.63 0.81 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.169 -0.957 . . . . 0.0 109.286 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -129.73 132.07 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.231 -0.918 . . . . 0.0 109.847 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 89.5 mt -111.4 125.57 54.01 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 76.4 mt -121.73 124.83 45.16 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.667 -0.646 . . . . 0.0 109.357 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -93.32 113.52 25.72 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.576 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.7 t -124.95 154.04 41.79 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.447 0.641 . . . . 0.0 110.028 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 18.5 mm 42.22 -86.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.883 -0.51 . . . . 0.0 110.339 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' B' ' 27' ' ' THR . 18.7 pt20 -143.51 -17.0 0.63 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.018 -1.051 . . . . 0.0 110.232 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.94 178.05 30.6 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.84 134.35 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 54.8 tp -105.42 127.28 52.9 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.368 -0.833 . . . . 0.0 109.463 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.7 m -116.55 120.69 39.52 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.716 . . . . 0.0 109.645 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 92.1 mt -109.85 129.91 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -127.92 143.22 51.1 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.627 -0.67 . . . . 0.0 109.423 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.61 -142.53 7.58 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.523 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -123.0 143.72 49.74 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.627 -0.925 . . . . 0.0 109.069 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' B' ' 54' ' ' GLU . 49.5 mtmt 51.77 63.32 2.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.341 -0.849 . . . . 0.0 111.184 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 8.7 mp -94.88 70.7 3.41 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.979 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.347 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 11.3 mp . . . . . 0 N--CA 1.507 2.376 0 CA-C-O 121.91 0.862 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -148.69 -43.6 0.15 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.433 -1.417 . . . . 0.0 108.318 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.54 1.94 35.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.638 -0.664 . . . . 0.0 109.573 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.63 21.43 72.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -87.92 160.05 18.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.423 -1.045 . . . . 0.0 109.563 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 16.3 m -125.86 133.25 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.606 -0.684 . . . . 0.0 109.292 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -120.07 143.24 48.23 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.422 -0.799 . . . . 0.0 108.941 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.7 t -124.17 135.59 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.629 -0.669 . . . . 0.0 109.513 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' B' ' 38' ' ' LYS . 44.0 tt0 -125.94 135.05 51.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.62 -177.1 27.09 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.67 127.2 45.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.347 -1.09 . . . . 0.0 108.556 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.497 ' CD1' ' N ' ' B' ' 57' ' ' ILE . 1.3 mp -79.8 128.06 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.925 . . . . 0.0 109.752 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -108.93 -39.54 5.29 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.29 149.66 32.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 110.094 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.69 131.21 42.9 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.09 128.77 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' B' ' 62' ' ' TYR . 19.8 t80 -143.53 140.06 17.07 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.57 85.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 120.986 1.124 . . . . 0.0 112.051 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.558 ' H ' ' CD2' ' B' ' 64' ' ' LEU . 0.9 OUTLIER -95.29 5.01 52.86 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.54 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.92 -18.96 2.31 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.458 -0.776 . . . . 0.0 109.64 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.467 ' C ' ' ND1' ' B' ' 67' ' ' HIS . 14.8 m-70 56.55 174.78 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.89 0.852 . . . . 0.0 110.173 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.467 ' ND1' ' C ' ' B' ' 66' ' ' HIS . 0.0 OUTLIER 52.33 169.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.03 0.919 . . . . 0.0 110.438 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -172.91 155.95 3.24 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -86.31 21.76 1.98 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.602 ' ND1' ' N ' ' B' ' 71' ' ' HIS . 0.2 OUTLIER -68.4 133.14 48.22 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 121.831 0.824 . . . . 0.0 109.196 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.602 ' N ' ' ND1' ' B' ' 70' ' ' HIS . 24.5 t-80 . . . . . 0 C--N 1.295 -1.795 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.291 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.388 0.614 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.7 t0 58.79 33.28 22.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.329 -0.857 . . . . 0.0 108.861 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -100.87 13.24 35.7 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.509 -0.744 . . . . 0.0 109.182 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -88.84 132.1 34.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.104 -0.997 . . . . 0.0 108.87 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -147.75 161.07 41.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.994 -1.066 . . . . 0.0 109.346 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -108.52 131.17 55.09 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.3 tt -117.82 121.77 41.63 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.8 t -116.04 132.34 56.68 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.538 -0.726 . . . . 0.0 109.657 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.5 tp -147.31 153.72 40.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.361 -0.837 . . . . 0.0 109.317 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.463 ' OG1' ' N ' ' A' ' 11' ' ' GLY . 6.1 t -149.85 -164.54 2.05 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.36 -0.838 . . . . 0.0 109.847 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.463 ' N ' ' OG1' ' A' ' 10' ' ' THR . . . 65.24 19.38 66.2 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.5 t -70.25 141.66 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.677 -0.896 . . . . 0.0 110.617 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.3 m -71.78 -43.5 65.6 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.91 160.36 3.55 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.234 -0.916 . . . . 0.0 109.918 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.2 t -88.66 129.96 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.4 -0.812 . . . . 0.0 109.852 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -97.34 -35.1 10.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.386 -0.821 . . . . 0.0 109.23 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.8 t -169.67 145.61 3.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.566 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -137.61 113.94 10.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.513 -0.742 . . . . 0.0 109.132 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -133.24 153.56 80.73 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.03 -20.08 44.82 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.295 1.997 . . . . 0.0 111.605 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -102.07 -4.56 25.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.539 -0.726 . . . . 0.0 109.318 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -172.87 142.04 1.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.444 -0.785 . . . . 0.0 109.045 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.421 HD12 HG22 ' A' ' 23' ' ' ILE . 95.8 mt -132.48 130.24 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.427 -0.796 . . . . 0.0 109.725 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.5 mt -118.06 121.44 40.59 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.6 mt -124.37 125.09 43.73 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -81.76 114.75 20.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.347 -0.846 . . . . 0.0 109.924 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 28' ' ' ILE . 14.5 t -124.68 -179.52 4.54 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.659 0.742 . . . . 0.0 110.215 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.492 ' O ' ' O ' ' A' ' 27' ' ' THR . 1.3 mt -36.51 161.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 121.736 0.779 . . . . 0.0 110.414 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.414 ' OE1' ' OD1' ' B' ' 58' ' ' ASP . 78.6 mm-40 65.12 -61.9 0.22 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.139 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.41 ' O ' ' O ' ' A' ' 27' ' ' THR . . . -165.94 -127.26 0.88 Allowed Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.093 -1.527 . . . . 0.0 109.962 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.6 t -122.37 135.18 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.593 -0.945 . . . . 0.0 110.338 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.8 tp -105.55 125.41 50.96 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.8 m -103.61 123.0 46.16 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -107.75 125.02 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -116.57 140.83 48.95 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.47 -151.38 9.43 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -143.32 146.39 33.51 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.337 -1.096 . . . . 0.0 109.024 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 54' ' ' GLU . 67.5 mttm 58.33 55.22 5.14 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.486 0.66 . . . . 0.0 109.68 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.435 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 10.7 mp -92.9 72.64 4.81 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.849 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -179.125 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.6 tp . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.578 0.704 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -144.4 -83.94 0.15 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.735 -0.603 . . . . 0.0 109.399 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.53 -5.39 58.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 0.0 109.415 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.44 18.97 79.96 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -91.6 162.15 14.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.17 -1.194 . . . . 0.0 109.859 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.4 t -115.05 131.97 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -131.16 136.56 48.42 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.76 135.01 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 38' ' ' LYS . 5.1 tm-20 -116.89 126.55 53.16 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.0 -174.61 41.62 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.211 -1.471 . . . . 0.0 110.032 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.42 118.21 36.06 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.809 -0.818 . . . . 0.0 109.387 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.52 ' CD1' ' N ' ' A' ' 57' ' ' ILE . 1.4 mp -74.05 128.08 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.337 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -105.73 -21.9 13.07 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.89 158.28 12.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.991 -1.068 . . . . 0.0 110.834 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.64 135.34 40.1 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.8 t -133.96 119.94 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.436 -0.79 . . . . 0.0 109.63 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.402 ' O ' ' N ' ' A' ' 64' ' ' LEU . 29.2 t80 -133.46 140.06 35.85 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.77 68.4 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.602 1.535 . . . . 0.0 111.924 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -71.54 55.08 0.24 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.734 -0.604 . . . . 0.0 109.689 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' A' ' 67' ' ' HIS . 8.1 pt-20 -39.56 -23.53 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.997 -1.065 . . . . 0.0 109.974 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.573 ' N ' ' O ' ' A' ' 64' ' ' LEU . 2.0 t-80 51.16 11.41 0.1 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.691 -0.631 . . . . 0.0 109.616 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.526 ' ND1' ' OXT' ' A' ' 71' ' ' HIS . 12.2 t-80 -140.11 119.57 13.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.425 -0.797 . . . . 0.0 109.766 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.431 ' CD2' ' N ' ' A' ' 68' ' ' HIS . 0.4 OUTLIER -74.58 144.75 43.82 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.651 0.739 . . . . 0.0 110.151 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.706 ' CD2' ' H ' ' A' ' 70' ' ' HIS . 9.1 t-160 60.79 173.17 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.39 0.614 . . . . 0.0 110.677 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.706 ' H ' ' CD2' ' A' ' 69' ' ' HIS . 15.2 m80 44.4 -115.06 0.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.526 ' OXT' ' ND1' ' A' ' 67' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 117.873 -1.061 . . . . 0.0 109.196 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.6 ttm . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.315 0.579 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 21.6 t0 56.02 69.0 0.78 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.355 -0.84 . . . . 0.0 109.635 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -104.27 17.52 23.95 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 47.2 mmm-85 -88.66 137.77 32.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.657 -1.277 . . . . 0.0 109.451 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -139.05 149.92 45.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.295 -0.878 . . . . 0.0 109.502 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -109.46 129.55 55.55 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.9 tt -122.69 122.49 38.88 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 41.6 t -123.14 137.26 54.95 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.6 tp -145.25 151.59 38.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.221 -0.924 . . . . 0.0 109.835 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -140.49 159.74 41.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.708 -0.62 . . . . 0.0 109.629 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.47 24.19 26.86 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 p -62.62 141.37 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.166 -1.197 . . . . 0.0 110.034 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 10.0 m -92.28 -21.35 20.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.411 -0.806 . . . . 0.0 109.26 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -171.8 154.2 3.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.555 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 75.5 t -102.67 99.16 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -67.36 -40.55 85.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 109.07 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 25.8 t -170.76 167.97 7.49 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.408 -0.808 . . . . 0.0 109.523 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -149.7 105.2 3.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.532 -0.73 . . . . 0.0 109.123 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -132.77 147.82 67.04 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.59 -14.59 39.9 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 121.7 1.6 . . . . 0.0 111.735 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -104.05 -8.01 19.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.548 -0.72 . . . . 0.0 109.534 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -173.18 113.19 0.23 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.371 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.401 HG23 HD11 ' B' ' 23' ' ' ILE . 97.3 mt -109.35 127.14 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.235 -0.916 . . . . 0.0 109.221 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 68.4 mt -117.69 123.43 46.06 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 88.5 mt -131.22 129.49 41.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.465 -0.772 . . . . 0.0 109.391 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.2 111.47 17.65 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.604 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.487 ' O ' ' O ' ' B' ' 28' ' ' ILE . 12.9 t -124.39 -176.94 3.64 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.571 0.7 . . . . 0.0 110.29 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' B' ' 27' ' ' THR . 1.9 mt -32.62 157.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.886 0.85 . . . . 0.0 110.951 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 64.6 -62.45 0.18 Allowed 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.939 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' B' ' 28' ' ' ILE . . . -166.34 -120.09 0.5 Allowed Glycine 0 N--CA 1.486 1.968 0 C-N-CA 119.225 -1.464 . . . . 0.0 110.202 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 53.1 t -119.4 135.03 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.676 -0.897 . . . . 0.0 110.539 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 59.0 tp -109.33 123.38 49.22 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.4 t -107.4 123.66 48.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.792 -0.567 . . . . 0.0 109.989 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 94.6 mt -108.52 122.37 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -117.6 142.44 47.2 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.599 -0.688 . . . . 0.0 109.457 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.61 -146.74 8.71 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -139.1 142.06 38.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.365 -1.08 . . . . 0.0 109.489 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 88.9 mttt 56.21 57.1 5.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.668 -0.645 . . . . 0.0 109.798 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.479 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 8.6 mp -92.99 71.53 4.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.345 -0.847 . . . . 0.0 108.912 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . 0.41 ' O ' ' OE1' ' B' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 121.567 0.698 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -63.98 -46.74 83.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.607 -0.683 . . . . 0.0 109.463 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -169.71 47.77 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.384 -0.822 . . . . 0.0 108.816 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.91 17.62 62.91 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -125.15 154.58 41.28 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.316 -1.108 . . . . 0.0 109.399 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 m -124.07 133.12 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.652 -0.655 . . . . 0.0 109.381 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -126.35 127.96 46.32 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.92 140.68 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.46 -0.775 . . . . 0.0 109.91 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.41 ' OE1' ' O ' ' B' ' 40' ' ' GLY . 5.3 mp0 -114.99 139.58 49.73 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.92 170.66 26.97 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.16 131.33 38.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.242 -1.152 . . . . 0.0 109.469 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 44.2 mm -87.66 113.98 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.099 -1.001 . . . . 0.0 108.862 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . 0.414 ' OD1' ' OE1' ' A' ' 29' ' ' GLN . 18.2 t0 -97.68 -7.0 31.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.593 -0.692 . . . . 0.0 109.222 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -177.19 154.85 1.09 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.048 -1.032 . . . . 0.0 110.823 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 mt -139.93 138.46 35.61 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.3 t -134.14 129.8 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.507 -0.746 . . . . 0.0 109.216 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.666 ' O ' ' N ' ' B' ' 64' ' ' LEU . 65.1 t80 -143.2 123.0 7.71 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' B' ' 65' ' ' GLU . 71.0 Cg_exo -48.44 71.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 121.983 1.788 . . . . 0.0 111.91 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.666 ' N ' ' O ' ' B' ' 62' ' ' TYR . 0.3 OUTLIER -71.53 40.89 0.07 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.886 0.851 . . . . 0.0 109.975 -179.128 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.494 ' H ' ' C ' ' B' ' 63' ' ' PRO . 13.7 mt-10 -86.58 116.57 24.79 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.265 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.513 ' C ' ' H ' ' B' ' 68' ' ' HIS . 65.1 t60 -95.07 170.06 9.68 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.503 ' O ' ' O ' ' B' ' 68' ' ' HIS . 5.3 t60 64.92 -45.0 0.34 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.513 ' H ' ' C ' ' B' ' 66' ' ' HIS . 0.1 OUTLIER 54.76 117.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.545 -0.722 . . . . 0.0 109.421 178.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.46 ' C ' ' O ' ' B' ' 68' ' ' HIS . 6.1 t-160 -33.54 91.7 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.289 0.566 . . . . 0.0 111.344 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' B' ' 68' ' ' HIS . 17.3 t-160 -89.69 -5.27 57.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.318 -0.864 . . . . 0.0 109.1 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.194 -0.941 . . . . 0.0 109.269 -179.707 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.345 0.593 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.32 113.05 24.28 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.377 -0.827 . . . . 0.0 109.556 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -93.35 1.14 57.05 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.368 -0.832 . . . . 0.0 109.705 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.6 mmm-85 -81.61 148.0 29.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.241 -0.912 . . . . 0.0 110.121 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -155.83 160.13 39.96 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.46 -0.775 . . . . 0.0 109.264 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -108.92 138.37 45.36 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.7 tt -126.82 124.72 40.3 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 t -127.81 149.12 50.41 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.0 tp -142.5 146.25 34.53 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.344 -0.848 . . . . 0.0 109.402 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -124.73 167.77 14.11 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.641 -0.662 . . . . 0.0 109.534 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.37 14.96 69.8 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.3 p -68.93 136.76 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -1.12 . . . . 0.0 109.685 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.5 m -73.18 -46.5 50.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.307 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.96 163.1 4.0 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.346 -0.846 . . . . 0.0 109.882 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.2 t -95.18 117.55 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.412 -0.805 . . . . 0.0 109.823 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -68.84 -35.9 77.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.373 -0.83 . . . . 0.0 109.184 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -167.31 161.61 14.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.294 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -151.29 111.47 4.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.394 -0.816 . . . . 0.0 108.97 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -126.9 156.63 73.7 Favored Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.436 -0.79 . . . . 0.0 108.888 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.19 -29.78 84.81 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.776 1.651 . . . . 0.0 112.514 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -117.17 17.71 14.72 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.469 -0.769 . . . . 0.0 110.589 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -171.24 132.36 0.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 0.0 109.168 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.42 HG22 HD11 ' A' ' 23' ' ' ILE . 96.7 mt -133.17 129.94 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.366 -0.834 . . . . 0.0 109.54 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.459 ' CD2' ' OG ' ' A' ' 33' ' ' SER . 64.4 mt -112.93 126.86 55.94 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.1 mt -121.53 132.43 54.7 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.666 -0.647 . . . . 0.0 109.763 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -101.68 113.94 27.54 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 28' ' ' ILE . 9.9 t -124.61 -162.84 1.12 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.396 0.617 . . . . 0.0 110.037 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.462 ' O ' ' C ' ' A' ' 29' ' ' GLN . 63.2 mt -33.48 99.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 28' ' ' ILE . 5.6 pt20 29.58 53.83 0.12 Allowed 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 121.294 0.569 . . . . 0.0 111.558 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.02 145.46 8.16 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.53 131.22 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.516 -0.991 . . . . 0.0 108.908 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.7 tp -108.05 118.31 36.41 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.459 ' OG ' ' CD2' ' A' ' 24' ' ' LEU . 22.8 t -104.64 123.58 47.83 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.1 mt -105.81 129.18 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.438 -0.789 . . . . 0.0 109.433 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -120.38 139.19 53.15 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.78 -149.3 8.82 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -133.19 142.54 48.66 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.373 -1.075 . . . . 0.0 109.456 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.5 mttp 54.63 59.9 3.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.565 -0.71 . . . . 0.0 110.545 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 39' ' ' LEU . 9.0 mp -91.38 74.19 6.08 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.95 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.098 -177.313 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 80.8 mt . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.625 0.726 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -84.3 -72.99 0.44 Allowed 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.571 0.701 . . . . 0.0 109.905 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.79 0.12 57.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.67 -0.644 . . . . 0.0 109.539 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.01 47.49 4.14 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -129.47 160.39 33.3 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.418 -1.048 . . . . 0.0 109.294 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.36 161.48 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.611 -0.681 . . . . 0.0 109.408 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -139.35 137.84 36.11 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.458 -0.776 . . . . 0.0 109.487 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 52.1 t -130.6 136.53 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -123.34 129.58 51.51 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.374 -0.829 . . . . 0.0 108.902 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.4 177.48 33.54 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.79 133.7 39.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.283 -1.128 . . . . 0.0 109.273 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.8 mt -90.54 111.7 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.148 -0.97 . . . . 0.0 109.727 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -99.31 -17.06 18.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.498 -0.751 . . . . 0.0 109.39 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.59 153.22 16.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.074 -1.016 . . . . 0.0 110.248 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.04 136.5 42.13 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 t -135.89 127.44 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.496 -0.752 . . . . 0.0 109.564 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.426 ' C ' ' CD1' ' A' ' 62' ' ' TYR . 9.2 t80 -144.06 139.86 16.39 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -64.19 79.92 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.002 1.135 . . . . 0.0 113.379 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 64' ' ' LEU . 1.4 tm? -103.12 82.28 2.06 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.989 -1.07 . . . . 0.0 108.7 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -135.22 14.31 3.53 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 32.5 m80 53.41 13.99 0.51 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.785 -0.572 . . . . 0.0 111.068 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.467 ' CE1' ' O ' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -139.35 155.58 47.58 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.814 -1.179 . . . . 0.0 109.492 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.467 ' O ' ' CE1' ' A' ' 67' ' ' HIS . 19.0 m80 -104.27 174.28 5.94 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.2 m80 -115.1 -162.89 0.84 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.446 -0.784 . . . . 0.0 110.003 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -62.24 -44.38 96.69 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.8 m80 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.265 -179.76 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ptp . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -86.56 108.85 18.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.394 -0.817 . . . . 0.0 109.645 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -107.46 8.39 29.43 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.366 -0.834 . . . . 0.0 110.121 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -71.44 143.41 50.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.047 -1.033 . . . . 0.0 109.315 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -146.45 152.76 39.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.431 -0.793 . . . . 0.0 109.598 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.598 ' N ' ' CD1' ' B' ' 6' ' ' PHE . 1.5 m-85 -124.18 145.38 49.36 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 7.0 tt -130.7 125.77 34.79 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 31.1 t -107.24 137.65 44.89 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.651 -0.656 . . . . 0.0 109.264 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.2 tp -149.32 155.27 40.26 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.044 -1.035 . . . . 0.0 109.652 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.7 t -149.95 157.86 43.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.131 -0.98 . . . . 0.0 109.273 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.33 12.95 57.99 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 87.0 t -67.29 135.15 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.997 -1.296 . . . . 0.0 109.28 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 33.2 m -71.87 -45.28 61.89 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.641 -0.823 . . . . 0.0 109.809 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.39 159.47 5.68 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.099 -1.001 . . . . 0.0 109.474 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 87.5 t -92.23 129.7 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.309 -0.869 . . . . 0.0 109.747 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -86.71 -26.69 24.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.421 -0.799 . . . . 0.0 109.795 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 32.7 t -171.88 160.74 5.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -0.896 . . . . 0.0 109.05 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -148.37 108.12 4.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.816 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -132.62 131.16 22.01 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.37 -24.73 9.07 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 CA-C-N 119.991 1.032 . . . . 0.0 111.829 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -93.63 -6.53 46.24 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.337 -0.852 . . . . 0.0 110.157 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -171.86 133.2 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.228 -0.92 . . . . 0.0 109.155 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.421 HD13 HG23 ' B' ' 23' ' ' ILE . 94.0 mt -128.12 131.13 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.4 -0.813 . . . . 0.0 109.469 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 17.2 mt -111.86 125.48 54.07 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 80.8 mt -122.34 118.49 28.59 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -89.55 116.5 27.75 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.576 ' O ' ' N ' ' B' ' 29' ' ' GLN . 2.9 t -123.73 149.04 46.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 109.771 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 59.3 mt 46.95 -85.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.079 0.466 . . . . 0.0 110.028 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' B' ' 27' ' ' THR . 28.1 pt20 -143.07 -23.39 0.62 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.089 -1.007 . . . . 0.0 110.786 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.6 171.56 32.04 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 54.9 t -119.92 130.22 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.848 -0.795 . . . . 0.0 108.883 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 48.6 tp -111.23 128.04 55.8 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.78 127.69 56.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 90.4 mt -105.71 126.53 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -119.49 130.63 55.32 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.7 -147.83 6.34 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -133.59 144.25 49.18 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.344 -1.091 . . . . 0.0 109.447 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 53.34 57.02 6.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.523 -0.735 . . . . 0.0 110.584 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 9.3 mp -84.11 73.39 10.4 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.562 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.694 -178.001 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.655 0.741 . . . . 0.0 109.269 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -65.41 -35.82 82.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.635 -0.666 . . . . 0.0 109.706 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.27 -0.55 57.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.394 -0.817 . . . . 0.0 109.855 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.5 19.2 79.64 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -139.45 158.5 44.04 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.404 -1.057 . . . . 0.0 109.15 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 14.8 p -128.17 153.91 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.372 -0.83 . . . . 0.0 109.51 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -141.13 119.46 12.18 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.22 153.85 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.334 -0.854 . . . . 0.0 108.888 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -123.66 133.21 53.94 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.456 0.646 . . . . 0.0 109.49 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.14 163.78 14.79 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.13 140.93 28.98 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.02 -1.282 . . . . 0.0 109.643 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 45.5 mm -84.31 126.17 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.322 -0.861 . . . . 0.0 109.481 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -113.53 -34.71 5.47 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -167.99 146.11 4.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.158 -0.964 . . . . 0.0 110.323 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.31 135.96 53.47 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.12 118.05 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.803 0.811 . . . . 0.0 108.97 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.524 ' O ' ' N ' ' B' ' 64' ' ' LEU . 55.8 t80 -138.66 100.98 8.11 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -46.13 84.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 121.473 1.449 . . . . 0.0 112.341 -177.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' B' ' 62' ' ' TYR . 0.2 OUTLIER -74.21 78.6 1.79 Allowed 'General case' 0 C--N 1.306 -1.288 0 O-C-N 120.884 -1.135 . . . . 0.0 108.883 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -156.96 147.93 21.82 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -46.54 119.89 2.63 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.884 -1.135 . . . . 0.0 109.737 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.506 ' C ' ' H ' ' B' ' 69' ' ' HIS . 0.1 OUTLIER -67.39 -104.56 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.771 -0.58 . . . . 0.0 110.899 -178.488 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 57.1 7.51 0.44 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.146 -0.971 . . . . 0.0 108.458 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.506 ' H ' ' C ' ' B' ' 67' ' ' HIS . 9.2 t-80 -170.98 125.24 0.66 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.534 ' N ' ' CD2' ' B' ' 70' ' ' HIS . 0.0 OUTLIER -121.49 157.63 30.21 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 4.6 t60 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.803 -1.094 . . . . 0.0 108.796 179.359 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ptt? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -147.98 25.04 1.04 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.405 HD21 ' CB ' ' A' ' 56' ' ' LEU . 8.5 p-10 -102.51 -24.0 13.85 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.554 0.692 . . . . 0.0 109.306 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.538 ' NH1' ' N ' ' A' ' 55' ' ' GLY . 7.6 mmm180 -54.08 148.33 11.14 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.322 -0.861 . . . . 0.0 109.743 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -155.16 159.09 39.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.529 -0.732 . . . . 0.0 110.167 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -99.62 148.94 23.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.629 -0.67 . . . . 0.0 109.366 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.0 tt -138.5 126.63 22.75 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.176 -0.952 . . . . 0.0 108.457 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.0 m -123.77 141.67 51.81 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.436 -0.79 . . . . 0.0 109.563 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.4 tp -150.76 145.64 25.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.386 -0.821 . . . . 0.0 109.354 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 p -137.92 172.14 13.37 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.462 -0.774 . . . . 0.0 109.09 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.62 20.85 59.19 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.91 134.84 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.028 -1.278 . . . . 0.0 110.067 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.1 m -74.71 -53.6 8.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.885 . . . . 0.0 109.841 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.14 156.19 28.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.042 -1.036 . . . . 0.0 109.835 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.1 t -88.92 129.5 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.348 -0.845 . . . . 0.0 109.841 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -97.98 -36.34 10.17 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.163 -0.961 . . . . 0.0 109.316 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.7 t -170.8 148.24 2.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.887 . . . . 0.0 108.907 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -141.49 110.78 6.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.343 -0.848 . . . . 0.0 109.142 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -133.48 144.58 52.83 Favored Pre-proline 0 N--CA 1.503 2.189 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.73 -35.67 48.62 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.027 1.152 . . . . 0.0 111.565 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -63.15 -45.09 93.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.2 -0.938 . . . . 0.0 110.0 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -156.83 156.15 32.72 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.393 -0.817 . . . . 0.0 109.089 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.5 mt -120.25 131.47 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.639 -0.663 . . . . 0.0 109.966 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.3 mt -112.93 116.62 30.27 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 mt -127.03 135.54 50.95 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.389 -0.819 . . . . 0.0 109.292 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -97.48 119.26 35.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.146 -0.971 . . . . 0.0 109.216 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.563 ' OG1' ' NE2' ' B' ' 5' ' ' GLN . 8.9 t -124.57 158.99 31.66 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.301 0.572 . . . . 0.0 110.348 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 27' ' ' THR . 44.8 mt 32.26 -86.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 CA-C-O 121.125 0.488 . . . . 0.0 111.261 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 27' ' ' THR . 24.9 pt20 -150.33 47.71 0.9 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.191 -0.943 . . . . 0.0 109.943 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -171.45 142.31 6.92 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.6 t -90.19 132.64 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.4 -1.059 . . . . 0.0 109.559 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.9 tp -106.95 125.09 50.55 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.6 t -113.05 124.46 52.66 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.6 mt -108.31 123.88 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -112.91 137.34 51.44 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.577 0.703 . . . . 0.0 109.558 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.92 -149.52 10.03 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -137.31 144.56 42.67 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.337 -1.096 . . . . 0.0 109.492 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp 56.1 59.01 3.94 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.726 0.774 . . . . 0.0 109.438 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.497 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 8.1 mp -92.23 73.86 5.39 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.572 0 C-N-CA 119.939 -1.124 . . . . 0.0 110.528 -178.355 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.8 tp . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -160.11 -74.09 0.07 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.0 108.669 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.07 -2.64 41.43 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.598 -0.689 . . . . 0.0 109.225 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.74 22.75 78.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -82.17 161.19 22.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.33 -1.1 . . . . 0.0 109.215 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.98 135.46 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.472 -0.768 . . . . 0.0 109.397 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -126.49 131.7 51.57 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.455 0.645 . . . . 0.0 109.588 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -120.58 136.25 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -130.08 146.33 51.74 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.538 ' N ' ' NH1' ' A' ' 4' ' ' ARG . . . 149.1 -175.57 28.27 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.405 ' CB ' HD21 ' A' ' 3' ' ' ASN . 2.4 pp -97.06 127.42 43.01 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.058 -1.26 . . . . 0.0 109.667 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.4 mm -87.32 120.91 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.273 -0.892 . . . . 0.0 109.837 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -105.7 -12.4 15.93 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.524 -0.735 . . . . 0.0 109.592 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -174.07 156.66 2.74 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.084 -1.01 . . . . 0.0 110.259 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.9 mt -138.7 135.48 34.83 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 77.7 t -128.08 128.88 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.554 -0.716 . . . . 0.0 109.248 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.434 ' CE1' ' O ' ' A' ' 63' ' ' PRO . 29.9 t80 -145.03 140.09 15.8 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.434 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 90.0 Cg_endo -80.3 113.01 2.85 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.442 1.428 . . . . 0.0 112.129 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -106.09 3.36 28.02 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.208 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.87 157.62 34.78 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.982 0.896 . . . . 0.0 110.891 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.489 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 2.6 p-80 -153.46 -107.76 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.586 ' CE1' ' CE1' ' A' ' 70' ' ' HIS . 1.7 t60 -166.87 115.34 0.85 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.907 -1.12 . . . . 0.0 109.796 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 69' ' ' HIS . 2.7 t-160 -148.29 102.32 3.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.135 -0.978 . . . . 0.0 108.96 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.49 ' CE1' ' O ' ' A' ' 70' ' ' HIS . 26.0 t-80 56.72 118.64 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.601 0.715 . . . . 0.0 110.138 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.586 ' CE1' ' CE1' ' A' ' 67' ' ' HIS . 4.8 m-70 -72.04 137.61 47.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.198 -0.939 . . . . 0.0 109.559 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.8 p80 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.325 179.662 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 29.9 tpp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -130.22 94.64 3.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.458 -0.776 . . . . 0.0 109.028 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -95.81 1.88 53.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.381 -0.825 . . . . 0.0 109.255 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -69.37 142.45 53.94 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.372 -0.83 . . . . 0.0 109.121 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . 0.563 ' NE2' ' OG1' ' A' ' 27' ' ' THR . 76.1 mt-30 -144.63 153.11 41.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.274 -0.891 . . . . 0.0 109.857 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -114.66 129.16 56.64 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.8 tt -120.63 124.63 45.73 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.386 -0.821 . . . . 0.0 109.102 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 7.6 m -118.98 138.37 52.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.664 -0.647 . . . . 0.0 109.338 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 53.7 tp -146.64 140.87 26.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 0.0 109.23 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' B' ' 10' ' ' THR . 1.0 OUTLIER -134.22 106.34 7.09 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.79 48.35 0.03 OUTLIER Glycine 0 N--CA 1.495 2.571 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.6 p -104.49 131.54 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.542 -0.975 . . . . 0.0 109.67 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 6.3 t -71.21 -43.86 66.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.261 -0.899 . . . . 0.0 109.005 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.81 159.27 5.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.29 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 88.0 t -91.09 127.36 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.131 -0.981 . . . . 0.0 109.59 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -88.35 -23.32 23.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.253 -0.904 . . . . 0.0 109.364 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 32.9 t -172.52 159.78 4.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.322 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -146.09 104.01 3.78 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.054 -1.029 . . . . 0.0 109.73 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.74 150.76 74.34 Favored Pre-proline 0 N--CA 1.497 1.887 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.44 -9.09 22.63 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.449 1.433 . . . . 0.0 111.095 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -99.43 -16.96 18.19 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.388 -0.82 . . . . 0.0 109.437 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.41 ' OE2' ' C ' ' B' ' 23' ' ' ILE . 2.1 tm-20 -173.74 125.04 0.37 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.41 ' C ' ' OE2' ' B' ' 22' ' ' GLU . 77.9 mt -116.04 129.27 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.331 -0.855 . . . . 0.0 109.371 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 86.9 mt -105.18 125.5 51.05 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 88.2 mt -124.06 122.18 37.18 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.659 -0.651 . . . . 0.0 109.697 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -89.65 110.76 21.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.571 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.9 t -124.45 148.91 47.33 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.659 0.742 . . . . 0.0 109.842 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 6.1 mm 51.95 -80.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.839 -0.538 . . . . 0.0 110.024 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' B' ' 27' ' ' THR . 15.3 pt20 -152.1 -21.46 0.18 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.195 -0.94 . . . . 0.0 109.825 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.99 177.87 32.96 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 47.7 t -119.93 132.42 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 38.5 tp -105.86 128.01 53.48 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.411 -0.806 . . . . 0.0 109.363 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 37.0 t -114.39 120.1 39.18 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 86.2 mt -107.19 123.39 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -114.44 140.67 48.51 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.47 0.652 . . . . 0.0 109.489 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.47 -154.46 24.69 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -130.97 149.92 52.37 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.389 -1.065 . . . . 0.0 109.321 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' B' ' 54' ' ' GLU . 26.1 mmtp 61.88 48.08 5.6 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.558 0.694 . . . . 0.0 109.382 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.439 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 10.1 mp -91.85 72.89 5.71 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.242 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -67.98 -33.37 74.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.623 -0.673 . . . . 0.0 109.519 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.75 -2.46 54.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.86 . . . . 0.0 108.862 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 50.16 71.97 0.55 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -138.22 159.11 42.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.256 -1.143 . . . . 0.0 108.731 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 8.1 m -126.11 131.29 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.385 -0.822 . . . . 0.0 109.845 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -130.46 126.39 36.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 69.6 t -116.58 136.56 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' B' ' 38' ' ' LYS . 29.6 mt-10 -123.42 144.43 49.5 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.99 177.41 23.98 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.18 144.11 26.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.093 -1.239 . . . . 0.0 109.283 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 35.5 mm -93.62 112.87 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.316 -0.865 . . . . 0.0 109.72 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -101.15 -21.55 14.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.335 -0.853 . . . . 0.0 109.249 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -167.06 152.65 7.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.744 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.99 133.06 39.08 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 53.3 t -134.95 127.07 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.547 -0.721 . . . . 0.0 110.0 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.571 ' O ' ' N ' ' B' ' 64' ' ' LEU . 16.0 t80 -141.46 122.49 8.8 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -43.87 84.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.214 1.276 . . . . 0.0 112.376 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.623 ' H ' ' CD2' ' B' ' 64' ' ' LEU . 0.9 OUTLIER -93.76 21.11 6.79 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -94.26 121.74 36.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.482 -0.761 . . . . 0.0 110.724 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -170.97 76.66 0.07 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.593 ' ND1' ' N ' ' B' ' 68' ' ' HIS . 1.1 t60 -143.11 141.74 31.31 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.593 ' N ' ' ND1' ' B' ' 67' ' ' HIS . 0.7 OUTLIER -99.14 110.08 22.69 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.355 -0.841 . . . . 0.0 109.606 -179.207 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.88 -38.99 87.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.443 -0.785 . . . . 0.0 109.086 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.562 ' CE1' ' CD2' ' B' ' 71' ' ' HIS . 3.0 t60 -52.68 170.91 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.379 -0.826 . . . . 0.0 110.099 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.562 ' CD2' ' CE1' ' B' ' 70' ' ' HIS . 78.7 m-70 . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.203 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.517 ' O ' ' N ' ' A' ' 3' ' ' ASN . 96.6 mtp . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.586 0.707 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.523 ' C ' ' OD1' ' A' ' 2' ' ' ASP . 1.4 p30 42.26 22.11 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.768 0.794 . . . . 0.0 110.069 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 1' ' ' MET . 31.3 p-10 -72.85 -5.04 35.5 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -82.26 122.31 27.77 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -142.14 163.57 32.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.188 -0.945 . . . . 0.0 109.625 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 1.1 m-85 -111.33 134.29 53.02 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.0 tt -120.28 121.91 39.7 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.5 m -115.3 146.74 41.22 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.526 -0.734 . . . . 0.0 109.409 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 tp -152.83 149.65 28.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 109.288 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.461 ' HG1' ' N ' ' A' ' 11' ' ' GLY . 3.1 t -140.76 165.81 26.47 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.368 -0.833 . . . . 0.0 109.651 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.461 ' N ' ' HG1' ' A' ' 10' ' ' THR . . . 86.35 20.87 53.75 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -67.68 136.81 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -1.126 . . . . 0.0 110.333 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t -73.08 -41.36 64.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.379 -0.826 . . . . 0.0 109.542 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -168.89 167.56 10.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.097 -1.002 . . . . 0.0 109.655 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.1 t -98.82 99.61 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.276 -0.89 . . . . 0.0 109.871 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -65.93 -40.68 91.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 108.886 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -168.5 153.44 6.3 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -149.33 107.08 3.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 108.621 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 21' ' ' LYS . 9.2 m-20 -132.76 152.92 80.75 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.82 5.96 0.91 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.025 1.817 . . . . 0.0 111.438 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 19' ' ' ASP . 55.8 mtpt -133.25 -2.27 3.15 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.461 -0.774 . . . . 0.0 109.5 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -171.92 130.1 0.64 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.918 . . . . 0.0 108.856 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.408 HD13 HG22 ' A' ' 23' ' ' ILE . 96.7 mt -130.85 128.73 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.329 -0.857 . . . . 0.0 109.979 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.2 mt -123.25 121.25 35.42 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.8 mt -129.39 131.63 46.86 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.536 -0.728 . . . . 0.0 109.203 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -96.43 119.42 34.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.985 -1.072 . . . . 0.0 109.582 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.569 ' O ' ' N ' ' A' ' 29' ' ' GLN . 5.2 t -124.2 148.61 47.15 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.538 0.685 . . . . 0.0 110.098 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.9 mm 54.81 -79.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.783 -0.573 . . . . 0.0 109.541 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 27' ' ' THR . 13.5 pt20 -154.52 -20.61 0.12 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 0.0 110.074 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.06 177.18 32.42 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.0 t -123.0 132.84 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.779 -0.836 . . . . 0.0 109.203 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.7 tp -105.12 126.51 52.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.487 -0.758 . . . . 0.0 108.971 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.3 t -113.6 123.43 49.93 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.426 HD12 HG22 ' A' ' 34' ' ' ILE . 96.5 mt -112.95 130.2 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.73 139.0 53.9 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.3 -153.24 16.09 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -131.25 153.6 49.35 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.503 -0.998 . . . . 0.0 109.312 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt 57.81 56.54 4.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.493 -0.754 . . . . 0.0 109.82 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.448 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 9.8 mp -93.0 71.91 4.68 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.713 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.114 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 49' ' ' GLY . 3.7 mm? . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 46' ' ' LEU . 38.1 ttpt 33.0 -89.63 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.369 0.604 . . . . 0.0 111.403 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . -77.82 16.33 0.71 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.159 -0.963 . . . . 0.0 109.867 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . 62.72 51.5 55.39 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -101.03 152.44 20.58 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.303 -1.116 . . . . 0.0 109.92 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.2 t -127.67 135.97 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -129.79 144.36 51.26 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.298 -0.876 . . . . 0.0 109.844 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.2 t -135.93 160.0 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.632 -0.667 . . . . 0.0 109.79 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -137.79 142.35 40.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.321 -0.862 . . . . 0.0 109.319 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.24 177.23 29.22 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.77 142.48 27.42 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.434 -1.039 . . . . 0.0 108.859 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.4 mm -89.4 121.38 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.292 -0.88 . . . . 0.0 109.692 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -106.58 -29.59 9.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.457 -0.777 . . . . 0.0 109.429 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.42 147.88 10.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.006 . . . . 0.0 109.933 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -130.36 131.18 45.22 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 54.4 t -131.99 132.95 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.612 0.72 . . . . 0.0 109.638 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.467 ' O ' ' N ' ' A' ' 64' ' ' LEU . 34.2 t80 -144.47 139.33 15.49 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.98 78.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 120.844 1.03 . . . . 0.0 111.596 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.536 ' CD2' ' H ' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -86.51 0.82 53.47 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -88.53 179.83 6.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.416 -0.803 . . . . 0.0 109.908 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.557 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 0.4 OUTLIER -113.84 -137.98 0.37 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.515 -0.741 . . . . 0.0 109.791 -179.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.48 109.94 21.77 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.316 -0.865 . . . . 0.0 109.869 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -164.4 -43.12 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.19 -0.944 . . . . 0.0 108.497 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.665 ' ND1' ' N ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -123.01 -38.59 2.59 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -59.92 -42.54 94.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.356 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.031 -1.043 . . . . 0.0 108.305 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mtp . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.526 0.679 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.96 134.7 54.49 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.794 0.807 . . . . 0.0 110.047 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -172.26 -23.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.4 mmm-85 -63.12 138.65 58.62 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.22 -0.925 . . . . 0.0 108.651 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -146.35 161.17 40.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.252 -0.905 . . . . 0.0 109.491 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -108.95 136.03 49.15 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 5.7 tt -122.56 120.68 34.53 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 9.2 p -111.42 140.52 45.94 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.576 -0.702 . . . . 0.0 109.303 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.3 tp -148.21 146.49 28.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.259 -0.901 . . . . 0.0 109.505 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.9 t -146.12 117.79 8.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.449 -0.782 . . . . 0.0 109.293 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.24 22.57 0.37 Allowed Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 79.3 t -76.82 132.14 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.084 -1.245 . . . . 0.0 109.775 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -72.83 -43.18 62.98 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.128 -0.983 . . . . 0.0 109.774 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.77 157.89 22.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.961 -1.087 . . . . 0.0 110.088 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 69.6 t -93.17 127.22 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.41 -0.806 . . . . 0.0 109.153 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -96.29 -35.56 11.2 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.97 -1.081 . . . . 0.0 109.368 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 36.4 t -173.06 150.22 1.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 108.85 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -143.24 113.44 7.27 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.106 -0.996 . . . . 0.0 109.147 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -126.34 152.73 74.32 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.18 -17.06 54.04 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.669 1.579 . . . . 0.0 111.446 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -114.47 8.21 16.44 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.567 -0.708 . . . . 0.0 109.447 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -171.74 133.37 0.76 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 109.252 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.65 129.31 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.194 -0.941 . . . . 0.0 109.784 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 72.6 mt -120.88 119.19 31.94 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 87.9 mt -133.46 131.96 40.51 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.476 -0.765 . . . . 0.0 109.49 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -94.28 118.39 31.52 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.016 -1.052 . . . . 0.0 109.156 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.546 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.9 t -124.39 154.25 40.68 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.421 ' C ' ' O ' ' B' ' 27' ' ' THR . 44.3 mt 37.87 -89.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.901 -0.499 . . . . 0.0 110.456 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.546 ' N ' ' O ' ' B' ' 27' ' ' THR . 15.0 pt20 -151.6 46.2 0.79 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.004 -1.06 . . . . 0.0 109.515 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.95 132.28 2.57 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 90.4 t -84.3 131.32 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -1.09 . . . . 0.0 109.262 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 48.9 tp -104.18 125.22 50.3 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 28.7 t -112.35 120.75 42.77 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 83.7 mt -107.3 130.77 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -124.27 138.86 54.35 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.23 -147.89 8.54 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -135.99 143.27 44.72 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.226 -1.161 . . . . 0.0 109.319 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 54.9 61.2 3.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.956 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.421 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 10.5 mp -92.95 72.31 4.74 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.187 -0.946 . . . . 0.0 108.805 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.492 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.636 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' B' ' 48' ' ' ALA . 10.4 mp . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.579 ' C ' ' H ' ' B' ' 49' ' ' GLY . 37.1 ttmt 45.08 -85.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.75 -0.594 . . . . 0.0 110.353 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' B' ' 46' ' ' LEU . . . -65.23 14.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.064 -1.023 . . . . 0.0 110.212 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' B' ' 47' ' ' LYS . . . 61.71 28.17 69.51 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -87.18 158.79 19.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -1.104 . . . . 0.0 109.368 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 16.6 m -131.77 157.47 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.417 -0.802 . . . . 0.0 109.243 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -144.68 148.07 33.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.27 -0.894 . . . . 0.0 109.508 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 53.8 t -127.08 135.58 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -120.79 131.14 54.31 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.537 -0.727 . . . . 0.0 109.185 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.98 179.19 29.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.95 133.78 41.96 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.404 -1.056 . . . . 0.0 109.187 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 90.4 mt -90.15 115.3 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.053 . . . . 0.0 109.706 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -99.49 -14.95 18.86 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.4 -0.813 . . . . 0.0 109.676 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.4 152.43 8.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.977 -1.077 . . . . 0.0 110.365 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.93 134.73 40.92 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 67.5 t -130.03 123.61 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.455 -0.778 . . . . 0.0 109.05 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.444 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 44.2 t80 -146.02 136.85 12.44 Favored Pre-proline 0 N--CA 1.494 1.753 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.444 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 70.9 Cg_endo -74.45 113.73 3.86 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.328 1.352 . . . . 0.0 112.001 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.64 ' CD1' ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -89.22 16.29 7.56 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 65.19 101.46 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.476 0.655 . . . . 0.0 110.497 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -81.1 -57.06 3.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 108.646 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -156.03 -132.26 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.681 ' CD2' ' H ' ' B' ' 69' ' ' HIS . 6.3 t60 -147.66 -179.94 7.24 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.57 -1.331 . . . . 0.0 109.65 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.681 ' H ' ' CD2' ' B' ' 68' ' ' HIS . 7.5 m80 58.54 6.52 0.59 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.916 -1.115 . . . . 0.0 108.818 -178.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.464 ' H ' ' C ' ' B' ' 68' ' ' HIS . 0.5 OUTLIER -61.21 149.0 38.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.376 -0.827 . . . . 0.0 109.958 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.134 179.259 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.98 103.96 3.1 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.475 HD21 ' CB ' ' A' ' 56' ' ' LEU . 1.3 p-10 -148.9 12.0 0.85 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -77.91 144.46 36.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.725 -1.235 . . . . 0.0 108.233 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.426 ' NE2' ' CD2' ' B' ' 9' ' ' LEU . 39.7 tt0 -146.66 156.23 43.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.121 -0.987 . . . . 0.0 110.263 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -109.13 114.02 27.38 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 tt -113.28 126.47 55.44 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 t -132.1 140.28 48.77 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.0 tp -131.03 148.14 52.71 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 p -125.26 153.38 43.28 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.48 8.54 87.1 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.52 143.84 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.144 -1.209 . . . . 0.0 109.927 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.2 m -73.34 -47.51 41.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.513 -0.742 . . . . 0.0 109.982 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -172.59 172.91 4.13 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.042 -1.036 . . . . 0.0 110.483 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.7 t -101.21 103.83 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -64.1 -40.43 96.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 109.796 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.4 t -158.17 151.87 23.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.341 -0.85 . . . . 0.0 109.323 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -131.14 112.0 12.46 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.57 150.99 77.36 Favored Pre-proline 0 N--CA 1.501 2.114 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.59 -10.63 25.46 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.962 1.775 . . . . 0.0 111.615 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -129.24 11.45 5.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.598 -0.689 . . . . 0.0 109.61 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -169.3 123.2 0.8 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mm -123.2 130.14 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.188 -0.945 . . . . 0.0 109.695 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.2 mt -113.87 129.85 56.55 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.75 124.29 33.11 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.496 -0.753 . . . . 0.0 110.346 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -96.16 123.36 39.75 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' GLN . 2.6 t -125.64 154.04 42.91 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.231 0.539 . . . . 0.0 109.746 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 27' ' ' THR . 46.7 mt 29.3 -85.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-O 121.16 0.505 . . . . 0.0 111.507 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' THR . 13.1 pt20 -144.05 59.54 1.36 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.16 -0.963 . . . . 0.0 110.148 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.9 160.69 28.93 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.0 t -116.35 130.68 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.655 -0.909 . . . . 0.0 109.06 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.3 tp -110.04 126.34 53.88 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.537 -0.727 . . . . 0.0 109.148 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.8 t -110.34 123.13 49.27 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.4 HG23 HD11 ' A' ' 34' ' ' ILE . 96.2 mt -112.39 129.72 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -116.63 140.69 49.11 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.87 -153.98 12.89 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -133.75 146.71 50.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.535 -0.979 . . . . 0.0 109.338 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 55.83 54.98 7.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.72 -0.613 . . . . 0.0 110.159 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.457 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 9.0 mp -90.45 69.15 6.87 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.895 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -178.752 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.597 ' O ' ' N ' ' A' ' 48' ' ' ALA . 68.7 mt . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 120.848 0.356 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? 56.28 -73.24 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.711 -0.618 . . . . 0.0 110.307 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . -73.63 -4.56 34.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.13 -0.982 . . . . 0.0 109.535 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.1 26.19 74.16 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -92.45 161.71 14.53 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.531 -0.982 . . . . 0.0 109.98 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.87 141.19 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.64 148.41 50.38 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.468 0.652 . . . . 0.0 110.085 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 75.4 t -136.97 136.3 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.43 128.86 47.65 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.05 -1.032 . . . . 0.0 108.379 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.67 174.84 32.04 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.475 ' CB ' HD21 ' A' ' 3' ' ' ASN . 0.2 OUTLIER -98.32 128.13 44.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.556 -0.967 . . . . 0.0 109.467 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.512 ' CD1' ' N ' ' A' ' 57' ' ' ILE . 1.7 mp -77.5 133.43 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 0.0 109.76 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -112.82 -26.11 8.72 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.88 154.01 9.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.417 -0.802 . . . . 0.0 110.034 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -131.1 130.36 43.05 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.5 t -134.56 130.95 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.733 0.777 . . . . 0.0 109.788 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.652 ' O ' ' N ' ' A' ' 64' ' ' LEU . 12.6 t80 -144.7 143.24 20.62 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -49.4 76.33 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.636 0 CA-C-N 120.405 1.18 . . . . 0.0 111.915 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.652 ' N ' ' O ' ' A' ' 62' ' ' TYR . 0.8 OUTLIER -92.73 15.23 14.99 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.363 -0.836 . . . . 0.0 109.034 -179.534 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.544 ' C ' ' O ' ' A' ' 64' ' ' LEU . 90.8 mt-10 -8.42 117.48 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 121.402 0.62 . . . . 0.0 112.171 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -73.1 -71.06 0.32 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.632 -0.668 . . . . 0.0 110.236 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -72.12 -96.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.448 -0.783 . . . . 0.0 110.037 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.685 ' CD2' ' H ' ' A' ' 69' ' ' HIS . 69.8 t60 -166.77 -172.06 2.01 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.464 -0.773 . . . . 0.0 109.264 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.685 ' H ' ' CD2' ' A' ' 68' ' ' HIS . 0.4 OUTLIER -66.49 -41.59 88.72 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.579 -0.701 . . . . 0.0 109.491 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -83.11 -64.08 1.24 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.49 -0.757 . . . . 0.0 109.567 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 118.157 -0.925 . . . . 0.0 108.879 179.739 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mtp . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.6 116.52 28.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.478 -0.764 . . . . 0.0 109.54 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' B' ' 3' ' ' ASN . 9.4 p-10 -166.53 -30.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.58 HH21 ' CD ' ' B' ' 54' ' ' GLU . 10.7 mmm180 -49.66 143.63 6.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.519 -0.738 . . . . 0.0 110.031 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -149.8 162.03 41.07 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.348 0.594 . . . . 0.0 109.476 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -118.18 141.88 48.03 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.1 tt -131.07 120.26 23.15 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 5.5 m -110.73 146.09 36.91 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.426 ' CD2' ' NE2' ' A' ' 5' ' ' GLN . 5.4 tp -146.92 139.1 24.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.298 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.15 107.57 7.79 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 146.42 -5.81 1.21 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.57 142.18 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.419 -1.048 . . . . 0.0 110.066 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -72.72 -51.56 18.75 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.665 -0.647 . . . . 0.0 109.629 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.15 160.31 6.29 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.124 -0.985 . . . . 0.0 110.297 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 20.6 t -81.39 133.07 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.654 -0.654 . . . . 0.0 109.891 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -88.79 -23.78 22.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.4 -0.813 . . . . 0.0 110.121 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 30.3 t -172.42 151.52 2.5 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.101 -0.999 . . . . 0.0 109.899 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -121.93 104.64 9.68 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.628 -0.67 . . . . 0.0 109.886 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.39 139.34 31.11 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.32 -17.4 35.07 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.815 1.677 . . . . 0.0 111.97 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -95.62 -10.75 28.62 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.322 -0.861 . . . . 0.0 109.472 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -174.75 130.01 0.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.66 129.49 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 62.0 mt -110.07 123.53 49.86 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 68.6 mt -119.07 131.12 55.91 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.577 -0.702 . . . . 0.0 109.704 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -83.64 104.97 14.18 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.463 ' O ' ' O ' ' B' ' 28' ' ' ILE . 12.9 t -124.87 169.95 11.55 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.73 0.776 . . . . 0.0 110.751 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' B' ' 27' ' ' THR . 8.0 mt -33.0 154.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.344 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 65.38 -60.51 0.26 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.18 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' B' ' 27' ' ' THR . . . -166.71 -168.13 28.43 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.459 -1.353 . . . . 0.0 109.795 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 15.5 t -86.88 135.37 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.405 -1.056 . . . . 0.0 110.146 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 43.0 tp -101.05 119.99 39.55 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 11.5 m -99.6 127.27 45.69 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 86.8 mt -103.95 126.84 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -118.98 144.47 46.47 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.536 0.684 . . . . 0.0 110.075 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.89 -138.05 4.74 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -138.83 139.58 38.23 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.246 -1.149 . . . . 0.0 109.766 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 46.98 73.8 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.686 -0.634 . . . . 0.0 109.834 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.488 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 9.1 mp -91.89 71.25 5.61 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.068 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' B' ' 47' ' ' LYS . 62.0 tp . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 121.278 0.561 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.528 ' C ' ' H ' ' B' ' 49' ' ' GLY . 53.2 tttp 59.05 136.1 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.506 0.669 . . . . 0.0 110.389 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . 63.55 -3.62 0.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.605 -0.684 . . . . 0.0 109.5 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' B' ' 47' ' ' LYS . . . 62.9 31.58 81.0 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -103.04 148.13 26.09 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.399 -1.059 . . . . 0.0 109.68 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.85 145.71 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -130.26 149.6 51.88 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.45 0.643 . . . . 0.0 109.387 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.32 135.42 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.58 ' CD ' HH21 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -116.83 125.39 51.49 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . 0.535 ' N ' ' OE1' ' B' ' 54' ' ' GLU . . . 154.77 176.13 26.66 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.14 132.79 46.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.679 -0.895 . . . . 0.0 109.475 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.533 ' CD1' ' N ' ' B' ' 57' ' ' ILE . 1.5 mp -87.12 118.81 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.191 -0.943 . . . . 0.0 108.965 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . 0.444 ' OD2' ' NE2' ' A' ' 29' ' ' GLN . 2.2 t70 -112.8 -5.64 13.88 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -169.05 156.55 7.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.419 -0.801 . . . . 0.0 110.338 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.28 135.87 34.3 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 t -129.97 124.18 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.575 0.702 . . . . 0.0 109.308 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -146.29 138.16 13.36 Favored Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.534 ' C ' ' H ' ' B' ' 65' ' ' GLU . 38.7 Cg_endo -70.13 104.66 1.41 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.295 1.33 . . . . 0.0 112.167 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.667 ' CD1' ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -75.57 18.39 0.24 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' B' ' 63' ' ' PRO . 0.7 OUTLIER 63.8 138.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -128.7 127.88 42.98 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.612 -0.68 . . . . 0.0 110.268 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' B' ' 67' ' ' HIS . 0.0 OUTLIER -153.59 -46.82 0.09 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -49.03 96.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.533 -0.729 . . . . 0.0 109.726 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.432 ' N ' ' O ' ' B' ' 67' ' ' HIS . 78.8 m-70 -85.95 -154.81 0.22 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.515 -0.74 . . . . 0.0 109.442 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.424 ' ND1' ' N ' ' B' ' 70' ' ' HIS . 7.6 m80 -56.86 -44.72 82.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.414 -0.804 . . . . 0.0 109.534 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.499 ' N ' ' ND1' ' B' ' 71' ' ' HIS . 1.6 p-80 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.591 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.396 0.617 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -91.61 106.47 18.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.331 -0.856 . . . . 0.0 109.885 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -173.92 -26.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -64.0 140.06 58.83 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.389 -0.819 . . . . 0.0 108.868 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -154.25 165.44 36.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 0.0 109.881 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -106.09 144.58 32.6 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.6 tt -132.33 121.54 23.69 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -114.24 140.97 48.14 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.593 -0.692 . . . . 0.0 109.903 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.508 ' CD2' ' NE2' ' B' ' 5' ' ' GLN . 4.8 tp -144.79 145.92 31.88 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.8 p -137.23 173.1 12.05 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.371 -0.831 . . . . 0.0 110.102 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 73.51 24.78 74.16 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.5 p -72.24 130.5 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.254 -1.145 . . . . 0.0 109.817 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -73.03 -43.25 62.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.09 -1.006 . . . . 0.0 109.195 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.25 153.52 4.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 109.591 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.5 t -92.28 117.02 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.848 . . . . 0.0 109.676 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -68.05 -37.44 81.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.48 -0.763 . . . . 0.0 109.508 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.7 t -169.04 169.47 9.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.825 . . . . 0.0 109.456 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -145.62 107.18 4.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 109.217 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -130.03 122.78 20.46 Favored Pre-proline 0 N--CA 1.5 2.035 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -45.66 -30.9 6.79 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.037 1.158 . . . . 0.0 111.618 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -92.97 -6.37 48.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.28 -0.888 . . . . 0.0 109.969 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.525 ' OE2' ' NZ ' ' A' ' 35' ' ' LYS . 34.2 tt0 -163.82 128.28 2.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 109.549 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.6 mm -120.44 130.21 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.482 -0.761 . . . . 0.0 109.57 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.3 mt -117.63 130.56 56.45 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.6 mt -133.36 134.53 43.88 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.476 -0.765 . . . . 0.0 109.851 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -108.9 113.17 25.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.602 -0.686 . . . . 0.0 109.166 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 29' ' ' GLN . 2.6 t -125.24 167.38 14.95 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.411 0.624 . . . . 0.0 110.152 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.7 mm 44.95 -87.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.805 -0.56 . . . . 0.0 110.134 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 27' ' ' THR . 27.8 pt20 -158.77 19.54 0.21 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.974 -1.078 . . . . 0.0 108.837 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.02 169.82 21.96 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.3 t -110.89 130.53 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.748 -0.854 . . . . 0.0 109.267 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.1 tp -110.8 123.15 49.52 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.0 m -110.18 120.31 42.04 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.8 mt -102.9 127.27 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.525 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 68.9 mttm -118.22 138.79 52.09 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.656 0.741 . . . . 0.0 109.318 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.98 -147.15 7.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -140.7 143.73 35.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.304 -1.115 . . . . 0.0 108.864 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.7 mttp 55.86 60.27 3.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.603 -0.685 . . . . 0.0 109.904 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 10.2 mp -92.59 72.21 5.05 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.493 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -178.811 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 49' ' ' GLY . 2.5 pp . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt 41.88 -103.74 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.533 0.682 . . . . 0.0 110.509 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.05 20.64 2.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.503 -0.748 . . . . 0.0 110.065 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . 87.4 32.58 13.35 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.491 ' OE1' ' N ' ' A' ' 50' ' ' GLN . 24.0 mp0 -104.55 152.93 21.81 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.28 -1.129 . . . . 0.0 109.111 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.66 158.76 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.372 -0.83 . . . . 0.0 109.667 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -141.16 149.28 41.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.296 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -124.88 133.41 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -119.07 125.46 49.36 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.36 -175.52 35.48 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.11 130.87 45.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.996 . . . . 0.0 109.225 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.1 mt -86.46 117.45 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.074 -1.016 . . . . 0.0 109.161 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -96.77 -23.82 16.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.456 -0.777 . . . . 0.0 109.143 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -170.1 157.49 6.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.986 . . . . 0.0 110.522 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.4 mt -133.01 139.22 47.12 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.2 t -132.07 115.14 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.511 -0.743 . . . . 0.0 109.628 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 62' ' ' TYR . 25.1 t80 -134.34 113.71 12.3 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.52 123.7 14.37 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 CA-C-N 120.06 1.057 . . . . 0.0 111.03 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.574 ' H ' ' CD1' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -98.7 17.26 19.71 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.128 -0.982 . . . . 0.0 108.712 179.103 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 66' ' ' HIS . 0.4 OUTLIER 68.44 -174.45 0.19 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.515 -0.741 . . . . 0.0 110.447 178.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.509 ' O ' ' CG ' ' A' ' 67' ' ' HIS . 1.8 t60 77.99 -145.75 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.406 -0.809 . . . . 0.0 109.752 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.509 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 45.9 p-80 41.19 94.23 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.626 0.727 . . . . 0.0 109.776 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -57.79 146.13 32.52 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.363 -0.835 . . . . 0.0 110.181 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -152.84 162.9 40.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.462 -0.774 . . . . 0.0 109.429 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -105.03 138.71 40.82 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 77.7 m80 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.815 -179.799 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 95.3 mtp . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 54.51 27.38 8.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.451 -0.781 . . . . 0.0 109.308 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -102.87 10.42 38.36 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 33.2 mmm-85 -74.08 141.35 45.7 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . 0.508 ' NE2' ' CD2' ' A' ' 9' ' ' LEU . 40.1 tt0 -141.36 147.11 37.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.305 -0.872 . . . . 0.0 109.375 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -117.23 131.55 56.82 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 tt -118.08 124.44 48.07 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 78.3 p -115.57 134.67 54.84 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.537 0.684 . . . . 0.0 109.625 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 tp -146.43 143.66 29.16 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -131.26 156.86 44.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.436 -0.79 . . . . 0.0 109.277 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.75 53.9 3.24 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -92.51 139.21 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.088 -1.242 . . . . 0.0 109.833 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -71.7 -42.38 67.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.952 . . . . 0.0 109.136 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -171.73 166.2 6.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.149 -0.969 . . . . 0.0 110.113 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 73.3 t -93.59 99.01 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.331 -0.856 . . . . 0.0 109.13 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -65.5 -40.0 92.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -0.868 . . . . 0.0 109.419 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -169.69 145.48 3.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.13 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -134.52 108.33 8.04 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.533 -0.73 . . . . 0.0 109.672 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -133.81 148.85 70.05 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.61 -12.4 31.22 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 121.706 1.604 . . . . 0.0 111.147 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -104.67 -7.84 19.31 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.522 -0.736 . . . . 0.0 109.539 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.489 ' OE2' ' NZ ' ' B' ' 35' ' ' LYS . 37.2 tt0 -173.74 140.63 0.78 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.463 -0.773 . . . . 0.0 109.158 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.2 130.1 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.383 -0.823 . . . . 0.0 110.438 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.405 ' CD2' ' OG ' ' B' ' 33' ' ' SER . 13.5 mt -122.03 125.41 46.21 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 65.4 mt -132.18 131.62 42.38 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.504 -0.748 . . . . 0.0 109.135 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -88.75 118.75 28.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.895 -1.128 . . . . 0.0 108.602 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.566 ' O ' ' N ' ' B' ' 29' ' ' GLN . 2.2 t -123.8 153.66 40.66 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.709 -0.619 . . . . 0.0 109.974 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' B' ' 27' ' ' THR . 54.8 mt 34.01 -86.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.168 0.509 . . . . 0.0 110.665 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' B' ' 27' ' ' THR . 18.9 pt20 -150.61 39.41 0.72 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.046 -1.034 . . . . 0.0 109.615 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -161.22 130.38 2.33 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 69.7 t -83.42 132.96 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.438 -1.037 . . . . 0.0 109.481 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 43.5 tp -107.48 128.54 54.59 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.405 ' OG ' ' CD2' ' B' ' 24' ' ' LEU . 25.1 m -111.16 125.49 53.84 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.3 0.572 . . . . 0.0 109.582 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 93.2 mt -106.77 129.86 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.489 ' NZ ' ' OE2' ' B' ' 22' ' ' GLU . 68.4 mttm -124.72 138.3 54.3 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.467 0.651 . . . . 0.0 109.453 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.57 -146.37 11.29 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -140.51 157.45 45.48 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.281 -1.129 . . . . 0.0 109.624 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.48 57.0 5.17 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.552 0.691 . . . . 0.0 109.783 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 8.8 mp -91.7 70.62 5.75 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 C-N-CA 120.305 -0.95 . . . . 0.0 110.941 -178.544 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 81.8 mt . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -63.88 -36.44 83.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.622 -0.674 . . . . 0.0 109.351 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.78 -8.77 10.8 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.661 -0.65 . . . . 0.0 109.417 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.4 24.98 71.65 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -122.2 155.71 35.26 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.555 -0.968 . . . . 0.0 109.282 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t -126.14 134.33 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.636 -0.665 . . . . 0.0 109.255 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -128.74 148.87 50.88 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 76.3 t -122.64 134.1 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -120.79 134.97 55.27 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.602 -0.686 . . . . 0.0 109.287 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.97 171.84 18.79 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.07 126.13 34.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.368 -1.078 . . . . 0.0 108.768 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.0 mt -88.56 113.08 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.078 -1.014 . . . . 0.0 109.184 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -94.26 -13.82 26.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.453 -0.78 . . . . 0.0 109.559 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -172.14 155.83 3.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.026 -1.046 . . . . 0.0 110.55 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.4 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 14.2 mt -138.62 142.77 39.11 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 54.1 t -135.72 126.91 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.415 -0.803 . . . . 0.0 109.382 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' B' ' 64' ' ' LEU . 12.0 t80 -141.07 135.89 15.6 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -42.89 82.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.69 1.593 . . . . 0.0 112.722 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' B' ' 62' ' ' TYR . 0.7 OUTLIER -63.14 -12.49 27.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.181 -0.95 . . . . 0.0 108.485 179.228 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' B' ' 67' ' ' HIS . 5.7 mt-10 -99.77 17.04 21.71 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.447 -0.783 . . . . 0.0 109.084 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 63.54 -68.1 0.09 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.55 ' N ' ' O ' ' B' ' 65' ' ' GLU . 0.3 OUTLIER -175.76 86.2 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.317 -0.865 . . . . 0.0 109.134 179.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -133.55 114.92 14.11 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.307 -0.871 . . . . 0.0 109.498 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.529 ' O ' ' ND1' ' B' ' 70' ' ' HIS . 34.7 p80 -80.49 129.4 34.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.71 -0.619 . . . . 0.0 109.618 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.529 ' ND1' ' O ' ' B' ' 69' ' ' HIS . 5.4 m-70 -136.24 145.31 45.5 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.349 -0.844 . . . . 0.0 109.96 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 11.7 m80 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.682 -179.845 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 122.052 0.929 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.449 ' OD2' ' CG ' ' A' ' 4' ' ' ARG . 4.2 p-10 -142.93 -146.48 0.19 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -108.22 4.47 24.77 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.705 -1.247 . . . . 0.0 109.291 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.449 ' CG ' ' OD2' ' A' ' 2' ' ' ASP . 30.4 mmm-85 -81.26 139.42 35.47 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -139.74 163.33 32.89 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.02 -1.05 . . . . 0.0 110.436 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -108.73 127.07 53.68 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.301 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.2 tt -125.71 119.88 29.17 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 51' ' ' VAL . 34.9 t -129.31 151.43 49.97 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.572 0.701 . . . . 0.0 109.927 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.4 tp -142.91 155.72 44.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.429 -0.794 . . . . 0.0 109.549 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.4 p -69.21 170.24 10.53 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.732 0.777 . . . . 0.0 110.804 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -40.07 117.11 0.82 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.412 ' CG2' ' N ' ' A' ' 13' ' ' SER . 9.1 p -83.51 165.84 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.693 -0.886 . . . . 0.0 110.417 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.412 ' N ' ' CG2' ' A' ' 12' ' ' VAL . 69.7 m -72.82 -45.43 58.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.0 109.313 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.17 145.12 1.71 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.069 -1.019 . . . . 0.0 109.831 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 80.6 t -89.88 128.24 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.195 -0.941 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -86.55 -22.42 26.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.464 -0.772 . . . . 0.0 110.033 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 t -172.26 157.16 4.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.968 -1.082 . . . . 0.0 109.837 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.484 ' CD1' ' C ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -145.9 105.2 3.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 109.566 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -134.61 147.47 63.37 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.8 -13.68 34.91 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.372 2.048 . . . . 0.0 110.807 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -100.88 -4.63 27.4 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.407 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -178.81 143.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.421 HD11 HG21 ' A' ' 23' ' ' ILE . 95.6 mt -134.53 131.44 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.092 -1.005 . . . . 0.0 109.407 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.3 mt -112.08 127.97 56.06 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.4 mt -124.88 128.05 48.06 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.614 -0.679 . . . . 0.0 109.626 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -103.46 117.0 33.45 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 29' ' ' GLN . 5.5 t -124.03 150.09 45.33 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.945 0.879 . . . . 0.0 110.705 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.4 mt 47.52 -83.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.359 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.4 pt20 -144.6 -23.04 0.52 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.118 -0.989 . . . . 0.0 109.691 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.6 170.15 32.11 Favored Glycine 0 N--CA 1.498 2.816 0 O-C-N 120.912 -1.118 . . . . 0.0 111.156 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.1 t -120.04 133.5 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.769 -0.842 . . . . 0.0 109.525 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.8 tp -110.12 124.5 51.64 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.4 m -110.64 124.04 51.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.546 -0.721 . . . . 0.0 109.737 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.5 mt -107.75 131.55 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -126.81 139.49 53.07 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.673 0.749 . . . . 0.0 109.456 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.92 -155.71 25.83 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -132.06 148.34 52.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.622 -0.928 . . . . 0.0 109.118 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 61.72 54.6 2.9 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.939 0.876 . . . . 0.0 109.403 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 10.1 mp -93.2 71.94 4.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.334 -0.854 . . . . 0.0 108.836 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.622 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 47' ' ' LYS . 55.4 tp . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.539 ' C ' ' H ' ' A' ' 49' ' ' GLY . 88.5 tttt -34.74 152.21 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.432 0.634 . . . . 0.0 110.984 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 72.9 -23.76 0.2 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 47' ' ' LYS . . . 64.96 28.61 73.71 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -95.57 161.13 14.18 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.273 -1.134 . . . . 0.0 110.447 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.42 ' O ' ' OG ' ' A' ' 8' ' ' SER . 55.6 t -120.63 136.98 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.433 0.635 . . . . 0.0 109.359 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -111.86 146.7 37.25 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.4 t -134.11 136.02 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -125.05 134.75 52.41 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.126 0.965 . . . . 0.0 109.535 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.549 ' N ' ' OE1' ' A' ' 54' ' ' GLU . . . 155.37 174.41 25.22 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.44 139.47 31.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.607 -0.937 . . . . 0.0 109.643 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.472 ' CD1' ' N ' ' A' ' 57' ' ' ILE . 1.5 mp -93.2 111.92 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 108.768 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -98.54 -22.83 15.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.588 -0.695 . . . . 0.0 109.403 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.27 149.45 11.97 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.829 -1.169 . . . . 0.0 110.705 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.407 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 67.4 mt -133.29 135.34 44.82 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 49.2 t -135.55 123.35 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.75 0.786 . . . . 0.0 109.303 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.455 ' O ' ' CD1' ' A' ' 64' ' ' LEU . 22.8 t80 -137.24 142.13 36.72 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.49 111.65 2.85 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.708 1.605 . . . . 0.0 112.432 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.589 ' CD1' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -103.7 -15.45 15.75 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -150.17 153.57 36.54 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.928 0.87 . . . . 0.0 109.979 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.522 ' O ' ' CG ' ' A' ' 67' ' ' HIS . 16.3 t60 -174.66 -35.69 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 3.4 m-70 174.68 106.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.622 0.725 . . . . 0.0 109.095 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m80 54.85 80.17 0.13 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.928 0.871 . . . . 0.0 108.818 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.595 ' CG ' ' H ' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -70.08 -83.5 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.676 -0.64 . . . . 0.0 110.279 -179.318 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.618 ' H ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -119.37 153.33 35.32 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 122.012 0.91 . . . . 0.0 110.076 -179.117 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 44.0 t60 . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.301 179.998 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.868 0.842 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' B' ' 3' ' ' ASN . 15.1 t70 -76.35 167.29 22.11 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.893 0.854 . . . . 0.0 110.559 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.423 ' N ' ' OD1' ' B' ' 2' ' ' ASP . 2.6 p-10 -82.72 -3.54 56.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.366 -0.834 . . . . 0.0 109.514 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 34.1 mmm-85 -77.59 139.6 39.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.065 -1.022 . . . . 0.0 109.869 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -139.16 156.65 46.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.474 -0.766 . . . . 0.0 109.468 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -112.04 133.91 53.92 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 tt -118.25 125.03 49.3 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 96.2 p -112.71 145.47 40.44 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.829 0.823 . . . . 0.0 109.988 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.2 tp -156.88 156.33 32.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.515 -0.741 . . . . 0.0 109.358 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.9 t -150.44 158.5 44.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.5 -0.75 . . . . 0.0 110.138 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.68 15.21 73.85 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.0 p -54.75 149.53 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -1.188 . . . . 0.0 110.254 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 3.2 t -73.06 -44.01 61.16 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -172.5 166.59 5.64 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.131 -0.981 . . . . 0.0 110.37 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 88.2 t -96.67 99.75 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.543 -0.723 . . . . 0.0 109.145 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -65.28 -48.39 73.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.509 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 32.1 t -168.82 129.26 1.16 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.05 -1.031 . . . . 0.0 109.409 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -112.34 117.27 32.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.51 -0.744 . . . . 0.0 109.276 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.02 151.16 77.43 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.66 -13.41 29.79 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.31 2.006 . . . . 0.0 111.62 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -115.5 -0.38 13.1 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.431 -0.793 . . . . 0.0 109.197 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.83 138.91 1.86 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 109.078 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.417 HD13 HG21 ' B' ' 23' ' ' ILE . 96.7 mt -131.56 130.91 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.332 -0.855 . . . . 0.0 110.297 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 19.0 mt -122.2 123.3 41.18 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.479 0.657 . . . . 0.0 109.567 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 94.6 mt -132.41 132.6 42.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.684 -0.635 . . . . 0.0 110.121 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -89.06 121.69 31.65 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.562 ' O ' ' N ' ' B' ' 29' ' ' GLN . 6.8 t -124.89 154.89 40.39 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.479 0.657 . . . . 0.0 110.191 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.438 HG21 HD11 ' B' ' 28' ' ' ILE . 24.8 mm 30.77 -84.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.578 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' B' ' 27' ' ' THR . 26.2 pt20 -147.03 48.65 1.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.873 -1.142 . . . . 0.0 109.191 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.06 167.31 39.37 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 53.4 t -117.09 134.6 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.384 -1.068 . . . . 0.0 110.155 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 48.1 tp -106.07 125.91 51.57 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 18.4 t -111.67 127.55 55.8 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.579 0.704 . . . . 0.0 109.313 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.405 HD11 HG22 ' B' ' 34' ' ' ILE . 81.8 mt -106.84 131.28 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.372 0.606 . . . . 0.0 109.387 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -123.64 142.1 51.37 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.554 0.692 . . . . 0.0 109.463 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.38 -148.56 18.34 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -130.58 147.98 52.32 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.475 -1.015 . . . . 0.0 110.048 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt 61.07 52.11 4.17 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.807 0.813 . . . . 0.0 109.495 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.525 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 7.5 mp -91.41 72.02 6.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.874 . . . . 0.0 109.287 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . 0.421 ' O ' ' OE1' ' B' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.48 ' N ' ' CD1' ' B' ' 46' ' ' LEU . 9.4 mp . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.79 0.805 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -64.33 -45.61 87.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 108.615 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.5 32.02 2.31 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.37 26.47 65.78 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -122.02 149.76 43.05 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.359 -1.083 . . . . 0.0 110.307 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -134.78 141.52 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -118.25 136.89 53.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.762 -0.586 . . . . 0.0 109.569 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 53.9 t -127.88 132.03 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' B' ' 54' ' ' GLU . 2.6 mp0 -116.17 145.69 42.89 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.854 0.835 . . . . 0.0 110.205 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.39 170.28 22.1 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.79 110.8 23.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.533 -0.98 . . . . 0.0 108.956 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.42 ' CD1' ' N ' ' B' ' 57' ' ' ILE . 2.1 mp -75.93 122.33 29.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.059 -1.026 . . . . 0.0 108.957 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -105.04 -22.38 13.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.541 -0.725 . . . . 0.0 109.131 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.22 150.82 16.86 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.75 -1.219 . . . . 0.0 110.659 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 17.2 mt -132.99 146.77 52.07 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.422 -0.799 . . . . 0.0 109.677 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 55.9 t -137.7 115.69 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.364 -0.835 . . . . 0.0 110.233 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.407 ' CG ' ' HB2' ' A' ' 60' ' ' LEU . 59.1 t80 -138.26 104.11 7.94 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -43.32 105.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.209 1.939 . . . . 0.0 112.428 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.702 ' CD1' ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -78.09 -5.28 51.05 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.483 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' B' ' 64' ' ' LEU . 2.3 mm-40 158.63 -161.27 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -141.67 -46.5 0.37 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.558 -1.339 . . . . 0.0 108.624 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.58 ' O ' ' N ' ' B' ' 69' ' ' HIS . 4.3 m-70 -157.0 172.94 17.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.415 -0.803 . . . . 0.0 109.026 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.569 ' O ' ' ND1' ' B' ' 69' ' ' HIS . 4.2 m80 -43.07 88.44 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.624 0.725 . . . . 0.0 110.595 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.58 ' N ' ' O ' ' B' ' 67' ' ' HIS . 0.0 OUTLIER -156.19 31.19 0.34 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.725 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -95.99 133.55 40.07 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.839 0.828 . . . . 0.0 110.302 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.456 ' C ' ' CD2' ' B' ' 71' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.4 mmm . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -88.36 114.92 25.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.432 -0.793 . . . . 0.0 109.276 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.519 HD21 ' HB3' ' A' ' 56' ' ' LEU . 2.8 p-10 -94.59 4.89 53.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.159 -0.963 . . . . 0.0 109.377 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.5 mmm-85 -69.21 142.58 54.21 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.291 -0.88 . . . . 0.0 108.916 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.497 ' NE2' ' CD2' ' B' ' 9' ' ' LEU . 50.1 tt0 -145.94 150.32 35.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.0 109.674 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.527 ' CD2' ' OE1' ' A' ' 54' ' ' GLU . 77.1 m-85 -103.12 145.25 30.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.565 -0.71 . . . . 0.0 109.3 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.0 tt -140.8 124.25 16.8 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.3 t -128.98 135.36 48.87 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.28 -0.887 . . . . 0.0 108.742 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.0 tp -146.48 154.34 41.46 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.077 -1.014 . . . . 0.0 109.336 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 t -144.0 164.24 31.19 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.256 -0.903 . . . . 0.0 109.383 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.68 18.53 51.43 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.9 t -66.25 137.71 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.284 -1.127 . . . . 0.0 110.236 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 m -72.19 -42.93 65.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.549 -0.719 . . . . 0.0 109.929 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.92 160.65 10.31 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.881 -1.137 . . . . 0.0 110.343 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.6 t -93.08 129.15 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.499 -0.75 . . . . 0.0 110.222 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -100.06 -35.69 9.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.436 -0.79 . . . . 0.0 108.939 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.0 t -173.02 144.3 1.24 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 0.0 109.559 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -129.81 107.83 9.7 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -133.67 148.99 70.8 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.94 -11.71 31.13 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.839 1.693 . . . . 0.0 111.792 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -108.97 -5.63 16.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.343 -0.848 . . . . 0.0 110.149 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -172.01 127.4 0.59 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.977 -1.077 . . . . 0.0 108.936 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.47 126.83 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.259 -0.901 . . . . 0.0 109.459 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.9 mt -118.79 110.76 17.62 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.1 mt -129.81 132.56 46.54 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.256 -0.903 . . . . 0.0 109.143 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -94.12 113.58 25.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.237 -0.914 . . . . 0.0 109.899 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 28' ' ' ILE . 4.4 t -124.36 147.67 48.05 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.835 0.826 . . . . 0.0 109.615 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.457 ' C ' ' O ' ' A' ' 27' ' ' THR . 37.4 mt 21.0 -96.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.238 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.411 ' CG ' ' O ' ' B' ' 57' ' ' ILE . 77.0 mm-40 -46.62 -73.76 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.494 -0.754 . . . . 0.0 111.596 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.96 -143.83 3.78 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 119.573 -1.298 . . . . 0.0 111.473 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 t -89.31 134.97 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.65 -0.912 . . . . 0.0 111.39 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.0 tp -112.82 120.46 41.54 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.1 m -108.73 124.55 50.73 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.6 mt -112.45 130.41 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -117.47 143.72 45.76 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.578 -0.701 . . . . 0.0 109.65 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.94 -148.34 13.59 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -136.29 152.05 50.28 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.316 -1.108 . . . . 0.0 109.517 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 54' ' ' GLU . 53.5 mtmt 56.16 52.11 10.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.552 -0.718 . . . . 0.0 110.142 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.465 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 8.5 mp -92.32 72.49 5.3 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.104 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.369 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.363 0.602 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -148.73 -63.52 0.24 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.381 -0.824 . . . . 0.0 109.43 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.43 2.0 49.31 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.327 -0.858 . . . . 0.0 109.412 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.54 20.33 78.57 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -97.63 161.51 13.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.334 -1.097 . . . . 0.0 109.544 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.9 t -116.15 131.86 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -118.86 130.51 55.78 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.8 t -127.34 133.89 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.501 -0.749 . . . . 0.0 109.068 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.527 ' OE1' ' CD2' ' A' ' 6' ' ' PHE . 17.3 tp10 -122.05 137.31 54.85 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 155.0 173.37 23.69 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.519 ' HB3' HD21 ' A' ' 3' ' ' ASN . 0.2 OUTLIER -96.91 140.55 31.29 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.416 -1.049 . . . . 0.0 109.599 -179.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.414 ' N ' ' CD1' ' A' ' 57' ' ' ILE . 1.7 mp -97.24 116.48 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.372 -0.83 . . . . 0.0 108.953 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -95.12 -18.97 20.5 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -171.42 151.45 3.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 0.0 109.764 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 mt -126.7 137.29 53.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.505 -0.747 . . . . 0.0 109.11 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.3 t -133.94 127.22 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.366 -0.834 . . . . 0.0 109.088 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.565 ' O ' ' N ' ' A' ' 64' ' ' LEU . 48.0 t80 -138.22 107.96 8.06 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -45.26 81.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.739 1.626 . . . . 0.0 112.479 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -79.67 80.77 6.02 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.371 -1.456 . . . . 0.0 108.958 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -144.59 91.28 2.16 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.249 -0.907 . . . . 0.0 109.504 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.532 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 59.2 t-80 -169.67 10.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -141.39 168.54 19.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.479 -0.763 . . . . 0.0 109.628 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -57.93 -174.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.595 0.712 . . . . 0.0 109.658 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -145.58 2.49 0.95 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.403 ' O ' ' C ' ' A' ' 71' ' ' HIS . 1.5 t-80 -80.05 159.57 26.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.186 -0.946 . . . . 0.0 109.903 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.516 ' ND1' ' OXT' ' A' ' 71' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.553 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mmm . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 t70 61.26 35.97 18.01 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.499 HD21 ' CB ' ' B' ' 56' ' ' LEU . 6.0 p-10 -95.2 -1.72 51.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.444 -0.785 . . . . 0.0 109.2 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -72.41 134.39 45.38 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.212 -0.93 . . . . 0.0 109.393 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -148.89 163.44 37.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.239 -0.913 . . . . 0.0 109.769 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -104.31 148.74 26.03 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.1 tt -135.64 118.66 16.4 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 28.6 t -111.49 131.08 55.48 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.428 -0.795 . . . . 0.0 109.335 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.497 ' CD2' ' NE2' ' A' ' 5' ' ' GLN . 3.1 tp -148.85 153.86 38.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.96 -1.088 . . . . 0.0 110.059 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.609 ' HG1' ' H ' ' B' ' 11' ' ' GLY . 12.7 t -154.45 -167.03 2.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.829 . . . . 0.0 109.529 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . 0.609 ' H ' ' HG1' ' B' ' 10' ' ' THR . . . 63.59 19.52 62.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.4 145.26 13.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.283 -1.128 . . . . 0.0 110.15 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 24.1 m -71.97 -43.13 65.67 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.27 -0.893 . . . . 0.0 108.941 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . 0.56 ' CB ' ' HZ3' ' B' ' 14' ' ' LYS . 0.0 OUTLIER -171.17 159.6 5.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.349 -0.844 . . . . 0.0 109.501 179.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.15 107.33 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.162 -0.961 . . . . 0.0 109.935 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -66.14 -40.57 90.71 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.239 -0.913 . . . . 0.0 109.067 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.445 ' HG ' ' N ' ' B' ' 18' ' ' PHE . 23.1 t -172.26 162.42 5.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.09 -1.006 . . . . 0.0 109.147 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . 0.445 ' N ' ' HG ' ' B' ' 17' ' ' SER . 3.7 t80 -140.25 110.41 6.57 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.327 -0.858 . . . . 0.0 109.76 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.97 148.01 67.72 Favored Pre-proline 0 N--CA 1.495 1.779 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.67 -9.81 27.07 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.851 1.701 . . . . 0.0 111.996 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -118.19 7.52 12.14 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.547 -0.721 . . . . 0.0 109.776 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -171.05 132.45 0.84 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.932 . . . . 0.0 109.194 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 47.0 mm -121.75 125.88 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.475 -0.765 . . . . 0.0 109.279 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 74.5 mt -119.89 113.14 20.12 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -131.64 140.31 49.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.329 -0.857 . . . . 0.0 109.303 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -107.63 117.77 34.98 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.569 ' O ' ' N ' ' B' ' 29' ' ' GLN . 3.7 t -125.01 153.01 43.48 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.417 0.627 . . . . 0.0 110.041 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.401 HD12 HG21 ' B' ' 28' ' ' ILE . 5.4 mm 53.39 -78.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.872 -0.518 . . . . 0.0 110.193 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' B' ' 27' ' ' THR . 22.0 pt20 -169.5 52.4 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -171.53 140.08 5.69 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 92.4 t -84.27 132.48 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.378 -1.072 . . . . 0.0 109.515 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 47.6 tp -111.26 123.12 49.56 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 24.0 m -109.87 119.63 39.96 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.325 -0.859 . . . . 0.0 109.076 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 95.9 mt -109.91 129.31 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -117.86 137.46 52.76 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.92 -152.72 10.4 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -134.22 145.37 49.11 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.307 -1.114 . . . . 0.0 109.608 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' B' ' 54' ' ' GLU . 72.4 mmtt 59.43 52.02 6.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.568 -0.707 . . . . 0.0 110.058 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.445 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 10.4 mp -88.45 72.04 8.91 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.952 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -178.547 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 62.0 mt . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 121.612 0.72 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -171.07 -81.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.2 8.85 5.21 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.462 -0.774 . . . . 0.0 109.471 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.13 35.44 15.15 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -129.82 159.99 34.87 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.412 -1.052 . . . . 0.0 109.182 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.38 137.42 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -122.04 147.35 46.2 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -126.69 135.33 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' B' ' 38' ' ' LYS . 47.7 tt0 -119.2 133.03 55.99 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.86 -178.69 34.04 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.499 ' CB ' HD21 ' B' ' 3' ' ' ASN . 0.2 OUTLIER -103.03 126.43 50.2 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.451 -1.029 . . . . 0.0 109.806 -179.625 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.528 ' CD1' ' N ' ' B' ' 57' ' ' ILE . 1.4 mp -76.9 126.1 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.962 . . . . 0.0 109.198 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -104.95 -23.28 13.0 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -169.26 153.28 5.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.055 -1.028 . . . . 0.0 110.019 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.19 134.16 46.22 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 4.1 t -135.43 124.72 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.786 -0.571 . . . . 0.0 110.033 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.463 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 17.9 t80 -144.19 140.32 16.77 Favored Pre-proline 0 N--CA 1.493 1.712 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.463 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 72.6 Cg_endo -74.46 108.48 2.7 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.538 1.492 . . . . 0.0 112.082 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.678 ' CD1' ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -82.25 8.84 10.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.535 -0.728 . . . . 0.0 109.164 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 72.9 155.48 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.502 0.668 . . . . 0.0 110.631 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.448 ' C ' ' H ' ' B' ' 68' ' ' HIS . 90.7 m-70 -88.39 17.49 5.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.611 -0.681 . . . . 0.0 109.371 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.528 ' CG ' ' O ' ' B' ' 67' ' ' HIS . 16.1 t-80 -77.51 39.81 0.28 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.323 -0.861 . . . . 0.0 108.775 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.561 ' O ' ' ND1' ' B' ' 69' ' ' HIS . 0.3 OUTLIER -80.61 -20.72 42.59 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.171 -0.956 . . . . 0.0 109.651 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.661 ' CG ' ' H ' ' B' ' 70' ' ' HIS . 0.0 OUTLIER 18.96 -125.9 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 CA-C-O 121.266 0.555 . . . . 0.0 112.268 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.661 ' H ' ' CG ' ' B' ' 69' ' ' HIS . 0.1 OUTLIER -46.19 -73.07 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.406 -0.809 . . . . 0.0 109.722 -179.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.412 ' C ' ' O ' ' B' ' 70' ' ' HIS . 8.7 t-160 . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.585 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.442 ' O ' ' O ' ' A' ' 2' ' ' ASP . 27.9 ttt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 1' ' ' MET . 30.6 t70 58.61 122.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.537 0.685 . . . . 0.0 110.478 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -144.17 -29.12 0.5 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.449 -0.782 . . . . 0.0 109.143 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 41.5 mmm-85 -60.48 141.29 56.65 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.327 -0.858 . . . . 0.0 108.785 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -152.19 161.93 41.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.125 -0.984 . . . . 0.0 109.917 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 1.2 m-85 -117.89 139.62 50.87 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.2 tt -115.8 126.06 53.52 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.393 -0.817 . . . . 0.0 108.996 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.4 t -115.25 126.75 54.9 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.4 tp -144.63 151.77 39.5 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 49' ' ' GLY . 3.6 t -143.15 166.84 23.56 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.278 -0.889 . . . . 0.0 109.631 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.4 10.95 67.33 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -69.97 145.23 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -1.219 . . . . 0.0 110.028 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 m -73.87 -51.97 14.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.361 -0.837 . . . . 0.0 109.529 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.591 ' HZ1' ' CB ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -167.37 158.69 11.88 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.067 -1.021 . . . . 0.0 109.619 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.7 t -89.27 116.01 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.268 -0.895 . . . . 0.0 109.403 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -69.19 -40.89 77.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 109.7 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.1 t -161.83 125.28 3.14 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.369 -0.832 . . . . 0.0 109.844 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -109.25 110.19 21.32 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -133.61 148.05 67.07 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.16 -20.1 50.14 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.715 1.61 . . . . 0.0 111.604 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -100.14 -5.44 27.79 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.341 -0.849 . . . . 0.0 109.671 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.547 ' OE2' ' NZ ' ' A' ' 35' ' ' LYS . 36.2 tt0 -171.32 142.91 1.77 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.208 -0.932 . . . . 0.0 109.603 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.8 mt -131.2 130.04 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.715 -0.616 . . . . 0.0 109.497 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.8 mt -117.28 125.75 51.61 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.3 mt -121.1 130.09 53.59 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.591 -0.693 . . . . 0.0 109.647 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -97.68 103.54 15.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.357 -0.839 . . . . 0.0 110.011 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 28' ' ' ILE . 6.6 t -127.18 -172.47 2.66 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.951 0.882 . . . . 0.0 110.562 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' THR . 4.2 mt -31.84 154.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.924 0.868 . . . . 0.0 111.244 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 64.49 -56.17 0.26 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.646 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -173.4 -129.48 1.16 Allowed Glycine 0 N--CA 1.487 2.059 0 C-N-CA 119.234 -1.46 . . . . 0.0 109.944 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 52.7 t -120.72 136.14 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.778 0.799 . . . . 0.0 110.862 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.9 tp -104.61 126.85 52.09 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -100.8 125.51 47.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.632 -0.668 . . . . 0.0 109.512 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.3 mt -111.3 128.54 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-O 121.294 0.569 . . . . 0.0 109.513 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.547 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 68.5 mttm -128.27 144.24 51.11 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.453 0.644 . . . . 0.0 109.629 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.9 -137.69 4.31 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -132.57 153.3 51.13 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.193 -1.181 . . . . 0.0 110.232 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 54' ' ' GLU . 98.9 mttt 49.72 40.64 20.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.619 -0.676 . . . . 0.0 110.135 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.3 mp -68.51 72.23 0.21 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 0.0 109.244 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.676 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.869 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.846 0.831 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 49' ' ' GLY . 1.0 OUTLIER -91.05 -11.75 37.81 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.025 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -43.8 -17.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.831 -0.543 . . . . 0.0 109.898 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 47' ' ' LYS . . . 126.55 23.79 1.47 Allowed Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -130.02 134.35 47.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.713 -0.875 . . . . 0.0 109.111 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.6 t -131.44 161.16 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.56 -0.712 . . . . 0.0 109.231 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -132.83 160.03 38.1 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.529 0.681 . . . . 0.0 109.673 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 t -128.84 157.82 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 38' ' ' LYS . 32.1 tt0 -135.37 134.56 39.89 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.6 172.14 13.18 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 pp -97.46 134.94 40.03 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.438 -1.037 . . . . 0.0 109.169 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 57' ' ' ILE . 1.3 mp -84.95 113.69 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.845 -1.16 . . . . 0.0 108.664 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -98.74 -22.19 16.0 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -159.47 148.57 18.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.315 -0.866 . . . . 0.0 110.298 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.463 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 51.5 mt -133.97 146.36 50.38 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.5 t -146.53 114.83 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.059 -1.025 . . . . 0.0 109.869 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.532 ' O ' ' N ' ' A' ' 64' ' ' LEU . 13.8 t80 -130.28 142.52 45.73 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.54 ' C ' ' H ' ' A' ' 65' ' ' GLU . 84.7 Cg_exo -44.87 85.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.34 1.36 . . . . 0.0 111.916 177.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.56 ' O ' ' CB ' ' A' ' 65' ' ' GLU . 2.1 tt -56.7 -7.83 0.49 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.817 -1.177 . . . . 0.0 108.525 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.56 ' CB ' ' O ' ' A' ' 64' ' ' LEU . 2.1 tp10 95.27 -73.91 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.431 ' CB ' ' O ' ' A' ' 65' ' ' GLU . 1.8 t60 75.63 172.56 0.25 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.512 -0.742 . . . . 0.0 109.178 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.447 ' O ' ' CB ' ' A' ' 68' ' ' HIS . 0.1 OUTLIER -77.41 149.49 35.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.005 -1.059 . . . . 0.0 110.164 -178.692 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.447 ' CB ' ' O ' ' A' ' 67' ' ' HIS . 4.0 t60 74.71 176.0 0.24 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.656 -0.652 . . . . 0.0 109.511 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 70' ' ' HIS . 6.5 t-80 -129.62 16.17 5.91 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 69' ' ' HIS . 34.5 m-70 44.31 -167.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.402 -0.811 . . . . 0.0 109.959 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.502 ' OXT' ' CG ' ' A' ' 71' ' ' HIS . 10.2 p80 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.346 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 77.6 mtm . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' B' ' 3' ' ' ASN . 7.0 t70 58.15 -171.04 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.416 -0.802 . . . . 0.0 109.85 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.465 HD21 ' CB ' ' B' ' 56' ' ' LEU . 2.7 p-10 -95.57 12.87 28.07 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 43.5 mmm-85 -89.39 131.46 35.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.964 -1.085 . . . . 0.0 109.128 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -144.52 159.01 43.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.288 -0.882 . . . . 0.0 109.903 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.9 115.17 29.65 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 7.6 tt -113.8 126.77 55.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.407 -0.808 . . . . 0.0 109.061 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 40.7 t -132.47 143.76 50.0 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 52.0 tp -133.64 150.09 51.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.527 -0.733 . . . . 0.0 109.154 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.6 p -129.3 171.12 12.8 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.704 -0.623 . . . . 0.0 109.35 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.52 5.46 63.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.04 135.32 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.339 -1.095 . . . . 0.0 109.695 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.3 t -72.56 -46.12 55.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 109.55 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.03 160.78 5.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.179 -0.95 . . . . 0.0 109.55 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 90.4 t -93.6 121.27 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.189 -0.944 . . . . 0.0 109.218 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -66.7 -40.03 88.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 109.545 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 47.7 t -162.43 149.77 13.75 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.43 -0.794 . . . . 0.0 108.889 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -136.24 117.85 14.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.377 -0.827 . . . . 0.0 109.491 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -132.45 150.81 76.94 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.06 -13.81 41.19 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.502 1.468 . . . . 0.0 111.07 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -118.2 3.12 12.01 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.749 -0.594 . . . . 0.0 109.603 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -170.03 134.43 1.27 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.269 -0.894 . . . . 0.0 109.409 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.414 HD13 HG22 ' B' ' 23' ' ' ILE . 96.2 mt -132.24 129.54 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.279 -0.888 . . . . 0.0 109.46 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 74.8 mt -112.34 125.64 54.41 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 87.1 mt -113.21 132.44 55.5 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.53 -0.731 . . . . 0.0 110.121 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -104.66 101.12 10.77 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.567 ' O ' ' N ' ' B' ' 29' ' ' GLN . 0.0 OUTLIER -108.73 148.86 29.84 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.822 -0.549 . . . . 0.0 110.447 -178.353 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' B' ' 27' ' ' THR . 39.9 mt 34.2 -86.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 122.151 -0.343 . . . . 0.0 110.83 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.567 ' N ' ' O ' ' B' ' 27' ' ' THR . 18.5 pt20 -137.49 -16.05 1.38 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.382 -0.824 . . . . 0.0 109.738 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.32 167.85 29.21 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 54.6 t -123.1 131.51 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 43.5 tp -110.76 126.18 54.32 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 19.1 t -106.69 122.8 47.08 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 94.9 mt -105.73 129.29 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -124.13 141.39 52.09 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.628 -0.67 . . . . 0.0 109.379 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.23 -153.42 22.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -121.45 150.85 40.95 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.571 -0.958 . . . . 0.0 109.847 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' B' ' 54' ' ' GLU . 95.3 mttt 51.93 61.68 3.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -0.8 . . . . 0.0 110.124 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 9.2 mp -93.05 71.56 4.63 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.764 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -179.11 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' B' ' 47' ' ' LYS . 53.3 tp . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.105 0.479 . . . . 0.0 110.51 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.539 ' C ' ' H ' ' B' ' 49' ' ' GLY . 88.1 tttt -39.44 150.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.424 -0.798 . . . . 0.0 110.583 -178.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . 71.38 -17.08 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.603 -0.686 . . . . 0.0 109.237 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' B' ' 47' ' ' LYS . . . 79.01 10.39 86.22 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -109.94 160.18 16.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.633 -0.922 . . . . 0.0 109.266 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.2 p -132.18 141.71 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.569 -0.707 . . . . 0.0 109.32 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -122.1 149.78 43.1 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 10.2 t -141.45 138.22 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.163 -0.961 . . . . 0.0 109.545 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' B' ' 38' ' ' LYS . 16.0 tt0 -127.62 137.59 52.59 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.61 178.36 26.29 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.465 ' CB ' HD21 ' B' ' 3' ' ' ASN . 0.2 OUTLIER -99.82 124.46 45.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.572 -0.958 . . . . 0.0 108.929 179.312 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.522 ' CD1' ' N ' ' B' ' 57' ' ' ILE . 1.5 mp -82.82 119.25 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.181 -0.949 . . . . 0.0 108.895 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -95.26 -21.46 18.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.386 -0.821 . . . . 0.0 109.488 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -170.29 153.5 4.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.117 -0.989 . . . . 0.0 109.8 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 96.2 mt -134.04 136.58 44.11 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 56.7 t -132.64 124.81 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.554 -0.716 . . . . 0.0 109.459 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.463 ' CG ' ' HB2' ' A' ' 60' ' ' LEU . 19.4 t80 -133.01 139.71 35.3 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.477 ' O ' ' C ' ' B' ' 64' ' ' LEU . 71.6 Cg_exo -44.5 -65.49 0.19 Allowed 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 122.026 1.818 . . . . 0.0 115.294 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' B' ' 63' ' ' PRO . 2.0 tm? 28.27 89.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.622 0.725 . . . . 0.0 111.002 -177.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.407 ' OE1' ' O ' ' B' ' 63' ' ' PRO . 2.9 mt-10 -140.44 141.43 35.48 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.65 ' ND1' ' N ' ' B' ' 67' ' ' HIS . 3.7 p80 -59.51 -42.76 92.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.762 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.65 ' N ' ' ND1' ' B' ' 66' ' ' HIS . 1.9 m170 -172.6 152.59 2.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -0.862 . . . . 0.0 108.723 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.22 174.44 10.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.075 -1.015 . . . . 0.0 109.824 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -81.21 14.91 2.14 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -57.71 141.96 46.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.6 -0.687 . . . . 0.0 109.527 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 t60 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.317 -179.605 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.629 0.728 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 31.9 t0 -72.58 163.79 27.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 109.919 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 1.9 p-10 -88.85 11.12 18.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.181 -0.949 . . . . 0.0 109.487 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.431 ' NE ' ' OE2' ' A' ' 54' ' ' GLU . 40.1 mmm-85 -71.23 147.89 47.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 109.126 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -141.37 156.86 45.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.187 -0.945 . . . . 0.0 109.996 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.51 ' CE1' ' OE1' ' A' ' 54' ' ' GLU . 69.6 m-85 -107.21 125.74 51.51 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 tt -117.92 124.97 49.56 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 t -115.94 135.1 54.3 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.639 -0.663 . . . . 0.0 109.633 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.4 tp -145.4 148.95 33.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.442 -0.786 . . . . 0.0 109.565 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.476 ' HG1' ' N ' ' A' ' 11' ' ' GLY . 2.4 p -142.76 -163.14 1.56 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.81 . . . . 0.0 109.717 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.476 ' N ' ' HG1' ' A' ' 10' ' ' THR . . . 53.62 17.97 7.2 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.65 141.72 16.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.165 -1.197 . . . . 0.0 109.939 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.2 m -71.43 -45.16 63.39 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.53 154.68 0.8 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.186 -0.946 . . . . 0.0 110.384 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.0 t -77.2 132.32 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.544 -0.722 . . . . 0.0 110.382 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -98.5 -34.66 10.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.49 -0.756 . . . . 0.0 108.968 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 p -161.54 163.28 30.27 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.016 -1.053 . . . . 0.0 109.683 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -148.96 104.77 3.47 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -133.85 125.85 18.5 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -47.14 -22.51 2.29 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.857 1.705 . . . . 0.0 111.868 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -94.25 -9.01 37.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.578 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -174.32 143.28 0.85 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 109.315 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.1 mt -128.38 131.35 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.353 -0.842 . . . . 0.0 109.007 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.1 mt -116.69 115.71 26.18 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.2 mt -117.79 130.43 56.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.569 -0.707 . . . . 0.0 109.637 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.07 103.16 11.5 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 28' ' ' ILE . 7.0 t -124.28 -177.96 3.95 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.586 0.708 . . . . 0.0 110.132 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 27' ' ' THR . 3.8 mt -31.91 153.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.765 0.793 . . . . 0.0 110.847 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 64.05 -63.26 0.15 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.504 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -161.85 -123.18 0.65 Allowed Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.191 -1.48 . . . . 0.0 110.014 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.8 t -120.58 135.88 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.668 -0.901 . . . . 0.0 109.727 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.7 tp -100.27 125.23 46.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.603 -0.685 . . . . 0.0 109.205 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.1 m -104.47 121.57 43.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 0.0 108.94 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.9 mt -110.73 127.42 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -117.48 147.96 42.27 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.453 0.644 . . . . 0.0 110.1 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.95 -149.65 12.14 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -136.38 145.92 45.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.346 -1.09 . . . . 0.0 109.472 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 54.99 57.65 5.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.545 -0.722 . . . . 0.0 110.092 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 8.6 mp -89.65 71.73 7.8 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.132 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.038 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 tt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 121.653 0.74 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' O ' ' CB ' ' A' ' 48' ' ' ALA . 87.8 tttt -169.03 129.3 1.1 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.421 -0.8 . . . . 0.0 109.386 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' LYS . . . 75.48 -6.11 2.04 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.785 -0.572 . . . . 0.0 109.504 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.14 52.67 2.85 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -155.14 159.48 40.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.995 -1.297 . . . . 0.0 109.056 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.2 t -126.94 134.66 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.574 -0.704 . . . . 0.0 109.261 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -118.41 153.01 34.79 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.716 -0.615 . . . . 0.0 109.624 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.7 t -124.66 135.56 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.51 ' OE1' ' CE1' ' A' ' 6' ' ' PHE . 16.4 tp10 -113.38 127.12 56.02 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.56 169.06 21.58 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.408 HD21 ' H ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -90.91 140.8 29.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.415 -1.05 . . . . 0.0 109.744 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.412 HD13 HG23 ' A' ' 57' ' ' ILE . 92.9 mt -93.82 115.17 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.991 -1.068 . . . . 0.0 109.714 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -98.64 -24.21 15.17 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.82 151.81 18.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.903 -1.123 . . . . 0.0 111.091 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.1 131.7 45.84 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 54.9 t -129.75 128.88 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.682 0.753 . . . . 0.0 109.588 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 64' ' ' LEU . 12.0 t80 -144.9 142.13 18.27 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -49.08 78.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.589 1.526 . . . . 0.0 111.968 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -60.93 -12.92 12.8 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.38 -0.825 . . . . 0.0 109.193 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -86.02 -167.74 1.97 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.257 -0.902 . . . . 0.0 110.251 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.627 ' CG ' ' H ' ' A' ' 67' ' ' HIS . 11.9 t-80 -141.43 -109.02 0.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.55 -0.719 . . . . 0.0 109.179 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.631 ' ND1' ' NE2' ' A' ' 69' ' ' HIS . 1.8 t-80 53.18 -163.93 0.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.402 -0.811 . . . . 0.0 110.2 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.4 81.26 1.66 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.631 ' NE2' ' ND1' ' A' ' 67' ' ' HIS . 55.8 m170 -102.01 -74.26 0.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 68.11 -14.88 0.23 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.587 ' H ' ' C ' ' A' ' 69' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.098 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.442 0.639 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -86.74 117.15 25.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.334 -0.853 . . . . 0.0 109.998 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -90.81 11.82 21.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.482 -0.762 . . . . 0.0 109.025 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -85.31 138.54 32.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.087 -1.008 . . . . 0.0 109.458 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -141.8 153.22 44.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 109.898 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -108.12 119.23 38.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.4 tt -108.09 121.67 45.3 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 8.2 p -114.78 137.25 52.17 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.354 0.597 . . . . 0.0 109.995 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.8 tp -149.3 148.31 29.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.546 -0.721 . . . . 0.0 109.306 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -142.42 164.59 29.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.274 -0.891 . . . . 0.0 110.256 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.98 21.02 58.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 p -59.5 142.29 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.117 -1.225 . . . . 0.0 110.432 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 15.1 m -72.86 -39.99 66.04 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -172.26 163.91 5.83 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.12 -0.988 . . . . 0.0 110.01 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 85.7 t -96.84 99.8 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.425 -0.797 . . . . 0.0 109.555 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -65.53 -39.22 91.52 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.313 -0.867 . . . . 0.0 109.128 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 47.0 t -172.67 152.33 2.52 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.27 -0.893 . . . . 0.0 109.318 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -133.81 107.98 8.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.557 -0.714 . . . . 0.0 109.259 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.93 145.79 57.32 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.6 -19.13 42.58 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.973 1.782 . . . . 0.0 111.426 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -98.52 -7.0 29.1 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.515 ' OE2' ' NZ ' ' B' ' 35' ' ' LYS . 29.9 tt0 -173.38 131.98 0.47 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.368 -0.833 . . . . 0.0 109.352 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.72 128.69 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.447 -0.783 . . . . 0.0 109.28 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 62.9 mt -118.45 121.88 41.38 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 88.8 mt -132.28 130.58 41.07 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -93.62 127.86 39.51 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.211 -0.931 . . . . 0.0 109.101 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.59 ' O ' ' N ' ' B' ' 29' ' ' GLN . 5.4 t -124.39 149.05 47.13 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.373 0.606 . . . . 0.0 109.47 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.4 HG21 HD11 ' B' ' 28' ' ' ILE . 5.9 mm 48.05 -81.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.049 0.452 . . . . 0.0 110.321 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' B' ' 27' ' ' THR . 11.4 pt20 -149.03 -21.21 0.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.052 -1.03 . . . . 0.0 109.359 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.67 165.14 25.7 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 120.987 -1.071 . . . . 0.0 110.509 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.63 130.6 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.609 -0.936 . . . . 0.0 109.488 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 50.9 tp -106.98 126.04 51.8 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 71.0 m -111.27 117.31 32.8 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.413 HD11 HG22 ' B' ' 34' ' ' ILE . 89.6 mt -100.77 128.04 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.515 ' NZ ' ' OE2' ' B' ' 22' ' ' GLU . 67.3 mttm -124.68 136.82 54.23 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.51 -149.01 9.79 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -133.83 148.63 51.33 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.513 -0.992 . . . . 0.0 109.813 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 56.23 57.96 4.63 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.732 0.777 . . . . 0.0 109.747 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 9.9 mp -91.34 72.03 6.12 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.386 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.443 ' N ' ' CD1' ' B' ' 46' ' ' LEU . 10.4 mp . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.182 0.515 . . . . 0.0 110.028 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -128.0 -17.61 4.35 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.08 29.74 0.57 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.134 -0.979 . . . . 0.0 109.056 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.12 22.01 78.34 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -104.57 155.75 18.56 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.302 -1.116 . . . . 0.0 109.487 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.3 t -127.78 135.1 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.504 -0.748 . . . . 0.0 109.355 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.72 159.88 40.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.658 -0.652 . . . . 0.0 109.381 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 99.3 t -127.73 138.25 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -117.96 138.47 52.15 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.17 -179.49 30.33 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.58 124.45 43.36 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.399 -1.059 . . . . 0.0 109.793 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.52 ' CD1' ' N ' ' B' ' 57' ' ' ILE . 1.3 mp -77.83 126.41 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.488 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -109.38 -19.14 13.38 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.15 152.25 9.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.927 -1.108 . . . . 0.0 110.305 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.19 129.56 35.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.569 -0.707 . . . . 0.0 109.176 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.0 t -126.59 128.41 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.416 ' O ' ' N ' ' B' ' 64' ' ' LEU . 45.4 t80 -144.02 101.47 4.9 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -46.62 89.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.111 1.874 . . . . 0.0 112.582 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.613 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -79.24 4.45 14.96 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.311 -0.868 . . . . 0.0 109.292 179.533 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -74.92 -100.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.385 -0.822 . . . . 0.0 110.081 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -124.31 165.67 17.25 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.607 0.718 . . . . 0.0 110.548 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' B' ' 68' ' ' HIS . 8.6 p80 -79.98 -11.02 59.82 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.524 ' C ' ' CG ' ' B' ' 69' ' ' HIS . 11.2 m80 -54.7 -163.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.498 -0.751 . . . . 0.0 110.199 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.524 ' CG ' ' C ' ' B' ' 68' ' ' HIS . 0.7 OUTLIER 79.88 -128.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' B' ' 71' ' ' HIS . 0.0 OUTLIER 60.37 15.89 5.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.907 -1.12 . . . . 0.0 110.528 179.497 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.657 ' N ' ' ND1' ' B' ' 71' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 118.184 -0.912 . . . . 0.0 109.73 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.71 0.767 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -87.73 110.18 20.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.388 -0.82 . . . . 0.0 109.49 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -101.32 -3.33 29.05 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.829 0.823 . . . . 0.0 109.397 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -71.4 138.62 49.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.172 -0.955 . . . . 0.0 109.911 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -146.27 154.99 42.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.293 -0.88 . . . . 0.0 110.005 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 8.1 m-85 -110.75 121.1 44.5 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.9 tt -114.08 124.58 52.46 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.509 -0.744 . . . . 0.0 109.223 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.8 p -125.41 149.56 48.07 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.778 0.799 . . . . 0.0 109.558 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.6 tp -147.8 144.45 28.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.45 -0.781 . . . . 0.0 109.511 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -125.99 164.38 20.94 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.714 0.768 . . . . 0.0 110.169 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.54 17.04 71.94 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.34 134.78 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -1.168 . . . . 0.0 110.438 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -72.68 -45.08 60.69 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.543 -0.723 . . . . 0.0 109.074 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.12 160.46 4.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.445 -0.785 . . . . 0.0 109.976 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.8 t -91.62 110.93 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.578 0.704 . . . . 0.0 109.873 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -68.55 -38.32 80.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.45 -0.781 . . . . 0.0 109.595 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.2 t -162.61 156.17 20.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.876 -1.14 . . . . 0.0 110.383 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -141.66 105.57 4.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.98 147.74 66.61 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.74 -18.0 42.16 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.447 2.098 . . . . 0.0 111.274 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -102.16 -9.12 20.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.43 -0.794 . . . . 0.0 109.344 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -171.83 133.68 0.76 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.212 -0.93 . . . . 0.0 109.704 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.1 mt -126.45 130.07 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.428 -0.795 . . . . 0.0 110.135 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.0 mt -116.27 125.89 52.82 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.7 mt -121.15 130.42 53.71 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.715 0.769 . . . . 0.0 109.466 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -98.01 113.69 25.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.6 -0.688 . . . . 0.0 109.556 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.549 ' O ' ' N ' ' A' ' 29' ' ' GLN . 9.0 t -124.65 157.6 35.14 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.941 0.877 . . . . 0.0 110.097 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.6 mm 38.2 -85.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.287 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.549 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.8 pp0? -142.62 -17.02 0.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.95 -1.094 . . . . 0.0 108.873 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.06 175.24 24.91 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.1 t -125.6 133.45 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.781 -0.835 . . . . 0.0 109.602 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.1 tp -102.76 128.31 49.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.621 -0.675 . . . . 0.0 109.51 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -112.85 126.79 55.83 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.823 0.82 . . . . 0.0 110.166 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.6 mt -108.98 130.25 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -124.84 140.49 52.88 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.575 0.703 . . . . 0.0 109.446 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.06 -145.75 9.42 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -134.53 144.52 48.06 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.463 -1.021 . . . . 0.0 109.362 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.8 mttp 55.48 61.22 2.95 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.834 0.826 . . . . 0.0 109.695 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.441 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 10.5 mp -92.56 71.64 5.05 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.912 0.863 . . . . 0.0 109.062 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.221 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 48' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.677 0.751 . . . . 0.0 109.997 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt 44.01 -85.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.379 0.609 . . . . 0.0 110.92 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . -83.95 -0.54 51.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 0.0 109.235 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 49.25 64.31 3.43 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -138.44 157.18 46.71 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.203 -1.175 . . . . 0.0 109.476 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.1 m -117.0 158.37 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.618 0.723 . . . . 0.0 109.848 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -141.52 140.11 33.4 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.9 t -125.81 134.89 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.591 -0.693 . . . . 0.0 109.423 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -117.18 125.88 51.89 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.04 174.6 30.03 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.164 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.35 128.76 37.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.667 -0.902 . . . . 0.0 110.092 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.473 ' CD1' ' N ' ' A' ' 57' ' ' ILE . 1.4 mp -78.74 125.96 38.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.435 -0.791 . . . . 0.0 109.126 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -112.19 -29.97 7.38 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.38 137.84 3.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.028 -1.045 . . . . 0.0 110.812 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.14 135.51 53.7 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.78 129.48 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.867 0.841 . . . . 0.0 110.075 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -145.47 137.84 13.51 Favored Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.02 108.42 2.12 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.788 1.658 . . . . 0.0 112.543 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.638 ' H ' ' CD1' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -87.54 -7.83 57.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.245 -0.909 . . . . 0.0 109.095 179.354 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -60.59 136.09 57.95 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 122.24 1.019 . . . . 0.0 110.584 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.468 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 34.5 t-80 -85.36 -6.71 59.21 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -99.48 -165.66 1.25 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.69 0.757 . . . . 0.0 109.911 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -161.34 -155.88 0.42 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.687 0.756 . . . . 0.0 109.874 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.403 ' O ' ' C ' ' A' ' 70' ' ' HIS . 1.3 t60 -55.0 97.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.498 -0.751 . . . . 0.0 110.474 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.727 ' CG ' ' H ' ' A' ' 71' ' ' HIS . 30.9 t60 41.33 -126.71 0.54 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.791 -0.568 . . . . 0.0 109.964 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.727 ' H ' ' CG ' ' A' ' 70' ' ' HIS . 50.7 m-70 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.799 -1.188 . . . . 0.0 108.87 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.647 0.737 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' B' ' 3' ' ' ASN . 14.6 t0 -88.96 -147.02 0.16 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.35 -0.844 . . . . 0.0 110.286 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' B' ' 4' ' ' ARG . 52.8 p-10 -105.37 -23.98 12.75 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.473 -0.767 . . . . 0.0 110.537 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.543 ' N ' ' OD1' ' B' ' 3' ' ' ASN . 45.0 mmm-85 -50.46 136.78 20.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.192 -0.942 . . . . 0.0 110.682 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -146.37 155.81 42.87 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.335 -0.853 . . . . 0.0 109.551 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' B' ' 6' ' ' PHE . 30.3 m-85 -115.04 121.64 43.71 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.4 tt -118.43 122.79 43.63 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 29.8 t -119.01 134.76 55.0 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.511 0.672 . . . . 0.0 109.825 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 48.9 tp -131.61 144.91 51.4 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.8 p -128.09 164.0 23.39 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.701 0.762 . . . . 0.0 110.26 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.33 20.06 61.19 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 p -67.39 135.71 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.187 -1.184 . . . . 0.0 110.01 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 56.2 m -72.45 -43.65 63.47 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.421 -0.8 . . . . 0.0 109.25 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.98 162.28 3.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.385 -0.822 . . . . 0.0 110.278 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.2 t -89.98 111.24 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.519 0.676 . . . . 0.0 110.066 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -67.2 -38.91 86.13 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.881 0.848 . . . . 0.0 108.791 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 30.1 t -168.89 166.37 11.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 0.0 109.655 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -145.48 104.7 3.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.37 -0.831 . . . . 0.0 109.513 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' B' ' 22' ' ' GLU . 13.7 m-20 -133.92 125.94 18.48 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.62 -26.27 16.63 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.824 1.683 . . . . 0.0 111.503 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -88.59 -5.05 58.42 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.708 0.766 . . . . 0.0 109.379 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' B' ' 19' ' ' ASP . 32.9 tt0 -176.35 132.99 0.23 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.517 -0.74 . . . . 0.0 109.399 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 93.5 mt -123.09 128.1 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.45 -0.781 . . . . 0.0 109.481 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 mt -117.84 129.07 55.44 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.361 0.601 . . . . 0.0 109.463 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 86.3 mt -131.03 131.87 44.58 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.665 0.745 . . . . 0.0 109.873 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -95.4 114.46 26.24 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.616 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.3 t -125.53 153.77 43.13 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.439 0.638 . . . . 0.0 110.114 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.428 HG21 HD11 ' B' ' 28' ' ' ILE . 14.0 mm 46.3 -78.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-O 121.558 0.694 . . . . 0.0 110.91 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.616 ' N ' ' O ' ' B' ' 27' ' ' THR . 13.3 pt20 -151.89 -22.84 0.19 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.161 -0.962 . . . . 0.0 109.118 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.94 176.17 29.29 Favored Glycine 0 N--CA 1.5 2.944 0 O-C-N 120.993 -1.067 . . . . 0.0 110.624 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 56.0 t -121.13 134.65 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.6 -0.941 . . . . 0.0 109.442 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 51.2 tp -104.88 128.27 53.03 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.473 0.654 . . . . 0.0 109.655 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 46.4 t -112.26 121.27 44.42 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 93.9 mt -106.05 130.95 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.551 0.691 . . . . 0.0 110.202 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -127.71 141.21 51.66 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.83 -141.47 4.7 Favored Glycine 0 N--CA 1.485 1.928 0 C-N-CA 119.655 -1.26 . . . . 0.0 110.235 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -129.42 135.62 48.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.708 -0.878 . . . . 0.0 109.544 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? 43.23 80.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.91 0.862 . . . . 0.0 110.08 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 8.7 mp -95.06 71.59 3.35 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.073 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -179.156 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 122.08 0.943 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -56.71 -69.23 0.16 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.884 0.849 . . . . 0.0 109.856 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.68 34.98 1.61 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.141 -0.975 . . . . 0.0 109.121 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.82 25.61 75.45 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -82.95 160.16 22.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.349 -1.089 . . . . 0.0 109.983 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 6.2 m -124.28 133.14 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.682 0.753 . . . . 0.0 109.793 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -127.15 129.3 47.61 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.27 136.43 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.648 -0.657 . . . . 0.0 109.25 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -121.06 134.5 55.27 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.713 0.768 . . . . 0.0 109.373 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.55 -179.82 29.57 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.52 126.87 43.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.667 -0.902 . . . . 0.0 109.52 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.498 ' CD1' ' N ' ' B' ' 57' ' ' ILE . 1.4 mp -83.78 121.65 36.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.418 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -106.95 -19.24 13.69 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.14 150.03 14.5 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.647 -1.283 . . . . 0.0 110.984 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.11 139.36 41.19 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.372 0.606 . . . . 0.0 109.386 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 54.7 t -141.03 131.61 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.454 -0.779 . . . . 0.0 110.198 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.505 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 11.9 t80 -145.73 140.16 15.47 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.505 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 68.4 Cg_endo -76.06 108.82 2.76 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.282 1.988 . . . . 0.0 112.336 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.538 ' CD1' ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -100.54 34.65 2.35 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.364 -0.835 . . . . 0.0 109.157 179.699 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' B' ' 65' ' ' GLU . 0.0 OUTLIER 40.19 -165.81 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.762 0.791 . . . . 0.0 110.696 179.254 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' B' ' 65' ' ' GLU . 2.5 t-160 36.58 61.31 0.84 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.86 0.838 . . . . 0.0 110.263 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.667 ' CD2' ' H ' ' B' ' 68' ' ' HIS . 6.0 p80 -150.61 -54.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.667 ' H ' ' CD2' ' B' ' 67' ' ' HIS . 5.0 t60 -165.76 126.88 1.88 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 109.956 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -84.6 162.04 19.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.519 -0.738 . . . . 0.0 109.018 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.526 ' O ' ' ND1' ' B' ' 70' ' ' HIS . 0.1 OUTLIER -124.51 139.4 53.92 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.399 -0.813 . . . . 0.0 110.004 -179.618 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.722 -179.847 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.421 ' O ' ' O ' ' A' ' 2' ' ' ASP . 78.5 mtm . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.242 0.544 . . . . 0.0 109.747 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 1' ' ' MET . 4.7 t70 44.82 -169.93 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.491 -0.756 . . . . 0.0 110.106 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -149.65 -28.71 0.25 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.212 -0.93 . . . . 0.0 109.609 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.7 mmm-85 -53.67 140.41 29.34 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.268 -0.895 . . . . 0.0 109.46 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -146.97 160.82 41.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.32 -0.862 . . . . 0.0 109.534 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -111.35 131.89 54.83 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.0 tt -118.2 139.83 50.71 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 m -121.79 146.69 46.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.509 -0.745 . . . . 0.0 109.262 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tp -156.1 149.0 24.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.113 -0.992 . . . . 0.0 109.868 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.3 163.76 34.51 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.582 -0.699 . . . . 0.0 109.562 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.14 18.96 56.77 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.14 140.22 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.171 -1.194 . . . . 0.0 109.798 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 t -73.44 -51.79 15.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.118 -0.989 . . . . 0.0 109.585 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -155.87 160.42 40.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.026 -1.046 . . . . 0.0 109.917 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.4 t -92.54 102.33 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -65.82 -39.22 90.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 109.445 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -167.74 164.36 14.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.156 -0.965 . . . . 0.0 109.513 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -147.06 108.07 4.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.186 -0.946 . . . . 0.0 108.863 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -132.26 146.97 63.89 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.91 -18.37 46.75 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 121.814 1.676 . . . . 0.0 111.367 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -100.12 -3.58 31.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.408 -0.808 . . . . 0.0 109.502 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.457 ' OE1' ' NZ ' ' A' ' 35' ' ' LYS . 29.8 tt0 -174.29 151.03 1.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.222 -0.924 . . . . 0.0 109.441 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.431 HG23 HD12 ' A' ' 23' ' ' ILE . 95.7 mt -133.98 129.76 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.27 -0.894 . . . . 0.0 109.733 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.0 mt -117.8 120.55 38.26 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.8 mt -134.09 133.23 40.88 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.25 -0.906 . . . . 0.0 109.413 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -102.53 118.56 37.11 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.244 -0.91 . . . . 0.0 108.974 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 29' ' ' GLN . 5.0 t -125.15 153.69 42.66 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.681 0.753 . . . . 0.0 110.143 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 28' ' ' ILE . 10.0 mm 53.8 -82.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.635 -0.665 . . . . 0.0 109.879 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' THR . 20.9 pt20 -164.04 51.05 0.14 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.976 -1.078 . . . . 0.0 109.748 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -171.43 155.12 23.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.2 t -95.99 130.38 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.329 -1.101 . . . . 0.0 109.942 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.4 tp -107.2 121.71 45.06 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.9 t -107.71 118.06 35.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.3 mt -103.89 127.14 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.457 ' NZ ' ' OE1' ' A' ' 22' ' ' GLU . 68.7 mttm -121.43 129.54 53.06 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.553 0.692 . . . . 0.0 109.153 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.67 -141.42 3.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -144.53 151.67 39.45 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.989 -1.301 . . . . 0.0 110.168 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 54' ' ' GLU . 45.6 mmtm 56.65 43.53 25.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.574 -0.704 . . . . 0.0 109.726 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 9.7 mp -73.77 71.99 1.5 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.706 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.093 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 47' ' ' LYS . 52.9 tp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.056 0.455 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.574 ' C ' ' H ' ' A' ' 49' ' ' GLY . 65.0 tttm -37.3 148.72 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.434 0.635 . . . . 0.0 110.99 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 63.2 -9.0 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.7 -0.625 . . . . 0.0 109.793 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 47' ' ' LYS . . . 52.07 27.56 22.92 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -93.06 154.1 18.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.374 -1.074 . . . . 0.0 108.835 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.65 159.7 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.294 -0.879 . . . . 0.0 109.193 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.15 146.35 42.67 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.8 t -123.07 135.24 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 38' ' ' LYS . 19.8 pt-20 -116.38 132.09 56.77 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.31 173.34 25.61 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 pp -96.84 124.51 40.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.252 -1.146 . . . . 0.0 109.745 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.7 mt -79.67 129.03 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.238 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -118.72 -27.63 5.81 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.77 146.88 25.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.025 -1.047 . . . . 0.0 110.532 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.93 134.1 42.2 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.5 t -130.68 123.29 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.243 -0.91 . . . . 0.0 109.937 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.41 ' CE1' ' O ' ' A' ' 63' ' ' PRO . 46.4 t80 -146.66 138.01 13.05 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.41 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 61.6 Cg_endo -75.03 116.41 4.57 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.454 1.436 . . . . 0.0 111.442 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.648 ' H ' ' CD1' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -88.55 39.95 0.94 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.196 -0.94 . . . . 0.0 108.473 179.736 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.499 ' O ' ' O ' ' A' ' 64' ' ' LEU . 0.8 OUTLIER 60.31 136.29 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.224 -0.923 . . . . 0.0 108.894 178.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.468 ' CG ' ' H ' ' A' ' 67' ' ' HIS . 5.8 t-80 -164.03 -170.01 2.01 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.468 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 1.7 t60 -146.91 142.01 27.15 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.937 -1.102 . . . . 0.0 109.721 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -77.36 135.85 38.39 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -94.51 126.38 39.76 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.961 -1.087 . . . . 0.0 109.796 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -88.68 176.81 6.94 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.676 -0.64 . . . . 0.0 109.541 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.098 -0.953 . . . . 0.0 109.445 179.533 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.543 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -76.32 118.04 18.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.089 -1.007 . . . . 0.0 109.631 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' B' ' 3' ' ' ASN . 7.2 p-10 -97.02 6.32 48.83 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.306 -0.871 . . . . 0.0 109.099 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -80.36 140.33 36.12 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.364 -0.835 . . . . 0.0 109.319 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -152.02 161.77 42.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 109.38 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' B' ' 6' ' ' PHE . 23.6 m-85 -104.2 146.03 29.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.628 -0.67 . . . . 0.0 109.412 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.2 tt -132.66 122.27 24.41 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 80.0 p -114.71 144.75 42.96 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.35 -0.844 . . . . 0.0 109.835 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.9 tp -150.67 150.72 31.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.295 -0.878 . . . . 0.0 109.323 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.6 160.76 41.76 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.476 -0.765 . . . . 0.0 109.472 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.37 14.3 60.36 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.31 135.11 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.235 -1.156 . . . . 0.0 109.689 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t -73.15 -43.41 61.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 109.857 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.56 165.03 10.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.941 -1.099 . . . . 0.0 109.798 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 71.4 t -98.31 129.68 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.22 -0.925 . . . . 0.0 109.917 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -83.57 -29.03 28.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 109.272 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 34.7 t -172.01 168.7 5.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.254 -0.904 . . . . 0.0 109.032 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -150.41 107.63 3.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.137 -0.977 . . . . 0.0 109.771 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -132.12 149.61 73.73 Favored Pre-proline 0 N--CA 1.497 1.923 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.19 -3.25 11.93 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.694 1.596 . . . . 0.0 111.606 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -122.26 -12.59 8.24 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.532 -0.73 . . . . 0.0 109.974 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.42 ' CD ' ' HZ3' ' B' ' 35' ' ' LYS . 80.2 tt0 -158.82 109.57 2.07 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.097 -1.002 . . . . 0.0 109.242 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 95.8 mt -111.67 128.74 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.403 ' CD2' ' OG ' ' B' ' 33' ' ' SER . 15.0 mt -111.6 125.05 53.52 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 80.0 mt -121.69 128.97 52.41 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.571 -0.706 . . . . 0.0 109.853 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -96.75 113.75 25.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.185 -0.947 . . . . 0.0 108.707 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.547 ' O ' ' N ' ' B' ' 29' ' ' GLN . 5.1 t -124.17 156.44 36.71 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.364 0.602 . . . . 0.0 110.514 -178.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.423 ' C ' ' O ' ' B' ' 27' ' ' THR . 45.4 mt 34.71 -87.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 CA-C-O 121.123 0.487 . . . . 0.0 110.639 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.547 ' N ' ' O ' ' B' ' 27' ' ' THR . 17.1 pt20 -150.73 45.19 0.85 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 0.0 109.682 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.68 136.69 4.29 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 74.7 t -91.55 132.73 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.391 -1.064 . . . . 0.0 109.751 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 53.0 tp -107.02 125.27 50.8 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.403 ' OG ' ' CD2' ' B' ' 24' ' ' LEU . 21.0 m -107.61 120.42 42.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.479 -0.763 . . . . 0.0 109.422 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 87.5 mt -106.78 127.5 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.42 ' HZ3' ' CD ' ' B' ' 22' ' ' GLU . 68.5 mttm -124.78 139.89 53.43 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.581 0.705 . . . . 0.0 109.355 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.8 -139.97 5.46 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -143.63 152.72 41.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.996 -1.296 . . . . 0.0 109.52 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' B' ' 54' ' ' GLU . 68.1 mttm 56.15 51.23 12.12 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.301 0.572 . . . . 0.0 110.201 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.439 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 9.8 mp -85.56 71.65 10.72 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -178.701 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.502 ' N ' ' CD1' ' B' ' 46' ' ' LEU . 8.5 mp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.55 -44.4 82.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.344 -0.848 . . . . 0.0 110.085 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.19 38.1 4.06 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.57 -0.706 . . . . 0.0 109.775 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 47.57 23.62 2.27 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -93.16 154.61 17.96 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.228 -1.16 . . . . 0.0 109.138 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.12 159.82 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.49 -0.756 . . . . 0.0 109.124 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . 0.429 ' CD ' ' N ' ' B' ' 52' ' ' GLU . 18.3 mp0 -138.68 153.86 48.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.347 -0.845 . . . . 0.0 109.508 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 55.4 t -131.42 156.25 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.403 ' O ' ' O ' ' B' ' 38' ' ' LYS . 31.3 tt0 -138.68 134.55 33.77 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.49 178.91 32.95 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.03 139.24 32.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.338 -1.095 . . . . 0.0 109.119 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 43.3 mm -86.38 118.07 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 109.257 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -107.69 -31.77 7.93 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.447 -0.783 . . . . 0.0 109.682 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.76 147.21 15.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.16 -0.963 . . . . 0.0 110.265 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -129.84 135.85 48.88 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 95.0 t -135.28 129.36 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.294 -0.879 . . . . 0.0 109.515 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' B' ' 64' ' ' LEU . 42.4 t80 -144.89 123.18 6.63 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -42.34 86.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.464 1.443 . . . . 0.0 112.224 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.588 ' H ' ' CD2' ' B' ' 64' ' ' LEU . 0.7 OUTLIER -95.17 21.56 7.72 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.467 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.562 ' N ' ' OE1' ' B' ' 65' ' ' GLU . 0.0 OUTLIER -41.1 155.88 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.617 0.723 . . . . 0.0 110.404 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' B' ' 64' ' ' LEU . 5.4 m80 -125.63 -13.48 6.48 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.358 -0.839 . . . . 0.0 109.307 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -150.82 161.2 43.13 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.112 -0.993 . . . . 0.0 109.548 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.65 ' ND1' ' N ' ' B' ' 69' ' ' HIS . 4.3 p80 -164.01 -38.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 0.0 109.042 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.65 ' N ' ' ND1' ' B' ' 68' ' ' HIS . 42.3 t-80 -105.76 122.77 46.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.627 -0.671 . . . . 0.0 109.669 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' B' ' 71' ' ' HIS . 1.7 t-80 -175.83 155.58 1.68 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.359 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.584 ' N ' ' ND1' ' B' ' 70' ' ' HIS . 5.3 t60 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.268 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.61 32.43 22.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.904 . . . . 0.0 108.599 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.51 11.33 39.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.352 -0.843 . . . . 0.0 109.142 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.3 mmm-85 -69.97 145.32 51.93 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.223 -0.923 . . . . 0.0 109.03 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.543 ' NE2' ' OG1' ' B' ' 27' ' ' THR . 83.2 mt-30 -135.56 146.65 48.21 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.676 0.751 . . . . 0.0 110.005 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -110.19 114.71 28.42 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.9 tt -111.27 125.08 53.45 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.424 -0.797 . . . . 0.0 108.867 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.7 t -119.58 148.04 43.78 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.477 0.656 . . . . 0.0 109.555 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 tp -149.07 -179.46 7.04 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.631 0.729 . . . . 0.0 109.717 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -175.13 158.18 2.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.344 -0.848 . . . . 0.0 109.378 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.12 20.63 57.04 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -66.48 139.88 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -1.078 . . . . 0.0 110.217 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.0 t -72.68 -43.36 63.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.429 -0.794 . . . . 0.0 109.598 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.99 159.12 9.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 0.0 109.93 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.5 t -91.61 106.61 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.472 -0.768 . . . . 0.0 109.959 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -69.09 -38.22 78.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 109.395 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -168.87 164.15 11.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.832 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -149.02 105.16 3.5 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -132.79 150.43 75.71 Favored Pre-proline 0 N--CA 1.498 1.957 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.64 -19.29 36.89 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.134 1.889 . . . . 0.0 111.231 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -100.02 -3.34 32.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.4 -0.813 . . . . 0.0 109.078 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -174.49 146.97 1.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.541 -0.724 . . . . 0.0 109.435 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.413 HD12 HG21 ' A' ' 23' ' ' ILE . 97.0 mt -133.04 129.81 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.335 -0.853 . . . . 0.0 109.614 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.8 mt -117.13 124.9 50.32 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.3 mt -136.64 129.36 30.61 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.56 -0.712 . . . . 0.0 109.192 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -104.7 123.05 46.94 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.526 -0.734 . . . . 0.0 109.444 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 29' ' ' GLN . 8.9 t -123.82 154.71 39.2 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.528 0.68 . . . . 0.0 109.72 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.6 mt 42.97 -84.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.999 -0.438 . . . . 0.0 110.623 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.578 ' N ' ' O ' ' A' ' 27' ' ' THR . 12.9 pt20 -154.9 57.24 0.67 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.932 -1.105 . . . . 0.0 109.85 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.71 141.65 6.15 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.187 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.4 t -86.34 132.2 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.487 -1.007 . . . . 0.0 109.518 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.9 tp -111.26 123.55 50.43 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 t -115.7 126.69 54.42 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.572 -0.705 . . . . 0.0 109.992 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.402 HG21 HD12 ' A' ' 34' ' ' ILE . 92.0 mt -112.59 130.74 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.36 144.67 50.74 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 121.499 0.666 . . . . 0.0 109.662 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.83 -140.1 5.52 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -135.93 143.06 44.74 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.421 -1.046 . . . . 0.0 108.885 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 54.44 62.21 2.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.523 -0.736 . . . . 0.0 110.171 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 10.3 mp -91.71 73.04 5.84 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.148 -0.97 . . . . 0.0 108.548 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.013 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 47' ' ' LYS . 47.6 tp . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.507 ' C ' ' H ' ' A' ' 49' ' ' GLY . 21.2 tptm -37.09 149.87 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.484 0.659 . . . . 0.0 110.74 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 47' ' ' LYS . . . 73.22 -14.56 0.6 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 47' ' ' LYS . . . 65.68 35.95 91.72 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -81.88 162.54 22.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.306 -1.114 . . . . 0.0 109.442 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -113.71 136.34 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -136.43 131.0 33.52 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.849 -0.796 . . . . 0.0 108.849 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.1 t -125.1 148.88 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.565 -0.709 . . . . 0.0 109.174 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -133.1 127.97 35.15 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.6 173.64 23.71 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.413 ' H ' HD22 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -95.44 128.3 42.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.371 -1.076 . . . . 0.0 109.343 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.1 mt -81.46 121.31 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.868 . . . . 0.0 109.639 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -103.37 -23.76 13.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.545 -0.722 . . . . 0.0 109.085 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.02 151.17 13.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.167 -0.958 . . . . 0.0 109.98 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.95 126.98 37.48 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.6 t -123.04 123.89 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.303 -0.873 . . . . 0.0 109.773 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -146.3 139.76 14.76 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.97 110.01 2.82 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.27 1.313 . . . . 0.0 111.769 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.65 ' H ' ' CD1' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -88.15 3.64 48.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.36 -0.838 . . . . 0.0 109.17 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' A' ' 68' ' ' HIS . 23.0 pt-20 -40.3 160.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.79 -0.569 . . . . 0.0 110.008 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -41.7 72.73 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.418 ' O ' ' O ' ' A' ' 68' ' ' HIS . 7.2 p-80 168.18 20.4 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.436 ' O ' ' OE2' ' A' ' 65' ' ' GLU . 28.2 m-70 -52.85 -167.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.949 0.88 . . . . 0.0 111.784 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.463 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 50.1 t60 -83.32 -111.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.571 0.7 . . . . 0.0 110.387 -178.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.643 ' CG ' ' N ' ' A' ' 71' ' ' HIS . 2.1 t-80 -170.7 -90.63 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.643 ' N ' ' CG ' ' A' ' 70' ' ' HIS . 25.0 m80 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.32 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.423 ' O ' ' O ' ' B' ' 2' ' ' ASP . 67.1 mtt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' B' ' 1' ' ' MET . 8.3 t70 57.5 112.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.401 -0.812 . . . . 0.0 110.251 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -101.76 12.82 36.46 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.401 -0.812 . . . . 0.0 109.253 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -87.56 137.25 32.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.154 -0.966 . . . . 0.0 109.296 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -146.13 163.75 34.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.409 -0.807 . . . . 0.0 109.299 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -108.96 129.79 55.45 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 7.5 tt -113.41 135.44 53.87 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 12.4 t -130.99 139.8 50.05 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.726 0.774 . . . . 0.0 110.226 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 45.6 tp -151.03 146.06 25.95 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.604 -0.685 . . . . 0.0 109.319 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.4 p -130.11 177.77 7.05 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.61 -0.681 . . . . 0.0 109.414 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.1 18.55 69.23 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 79.3 t -74.55 130.86 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.14 -1.212 . . . . 0.0 109.771 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 38.9 t -73.4 -42.37 62.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.355 -0.841 . . . . 0.0 109.114 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.2 160.29 9.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.155 -0.966 . . . . 0.0 109.946 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 10.1 t -82.08 104.15 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.435 -0.79 . . . . 0.0 109.506 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -67.53 -35.81 79.8 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.164 -0.96 . . . . 0.0 109.352 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 7.5 t -165.46 153.26 11.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.922 . . . . 0.0 109.223 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -140.27 104.54 4.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.278 -0.889 . . . . 0.0 109.455 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . 0.411 ' OD2' ' O ' ' B' ' 22' ' ' GLU . 0.4 OUTLIER -133.26 150.32 74.98 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.97 -16.69 32.46 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.846 1.697 . . . . 0.0 111.953 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -107.93 -8.54 15.91 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.353 -0.842 . . . . 0.0 109.743 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.411 ' O ' ' OD2' ' B' ' 19' ' ' ASP . 50.0 tt0 -167.33 126.78 1.39 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 109.435 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.2 mt -125.11 130.7 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.438 -0.789 . . . . 0.0 109.683 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 60.7 mt -112.95 128.43 56.48 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 94.7 mt -127.02 126.74 43.63 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.629 -0.67 . . . . 0.0 109.658 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -94.03 112.34 24.16 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.543 ' OG1' ' NE2' ' A' ' 5' ' ' GLN . 15.0 t -124.7 164.93 18.87 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.524 0.678 . . . . 0.0 110.488 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' B' ' 27' ' ' THR . 22.2 mm 33.21 -86.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.415 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' B' ' 27' ' ' THR . 27.2 pt20 -148.98 27.2 0.87 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.933 -1.104 . . . . 0.0 109.728 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.84 165.96 31.25 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 55.7 t -112.51 132.4 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.655 -0.909 . . . . 0.0 109.143 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 46.8 tp -104.52 124.33 49.1 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' B' ' 61' ' ' VAL . 5.4 p -107.52 122.59 46.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.591 -0.693 . . . . 0.0 109.48 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 mp -108.6 129.08 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.406 ' HZ1' ' CD ' ' B' ' 22' ' ' GLU . 68.5 mttm -123.27 133.3 54.18 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.565 0.698 . . . . 0.0 109.459 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.68 -147.72 8.62 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -136.61 153.76 50.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.357 -1.084 . . . . 0.0 109.767 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 67.8 mttm 55.96 57.41 5.16 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.539 0.685 . . . . 0.0 110.557 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.457 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 9.0 mp -92.35 70.09 5.13 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.557 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' B' ' 46' ' ' LEU . 10.3 mp . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.714 0.769 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.469 ' O ' ' CB ' ' B' ' 48' ' ' ALA . 1.3 tmtp? 60.9 117.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.378 -0.827 . . . . 0.0 110.015 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' B' ' 47' ' ' LYS . . . 79.05 -1.48 2.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.757 -0.589 . . . . 0.0 109.876 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.98 23.48 77.78 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -106.43 153.56 22.08 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.31 -1.112 . . . . 0.0 109.402 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.3 t -125.42 132.21 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-O 121.616 0.722 . . . . 0.0 109.26 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -144.11 127.67 17.03 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 t -118.17 162.55 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.655 -0.653 . . . . 0.0 109.678 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -123.46 132.93 54.08 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.89 179.71 37.62 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.68 138.84 33.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.301 -1.117 . . . . 0.0 109.201 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.457 ' CD1' ' N ' ' B' ' 57' ' ' ILE . 1.4 mp -91.31 117.6 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.247 -0.908 . . . . 0.0 109.061 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -108.13 -25.23 11.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.514 -0.741 . . . . 0.0 109.8 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.59 135.59 4.22 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.74 -1.225 . . . . 0.0 111.146 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.83 135.43 54.87 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . 0.426 ' O ' ' OG ' ' B' ' 33' ' ' SER . 46.6 t -132.58 122.75 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.543 0.687 . . . . 0.0 109.823 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' B' ' 64' ' ' LEU . 28.2 t80 -144.54 128.39 8.88 Favored Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -41.21 88.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.427 1.418 . . . . 0.0 111.785 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' B' ' 62' ' ' TYR . 0.4 OUTLIER -55.37 -21.2 14.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.783 -1.198 . . . . 0.0 108.678 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' B' ' 67' ' ' HIS . 0.7 OUTLIER -121.49 49.53 1.51 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.739 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.583 ' O ' ' CG ' ' B' ' 67' ' ' HIS . 0.0 OUTLIER -40.91 87.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.093 -178.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' B' ' 66' ' ' HIS . 23.5 m-70 -168.55 -1.18 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.5 ' O ' ' O ' ' B' ' 67' ' ' HIS . 77.1 t60 -44.43 -101.35 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.226 -0.921 . . . . 0.0 110.619 -178.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.454 ' N ' ' CD2' ' B' ' 68' ' ' HIS . 24.4 t-80 -174.47 -80.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.008 -1.058 . . . . 0.0 109.268 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -74.19 147.45 42.54 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.424 -0.798 . . . . 0.0 109.642 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 29.7 m170 . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.623 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.486 ' H2 ' ' CG ' ' A' ' 4' ' ' ARG . 52.9 ttp . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.69 -19.01 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.28 16.64 19.94 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.568 -0.707 . . . . 0.0 109.872 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.486 ' CG ' ' H2 ' ' A' ' 1' ' ' MET . 47.3 mmm-85 -69.95 140.92 53.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 108.742 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -142.3 162.0 36.59 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.124 -0.985 . . . . 0.0 110.088 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -108.99 142.07 40.18 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.2 tt -142.11 124.01 15.26 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.8 t -132.34 140.45 48.55 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.461 -0.774 . . . . 0.0 109.152 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.5 tp -144.65 142.54 30.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.305 -0.872 . . . . 0.0 109.008 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.5 p -130.61 112.68 13.37 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.548 -0.72 . . . . 0.0 109.468 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 143.33 31.87 0.1 Allowed Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.4 t -81.16 133.47 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -1.125 . . . . 0.0 110.238 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.1 m -72.65 -41.6 65.28 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.56 153.45 4.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.771 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 81.6 t -84.93 106.0 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.509 -0.745 . . . . 0.0 110.285 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -67.96 -42.01 81.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.96 . . . . 0.0 108.86 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.3 t -171.89 136.54 0.91 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.407 -0.808 . . . . 0.0 108.89 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.411 ' CE1' ' CD1' ' A' ' 23' ' ' ILE . 6.9 t80 -123.77 106.46 10.51 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.428 -0.795 . . . . 0.0 109.143 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.22 150.45 74.04 Favored Pre-proline 0 N--CA 1.498 1.968 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.1 -19.57 39.08 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.272 1.981 . . . . 0.0 111.364 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -97.47 -7.12 32.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.466 -0.771 . . . . 0.0 108.978 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -172.86 140.36 0.94 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.411 ' CD1' ' CE1' ' A' ' 18' ' ' PHE . 27.0 mm -127.12 127.51 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.323 -0.861 . . . . 0.0 109.437 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.8 mt -120.51 120.55 36.18 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.1 mt -131.31 125.61 33.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.419 -0.801 . . . . 0.0 108.849 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -92.4 120.83 33.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 29' ' ' GLN . 6.1 t -122.37 154.0 38.28 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.674 0.749 . . . . 0.0 110.271 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.3 mm 46.08 -82.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.085 0.469 . . . . 0.0 110.764 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.578 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.8 pp0? -147.71 -21.36 0.37 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.102 -0.999 . . . . 0.0 109.898 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.485 ' N ' ' CD ' ' A' ' 29' ' ' GLN . . . -97.45 173.77 28.91 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.7 t -118.95 132.67 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.753 -0.851 . . . . 0.0 109.107 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.3 tp -109.62 127.81 54.79 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.6 t -113.22 122.4 47.37 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.7 mt -108.12 130.14 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.403 -0.811 . . . . 0.0 109.264 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -129.16 141.17 51.25 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.488 -0.757 . . . . 0.0 109.37 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.07 -138.1 4.91 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -133.03 150.03 52.16 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.492 -1.005 . . . . 0.0 110.711 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 54' ' ' GLU . 55.0 mmtt 54.08 66.36 1.25 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.492 178.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.1 mp -98.39 71.18 2.03 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.138 0 O-C-N 121.128 -0.982 . . . . 0.0 110.793 -178.146 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 47' ' ' LYS . 91.2 mt . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.516 ' C ' ' H ' ' A' ' 49' ' ' GLY . 87.5 tttt 59.14 134.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.548 0.689 . . . . 0.0 110.388 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 70.58 -14.87 0.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.605 -0.685 . . . . 0.0 109.497 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 47' ' ' LYS . . . 82.38 18.34 66.79 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -101.13 160.0 14.76 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.315 -1.109 . . . . 0.0 109.094 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.0 t -122.65 131.8 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.529 -0.732 . . . . 0.0 109.103 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -130.64 130.98 44.63 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 t -136.36 138.36 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.496 -0.753 . . . . 0.0 109.097 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.491 ' O ' ' O ' ' A' ' 38' ' ' LYS . 24.0 tt0 -118.42 145.98 44.79 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.15 166.14 15.6 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 pp -88.69 128.83 35.62 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.391 -1.064 . . . . 0.0 109.656 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.3 mm -80.12 135.31 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.85 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -125.26 -31.05 3.1 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.02 143.4 16.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.064 -1.023 . . . . 0.0 110.598 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.1 mt -129.73 143.31 50.76 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 54.3 t -139.23 118.22 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.102 -0.999 . . . . 0.0 110.165 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -139.72 108.97 7.17 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.96 109.36 0.23 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.406 1.404 . . . . 0.0 112.426 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.688 ' H ' ' CD1' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -82.44 -8.04 59.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.323 -0.861 . . . . 0.0 109.588 179.693 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 66.86 137.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.644 0.735 . . . . 0.0 110.551 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.526 ' O ' ' N ' ' A' ' 68' ' ' HIS . 5.5 m80 -159.98 -31.47 0.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -42.65 89.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.808 -0.558 . . . . 0.0 110.669 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' A' ' 66' ' ' HIS . 5.9 t60 -172.76 65.54 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.456 -0.777 . . . . 0.0 109.791 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.473 ' ND1' ' C ' ' A' ' 68' ' ' HIS . 2.3 m-70 -124.92 147.58 48.78 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.423 -0.798 . . . . 0.0 109.053 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.79 106.45 9.62 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.212 1.006 . . . . 0.0 108.741 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.648 ' H ' ' CD2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.292 -1.922 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.642 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ptt? . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.9 0.857 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.19 121.69 30.88 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.552 0.692 . . . . 0.0 110.335 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -161.3 9.61 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.541 -0.724 . . . . 0.0 109.55 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.8 mmm-85 -69.25 142.71 54.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.97 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . 0.498 ' NE2' ' OG1' ' A' ' 27' ' ' THR . 86.3 mt-30 -140.15 148.29 41.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.517 -0.739 . . . . 0.0 109.577 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -103.95 119.5 39.06 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.2 tt -119.16 121.24 39.29 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.262 -0.899 . . . . 0.0 108.638 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 70.1 m -132.53 151.37 51.94 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.509 -0.744 . . . . 0.0 109.163 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 tp -147.29 149.3 32.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.193 -0.942 . . . . 0.0 109.5 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.2 p -128.67 163.7 24.53 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.588 -0.695 . . . . 0.0 109.612 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.43 29.27 56.17 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.41 131.37 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -1.174 . . . . 0.0 109.901 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' SER . . . . . 0.54 ' HG ' ' N ' ' B' ' 28' ' ' ILE . 58.2 m -73.83 -40.07 63.58 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.615 -0.678 . . . . 0.0 110.613 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -158.91 158.38 33.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.983 -1.073 . . . . 0.0 109.914 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 76.3 t -103.63 99.96 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -68.96 -49.25 59.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 110.532 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 31.8 t -170.4 146.58 2.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.924 -1.11 . . . . 0.0 110.211 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.71 110.18 17.53 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.673 -0.642 . . . . 0.0 109.882 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' B' ' 22' ' ' GLU . 0.3 OUTLIER -133.76 119.89 15.16 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.431 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -50.19 -27.14 16.7 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.476 1.45 . . . . 0.0 111.443 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -94.52 -5.4 46.13 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' B' ' 19' ' ' ASP . 40.2 tt0 -170.8 115.57 0.45 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 97.0 mt -114.45 126.33 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.203 -0.936 . . . . 0.0 109.194 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 57.9 mt -119.35 126.53 51.63 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 87.0 mt -135.58 123.76 23.04 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.256 -0.902 . . . . 0.0 108.988 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -81.73 118.32 22.76 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.128 -0.982 . . . . 0.0 108.84 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.562 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.8 t -109.54 149.19 30.0 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.472 -0.767 . . . . 0.0 110.201 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.54 ' N ' ' HG ' ' B' ' 13' ' ' SER . 58.7 mt 38.47 -87.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.037 0.446 . . . . 0.0 110.798 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' B' ' 27' ' ' THR . 24.0 pt20 -133.68 -22.52 1.89 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.38 -0.825 . . . . 0.0 110.198 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.6 173.99 30.21 Favored Glycine 0 N--CA 1.498 2.769 0 O-C-N 121.139 -0.976 . . . . 0.0 110.724 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -119.34 131.57 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.79 -0.829 . . . . 0.0 109.401 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 48.7 tp -111.92 128.79 56.25 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.3 t -110.2 120.41 42.37 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 84.3 mt -99.81 125.56 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -130.53 139.06 50.48 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.502 -0.749 . . . . 0.0 109.52 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.66 -138.28 3.28 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -131.86 136.81 47.73 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.348 -1.089 . . . . 0.0 109.836 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt 46.92 75.38 0.12 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 110.283 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.522 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 8.5 mp -93.24 72.12 4.54 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.18 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 40.2 tp . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.552 0.692 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.486 ' NZ ' ' OE2' ' B' ' 52' ' ' GLU . 20.7 ptmt -65.48 -40.28 92.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.561 -0.712 . . . . 0.0 109.66 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -179.28 -27.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 140.02 33.83 0.15 Allowed Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -135.6 156.74 48.39 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.262 -1.14 . . . . 0.0 109.492 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 m -122.49 132.55 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-O 121.539 0.685 . . . . 0.0 109.513 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . 0.486 ' OE2' ' NZ ' ' B' ' 47' ' ' LYS . 90.2 mt-10 -126.62 131.58 51.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.9 t -125.96 137.54 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.499 -0.751 . . . . 0.0 109.721 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -117.24 131.42 56.84 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.7 174.21 28.11 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.99 127.04 40.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.066 -1.256 . . . . 0.0 109.429 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.538 ' CD1' ' N ' ' B' ' 57' ' ' ILE . 1.4 mp -85.63 113.4 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 108.684 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.37 -10.29 16.4 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -159.9 146.28 15.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.904 -1.123 . . . . 0.0 110.522 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 52.8 mt -141.3 138.49 33.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.469 -0.769 . . . . 0.0 108.972 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 53.4 t -133.2 128.23 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.194 -0.941 . . . . 0.0 109.89 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -145.37 137.88 13.59 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.34 109.28 2.86 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.384 1.39 . . . . 0.0 111.74 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.676 ' CD1' ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -81.83 -11.27 59.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.479 -0.763 . . . . 0.0 108.981 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 55.73 51.88 11.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.802 -0.561 . . . . 0.0 111.09 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -128.59 7.48 5.76 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.315 -0.866 . . . . 0.0 109.123 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -72.93 -36.4 67.21 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 86.89 0.3 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.533 -0.729 . . . . 0.0 110.137 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -174.82 94.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -104.06 -11.41 17.38 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.166 -0.959 . . . . 0.0 108.71 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' B' ' 71' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.306 -1.302 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.333 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.438 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -69.16 139.23 54.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.655 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.57 35.99 0.46 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.318 -0.864 . . . . 0.0 108.763 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.445 ' NE ' ' OE2' ' A' ' 54' ' ' GLU . 46.4 mmm-85 -88.39 138.43 31.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.344 -0.848 . . . . 0.0 109.13 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.444 HE22 ' HG1' ' B' ' 27' ' ' THR . 4.4 pt20 -145.19 161.88 38.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.181 -0.949 . . . . 0.0 109.187 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -119.8 146.4 45.72 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.505 0.669 . . . . 0.0 109.916 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.4 tt -132.51 122.7 25.26 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.3 t -113.8 133.04 55.63 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.49 -0.756 . . . . 0.0 109.283 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.6 tp -144.76 151.5 38.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.35 -0.844 . . . . 0.0 109.444 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.4 t -146.48 162.88 37.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.399 -0.813 . . . . 0.0 108.944 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.27 24.99 41.51 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.45 138.14 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -1.1 . . . . 0.0 109.652 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.5 m -73.57 -38.36 65.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.232 -0.918 . . . . 0.0 109.257 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -169.89 166.71 9.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.177 -0.952 . . . . 0.0 109.499 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.5 t -98.32 96.19 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.329 -0.857 . . . . 0.0 109.063 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -65.21 -39.39 92.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.146 -0.971 . . . . 0.0 109.463 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 t -168.82 152.85 5.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 109.256 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -146.89 107.73 4.16 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.247 -0.908 . . . . 0.0 109.422 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.3 158.68 75.11 Favored Pre-proline 0 N--CA 1.502 2.161 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.83 -26.07 67.67 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 121.672 1.581 . . . . 0.0 112.142 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -106.04 3.43 28.2 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.372 -0.83 . . . . 0.0 110.276 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -171.54 133.46 0.8 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.031 -1.043 . . . . 0.0 109.46 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.9 mt -130.84 126.83 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.421 -0.799 . . . . 0.0 109.184 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.2 mt -117.5 122.18 43.03 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.711 . . . . 0.0 109.271 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.9 mt -133.37 124.56 27.4 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.375 -0.828 . . . . 0.0 108.839 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -91.73 124.74 36.1 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.679 -1.263 . . . . 0.0 109.72 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 29' ' ' GLN . 6.1 t -124.5 153.33 42.2 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.462 0.649 . . . . 0.0 109.755 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.413 HD12 HG21 ' A' ' 28' ' ' ILE . 20.4 mm 44.74 -88.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.868 -0.52 . . . . 0.0 110.094 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.544 ' N ' ' O ' ' A' ' 27' ' ' THR . 25.7 pt20 -143.19 -17.4 0.65 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.965 -1.084 . . . . 0.0 110.213 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.29 173.67 30.32 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.2 t -121.25 131.21 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.779 -0.836 . . . . 0.0 108.909 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -107.56 126.12 52.15 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.37 -0.831 . . . . 0.0 109.554 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -116.9 124.03 48.46 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.639 -0.663 . . . . 0.0 109.417 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.2 mt -107.77 130.0 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.521 -0.737 . . . . 0.0 109.238 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -124.69 138.79 54.27 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.493 -0.754 . . . . 0.0 109.657 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.58 -146.36 9.41 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -140.61 151.87 44.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.036 -1.273 . . . . 0.0 109.802 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 54' ' ' GLU . 73.7 mmtt 58.34 55.24 5.12 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.681 -0.637 . . . . 0.0 109.939 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.503 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 7.9 mp -93.75 70.6 4.12 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.38 0 C-N-CA 120.247 -0.978 . . . . 0.0 110.732 -178.898 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 46' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.611 0.719 . . . . 0.0 109.592 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -64.63 -50.08 68.5 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.774 0.797 . . . . 0.0 110.1 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.72 33.05 0.1 Allowed 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.925 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.96 14.47 60.73 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -107.98 159.92 16.18 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.498 -1.001 . . . . 0.0 108.718 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 m -131.43 156.1 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.265 -0.897 . . . . 0.0 109.964 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -142.8 150.37 39.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.425 -0.797 . . . . 0.0 109.107 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.7 t -126.65 134.92 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.458 -0.776 . . . . 0.0 110.109 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.473 ' OE1' ' N ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -114.57 126.08 54.51 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.473 ' N ' ' OE1' ' A' ' 54' ' ' GLU . . . 163.72 176.44 35.64 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.158 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.17 121.44 37.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.527 -0.984 . . . . 0.0 108.885 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.535 ' CD1' ' N ' ' A' ' 57' ' ' ILE . 1.7 mp -90.43 113.3 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.018 -1.051 . . . . 0.0 108.937 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -99.94 -10.77 21.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.452 -0.78 . . . . 0.0 109.988 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.94 145.74 13.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.816 -1.178 . . . . 0.0 110.428 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 mt -135.19 134.53 40.2 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.61 -0.681 . . . . 0.0 109.297 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.8 t -129.81 126.0 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.527 -0.733 . . . . 0.0 109.571 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.558 ' O ' ' N ' ' A' ' 64' ' ' LEU . 10.8 t80 -141.0 127.61 11.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -45.68 84.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.247 1.298 . . . . 0.0 112.206 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.609 ' CD2' ' H ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -91.72 22.67 3.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.363 -0.836 . . . . 0.0 109.207 179.785 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 68.07 159.23 0.16 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.42 0.629 . . . . 0.0 110.342 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -128.36 -79.09 0.57 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.706 -0.621 . . . . 0.0 109.687 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 68' ' ' HIS . 7.1 t60 -66.4 -42.81 87.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.474 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 67' ' ' HIS . 1.4 t-80 60.36 130.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.349 -0.844 . . . . 0.0 109.651 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.49 142.01 31.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.097 -1.002 . . . . 0.0 109.578 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 53.23 177.4 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.56 -0.712 . . . . 0.0 110.549 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.562 ' ND1' ' N ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.344 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mmm . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 43.2 t0 46.66 89.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.894 . . . . 0.0 110.069 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -99.54 10.81 40.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.456 -0.777 . . . . 0.0 109.272 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 31.7 mmm-85 -73.0 142.14 47.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.318 -0.863 . . . . 0.0 109.425 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -147.04 156.09 42.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.272 -0.893 . . . . 0.0 109.025 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -98.79 141.37 31.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.328 -0.858 . . . . 0.0 109.393 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 tt -139.95 126.47 20.31 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 69.8 m -128.53 150.96 49.95 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.442 -0.786 . . . . 0.0 109.594 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.8 tp -146.91 153.21 39.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.35 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.4 t -143.48 164.44 30.32 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.299 -0.876 . . . . 0.0 109.189 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.07 14.95 59.85 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 p -69.14 137.41 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.341 -1.094 . . . . 0.0 109.443 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 4.5 t -73.96 -52.18 13.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.213 -0.929 . . . . 0.0 108.938 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.18 150.6 13.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.253 -0.904 . . . . 0.0 109.646 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 93.0 t -82.58 131.46 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.199 -0.938 . . . . 0.0 110.058 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -95.59 -32.25 12.9 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.314 -0.866 . . . . 0.0 109.247 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 47.3 t -169.04 153.97 5.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.89 . . . . 0.0 108.981 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -145.65 112.49 5.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.004 -1.06 . . . . 0.0 109.408 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' B' ' 19' ' ' ASP . 0.3 OUTLIER -132.6 151.73 78.68 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.59 -18.21 48.52 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.658 1.572 . . . . 0.0 111.382 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -107.7 -3.29 19.32 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.491 -0.756 . . . . 0.0 109.581 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -169.98 127.85 0.88 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.284 -0.885 . . . . 0.0 109.227 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.8 mt -127.74 129.65 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.241 -0.912 . . . . 0.0 109.921 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 70.0 mt -115.06 124.15 50.85 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.336 -0.853 . . . . 0.0 109.639 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 41.5 mt -126.31 131.26 51.88 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.303 -0.873 . . . . 0.0 109.138 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -90.91 119.87 31.45 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.556 ' O ' ' N ' ' B' ' 29' ' ' GLN . 3.1 t -123.53 148.36 46.36 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.669 0.747 . . . . 0.0 110.186 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 68.5 mt 39.05 -88.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.145 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' B' ' 27' ' ' THR . 29.7 pt20 -139.0 -18.17 1.03 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.392 -0.817 . . . . 0.0 109.999 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.19 144.5 17.17 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 18.6 t -94.15 129.64 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.343 -1.092 . . . . 0.0 108.848 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 37.5 tp -106.21 126.02 51.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.445 -0.784 . . . . 0.0 109.415 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 70.9 m -109.34 124.4 50.89 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . 0.425 HD12 HG23 ' B' ' 34' ' ' ILE . 90.8 mt -106.13 129.41 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.534 -0.729 . . . . 0.0 109.178 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -125.25 141.74 51.91 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.507 -0.746 . . . . 0.0 109.414 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.04 -151.52 17.93 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -140.07 150.26 44.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.226 -1.161 . . . . 0.0 108.93 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt 60.27 51.24 5.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.553 -0.717 . . . . 0.0 109.668 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 9.0 mp -91.24 72.99 6.23 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.386 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -178.706 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 tt . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.325 0.584 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.535 ' NZ ' ' OE2' ' B' ' 52' ' ' GLU . 20.5 ptmt -93.0 -35.37 13.3 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.202 -0.936 . . . . 0.0 109.208 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -165.66 48.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 109.476 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.57 18.33 71.11 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -140.01 157.32 45.86 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.315 -1.109 . . . . 0.0 109.052 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.07 131.73 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.46 -0.775 . . . . 0.0 108.91 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . 0.535 ' OE2' ' NZ ' ' B' ' 47' ' ' LYS . 25.0 mt-10 -119.5 137.29 53.9 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.516 -0.74 . . . . 0.0 109.077 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -128.39 160.84 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.411 -0.806 . . . . 0.0 110.086 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.32 146.87 47.06 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.26 176.02 23.68 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.0 136.44 38.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.357 -1.084 . . . . 0.0 108.545 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 36.1 mm -93.49 111.53 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.884 -1.135 . . . . 0.0 109.186 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -100.38 -24.48 14.5 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.399 -0.813 . . . . 0.0 109.799 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.04 147.05 12.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.937 -1.102 . . . . 0.0 110.632 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 9.5 mt -132.48 141.17 48.68 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 77.9 t -133.91 118.97 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.578 -0.701 . . . . 0.0 109.154 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' B' ' 62' ' ' TYR . 18.2 t80 -135.86 140.81 34.57 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -79.84 105.78 1.87 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.491 1.461 . . . . 0.0 112.485 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.589 ' CD1' ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -96.18 2.45 53.08 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -51.39 98.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.35 -0.843 . . . . 0.0 110.099 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -168.19 36.37 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.485 ' CG ' ' H ' ' B' ' 68' ' ' HIS . 0.7 OUTLIER -65.35 -151.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.462 0.649 . . . . 0.0 110.365 -178.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.64 ' ND1' ' N ' ' B' ' 69' ' ' HIS . 60.0 t-80 -61.03 -112.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.435 -0.791 . . . . 0.0 110.046 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.64 ' N ' ' ND1' ' B' ' 68' ' ' HIS . 2.2 m80 43.05 85.41 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.34 -0.85 . . . . 0.0 109.672 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.569 ' CG ' ' N ' ' B' ' 71' ' ' HIS . 0.6 OUTLIER -61.67 -132.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 0.0 110.102 -179.395 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.569 ' N ' ' CG ' ' B' ' 70' ' ' HIS . 1.9 m-70 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.653 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 ttp . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.991 0.9 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -164.93 -175.0 3.54 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.587 -0.696 . . . . 0.0 110.348 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -99.59 8.18 44.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.213 -0.93 . . . . 0.0 109.861 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 41.8 mmm-85 -65.16 141.31 58.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.92 -1.112 . . . . 0.0 109.145 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.541 ' NE2' ' OG1' ' B' ' 27' ' ' THR . 85.3 mt-30 -135.38 147.78 49.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.205 -0.934 . . . . 0.0 110.557 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -112.99 113.28 25.26 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.5 tt -111.68 123.11 49.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 108.89 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.3 t -115.22 133.72 55.78 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.48 0.657 . . . . 0.0 109.662 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 tp -141.02 139.11 34.09 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.725 0.774 . . . . 0.0 109.345 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -130.51 168.4 17.1 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.723 -0.61 . . . . 0.0 109.44 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.4 14.09 74.8 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.0 t -67.94 133.94 30.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 109.761 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.6 t -71.15 -43.25 67.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 109.189 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.68 163.82 3.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 0.0 110.026 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.3 t -88.81 111.45 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.432 -0.792 . . . . 0.0 110.086 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -67.46 -31.23 71.26 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.476 -0.765 . . . . 0.0 109.097 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.1 t -167.91 159.34 11.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.099 -1.0 . . . . 0.0 109.537 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.443 ' CD1' ' C ' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -138.77 107.09 5.79 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.342 -0.849 . . . . 0.0 109.31 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.84 145.03 54.29 Favored Pre-proline 0 N--CA 1.495 1.799 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.61 -13.69 32.76 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.444 2.096 . . . . 0.0 111.609 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -115.5 -1.74 12.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.28 -0.887 . . . . 0.0 108.967 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -169.07 111.61 0.51 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.149 -0.97 . . . . 0.0 109.157 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.5 mt -112.51 129.7 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.152 -0.967 . . . . 0.0 109.475 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.3 mt -113.41 123.54 50.32 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.531 -0.73 . . . . 0.0 109.039 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.3 mt -120.95 126.87 51.07 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.587 0.708 . . . . 0.0 109.112 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.81 118.25 31.45 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.35 -0.844 . . . . 0.0 108.974 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.579 ' O ' ' N ' ' A' ' 29' ' ' GLN . 3.4 t -116.95 154.49 30.76 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.345 0.593 . . . . 0.0 110.392 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.523 ' N ' ' HG1' ' A' ' 27' ' ' THR . 27.1 mm 34.09 -85.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-O 121.451 0.643 . . . . 0.0 110.933 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 27' ' ' THR . 24.0 pt20 -138.82 -17.48 1.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.927 . . . . 0.0 108.944 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.58 167.51 25.93 Favored Glycine 0 N--CA 1.497 2.735 0 O-C-N 120.855 -1.153 . . . . 0.0 110.797 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -120.43 132.94 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.513 -0.992 . . . . 0.0 109.305 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.7 tp -112.23 131.92 55.21 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.7 t -115.79 129.9 56.63 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.453 0.644 . . . . 0.0 109.358 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.7 mt -112.8 132.23 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 121.315 0.578 . . . . 0.0 109.457 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -131.33 146.65 52.38 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.575 0.702 . . . . 0.0 109.488 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' OE1' ' A' ' 37' ' ' GLU . . . 168.63 -148.21 12.18 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 36' ' ' GLY . 0.7 OUTLIER -118.89 137.36 53.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.866 -0.785 . . . . 0.0 109.83 -178.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt 50.94 71.3 0.44 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.018 0.913 . . . . 0.0 110.179 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 8.4 mp -98.75 72.55 1.98 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.982 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 -178.869 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.4 tp . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -64.64 -64.43 0.88 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.201 -0.937 . . . . 0.0 109.83 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.05 42.63 0.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.228 -0.92 . . . . 0.0 109.375 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.07 24.78 76.32 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -112.35 154.85 25.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.338 -1.096 . . . . 0.0 109.694 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.9 m -133.42 163.0 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.538 -0.726 . . . . 0.0 109.731 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -135.45 160.78 37.38 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.701 0.762 . . . . 0.0 109.688 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.08 135.17 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -122.04 125.52 46.43 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.838 0.827 . . . . 0.0 109.322 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.4 178.47 24.43 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.82 129.83 44.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -1.081 . . . . 0.0 109.297 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.48 122.52 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.282 -0.887 . . . . 0.0 109.519 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -102.22 -24.43 13.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.482 -0.761 . . . . 0.0 109.036 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.93 149.7 14.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.843 -1.161 . . . . 0.0 110.749 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.7 mt -131.2 144.74 51.57 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.24 122.0 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.763 0.792 . . . . 0.0 110.3 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.557 ' O ' ' N ' ' A' ' 64' ' ' LEU . 19.6 t80 -139.73 115.77 8.16 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 65' ' ' GLU . 53.2 Cg_exo -52.54 78.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.43 1.42 . . . . 0.0 111.419 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -53.3 85.01 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 122.338 1.066 . . . . 0.0 109.498 -179.153 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.579 ' N ' ' O ' ' A' ' 63' ' ' PRO . 0.2 OUTLIER 54.78 107.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.918 0.866 . . . . 0.0 110.922 179.593 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.6 ' CG ' ' N ' ' A' ' 67' ' ' HIS . 55.4 t-80 47.47 170.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.429 1.109 . . . . 0.0 112.094 177.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.6 ' N ' ' CG ' ' A' ' 66' ' ' HIS . 1.4 t60 -174.81 -166.85 0.26 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 122.122 0.963 . . . . 0.0 110.276 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 48.88 42.56 20.49 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.913 0.863 . . . . 0.0 108.711 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.407 ' O ' ' CD2' ' A' ' 69' ' ' HIS . 6.1 p-80 -72.0 146.88 47.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.055 -1.028 . . . . 0.0 110.899 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -179.26 144.02 0.22 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.708 0.766 . . . . 0.0 109.094 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.2 p80 . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.617 -179.247 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ptt? . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.641 0.734 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 55.43 24.41 6.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.466 -0.771 . . . . 0.0 109.431 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -112.01 9.95 20.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.447 -0.783 . . . . 0.0 109.098 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -69.72 144.65 52.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.107 -0.995 . . . . 0.0 109.9 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . 0.529 ' NE2' ' OG1' ' A' ' 27' ' ' THR . 75.5 mt-30 -140.71 150.06 42.97 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.785 0.802 . . . . 0.0 109.691 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -110.58 127.25 55.14 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.5 tt -122.33 122.25 38.63 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.229 -0.92 . . . . 0.0 108.876 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 18.2 p -121.19 147.89 44.99 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.726 0.774 . . . . 0.0 109.994 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 32.0 tp -148.83 143.78 26.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.568 -0.707 . . . . 0.0 109.102 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -130.25 161.39 31.3 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.651 0.739 . . . . 0.0 109.933 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.41 20.75 61.6 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.83 134.63 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.834 -1.392 . . . . 0.0 109.78 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 34.0 m -72.92 -41.84 64.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.193 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.02 164.83 4.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.819 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 77.1 t -99.29 128.22 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.429 -0.794 . . . . 0.0 109.66 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -84.0 -29.65 26.8 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.686 0.755 . . . . 0.0 109.187 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 35.6 t -169.3 155.5 6.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.121 -0.987 . . . . 0.0 109.289 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -137.42 108.86 6.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 0.0 109.779 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . 0.42 ' OD2' ' O ' ' B' ' 22' ' ' GLU . 0.8 OUTLIER -132.91 149.12 72.01 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.293 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.5 -7.76 19.89 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.327 2.018 . . . . 0.0 111.607 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -114.47 -20.96 10.56 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.781 0.8 . . . . 0.0 109.03 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.447 ' CD ' ' HZ2' ' B' ' 35' ' ' LYS . 74.6 tt0 -153.46 115.62 4.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.142 -0.974 . . . . 0.0 109.078 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 81.3 mt -115.88 130.22 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.217 -0.927 . . . . 0.0 109.959 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 14.5 mt -112.39 126.34 55.17 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 81.1 mt -120.57 125.91 48.97 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.808 0.813 . . . . 0.0 109.148 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -95.12 110.4 22.35 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.583 ' O ' ' N ' ' B' ' 29' ' ' GLN . 0.1 OUTLIER -113.92 151.74 31.82 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.313 0.578 . . . . 0.0 110.031 -178.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' B' ' 27' ' ' THR . 55.0 mt 34.51 -85.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-O 121.161 0.505 . . . . 0.0 110.765 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.583 ' N ' ' O ' ' B' ' 27' ' ' THR . 20.5 pt20 -138.51 -14.91 1.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.127 -0.983 . . . . 0.0 109.638 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.01 165.19 20.76 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.971 -1.081 . . . . 0.0 110.807 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 53.1 t -122.32 132.93 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.253 -1.145 . . . . 0.0 109.107 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 53.9 tp -115.58 137.57 51.93 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.335 0.588 . . . . 0.0 109.926 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.11 138.15 53.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.607 -0.683 . . . . 0.0 109.167 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 5.0 mp -115.25 130.89 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.591 -0.693 . . . . 0.0 109.426 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.447 ' HZ2' ' CD ' ' B' ' 22' ' ' GLU . 68.3 mttm -128.57 140.99 51.51 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.518 0.675 . . . . 0.0 109.837 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.99 -139.27 5.46 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.452 ' CD ' ' HZ3' ' B' ' 38' ' ' LYS . 0.4 OUTLIER -117.59 138.31 52.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.627 -0.925 . . . . 0.0 109.059 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . 0.452 ' HZ3' ' CD ' ' B' ' 37' ' ' GLU . 32.3 mtmm 36.42 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.996 0.903 . . . . 0.0 110.754 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.446 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 9.1 mp -100.14 71.6 1.61 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.633 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.898 -178.4 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 14.3 tp . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.685 0.755 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -84.41 -82.16 0.17 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.689 0.757 . . . . 0.0 110.31 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.38 5.33 10.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -0.943 . . . . 0.0 109.255 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.02 30.95 36.46 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -81.96 148.77 28.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -1.119 . . . . 0.0 110.155 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 53.9 t -128.08 134.64 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.401 -0.812 . . . . 0.0 109.805 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -120.71 147.16 45.66 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.94 135.06 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.432 -0.793 . . . . 0.0 109.308 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.12 126.12 49.93 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.63 0.729 . . . . 0.0 109.744 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.02 171.2 23.66 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.04 111.94 23.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.29 -1.123 . . . . 0.0 108.805 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.416 HD13 HG23 ' B' ' 57' ' ' ILE . 96.7 mt -74.24 112.18 10.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.311 -0.868 . . . . 0.0 109.564 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -101.53 -11.46 19.26 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.58 143.17 6.93 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.726 -1.234 . . . . 0.0 110.744 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 15.0 mt -127.1 144.64 50.98 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 2.3 t -135.36 128.27 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.534 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -140.14 137.37 17.96 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . 0.582 ' C ' ' H ' ' B' ' 65' ' ' GLU . 96.8 Cg_exo -36.52 -39.62 0.42 Allowed 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.414 2.076 . . . . 0.0 112.506 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' LEU . . . . . 0.498 ' O ' ' CD2' ' B' ' 64' ' ' LEU . 2.2 tt 59.98 -1.88 0.16 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.582 ' H ' ' C ' ' B' ' 63' ' ' PRO . 5.3 mm-40 72.49 128.21 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.038 0.923 . . . . 0.0 110.431 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -64.04 157.77 24.34 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.876 0.846 . . . . 0.0 110.37 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' HIS . . . . . 0.428 ' C ' ' H ' ' B' ' 69' ' ' HIS . 94.5 m-70 -81.76 119.68 24.17 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -55.49 -11.07 0.76 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.098 -1.001 . . . . 0.0 109.51 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' B' ' 71' ' ' HIS . 10.9 t-160 -55.17 -86.71 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.311 -0.868 . . . . 0.0 109.659 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.55 ' O ' ' CD2' ' B' ' 71' ' ' HIS . 0.5 OUTLIER 42.83 20.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.903 0.858 . . . . 0.0 109.777 -179.323 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' HIS . . . . . 0.55 ' CD2' ' O ' ' B' ' 70' ' ' HIS . 1.3 p80 . . . . . 0 C--N 1.294 -1.83 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.958 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.542 ' N ' HD21 ' A' ' 3' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -73.95 143.04 45.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.311 -0.868 . . . . 0.0 109.142 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.486 ' NE2' ' OG1' ' B' ' 27' ' ' THR . 79.1 mt-30 -144.65 158.02 43.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.2 -0.938 . . . . 0.0 109.803 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -114.91 132.7 56.45 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.6 tt -121.68 130.27 53.35 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.3 p -127.04 147.43 50.15 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.527 -0.733 . . . . 0.0 109.745 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.2 tp -158.56 160.47 36.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.402 -0.811 . . . . 0.0 109.162 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t -151.52 -165.94 2.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.42 -0.8 . . . . 0.0 108.972 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.48 28.35 55.57 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.0 t -66.4 137.83 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.512 -0.993 . . . . 0.0 109.839 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.4 p -72.63 -37.0 68.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 0.0 109.261 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -170.37 163.59 8.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.0 109.451 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.1 t -98.5 96.5 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.23 -0.919 . . . . 0.0 109.3 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.23 -38.83 88.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.148 -0.97 . . . . 0.0 108.977 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 t -170.26 161.54 8.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.823 . . . . 0.0 109.294 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -146.6 105.49 3.86 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.93 151.62 78.82 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.543 -0.723 . . . . 0.0 109.186 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.87 -16.82 32.84 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.159 1.906 . . . . 0.0 111.086 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -104.97 -10.59 17.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.524 -0.735 . . . . 0.0 109.475 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -169.28 131.4 1.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.413 -0.805 . . . . 0.0 109.209 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.79 129.33 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.695 -0.628 . . . . 0.0 109.496 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 mt -120.48 118.41 30.2 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -133.39 127.93 34.49 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -91.01 123.8 34.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.923 -1.11 . . . . 0.0 109.692 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.611 ' O ' ' N ' ' A' ' 29' ' ' GLN . 1.9 t -119.39 149.24 42.16 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.7 mt 50.46 -80.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.3 pt20 -153.45 -18.19 0.14 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.967 -1.083 . . . . 0.0 110.67 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.67 168.94 26.81 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.36 131.95 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.447 -1.031 . . . . 0.0 109.598 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.0 tp -108.23 128.79 55.03 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.465 0.65 . . . . 0.0 109.445 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.5 t -111.42 126.25 54.74 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.3 mm -106.54 127.53 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.798 -0.564 . . . . 0.0 109.551 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -122.94 135.08 54.35 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.17 -156.5 19.53 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -135.84 146.44 47.49 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.417 -1.049 . . . . 0.0 108.825 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt 55.79 56.45 6.09 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.626 -0.672 . . . . 0.0 110.193 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 39' ' ' LEU . 7.6 mp -93.64 68.84 4.05 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.946 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -179.075 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.88 139.16 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.47 -0.769 . . . . 0.0 108.937 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -114.82 160.11 19.84 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -137.43 138.15 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.31 -0.869 . . . . 0.0 109.121 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -120.68 124.79 46.06 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.47 172.78 31.39 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.99 127.64 44.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.492 -1.005 . . . . 0.0 108.817 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -83.01 117.1 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.058 -1.027 . . . . 0.0 109.284 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -96.96 -12.18 23.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.327 -0.858 . . . . 0.0 109.284 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -173.86 154.27 2.35 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.177 -0.952 . . . . 0.0 110.196 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.433 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 13.6 mt -137.17 134.7 36.61 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.2 t -133.23 123.83 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.234 -0.916 . . . . 0.0 109.708 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.54 ' CE1' ' O ' ' A' ' 63' ' ' PRO . 15.3 t80 -139.72 120.72 9.51 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.54 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 31.5 Cg_exo -56.86 127.86 27.58 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 CA-C-N 120.641 1.265 . . . . 0.0 111.109 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.832 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.077 0 O-C-N 121.19 -0.944 . . . . 0.0 109.005 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.885 HD21 ' N ' ' B' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.959 0 CA-C-O 121.321 0.581 . . . . 0.0 109.476 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -68.84 141.04 55.22 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.313 -0.867 . . . . 0.0 109.436 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' GLN . . . . . 0.516 ' NE2' ' OG1' ' A' ' 27' ' ' THR . 26.5 mt-30 -146.74 158.27 43.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.183 -0.948 . . . . 0.0 109.782 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -103.81 135.63 44.99 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.504 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.2 tt -138.41 125.48 21.39 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.396 -0.815 . . . . 0.0 108.841 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' SER . . . . . 0.474 ' N ' HD23 ' B' ' 7' ' ' LEU . 1.8 m -129.41 149.31 51.25 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.4 tp -145.96 146.52 31.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.225 -0.922 . . . . 0.0 109.302 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -132.74 171.33 14.02 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.547 -0.72 . . . . 0.0 109.192 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.75 23.21 70.33 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -77.61 137.17 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -1.158 . . . . 0.0 109.612 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 41.2 t -71.03 -44.31 66.09 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.061 -1.024 . . . . 0.0 109.882 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.68 151.81 4.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.899 -1.126 . . . . 0.0 110.36 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 70.4 t -85.55 130.35 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.458 -0.776 . . . . 0.0 109.349 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -98.54 -42.15 7.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.176 -0.953 . . . . 0.0 109.919 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -157.57 118.7 3.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.111 -0.993 . . . . 0.0 109.261 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -111.86 106.39 15.1 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.472 -0.768 . . . . 0.0 109.133 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -132.42 151.08 77.61 Favored Pre-proline 0 N--CA 1.498 1.971 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.36 -20.27 48.75 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.12 1.88 . . . . 0.0 112.18 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -110.89 6.9 21.56 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.366 -0.834 . . . . 0.0 109.408 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -170.46 137.94 1.47 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.346 -0.846 . . . . 0.0 109.172 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 91.3 mt -137.92 128.37 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.17 -0.956 . . . . 0.0 109.478 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 mt -124.21 109.83 13.91 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 86.7 mt -113.77 124.2 51.69 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -83.36 104.89 13.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.285 -0.884 . . . . 0.0 109.15 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.486 ' OG1' ' NE2' ' A' ' 5' ' ' GLN . 13.8 t -123.95 -178.92 4.21 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.397 0.618 . . . . 0.0 109.548 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' B' ' 27' ' ' THR . 8.6 mm -34.31 157.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.908 0.861 . . . . 0.0 110.629 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 64.94 -57.76 0.27 Allowed 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.961 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' B' ' 28' ' ' ILE . . . -171.36 -131.61 1.37 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.214 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -121.47 134.43 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.718 -0.872 . . . . 0.0 110.175 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 29.3 tp -100.0 126.58 46.21 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -106.34 135.33 48.03 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.541 -0.724 . . . . 0.0 109.619 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 79.7 mt -124.71 132.39 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -124.82 141.53 52.05 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.546 0.689 . . . . 0.0 109.85 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.23 -153.23 21.65 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -130.95 143.74 50.95 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.204 -1.174 . . . . 0.0 109.421 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 55.66 57.0 5.61 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.695 . . . . 0.0 109.704 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.437 ' N ' HD12 ' B' ' 39' ' ' LEU . 9.1 mp -97.5 72.29 2.35 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.432 -0.792 . . . . 0.0 109.194 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.002 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.499 1.978 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -125.91 132.83 52.05 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.99 135.21 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -124.38 133.32 53.45 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.436 -0.79 . . . . 0.0 108.967 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.51 -178.38 39.08 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.415 ' H ' HD23 ' B' ' 56' ' ' LEU . 0.2 OUTLIER -95.13 120.64 35.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.412 -1.052 . . . . 0.0 108.927 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.3 mt -91.79 110.27 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.078 -1.014 . . . . 0.0 108.762 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -97.88 -16.43 19.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.373 -0.829 . . . . 0.0 109.997 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.96 147.33 23.98 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.823 -1.173 . . . . 0.0 110.884 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.43 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 13.1 mt -139.15 132.16 29.51 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 54.2 t -130.64 127.01 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.308 -0.87 . . . . 0.0 109.318 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 14.6 t80 -138.71 141.44 30.77 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' PRO . . . . . 0.531 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 71.9 Cg_endo -76.6 112.41 3.45 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.867 1.711 . . . . 0.0 111.908 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.871 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.138 0 O-C-N 121.187 -0.946 . . . . 0.0 109.022 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.596 ' N ' HD21 ' A' ' 3' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.903 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.405 ' N ' ' ND2' ' A' ' 3' ' ' ASN . 43.2 mmm-85 -59.77 142.47 53.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.559 -0.713 . . . . 0.0 110.525 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.444 ' CD ' HD11 ' B' ' 9' ' ' LEU . 16.4 pt20 -154.34 162.12 41.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.477 -0.764 . . . . 0.0 109.579 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.549 ' N ' ' CD1' ' A' ' 6' ' ' PHE . 9.7 m-85 -106.66 130.86 54.33 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.552 -0.718 . . . . 0.0 109.469 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.698 HD21 ' CD1' ' B' ' 9' ' ' LEU . 4.0 mm? -113.64 146.83 39.16 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.143 0.973 . . . . 0.0 109.267 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.0 t -139.44 143.2 37.49 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.374 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.748 HD11 ' NE2' ' B' ' 5' ' ' GLN . 17.4 tp -155.22 139.47 16.62 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.342 -0.848 . . . . 0.0 109.743 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 t -145.33 164.9 30.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.397 -0.814 . . . . 0.0 109.376 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.61 11.55 77.18 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 13' ' ' SER . 21.6 t -66.82 159.78 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.769 -0.842 . . . . 0.0 110.633 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.447 ' N ' HG12 ' A' ' 12' ' ' VAL . 22.1 p -74.68 -53.09 9.95 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.4 ' N ' ' OG ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -171.7 158.09 4.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.261 -0.9 . . . . 0.0 109.706 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 t -83.8 108.18 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.86 . . . . 0.0 110.099 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -66.89 -41.57 86.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.426 -0.796 . . . . 0.0 109.094 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.8 t -172.62 143.62 1.34 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.414 -0.804 . . . . 0.0 109.18 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -127.61 116.72 20.76 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.55 -0.719 . . . . 0.0 109.227 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.0 147.87 67.11 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.84 -16.82 46.53 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.835 1.69 . . . . 0.0 110.77 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -98.39 -7.86 27.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.621 -0.675 . . . . 0.0 109.198 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 23' ' ' ILE . 9.5 tm-20 -174.61 150.84 1.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.366 -0.833 . . . . 0.0 109.082 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.479 ' N ' ' CD ' ' A' ' 22' ' ' GLU . 96.5 mt -133.44 130.86 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.299 -0.875 . . . . 0.0 109.991 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.2 mt -115.52 128.11 55.76 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.2 mt -128.54 132.48 48.27 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.393 -0.817 . . . . 0.0 109.155 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -98.81 110.22 22.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 108.709 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.611 ' O ' ' N ' ' A' ' 29' ' ' GLN . 12.3 t -113.43 149.06 34.73 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.411 0.624 . . . . 0.0 109.97 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 28' ' ' ILE . 3.8 mm 43.26 -80.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.652 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' A' ' 27' ' ' THR . 9.0 mt-30 -143.58 -24.65 0.58 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.11 -0.994 . . . . 0.0 109.836 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.01 174.78 36.01 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.76 130.31 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.849 -0.795 . . . . 0.0 109.019 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.46 HD13 HD13 ' B' ' 60' ' ' LEU . 31.1 tp -103.75 126.59 50.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.582 -0.699 . . . . 0.0 109.42 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.7 t -113.35 128.11 56.35 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.5 mt -107.27 130.33 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -124.42 138.6 54.34 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.477 0.656 . . . . 0.0 109.416 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.71 -144.92 8.65 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -133.93 144.46 48.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.317 -1.108 . . . . 0.0 108.939 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 54' ' ' GLU . 71.1 mmtt 58.3 57.69 3.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 0.0 109.351 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.1 mp -95.56 72.79 3.18 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.601 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.0 t -113.79 132.23 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -125.95 141.02 52.16 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.1 t -131.0 133.67 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.508 ' OE1' ' CD2' ' A' ' 6' ' ' PHE . 27.1 tp10 -117.69 143.13 46.48 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.71 -172.7 30.4 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.93 126.95 54.42 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.632 -0.922 . . . . 0.0 109.218 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.31 118.96 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.033 -1.042 . . . . 0.0 109.552 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -98.7 -19.5 17.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.414 -0.804 . . . . 0.0 108.855 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -168.25 154.33 7.18 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.131 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.446 HD13 HD13 ' B' ' 32' ' ' LEU . 12.9 mt -133.32 139.48 46.89 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.2 t -134.58 122.41 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.526 -0.734 . . . . 0.0 109.796 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.439 ' CD1' ' C ' ' A' ' 62' ' ' TYR . 10.0 t80 -136.23 139.79 30.97 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.16 87.71 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.472 1.448 . . . . 0.0 112.245 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.708 ' CD2' ' H ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.93 HD21 ' N ' ' B' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -79.53 139.11 37.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.586 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' GLN . . . . . 0.748 ' NE2' HD11 ' A' ' 9' ' ' LEU . 4.0 pt20 -148.14 158.43 44.07 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.138 -0.976 . . . . 0.0 109.734 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -113.94 134.35 54.88 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.483 -0.76 . . . . 0.0 109.021 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.8 mt -116.06 147.3 41.41 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 43.1 t -141.04 131.67 25.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.497 -0.752 . . . . 0.0 109.577 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.698 ' CD1' HD21 ' A' ' 7' ' ' LEU . 25.1 tp -142.82 145.25 33.02 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.501 ' O ' ' N ' ' B' ' 12' ' ' VAL . 14.1 p -68.25 165.64 18.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.208 -0.933 . . . . 0.0 110.649 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.19 92.87 0.01 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.523 HG22 ' N ' ' B' ' 13' ' ' SER . 9.3 p -48.2 168.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.51 -0.994 . . . . 0.0 110.26 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' SER . . . . . 0.523 ' N ' HG22 ' B' ' 12' ' ' VAL . 15.7 m -72.86 -39.8 66.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.665 -0.647 . . . . 0.0 110.528 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -148.98 147.66 28.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.883 -1.136 . . . . 0.0 109.949 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 78.6 t -103.32 97.48 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -65.13 -41.83 94.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.851 . . . . 0.0 109.83 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 31.1 t -174.43 147.0 1.1 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.886 . . . . 0.0 109.07 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' PHE . . . . . 0.512 ' CE1' HD12 ' B' ' 23' ' ' ILE . 1.6 t80 -128.88 112.46 14.13 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.454 ' H ' HD13 ' B' ' 23' ' ' ILE . 4.9 m-20 -130.7 148.14 68.91 Favored Pre-proline 0 N--CA 1.498 1.93 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.6 -10.33 28.37 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.792 1.662 . . . . 0.0 111.496 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -118.38 3.86 11.86 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.768 -0.582 . . . . 0.0 109.64 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -172.07 129.76 0.61 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.261 -0.899 . . . . 0.0 109.382 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.512 HD12 ' CE1' ' B' ' 18' ' ' PHE . 50.8 mm -122.03 121.65 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.347 -0.845 . . . . 0.0 109.214 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 58.4 mt -119.21 114.53 22.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 46.3 mt -131.35 127.11 36.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.394 -0.816 . . . . 0.0 108.883 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -87.39 111.34 21.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.021 -1.049 . . . . 0.0 109.414 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.618 ' O ' ' N ' ' B' ' 29' ' ' GLN . 9.6 t -105.74 150.06 25.86 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.475 -0.766 . . . . 0.0 109.96 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 57.5 mt 38.26 -84.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 121.06 0.457 . . . . 0.0 110.485 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.618 ' N ' ' O ' ' B' ' 27' ' ' THR . 15.9 pt20 -139.4 -19.47 0.96 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.338 -0.851 . . . . 0.0 110.26 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.58 166.24 23.91 Favored Glycine 0 N--CA 1.496 2.654 0 O-C-N 121.077 -1.015 . . . . 0.0 110.665 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 69.1 t -114.97 131.31 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.725 -0.868 . . . . 0.0 108.668 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 60' ' ' LEU . 52.7 tp -109.77 127.61 54.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.613 -0.679 . . . . 0.0 109.24 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.5 t -117.23 124.2 48.48 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 74.1 mt -110.18 131.38 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.387 -0.821 . . . . 0.0 108.997 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -124.84 139.56 53.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.546 -0.721 . . . . 0.0 109.365 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.67 -144.69 8.05 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.566 ' N ' ' OE1' ' B' ' 37' ' ' GLU . 7.5 mp0 -138.65 147.44 42.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.522 -0.987 . . . . 0.0 109.204 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' B' ' 54' ' ' GLU . 68.8 mmtt 62.54 49.75 3.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.667 -0.646 . . . . 0.0 109.94 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.576 ' N ' HD12 ' B' ' 39' ' ' LEU . 10.0 mp -93.01 71.17 4.63 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.005 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -178.736 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.497 1.906 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -136.97 149.93 47.84 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.427 HG12 ' N ' ' B' ' 54' ' ' GLU . 23.8 t -130.62 159.16 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.311 -0.868 . . . . 0.0 109.623 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.427 ' N ' HG12 ' B' ' 53' ' ' VAL . 7.5 pt-20 -143.38 144.33 32.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.332 -0.855 . . . . 0.0 109.244 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.46 -175.53 31.82 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.54 113.85 27.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.442 -1.034 . . . . 0.0 109.208 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.592 ' N ' HD12 ' B' ' 57' ' ' ILE . 1.5 mp -81.14 127.07 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.156 -0.965 . . . . 0.0 109.759 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -101.78 -23.0 14.26 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.07 155.01 15.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.043 -1.036 . . . . 0.0 110.655 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.46 HD13 HD13 ' A' ' 32' ' ' LEU . 14.0 mt -130.82 142.56 50.4 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.473 HG22 HD12 ' A' ' 64' ' ' LEU . 71.3 t -134.19 119.77 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.421 -0.8 . . . . 0.0 109.177 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.591 ' O ' HD13 ' B' ' 64' ' ' LEU . 50.2 t80 -133.71 102.86 12.32 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.66 97.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.829 1.686 . . . . 0.0 112.745 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.779 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.483 -0.761 . . . . 0.0 109.22 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.69 ' N ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.478 0.656 . . . . 0.0 109.594 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.3 mmm-85 -69.4 138.3 53.48 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.5 -0.75 . . . . 0.0 109.693 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -150.44 155.75 40.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.454 -0.779 . . . . 0.0 109.139 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -114.34 131.93 56.37 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.611 HD23 ' N ' ' A' ' 8' ' ' SER . 6.0 tt -120.3 123.73 43.87 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.611 ' N ' HD23 ' A' ' 7' ' ' LEU . 38.3 t -109.93 132.24 54.34 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.498 -0.751 . . . . 0.0 109.601 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.624 HD11 ' NE2' ' B' ' 5' ' ' GLN . 44.6 tp -146.92 147.29 30.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.785 . . . . 0.0 109.232 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.408 HG21 ' OE1' ' A' ' 50' ' ' GLN . 1.9 t -148.43 177.74 9.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.306 -0.871 . . . . 0.0 109.187 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.3 20.98 76.51 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 p -62.46 144.37 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.586 -0.949 . . . . 0.0 110.001 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 t -72.38 -42.7 64.93 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.543 -0.723 . . . . 0.0 109.573 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -165.12 160.65 18.95 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.983 -1.073 . . . . 0.0 110.179 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -94.85 108.89 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -81.9 -56.3 4.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -0.816 . . . . 0.0 110.024 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 t -162.18 127.16 3.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.304 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.492 ' CE1' HD12 ' A' ' 23' ' ' ILE . 1.7 t80 -109.66 117.43 33.91 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.423 ' H ' HD13 ' A' ' 23' ' ' ILE . 1.1 m-20 -131.05 148.41 70.14 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 121.309 -0.869 . . . . 0.0 109.466 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.66 -11.8 31.73 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.508 1.472 . . . . 0.0 110.515 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -105.71 -14.52 15.23 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.791 -0.568 . . . . 0.0 110.094 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -167.82 145.89 4.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.232 -0.917 . . . . 0.0 109.306 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.492 HD12 ' CE1' ' A' ' 18' ' ' PHE . 51.2 mm -121.74 125.29 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.561 -0.712 . . . . 0.0 109.079 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.4 mt -118.39 115.56 24.92 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.4 mt -133.38 133.56 42.59 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -75.7 116.33 16.3 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.312 -0.867 . . . . 0.0 109.3 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.499 ' O ' ' C ' ' A' ' 28' ' ' ILE . 13.3 t -114.51 146.96 40.06 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.499 ' C ' ' O ' ' A' ' 27' ' ' THR . 10.0 mm -1.97 -75.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 123.557 0.743 . . . . 0.0 112.932 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.469 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 99.4 mm-40 -59.35 -71.01 0.13 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.438 -0.789 . . . . 0.0 111.749 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.55 -128.24 1.9 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.2 t -116.72 131.81 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.916 0.865 . . . . 0.0 110.711 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.4 tp -100.71 129.86 46.67 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.7 m -110.21 120.69 43.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.6 mt -105.32 124.04 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -118.41 141.32 48.66 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.754 0.788 . . . . 0.0 109.35 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.444 ' HA2' ' H ' ' A' ' 58' ' ' ASP . . . -179.58 -138.56 3.36 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.401 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.78 132.35 43.71 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.48 -1.012 . . . . 0.0 108.353 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp 39.72 86.13 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.642 0.734 . . . . 0.0 110.646 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.2 mp -96.8 72.12 2.58 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.686 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.539 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.408 ' OE1' HG21 ' A' ' 10' ' ' THR . 94.1 mm-40 . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.7 t -122.22 133.08 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.539 ' N ' ' OE1' ' A' ' 52' ' ' GLU . 13.3 mp0 -131.67 146.68 52.31 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.501 0.667 . . . . 0.0 109.428 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.1 t -129.06 134.41 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -117.32 134.76 54.43 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.694 0.759 . . . . 0.0 109.243 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.83 -176.05 34.21 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.415 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -103.71 120.92 41.91 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.9 mt -83.76 116.9 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.056 -1.028 . . . . 0.0 109.772 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.444 ' H ' ' HA2' ' A' ' 36' ' ' GLY . 59.0 m-20 -96.99 -15.42 21.09 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.481 -0.762 . . . . 0.0 109.81 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.6 152.96 8.67 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.083 -1.011 . . . . 0.0 110.446 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.418 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 8.8 mt -138.63 134.97 34.41 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 49.7 t -130.86 124.91 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.496 -0.753 . . . . 0.0 109.421 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.556 ' O ' ' N ' ' A' ' 64' ' ' LEU . 33.7 t80 -133.63 111.54 12.55 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.12 78.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.413 1.409 . . . . 0.0 112.326 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.895 HD12 HG22 ' B' ' 61' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.304 -1.402 0 O-C-N 120.528 -1.358 . . . . 0.0 108.667 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.895 HD21 ' N ' ' B' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 121.246 0.546 . . . . 0.0 109.809 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 38.6 mmm-85 -72.18 141.22 49.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.295 -0.878 . . . . 0.0 109.166 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' GLN . . . . . 0.624 ' NE2' HD11 ' A' ' 9' ' ' LEU . 2.8 pt20 -146.61 150.78 36.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.359 -0.838 . . . . 0.0 109.477 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -98.49 144.82 27.42 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.458 HD23 ' N ' ' B' ' 8' ' ' SER . 7.0 tt -127.79 125.9 40.71 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' SER . . . . . 0.458 ' N ' HD23 ' B' ' 7' ' ' LEU . 3.7 m -122.17 145.44 48.19 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.533 -0.73 . . . . 0.0 110.126 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.6 tp -153.17 149.29 27.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.4 t -151.15 159.06 44.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.089 -1.007 . . . . 0.0 109.885 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.49 15.07 72.13 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.6 p -62.3 153.03 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -1.079 . . . . 0.0 110.378 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 67.1 m -73.71 -54.07 8.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.15 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.41 153.34 4.3 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.2 -0.937 . . . . 0.0 109.614 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 79.8 t -86.22 130.12 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.416 -0.802 . . . . 0.0 109.886 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -92.8 -23.82 18.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.291 -0.88 . . . . 0.0 109.378 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 21.5 t -171.55 158.16 5.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.133 -0.98 . . . . 0.0 109.893 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -147.52 112.27 5.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.401 -0.812 . . . . 0.0 109.492 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.458 ' OD2' ' O ' ' B' ' 22' ' ' GLU . 1.1 m-20 -133.18 152.88 80.35 Favored Pre-proline 0 N--CA 1.5 2.067 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.58 -12.61 36.23 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.654 1.569 . . . . 0.0 111.556 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -125.88 2.48 7.37 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.574 -0.704 . . . . 0.0 109.563 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.458 ' O ' ' OD2' ' B' ' 19' ' ' ASP . 55.1 tt0 -160.85 119.63 2.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.334 -0.853 . . . . 0.0 109.256 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.6 mt -129.02 127.87 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.173 -0.955 . . . . 0.0 109.416 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 79.3 mt -108.77 134.92 50.82 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 93.7 mt -135.05 123.42 23.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.349 -0.845 . . . . 0.0 109.7 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -93.93 123.17 37.11 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.566 ' O ' ' N ' ' B' ' 29' ' ' GLN . 7.0 t -123.58 149.45 45.28 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.606 0.717 . . . . 0.0 109.886 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 16.7 mt 45.04 -85.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.922 -0.486 . . . . 0.0 110.218 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' B' ' 27' ' ' THR . 17.1 pt20 -142.88 -20.62 0.65 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.08 -1.013 . . . . 0.0 110.201 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.98 171.59 35.88 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -116.54 131.4 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.879 -0.777 . . . . 0.0 109.125 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 31.8 tp -112.76 127.17 56.08 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.42 0.629 . . . . 0.0 109.485 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 40.5 t -108.94 123.46 49.13 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 39.3 mm -99.71 128.15 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -133.06 125.64 30.08 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.83 -139.5 2.65 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -137.94 136.93 37.47 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.349 -1.089 . . . . 0.0 109.99 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 54.84 57.84 5.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.467 -0.771 . . . . 0.0 110.09 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.565 ' N ' HD12 ' B' ' 39' ' ' LEU . 8.8 mp -85.15 72.15 10.8 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.791 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -178.716 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.498 1.954 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -146.45 159.6 43.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.236 -0.915 . . . . 0.0 110.131 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.415 HG12 ' N ' ' B' ' 54' ' ' GLU . 21.4 t -134.15 159.38 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.691 -0.63 . . . . 0.0 109.513 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.415 ' N ' HG12 ' B' ' 53' ' ' VAL . 3.3 tm-20 -127.81 142.11 51.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.435 -0.79 . . . . 0.0 109.139 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.27 -177.76 31.49 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.66 128.81 52.82 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 30.6 mm -78.61 125.34 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.073 -1.017 . . . . 0.0 109.656 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -110.09 -9.85 14.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.658 -0.652 . . . . 0.0 109.478 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -174.24 149.29 1.38 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.096 -1.002 . . . . 0.0 110.095 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.416 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 13.0 mt -138.34 137.5 37.42 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.895 HG22 HD12 ' A' ' 64' ' ' LEU . 9.4 t -134.42 122.74 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.491 -0.755 . . . . 0.0 109.982 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.418 ' CG ' ' HB2' ' A' ' 60' ' ' LEU . 26.9 t80 -140.33 106.08 6.6 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -50.59 113.05 0.89 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.302 1.334 . . . . 0.0 112.336 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.979 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.098 0 O-C-N 121.187 -0.946 . . . . 0.0 108.922 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.613 ' N ' HD21 ' A' ' 3' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.081 0 CA-C-O 121.434 0.635 . . . . 0.0 109.934 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -71.18 146.67 48.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 109.649 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.58 ' NE2' HD11 ' B' ' 9' ' ' LEU . 2.8 pt20 -150.2 160.12 43.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.37 -0.831 . . . . 0.0 109.174 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -100.08 141.56 32.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.377 -0.827 . . . . 0.0 109.053 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 8' ' ' SER . 6.6 tt -133.76 123.85 25.61 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.516 ' N ' HD23 ' A' ' 7' ' ' LEU . 40.4 t -131.88 139.62 48.84 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.736 -0.603 . . . . 0.0 109.556 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.506 HD11 ' NE2' ' B' ' 5' ' ' GLN . 41.8 tp -133.3 147.62 51.9 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p -130.71 159.12 38.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.526 -0.734 . . . . 0.0 109.544 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.95 21.05 69.04 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.35 137.05 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -1.154 . . . . 0.0 109.898 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.5 m -73.12 -44.35 60.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.206 -0.934 . . . . 0.0 109.796 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.56 163.2 5.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.163 -0.961 . . . . 0.0 109.564 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.0 t -93.99 127.71 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.282 -0.886 . . . . 0.0 109.433 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -85.19 -30.92 23.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.046 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.8 t -174.01 167.26 4.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.516 -0.74 . . . . 0.0 109.293 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -149.77 106.54 3.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.344 -0.847 . . . . 0.0 108.856 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.62 126.02 19.81 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -47.24 -24.21 3.58 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.361 1.374 . . . . 0.0 112.228 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -90.7 -8.15 50.67 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.985 -1.072 . . . . 0.0 109.98 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -176.65 141.58 0.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.472 -0.767 . . . . 0.0 109.081 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mt -130.76 130.58 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.105 -0.997 . . . . 0.0 109.085 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.1 mt -114.35 125.0 53.36 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.8 mt -124.33 131.35 53.51 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.566 -0.709 . . . . 0.0 109.624 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -95.28 122.59 38.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.401 -0.812 . . . . 0.0 109.162 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 29' ' ' GLN . 2.9 t -124.18 148.67 47.08 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.44 0.638 . . . . 0.0 110.348 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' A' ' 27' ' ' THR . 60.0 mt 38.09 -90.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.971 -0.455 . . . . 0.0 110.5 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.525 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.1 pt20 -136.47 -15.79 1.62 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.227 -0.921 . . . . 0.0 109.786 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.21 153.82 20.06 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.1 t -111.13 131.05 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.553 -0.969 . . . . 0.0 108.39 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.8 tp -107.34 124.07 49.27 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.693 -0.629 . . . . 0.0 109.633 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.1 m -107.49 120.36 41.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.1 mt -104.73 127.11 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.52 127.64 52.37 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.96 -148.61 5.38 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -142.79 139.23 30.91 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.4 ' C ' HD12 ' A' ' 39' ' ' LEU . 33.1 mtmm 57.25 63.3 1.92 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.524 -0.735 . . . . 0.0 110.315 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.0 mp -94.73 72.06 3.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.268 -0.895 . . . . 0.0 109.023 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.367 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.533 -179.087 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 . . . . . 0 N--CA 1.5 2.047 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.58 135.47 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.509 -0.744 . . . . 0.0 109.422 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -126.93 137.9 53.2 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.5 t -137.48 141.08 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -0.799 . . . . 0.0 108.951 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -114.96 125.21 53.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.497 -0.752 . . . . 0.0 109.033 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.49 166.17 27.12 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.703 ' C ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -86.77 151.42 23.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.52 -0.988 . . . . 0.0 110.772 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.411 HD12 ' OE1' ' A' ' 5' ' ' GLN . 87.9 mt -103.46 119.28 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.832 -1.167 . . . . 0.0 109.168 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -112.5 -11.94 13.55 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.405 -0.81 . . . . 0.0 108.995 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.78 149.03 6.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.105 -0.997 . . . . 0.0 110.086 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.5 mt -138.08 141.46 40.26 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.525 HG22 HD12 ' B' ' 64' ' ' LEU . 65.3 t -134.62 123.4 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.419 -0.801 . . . . 0.0 109.792 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.548 ' O ' ' N ' ' A' ' 64' ' ' LEU . 13.1 t80 -145.69 136.66 12.48 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -44.67 88.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.288 0 CA-C-N 120.22 1.114 . . . . 0.0 111.492 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.592 HD23 ' C ' ' A' ' 64' ' ' LEU . 1.7 tt . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.245 -0.909 . . . . 0.0 109.33 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.708 HD21 ' N ' ' B' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.025 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.3 mmm-85 -77.25 141.84 39.8 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.407 -0.808 . . . . 0.0 109.12 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' GLN . . . . . 0.506 ' NE2' HD11 ' A' ' 9' ' ' LEU . 2.9 pt20 -147.63 161.3 41.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.213 -0.93 . . . . 0.0 109.591 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -116.52 130.77 56.93 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.538 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.4 tt -123.12 121.81 36.91 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' SER . . . . . 0.524 ' N ' HD23 ' B' ' 7' ' ' LEU . 97.8 p -114.0 145.76 41.1 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.7 -0.625 . . . . 0.0 109.695 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.58 HD11 ' NE2' ' A' ' 5' ' ' GLN . 34.1 tp -148.09 144.2 27.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.357 -0.839 . . . . 0.0 109.259 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 46.0 p -130.93 170.07 14.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.616 -0.677 . . . . 0.0 109.577 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.02 11.04 77.3 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 83.4 t -72.24 133.75 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -1.166 . . . . 0.0 109.684 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.8 t -72.28 -45.37 60.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.313 -0.867 . . . . 0.0 109.605 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.21 163.06 8.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.077 -1.014 . . . . 0.0 109.658 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 98.1 t -84.67 110.55 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.869 . . . . 0.0 109.979 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -66.35 -41.05 90.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 0.0 109.16 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 5.5 p -160.19 163.96 33.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.338 -0.851 . . . . 0.0 108.963 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -151.21 110.68 3.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.006 -1.058 . . . . 0.0 110.073 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.25 150.0 74.76 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.01 -16.5 49.66 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.612 1.541 . . . . 0.0 111.479 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -111.67 -1.97 15.53 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.557 -0.714 . . . . 0.0 109.517 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.554 ' OE2' HD21 ' B' ' 24' ' ' LEU . 2.7 tm-20 -170.86 130.63 0.81 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.169 -0.957 . . . . 0.0 109.286 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -129.73 132.07 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.231 -0.918 . . . . 0.0 109.847 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.554 HD21 ' OE2' ' B' ' 22' ' ' GLU . 89.5 mt -111.4 125.57 54.01 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 76.4 mt -121.73 124.83 45.16 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.667 -0.646 . . . . 0.0 109.357 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -93.32 113.52 25.72 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.576 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.7 t -124.95 154.04 41.79 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.447 0.641 . . . . 0.0 110.028 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 18.5 mm 42.22 -86.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.883 -0.51 . . . . 0.0 110.339 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' B' ' 27' ' ' THR . 18.7 pt20 -143.51 -17.0 0.63 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.018 -1.051 . . . . 0.0 110.232 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.94 178.05 30.6 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.84 134.35 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 54.8 tp -105.42 127.28 52.9 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.368 -0.833 . . . . 0.0 109.463 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.7 m -116.55 120.69 39.52 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.716 . . . . 0.0 109.645 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 92.1 mt -109.85 129.91 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -127.92 143.22 51.1 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.627 -0.67 . . . . 0.0 109.423 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.61 -142.53 7.58 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.523 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.419 ' HB3' HD11 ' B' ' 56' ' ' LEU . 27.2 tp10 -123.0 143.72 49.74 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.627 -0.925 . . . . 0.0 109.069 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' B' ' 54' ' ' GLU . 49.5 mtmt 51.77 63.32 2.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.341 -0.849 . . . . 0.0 111.184 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.517 ' N ' HD12 ' B' ' 39' ' ' LEU . 8.7 mp -94.88 70.7 3.41 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.979 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.347 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -120.07 143.24 48.23 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.422 -0.799 . . . . 0.0 108.941 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.7 t -124.17 135.59 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.629 -0.669 . . . . 0.0 109.513 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' B' ' 38' ' ' LYS . 44.0 tt0 -125.94 135.05 51.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.62 -177.1 27.09 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.461 HD23 ' H ' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -99.67 127.2 45.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.347 -1.09 . . . . 0.0 108.556 179.388 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.509 ' N ' HD12 ' B' ' 57' ' ' ILE . 1.3 mp -79.8 128.06 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.925 . . . . 0.0 109.752 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -108.93 -39.54 5.29 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.569 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -148.29 149.66 32.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 110.094 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.569 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.8 OUTLIER -131.69 131.21 42.9 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.272 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.473 HG13 HD12 ' A' ' 64' ' ' LEU . 47.4 t -129.09 128.77 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' B' ' 62' ' ' TYR . 19.8 t80 -143.53 140.06 17.07 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.57 85.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 120.986 1.124 . . . . 0.0 112.051 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.651 ' H ' ' CD2' ' B' ' 64' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.661 ' N ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -88.84 132.1 34.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.104 -0.997 . . . . 0.0 108.87 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -147.75 161.07 41.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.994 -1.066 . . . . 0.0 109.346 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -108.52 131.17 55.09 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 7' ' ' LEU . 6.3 tt -117.82 121.77 41.63 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.548 ' N ' HD23 ' A' ' 7' ' ' LEU . 46.8 t -116.04 132.34 56.68 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.538 -0.726 . . . . 0.0 109.657 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.539 HD21 ' NE2' ' B' ' 5' ' ' GLN . 5.5 tp -147.31 153.72 40.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.361 -0.837 . . . . 0.0 109.317 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.463 ' OG1' ' N ' ' A' ' 11' ' ' GLY . 6.1 t -149.85 -164.54 2.05 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.36 -0.838 . . . . 0.0 109.847 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.463 ' N ' ' OG1' ' A' ' 10' ' ' THR . . . 65.24 19.38 66.2 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.5 t -70.25 141.66 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.677 -0.896 . . . . 0.0 110.617 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.3 m -71.78 -43.5 65.6 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.91 160.36 3.55 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.234 -0.916 . . . . 0.0 109.918 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.2 t -88.66 129.96 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.4 -0.812 . . . . 0.0 109.852 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -97.34 -35.1 10.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.386 -0.821 . . . . 0.0 109.23 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.8 t -169.67 145.61 3.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.566 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -137.61 113.94 10.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.513 -0.742 . . . . 0.0 109.132 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -133.24 153.56 80.73 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.03 -20.08 44.82 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.295 1.997 . . . . 0.0 111.605 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -102.07 -4.56 25.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.539 -0.726 . . . . 0.0 109.318 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -172.87 142.04 1.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.444 -0.785 . . . . 0.0 109.045 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.8 mt -132.48 130.24 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.427 -0.796 . . . . 0.0 109.725 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.5 mt -118.06 121.44 40.59 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.6 mt -124.37 125.09 43.73 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -81.76 114.75 20.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.347 -0.846 . . . . 0.0 109.924 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 28' ' ' ILE . 14.5 t -124.68 -179.52 4.54 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.659 0.742 . . . . 0.0 110.215 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.492 ' O ' ' O ' ' A' ' 27' ' ' THR . 1.3 mt -36.51 161.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 121.736 0.779 . . . . 0.0 110.414 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.414 ' OE1' ' OD1' ' B' ' 58' ' ' ASP . 78.6 mm-40 65.12 -61.9 0.22 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.139 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -165.94 -127.26 0.88 Allowed Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.093 -1.527 . . . . 0.0 109.962 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.6 t -122.37 135.18 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.593 -0.945 . . . . 0.0 110.338 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.451 HD11 HD12 ' A' ' 60' ' ' LEU . 42.8 tp -105.55 125.41 50.96 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.8 m -103.61 123.0 46.16 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -107.75 125.02 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -116.57 140.83 48.95 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.47 -151.38 9.43 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.415 ' HB3' HD11 ' A' ' 56' ' ' LEU . 14.1 tp10 -143.32 146.39 33.51 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.337 -1.096 . . . . 0.0 109.024 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 54' ' ' GLU . 67.5 mttm 58.33 55.22 5.14 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.486 0.66 . . . . 0.0 109.68 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.7 mp -92.9 72.64 4.81 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.849 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -179.125 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.015 0.435 . . . . 0.0 109.859 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.4 t -115.05 131.97 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -131.16 136.56 48.42 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.76 135.01 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 38' ' ' LYS . 5.1 tm-20 -116.89 126.55 53.16 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.0 -174.61 41.62 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.211 -1.471 . . . . 0.0 110.032 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.415 HD11 ' HB3' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -106.42 118.21 36.06 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.809 -0.818 . . . . 0.0 109.387 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.53 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.4 mp -74.05 128.08 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.337 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -105.73 -21.9 13.07 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.629 ' O ' HD22 ' A' ' 60' ' ' LEU . . . -166.89 158.28 12.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.991 -1.068 . . . . 0.0 110.834 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.629 HD22 ' O ' ' A' ' 59' ' ' ALA . 0.7 OUTLIER -135.64 135.34 40.1 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.461 HG22 HD12 ' B' ' 64' ' ' LEU . 58.8 t -133.96 119.94 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.436 -0.79 . . . . 0.0 109.63 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 64' ' ' LEU . 29.2 t80 -133.46 140.06 35.85 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.77 68.4 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.602 1.535 . . . . 0.0 111.924 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.608 HD12 HG22 ' B' ' 61' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.734 -0.604 . . . . 0.0 109.689 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.567 HD21 ' N ' ' B' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 47.2 mmm-85 -88.66 137.77 32.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.657 -1.277 . . . . 0.0 109.451 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' GLN . . . . . 0.539 ' NE2' HD21 ' A' ' 9' ' ' LEU . 46.5 tt0 -139.05 149.92 45.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.295 -0.878 . . . . 0.0 109.502 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -109.46 129.55 55.55 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.508 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.9 tt -122.69 122.49 38.88 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' SER . . . . . 0.46 ' N ' HD23 ' B' ' 7' ' ' LEU . 41.6 t -123.14 137.26 54.95 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.6 tp -145.25 151.59 38.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.221 -0.924 . . . . 0.0 109.835 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -140.49 159.74 41.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.708 -0.62 . . . . 0.0 109.629 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.47 24.19 26.86 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.439 HG22 ' H ' ' B' ' 14' ' ' LYS . 6.2 p -62.62 141.37 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.166 -1.197 . . . . 0.0 110.034 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 10.0 m -92.28 -21.35 20.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.411 -0.806 . . . . 0.0 109.26 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.439 ' H ' HG22 ' B' ' 12' ' ' VAL . 9.8 tttt -171.8 154.2 3.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.555 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 75.5 t -102.67 99.16 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -67.36 -40.55 85.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 109.07 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 25.8 t -170.76 167.97 7.49 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.408 -0.808 . . . . 0.0 109.523 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -149.7 105.2 3.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.532 -0.73 . . . . 0.0 109.123 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -132.77 147.82 67.04 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.59 -14.59 39.9 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 121.7 1.6 . . . . 0.0 111.735 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -104.05 -8.01 19.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.548 -0.72 . . . . 0.0 109.534 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -173.18 113.19 0.23 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.371 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 97.3 mt -109.35 127.14 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.235 -0.916 . . . . 0.0 109.221 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 68.4 mt -117.69 123.43 46.06 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 88.5 mt -131.22 129.49 41.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.465 -0.772 . . . . 0.0 109.391 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.2 111.47 17.65 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.604 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.487 ' O ' ' O ' ' B' ' 28' ' ' ILE . 12.9 t -124.39 -176.94 3.64 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.571 0.7 . . . . 0.0 110.29 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' B' ' 27' ' ' THR . 1.9 mt -32.62 157.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.886 0.85 . . . . 0.0 110.951 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 64.6 -62.45 0.18 Allowed 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.939 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' B' ' 28' ' ' ILE . . . -166.34 -120.09 0.5 Allowed Glycine 0 N--CA 1.486 1.968 0 C-N-CA 119.225 -1.464 . . . . 0.0 110.202 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 53.1 t -119.4 135.03 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.676 -0.897 . . . . 0.0 110.539 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 59.0 tp -109.33 123.38 49.22 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.4 t -107.4 123.66 48.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.792 -0.567 . . . . 0.0 109.989 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 94.6 mt -108.52 122.37 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -117.6 142.44 47.2 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.599 -0.688 . . . . 0.0 109.457 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' GLY . . . . . 0.433 ' HA2' ' H ' ' B' ' 58' ' ' ASP . . . 174.61 -146.74 8.71 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -139.1 142.06 38.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.365 -1.08 . . . . 0.0 109.489 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 88.9 mttt 56.21 57.1 5.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.668 -0.645 . . . . 0.0 109.798 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.511 ' N ' HD12 ' B' ' 39' ' ' LEU . 8.6 mp -92.99 71.53 4.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.345 -0.847 . . . . 0.0 108.912 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' GLY . . . . . 0.41 ' O ' ' OE1' ' B' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -126.35 127.96 46.32 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.92 140.68 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.46 -0.775 . . . . 0.0 109.91 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.41 ' OE1' ' O ' ' B' ' 40' ' ' GLY . 5.3 mp0 -114.99 139.58 49.73 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.92 170.66 26.97 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.16 131.33 38.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.242 -1.152 . . . . 0.0 109.469 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 44.2 mm -87.66 113.98 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.099 -1.001 . . . . 0.0 108.862 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' ASP . . . . . 0.433 ' H ' ' HA2' ' B' ' 36' ' ' GLY . 18.2 t0 -97.68 -7.0 31.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.593 -0.692 . . . . 0.0 109.222 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -177.19 154.85 1.09 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.048 -1.032 . . . . 0.0 110.823 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.4 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 11.8 mt -139.93 138.46 35.61 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.608 HG22 HD12 ' A' ' 64' ' ' LEU . 61.3 t -134.14 129.8 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.507 -0.746 . . . . 0.0 109.216 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.666 ' O ' ' N ' ' B' ' 64' ' ' LEU . 65.1 t80 -143.2 123.0 7.71 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -48.44 71.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 121.983 1.788 . . . . 0.0 111.91 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.666 ' N ' ' O ' ' B' ' 62' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.298 -1.642 0 CA-C-O 121.886 0.851 . . . . 0.0 109.975 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 121.307 0.575 . . . . 0.0 109.705 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.6 mmm-85 -81.61 148.0 29.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.241 -0.912 . . . . 0.0 110.121 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -155.83 160.13 39.96 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.46 -0.775 . . . . 0.0 109.264 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -108.92 138.37 45.36 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.536 HD23 ' N ' ' A' ' 8' ' ' SER . 6.7 tt -126.82 124.72 40.3 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.536 ' N ' HD23 ' A' ' 7' ' ' LEU . 44.2 t -127.81 149.12 50.41 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.543 HD21 ' NE2' ' B' ' 5' ' ' GLN . 9.0 tp -142.5 146.25 34.53 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.344 -0.848 . . . . 0.0 109.402 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -124.73 167.77 14.11 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.641 -0.662 . . . . 0.0 109.534 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.37 14.96 69.8 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.3 p -68.93 136.76 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -1.12 . . . . 0.0 109.685 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.5 m -73.18 -46.5 50.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.307 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.96 163.1 4.0 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.346 -0.846 . . . . 0.0 109.882 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.2 t -95.18 117.55 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.412 -0.805 . . . . 0.0 109.823 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -68.84 -35.9 77.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.373 -0.83 . . . . 0.0 109.184 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -167.31 161.61 14.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.294 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -151.29 111.47 4.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.394 -0.816 . . . . 0.0 108.97 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -126.9 156.63 73.7 Favored Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.436 -0.79 . . . . 0.0 108.888 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.19 -29.78 84.81 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.776 1.651 . . . . 0.0 112.514 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -117.17 17.71 14.72 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.469 -0.769 . . . . 0.0 110.589 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -171.24 132.36 0.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 0.0 109.168 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.17 129.94 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.366 -0.834 . . . . 0.0 109.54 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.459 ' CD2' ' OG ' ' A' ' 33' ' ' SER . 64.4 mt -112.93 126.86 55.94 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.1 mt -121.53 132.43 54.7 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.666 -0.647 . . . . 0.0 109.763 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -101.68 113.94 27.54 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 28' ' ' ILE . 9.9 t -124.61 -162.84 1.12 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.396 0.617 . . . . 0.0 110.037 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.493 HD11 ' O ' ' B' ' 3' ' ' ASN . 63.2 mt -33.48 99.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 28' ' ' ILE . 5.6 pt20 29.58 53.83 0.12 Allowed 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 121.294 0.569 . . . . 0.0 111.558 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.02 145.46 8.16 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.53 131.22 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.516 -0.991 . . . . 0.0 108.908 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.7 tp -108.05 118.31 36.41 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.459 ' OG ' ' CD2' ' A' ' 24' ' ' LEU . 22.8 t -104.64 123.58 47.83 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.1 mt -105.81 129.18 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.438 -0.789 . . . . 0.0 109.433 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -120.38 139.19 53.15 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.78 -149.3 8.82 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -133.19 142.54 48.66 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.373 -1.075 . . . . 0.0 109.456 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.5 mttp 54.63 59.9 3.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.565 -0.71 . . . . 0.0 110.545 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.0 mp -91.38 74.19 6.08 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.95 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.098 -177.313 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 . . . . . 0 N--CA 1.5 2.061 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.36 161.48 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.611 -0.681 . . . . 0.0 109.408 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -139.35 137.84 36.11 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.458 -0.776 . . . . 0.0 109.487 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 52.1 t -130.6 136.53 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -123.34 129.58 51.51 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.374 -0.829 . . . . 0.0 108.902 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.4 177.48 33.54 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -95.79 133.7 39.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.283 -1.128 . . . . 0.0 109.273 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.441 ' CG2' HD23 ' A' ' 60' ' ' LEU . 91.8 mt -90.54 111.7 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.148 -0.97 . . . . 0.0 109.727 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -99.31 -17.06 18.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.498 -0.751 . . . . 0.0 109.39 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.59 153.22 16.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.074 -1.016 . . . . 0.0 110.248 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.441 HD23 ' CG2' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -135.04 136.5 42.13 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.39 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.695 HG22 HD12 ' B' ' 64' ' ' LEU . 3.2 t -135.89 127.44 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.496 -0.752 . . . . 0.0 109.564 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.426 ' C ' ' CD1' ' A' ' 62' ' ' TYR . 9.2 t80 -144.06 139.86 16.39 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -64.19 79.92 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.002 1.135 . . . . 0.0 113.379 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.829 HD13 ' O ' ' A' ' 64' ' ' LEU . 1.4 tm? . . . . . 0 C--N 1.304 -1.375 0 O-C-N 120.989 -1.07 . . . . 0.0 108.7 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.696 HD21 ' N ' ' B' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.091 0 CA-C-O 120.847 0.356 . . . . 0.0 110.121 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -71.44 143.41 50.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.047 -1.033 . . . . 0.0 109.315 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' GLN . . . . . 0.543 ' NE2' HD21 ' A' ' 9' ' ' LEU . 35.8 tt0 -146.45 152.76 39.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.431 -0.793 . . . . 0.0 109.598 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.598 ' N ' ' CD1' ' B' ' 6' ' ' PHE . 1.5 m-85 -124.18 145.38 49.36 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.579 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.0 tt -130.7 125.77 34.79 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' SER . . . . . 0.555 ' N ' HD23 ' B' ' 7' ' ' LEU . 31.1 t -107.24 137.65 44.89 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.651 -0.656 . . . . 0.0 109.264 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.717 ' O ' HG12 ' B' ' 51' ' ' VAL . 10.2 tp -149.32 155.27 40.26 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.044 -1.035 . . . . 0.0 109.652 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.7 t -149.95 157.86 43.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.131 -0.98 . . . . 0.0 109.273 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.33 12.95 57.99 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 87.0 t -67.29 135.15 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.997 -1.296 . . . . 0.0 109.28 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 33.2 m -71.87 -45.28 61.89 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.641 -0.823 . . . . 0.0 109.809 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.39 159.47 5.68 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.099 -1.001 . . . . 0.0 109.474 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 87.5 t -92.23 129.7 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.309 -0.869 . . . . 0.0 109.747 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -86.71 -26.69 24.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.421 -0.799 . . . . 0.0 109.795 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 32.7 t -171.88 160.74 5.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -0.896 . . . . 0.0 109.05 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -148.37 108.12 4.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.816 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -132.62 131.16 22.01 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.37 -24.73 9.07 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 CA-C-N 119.991 1.032 . . . . 0.0 111.829 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -93.63 -6.53 46.24 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.337 -0.852 . . . . 0.0 110.157 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -171.86 133.2 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.228 -0.92 . . . . 0.0 109.155 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 94.0 mt -128.12 131.13 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.4 -0.813 . . . . 0.0 109.469 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 17.2 mt -111.86 125.48 54.07 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 80.8 mt -122.34 118.49 28.59 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -89.55 116.5 27.75 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.576 ' O ' ' N ' ' B' ' 29' ' ' GLN . 2.9 t -123.73 149.04 46.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 109.771 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 59.3 mt 46.95 -85.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.079 0.466 . . . . 0.0 110.028 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' B' ' 27' ' ' THR . 28.1 pt20 -143.07 -23.39 0.62 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.089 -1.007 . . . . 0.0 110.786 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.6 171.56 32.04 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 54.9 t -119.92 130.22 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.848 -0.795 . . . . 0.0 108.883 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.402 HD11 HD12 ' B' ' 60' ' ' LEU . 48.6 tp -111.23 128.04 55.8 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.78 127.69 56.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 90.4 mt -105.71 126.53 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -119.49 130.63 55.32 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.7 -147.83 6.34 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -133.59 144.25 49.18 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.344 -1.091 . . . . 0.0 109.447 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 53.34 57.02 6.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.523 -0.735 . . . . 0.0 110.584 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.513 ' N ' HD12 ' B' ' 39' ' ' LEU . 9.3 mp -84.11 73.39 10.4 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.562 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.694 -178.001 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.717 HG12 ' O ' ' B' ' 9' ' ' LEU . 14.8 p . . . . . 0 N--CA 1.5 2.052 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -141.13 119.46 12.18 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.22 153.85 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.334 -0.854 . . . . 0.0 108.888 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -123.66 133.21 53.94 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.456 0.646 . . . . 0.0 109.49 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.14 163.78 14.79 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.448 HD23 ' H ' ' B' ' 56' ' ' LEU . 0.1 OUTLIER -88.13 140.93 28.98 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.02 -1.282 . . . . 0.0 109.643 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.485 ' H ' HD12 ' A' ' 28' ' ' ILE . 45.5 mm -84.31 126.17 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.322 -0.861 . . . . 0.0 109.481 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -113.53 -34.71 5.47 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.45 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -167.99 146.11 4.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.158 -0.964 . . . . 0.0 110.323 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.45 HD22 ' O ' ' B' ' 59' ' ' ALA . 3.9 mm? -117.31 135.96 53.47 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.12 118.05 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.803 0.811 . . . . 0.0 108.97 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.524 ' O ' ' N ' ' B' ' 64' ' ' LEU . 55.8 t80 -138.66 100.98 8.11 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -46.13 84.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 121.473 1.449 . . . . 0.0 112.341 -177.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.695 HD12 HG22 ' A' ' 61' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.306 -1.288 0 O-C-N 120.884 -1.135 . . . . 0.0 108.883 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 121.554 0.692 . . . . 0.0 109.306 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.538 ' NH1' ' N ' ' A' ' 55' ' ' GLY . 7.6 mmm180 -54.08 148.33 11.14 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.322 -0.861 . . . . 0.0 109.743 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.445 ' OE1' HD11 ' B' ' 9' ' ' LEU . 16.0 pt20 -155.16 159.09 39.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.529 -0.732 . . . . 0.0 110.167 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -99.62 148.94 23.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.629 -0.67 . . . . 0.0 109.366 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.505 HD23 ' N ' ' A' ' 8' ' ' SER . 7.0 tt -138.5 126.63 22.75 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.176 -0.952 . . . . 0.0 108.457 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.505 ' N ' HD23 ' A' ' 7' ' ' LEU . 20.0 m -123.77 141.67 51.81 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.436 -0.79 . . . . 0.0 109.563 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.4 tp -150.76 145.64 25.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.386 -0.821 . . . . 0.0 109.354 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 p -137.92 172.14 13.37 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.462 -0.774 . . . . 0.0 109.09 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.62 20.85 59.19 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.91 134.84 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.028 -1.278 . . . . 0.0 110.067 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.1 m -74.71 -53.6 8.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.885 . . . . 0.0 109.841 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.14 156.19 28.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.042 -1.036 . . . . 0.0 109.835 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.1 t -88.92 129.5 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.348 -0.845 . . . . 0.0 109.841 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -97.98 -36.34 10.17 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.163 -0.961 . . . . 0.0 109.316 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.7 t -170.8 148.24 2.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.887 . . . . 0.0 108.907 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -141.49 110.78 6.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.343 -0.848 . . . . 0.0 109.142 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -133.48 144.58 52.83 Favored Pre-proline 0 N--CA 1.503 2.189 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.73 -35.67 48.62 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.027 1.152 . . . . 0.0 111.565 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -63.15 -45.09 93.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.2 -0.938 . . . . 0.0 110.0 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -156.83 156.15 32.72 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.393 -0.817 . . . . 0.0 109.089 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.5 mt -120.25 131.47 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.639 -0.663 . . . . 0.0 109.966 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.3 mt -112.93 116.62 30.27 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 mt -127.03 135.54 50.95 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.389 -0.819 . . . . 0.0 109.292 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -97.48 119.26 35.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.146 -0.971 . . . . 0.0 109.216 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 29' ' ' GLN . 8.9 t -124.57 158.99 31.66 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.301 0.572 . . . . 0.0 110.348 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 27' ' ' THR . 44.8 mt 32.26 -86.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 CA-C-O 121.125 0.488 . . . . 0.0 111.261 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 27' ' ' THR . 24.9 pt20 -150.33 47.71 0.9 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.191 -0.943 . . . . 0.0 109.943 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -171.45 142.31 6.92 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.6 t -90.19 132.64 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.4 -1.059 . . . . 0.0 109.559 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.9 tp -106.95 125.09 50.55 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.6 t -113.05 124.46 52.66 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.6 mt -108.31 123.88 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -112.91 137.34 51.44 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.577 0.703 . . . . 0.0 109.558 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.92 -149.52 10.03 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -137.31 144.56 42.67 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.337 -1.096 . . . . 0.0 109.492 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp 56.1 59.01 3.94 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.726 0.774 . . . . 0.0 109.438 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.1 mp -92.23 73.86 5.39 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.572 0 C-N-CA 119.939 -1.124 . . . . 0.0 110.528 -178.355 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.98 135.46 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.472 -0.768 . . . . 0.0 109.397 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -126.49 131.7 51.57 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.455 0.645 . . . . 0.0 109.588 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -120.58 136.25 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HB2' HH22 ' A' ' 4' ' ' ARG . 2.6 pt-20 -130.08 146.33 51.74 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.538 ' N ' ' NH1' ' A' ' 4' ' ' ARG . . . 149.1 -175.57 28.27 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 pp -97.06 127.42 43.01 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.058 -1.26 . . . . 0.0 109.667 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.4 mm -87.32 120.91 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.273 -0.892 . . . . 0.0 109.837 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -105.7 -12.4 15.93 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.524 -0.735 . . . . 0.0 109.592 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -174.07 156.66 2.74 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.084 -1.01 . . . . 0.0 110.259 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.9 mt -138.7 135.48 34.83 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.488 HG22 HD12 ' B' ' 64' ' ' LEU . 77.7 t -128.08 128.88 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.554 -0.716 . . . . 0.0 109.248 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.434 ' CE1' ' O ' ' A' ' 63' ' ' PRO . 29.9 t80 -145.03 140.09 15.8 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.434 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 90.0 Cg_endo -80.3 113.01 2.85 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.442 1.428 . . . . 0.0 112.129 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.866 ' H ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.131 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.488 HD21 ' N ' ' B' ' 3' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.535 0.683 . . . . 0.0 109.255 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -69.37 142.45 53.94 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.372 -0.83 . . . . 0.0 109.121 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -144.63 153.11 41.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.274 -0.891 . . . . 0.0 109.857 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -114.66 129.16 56.64 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.574 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.8 tt -120.63 124.63 45.73 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.386 -0.821 . . . . 0.0 109.102 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' SER . . . . . 0.563 ' N ' HD23 ' B' ' 7' ' ' LEU . 7.6 m -118.98 138.37 52.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.664 -0.647 . . . . 0.0 109.338 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.445 HD11 ' OE1' ' A' ' 5' ' ' GLN . 53.7 tp -146.64 140.87 26.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 0.0 109.23 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.411 ' O ' ' OG1' ' B' ' 10' ' ' THR . 1.0 OUTLIER -134.22 106.34 7.09 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.79 48.35 0.03 OUTLIER Glycine 0 N--CA 1.495 2.571 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.457 ' O ' HG13 ' B' ' 12' ' ' VAL . 14.6 p -104.49 131.54 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.542 -0.975 . . . . 0.0 109.67 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 6.3 t -71.21 -43.86 66.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.261 -0.899 . . . . 0.0 109.005 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.81 159.27 5.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.29 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 88.0 t -91.09 127.36 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.131 -0.981 . . . . 0.0 109.59 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -88.35 -23.32 23.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.253 -0.904 . . . . 0.0 109.364 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 32.9 t -172.52 159.78 4.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.322 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -146.09 104.01 3.78 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.054 -1.029 . . . . 0.0 109.73 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.74 150.76 74.34 Favored Pre-proline 0 N--CA 1.497 1.887 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.44 -9.09 22.63 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.449 1.433 . . . . 0.0 111.095 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -99.43 -16.96 18.19 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.388 -0.82 . . . . 0.0 109.437 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.41 ' OE2' ' C ' ' B' ' 23' ' ' ILE . 2.1 tm-20 -173.74 125.04 0.37 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.41 ' C ' ' OE2' ' B' ' 22' ' ' GLU . 77.9 mt -116.04 129.27 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.331 -0.855 . . . . 0.0 109.371 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 86.9 mt -105.18 125.5 51.05 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 88.2 mt -124.06 122.18 37.18 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.659 -0.651 . . . . 0.0 109.697 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -89.65 110.76 21.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.571 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.9 t -124.45 148.91 47.33 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.659 0.742 . . . . 0.0 109.842 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.402 HD13 ' N ' ' B' ' 28' ' ' ILE . 6.1 mm 51.95 -80.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.839 -0.538 . . . . 0.0 110.024 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' B' ' 27' ' ' THR . 15.3 pt20 -152.1 -21.46 0.18 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.195 -0.94 . . . . 0.0 109.825 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.99 177.87 32.96 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 47.7 t -119.93 132.42 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 38.5 tp -105.86 128.01 53.48 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.411 -0.806 . . . . 0.0 109.363 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 37.0 t -114.39 120.1 39.18 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 86.2 mt -107.19 123.39 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -114.44 140.67 48.51 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.47 0.652 . . . . 0.0 109.489 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.47 -154.46 24.69 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -130.97 149.92 52.37 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.389 -1.065 . . . . 0.0 109.321 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' B' ' 54' ' ' GLU . 26.1 mmtp 61.88 48.08 5.6 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.558 0.694 . . . . 0.0 109.382 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.536 ' N ' HD12 ' B' ' 39' ' ' LEU . 10.1 mp -91.85 72.89 5.71 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.242 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 121.613 0.72 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -130.46 126.39 36.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 69.6 t -116.58 136.56 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' B' ' 38' ' ' LYS . 29.6 mt-10 -123.42 144.43 49.5 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.99 177.41 23.98 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.436 HD23 ' H ' ' B' ' 56' ' ' LEU . 0.1 OUTLIER -90.18 144.11 26.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.093 -1.239 . . . . 0.0 109.283 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.507 ' CG2' HD23 ' B' ' 60' ' ' LEU . 35.5 mm -93.62 112.87 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.316 -0.865 . . . . 0.0 109.72 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -101.15 -21.55 14.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.335 -0.853 . . . . 0.0 109.249 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.555 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -167.06 152.65 7.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.744 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.555 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.5 OUTLIER -134.99 133.06 39.08 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.505 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 53.3 t -134.95 127.07 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.547 -0.721 . . . . 0.0 110.0 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.571 ' O ' ' N ' ' B' ' 64' ' ' LEU . 16.0 t80 -141.46 122.49 8.8 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -43.87 84.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.214 1.276 . . . . 0.0 112.376 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.724 ' H ' HD23 ' B' ' 64' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -82.26 122.31 27.77 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -142.14 163.57 32.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.188 -0.945 . . . . 0.0 109.625 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.457 ' N ' ' CD1' ' A' ' 6' ' ' PHE . 1.1 m-85 -111.33 134.29 53.02 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.573 HD23 ' C ' ' A' ' 7' ' ' LEU . 6.0 tt -120.28 121.91 39.7 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.573 ' N ' HD23 ' A' ' 7' ' ' LEU . 68.5 m -115.3 146.74 41.22 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.526 -0.734 . . . . 0.0 109.409 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 tp -152.83 149.65 28.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 109.288 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 t -140.76 165.81 26.47 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.368 -0.833 . . . . 0.0 109.651 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.35 20.87 53.75 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -67.68 136.81 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -1.126 . . . . 0.0 110.333 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t -73.08 -41.36 64.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.379 -0.826 . . . . 0.0 109.542 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -168.89 167.56 10.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.097 -1.002 . . . . 0.0 109.655 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.1 t -98.82 99.61 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.276 -0.89 . . . . 0.0 109.871 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -65.93 -40.68 91.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 108.886 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -168.5 153.44 6.3 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -149.33 107.08 3.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 108.621 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -132.76 152.92 80.75 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.82 5.96 0.91 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.025 1.817 . . . . 0.0 111.438 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -133.25 -2.27 3.15 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.461 -0.774 . . . . 0.0 109.5 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -171.92 130.1 0.64 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.918 . . . . 0.0 108.856 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.85 128.73 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.329 -0.857 . . . . 0.0 109.979 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.2 mt -123.25 121.25 35.42 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.8 mt -129.39 131.63 46.86 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.536 -0.728 . . . . 0.0 109.203 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -96.43 119.42 34.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.985 -1.072 . . . . 0.0 109.582 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.569 ' O ' ' N ' ' A' ' 29' ' ' GLN . 5.2 t -124.2 148.61 47.15 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.538 0.685 . . . . 0.0 110.098 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.401 ' N ' HD13 ' A' ' 28' ' ' ILE . 5.9 mm 54.81 -79.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.783 -0.573 . . . . 0.0 109.541 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 27' ' ' THR . 13.5 pt20 -154.52 -20.61 0.12 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 0.0 110.074 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.06 177.18 32.42 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.0 t -123.0 132.84 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.779 -0.836 . . . . 0.0 109.203 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.7 tp -105.12 126.51 52.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.487 -0.758 . . . . 0.0 108.971 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.3 t -113.6 123.43 49.93 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.5 mt -112.95 130.2 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.73 139.0 53.9 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.3 -153.24 16.09 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -131.25 153.6 49.35 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.503 -0.998 . . . . 0.0 109.312 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt 57.81 56.54 4.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.493 -0.754 . . . . 0.0 109.82 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.8 mp -93.0 71.91 4.68 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.713 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.114 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 . . . . . 0 N--CA 1.499 1.989 0 CA-C-O 121.206 0.526 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.2 t -127.67 135.97 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -129.79 144.36 51.26 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.298 -0.876 . . . . 0.0 109.844 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 54' ' ' GLU . 39.2 t -135.93 160.0 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.632 -0.667 . . . . 0.0 109.79 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.454 ' N ' HG12 ' A' ' 53' ' ' VAL . 22.4 pt-20 -137.79 142.35 40.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.321 -0.862 . . . . 0.0 109.319 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.24 177.23 29.22 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.521 HD23 ' H ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -94.77 142.48 27.42 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.434 -1.039 . . . . 0.0 108.859 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.457 ' CG2' HD23 ' A' ' 60' ' ' LEU . 46.4 mm -89.4 121.38 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.292 -0.88 . . . . 0.0 109.692 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -106.58 -29.59 9.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.457 -0.777 . . . . 0.0 109.429 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.602 ' O ' HD22 ' A' ' 60' ' ' LEU . . . -163.42 147.88 10.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.006 . . . . 0.0 109.933 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.602 HD22 ' O ' ' A' ' 59' ' ' ALA . 1.1 mm? -130.36 131.18 45.22 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 54.4 t -131.99 132.95 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.612 0.72 . . . . 0.0 109.638 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.467 ' O ' ' N ' ' A' ' 64' ' ' LEU . 34.2 t80 -144.47 139.33 15.49 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.98 78.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 120.844 1.03 . . . . 0.0 111.596 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.627 ' CD2' ' H ' ' A' ' 64' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.554 HD21 ' N ' ' B' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.4 mmm-85 -63.12 138.65 58.62 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.22 -0.925 . . . . 0.0 108.651 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' GLN . . . . . 0.53 ' NE2' HD12 ' B' ' 57' ' ' ILE . 25.3 pt20 -146.35 161.17 40.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.252 -0.905 . . . . 0.0 109.491 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -108.95 136.03 49.15 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.586 HD23 ' N ' ' B' ' 8' ' ' SER . 5.7 tt -122.56 120.68 34.53 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' SER . . . . . 0.586 ' N ' HD23 ' B' ' 7' ' ' LEU . 9.2 p -111.42 140.52 45.94 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.576 -0.702 . . . . 0.0 109.303 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.3 tp -148.21 146.49 28.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.259 -0.901 . . . . 0.0 109.505 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.454 HG23 ' O ' ' B' ' 10' ' ' THR . 4.9 t -146.12 117.79 8.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.449 -0.782 . . . . 0.0 109.293 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.24 22.57 0.37 Allowed Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 79.3 t -76.82 132.14 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.084 -1.245 . . . . 0.0 109.775 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -72.83 -43.18 62.98 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.128 -0.983 . . . . 0.0 109.774 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.77 157.89 22.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.961 -1.087 . . . . 0.0 110.088 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 69.6 t -93.17 127.22 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.41 -0.806 . . . . 0.0 109.153 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -96.29 -35.56 11.2 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.97 -1.081 . . . . 0.0 109.368 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 36.4 t -173.06 150.22 1.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 108.85 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' PHE . . . . . 0.418 ' CZ ' HD13 ' B' ' 23' ' ' ILE . 5.7 t80 -143.24 113.44 7.27 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.106 -0.996 . . . . 0.0 109.147 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -126.34 152.73 74.32 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.18 -17.06 54.04 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.669 1.579 . . . . 0.0 111.446 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -114.47 8.21 16.44 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.567 -0.708 . . . . 0.0 109.447 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -171.74 133.37 0.76 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 109.252 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.418 HD13 ' CZ ' ' B' ' 18' ' ' PHE . 96.7 mt -130.65 129.31 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.194 -0.941 . . . . 0.0 109.784 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 72.6 mt -120.88 119.19 31.94 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 87.9 mt -133.46 131.96 40.51 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.476 -0.765 . . . . 0.0 109.49 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -94.28 118.39 31.52 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.016 -1.052 . . . . 0.0 109.156 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.546 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.9 t -124.39 154.25 40.68 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.421 ' C ' ' O ' ' B' ' 27' ' ' THR . 44.3 mt 37.87 -89.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.901 -0.499 . . . . 0.0 110.456 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.546 ' N ' ' O ' ' B' ' 27' ' ' THR . 15.0 pt20 -151.6 46.2 0.79 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.004 -1.06 . . . . 0.0 109.515 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.95 132.28 2.57 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 90.4 t -84.3 131.32 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -1.09 . . . . 0.0 109.262 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 48.9 tp -104.18 125.22 50.3 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 28.7 t -112.35 120.75 42.77 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 83.7 mt -107.3 130.77 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -124.27 138.86 54.35 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.23 -147.89 8.54 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -135.99 143.27 44.72 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.226 -1.161 . . . . 0.0 109.319 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 54.9 61.2 3.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.956 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.529 ' N ' HD12 ' B' ' 39' ' ' LEU . 10.5 mp -92.95 72.31 4.74 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.187 -0.946 . . . . 0.0 108.805 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.492 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.636 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -144.68 148.07 33.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.27 -0.894 . . . . 0.0 109.508 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 53.8 t -127.08 135.58 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -120.79 131.14 54.31 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.537 -0.727 . . . . 0.0 109.185 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.98 179.19 29.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.436 HD23 ' H ' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -97.95 133.78 41.96 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.404 -1.056 . . . . 0.0 109.187 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.53 HD12 ' NE2' ' B' ' 5' ' ' GLN . 90.4 mt -90.15 115.3 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.053 . . . . 0.0 109.706 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -99.49 -14.95 18.86 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.4 -0.813 . . . . 0.0 109.676 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.4 152.43 8.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.977 -1.077 . . . . 0.0 110.365 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.446 HD23 HG21 ' B' ' 57' ' ' ILE . 0.3 OUTLIER -134.93 134.73 40.92 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.35 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.404 HG22 HD12 ' A' ' 64' ' ' LEU . 67.5 t -130.03 123.61 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.455 -0.778 . . . . 0.0 109.05 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.444 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 44.2 t80 -146.02 136.85 12.44 Favored Pre-proline 0 N--CA 1.494 1.753 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' PRO . . . . . 0.444 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 70.9 Cg_endo -74.45 113.73 3.86 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.328 1.352 . . . . 0.0 112.001 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.949 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.409 ' CA ' HD13 ' B' ' 28' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -77.91 144.46 36.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.725 -1.235 . . . . 0.0 108.233 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.576 ' NE2' HD21 ' B' ' 9' ' ' LEU . 39.7 tt0 -146.66 156.23 43.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.121 -0.987 . . . . 0.0 110.263 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -109.13 114.02 27.38 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.525 HD23 ' C ' ' A' ' 7' ' ' LEU . 7.3 tt -113.28 126.47 55.44 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.495 ' N ' HD23 ' A' ' 7' ' ' LEU . 42.0 t -132.1 140.28 48.77 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.401 HD11 HE21 ' B' ' 5' ' ' GLN . 45.0 tp -131.03 148.14 52.71 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 p -125.26 153.38 43.28 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.48 8.54 87.1 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.52 143.84 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.144 -1.209 . . . . 0.0 109.927 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.2 m -73.34 -47.51 41.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.513 -0.742 . . . . 0.0 109.982 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -172.59 172.91 4.13 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.042 -1.036 . . . . 0.0 110.483 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.7 t -101.21 103.83 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -64.1 -40.43 96.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 109.796 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.4 t -158.17 151.87 23.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.341 -0.85 . . . . 0.0 109.323 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -131.14 112.0 12.46 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.57 150.99 77.36 Favored Pre-proline 0 N--CA 1.501 2.114 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.59 -10.63 25.46 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.962 1.775 . . . . 0.0 111.615 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -129.24 11.45 5.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.598 -0.689 . . . . 0.0 109.61 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -169.3 123.2 0.8 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mm -123.2 130.14 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.188 -0.945 . . . . 0.0 109.695 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.2 mt -113.87 129.85 56.55 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.75 124.29 33.11 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.496 -0.753 . . . . 0.0 110.346 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -96.16 123.36 39.75 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' GLN . 2.6 t -125.64 154.04 42.91 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.231 0.539 . . . . 0.0 109.746 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 27' ' ' THR . 46.7 mt 29.3 -85.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-O 121.16 0.505 . . . . 0.0 111.507 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' THR . 13.1 pt20 -144.05 59.54 1.36 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.16 -0.963 . . . . 0.0 110.148 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.9 160.69 28.93 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.0 t -116.35 130.68 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.655 -0.909 . . . . 0.0 109.06 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.449 HD11 HD12 ' A' ' 60' ' ' LEU . 52.3 tp -110.04 126.34 53.88 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.537 -0.727 . . . . 0.0 109.148 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.8 t -110.34 123.13 49.27 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.432 HG12 HD11 ' A' ' 60' ' ' LEU . 96.2 mt -112.39 129.72 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -116.63 140.69 49.11 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.87 -153.98 12.89 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -133.75 146.71 50.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.535 -0.979 . . . . 0.0 109.338 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 55.83 54.98 7.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.72 -0.613 . . . . 0.0 110.159 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.0 mp -90.45 69.15 6.87 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.895 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -178.752 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.223 0.535 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.87 141.19 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.64 148.41 50.38 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.468 0.652 . . . . 0.0 110.085 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 75.4 t -136.97 136.3 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.43 128.86 47.65 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.05 -1.032 . . . . 0.0 108.379 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.67 174.84 32.04 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.421 HD23 ' H ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -98.32 128.13 44.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.556 -0.967 . . . . 0.0 109.467 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.635 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.7 mp -77.5 133.43 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 0.0 109.76 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -112.82 -26.11 8.72 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.603 ' O ' HD22 ' A' ' 60' ' ' LEU . . . -166.88 154.01 9.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.417 -0.802 . . . . 0.0 110.034 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.603 HD22 ' O ' ' A' ' 59' ' ' ALA . 1.1 mm? -131.1 130.36 43.05 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.5 t -134.56 130.95 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.733 0.777 . . . . 0.0 109.788 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.652 ' O ' ' N ' ' A' ' 64' ' ' LEU . 12.6 t80 -144.7 143.24 20.62 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -49.4 76.33 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.636 0 CA-C-N 120.405 1.18 . . . . 0.0 111.915 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.652 ' N ' ' O ' ' A' ' 62' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--N 1.297 -1.703 0 O-C-N 121.363 -0.836 . . . . 0.0 109.034 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.863 HD21 ' N ' ' B' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.602 HH21 ' CD ' ' B' ' 54' ' ' GLU . 10.7 mmm180 -49.66 143.63 6.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.519 -0.738 . . . . 0.0 110.031 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' GLN . . . . . 0.401 HE21 HD11 ' A' ' 9' ' ' LEU . 5.7 pt20 -149.8 162.03 41.07 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.348 0.594 . . . . 0.0 109.476 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -118.18 141.88 48.03 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.579 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.1 tt -131.07 120.26 23.15 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' SER . . . . . 0.566 ' N ' HD23 ' B' ' 7' ' ' LEU . 5.5 m -110.73 146.09 36.91 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.576 HD21 ' NE2' ' A' ' 5' ' ' GLN . 5.4 tp -146.92 139.1 24.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.298 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.15 107.57 7.79 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 146.42 -5.81 1.21 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.57 142.18 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.419 -1.048 . . . . 0.0 110.066 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -72.72 -51.56 18.75 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.665 -0.647 . . . . 0.0 109.629 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.15 160.31 6.29 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.124 -0.985 . . . . 0.0 110.297 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' VAL . . . . . 0.592 HG11 ' CE2' ' B' ' 18' ' ' PHE . 20.6 t -81.39 133.07 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.654 -0.654 . . . . 0.0 109.891 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -88.79 -23.78 22.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.4 -0.813 . . . . 0.0 110.121 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 30.3 t -172.42 151.52 2.5 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.101 -0.999 . . . . 0.0 109.899 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' PHE . . . . . 0.592 ' CE2' HG11 ' B' ' 15' ' ' VAL . 4.5 m-85 -121.93 104.64 9.68 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.628 -0.67 . . . . 0.0 109.886 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.39 139.34 31.11 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.32 -17.4 35.07 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.815 1.677 . . . . 0.0 111.97 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -95.62 -10.75 28.62 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.322 -0.861 . . . . 0.0 109.472 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -174.75 130.01 0.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.66 129.49 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 62.0 mt -110.07 123.53 49.86 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' LEU . . . . . 0.404 HD23 HG13 ' B' ' 15' ' ' VAL . 68.6 mt -119.07 131.12 55.91 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.577 -0.702 . . . . 0.0 109.704 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -83.64 104.97 14.18 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.463 ' O ' ' O ' ' B' ' 28' ' ' ILE . 12.9 t -124.87 169.95 11.55 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.73 0.776 . . . . 0.0 110.751 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' B' ' 27' ' ' THR . 8.0 mt -33.0 154.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.344 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 65.38 -60.51 0.26 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.18 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' B' ' 27' ' ' THR . . . -166.71 -168.13 28.43 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.459 -1.353 . . . . 0.0 109.795 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 15.5 t -86.88 135.37 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.405 -1.056 . . . . 0.0 110.146 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 43.0 tp -101.05 119.99 39.55 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 11.5 m -99.6 127.27 45.69 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 86.8 mt -103.95 126.84 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -118.98 144.47 46.47 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.536 0.684 . . . . 0.0 110.075 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.89 -138.05 4.74 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -138.83 139.58 38.23 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.246 -1.149 . . . . 0.0 109.766 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 46.98 73.8 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.686 -0.634 . . . . 0.0 109.834 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.558 ' N ' HD12 ' B' ' 39' ' ' LEU . 9.1 mp -91.89 71.25 5.61 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.068 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.497 1.906 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -130.26 149.6 51.88 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.45 0.643 . . . . 0.0 109.387 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.32 135.42 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.602 ' CD ' HH21 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -116.83 125.39 51.49 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 55' ' ' GLY . . . . . 0.535 ' N ' ' OE1' ' B' ' 54' ' ' GLU . . . 154.77 176.13 26.66 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.14 132.79 46.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.679 -0.895 . . . . 0.0 109.475 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.621 ' N ' HD12 ' B' ' 57' ' ' ILE . 1.5 mp -87.12 118.81 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.191 -0.943 . . . . 0.0 108.965 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' ASP . . . . . 0.444 ' OD2' ' NE2' ' A' ' 29' ' ' GLN . 2.2 t70 -112.8 -5.64 13.88 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.621 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -169.05 156.55 7.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.419 -0.801 . . . . 0.0 110.338 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.621 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.4 OUTLIER -139.28 135.87 34.3 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 t -129.97 124.18 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.575 0.702 . . . . 0.0 109.308 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.579 ' O ' HD13 ' B' ' 64' ' ' LEU . 36.0 t80 -146.29 138.16 13.36 Favored Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -70.13 104.66 1.41 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.295 1.33 . . . . 0.0 112.167 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.954 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.531 ' N ' HD21 ' A' ' 3' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -64.0 140.06 58.83 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.389 -0.819 . . . . 0.0 108.868 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -154.25 165.44 36.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 0.0 109.881 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -106.09 144.58 32.6 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.609 HD23 ' N ' ' A' ' 8' ' ' SER . 5.6 tt -132.33 121.54 23.69 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.609 ' N ' HD23 ' A' ' 7' ' ' LEU . 4.6 m -114.24 140.97 48.14 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.593 -0.692 . . . . 0.0 109.903 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.584 HD21 ' NE2' ' B' ' 5' ' ' GLN . 4.8 tp -144.79 145.92 31.88 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.8 p -137.23 173.1 12.05 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.371 -0.831 . . . . 0.0 110.102 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 73.51 24.78 74.16 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 12' ' ' VAL . 10.5 p -72.24 130.5 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.254 -1.145 . . . . 0.0 109.817 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -73.03 -43.25 62.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.09 -1.006 . . . . 0.0 109.195 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.25 153.52 4.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 109.591 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.5 t -92.28 117.02 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.848 . . . . 0.0 109.676 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -68.05 -37.44 81.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.48 -0.763 . . . . 0.0 109.508 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.7 t -169.04 169.47 9.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.825 . . . . 0.0 109.456 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.534 ' CD1' HD12 ' A' ' 23' ' ' ILE . 86.3 t80 -145.62 107.18 4.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 109.217 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.484 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -130.03 122.78 20.46 Favored Pre-proline 0 N--CA 1.5 2.035 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.795 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -45.66 -30.9 6.79 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.037 1.158 . . . . 0.0 111.618 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -92.97 -6.37 48.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.28 -0.888 . . . . 0.0 109.969 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.525 ' OE2' ' NZ ' ' A' ' 35' ' ' LYS . 34.2 tt0 -163.82 128.28 2.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 109.549 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.534 HD12 ' CD1' ' A' ' 18' ' ' PHE . 46.6 mm -120.44 130.21 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.482 -0.761 . . . . 0.0 109.57 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.3 mt -117.63 130.56 56.45 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.6 mt -133.36 134.53 43.88 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.476 -0.765 . . . . 0.0 109.851 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -108.9 113.17 25.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.602 -0.686 . . . . 0.0 109.166 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 29' ' ' GLN . 2.6 t -125.24 167.38 14.95 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.411 0.624 . . . . 0.0 110.152 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.7 mm 44.95 -87.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.805 -0.56 . . . . 0.0 110.134 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 27' ' ' THR . 27.8 pt20 -158.77 19.54 0.21 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.974 -1.078 . . . . 0.0 108.837 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.02 169.82 21.96 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.3 t -110.89 130.53 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.748 -0.854 . . . . 0.0 109.267 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.1 tp -110.8 123.15 49.52 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.0 m -110.18 120.31 42.04 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.8 mt -102.9 127.27 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.525 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 68.9 mttm -118.22 138.79 52.09 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.656 0.741 . . . . 0.0 109.318 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.98 -147.15 7.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -140.7 143.73 35.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.304 -1.115 . . . . 0.0 108.864 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.7 mttp 55.86 60.27 3.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.603 -0.685 . . . . 0.0 109.904 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.2 mp -92.59 72.21 5.05 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.493 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -178.811 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.491 ' OE1' ' N ' ' A' ' 50' ' ' GLN . 24.0 mp0 . . . . . 0 N--CA 1.498 1.958 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.66 158.76 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.372 -0.83 . . . . 0.0 109.667 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -141.16 149.28 41.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.296 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -124.88 133.41 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -119.07 125.46 49.36 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.36 -175.52 35.48 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.416 HD23 ' H ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -99.11 130.87 45.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.996 . . . . 0.0 109.225 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.1 mt -86.46 117.45 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.074 -1.016 . . . . 0.0 109.161 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -96.77 -23.82 16.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.456 -0.777 . . . . 0.0 109.143 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -170.1 157.49 6.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.986 . . . . 0.0 110.522 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.408 HD13 HD13 ' B' ' 32' ' ' LEU . 10.4 mt -133.01 139.22 47.12 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.2 t -132.07 115.14 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.511 -0.743 . . . . 0.0 109.628 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 62' ' ' TYR . 25.1 t80 -134.34 113.71 12.3 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.52 123.7 14.37 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 CA-C-N 120.06 1.057 . . . . 0.0 111.03 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.887 ' H ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.062 0 O-C-N 121.128 -0.982 . . . . 0.0 108.712 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 33.2 mmm-85 -74.08 141.35 45.7 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' GLN . . . . . 0.584 ' NE2' HD21 ' A' ' 9' ' ' LEU . 40.1 tt0 -141.36 147.11 37.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.305 -0.872 . . . . 0.0 109.375 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -117.23 131.55 56.82 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.509 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.1 tt -118.08 124.44 48.07 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' SER . . . . . 0.467 ' N ' HD23 ' B' ' 7' ' ' LEU . 78.3 p -115.57 134.67 54.84 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.537 0.684 . . . . 0.0 109.625 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 tp -146.43 143.66 29.16 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -131.26 156.86 44.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.436 -0.79 . . . . 0.0 109.277 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.75 53.9 3.24 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -92.51 139.21 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.088 -1.242 . . . . 0.0 109.833 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -71.7 -42.38 67.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.952 . . . . 0.0 109.136 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -171.73 166.2 6.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.149 -0.969 . . . . 0.0 110.113 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 73.3 t -93.59 99.01 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.331 -0.856 . . . . 0.0 109.13 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -65.5 -40.0 92.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -0.868 . . . . 0.0 109.419 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -169.69 145.48 3.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.13 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -134.52 108.33 8.04 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.533 -0.73 . . . . 0.0 109.672 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -133.81 148.85 70.05 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.61 -12.4 31.22 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 121.706 1.604 . . . . 0.0 111.147 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -104.67 -7.84 19.31 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.522 -0.736 . . . . 0.0 109.539 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -173.74 140.63 0.78 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.463 -0.773 . . . . 0.0 109.158 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.2 130.1 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.383 -0.823 . . . . 0.0 110.438 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.405 ' CD2' ' OG ' ' B' ' 33' ' ' SER . 13.5 mt -122.03 125.41 46.21 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 65.4 mt -132.18 131.62 42.38 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.504 -0.748 . . . . 0.0 109.135 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -88.75 118.75 28.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.895 -1.128 . . . . 0.0 108.602 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.566 ' O ' ' N ' ' B' ' 29' ' ' GLN . 2.2 t -123.8 153.66 40.66 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.709 -0.619 . . . . 0.0 109.974 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' B' ' 27' ' ' THR . 54.8 mt 34.01 -86.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.168 0.509 . . . . 0.0 110.665 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' B' ' 27' ' ' THR . 18.9 pt20 -150.61 39.41 0.72 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.046 -1.034 . . . . 0.0 109.615 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -161.22 130.38 2.33 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 69.7 t -83.42 132.96 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.438 -1.037 . . . . 0.0 109.481 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.408 HD13 HD13 ' A' ' 60' ' ' LEU . 43.5 tp -107.48 128.54 54.59 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.405 ' OG ' ' CD2' ' B' ' 24' ' ' LEU . 25.1 m -111.16 125.49 53.84 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.3 0.572 . . . . 0.0 109.582 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 93.2 mt -106.77 129.86 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -124.72 138.3 54.3 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.467 0.651 . . . . 0.0 109.453 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.57 -146.37 11.29 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -140.51 157.45 45.48 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.281 -1.129 . . . . 0.0 109.624 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.48 57.0 5.17 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.552 0.691 . . . . 0.0 109.783 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.542 ' N ' HD12 ' B' ' 39' ' ' LEU . 8.8 mp -91.7 70.62 5.75 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 C-N-CA 120.305 -0.95 . . . . 0.0 110.941 -178.544 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t . . . . . 0 N--CA 1.499 1.991 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -128.74 148.87 50.88 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 76.3 t -122.64 134.1 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -120.79 134.97 55.27 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.602 -0.686 . . . . 0.0 109.287 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.97 171.84 18.79 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.459 HD23 ' H ' ' B' ' 56' ' ' LEU . 0.1 OUTLIER -87.07 126.13 34.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.368 -1.078 . . . . 0.0 108.768 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.0 mt -88.56 113.08 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.078 -1.014 . . . . 0.0 109.184 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -94.26 -13.82 26.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.453 -0.78 . . . . 0.0 109.559 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -172.14 155.83 3.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.026 -1.046 . . . . 0.0 110.55 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.413 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 14.2 mt -138.62 142.77 39.11 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.402 HG22 HD12 ' A' ' 64' ' ' LEU . 54.1 t -135.72 126.91 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.415 -0.803 . . . . 0.0 109.382 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' B' ' 64' ' ' LEU . 12.0 t80 -141.07 135.89 15.6 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -42.89 82.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.69 1.593 . . . . 0.0 112.722 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.633 ' C ' HD23 ' B' ' 64' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.3 -1.545 0 O-C-N 121.181 -0.95 . . . . 0.0 108.485 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 121.772 0.796 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.4 mmm-85 -81.26 139.42 35.47 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -139.74 163.33 32.89 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.02 -1.05 . . . . 0.0 110.436 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.412 ' CD2' ' HG2' ' A' ' 54' ' ' GLU . 36.7 m-85 -108.73 127.07 53.68 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.301 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.459 HD23 ' C ' ' A' ' 7' ' ' LEU . 6.2 tt -125.71 119.88 29.17 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.416 ' N ' HD23 ' A' ' 7' ' ' LEU . 34.9 t -129.31 151.43 49.97 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.572 0.701 . . . . 0.0 109.927 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.4 tp -142.91 155.72 44.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.429 -0.794 . . . . 0.0 109.549 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.4 p -69.21 170.24 10.53 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.732 0.777 . . . . 0.0 110.804 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -40.07 117.11 0.82 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.572 HG22 ' N ' ' A' ' 13' ' ' SER . 9.1 p -83.51 165.84 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.693 -0.886 . . . . 0.0 110.417 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 12' ' ' VAL . 69.7 m -72.82 -45.43 58.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.0 109.313 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.17 145.12 1.71 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.069 -1.019 . . . . 0.0 109.831 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 80.6 t -89.88 128.24 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.195 -0.941 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -86.55 -22.42 26.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.464 -0.772 . . . . 0.0 110.033 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 t -172.26 157.16 4.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.968 -1.082 . . . . 0.0 109.837 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.484 ' C ' ' CD1' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -145.9 105.2 3.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 109.566 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -134.61 147.47 63.37 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.8 -13.68 34.91 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.372 2.048 . . . . 0.0 110.807 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -100.88 -4.63 27.4 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.407 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -178.81 143.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.6 mt -134.53 131.44 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.092 -1.005 . . . . 0.0 109.407 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.3 mt -112.08 127.97 56.06 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.4 mt -124.88 128.05 48.06 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.614 -0.679 . . . . 0.0 109.626 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -103.46 117.0 33.45 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 29' ' ' GLN . 5.5 t -124.03 150.09 45.33 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.945 0.879 . . . . 0.0 110.705 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.4 HD11 ' O ' ' B' ' 3' ' ' ASN . 61.4 mt 47.52 -83.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.359 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.4 pt20 -144.6 -23.04 0.52 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.118 -0.989 . . . . 0.0 109.691 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.6 170.15 32.11 Favored Glycine 0 N--CA 1.498 2.816 0 O-C-N 120.912 -1.118 . . . . 0.0 111.156 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.1 t -120.04 133.5 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.769 -0.842 . . . . 0.0 109.525 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.8 tp -110.12 124.5 51.64 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.4 m -110.64 124.04 51.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.546 -0.721 . . . . 0.0 109.737 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.5 mt -107.75 131.55 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -126.81 139.49 53.07 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.673 0.749 . . . . 0.0 109.456 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.92 -155.71 25.83 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -132.06 148.34 52.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.622 -0.928 . . . . 0.0 109.118 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 61.72 54.6 2.9 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.939 0.876 . . . . 0.0 109.403 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.1 mp -93.2 71.94 4.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.334 -0.854 . . . . 0.0 108.836 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.622 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.643 0.735 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.6 t -120.63 136.98 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.433 0.635 . . . . 0.0 109.359 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -111.86 146.7 37.25 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.4 t -134.11 136.02 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -125.05 134.75 52.41 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.126 0.965 . . . . 0.0 109.535 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.549 ' N ' ' OE1' ' A' ' 54' ' ' GLU . . . 155.37 174.41 25.22 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.401 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -95.44 139.47 31.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.607 -0.937 . . . . 0.0 109.643 -179.639 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.5 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.5 mp -93.2 111.92 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 108.768 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -98.54 -22.83 15.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.588 -0.695 . . . . 0.0 109.403 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.27 149.45 11.97 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.829 -1.169 . . . . 0.0 110.705 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.432 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 67.4 mt -133.29 135.34 44.82 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 49.2 t -135.55 123.35 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.75 0.786 . . . . 0.0 109.303 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.518 ' O ' HD13 ' A' ' 64' ' ' LEU . 22.8 t80 -137.24 142.13 36.72 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.49 111.65 2.85 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.708 1.605 . . . . 0.0 112.432 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.86 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.4 ' O ' HD11 ' A' ' 28' ' ' ILE . 6.9 p30 . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 121.497 0.665 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 34.1 mmm-85 -77.59 139.6 39.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.065 -1.022 . . . . 0.0 109.869 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' GLN . . . . . 0.422 ' NE2' ' OG1' ' A' ' 27' ' ' THR . 33.6 mt-30 -139.16 156.65 46.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.474 -0.766 . . . . 0.0 109.468 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -112.04 133.91 53.92 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.431 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.1 tt -118.25 125.03 49.3 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 96.2 p -112.71 145.47 40.44 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.829 0.823 . . . . 0.0 109.988 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.2 tp -156.88 156.33 32.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.515 -0.741 . . . . 0.0 109.358 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.9 t -150.44 158.5 44.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.5 -0.75 . . . . 0.0 110.138 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.68 15.21 73.85 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.0 p -54.75 149.53 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -1.188 . . . . 0.0 110.254 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 3.2 t -73.06 -44.01 61.16 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -172.5 166.59 5.64 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.131 -0.981 . . . . 0.0 110.37 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 88.2 t -96.67 99.75 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.543 -0.723 . . . . 0.0 109.145 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -65.28 -48.39 73.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.509 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 32.1 t -168.82 129.26 1.16 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.05 -1.031 . . . . 0.0 109.409 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -112.34 117.27 32.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.51 -0.744 . . . . 0.0 109.276 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.02 151.16 77.43 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.66 -13.41 29.79 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.31 2.006 . . . . 0.0 111.62 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -115.5 -0.38 13.1 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.431 -0.793 . . . . 0.0 109.197 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.83 138.91 1.86 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 109.078 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.56 130.91 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.332 -0.855 . . . . 0.0 110.297 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 19.0 mt -122.2 123.3 41.18 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.479 0.657 . . . . 0.0 109.567 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 94.6 mt -132.41 132.6 42.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.684 -0.635 . . . . 0.0 110.121 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -89.06 121.69 31.65 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.562 ' O ' ' N ' ' B' ' 29' ' ' GLN . 6.8 t -124.89 154.89 40.39 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.479 0.657 . . . . 0.0 110.191 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.424 ' C ' ' O ' ' B' ' 27' ' ' THR . 24.8 mm 30.77 -84.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.578 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' B' ' 27' ' ' THR . 26.2 pt20 -147.03 48.65 1.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.873 -1.142 . . . . 0.0 109.191 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.06 167.31 39.37 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 53.4 t -117.09 134.6 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.384 -1.068 . . . . 0.0 110.155 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 48.1 tp -106.07 125.91 51.57 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 18.4 t -111.67 127.55 55.8 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.579 0.704 . . . . 0.0 109.313 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 81.8 mt -106.84 131.28 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.372 0.606 . . . . 0.0 109.387 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -123.64 142.1 51.37 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.554 0.692 . . . . 0.0 109.463 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.38 -148.56 18.34 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -130.58 147.98 52.32 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.475 -1.015 . . . . 0.0 110.048 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt 61.07 52.11 4.17 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.807 0.813 . . . . 0.0 109.495 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.565 ' N ' HD12 ' B' ' 39' ' ' LEU . 7.5 mp -91.41 72.02 6.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.874 . . . . 0.0 109.287 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' GLY . . . . . 0.421 ' O ' ' OE1' ' B' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -118.25 136.89 53.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.762 -0.586 . . . . 0.0 109.569 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 53.9 t -127.88 132.03 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' B' ' 54' ' ' GLU . 2.6 mp0 -116.17 145.69 42.89 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.854 0.835 . . . . 0.0 110.205 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.39 170.28 22.1 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.4 ' H ' HD23 ' B' ' 56' ' ' LEU . 0.2 OUTLIER -97.79 110.8 23.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.533 -0.98 . . . . 0.0 108.956 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.618 ' N ' HD12 ' B' ' 57' ' ' ILE . 2.1 mp -75.93 122.33 29.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.059 -1.026 . . . . 0.0 108.957 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -105.04 -22.38 13.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.541 -0.725 . . . . 0.0 109.131 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.22 150.82 16.86 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.75 -1.219 . . . . 0.0 110.659 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 17.2 mt -132.99 146.77 52.07 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.422 -0.799 . . . . 0.0 109.677 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 55.9 t -137.7 115.69 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.364 -0.835 . . . . 0.0 110.233 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.432 ' CG ' ' HB2' ' A' ' 60' ' ' LEU . 59.1 t80 -138.26 104.11 7.94 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -43.32 105.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.209 1.939 . . . . 0.0 112.428 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 1.0 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.503 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 p30 . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.5 mmm-85 -69.21 142.58 54.21 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.291 -0.88 . . . . 0.0 108.916 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -145.94 150.32 35.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.0 109.674 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.527 ' CD2' ' OE1' ' A' ' 54' ' ' GLU . 77.1 m-85 -103.12 145.25 30.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.565 -0.71 . . . . 0.0 109.3 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.46 HD23 ' C ' ' A' ' 7' ' ' LEU . 7.0 tt -140.8 124.25 16.8 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.457 ' N ' HD23 ' A' ' 7' ' ' LEU . 41.3 t -128.98 135.36 48.87 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.28 -0.887 . . . . 0.0 108.742 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.0 tp -146.48 154.34 41.46 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.077 -1.014 . . . . 0.0 109.336 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 t -144.0 164.24 31.19 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.256 -0.903 . . . . 0.0 109.383 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.68 18.53 51.43 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.9 t -66.25 137.71 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.284 -1.127 . . . . 0.0 110.236 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 m -72.19 -42.93 65.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.549 -0.719 . . . . 0.0 109.929 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.92 160.65 10.31 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.881 -1.137 . . . . 0.0 110.343 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.6 t -93.08 129.15 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.499 -0.75 . . . . 0.0 110.222 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -100.06 -35.69 9.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.436 -0.79 . . . . 0.0 108.939 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.0 t -173.02 144.3 1.24 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 0.0 109.559 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -129.81 107.83 9.7 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -133.67 148.99 70.8 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.94 -11.71 31.13 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.839 1.693 . . . . 0.0 111.792 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -108.97 -5.63 16.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.343 -0.848 . . . . 0.0 110.149 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -172.01 127.4 0.59 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.977 -1.077 . . . . 0.0 108.936 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.47 126.83 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.259 -0.901 . . . . 0.0 109.459 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.9 mt -118.79 110.76 17.62 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.1 mt -129.81 132.56 46.54 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.256 -0.903 . . . . 0.0 109.143 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -94.12 113.58 25.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.237 -0.914 . . . . 0.0 109.899 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 28' ' ' ILE . 4.4 t -124.36 147.67 48.05 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.835 0.826 . . . . 0.0 109.615 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.457 ' C ' ' O ' ' A' ' 27' ' ' THR . 37.4 mt 21.0 -96.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.238 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.411 ' CG ' ' O ' ' B' ' 57' ' ' ILE . 20.9 mm100 -46.62 -73.76 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.494 -0.754 . . . . 0.0 111.596 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.96 -143.83 3.78 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 119.573 -1.298 . . . . 0.0 111.473 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 t -89.31 134.97 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.65 -0.912 . . . . 0.0 111.39 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.0 tp -112.82 120.46 41.54 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.1 m -108.73 124.55 50.73 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.6 mt -112.45 130.41 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -117.47 143.72 45.76 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.578 -0.701 . . . . 0.0 109.65 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.94 -148.34 13.59 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -136.29 152.05 50.28 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.316 -1.108 . . . . 0.0 109.517 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 54' ' ' GLU . 53.5 mtmt 56.16 52.11 10.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.552 -0.718 . . . . 0.0 110.142 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.5 mp -92.32 72.49 5.3 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.104 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.369 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.9 t -116.15 131.86 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -118.86 130.51 55.78 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.8 t -127.34 133.89 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.501 -0.749 . . . . 0.0 109.068 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.527 ' OE1' ' CD2' ' A' ' 6' ' ' PHE . 17.3 tp10 -122.05 137.31 54.85 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 155.0 173.37 23.69 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.487 HD23 ' H ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -96.91 140.55 31.29 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.416 -1.049 . . . . 0.0 109.599 -179.719 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.536 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.7 mp -97.24 116.48 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.372 -0.83 . . . . 0.0 108.953 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -95.12 -18.97 20.5 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -171.42 151.45 3.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 0.0 109.764 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 mt -126.7 137.29 53.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.505 -0.747 . . . . 0.0 109.11 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.3 t -133.94 127.22 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.366 -0.834 . . . . 0.0 109.088 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.565 ' O ' ' N ' ' A' ' 64' ' ' LEU . 48.0 t80 -138.22 107.96 8.06 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -45.26 81.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.739 1.626 . . . . 0.0 112.479 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.946 HD12 HG22 ' B' ' 61' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 O-C-N 120.371 -1.456 . . . . 0.0 108.958 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.536 ' ND2' ' N ' ' B' ' 3' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -72.41 134.39 45.38 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.212 -0.93 . . . . 0.0 109.393 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -148.89 163.44 37.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.239 -0.913 . . . . 0.0 109.769 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -104.31 148.74 26.03 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.446 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.1 tt -135.64 118.66 16.4 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 28.6 t -111.49 131.08 55.48 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.428 -0.795 . . . . 0.0 109.335 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 tp -148.85 153.86 38.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.96 -1.088 . . . . 0.0 110.059 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 12.7 t -154.45 -167.03 2.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.829 . . . . 0.0 109.529 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.59 19.52 62.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.4 145.26 13.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.283 -1.128 . . . . 0.0 110.15 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 24.1 m -71.97 -43.13 65.67 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.27 -0.893 . . . . 0.0 108.941 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' LYS . . . . . 0.426 ' HB2' ' HZ2' ' B' ' 14' ' ' LYS . 0.0 OUTLIER -171.17 159.6 5.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.349 -0.844 . . . . 0.0 109.501 179.44 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.15 107.33 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.162 -0.961 . . . . 0.0 109.935 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -66.14 -40.57 90.71 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.239 -0.913 . . . . 0.0 109.067 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 23.1 t -172.26 162.42 5.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.09 -1.006 . . . . 0.0 109.147 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -140.25 110.41 6.57 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.327 -0.858 . . . . 0.0 109.76 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.97 148.01 67.72 Favored Pre-proline 0 N--CA 1.495 1.779 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.67 -9.81 27.07 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.851 1.701 . . . . 0.0 111.996 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -118.19 7.52 12.14 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.547 -0.721 . . . . 0.0 109.776 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -171.05 132.45 0.84 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.932 . . . . 0.0 109.194 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 47.0 mm -121.75 125.88 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.475 -0.765 . . . . 0.0 109.279 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 74.5 mt -119.89 113.14 20.12 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -131.64 140.31 49.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.329 -0.857 . . . . 0.0 109.303 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -107.63 117.77 34.98 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.569 ' O ' ' N ' ' B' ' 29' ' ' GLN . 3.7 t -125.01 153.01 43.48 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.417 0.627 . . . . 0.0 110.041 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.406 ' N ' HD13 ' B' ' 28' ' ' ILE . 5.4 mm 53.39 -78.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.872 -0.518 . . . . 0.0 110.193 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' B' ' 27' ' ' THR . 22.0 pt20 -169.5 52.4 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -171.53 140.08 5.69 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 92.4 t -84.27 132.48 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.378 -1.072 . . . . 0.0 109.515 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.428 HD11 HD12 ' B' ' 60' ' ' LEU . 47.6 tp -111.26 123.12 49.56 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 24.0 m -109.87 119.63 39.96 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.325 -0.859 . . . . 0.0 109.076 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 95.9 mt -109.91 129.31 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -117.86 137.46 52.76 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.92 -152.72 10.4 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -134.22 145.37 49.11 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.307 -1.114 . . . . 0.0 109.608 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' B' ' 54' ' ' GLU . 72.4 mmtt 59.43 52.02 6.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.568 -0.707 . . . . 0.0 110.058 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.555 ' N ' HD12 ' B' ' 39' ' ' LEU . 10.4 mp -88.45 72.04 8.91 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.952 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -178.547 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -122.04 147.35 46.2 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -126.69 135.33 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' B' ' 38' ' ' LYS . 47.7 tt0 -119.2 133.03 55.99 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.86 -178.69 34.04 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.03 126.43 50.2 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.451 -1.029 . . . . 0.0 109.806 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.554 ' N ' HD12 ' B' ' 57' ' ' ILE . 1.4 mp -76.9 126.1 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.962 . . . . 0.0 109.198 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -104.95 -23.28 13.0 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.618 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -169.26 153.28 5.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.055 -1.028 . . . . 0.0 110.019 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.618 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.9 OUTLIER -131.19 134.16 46.22 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.479 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.946 HG22 HD12 ' A' ' 64' ' ' LEU . 4.1 t -135.43 124.72 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.786 -0.571 . . . . 0.0 110.033 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.463 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 17.9 t80 -144.19 140.32 16.77 Favored Pre-proline 0 N--CA 1.493 1.712 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 63' ' ' PRO . . . . . 0.463 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 72.6 Cg_endo -74.46 108.48 2.7 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.538 1.492 . . . . 0.0 112.082 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.96 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.535 -0.728 . . . . 0.0 109.164 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.457 ' N ' HD21 ' A' ' 3' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 41.5 mmm-85 -60.48 141.29 56.65 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.327 -0.858 . . . . 0.0 108.785 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -152.19 161.93 41.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.125 -0.984 . . . . 0.0 109.917 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 6' ' ' PHE . 1.2 m-85 -117.89 139.62 50.87 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.493 HD23 ' C ' ' A' ' 7' ' ' LEU . 7.2 tt -115.8 126.06 53.52 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.393 -0.817 . . . . 0.0 108.996 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.476 ' N ' HD23 ' A' ' 7' ' ' LEU . 32.4 t -115.25 126.75 54.9 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.4 tp -144.63 151.77 39.5 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 t -143.15 166.84 23.56 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.278 -0.889 . . . . 0.0 109.631 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.4 10.95 67.33 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -69.97 145.23 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -1.219 . . . . 0.0 110.028 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 m -73.87 -51.97 14.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.361 -0.837 . . . . 0.0 109.529 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.43 ' HZ2' ' HB2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -167.37 158.69 11.88 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.067 -1.021 . . . . 0.0 109.619 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.7 t -89.27 116.01 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.268 -0.895 . . . . 0.0 109.403 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -69.19 -40.89 77.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 109.7 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.1 t -161.83 125.28 3.14 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.369 -0.832 . . . . 0.0 109.844 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -109.25 110.19 21.32 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -133.61 148.05 67.07 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.16 -20.1 50.14 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.715 1.61 . . . . 0.0 111.604 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -100.14 -5.44 27.79 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.341 -0.849 . . . . 0.0 109.671 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.403 ' OE2' ' NZ ' ' A' ' 35' ' ' LYS . 36.2 tt0 -171.32 142.91 1.77 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.208 -0.932 . . . . 0.0 109.603 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.8 mt -131.2 130.04 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.715 -0.616 . . . . 0.0 109.497 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.8 mt -117.28 125.75 51.61 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.3 mt -121.1 130.09 53.59 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.591 -0.693 . . . . 0.0 109.647 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.403 ' HG2' HG22 ' A' ' 31' ' ' VAL . 29.4 mt-10 -97.68 103.54 15.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.357 -0.839 . . . . 0.0 110.011 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 28' ' ' ILE . 6.6 t -127.18 -172.47 2.66 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.951 0.882 . . . . 0.0 110.562 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' THR . 4.2 mt -31.84 154.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.924 0.868 . . . . 0.0 111.244 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 64.49 -56.17 0.26 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.646 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -173.4 -129.48 1.16 Allowed Glycine 0 N--CA 1.487 2.059 0 C-N-CA 119.234 -1.46 . . . . 0.0 109.944 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.403 HG22 ' HG2' ' A' ' 26' ' ' GLU . 52.7 t -120.72 136.14 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.778 0.799 . . . . 0.0 110.862 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.9 tp -104.61 126.85 52.09 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -100.8 125.51 47.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.632 -0.668 . . . . 0.0 109.512 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.3 mt -111.3 128.54 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-O 121.294 0.569 . . . . 0.0 109.513 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.403 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 68.5 mttm -128.27 144.24 51.11 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.453 0.644 . . . . 0.0 109.629 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.9 -137.69 4.31 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -132.57 153.3 51.13 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.193 -1.181 . . . . 0.0 110.232 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 54' ' ' GLU . 98.9 mttt 49.72 40.64 20.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.619 -0.676 . . . . 0.0 110.135 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.3 mp -68.51 72.23 0.21 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 0.0 109.244 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.676 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.869 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 52' ' ' GLU . 40.6 t -131.44 161.16 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.56 -0.712 . . . . 0.0 109.231 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.483 ' N ' HG12 ' A' ' 51' ' ' VAL . 92.5 mt-10 -132.83 160.03 38.1 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.529 0.681 . . . . 0.0 109.673 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 t -128.84 157.82 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 38' ' ' LYS . 32.1 tt0 -135.37 134.56 39.89 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.6 172.14 13.18 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 pp -97.46 134.94 40.03 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.438 -1.037 . . . . 0.0 109.169 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.3 mp -84.95 113.69 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.845 -1.16 . . . . 0.0 108.664 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -98.74 -22.19 16.0 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -159.47 148.57 18.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.315 -0.866 . . . . 0.0 110.298 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.49 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 51.5 mt -133.97 146.36 50.38 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.5 t -146.53 114.83 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.059 -1.025 . . . . 0.0 109.869 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.532 ' O ' ' N ' ' A' ' 64' ' ' LEU . 13.8 t80 -130.28 142.52 45.73 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.87 85.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.34 1.36 . . . . 0.0 111.916 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.647 ' O ' HD23 ' A' ' 64' ' ' LEU . 2.1 tt . . . . . 0 N--CA 1.492 1.653 0 O-C-N 120.817 -1.177 . . . . 0.0 108.525 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.565 ' ND2' ' N ' ' B' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 43.5 mmm-85 -89.39 131.46 35.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.964 -1.085 . . . . 0.0 109.128 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -144.52 159.01 43.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.288 -0.882 . . . . 0.0 109.903 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.9 115.17 29.65 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.437 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.6 tt -113.8 126.77 55.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.407 -0.808 . . . . 0.0 109.061 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 8' ' ' SER . . . . . 0.401 ' N ' HD23 ' B' ' 7' ' ' LEU . 40.7 t -132.47 143.76 50.0 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.418 ' O ' HG12 ' B' ' 51' ' ' VAL . 52.0 tp -133.64 150.09 51.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.527 -0.733 . . . . 0.0 109.154 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.6 p -129.3 171.12 12.8 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.704 -0.623 . . . . 0.0 109.35 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.52 5.46 63.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.04 135.32 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.339 -1.095 . . . . 0.0 109.695 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.3 t -72.56 -46.12 55.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 109.55 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.03 160.78 5.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.179 -0.95 . . . . 0.0 109.55 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 90.4 t -93.6 121.27 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.189 -0.944 . . . . 0.0 109.218 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -66.7 -40.03 88.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 109.545 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 47.7 t -162.43 149.77 13.75 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.43 -0.794 . . . . 0.0 108.889 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -136.24 117.85 14.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.377 -0.827 . . . . 0.0 109.491 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -132.45 150.81 76.94 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.06 -13.81 41.19 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.502 1.468 . . . . 0.0 111.07 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -118.2 3.12 12.01 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.749 -0.594 . . . . 0.0 109.603 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -170.03 134.43 1.27 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.269 -0.894 . . . . 0.0 109.409 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.2 mt -132.24 129.54 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.279 -0.888 . . . . 0.0 109.46 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 74.8 mt -112.34 125.64 54.41 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 87.1 mt -113.21 132.44 55.5 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.53 -0.731 . . . . 0.0 110.121 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -104.66 101.12 10.77 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.567 ' O ' ' N ' ' B' ' 29' ' ' GLN . 0.0 OUTLIER -108.73 148.86 29.84 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.822 -0.549 . . . . 0.0 110.447 -178.353 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' B' ' 27' ' ' THR . 39.9 mt 34.2 -86.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 122.151 -0.343 . . . . 0.0 110.83 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.567 ' N ' ' O ' ' B' ' 27' ' ' THR . 18.5 pt20 -137.49 -16.05 1.38 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.382 -0.824 . . . . 0.0 109.738 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.32 167.85 29.21 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 54.6 t -123.1 131.51 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 43.5 tp -110.76 126.18 54.32 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 19.1 t -106.69 122.8 47.08 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 94.9 mt -105.73 129.29 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -124.13 141.39 52.09 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.628 -0.67 . . . . 0.0 109.379 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.23 -153.42 22.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -121.45 150.85 40.95 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.571 -0.958 . . . . 0.0 109.847 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' B' ' 54' ' ' GLU . 95.3 mttt 51.93 61.68 3.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -0.8 . . . . 0.0 110.124 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.406 ' N ' HD12 ' B' ' 39' ' ' LEU . 9.2 mp -93.05 71.56 4.63 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.764 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -179.11 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.418 HG12 ' O ' ' B' ' 9' ' ' LEU . 2.2 p . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 121.563 0.696 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -122.1 149.78 43.1 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 10.2 t -141.45 138.22 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.163 -0.961 . . . . 0.0 109.545 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' B' ' 38' ' ' LYS . 16.0 tt0 -127.62 137.59 52.59 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.61 178.36 26.29 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.82 124.46 45.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.572 -0.958 . . . . 0.0 108.929 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.586 ' N ' HD12 ' B' ' 57' ' ' ILE . 1.5 mp -82.82 119.25 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.181 -0.949 . . . . 0.0 108.895 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -95.26 -21.46 18.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.386 -0.821 . . . . 0.0 109.488 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -170.29 153.5 4.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.117 -0.989 . . . . 0.0 109.8 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.413 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 96.2 mt -134.04 136.58 44.11 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 56.7 t -132.64 124.81 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.554 -0.716 . . . . 0.0 109.459 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.49 ' CG ' ' HB2' ' A' ' 60' ' ' LEU . 19.4 t80 -133.01 139.71 35.3 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 63' ' ' PRO . . . . . 0.477 ' O ' ' C ' ' B' ' 64' ' ' LEU . 71.6 Cg_exo -44.5 -65.49 0.19 Allowed 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 122.026 1.818 . . . . 0.0 115.294 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.835 ' O ' HD13 ' B' ' 64' ' ' LEU . 2.0 tm? . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.622 0.725 . . . . 0.0 111.002 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.6 p30 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.343 0.592 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.431 ' NE ' ' OE2' ' A' ' 54' ' ' GLU . 40.1 mmm-85 -71.23 147.89 47.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 109.126 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -141.37 156.86 45.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.187 -0.945 . . . . 0.0 109.996 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.51 ' CE1' ' OE1' ' A' ' 54' ' ' GLU . 69.6 m-85 -107.21 125.74 51.51 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.468 HD23 ' C ' ' A' ' 7' ' ' LEU . 7.3 tt -117.92 124.97 49.56 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.423 ' N ' HD23 ' A' ' 7' ' ' LEU . 44.2 t -115.94 135.1 54.3 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.639 -0.663 . . . . 0.0 109.633 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.4 tp -145.4 148.95 33.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.442 -0.786 . . . . 0.0 109.565 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 p -142.76 -163.14 1.56 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.81 . . . . 0.0 109.717 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.62 17.97 7.2 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.65 141.72 16.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.165 -1.197 . . . . 0.0 109.939 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.2 m -71.43 -45.16 63.39 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.53 154.68 0.8 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.186 -0.946 . . . . 0.0 110.384 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.0 t -77.2 132.32 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.544 -0.722 . . . . 0.0 110.382 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.526 ' OE1' HG21 ' A' ' 31' ' ' VAL . 45.3 tt0 -98.5 -34.66 10.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.49 -0.756 . . . . 0.0 108.968 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 p -161.54 163.28 30.27 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.016 -1.053 . . . . 0.0 109.683 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -148.96 104.77 3.47 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -133.85 125.85 18.5 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -47.14 -22.51 2.29 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.857 1.705 . . . . 0.0 111.868 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -94.25 -9.01 37.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.578 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -174.32 143.28 0.85 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 109.315 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.1 mt -128.38 131.35 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.353 -0.842 . . . . 0.0 109.007 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.1 mt -116.69 115.71 26.18 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.2 mt -117.79 130.43 56.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.569 -0.707 . . . . 0.0 109.637 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.07 103.16 11.5 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 28' ' ' ILE . 7.0 t -124.28 -177.96 3.95 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.586 0.708 . . . . 0.0 110.132 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 27' ' ' THR . 3.8 mt -31.91 153.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.765 0.793 . . . . 0.0 110.847 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 64.05 -63.26 0.15 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.504 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -161.85 -123.18 0.65 Allowed Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.191 -1.48 . . . . 0.0 110.014 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.526 HG21 ' OE1' ' A' ' 16' ' ' GLN . 55.8 t -120.58 135.88 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.668 -0.901 . . . . 0.0 109.727 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.7 tp -100.27 125.23 46.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.603 -0.685 . . . . 0.0 109.205 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.1 m -104.47 121.57 43.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 0.0 108.94 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.9 mt -110.73 127.42 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -117.48 147.96 42.27 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.453 0.644 . . . . 0.0 110.1 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.95 -149.65 12.14 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -136.38 145.92 45.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.346 -1.09 . . . . 0.0 109.472 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 54.99 57.65 5.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.545 -0.722 . . . . 0.0 110.092 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.6 mp -89.65 71.73 7.8 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.132 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.038 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.2 t -126.94 134.66 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.574 -0.704 . . . . 0.0 109.261 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -118.41 153.01 34.79 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.716 -0.615 . . . . 0.0 109.624 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.7 t -124.66 135.56 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.51 ' OE1' ' CE1' ' A' ' 6' ' ' PHE . 16.4 tp10 -113.38 127.12 56.02 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.56 169.06 21.58 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -90.91 140.8 29.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.415 -1.05 . . . . 0.0 109.744 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.435 ' CG2' HD23 ' A' ' 60' ' ' LEU . 92.9 mt -93.82 115.17 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.991 -1.068 . . . . 0.0 109.714 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -98.64 -24.21 15.17 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.82 151.81 18.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.903 -1.123 . . . . 0.0 111.091 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.435 HD23 ' CG2' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -130.1 131.7 45.84 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.249 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 54.9 t -129.75 128.88 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.682 0.753 . . . . 0.0 109.588 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 64' ' ' LEU . 12.0 t80 -144.9 142.13 18.27 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -49.08 78.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.589 1.526 . . . . 0.0 111.968 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.638 HD23 ' C ' ' A' ' 64' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.302 -1.472 0 O-C-N 121.38 -0.825 . . . . 0.0 109.193 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -85.31 138.54 32.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.087 -1.008 . . . . 0.0 109.458 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -141.8 153.22 44.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 109.898 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -108.12 119.23 38.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.564 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.4 tt -108.09 121.67 45.3 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 8' ' ' SER . . . . . 0.545 ' N ' HD23 ' B' ' 7' ' ' LEU . 8.2 p -114.78 137.25 52.17 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.354 0.597 . . . . 0.0 109.995 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.8 tp -149.3 148.31 29.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.546 -0.721 . . . . 0.0 109.306 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -142.42 164.59 29.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.274 -0.891 . . . . 0.0 110.256 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.98 21.02 58.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 p -59.5 142.29 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.117 -1.225 . . . . 0.0 110.432 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 15.1 m -72.86 -39.99 66.04 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -172.26 163.91 5.83 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.12 -0.988 . . . . 0.0 110.01 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 85.7 t -96.84 99.8 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.425 -0.797 . . . . 0.0 109.555 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -65.53 -39.22 91.52 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.313 -0.867 . . . . 0.0 109.128 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 47.0 t -172.67 152.33 2.52 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.27 -0.893 . . . . 0.0 109.318 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -133.81 107.98 8.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.557 -0.714 . . . . 0.0 109.259 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.93 145.79 57.32 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.6 -19.13 42.58 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.973 1.782 . . . . 0.0 111.426 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -98.52 -7.0 29.1 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -173.38 131.98 0.47 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.368 -0.833 . . . . 0.0 109.352 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.72 128.69 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.447 -0.783 . . . . 0.0 109.28 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 62.9 mt -118.45 121.88 41.38 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 88.8 mt -132.28 130.58 41.07 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -93.62 127.86 39.51 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.211 -0.931 . . . . 0.0 109.101 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.59 ' O ' ' N ' ' B' ' 29' ' ' GLN . 5.4 t -124.39 149.05 47.13 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.373 0.606 . . . . 0.0 109.47 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.411 ' N ' HD13 ' B' ' 28' ' ' ILE . 5.9 mm 48.05 -81.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.049 0.452 . . . . 0.0 110.321 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' B' ' 27' ' ' THR . 11.4 pt20 -149.03 -21.21 0.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.052 -1.03 . . . . 0.0 109.359 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.67 165.14 25.7 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 120.987 -1.071 . . . . 0.0 110.509 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.63 130.6 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.609 -0.936 . . . . 0.0 109.488 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 50.9 tp -106.98 126.04 51.8 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 71.0 m -111.27 117.31 32.8 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 89.6 mt -100.77 128.04 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -124.68 136.82 54.23 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.51 -149.01 9.79 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -133.83 148.63 51.33 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.513 -0.992 . . . . 0.0 109.813 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 56.23 57.96 4.63 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.732 0.777 . . . . 0.0 109.747 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.505 ' N ' HD12 ' B' ' 39' ' ' LEU . 9.9 mp -91.34 72.03 6.12 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.386 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.72 159.88 40.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.658 -0.652 . . . . 0.0 109.381 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 99.3 t -127.73 138.25 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -117.96 138.47 52.15 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.17 -179.49 30.33 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.58 124.45 43.36 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.399 -1.059 . . . . 0.0 109.793 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.534 ' N ' HD12 ' B' ' 57' ' ' ILE . 1.3 mp -77.83 126.41 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.488 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -109.38 -19.14 13.38 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.647 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -166.15 152.25 9.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.927 -1.108 . . . . 0.0 110.305 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.647 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.6 OUTLIER -134.19 129.56 35.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.569 -0.707 . . . . 0.0 109.176 179.423 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.0 t -126.59 128.41 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.578 ' O ' HD13 ' B' ' 64' ' ' LEU . 45.4 t80 -144.02 101.47 4.9 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -46.62 89.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.111 1.874 . . . . 0.0 112.582 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.903 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.4 0 O-C-N 121.311 -0.868 . . . . 0.0 109.292 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.852 ' N ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.829 0.823 . . . . 0.0 109.397 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -71.4 138.62 49.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.172 -0.955 . . . . 0.0 109.911 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -146.27 154.99 42.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.293 -0.88 . . . . 0.0 110.005 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 6' ' ' PHE . 8.1 m-85 -110.75 121.1 44.5 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.526 HD23 ' C ' ' A' ' 7' ' ' LEU . 6.9 tt -114.08 124.58 52.46 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.509 -0.744 . . . . 0.0 109.223 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.523 ' N ' HD23 ' A' ' 7' ' ' LEU . 23.8 p -125.41 149.56 48.07 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.778 0.799 . . . . 0.0 109.558 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.621 HD11 ' NE2' ' B' ' 5' ' ' GLN . 36.6 tp -147.8 144.45 28.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.45 -0.781 . . . . 0.0 109.511 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -125.99 164.38 20.94 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.714 0.768 . . . . 0.0 110.169 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.54 17.04 71.94 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.34 134.78 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -1.168 . . . . 0.0 110.438 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -72.68 -45.08 60.69 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.543 -0.723 . . . . 0.0 109.074 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.12 160.46 4.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.445 -0.785 . . . . 0.0 109.976 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.8 t -91.62 110.93 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.578 0.704 . . . . 0.0 109.873 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -68.55 -38.32 80.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.45 -0.781 . . . . 0.0 109.595 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.2 t -162.61 156.17 20.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.876 -1.14 . . . . 0.0 110.383 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -141.66 105.57 4.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.98 147.74 66.61 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.74 -18.0 42.16 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.447 2.098 . . . . 0.0 111.274 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -102.16 -9.12 20.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.43 -0.794 . . . . 0.0 109.344 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -171.83 133.68 0.76 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.212 -0.93 . . . . 0.0 109.704 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.1 mt -126.45 130.07 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.428 -0.795 . . . . 0.0 110.135 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.0 mt -116.27 125.89 52.82 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.7 mt -121.15 130.42 53.71 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.715 0.769 . . . . 0.0 109.466 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -98.01 113.69 25.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.6 -0.688 . . . . 0.0 109.556 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.549 ' O ' ' N ' ' A' ' 29' ' ' GLN . 9.0 t -124.65 157.6 35.14 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.941 0.877 . . . . 0.0 110.097 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.407 HD12 ' HB2' ' B' ' 3' ' ' ASN . 14.6 mm 38.2 -85.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.287 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.549 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.8 pp0? -142.62 -17.02 0.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.95 -1.094 . . . . 0.0 108.873 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.06 175.24 24.91 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.1 t -125.6 133.45 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.781 -0.835 . . . . 0.0 109.602 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.1 tp -102.76 128.31 49.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.621 -0.675 . . . . 0.0 109.51 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -112.85 126.79 55.83 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.823 0.82 . . . . 0.0 110.166 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.6 mt -108.98 130.25 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -124.84 140.49 52.88 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.575 0.703 . . . . 0.0 109.446 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.06 -145.75 9.42 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -134.53 144.52 48.06 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.463 -1.021 . . . . 0.0 109.362 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.8 mttp 55.48 61.22 2.95 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.834 0.826 . . . . 0.0 109.695 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.5 mp -92.56 71.64 5.05 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.912 0.863 . . . . 0.0 109.062 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.221 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.1 m -117.0 158.37 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.618 0.723 . . . . 0.0 109.848 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -141.52 140.11 33.4 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.9 t -125.81 134.89 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.591 -0.693 . . . . 0.0 109.423 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -117.18 125.88 51.89 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.04 174.6 30.03 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.164 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.547 HD23 ' H ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -91.35 128.76 37.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.667 -0.902 . . . . 0.0 110.092 -179.365 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.4 mp -78.74 125.96 38.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.435 -0.791 . . . . 0.0 109.126 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -112.19 -29.97 7.38 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.473 ' O ' HD22 ' A' ' 60' ' ' LEU . . . -166.38 137.84 3.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.028 -1.045 . . . . 0.0 110.812 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.473 HD22 ' O ' ' A' ' 59' ' ' ALA . 3.1 mm? -117.14 135.51 53.7 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.78 129.48 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.867 0.841 . . . . 0.0 110.075 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -145.47 137.84 13.51 Favored Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.02 108.42 2.12 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.788 1.658 . . . . 0.0 112.543 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.979 ' H ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.245 -0.909 . . . . 0.0 109.095 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' B' ' 4' ' ' ARG . 52.8 p-10 . . . . . 0 N--CA 1.5 2.037 0 CA-C-O 121.549 0.69 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.543 ' N ' ' OD1' ' B' ' 3' ' ' ASN . 45.0 mmm-85 -50.46 136.78 20.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.192 -0.942 . . . . 0.0 110.682 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 5' ' ' GLN . . . . . 0.621 ' NE2' HD11 ' A' ' 9' ' ' LEU . 2.3 pt20 -146.37 155.81 42.87 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.335 -0.853 . . . . 0.0 109.551 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' B' ' 6' ' ' PHE . 30.3 m-85 -115.04 121.64 43.71 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.635 HD23 ' N ' ' B' ' 8' ' ' SER . 6.4 tt -118.43 122.79 43.63 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 8' ' ' SER . . . . . 0.635 ' N ' HD23 ' B' ' 7' ' ' LEU . 29.8 t -119.01 134.76 55.0 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.511 0.672 . . . . 0.0 109.825 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 48.9 tp -131.61 144.91 51.4 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.8 p -128.09 164.0 23.39 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.701 0.762 . . . . 0.0 110.26 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.33 20.06 61.19 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 p -67.39 135.71 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.187 -1.184 . . . . 0.0 110.01 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 56.2 m -72.45 -43.65 63.47 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.421 -0.8 . . . . 0.0 109.25 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.98 162.28 3.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.385 -0.822 . . . . 0.0 110.278 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.2 t -89.98 111.24 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.519 0.676 . . . . 0.0 110.066 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -67.2 -38.91 86.13 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.881 0.848 . . . . 0.0 108.791 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 30.1 t -168.89 166.37 11.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 0.0 109.655 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -145.48 104.7 3.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.37 -0.831 . . . . 0.0 109.513 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' B' ' 22' ' ' GLU . 13.7 m-20 -133.92 125.94 18.48 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.62 -26.27 16.63 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.824 1.683 . . . . 0.0 111.503 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -88.59 -5.05 58.42 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.708 0.766 . . . . 0.0 109.379 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' B' ' 19' ' ' ASP . 32.9 tt0 -176.35 132.99 0.23 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.517 -0.74 . . . . 0.0 109.399 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 93.5 mt -123.09 128.1 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.45 -0.781 . . . . 0.0 109.481 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 mt -117.84 129.07 55.44 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.361 0.601 . . . . 0.0 109.463 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 86.3 mt -131.03 131.87 44.58 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.665 0.745 . . . . 0.0 109.873 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -95.4 114.46 26.24 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.616 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.3 t -125.53 153.77 43.13 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.439 0.638 . . . . 0.0 110.114 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 14.0 mm 46.3 -78.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-O 121.558 0.694 . . . . 0.0 110.91 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.616 ' N ' ' O ' ' B' ' 27' ' ' THR . 13.3 pt20 -151.89 -22.84 0.19 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.161 -0.962 . . . . 0.0 109.118 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.94 176.17 29.29 Favored Glycine 0 N--CA 1.5 2.944 0 O-C-N 120.993 -1.067 . . . . 0.0 110.624 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 56.0 t -121.13 134.65 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.6 -0.941 . . . . 0.0 109.442 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 51.2 tp -104.88 128.27 53.03 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.473 0.654 . . . . 0.0 109.655 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 46.4 t -112.26 121.27 44.42 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 93.9 mt -106.05 130.95 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.551 0.691 . . . . 0.0 110.202 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -127.71 141.21 51.66 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.83 -141.47 4.7 Favored Glycine 0 N--CA 1.485 1.928 0 C-N-CA 119.655 -1.26 . . . . 0.0 110.235 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -129.42 135.62 48.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.708 -0.878 . . . . 0.0 109.544 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? 43.23 80.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.91 0.862 . . . . 0.0 110.08 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.477 ' N ' HD12 ' B' ' 39' ' ' LEU . 8.7 mp -95.06 71.59 3.35 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.073 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -179.156 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 121.682 0.753 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -127.15 129.3 47.61 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.27 136.43 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.648 -0.657 . . . . 0.0 109.25 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -121.06 134.5 55.27 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.713 0.768 . . . . 0.0 109.373 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.55 -179.82 29.57 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.52 126.87 43.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.667 -0.902 . . . . 0.0 109.52 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.522 ' N ' HD12 ' B' ' 57' ' ' ILE . 1.4 mp -83.78 121.65 36.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.418 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -106.95 -19.24 13.69 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.667 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -162.14 150.03 14.5 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.647 -1.283 . . . . 0.0 110.984 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.667 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.6 OUTLIER -137.11 139.36 41.19 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.372 0.606 . . . . 0.0 109.386 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 54.7 t -141.03 131.61 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.454 -0.779 . . . . 0.0 110.198 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.505 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 11.9 t80 -145.73 140.16 15.47 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 63' ' ' PRO . . . . . 0.505 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 68.4 Cg_endo -76.06 108.82 2.76 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.282 1.988 . . . . 0.0 112.336 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.86 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.961 0 O-C-N 121.364 -0.835 . . . . 0.0 109.157 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.0 p30 . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 121.305 0.574 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.7 mmm-85 -53.67 140.41 29.34 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.268 -0.895 . . . . 0.0 109.46 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -146.97 160.82 41.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.32 -0.862 . . . . 0.0 109.534 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -111.35 131.89 54.83 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.0 tt -118.2 139.83 50.71 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 m -121.79 146.69 46.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.509 -0.745 . . . . 0.0 109.262 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tp -156.1 149.0 24.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.113 -0.992 . . . . 0.0 109.868 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.3 163.76 34.51 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.582 -0.699 . . . . 0.0 109.562 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.14 18.96 56.77 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.14 140.22 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.171 -1.194 . . . . 0.0 109.798 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 t -73.44 -51.79 15.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.118 -0.989 . . . . 0.0 109.585 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -155.87 160.42 40.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.026 -1.046 . . . . 0.0 109.917 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.4 t -92.54 102.33 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -65.82 -39.22 90.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 109.445 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -167.74 164.36 14.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.156 -0.965 . . . . 0.0 109.513 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -147.06 108.07 4.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.186 -0.946 . . . . 0.0 108.863 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -132.26 146.97 63.89 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.91 -18.37 46.75 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 121.814 1.676 . . . . 0.0 111.367 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -100.12 -3.58 31.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.408 -0.808 . . . . 0.0 109.502 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.445 ' OE1' ' NZ ' ' A' ' 35' ' ' LYS . 29.8 tt0 -174.29 151.03 1.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.222 -0.924 . . . . 0.0 109.441 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.7 mt -133.98 129.76 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.27 -0.894 . . . . 0.0 109.733 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.0 mt -117.8 120.55 38.26 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.8 mt -134.09 133.23 40.88 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.25 -0.906 . . . . 0.0 109.413 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -102.53 118.56 37.11 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.244 -0.91 . . . . 0.0 108.974 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 29' ' ' GLN . 5.0 t -125.15 153.69 42.66 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.681 0.753 . . . . 0.0 110.143 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.0 mm 53.8 -82.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.635 -0.665 . . . . 0.0 109.879 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' THR . 20.9 pt20 -164.04 51.05 0.14 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.976 -1.078 . . . . 0.0 109.748 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -171.43 155.12 23.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.2 t -95.99 130.38 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.329 -1.101 . . . . 0.0 109.942 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.4 tp -107.2 121.71 45.06 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.9 t -107.71 118.06 35.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.3 mt -103.89 127.14 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.445 ' NZ ' ' OE1' ' A' ' 22' ' ' GLU . 68.7 mttm -121.43 129.54 53.06 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.553 0.692 . . . . 0.0 109.153 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.67 -141.42 3.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -144.53 151.67 39.45 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.989 -1.301 . . . . 0.0 110.168 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 54' ' ' GLU . 45.6 mmtm 56.65 43.53 25.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.574 -0.704 . . . . 0.0 109.726 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.7 mp -73.77 71.99 1.5 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.706 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.093 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.65 159.7 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.294 -0.879 . . . . 0.0 109.193 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.15 146.35 42.67 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.8 t -123.07 135.24 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 38' ' ' LYS . 19.8 pt-20 -116.38 132.09 56.77 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.31 173.34 25.61 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.412 ' O ' HD12 ' A' ' 56' ' ' LEU . 2.6 pp -96.84 124.51 40.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.252 -1.146 . . . . 0.0 109.745 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.7 mt -79.67 129.03 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.238 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -118.72 -27.63 5.81 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.59 ' O ' HD22 ' A' ' 60' ' ' LEU . . . -152.77 146.88 25.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.025 -1.047 . . . . 0.0 110.532 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -133.93 134.1 42.2 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.426 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.444 HG22 HD12 ' B' ' 64' ' ' LEU . 98.5 t -130.68 123.29 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.243 -0.91 . . . . 0.0 109.937 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.41 ' CE1' ' O ' ' A' ' 63' ' ' PRO . 46.4 t80 -146.66 138.01 13.05 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.41 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 61.6 Cg_endo -75.03 116.41 4.57 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.454 1.436 . . . . 0.0 111.442 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.972 ' H ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.196 -0.94 . . . . 0.0 108.473 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.922 HD21 ' N ' ' B' ' 3' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -80.36 140.33 36.12 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.364 -0.835 . . . . 0.0 109.319 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -152.02 161.77 42.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 109.38 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.484 ' N ' ' CD1' ' B' ' 6' ' ' PHE . 23.6 m-85 -104.2 146.03 29.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.628 -0.67 . . . . 0.0 109.412 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.589 HD23 ' N ' ' B' ' 8' ' ' SER . 6.2 tt -132.66 122.27 24.41 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 8' ' ' SER . . . . . 0.589 ' N ' HD23 ' B' ' 7' ' ' LEU . 80.0 p -114.71 144.75 42.96 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.35 -0.844 . . . . 0.0 109.835 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.9 tp -150.67 150.72 31.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.295 -0.878 . . . . 0.0 109.323 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.6 160.76 41.76 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.476 -0.765 . . . . 0.0 109.472 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.37 14.3 60.36 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.31 135.11 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.235 -1.156 . . . . 0.0 109.689 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t -73.15 -43.41 61.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 109.857 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.56 165.03 10.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.941 -1.099 . . . . 0.0 109.798 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 71.4 t -98.31 129.68 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.22 -0.925 . . . . 0.0 109.917 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -83.57 -29.03 28.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 109.272 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 34.7 t -172.01 168.7 5.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.254 -0.904 . . . . 0.0 109.032 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -150.41 107.63 3.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.137 -0.977 . . . . 0.0 109.771 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -132.12 149.61 73.73 Favored Pre-proline 0 N--CA 1.497 1.923 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.19 -3.25 11.93 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.694 1.596 . . . . 0.0 111.606 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -122.26 -12.59 8.24 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.532 -0.73 . . . . 0.0 109.974 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -158.82 109.57 2.07 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.097 -1.002 . . . . 0.0 109.242 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 95.8 mt -111.67 128.74 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.403 ' CD2' ' OG ' ' B' ' 33' ' ' SER . 15.0 mt -111.6 125.05 53.52 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 80.0 mt -121.69 128.97 52.41 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.571 -0.706 . . . . 0.0 109.853 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -96.75 113.75 25.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.185 -0.947 . . . . 0.0 108.707 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.547 ' O ' ' N ' ' B' ' 29' ' ' GLN . 5.1 t -124.17 156.44 36.71 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.364 0.602 . . . . 0.0 110.514 -178.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.423 ' C ' ' O ' ' B' ' 27' ' ' THR . 45.4 mt 34.71 -87.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 CA-C-O 121.123 0.487 . . . . 0.0 110.639 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.547 ' N ' ' O ' ' B' ' 27' ' ' THR . 17.1 pt20 -150.73 45.19 0.85 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 0.0 109.682 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.68 136.69 4.29 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 74.7 t -91.55 132.73 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.391 -1.064 . . . . 0.0 109.751 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 53.0 tp -107.02 125.27 50.8 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.403 ' OG ' ' CD2' ' B' ' 24' ' ' LEU . 21.0 m -107.61 120.42 42.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.479 -0.763 . . . . 0.0 109.422 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 87.5 mt -106.78 127.5 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -124.78 139.89 53.43 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.581 0.705 . . . . 0.0 109.355 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.8 -139.97 5.46 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -143.63 152.72 41.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.996 -1.296 . . . . 0.0 109.52 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' B' ' 54' ' ' GLU . 68.1 mttm 56.15 51.23 12.12 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.301 0.572 . . . . 0.0 110.201 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.526 ' N ' HD12 ' B' ' 39' ' ' LEU . 9.8 mp -85.56 71.65 10.72 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -178.701 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.498 1.968 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 52' ' ' GLU . . . . . 0.429 ' CD ' ' N ' ' B' ' 52' ' ' GLU . 18.3 mp0 -138.68 153.86 48.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.347 -0.845 . . . . 0.0 109.508 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.412 HG12 ' N ' ' B' ' 54' ' ' GLU . 55.4 t -131.42 156.25 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.412 ' N ' HG12 ' B' ' 53' ' ' VAL . 31.3 tt0 -138.68 134.55 33.77 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.49 178.91 32.95 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.443 HD23 ' H ' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -96.03 139.24 32.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.338 -1.095 . . . . 0.0 109.119 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 43.3 mm -86.38 118.07 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 109.257 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -107.69 -31.77 7.93 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.447 -0.783 . . . . 0.0 109.682 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.581 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -160.76 147.21 15.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.16 -0.963 . . . . 0.0 110.265 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.581 HD22 ' O ' ' B' ' 59' ' ' ALA . 1.3 mm? -129.84 135.85 48.88 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 95.0 t -135.28 129.36 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.294 -0.879 . . . . 0.0 109.515 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' B' ' 64' ' ' LEU . 42.4 t80 -144.89 123.18 6.63 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -42.34 86.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.464 1.443 . . . . 0.0 112.224 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.682 ' H ' ' CD2' ' B' ' 64' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.2 p30 . . . . . 0 N--CA 1.493 1.725 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.3 mmm-85 -69.97 145.32 51.93 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.223 -0.923 . . . . 0.0 109.03 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -135.56 146.65 48.21 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.676 0.751 . . . . 0.0 110.005 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -110.19 114.71 28.42 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.605 HD23 ' C ' ' A' ' 7' ' ' LEU . 6.9 tt -111.27 125.08 53.45 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.424 -0.797 . . . . 0.0 108.867 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.599 ' N ' HD23 ' A' ' 7' ' ' LEU . 37.7 t -119.58 148.04 43.78 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.477 0.656 . . . . 0.0 109.555 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 tp -149.07 -179.46 7.04 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.631 0.729 . . . . 0.0 109.717 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.514 HG21 ' NE2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -175.13 158.18 2.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.344 -0.848 . . . . 0.0 109.378 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.12 20.63 57.04 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -66.48 139.88 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -1.078 . . . . 0.0 110.217 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.0 t -72.68 -43.36 63.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.429 -0.794 . . . . 0.0 109.598 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.99 159.12 9.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 0.0 109.93 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.5 t -91.61 106.61 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.472 -0.768 . . . . 0.0 109.959 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -69.09 -38.22 78.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 109.395 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -168.87 164.15 11.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.832 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -149.02 105.16 3.5 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -132.79 150.43 75.71 Favored Pre-proline 0 N--CA 1.498 1.957 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.64 -19.29 36.89 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.134 1.889 . . . . 0.0 111.231 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -100.02 -3.34 32.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.4 -0.813 . . . . 0.0 109.078 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -174.49 146.97 1.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.541 -0.724 . . . . 0.0 109.435 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.0 mt -133.04 129.81 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.335 -0.853 . . . . 0.0 109.614 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.8 mt -117.13 124.9 50.32 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.3 mt -136.64 129.36 30.61 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.56 -0.712 . . . . 0.0 109.192 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -104.7 123.05 46.94 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.526 -0.734 . . . . 0.0 109.444 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 29' ' ' GLN . 8.9 t -123.82 154.71 39.2 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.528 0.68 . . . . 0.0 109.72 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.6 mt 42.97 -84.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.999 -0.438 . . . . 0.0 110.623 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.578 ' N ' ' O ' ' A' ' 27' ' ' THR . 12.9 pt20 -154.9 57.24 0.67 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.932 -1.105 . . . . 0.0 109.85 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.71 141.65 6.15 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.187 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.4 t -86.34 132.2 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.487 -1.007 . . . . 0.0 109.518 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.9 tp -111.26 123.55 50.43 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 t -115.7 126.69 54.42 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.572 -0.705 . . . . 0.0 109.992 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.0 mt -112.59 130.74 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.36 144.67 50.74 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 121.499 0.666 . . . . 0.0 109.662 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.83 -140.1 5.52 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -135.93 143.06 44.74 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.421 -1.046 . . . . 0.0 108.885 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 54.44 62.21 2.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.523 -0.736 . . . . 0.0 110.171 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.3 mp -91.71 73.04 5.84 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.148 -0.97 . . . . 0.0 108.548 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.013 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.514 ' NE2' HG21 ' A' ' 10' ' ' THR . 2.0 tp60 . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 121.475 0.655 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -113.71 136.34 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -136.43 131.0 33.52 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.849 -0.796 . . . . 0.0 108.849 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.1 t -125.1 148.88 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.565 -0.709 . . . . 0.0 109.174 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -133.1 127.97 35.15 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.6 173.64 23.71 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.438 HD23 ' H ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -95.44 128.3 42.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.371 -1.076 . . . . 0.0 109.343 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.1 mt -81.46 121.31 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.868 . . . . 0.0 109.639 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -103.37 -23.76 13.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.545 -0.722 . . . . 0.0 109.085 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.02 151.17 13.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.167 -0.958 . . . . 0.0 109.98 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.615 HD13 ' N ' ' A' ' 61' ' ' VAL . 0.3 OUTLIER -130.95 126.98 37.48 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.546 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.615 ' N ' HD13 ' A' ' 60' ' ' LEU . 58.6 t -123.04 123.89 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.303 -0.873 . . . . 0.0 109.773 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -146.3 139.76 14.76 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.97 110.01 2.82 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.27 1.313 . . . . 0.0 111.769 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.968 ' H ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.36 -0.838 . . . . 0.0 109.17 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -87.56 137.25 32.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.154 -0.966 . . . . 0.0 109.296 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -146.13 163.75 34.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.409 -0.807 . . . . 0.0 109.299 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -108.96 129.79 55.45 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 7.5 tt -113.41 135.44 53.87 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 12.4 t -130.99 139.8 50.05 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.726 0.774 . . . . 0.0 110.226 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' B' ' 9' ' ' LEU . 45.6 tp -151.03 146.06 25.95 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.604 -0.685 . . . . 0.0 109.319 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.4 p -130.11 177.77 7.05 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.61 -0.681 . . . . 0.0 109.414 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.1 18.55 69.23 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 79.3 t -74.55 130.86 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.14 -1.212 . . . . 0.0 109.771 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 38.9 t -73.4 -42.37 62.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.355 -0.841 . . . . 0.0 109.114 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.2 160.29 9.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.155 -0.966 . . . . 0.0 109.946 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 10.1 t -82.08 104.15 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.435 -0.79 . . . . 0.0 109.506 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -67.53 -35.81 79.8 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.164 -0.96 . . . . 0.0 109.352 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 7.5 t -165.46 153.26 11.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.922 . . . . 0.0 109.223 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -140.27 104.54 4.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.278 -0.889 . . . . 0.0 109.455 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.411 ' OD2' ' O ' ' B' ' 22' ' ' GLU . 0.4 OUTLIER -133.26 150.32 74.98 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.97 -16.69 32.46 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.846 1.697 . . . . 0.0 111.953 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -107.93 -8.54 15.91 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.353 -0.842 . . . . 0.0 109.743 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.447 ' CD ' ' HZ1' ' B' ' 35' ' ' LYS . 50.0 tt0 -167.33 126.78 1.39 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 109.435 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.2 mt -125.11 130.7 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.438 -0.789 . . . . 0.0 109.683 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 60.7 mt -112.95 128.43 56.48 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 94.7 mt -127.02 126.74 43.63 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.629 -0.67 . . . . 0.0 109.658 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -94.03 112.34 24.16 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.534 ' O ' ' N ' ' B' ' 29' ' ' GLN . 15.0 t -124.7 164.93 18.87 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.524 0.678 . . . . 0.0 110.488 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' B' ' 27' ' ' THR . 22.2 mm 33.21 -86.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.415 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' B' ' 27' ' ' THR . 27.2 pt20 -148.98 27.2 0.87 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.933 -1.104 . . . . 0.0 109.728 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.84 165.96 31.25 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 55.7 t -112.51 132.4 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.655 -0.909 . . . . 0.0 109.143 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 46.8 tp -104.52 124.33 49.1 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' B' ' 61' ' ' VAL . 5.4 p -107.52 122.59 46.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.591 -0.693 . . . . 0.0 109.48 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' ILE . . . . . 0.54 ' N ' HD12 ' B' ' 34' ' ' ILE . 4.4 mp -108.6 129.08 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' LYS . . . . . 0.447 ' HZ1' ' CD ' ' B' ' 22' ' ' GLU . 68.5 mttm -123.27 133.3 54.18 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.565 0.698 . . . . 0.0 109.459 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.68 -147.72 8.62 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -136.61 153.76 50.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.357 -1.084 . . . . 0.0 109.767 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 67.8 mttm 55.96 57.41 5.16 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.539 0.685 . . . . 0.0 110.557 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.528 ' N ' HD12 ' B' ' 39' ' ' LEU . 9.0 mp -92.35 70.09 5.13 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.557 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.3 t . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 121.616 0.722 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -144.11 127.67 17.03 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 t -118.17 162.55 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.655 -0.653 . . . . 0.0 109.678 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -123.46 132.93 54.08 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.89 179.71 37.62 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.439 HD23 ' H ' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -96.68 138.84 33.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.301 -1.117 . . . . 0.0 109.201 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.459 ' N ' HD12 ' B' ' 57' ' ' ILE . 1.4 mp -91.31 117.6 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.247 -0.908 . . . . 0.0 109.061 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -108.13 -25.23 11.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.514 -0.741 . . . . 0.0 109.8 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' ALA . . . . . 0.505 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -164.59 135.59 4.22 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.74 -1.225 . . . . 0.0 111.146 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.505 HD22 ' O ' ' B' ' 59' ' ' ALA . 3.1 mm? -119.83 135.43 54.87 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.426 ' O ' ' OG ' ' B' ' 33' ' ' SER . 46.6 t -132.58 122.75 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.543 0.687 . . . . 0.0 109.823 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' B' ' 64' ' ' LEU . 28.2 t80 -144.54 128.39 8.88 Favored Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -41.21 88.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.427 1.418 . . . . 0.0 111.785 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.683 ' C ' HD23 ' B' ' 64' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 120.783 -1.198 . . . . 0.0 108.678 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 121.092 0.472 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -69.95 140.92 53.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 108.742 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -142.3 162.0 36.59 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.124 -0.985 . . . . 0.0 110.088 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -108.99 142.07 40.18 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.564 HD23 ' N ' ' A' ' 8' ' ' SER . 6.2 tt -142.11 124.01 15.26 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.564 ' N ' HD23 ' A' ' 7' ' ' LEU . 37.8 t -132.34 140.45 48.55 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.461 -0.774 . . . . 0.0 109.152 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.5 tp -144.65 142.54 30.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.305 -0.872 . . . . 0.0 109.008 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.5 p -130.61 112.68 13.37 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.548 -0.72 . . . . 0.0 109.468 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 143.33 31.87 0.1 Allowed Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.4 t -81.16 133.47 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -1.125 . . . . 0.0 110.238 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.1 m -72.65 -41.6 65.28 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.56 153.45 4.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.771 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 81.6 t -84.93 106.0 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.509 -0.745 . . . . 0.0 110.285 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -67.96 -42.01 81.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.96 . . . . 0.0 108.86 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.3 t -171.89 136.54 0.91 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.407 -0.808 . . . . 0.0 108.89 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.437 ' CE1' HD12 ' A' ' 23' ' ' ILE . 6.9 t80 -123.77 106.46 10.51 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.428 -0.795 . . . . 0.0 109.143 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.413 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -128.22 150.45 74.04 Favored Pre-proline 0 N--CA 1.498 1.968 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.513 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.1 -19.57 39.08 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.272 1.981 . . . . 0.0 111.364 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -97.47 -7.12 32.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.466 -0.771 . . . . 0.0 108.978 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -172.86 140.36 0.94 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.437 HD12 ' CE1' ' A' ' 18' ' ' PHE . 27.0 mm -127.12 127.51 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.323 -0.861 . . . . 0.0 109.437 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.8 mt -120.51 120.55 36.18 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.1 mt -131.31 125.61 33.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.419 -0.801 . . . . 0.0 108.849 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -92.4 120.83 33.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 29' ' ' GLN . 6.1 t -122.37 154.0 38.28 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.674 0.749 . . . . 0.0 110.271 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.3 mm 46.08 -82.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.085 0.469 . . . . 0.0 110.764 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.578 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.8 pp0? -147.71 -21.36 0.37 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.102 -0.999 . . . . 0.0 109.898 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.485 ' N ' ' CD ' ' A' ' 29' ' ' GLN . . . -97.45 173.77 28.91 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.7 t -118.95 132.67 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.753 -0.851 . . . . 0.0 109.107 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.471 HD13 HD12 ' B' ' 60' ' ' LEU . 60.3 tp -109.62 127.81 54.79 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.6 t -113.22 122.4 47.37 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.7 mt -108.12 130.14 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.403 -0.811 . . . . 0.0 109.264 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -129.16 141.17 51.25 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.488 -0.757 . . . . 0.0 109.37 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.07 -138.1 4.91 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.454 ' HB3' HD21 ' A' ' 56' ' ' LEU . 6.7 tt0 -133.03 150.03 52.16 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.492 -1.005 . . . . 0.0 110.711 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 54' ' ' GLU . 55.0 mmtt 54.08 66.36 1.25 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.492 178.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 39' ' ' LEU . 11.1 mp -98.39 71.18 2.03 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.138 0 O-C-N 121.128 -0.982 . . . . 0.0 110.793 -178.146 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 . . . . . 0 N--CA 1.495 1.821 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.0 t -122.65 131.8 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.529 -0.732 . . . . 0.0 109.103 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -130.64 130.98 44.63 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 t -136.36 138.36 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.496 -0.753 . . . . 0.0 109.097 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.491 ' O ' ' O ' ' A' ' 38' ' ' LYS . 24.0 tt0 -118.42 145.98 44.79 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.15 166.14 15.6 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.454 HD21 ' HB3' ' A' ' 37' ' ' GLU . 2.5 pp -88.69 128.83 35.62 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.391 -1.064 . . . . 0.0 109.656 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.3 mm -80.12 135.31 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.85 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -125.26 -31.05 3.1 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.02 143.4 16.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.064 -1.023 . . . . 0.0 110.598 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.435 HD13 HD13 ' B' ' 32' ' ' LEU . 9.1 mt -129.73 143.31 50.76 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 54.3 t -139.23 118.22 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.102 -0.999 . . . . 0.0 110.165 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -139.72 108.97 7.17 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.96 109.36 0.23 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.406 1.404 . . . . 0.0 112.426 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.017 ' H ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.323 -0.861 . . . . 0.0 109.588 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.476 ' ND2' ' N ' ' B' ' 3' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.8 mmm-85 -69.25 142.71 54.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.97 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -140.15 148.29 41.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.517 -0.739 . . . . 0.0 109.577 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -103.95 119.5 39.06 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.517 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.2 tt -119.16 121.24 39.29 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.262 -0.899 . . . . 0.0 108.638 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 8' ' ' SER . . . . . 0.487 ' N ' HD23 ' B' ' 7' ' ' LEU . 70.1 m -132.53 151.37 51.94 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.509 -0.744 . . . . 0.0 109.163 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 tp -147.29 149.3 32.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.193 -0.942 . . . . 0.0 109.5 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.2 p -128.67 163.7 24.53 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.588 -0.695 . . . . 0.0 109.612 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.43 29.27 56.17 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.41 131.37 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -1.174 . . . . 0.0 109.901 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' B' ' 28' ' ' ILE . 58.2 m -73.83 -40.07 63.58 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.615 -0.678 . . . . 0.0 110.613 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -158.91 158.38 33.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.983 -1.073 . . . . 0.0 109.914 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 76.3 t -103.63 99.96 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -68.96 -49.25 59.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 110.532 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 31.8 t -170.4 146.58 2.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.924 -1.11 . . . . 0.0 110.211 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.71 110.18 17.53 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.673 -0.642 . . . . 0.0 109.882 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' B' ' 22' ' ' GLU . 0.3 OUTLIER -133.76 119.89 15.16 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.431 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -50.19 -27.14 16.7 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.476 1.45 . . . . 0.0 111.443 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -94.52 -5.4 46.13 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' B' ' 19' ' ' ASP . 40.2 tt0 -170.8 115.57 0.45 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 97.0 mt -114.45 126.33 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.203 -0.936 . . . . 0.0 109.194 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 57.9 mt -119.35 126.53 51.63 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 87.0 mt -135.58 123.76 23.04 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.256 -0.902 . . . . 0.0 108.988 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -81.73 118.32 22.76 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.128 -0.982 . . . . 0.0 108.84 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.562 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.8 t -109.54 149.19 30.0 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.472 -0.767 . . . . 0.0 110.201 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.494 ' N ' ' OG ' ' B' ' 13' ' ' SER . 58.7 mt 38.47 -87.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.037 0.446 . . . . 0.0 110.798 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' B' ' 27' ' ' THR . 24.0 pt20 -133.68 -22.52 1.89 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.38 -0.825 . . . . 0.0 110.198 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.6 173.99 30.21 Favored Glycine 0 N--CA 1.498 2.769 0 O-C-N 121.139 -0.976 . . . . 0.0 110.724 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -119.34 131.57 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.79 -0.829 . . . . 0.0 109.401 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 60' ' ' LEU . 48.7 tp -111.92 128.79 56.25 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.3 t -110.2 120.41 42.37 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 84.3 mt -99.81 125.56 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -130.53 139.06 50.48 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.502 -0.749 . . . . 0.0 109.52 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.66 -138.28 3.28 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -131.86 136.81 47.73 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.348 -1.089 . . . . 0.0 109.836 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.415 ' C ' HD12 ' B' ' 39' ' ' LEU . 52.9 mtmt 46.92 75.38 0.12 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 110.283 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.6 ' N ' HD12 ' B' ' 39' ' ' LEU . 8.5 mp -93.24 72.12 4.54 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.18 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 121.539 0.685 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -126.62 131.58 51.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.9 t -125.96 137.54 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.499 -0.751 . . . . 0.0 109.721 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -117.24 131.42 56.84 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.7 174.21 28.11 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.99 127.04 40.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.066 -1.256 . . . . 0.0 109.429 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.568 ' N ' HD12 ' B' ' 57' ' ' ILE . 1.4 mp -85.63 113.4 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 108.684 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.37 -10.29 16.4 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -159.9 146.28 15.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.904 -1.123 . . . . 0.0 110.522 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.471 HD12 HD13 ' A' ' 32' ' ' LEU . 52.8 mt -141.3 138.49 33.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.469 -0.769 . . . . 0.0 108.972 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 53.4 t -133.2 128.23 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.194 -0.941 . . . . 0.0 109.89 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -145.37 137.88 13.59 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.34 109.28 2.86 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.384 1.39 . . . . 0.0 111.74 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.936 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.479 -0.763 . . . . 0.0 108.981 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 p30 . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.445 ' NE ' ' OE2' ' A' ' 54' ' ' GLU . 46.4 mmm-85 -88.39 138.43 31.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.344 -0.848 . . . . 0.0 109.13 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -145.19 161.88 38.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.181 -0.949 . . . . 0.0 109.187 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -119.8 146.4 45.72 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.505 0.669 . . . . 0.0 109.916 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.579 HD23 ' C ' ' A' ' 7' ' ' LEU . 6.4 tt -132.51 122.7 25.26 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.571 ' N ' HD23 ' A' ' 7' ' ' LEU . 33.3 t -113.8 133.04 55.63 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.49 -0.756 . . . . 0.0 109.283 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.6 tp -144.76 151.5 38.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.35 -0.844 . . . . 0.0 109.444 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.4 t -146.48 162.88 37.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.399 -0.813 . . . . 0.0 108.944 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.27 24.99 41.51 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.45 138.14 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -1.1 . . . . 0.0 109.652 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.5 m -73.57 -38.36 65.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.232 -0.918 . . . . 0.0 109.257 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -169.89 166.71 9.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.177 -0.952 . . . . 0.0 109.499 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.5 t -98.32 96.19 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.329 -0.857 . . . . 0.0 109.063 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -65.21 -39.39 92.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.146 -0.971 . . . . 0.0 109.463 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 t -168.82 152.85 5.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 109.256 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -146.89 107.73 4.16 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.247 -0.908 . . . . 0.0 109.422 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.3 158.68 75.11 Favored Pre-proline 0 N--CA 1.502 2.161 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.83 -26.07 67.67 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 121.672 1.581 . . . . 0.0 112.142 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -106.04 3.43 28.2 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.372 -0.83 . . . . 0.0 110.276 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -171.54 133.46 0.8 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.031 -1.043 . . . . 0.0 109.46 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.9 mt -130.84 126.83 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.421 -0.799 . . . . 0.0 109.184 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.2 mt -117.5 122.18 43.03 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.711 . . . . 0.0 109.271 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.9 mt -133.37 124.56 27.4 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.375 -0.828 . . . . 0.0 108.839 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -91.73 124.74 36.1 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.679 -1.263 . . . . 0.0 109.72 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 29' ' ' GLN . 6.1 t -124.5 153.33 42.2 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.462 0.649 . . . . 0.0 109.755 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.48 HD12 ' CB ' ' B' ' 3' ' ' ASN . 20.4 mm 44.74 -88.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.868 -0.52 . . . . 0.0 110.094 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.544 ' N ' ' O ' ' A' ' 27' ' ' THR . 25.7 pt20 -143.19 -17.4 0.65 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.965 -1.084 . . . . 0.0 110.213 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.29 173.67 30.32 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.2 t -121.25 131.21 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.779 -0.836 . . . . 0.0 108.909 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -107.56 126.12 52.15 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.37 -0.831 . . . . 0.0 109.554 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -116.9 124.03 48.46 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.639 -0.663 . . . . 0.0 109.417 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.2 mt -107.77 130.0 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.521 -0.737 . . . . 0.0 109.238 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -124.69 138.79 54.27 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.493 -0.754 . . . . 0.0 109.657 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.58 -146.36 9.41 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -140.61 151.87 44.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.036 -1.273 . . . . 0.0 109.802 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 54' ' ' GLU . 73.7 mmtt 58.34 55.24 5.12 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.681 -0.637 . . . . 0.0 109.939 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 39' ' ' LEU . 7.9 mp -93.75 70.6 4.12 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.38 0 C-N-CA 120.247 -0.978 . . . . 0.0 110.732 -178.898 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 m -131.43 156.1 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.265 -0.897 . . . . 0.0 109.964 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -142.8 150.37 39.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.425 -0.797 . . . . 0.0 109.107 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.7 t -126.65 134.92 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.458 -0.776 . . . . 0.0 110.109 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.473 ' OE1' ' N ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -114.57 126.08 54.51 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.473 ' N ' ' OE1' ' A' ' 54' ' ' GLU . . . 163.72 176.44 35.64 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.158 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.406 HD23 ' H ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -96.17 121.44 37.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.527 -0.984 . . . . 0.0 108.885 179.762 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.69 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.7 mp -90.43 113.3 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.018 -1.051 . . . . 0.0 108.937 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -99.94 -10.77 21.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.452 -0.78 . . . . 0.0 109.988 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.94 145.74 13.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.816 -1.178 . . . . 0.0 110.428 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 mt -135.19 134.53 40.2 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.61 -0.681 . . . . 0.0 109.297 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.8 t -129.81 126.0 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.527 -0.733 . . . . 0.0 109.571 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.558 ' O ' ' N ' ' A' ' 64' ' ' LEU . 10.8 t80 -141.0 127.61 11.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -45.68 84.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.247 1.298 . . . . 0.0 112.206 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.7 ' CD2' ' H ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 O-C-N 121.363 -0.836 . . . . 0.0 109.207 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.48 ' CB ' HD12 ' A' ' 28' ' ' ILE . 8.2 p30 . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 31.7 mmm-85 -73.0 142.14 47.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.318 -0.863 . . . . 0.0 109.425 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -147.04 156.09 42.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.272 -0.893 . . . . 0.0 109.025 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -98.79 141.37 31.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.328 -0.858 . . . . 0.0 109.393 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.549 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.1 tt -139.95 126.47 20.31 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 8' ' ' SER . . . . . 0.545 ' N ' HD23 ' B' ' 7' ' ' LEU . 69.8 m -128.53 150.96 49.95 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.442 -0.786 . . . . 0.0 109.594 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.8 tp -146.91 153.21 39.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.35 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.4 t -143.48 164.44 30.32 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.299 -0.876 . . . . 0.0 109.189 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.07 14.95 59.85 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 p -69.14 137.41 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.341 -1.094 . . . . 0.0 109.443 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 4.5 t -73.96 -52.18 13.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.213 -0.929 . . . . 0.0 108.938 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.18 150.6 13.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.253 -0.904 . . . . 0.0 109.646 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 93.0 t -82.58 131.46 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.199 -0.938 . . . . 0.0 110.058 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -95.59 -32.25 12.9 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.314 -0.866 . . . . 0.0 109.247 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 47.3 t -169.04 153.97 5.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.89 . . . . 0.0 108.981 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' PHE . . . . . 0.45 ' CZ ' HD13 ' B' ' 23' ' ' ILE . 3.0 t80 -145.65 112.49 5.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.004 -1.06 . . . . 0.0 109.408 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' B' ' 19' ' ' ASP . 0.3 OUTLIER -132.6 151.73 78.68 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.59 -18.21 48.52 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.658 1.572 . . . . 0.0 111.382 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -107.7 -3.29 19.32 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.491 -0.756 . . . . 0.0 109.581 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -169.98 127.85 0.88 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.284 -0.885 . . . . 0.0 109.227 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.45 HD13 ' CZ ' ' B' ' 18' ' ' PHE . 96.8 mt -127.74 129.65 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.241 -0.912 . . . . 0.0 109.921 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 70.0 mt -115.06 124.15 50.85 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.336 -0.853 . . . . 0.0 109.639 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 41.5 mt -126.31 131.26 51.88 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.303 -0.873 . . . . 0.0 109.138 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -90.91 119.87 31.45 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.556 ' O ' ' N ' ' B' ' 29' ' ' GLN . 3.1 t -123.53 148.36 46.36 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.669 0.747 . . . . 0.0 110.186 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 68.5 mt 39.05 -88.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.145 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' B' ' 27' ' ' THR . 29.7 pt20 -139.0 -18.17 1.03 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.392 -0.817 . . . . 0.0 109.999 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.19 144.5 17.17 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 18.6 t -94.15 129.64 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.343 -1.092 . . . . 0.0 108.848 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 37.5 tp -106.21 126.02 51.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.445 -0.784 . . . . 0.0 109.415 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 70.9 m -109.34 124.4 50.89 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 90.8 mt -106.13 129.41 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.534 -0.729 . . . . 0.0 109.178 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -125.25 141.74 51.91 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.507 -0.746 . . . . 0.0 109.414 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.04 -151.52 17.93 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -140.07 150.26 44.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.226 -1.161 . . . . 0.0 108.93 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt 60.27 51.24 5.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.553 -0.717 . . . . 0.0 109.668 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.551 ' N ' HD12 ' B' ' 39' ' ' LEU . 9.0 mp -91.24 72.99 6.23 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.386 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -178.706 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.2 t . . . . . 0 N--CA 1.499 2.016 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -119.5 137.29 53.9 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.516 -0.74 . . . . 0.0 109.077 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.423 HG12 ' N ' ' B' ' 54' ' ' GLU . 21.4 t -128.39 160.84 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.411 -0.806 . . . . 0.0 110.086 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.423 ' N ' HG12 ' B' ' 53' ' ' VAL . 0.0 OUTLIER -136.32 146.87 47.06 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.26 176.02 23.68 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.405 HD23 ' H ' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -99.0 136.44 38.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.357 -1.084 . . . . 0.0 108.545 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 36.1 mm -93.49 111.53 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.884 -1.135 . . . . 0.0 109.186 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -100.38 -24.48 14.5 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.399 -0.813 . . . . 0.0 109.799 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.04 147.05 12.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.937 -1.102 . . . . 0.0 110.632 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 9.5 mt -132.48 141.17 48.68 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.417 HG22 HD12 ' A' ' 64' ' ' LEU . 77.9 t -133.91 118.97 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.578 -0.701 . . . . 0.0 109.154 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.433 ' O ' HD13 ' B' ' 64' ' ' LEU . 18.2 t80 -135.86 140.81 34.57 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -79.84 105.78 1.87 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.491 1.461 . . . . 0.0 112.485 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.937 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.925 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.6 p30 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.592 0.71 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 41.8 mmm-85 -65.16 141.31 58.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.92 -1.112 . . . . 0.0 109.145 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -135.38 147.78 49.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.205 -0.934 . . . . 0.0 110.557 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -112.99 113.28 25.26 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.515 HD23 ' C ' ' A' ' 7' ' ' LEU . 6.5 tt -111.68 123.11 49.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 108.89 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.499 ' N ' HD23 ' A' ' 7' ' ' LEU . 30.3 t -115.22 133.72 55.78 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.48 0.657 . . . . 0.0 109.662 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 tp -141.02 139.11 34.09 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.725 0.774 . . . . 0.0 109.345 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -130.51 168.4 17.1 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.723 -0.61 . . . . 0.0 109.44 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.4 14.09 74.8 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.0 t -67.94 133.94 30.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 109.761 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.6 t -71.15 -43.25 67.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 109.189 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.68 163.82 3.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 0.0 110.026 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.3 t -88.81 111.45 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.432 -0.792 . . . . 0.0 110.086 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -67.46 -31.23 71.26 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.476 -0.765 . . . . 0.0 109.097 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.1 t -167.91 159.34 11.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.099 -1.0 . . . . 0.0 109.537 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.443 ' C ' ' CD1' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -138.77 107.09 5.79 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.342 -0.849 . . . . 0.0 109.31 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.84 145.03 54.29 Favored Pre-proline 0 N--CA 1.495 1.799 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.61 -13.69 32.76 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.444 2.096 . . . . 0.0 111.609 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -115.5 -1.74 12.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.28 -0.887 . . . . 0.0 108.967 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -169.07 111.61 0.51 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.149 -0.97 . . . . 0.0 109.157 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.5 mt -112.51 129.7 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.152 -0.967 . . . . 0.0 109.475 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.3 mt -113.41 123.54 50.32 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.531 -0.73 . . . . 0.0 109.039 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.3 mt -120.95 126.87 51.07 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.587 0.708 . . . . 0.0 109.112 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.81 118.25 31.45 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.35 -0.844 . . . . 0.0 108.974 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.579 ' O ' ' N ' ' A' ' 29' ' ' GLN . 3.4 t -116.95 154.49 30.76 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.345 0.593 . . . . 0.0 110.392 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.405 ' C ' ' O ' ' A' ' 27' ' ' THR . 27.1 mm 34.09 -85.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-O 121.451 0.643 . . . . 0.0 110.933 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 27' ' ' THR . 24.0 pt20 -138.82 -17.48 1.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.927 . . . . 0.0 108.944 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.58 167.51 25.93 Favored Glycine 0 N--CA 1.497 2.735 0 O-C-N 120.855 -1.153 . . . . 0.0 110.797 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -120.43 132.94 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.513 -0.992 . . . . 0.0 109.305 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.559 HD13 HD13 ' B' ' 60' ' ' LEU . 57.7 tp -112.23 131.92 55.21 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.7 t -115.79 129.9 56.63 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.453 0.644 . . . . 0.0 109.358 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.7 mt -112.8 132.23 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 121.315 0.578 . . . . 0.0 109.457 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -131.33 146.65 52.38 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.575 0.702 . . . . 0.0 109.488 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' OE1' ' A' ' 37' ' ' GLU . . . 168.63 -148.21 12.18 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 36' ' ' GLY . 0.7 OUTLIER -118.89 137.36 53.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.866 -0.785 . . . . 0.0 109.83 -178.722 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.421 ' C ' HD12 ' A' ' 39' ' ' LEU . 70.7 mmtt 50.94 71.3 0.44 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.018 0.913 . . . . 0.0 110.179 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.4 mp -98.75 72.55 1.98 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.982 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 -178.869 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 121.513 0.673 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.9 m -133.42 163.0 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.538 -0.726 . . . . 0.0 109.731 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -135.45 160.78 37.38 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.701 0.762 . . . . 0.0 109.688 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.08 135.17 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -122.04 125.52 46.43 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.838 0.827 . . . . 0.0 109.322 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.4 178.47 24.43 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.82 129.83 44.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -1.081 . . . . 0.0 109.297 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.48 122.52 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.282 -0.887 . . . . 0.0 109.519 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -102.22 -24.43 13.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.482 -0.761 . . . . 0.0 109.036 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.93 149.7 14.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.843 -1.161 . . . . 0.0 110.749 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.465 HD13 HD13 ' B' ' 32' ' ' LEU . 12.7 mt -131.2 144.74 51.57 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.502 HG13 HD12 ' B' ' 64' ' ' LEU . 21.8 t -141.24 122.0 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.763 0.792 . . . . 0.0 110.3 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.557 ' O ' ' N ' ' A' ' 64' ' ' LEU . 19.6 t80 -139.73 115.77 8.16 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.54 78.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.43 1.42 . . . . 0.0 111.419 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 62' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.505 0 CA-C-O 122.338 1.066 . . . . 0.0 109.498 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 3' ' ' ASN . . . . . 0.466 ' ND2' ' N ' ' B' ' 3' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 121.65 0.738 . . . . 0.0 109.098 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -69.72 144.65 52.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.107 -0.995 . . . . 0.0 109.9 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -140.71 150.06 42.97 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.785 0.802 . . . . 0.0 109.691 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -110.58 127.25 55.14 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.476 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.5 tt -122.33 122.25 38.63 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.229 -0.92 . . . . 0.0 108.876 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 8' ' ' SER . . . . . 0.453 ' N ' HD23 ' B' ' 7' ' ' LEU . 18.2 p -121.19 147.89 44.99 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.726 0.774 . . . . 0.0 109.994 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 32.0 tp -148.83 143.78 26.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.568 -0.707 . . . . 0.0 109.102 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -130.25 161.39 31.3 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.651 0.739 . . . . 0.0 109.933 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.41 20.75 61.6 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.83 134.63 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.834 -1.392 . . . . 0.0 109.78 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 34.0 m -72.92 -41.84 64.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.193 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.02 164.83 4.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.819 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 77.1 t -99.29 128.22 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.429 -0.794 . . . . 0.0 109.66 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -84.0 -29.65 26.8 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.686 0.755 . . . . 0.0 109.187 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 35.6 t -169.3 155.5 6.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.121 -0.987 . . . . 0.0 109.289 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -137.42 108.86 6.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 0.0 109.779 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' ASP . . . . . 0.42 ' OD2' ' O ' ' B' ' 22' ' ' GLU . 0.8 OUTLIER -132.91 149.12 72.01 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.293 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.5 -7.76 19.89 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.327 2.018 . . . . 0.0 111.607 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -114.47 -20.96 10.56 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.781 0.8 . . . . 0.0 109.03 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.431 ' CD ' ' NZ ' ' B' ' 35' ' ' LYS . 74.6 tt0 -153.46 115.62 4.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.142 -0.974 . . . . 0.0 109.078 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 81.3 mt -115.88 130.22 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.217 -0.927 . . . . 0.0 109.959 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 14.5 mt -112.39 126.34 55.17 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 81.1 mt -120.57 125.91 48.97 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.808 0.813 . . . . 0.0 109.148 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -95.12 110.4 22.35 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.583 ' O ' ' N ' ' B' ' 29' ' ' GLN . 0.1 OUTLIER -113.92 151.74 31.82 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.313 0.578 . . . . 0.0 110.031 -178.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' B' ' 27' ' ' THR . 55.0 mt 34.51 -85.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-O 121.161 0.505 . . . . 0.0 110.765 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.583 ' N ' ' O ' ' B' ' 27' ' ' THR . 20.5 pt20 -138.51 -14.91 1.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.127 -0.983 . . . . 0.0 109.638 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.01 165.19 20.76 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.971 -1.081 . . . . 0.0 110.807 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 53.1 t -122.32 132.93 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.253 -1.145 . . . . 0.0 109.107 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.465 HD13 HD13 ' A' ' 60' ' ' LEU . 53.9 tp -115.58 137.57 51.93 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.335 0.588 . . . . 0.0 109.926 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.11 138.15 53.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.607 -0.683 . . . . 0.0 109.167 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 5.0 mp -115.25 130.89 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.591 -0.693 . . . . 0.0 109.426 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' LYS . . . . . 0.431 ' NZ ' ' CD ' ' B' ' 22' ' ' GLU . 68.3 mttm -128.57 140.99 51.51 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.518 0.675 . . . . 0.0 109.837 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.99 -139.27 5.46 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' B' ' 38' ' ' LYS . 0.4 OUTLIER -117.59 138.31 52.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.627 -0.925 . . . . 0.0 109.059 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 38' ' ' LYS . . . . . 0.44 ' C ' HD12 ' B' ' 39' ' ' LEU . 32.3 mtmm 36.42 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.996 0.903 . . . . 0.0 110.754 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.483 ' N ' HD12 ' B' ' 39' ' ' LEU . 9.1 mp -100.14 71.6 1.61 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.633 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.898 -178.4 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 121.691 0.757 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -120.71 147.16 45.66 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.94 135.06 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.432 -0.793 . . . . 0.0 109.308 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.12 126.12 49.93 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.63 0.729 . . . . 0.0 109.744 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.02 171.2 23.66 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.04 111.94 23.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.29 -1.123 . . . . 0.0 108.805 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -74.24 112.18 10.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.311 -0.868 . . . . 0.0 109.564 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -101.53 -11.46 19.26 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.58 143.17 6.93 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.726 -1.234 . . . . 0.0 110.744 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.559 HD13 HD13 ' A' ' 32' ' ' LEU . 15.0 mt -127.1 144.64 50.98 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.472 HG22 HD12 ' A' ' 64' ' ' LEU . 2.3 t -135.36 128.27 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.534 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' TYR . . . . . 0.434 ' HD2' ' H ' ' B' ' 64' ' ' LEU . 73.3 t80 -140.14 137.37 17.96 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -36.52 -39.62 0.42 Allowed 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.414 2.076 . . . . 0.0 112.506 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' LEU . . . . . 0.677 HD23 ' O ' ' B' ' 64' ' ' LEU . 2.2 tt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.9 mtp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.344 0.592 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -86.35 109.5 19.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.883 . . . . 0.0 109.587 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -104.95 5.86 33.1 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -73.95 143.04 45.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.311 -0.868 . . . . 0.0 109.142 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.486 ' NE2' ' OG1' ' B' ' 27' ' ' THR . 79.1 mt-30 -144.65 158.02 43.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.2 -0.938 . . . . 0.0 109.803 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -114.91 132.7 56.45 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.6 tt -121.68 130.27 53.35 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.3 p -127.04 147.43 50.15 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.527 -0.733 . . . . 0.0 109.745 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.2 tp -158.56 160.47 36.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.402 -0.811 . . . . 0.0 109.162 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t -151.52 -165.94 2.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.42 -0.8 . . . . 0.0 108.972 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.48 28.35 55.57 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.0 t -66.4 137.83 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.512 -0.993 . . . . 0.0 109.839 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.4 p -72.63 -37.0 68.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 0.0 109.261 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -170.37 163.59 8.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.0 109.451 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.1 t -98.5 96.5 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.23 -0.919 . . . . 0.0 109.3 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.23 -38.83 88.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.148 -0.97 . . . . 0.0 108.977 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 t -170.26 161.54 8.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.823 . . . . 0.0 109.294 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -146.6 105.49 3.86 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.93 151.62 78.82 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.543 -0.723 . . . . 0.0 109.186 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.87 -16.82 32.84 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.159 1.906 . . . . 0.0 111.086 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -104.97 -10.59 17.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.524 -0.735 . . . . 0.0 109.475 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -169.28 131.4 1.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.413 -0.805 . . . . 0.0 109.209 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.79 129.33 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.695 -0.628 . . . . 0.0 109.496 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 mt -120.48 118.41 30.2 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -133.39 127.93 34.49 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -91.01 123.8 34.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.923 -1.11 . . . . 0.0 109.692 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.611 ' O ' ' N ' ' A' ' 29' ' ' GLN . 1.9 t -119.39 149.24 42.16 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.7 mt 50.46 -80.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.3 pt20 -153.45 -18.19 0.14 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.967 -1.083 . . . . 0.0 110.67 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.67 168.94 26.81 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.36 131.95 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.447 -1.031 . . . . 0.0 109.598 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.0 tp -108.23 128.79 55.03 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.465 0.65 . . . . 0.0 109.445 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.5 t -111.42 126.25 54.74 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.3 mm -106.54 127.53 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.798 -0.564 . . . . 0.0 109.551 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -122.94 135.08 54.35 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.17 -156.5 19.53 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -135.84 146.44 47.49 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.417 -1.049 . . . . 0.0 108.825 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt 55.79 56.45 6.09 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.626 -0.672 . . . . 0.0 110.193 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 39' ' ' LEU . 7.6 mp -93.64 68.84 4.05 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.946 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -179.075 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 47' ' ' LYS . 42.0 tp . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.566 ' C ' ' H ' ' A' ' 49' ' ' GLY . 52.7 mmtt 55.93 152.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.201 1.0 . . . . 0.0 111.311 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 57.52 -4.04 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.741 -0.599 . . . . 0.0 110.159 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 47' ' ' LYS . . . 63.85 24.39 68.26 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -111.98 153.09 27.31 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.563 -0.963 . . . . 0.0 109.174 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.88 139.16 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.47 -0.769 . . . . 0.0 108.937 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -114.82 160.11 19.84 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -137.43 138.15 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.31 -0.869 . . . . 0.0 109.121 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -120.68 124.79 46.06 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.47 172.78 31.39 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.99 127.64 44.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.492 -1.005 . . . . 0.0 108.817 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -83.01 117.1 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.058 -1.027 . . . . 0.0 109.284 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -96.96 -12.18 23.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.327 -0.858 . . . . 0.0 109.284 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -173.86 154.27 2.35 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.177 -0.952 . . . . 0.0 110.196 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.433 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 13.6 mt -137.17 134.7 36.61 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.2 t -133.23 123.83 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.234 -0.916 . . . . 0.0 109.708 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.54 ' CE1' ' O ' ' A' ' 63' ' ' PRO . 15.3 t80 -139.72 120.72 9.51 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.54 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 31.5 Cg_exo -56.86 127.86 27.58 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 CA-C-N 120.641 1.265 . . . . 0.0 111.109 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.832 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -103.59 49.76 0.82 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.19 -0.944 . . . . 0.0 109.005 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -51.11 84.5 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.162 -0.961 . . . . 0.0 110.374 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.611 ' N ' ' O ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER -175.98 -30.39 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.39 134.0 47.43 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.618 -0.676 . . . . 0.0 109.849 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 69' ' ' HIS . 0.1 OUTLIER -127.57 -39.72 1.82 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 68' ' ' HIS . 2.2 t-80 57.38 151.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.665 0.745 . . . . 0.0 110.432 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -76.58 -68.39 0.6 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -0.929 . . . . 0.0 109.844 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.6 t60 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.522 -179.32 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' B' ' 3' ' ' ASN . 21.6 t70 60.11 -176.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.501 -0.749 . . . . 0.0 110.176 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.462 ' N ' ' OD1' ' B' ' 3' ' ' ASN . 13.7 p-10 -126.57 -18.55 4.79 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.643 -0.661 . . . . 0.0 109.476 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -68.84 141.04 55.22 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.313 -0.867 . . . . 0.0 109.436 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLN . . . . . 0.516 ' NE2' ' OG1' ' A' ' 27' ' ' THR . 26.5 mt-30 -146.74 158.27 43.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.183 -0.948 . . . . 0.0 109.782 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -103.81 135.63 44.99 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.504 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.2 tt -138.41 125.48 21.39 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.396 -0.815 . . . . 0.0 108.841 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.474 ' N ' HD23 ' B' ' 7' ' ' LEU . 1.8 m -129.41 149.31 51.25 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.4 tp -145.96 146.52 31.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.225 -0.922 . . . . 0.0 109.302 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -132.74 171.33 14.02 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.547 -0.72 . . . . 0.0 109.192 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.75 23.21 70.33 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -77.61 137.17 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -1.158 . . . . 0.0 109.612 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 41.2 t -71.03 -44.31 66.09 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.061 -1.024 . . . . 0.0 109.882 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.68 151.81 4.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.899 -1.126 . . . . 0.0 110.36 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 70.4 t -85.55 130.35 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.458 -0.776 . . . . 0.0 109.349 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -98.54 -42.15 7.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.176 -0.953 . . . . 0.0 109.919 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -157.57 118.7 3.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.111 -0.993 . . . . 0.0 109.261 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -111.86 106.39 15.1 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.472 -0.768 . . . . 0.0 109.133 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -132.42 151.08 77.61 Favored Pre-proline 0 N--CA 1.498 1.971 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.36 -20.27 48.75 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.12 1.88 . . . . 0.0 112.18 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -110.89 6.9 21.56 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.366 -0.834 . . . . 0.0 109.408 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -170.46 137.94 1.47 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.346 -0.846 . . . . 0.0 109.172 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 91.3 mt -137.92 128.37 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.17 -0.956 . . . . 0.0 109.478 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 mt -124.21 109.83 13.91 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 86.7 mt -113.77 124.2 51.69 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -83.36 104.89 13.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.285 -0.884 . . . . 0.0 109.15 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.486 ' OG1' ' NE2' ' A' ' 5' ' ' GLN . 13.8 t -123.95 -178.92 4.21 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.397 0.618 . . . . 0.0 109.548 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' B' ' 27' ' ' THR . 8.6 mm -34.31 157.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.908 0.861 . . . . 0.0 110.629 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 64.94 -57.76 0.27 Allowed 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.961 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' B' ' 28' ' ' ILE . . . -171.36 -131.61 1.37 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.214 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -121.47 134.43 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.718 -0.872 . . . . 0.0 110.175 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 29.3 tp -100.0 126.58 46.21 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -106.34 135.33 48.03 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.541 -0.724 . . . . 0.0 109.619 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 79.7 mt -124.71 132.39 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -124.82 141.53 52.05 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.546 0.689 . . . . 0.0 109.85 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.23 -153.23 21.65 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -130.95 143.74 50.95 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.204 -1.174 . . . . 0.0 109.421 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 55.66 57.0 5.61 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.695 . . . . 0.0 109.704 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.437 ' N ' HD12 ' B' ' 39' ' ' LEU . 9.1 mp -97.5 72.29 2.35 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.432 -0.792 . . . . 0.0 109.194 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.002 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.588 HD23 ' N ' ' B' ' 47' ' ' LYS . 2.5 tt . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.612 ' C ' ' H ' ' B' ' 49' ' ' GLY . 18.0 ptpt -108.59 -161.92 0.79 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.346 -0.846 . . . . 0.0 109.261 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' B' ' 47' ' ' LYS . . . 63.73 -20.83 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.442 -0.786 . . . . 0.0 109.838 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' GLY . . . . . 0.612 ' H ' ' C ' ' B' ' 47' ' ' LYS . . . 78.0 25.5 62.0 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -101.9 160.04 14.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.472 -1.016 . . . . 0.0 109.393 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.03 132.99 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.491 -0.756 . . . . 0.0 109.149 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -125.91 132.83 52.05 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.99 135.21 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -124.38 133.32 53.45 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.436 -0.79 . . . . 0.0 108.967 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.51 -178.38 39.08 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.415 ' H ' HD23 ' B' ' 56' ' ' LEU . 0.2 OUTLIER -95.13 120.64 35.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.412 -1.052 . . . . 0.0 108.927 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.3 mt -91.79 110.27 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.078 -1.014 . . . . 0.0 108.762 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -97.88 -16.43 19.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.373 -0.829 . . . . 0.0 109.997 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.96 147.33 23.98 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.823 -1.173 . . . . 0.0 110.884 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.43 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 13.1 mt -139.15 132.16 29.51 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 54.2 t -130.64 127.01 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.308 -0.87 . . . . 0.0 109.318 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 14.6 t80 -138.71 141.44 30.77 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.531 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 71.9 Cg_endo -76.6 112.41 3.45 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.867 1.711 . . . . 0.0 111.908 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.871 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -98.98 48.46 0.96 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.187 -0.946 . . . . 0.0 109.022 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' B' ' 67' ' ' HIS . 5.7 mm-40 -76.34 -95.97 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 109.784 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.639 ' N ' ' ND1' ' B' ' 66' ' ' HIS . 0.1 OUTLIER 61.48 -70.57 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.477 -0.765 . . . . 0.0 109.884 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.538 ' N ' ' O ' ' B' ' 65' ' ' GLU . 2.5 m-70 -118.53 158.15 25.94 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 0.452 ' ND1' ' N ' ' B' ' 68' ' ' HIS . 8.0 m80 -77.01 136.96 38.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.166 -0.959 . . . . 0.0 110.111 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -154.88 95.46 1.76 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -140.57 149.81 42.86 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.38 -0.825 . . . . 0.0 109.968 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 117.952 -1.023 . . . . 0.0 108.943 179.511 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ptp . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -93.57 106.52 18.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.066 -1.021 . . . . 0.0 108.399 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -152.16 -19.1 0.18 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.515 -0.741 . . . . 0.0 109.533 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 43.2 mmm-85 -59.77 142.47 53.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.559 -0.713 . . . . 0.0 110.525 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.444 ' CD ' HD11 ' B' ' 9' ' ' LEU . 16.4 pt20 -154.34 162.12 41.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.477 -0.764 . . . . 0.0 109.579 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.549 ' N ' ' CD1' ' A' ' 6' ' ' PHE . 9.7 m-85 -106.66 130.86 54.33 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.552 -0.718 . . . . 0.0 109.469 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.698 HD21 ' CD1' ' B' ' 9' ' ' LEU . 4.0 mm? -113.64 146.83 39.16 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.143 0.973 . . . . 0.0 109.267 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.0 t -139.44 143.2 37.49 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.374 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.748 HD11 ' NE2' ' B' ' 5' ' ' GLN . 17.4 tp -155.22 139.47 16.62 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.342 -0.848 . . . . 0.0 109.743 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 t -145.33 164.9 30.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.397 -0.814 . . . . 0.0 109.376 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.61 11.55 77.18 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 13' ' ' SER . 21.6 t -66.82 159.78 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.769 -0.842 . . . . 0.0 110.633 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.447 ' N ' HG12 ' A' ' 12' ' ' VAL . 22.1 p -74.68 -53.09 9.95 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.4 ' N ' ' OG ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -171.7 158.09 4.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.261 -0.9 . . . . 0.0 109.706 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 t -83.8 108.18 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.86 . . . . 0.0 110.099 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -66.89 -41.57 86.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.426 -0.796 . . . . 0.0 109.094 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.8 t -172.62 143.62 1.34 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.414 -0.804 . . . . 0.0 109.18 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -127.61 116.72 20.76 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.55 -0.719 . . . . 0.0 109.227 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.0 147.87 67.11 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.84 -16.82 46.53 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.835 1.69 . . . . 0.0 110.77 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -98.39 -7.86 27.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.621 -0.675 . . . . 0.0 109.198 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 23' ' ' ILE . 9.5 tm-20 -174.61 150.84 1.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.366 -0.833 . . . . 0.0 109.082 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.479 ' N ' ' CD ' ' A' ' 22' ' ' GLU . 96.5 mt -133.44 130.86 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.299 -0.875 . . . . 0.0 109.991 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.2 mt -115.52 128.11 55.76 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.2 mt -128.54 132.48 48.27 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.393 -0.817 . . . . 0.0 109.155 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -98.81 110.22 22.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 108.709 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.611 ' O ' ' N ' ' A' ' 29' ' ' GLN . 12.3 t -113.43 149.06 34.73 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.411 0.624 . . . . 0.0 109.97 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 28' ' ' ILE . 3.8 mm 43.26 -80.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.652 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' A' ' 27' ' ' THR . 9.0 mt-30 -143.58 -24.65 0.58 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.11 -0.994 . . . . 0.0 109.836 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.01 174.78 36.01 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.76 130.31 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.849 -0.795 . . . . 0.0 109.019 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.46 HD13 HD13 ' B' ' 60' ' ' LEU . 31.1 tp -103.75 126.59 50.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.582 -0.699 . . . . 0.0 109.42 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.7 t -113.35 128.11 56.35 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.5 mt -107.27 130.33 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -124.42 138.6 54.34 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.477 0.656 . . . . 0.0 109.416 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.71 -144.92 8.65 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -133.93 144.46 48.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.317 -1.108 . . . . 0.0 108.939 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 54' ' ' GLU . 71.1 mmtt 58.3 57.69 3.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 0.0 109.351 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.1 mp -95.56 72.79 3.18 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.601 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 46' ' ' LEU . 10.2 mp . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 120.655 0.264 . . . . 0.0 110.775 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.0 tttt 59.91 -70.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.243 0.544 . . . . 0.0 109.862 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . -72.21 0.95 8.48 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.454 -0.778 . . . . 0.0 109.446 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.82 28.94 74.09 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -134.11 161.05 35.94 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.441 -1.035 . . . . 0.0 109.338 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.0 t -113.79 132.23 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -125.95 141.02 52.16 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.1 t -131.0 133.67 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.508 ' OE1' ' CD2' ' A' ' 6' ' ' PHE . 27.1 tp10 -117.69 143.13 46.48 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.71 -172.7 30.4 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.93 126.95 54.42 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.632 -0.922 . . . . 0.0 109.218 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.31 118.96 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.033 -1.042 . . . . 0.0 109.552 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -98.7 -19.5 17.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.414 -0.804 . . . . 0.0 108.855 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -168.25 154.33 7.18 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.131 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.446 HD13 HD13 ' B' ' 32' ' ' LEU . 12.9 mt -133.32 139.48 46.89 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.2 t -134.58 122.41 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.526 -0.734 . . . . 0.0 109.796 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.439 ' CD1' ' C ' ' A' ' 62' ' ' TYR . 10.0 t80 -136.23 139.79 30.97 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.16 87.71 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.472 1.448 . . . . 0.0 112.245 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.708 ' CD2' ' H ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER -99.18 7.82 45.42 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 64' ' ' LEU . 3.0 pp20? -37.33 154.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.576 0.703 . . . . 0.0 110.771 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.655 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 1.0 OUTLIER -158.09 75.47 0.75 Allowed 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 179.315 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.571 ' C ' ' O ' ' A' ' 66' ' ' HIS . 5.7 m-70 -18.39 -92.14 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.671 -0.643 . . . . 0.0 110.88 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.496 ' ND1' ' N ' ' A' ' 69' ' ' HIS . 16.2 p80 -176.46 -156.15 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.496 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 1.7 t60 73.7 162.69 0.26 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.505 0.669 . . . . 0.0 110.296 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -157.07 -3.28 0.11 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.511 0.672 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' B' ' 2' ' ' ASP . 0.0 OUTLIER -166.92 -171.31 1.77 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.738 -179.321 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' B' ' 3' ' ' ASN . 8.9 p-10 -86.36 -1.05 57.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.462 -0.774 . . . . 0.0 110.088 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -79.53 139.11 37.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.586 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' GLN . . . . . 0.748 ' NE2' HD11 ' A' ' 9' ' ' LEU . 4.0 pt20 -148.14 158.43 44.07 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.138 -0.976 . . . . 0.0 109.734 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -113.94 134.35 54.88 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.483 -0.76 . . . . 0.0 109.021 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.8 mt -116.06 147.3 41.41 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 43.1 t -141.04 131.67 25.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.497 -0.752 . . . . 0.0 109.577 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.698 ' CD1' HD21 ' A' ' 7' ' ' LEU . 25.1 tp -142.82 145.25 33.02 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.501 ' O ' ' N ' ' B' ' 12' ' ' VAL . 14.1 p -68.25 165.64 18.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.208 -0.933 . . . . 0.0 110.649 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.19 92.87 0.01 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.523 HG22 ' N ' ' B' ' 13' ' ' SER . 9.3 p -48.2 168.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.51 -0.994 . . . . 0.0 110.26 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' SER . . . . . 0.523 ' N ' HG22 ' B' ' 12' ' ' VAL . 15.7 m -72.86 -39.8 66.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.665 -0.647 . . . . 0.0 110.528 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -148.98 147.66 28.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.883 -1.136 . . . . 0.0 109.949 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 78.6 t -103.32 97.48 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -65.13 -41.83 94.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.851 . . . . 0.0 109.83 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 31.1 t -174.43 147.0 1.1 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.886 . . . . 0.0 109.07 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' PHE . . . . . 0.512 ' CE1' HD12 ' B' ' 23' ' ' ILE . 1.6 t80 -128.88 112.46 14.13 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.454 ' H ' HD13 ' B' ' 23' ' ' ILE . 4.9 m-20 -130.7 148.14 68.91 Favored Pre-proline 0 N--CA 1.498 1.93 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.6 -10.33 28.37 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.792 1.662 . . . . 0.0 111.496 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -118.38 3.86 11.86 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.768 -0.582 . . . . 0.0 109.64 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -172.07 129.76 0.61 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.261 -0.899 . . . . 0.0 109.382 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.512 HD12 ' CE1' ' B' ' 18' ' ' PHE . 50.8 mm -122.03 121.65 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.347 -0.845 . . . . 0.0 109.214 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 58.4 mt -119.21 114.53 22.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 46.3 mt -131.35 127.11 36.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.394 -0.816 . . . . 0.0 108.883 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -87.39 111.34 21.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.021 -1.049 . . . . 0.0 109.414 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.618 ' O ' ' N ' ' B' ' 29' ' ' GLN . 9.6 t -105.74 150.06 25.86 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.475 -0.766 . . . . 0.0 109.96 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 57.5 mt 38.26 -84.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 121.06 0.457 . . . . 0.0 110.485 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.618 ' N ' ' O ' ' B' ' 27' ' ' THR . 15.9 pt20 -139.4 -19.47 0.96 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.338 -0.851 . . . . 0.0 110.26 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.58 166.24 23.91 Favored Glycine 0 N--CA 1.496 2.654 0 O-C-N 121.077 -1.015 . . . . 0.0 110.665 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 69.1 t -114.97 131.31 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.725 -0.868 . . . . 0.0 108.668 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 60' ' ' LEU . 52.7 tp -109.77 127.61 54.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.613 -0.679 . . . . 0.0 109.24 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.5 t -117.23 124.2 48.48 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 74.1 mt -110.18 131.38 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.387 -0.821 . . . . 0.0 108.997 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -124.84 139.56 53.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.546 -0.721 . . . . 0.0 109.365 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.67 -144.69 8.05 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.566 ' N ' ' OE1' ' B' ' 37' ' ' GLU . 7.5 mp0 -138.65 147.44 42.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.522 -0.987 . . . . 0.0 109.204 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' B' ' 54' ' ' GLU . 68.8 mmtt 62.54 49.75 3.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.667 -0.646 . . . . 0.0 109.94 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.576 ' N ' HD12 ' B' ' 39' ' ' LEU . 10.0 mp -93.01 71.17 4.63 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.005 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -178.736 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.557 ' N ' HD12 ' B' ' 46' ' ' LEU . 10.8 mp . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.573 0.701 . . . . 0.0 109.647 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -92.47 -80.39 0.37 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.411 -0.805 . . . . 0.0 109.459 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.05 6.38 25.62 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.83 15.78 69.51 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -90.63 160.31 15.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.439 -1.036 . . . . 0.0 109.683 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.18 144.02 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.405 -0.809 . . . . 0.0 109.252 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -136.97 149.93 47.84 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.427 HG12 ' N ' ' B' ' 54' ' ' GLU . 23.8 t -130.62 159.16 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.311 -0.868 . . . . 0.0 109.623 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.427 ' N ' HG12 ' B' ' 53' ' ' VAL . 7.5 pt-20 -143.38 144.33 32.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.332 -0.855 . . . . 0.0 109.244 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.46 -175.53 31.82 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.54 113.85 27.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.442 -1.034 . . . . 0.0 109.208 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.592 ' N ' HD12 ' B' ' 57' ' ' ILE . 1.5 mp -81.14 127.07 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.156 -0.965 . . . . 0.0 109.759 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -101.78 -23.0 14.26 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.07 155.01 15.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.043 -1.036 . . . . 0.0 110.655 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.46 HD13 HD13 ' A' ' 32' ' ' LEU . 14.0 mt -130.82 142.56 50.4 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.473 HG22 HD12 ' A' ' 64' ' ' LEU . 71.3 t -134.19 119.77 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.421 -0.8 . . . . 0.0 109.177 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.591 ' O ' HD13 ' B' ' 64' ' ' LEU . 50.2 t80 -133.71 102.86 12.32 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.66 97.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.829 1.686 . . . . 0.0 112.745 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.779 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -88.23 11.78 15.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.483 -0.761 . . . . 0.0 109.22 179.183 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' B' ' 64' ' ' LEU . 1.6 pm0 44.22 178.68 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 122.25 1.024 . . . . 0.0 112.082 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -174.84 73.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 109.138 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -68.24 -60.01 2.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.263 -0.898 . . . . 0.0 109.189 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.55 -178.76 6.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 110.483 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.537 ' O ' ' N ' ' B' ' 71' ' ' HIS . 0.1 OUTLIER -176.39 -120.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.083 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.461 ' H ' ' HB3' ' B' ' 69' ' ' HIS . 4.3 p-80 -45.66 -16.3 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.508 -1.37 . . . . 0.0 109.873 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' B' ' 69' ' ' HIS . 27.4 t60 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 118.113 -0.946 . . . . 0.0 109.874 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.4 mmm . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.458 0.647 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.2 t70 63.34 114.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.459 -0.776 . . . . 0.0 109.921 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -100.88 -14.2 18.05 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.445 -0.784 . . . . 0.0 109.594 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.3 mmm-85 -69.4 138.3 53.48 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.5 -0.75 . . . . 0.0 109.693 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -150.44 155.75 40.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.454 -0.779 . . . . 0.0 109.139 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -114.34 131.93 56.37 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.611 HD23 ' N ' ' A' ' 8' ' ' SER . 6.0 tt -120.3 123.73 43.87 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.611 ' N ' HD23 ' A' ' 7' ' ' LEU . 38.3 t -109.93 132.24 54.34 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.498 -0.751 . . . . 0.0 109.601 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.624 HD11 ' NE2' ' B' ' 5' ' ' GLN . 44.6 tp -146.92 147.29 30.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.785 . . . . 0.0 109.232 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.408 HG21 ' OE1' ' A' ' 50' ' ' GLN . 1.9 t -148.43 177.74 9.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.306 -0.871 . . . . 0.0 109.187 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.3 20.98 76.51 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 p -62.46 144.37 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.586 -0.949 . . . . 0.0 110.001 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 t -72.38 -42.7 64.93 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.543 -0.723 . . . . 0.0 109.573 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -165.12 160.65 18.95 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.983 -1.073 . . . . 0.0 110.179 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -94.85 108.89 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -81.9 -56.3 4.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -0.816 . . . . 0.0 110.024 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 t -162.18 127.16 3.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.304 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.492 ' CE1' HD12 ' A' ' 23' ' ' ILE . 1.7 t80 -109.66 117.43 33.91 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.423 ' H ' HD13 ' A' ' 23' ' ' ILE . 1.1 m-20 -131.05 148.41 70.14 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 121.309 -0.869 . . . . 0.0 109.466 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.66 -11.8 31.73 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.508 1.472 . . . . 0.0 110.515 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -105.71 -14.52 15.23 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.791 -0.568 . . . . 0.0 110.094 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -167.82 145.89 4.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.232 -0.917 . . . . 0.0 109.306 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.492 HD12 ' CE1' ' A' ' 18' ' ' PHE . 51.2 mm -121.74 125.29 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.561 -0.712 . . . . 0.0 109.079 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.4 mt -118.39 115.56 24.92 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.4 mt -133.38 133.56 42.59 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -75.7 116.33 16.3 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.312 -0.867 . . . . 0.0 109.3 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.499 ' O ' ' C ' ' A' ' 28' ' ' ILE . 13.3 t -114.51 146.96 40.06 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.499 ' C ' ' O ' ' A' ' 27' ' ' THR . 10.0 mm -1.97 -75.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 123.557 0.743 . . . . 0.0 112.932 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.469 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 99.4 mm-40 -59.35 -71.01 0.13 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.438 -0.789 . . . . 0.0 111.749 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.55 -128.24 1.9 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.2 t -116.72 131.81 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.916 0.865 . . . . 0.0 110.711 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.4 tp -100.71 129.86 46.67 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.7 m -110.21 120.69 43.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.6 mt -105.32 124.04 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -118.41 141.32 48.66 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.754 0.788 . . . . 0.0 109.35 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.444 ' HA2' ' H ' ' A' ' 58' ' ' ASP . . . -179.58 -138.56 3.36 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.401 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.78 132.35 43.71 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.48 -1.012 . . . . 0.0 108.353 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp 39.72 86.13 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.642 0.734 . . . . 0.0 110.646 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.2 mp -96.8 72.12 2.58 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.686 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.539 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 46' ' ' LEU . 9.5 mp . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.506 0.67 . . . . 0.0 109.584 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -63.35 -51.12 67.23 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.495 -0.753 . . . . 0.0 109.542 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.06 49.31 0.78 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.457 -0.777 . . . . 0.0 109.872 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.99 20.31 79.92 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.408 ' OE1' HG21 ' A' ' 10' ' ' THR . 94.1 mm-40 -104.23 159.68 15.5 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.294 -1.121 . . . . 0.0 109.032 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.7 t -122.22 133.08 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.539 ' N ' ' OE1' ' A' ' 52' ' ' GLU . 13.3 mp0 -131.67 146.68 52.31 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.501 0.667 . . . . 0.0 109.428 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.1 t -129.06 134.41 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -117.32 134.76 54.43 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.694 0.759 . . . . 0.0 109.243 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.83 -176.05 34.21 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.415 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -103.71 120.92 41.91 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.9 mt -83.76 116.9 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.056 -1.028 . . . . 0.0 109.772 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.444 ' H ' ' HA2' ' A' ' 36' ' ' GLY . 59.0 m-20 -96.99 -15.42 21.09 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.481 -0.762 . . . . 0.0 109.81 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.6 152.96 8.67 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.083 -1.011 . . . . 0.0 110.446 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.418 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 8.8 mt -138.63 134.97 34.41 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 49.7 t -130.86 124.91 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.496 -0.753 . . . . 0.0 109.421 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.556 ' O ' ' N ' ' A' ' 64' ' ' LEU . 33.7 t80 -133.63 111.54 12.55 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.12 78.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.413 1.409 . . . . 0.0 112.326 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.895 HD12 HG22 ' B' ' 61' ' ' VAL . 0.4 OUTLIER -75.08 84.14 2.31 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.528 -1.358 . . . . 0.0 108.667 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -163.47 126.63 2.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.562 -0.711 . . . . 0.0 109.555 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.627 ' CE1' ' ND1' ' A' ' 67' ' ' HIS . 14.9 p-80 -88.23 11.04 17.53 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.627 ' ND1' ' CE1' ' A' ' 66' ' ' HIS . 27.8 p-80 -152.44 165.07 36.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.582 -0.699 . . . . 0.0 109.659 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -153.97 41.36 0.51 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -167.48 -177.92 3.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.393 -0.817 . . . . 0.0 109.68 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.467 ' O ' ' OXT' ' A' ' 71' ' ' HIS . 1.4 p-80 -153.86 -55.49 0.11 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.193 -0.942 . . . . 0.0 109.29 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.467 ' OXT' ' O ' ' A' ' 70' ' ' HIS . 71.3 m-70 . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 117.903 -1.046 . . . . 0.0 109.838 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 78.8 mtm . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.444 0.64 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 13.7 t0 62.88 33.44 15.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.529 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' B' ' 3' ' ' ASN . 10.7 p-10 -90.2 -5.73 56.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.378 -0.826 . . . . 0.0 109.809 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 38.6 mmm-85 -72.18 141.22 49.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.295 -0.878 . . . . 0.0 109.166 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' GLN . . . . . 0.624 ' NE2' HD11 ' A' ' 9' ' ' LEU . 2.8 pt20 -146.61 150.78 36.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.359 -0.838 . . . . 0.0 109.477 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -98.49 144.82 27.42 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.458 HD23 ' N ' ' B' ' 8' ' ' SER . 7.0 tt -127.79 125.9 40.71 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.458 ' N ' HD23 ' B' ' 7' ' ' LEU . 3.7 m -122.17 145.44 48.19 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.533 -0.73 . . . . 0.0 110.126 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.6 tp -153.17 149.29 27.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.4 t -151.15 159.06 44.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.089 -1.007 . . . . 0.0 109.885 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.49 15.07 72.13 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.6 p -62.3 153.03 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -1.079 . . . . 0.0 110.378 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 67.1 m -73.71 -54.07 8.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.15 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.41 153.34 4.3 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.2 -0.937 . . . . 0.0 109.614 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 79.8 t -86.22 130.12 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.416 -0.802 . . . . 0.0 109.886 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -92.8 -23.82 18.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.291 -0.88 . . . . 0.0 109.378 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 21.5 t -171.55 158.16 5.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.133 -0.98 . . . . 0.0 109.893 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -147.52 112.27 5.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.401 -0.812 . . . . 0.0 109.492 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.458 ' OD2' ' O ' ' B' ' 22' ' ' GLU . 1.1 m-20 -133.18 152.88 80.35 Favored Pre-proline 0 N--CA 1.5 2.067 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.58 -12.61 36.23 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.654 1.569 . . . . 0.0 111.556 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -125.88 2.48 7.37 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.574 -0.704 . . . . 0.0 109.563 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.458 ' O ' ' OD2' ' B' ' 19' ' ' ASP . 55.1 tt0 -160.85 119.63 2.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.334 -0.853 . . . . 0.0 109.256 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.6 mt -129.02 127.87 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.173 -0.955 . . . . 0.0 109.416 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 79.3 mt -108.77 134.92 50.82 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 93.7 mt -135.05 123.42 23.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.349 -0.845 . . . . 0.0 109.7 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -93.93 123.17 37.11 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.566 ' O ' ' N ' ' B' ' 29' ' ' GLN . 7.0 t -123.58 149.45 45.28 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.606 0.717 . . . . 0.0 109.886 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 16.7 mt 45.04 -85.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.922 -0.486 . . . . 0.0 110.218 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' B' ' 27' ' ' THR . 17.1 pt20 -142.88 -20.62 0.65 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.08 -1.013 . . . . 0.0 110.201 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.98 171.59 35.88 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -116.54 131.4 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.879 -0.777 . . . . 0.0 109.125 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 31.8 tp -112.76 127.17 56.08 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.42 0.629 . . . . 0.0 109.485 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 40.5 t -108.94 123.46 49.13 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 39.3 mm -99.71 128.15 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -133.06 125.64 30.08 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.83 -139.5 2.65 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -137.94 136.93 37.47 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.349 -1.089 . . . . 0.0 109.99 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 54.84 57.84 5.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.467 -0.771 . . . . 0.0 110.09 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.565 ' N ' HD12 ' B' ' 39' ' ' LEU . 8.8 mp -85.15 72.15 10.8 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.791 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -178.716 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 66.3 mt . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.696 0.76 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -82.6 133.67 35.18 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.313 0.578 . . . . 0.0 109.479 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . 51.3 16.42 0.4 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.32 -0.862 . . . . 0.0 110.261 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.24 25.23 37.47 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 120.823 -1.173 . . . . 0.0 110.185 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -137.24 159.71 41.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.257 -1.143 . . . . 0.0 109.089 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 5.8 p -127.86 136.88 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -146.45 159.6 43.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.236 -0.915 . . . . 0.0 110.131 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.415 HG12 ' N ' ' B' ' 54' ' ' GLU . 21.4 t -134.15 159.38 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.691 -0.63 . . . . 0.0 109.513 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.415 ' N ' HG12 ' B' ' 53' ' ' VAL . 3.3 tm-20 -127.81 142.11 51.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.435 -0.79 . . . . 0.0 109.139 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.27 -177.76 31.49 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.66 128.81 52.82 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 30.6 mm -78.61 125.34 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.073 -1.017 . . . . 0.0 109.656 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -110.09 -9.85 14.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.658 -0.652 . . . . 0.0 109.478 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -174.24 149.29 1.38 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.096 -1.002 . . . . 0.0 110.095 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.416 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 13.0 mt -138.34 137.5 37.42 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.895 HG22 HD12 ' A' ' 64' ' ' LEU . 9.4 t -134.42 122.74 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.491 -0.755 . . . . 0.0 109.982 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.418 ' CG ' ' HB2' ' A' ' 60' ' ' LEU . 26.9 t80 -140.33 106.08 6.6 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -50.59 113.05 0.89 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.302 1.334 . . . . 0.0 112.336 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.979 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -93.61 5.79 50.44 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.187 -0.946 . . . . 0.0 108.922 179.066 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.476 ' N ' HD22 ' B' ' 64' ' ' LEU . 0.7 OUTLIER -87.05 123.9 32.63 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.547 -0.721 . . . . 0.0 110.119 -179.134 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -88.25 -70.02 0.66 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.411 -0.805 . . . . 0.0 109.655 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.467 ' C ' ' H ' ' B' ' 69' ' ' HIS . 54.1 m80 -110.57 120.34 42.11 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' B' ' 70' ' ' HIS . 28.8 m80 -71.99 14.55 0.21 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.55 -0.719 . . . . 0.0 110.006 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.467 ' H ' ' C ' ' B' ' 67' ' ' HIS . 75.5 m80 59.04 -68.76 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.281 0.562 . . . . 0.0 110.397 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.644 ' N ' ' ND1' ' B' ' 70' ' ' HIS . 0.1 OUTLIER -57.04 -165.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.905 . . . . 0.0 110.52 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 12.3 m80 . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.037 -179.624 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.2 mtp . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.929 0.871 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 54.5 p-10 -146.61 -157.01 0.76 Allowed 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.778 -0.576 . . . . 0.0 109.499 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.414 ' ND2' ' HG ' ' A' ' 56' ' ' LEU . 18.1 p-10 -107.66 1.84 23.42 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.305 -0.872 . . . . 0.0 109.934 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -71.18 146.67 48.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 109.649 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.58 ' NE2' HD11 ' B' ' 9' ' ' LEU . 2.8 pt20 -150.2 160.12 43.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.37 -0.831 . . . . 0.0 109.174 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -100.08 141.56 32.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.377 -0.827 . . . . 0.0 109.053 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 8' ' ' SER . 6.6 tt -133.76 123.85 25.61 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.516 ' N ' HD23 ' A' ' 7' ' ' LEU . 40.4 t -131.88 139.62 48.84 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.736 -0.603 . . . . 0.0 109.556 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.506 HD11 ' NE2' ' B' ' 5' ' ' GLN . 41.8 tp -133.3 147.62 51.9 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p -130.71 159.12 38.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.526 -0.734 . . . . 0.0 109.544 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.95 21.05 69.04 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.35 137.05 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -1.154 . . . . 0.0 109.898 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.5 m -73.12 -44.35 60.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.206 -0.934 . . . . 0.0 109.796 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.56 163.2 5.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.163 -0.961 . . . . 0.0 109.564 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.0 t -93.99 127.71 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.282 -0.886 . . . . 0.0 109.433 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -85.19 -30.92 23.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.046 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.8 t -174.01 167.26 4.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.516 -0.74 . . . . 0.0 109.293 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -149.77 106.54 3.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.344 -0.847 . . . . 0.0 108.856 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.62 126.02 19.81 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -47.24 -24.21 3.58 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.361 1.374 . . . . 0.0 112.228 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -90.7 -8.15 50.67 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.985 -1.072 . . . . 0.0 109.98 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -176.65 141.58 0.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.472 -0.767 . . . . 0.0 109.081 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mt -130.76 130.58 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.105 -0.997 . . . . 0.0 109.085 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.1 mt -114.35 125.0 53.36 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.8 mt -124.33 131.35 53.51 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.566 -0.709 . . . . 0.0 109.624 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -95.28 122.59 38.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.401 -0.812 . . . . 0.0 109.162 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 29' ' ' GLN . 2.9 t -124.18 148.67 47.08 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.44 0.638 . . . . 0.0 110.348 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' A' ' 27' ' ' THR . 60.0 mt 38.09 -90.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.971 -0.455 . . . . 0.0 110.5 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.525 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.1 pt20 -136.47 -15.79 1.62 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.227 -0.921 . . . . 0.0 109.786 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.21 153.82 20.06 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.1 t -111.13 131.05 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.553 -0.969 . . . . 0.0 108.39 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.8 tp -107.34 124.07 49.27 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.693 -0.629 . . . . 0.0 109.633 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.1 m -107.49 120.36 41.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.1 mt -104.73 127.11 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.52 127.64 52.37 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.96 -148.61 5.38 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -142.79 139.23 30.91 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.4 ' C ' HD12 ' A' ' 39' ' ' LEU . 33.1 mtmm 57.25 63.3 1.92 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.524 -0.735 . . . . 0.0 110.315 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.0 mp -94.73 72.06 3.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.268 -0.895 . . . . 0.0 109.023 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.367 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.533 -179.087 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 47.8 tp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.216 0.532 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.534 ' C ' ' H ' ' A' ' 49' ' ' GLY . 63.2 pttt -172.39 -175.45 1.38 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.324 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 47' ' ' LYS . . . 65.78 -15.51 0.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.415 -0.803 . . . . 0.0 110.204 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' A' ' 47' ' ' LYS . . . 82.49 20.4 62.16 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 48' ' ' ALA . 20.9 mp0 -122.49 151.63 41.13 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.397 -1.061 . . . . 0.0 108.974 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.58 135.47 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.509 -0.744 . . . . 0.0 109.422 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -126.93 137.9 53.2 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.5 t -137.48 141.08 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -0.799 . . . . 0.0 108.951 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -114.96 125.21 53.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.497 -0.752 . . . . 0.0 109.033 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.49 166.17 27.12 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.703 ' C ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -86.77 151.42 23.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.52 -0.988 . . . . 0.0 110.772 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.411 HD12 ' OE1' ' A' ' 5' ' ' GLN . 87.9 mt -103.46 119.28 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.832 -1.167 . . . . 0.0 109.168 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -112.5 -11.94 13.55 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.405 -0.81 . . . . 0.0 108.995 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.78 149.03 6.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.105 -0.997 . . . . 0.0 110.086 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.5 mt -138.08 141.46 40.26 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.525 HG22 HD12 ' B' ' 64' ' ' LEU . 65.3 t -134.62 123.4 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.419 -0.801 . . . . 0.0 109.792 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.548 ' O ' ' N ' ' A' ' 64' ' ' LEU . 13.1 t80 -145.69 136.66 12.48 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -44.67 88.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.288 0 CA-C-N 120.22 1.114 . . . . 0.0 111.492 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.592 HD23 ' C ' ' A' ' 64' ' ' LEU . 1.7 tt -58.88 -14.01 7.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.245 -0.909 . . . . 0.0 109.33 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.567 ' HB2' HD23 ' A' ' 64' ' ' LEU . 21.1 tt0 -159.91 -118.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.111 -0.993 . . . . 0.0 108.854 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.34 146.42 34.41 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.395 -0.815 . . . . 0.0 109.615 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.584 ' C ' ' ND1' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -75.93 141.33 42.3 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.01 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.447 ' O ' ' C ' ' A' ' 69' ' ' HIS . 48.1 m170 -116.95 139.93 50.07 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.683 ' N ' ' ND1' ' A' ' 69' ' ' HIS . 0.1 OUTLIER -38.91 111.01 0.15 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.617 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -42.04 144.61 0.43 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.563 -0.711 . . . . 0.0 110.777 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.386 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.28 0.562 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -148.51 99.98 3.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.259 -0.901 . . . . 0.0 110.088 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -106.52 4.83 28.61 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.458 -0.776 . . . . 0.0 109.335 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.3 mmm-85 -77.25 141.84 39.8 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.407 -0.808 . . . . 0.0 109.12 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' GLN . . . . . 0.506 ' NE2' HD11 ' A' ' 9' ' ' LEU . 2.9 pt20 -147.63 161.3 41.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.213 -0.93 . . . . 0.0 109.591 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -116.52 130.77 56.93 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.538 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.4 tt -123.12 121.81 36.91 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.524 ' N ' HD23 ' B' ' 7' ' ' LEU . 97.8 p -114.0 145.76 41.1 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.7 -0.625 . . . . 0.0 109.695 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.58 HD11 ' NE2' ' A' ' 5' ' ' GLN . 34.1 tp -148.09 144.2 27.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.357 -0.839 . . . . 0.0 109.259 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 46.0 p -130.93 170.07 14.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.616 -0.677 . . . . 0.0 109.577 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.02 11.04 77.3 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 83.4 t -72.24 133.75 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -1.166 . . . . 0.0 109.684 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.8 t -72.28 -45.37 60.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.313 -0.867 . . . . 0.0 109.605 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.21 163.06 8.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.077 -1.014 . . . . 0.0 109.658 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 98.1 t -84.67 110.55 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.869 . . . . 0.0 109.979 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -66.35 -41.05 90.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 0.0 109.16 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 5.5 p -160.19 163.96 33.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.338 -0.851 . . . . 0.0 108.963 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -151.21 110.68 3.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.006 -1.058 . . . . 0.0 110.073 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.25 150.0 74.76 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.01 -16.5 49.66 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.612 1.541 . . . . 0.0 111.479 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -111.67 -1.97 15.53 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.557 -0.714 . . . . 0.0 109.517 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.554 ' OE2' HD21 ' B' ' 24' ' ' LEU . 2.7 tm-20 -170.86 130.63 0.81 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.169 -0.957 . . . . 0.0 109.286 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -129.73 132.07 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.231 -0.918 . . . . 0.0 109.847 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.554 HD21 ' OE2' ' B' ' 22' ' ' GLU . 89.5 mt -111.4 125.57 54.01 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 76.4 mt -121.73 124.83 45.16 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.667 -0.646 . . . . 0.0 109.357 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -93.32 113.52 25.72 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.576 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.7 t -124.95 154.04 41.79 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.447 0.641 . . . . 0.0 110.028 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 18.5 mm 42.22 -86.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.883 -0.51 . . . . 0.0 110.339 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' B' ' 27' ' ' THR . 18.7 pt20 -143.51 -17.0 0.63 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.018 -1.051 . . . . 0.0 110.232 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.94 178.05 30.6 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.84 134.35 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 54.8 tp -105.42 127.28 52.9 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.368 -0.833 . . . . 0.0 109.463 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.7 m -116.55 120.69 39.52 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.716 . . . . 0.0 109.645 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 92.1 mt -109.85 129.91 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -127.92 143.22 51.1 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.627 -0.67 . . . . 0.0 109.423 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.61 -142.53 7.58 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.523 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.419 ' HB3' HD11 ' B' ' 56' ' ' LEU . 27.2 tp10 -123.0 143.72 49.74 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.627 -0.925 . . . . 0.0 109.069 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' B' ' 54' ' ' GLU . 49.5 mtmt 51.77 63.32 2.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.341 -0.849 . . . . 0.0 111.184 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.517 ' N ' HD12 ' B' ' 39' ' ' LEU . 8.7 mp -94.88 70.7 3.41 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.979 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.347 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.494 ' N ' HD12 ' B' ' 46' ' ' LEU . 11.3 mp . . . . . 0 N--CA 1.507 2.376 0 CA-C-O 121.91 0.862 . . . . 0.0 109.899 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -148.69 -43.6 0.15 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.433 -1.417 . . . . 0.0 108.318 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.54 1.94 35.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.638 -0.664 . . . . 0.0 109.573 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.63 21.43 72.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -87.92 160.05 18.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.423 -1.045 . . . . 0.0 109.563 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 16.3 m -125.86 133.25 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.606 -0.684 . . . . 0.0 109.292 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -120.07 143.24 48.23 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.422 -0.799 . . . . 0.0 108.941 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.7 t -124.17 135.59 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.629 -0.669 . . . . 0.0 109.513 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' B' ' 38' ' ' LYS . 44.0 tt0 -125.94 135.05 51.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.62 -177.1 27.09 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.461 HD23 ' H ' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -99.67 127.2 45.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.347 -1.09 . . . . 0.0 108.556 179.388 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.509 ' N ' HD12 ' B' ' 57' ' ' ILE . 1.3 mp -79.8 128.06 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.925 . . . . 0.0 109.752 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -108.93 -39.54 5.29 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.569 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -148.29 149.66 32.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 110.094 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.569 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.8 OUTLIER -131.69 131.21 42.9 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.272 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.473 HG13 HD12 ' A' ' 64' ' ' LEU . 47.4 t -129.09 128.77 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' B' ' 62' ' ' TYR . 19.8 t80 -143.53 140.06 17.07 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.57 85.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 120.986 1.124 . . . . 0.0 112.051 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.651 ' H ' ' CD2' ' B' ' 64' ' ' LEU . 0.9 OUTLIER -95.29 5.01 52.86 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.54 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.92 -18.96 2.31 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.458 -0.776 . . . . 0.0 109.64 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.467 ' C ' ' ND1' ' B' ' 67' ' ' HIS . 14.8 m-70 56.55 174.78 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.89 0.852 . . . . 0.0 110.173 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.467 ' ND1' ' C ' ' B' ' 66' ' ' HIS . 0.0 OUTLIER 52.33 169.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.03 0.919 . . . . 0.0 110.438 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -172.91 155.95 3.24 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -86.31 21.76 1.98 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.602 ' ND1' ' N ' ' B' ' 71' ' ' HIS . 0.2 OUTLIER -68.4 133.14 48.22 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 121.831 0.824 . . . . 0.0 109.196 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 71' ' ' HIS . . . . . 0.602 ' N ' ' ND1' ' B' ' 70' ' ' HIS . 24.5 t-80 . . . . . 0 C--N 1.295 -1.795 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.291 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.388 0.614 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.7 t0 58.79 33.28 22.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.329 -0.857 . . . . 0.0 108.861 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -100.87 13.24 35.7 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.509 -0.744 . . . . 0.0 109.182 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -88.84 132.1 34.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.104 -0.997 . . . . 0.0 108.87 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -147.75 161.07 41.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.994 -1.066 . . . . 0.0 109.346 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -108.52 131.17 55.09 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 7' ' ' LEU . 6.3 tt -117.82 121.77 41.63 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.548 ' N ' HD23 ' A' ' 7' ' ' LEU . 46.8 t -116.04 132.34 56.68 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.538 -0.726 . . . . 0.0 109.657 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.539 HD21 ' NE2' ' B' ' 5' ' ' GLN . 5.5 tp -147.31 153.72 40.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.361 -0.837 . . . . 0.0 109.317 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.463 ' OG1' ' N ' ' A' ' 11' ' ' GLY . 6.1 t -149.85 -164.54 2.05 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.36 -0.838 . . . . 0.0 109.847 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.463 ' N ' ' OG1' ' A' ' 10' ' ' THR . . . 65.24 19.38 66.2 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.5 t -70.25 141.66 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.677 -0.896 . . . . 0.0 110.617 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.3 m -71.78 -43.5 65.6 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.91 160.36 3.55 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.234 -0.916 . . . . 0.0 109.918 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.2 t -88.66 129.96 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.4 -0.812 . . . . 0.0 109.852 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -97.34 -35.1 10.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.386 -0.821 . . . . 0.0 109.23 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.8 t -169.67 145.61 3.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.566 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -137.61 113.94 10.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.513 -0.742 . . . . 0.0 109.132 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -133.24 153.56 80.73 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.03 -20.08 44.82 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.295 1.997 . . . . 0.0 111.605 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -102.07 -4.56 25.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.539 -0.726 . . . . 0.0 109.318 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -172.87 142.04 1.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.444 -0.785 . . . . 0.0 109.045 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.8 mt -132.48 130.24 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.427 -0.796 . . . . 0.0 109.725 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.5 mt -118.06 121.44 40.59 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.6 mt -124.37 125.09 43.73 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -81.76 114.75 20.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.347 -0.846 . . . . 0.0 109.924 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 28' ' ' ILE . 14.5 t -124.68 -179.52 4.54 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.659 0.742 . . . . 0.0 110.215 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.492 ' O ' ' O ' ' A' ' 27' ' ' THR . 1.3 mt -36.51 161.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 121.736 0.779 . . . . 0.0 110.414 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.414 ' OE1' ' OD1' ' B' ' 58' ' ' ASP . 78.6 mm-40 65.12 -61.9 0.22 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.139 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -165.94 -127.26 0.88 Allowed Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.093 -1.527 . . . . 0.0 109.962 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.6 t -122.37 135.18 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.593 -0.945 . . . . 0.0 110.338 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.451 HD11 HD12 ' A' ' 60' ' ' LEU . 42.8 tp -105.55 125.41 50.96 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.8 m -103.61 123.0 46.16 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -107.75 125.02 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -116.57 140.83 48.95 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.47 -151.38 9.43 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.415 ' HB3' HD11 ' A' ' 56' ' ' LEU . 14.1 tp10 -143.32 146.39 33.51 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.337 -1.096 . . . . 0.0 109.024 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 54' ' ' GLU . 67.5 mttm 58.33 55.22 5.14 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.486 0.66 . . . . 0.0 109.68 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.7 mp -92.9 72.64 4.81 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.849 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -179.125 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.6 tp . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.578 0.704 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -144.4 -83.94 0.15 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.735 -0.603 . . . . 0.0 109.399 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.53 -5.39 58.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 0.0 109.415 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.44 18.97 79.96 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -91.6 162.15 14.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.17 -1.194 . . . . 0.0 109.859 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.4 t -115.05 131.97 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -131.16 136.56 48.42 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.76 135.01 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 38' ' ' LYS . 5.1 tm-20 -116.89 126.55 53.16 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.0 -174.61 41.62 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.211 -1.471 . . . . 0.0 110.032 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.415 HD11 ' HB3' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -106.42 118.21 36.06 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.809 -0.818 . . . . 0.0 109.387 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.53 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.4 mp -74.05 128.08 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.337 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -105.73 -21.9 13.07 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.629 ' O ' HD22 ' A' ' 60' ' ' LEU . . . -166.89 158.28 12.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.991 -1.068 . . . . 0.0 110.834 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.629 HD22 ' O ' ' A' ' 59' ' ' ALA . 0.7 OUTLIER -135.64 135.34 40.1 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.461 HG22 HD12 ' B' ' 64' ' ' LEU . 58.8 t -133.96 119.94 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.436 -0.79 . . . . 0.0 109.63 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 64' ' ' LEU . 29.2 t80 -133.46 140.06 35.85 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.77 68.4 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.602 1.535 . . . . 0.0 111.924 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.608 HD12 HG22 ' B' ' 61' ' ' VAL . 0.2 OUTLIER -71.54 55.08 0.24 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.734 -0.604 . . . . 0.0 109.689 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 64' ' ' LEU . 8.1 pt-20 -39.56 -23.53 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.997 -1.065 . . . . 0.0 109.974 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.573 ' N ' ' O ' ' A' ' 64' ' ' LEU . 2.0 t-80 51.16 11.41 0.1 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.691 -0.631 . . . . 0.0 109.616 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.51 ' ND1' ' OXT' ' A' ' 71' ' ' HIS . 12.2 t-80 -140.11 119.57 13.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.425 -0.797 . . . . 0.0 109.766 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.58 144.75 43.82 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.651 0.739 . . . . 0.0 110.151 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.474 ' CD2' ' CE1' ' A' ' 70' ' ' HIS . 0.7 OUTLIER 60.79 173.17 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.39 0.614 . . . . 0.0 110.677 179.458 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.474 ' CE1' ' CD2' ' A' ' 69' ' ' HIS . 15.2 m80 44.4 -115.06 0.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.51 ' OXT' ' ND1' ' A' ' 67' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 117.873 -1.061 . . . . 0.0 109.196 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.6 ttm . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.315 0.579 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 21.6 t0 56.02 69.0 0.78 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.355 -0.84 . . . . 0.0 109.635 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -104.27 17.52 23.95 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 47.2 mmm-85 -88.66 137.77 32.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.657 -1.277 . . . . 0.0 109.451 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' GLN . . . . . 0.539 ' NE2' HD21 ' A' ' 9' ' ' LEU . 46.5 tt0 -139.05 149.92 45.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.295 -0.878 . . . . 0.0 109.502 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -109.46 129.55 55.55 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.508 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.9 tt -122.69 122.49 38.88 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.46 ' N ' HD23 ' B' ' 7' ' ' LEU . 41.6 t -123.14 137.26 54.95 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.6 tp -145.25 151.59 38.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.221 -0.924 . . . . 0.0 109.835 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -140.49 159.74 41.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.708 -0.62 . . . . 0.0 109.629 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.47 24.19 26.86 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.439 HG22 ' H ' ' B' ' 14' ' ' LYS . 6.2 p -62.62 141.37 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.166 -1.197 . . . . 0.0 110.034 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 10.0 m -92.28 -21.35 20.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.411 -0.806 . . . . 0.0 109.26 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.439 ' H ' HG22 ' B' ' 12' ' ' VAL . 9.8 tttt -171.8 154.2 3.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.555 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 75.5 t -102.67 99.16 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -67.36 -40.55 85.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 109.07 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 25.8 t -170.76 167.97 7.49 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.408 -0.808 . . . . 0.0 109.523 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -149.7 105.2 3.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.532 -0.73 . . . . 0.0 109.123 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -132.77 147.82 67.04 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.59 -14.59 39.9 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 121.7 1.6 . . . . 0.0 111.735 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -104.05 -8.01 19.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.548 -0.72 . . . . 0.0 109.534 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -173.18 113.19 0.23 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.371 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 97.3 mt -109.35 127.14 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.235 -0.916 . . . . 0.0 109.221 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 68.4 mt -117.69 123.43 46.06 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 88.5 mt -131.22 129.49 41.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.465 -0.772 . . . . 0.0 109.391 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.2 111.47 17.65 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.604 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.487 ' O ' ' O ' ' B' ' 28' ' ' ILE . 12.9 t -124.39 -176.94 3.64 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.571 0.7 . . . . 0.0 110.29 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' B' ' 27' ' ' THR . 1.9 mt -32.62 157.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.886 0.85 . . . . 0.0 110.951 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 22.6 mm100 64.6 -62.45 0.18 Allowed 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.939 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' B' ' 28' ' ' ILE . . . -166.34 -120.09 0.5 Allowed Glycine 0 N--CA 1.486 1.968 0 C-N-CA 119.225 -1.464 . . . . 0.0 110.202 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 53.1 t -119.4 135.03 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.676 -0.897 . . . . 0.0 110.539 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 59.0 tp -109.33 123.38 49.22 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.4 t -107.4 123.66 48.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.792 -0.567 . . . . 0.0 109.989 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 94.6 mt -108.52 122.37 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -117.6 142.44 47.2 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.599 -0.688 . . . . 0.0 109.457 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' GLY . . . . . 0.433 ' HA2' ' H ' ' B' ' 58' ' ' ASP . . . 174.61 -146.74 8.71 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -139.1 142.06 38.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.365 -1.08 . . . . 0.0 109.489 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 88.9 mttt 56.21 57.1 5.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.668 -0.645 . . . . 0.0 109.798 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.511 ' N ' HD12 ' B' ' 39' ' ' LEU . 8.6 mp -92.99 71.53 4.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.345 -0.847 . . . . 0.0 108.912 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' GLY . . . . . 0.41 ' O ' ' OE1' ' B' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 121.567 0.698 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -63.98 -46.74 83.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.607 -0.683 . . . . 0.0 109.463 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -169.71 47.77 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.384 -0.822 . . . . 0.0 108.816 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.91 17.62 62.91 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -125.15 154.58 41.28 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.316 -1.108 . . . . 0.0 109.399 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 m -124.07 133.12 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.652 -0.655 . . . . 0.0 109.381 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -126.35 127.96 46.32 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.92 140.68 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.46 -0.775 . . . . 0.0 109.91 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.41 ' OE1' ' O ' ' B' ' 40' ' ' GLY . 5.3 mp0 -114.99 139.58 49.73 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.92 170.66 26.97 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.16 131.33 38.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.242 -1.152 . . . . 0.0 109.469 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 44.2 mm -87.66 113.98 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.099 -1.001 . . . . 0.0 108.862 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' ASP . . . . . 0.433 ' H ' ' HA2' ' B' ' 36' ' ' GLY . 18.2 t0 -97.68 -7.0 31.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.593 -0.692 . . . . 0.0 109.222 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -177.19 154.85 1.09 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.048 -1.032 . . . . 0.0 110.823 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.4 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 11.8 mt -139.93 138.46 35.61 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.608 HG22 HD12 ' A' ' 64' ' ' LEU . 61.3 t -134.14 129.8 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.507 -0.746 . . . . 0.0 109.216 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.666 ' O ' ' N ' ' B' ' 64' ' ' LEU . 65.1 t80 -143.2 123.0 7.71 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' B' ' 65' ' ' GLU . 71.0 Cg_exo -48.44 71.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 121.983 1.788 . . . . 0.0 111.91 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.666 ' N ' ' O ' ' B' ' 62' ' ' TYR . 0.3 OUTLIER -71.53 40.89 0.07 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.886 0.851 . . . . 0.0 109.975 -179.128 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.452 ' H ' ' C ' ' B' ' 63' ' ' PRO . 13.7 mt-10 -86.58 116.57 24.79 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.265 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.547 ' O ' ' N ' ' B' ' 68' ' ' HIS . 65.1 t60 -95.07 170.06 9.68 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.503 ' O ' ' O ' ' B' ' 68' ' ' HIS . 10.8 t-80 64.92 -45.0 0.34 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 0.547 ' N ' ' O ' ' B' ' 66' ' ' HIS . 0.1 OUTLIER 54.76 117.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.545 -0.722 . . . . 0.0 109.421 178.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.46 ' C ' ' O ' ' B' ' 68' ' ' HIS . 6.1 t-160 -33.54 91.7 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.289 0.566 . . . . 0.0 111.344 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' B' ' 68' ' ' HIS . 0.9 OUTLIER -89.69 -5.27 57.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.318 -0.864 . . . . 0.0 109.1 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.194 -0.941 . . . . 0.0 109.269 -179.707 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.345 0.593 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.32 113.05 24.28 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.377 -0.827 . . . . 0.0 109.556 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -93.35 1.14 57.05 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.368 -0.832 . . . . 0.0 109.705 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.6 mmm-85 -81.61 148.0 29.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.241 -0.912 . . . . 0.0 110.121 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -155.83 160.13 39.96 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.46 -0.775 . . . . 0.0 109.264 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -108.92 138.37 45.36 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.536 HD23 ' N ' ' A' ' 8' ' ' SER . 6.7 tt -126.82 124.72 40.3 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.536 ' N ' HD23 ' A' ' 7' ' ' LEU . 44.2 t -127.81 149.12 50.41 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.543 HD21 ' NE2' ' B' ' 5' ' ' GLN . 9.0 tp -142.5 146.25 34.53 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.344 -0.848 . . . . 0.0 109.402 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -124.73 167.77 14.11 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.641 -0.662 . . . . 0.0 109.534 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.37 14.96 69.8 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.3 p -68.93 136.76 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -1.12 . . . . 0.0 109.685 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.5 m -73.18 -46.5 50.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.307 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.96 163.1 4.0 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.346 -0.846 . . . . 0.0 109.882 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.2 t -95.18 117.55 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.412 -0.805 . . . . 0.0 109.823 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -68.84 -35.9 77.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.373 -0.83 . . . . 0.0 109.184 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -167.31 161.61 14.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.294 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -151.29 111.47 4.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.394 -0.816 . . . . 0.0 108.97 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -126.9 156.63 73.7 Favored Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.436 -0.79 . . . . 0.0 108.888 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.19 -29.78 84.81 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.776 1.651 . . . . 0.0 112.514 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -117.17 17.71 14.72 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.469 -0.769 . . . . 0.0 110.589 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -171.24 132.36 0.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 0.0 109.168 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.17 129.94 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.366 -0.834 . . . . 0.0 109.54 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.459 ' CD2' ' OG ' ' A' ' 33' ' ' SER . 64.4 mt -112.93 126.86 55.94 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.1 mt -121.53 132.43 54.7 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.666 -0.647 . . . . 0.0 109.763 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -101.68 113.94 27.54 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 28' ' ' ILE . 9.9 t -124.61 -162.84 1.12 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.396 0.617 . . . . 0.0 110.037 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.493 HD11 ' O ' ' B' ' 3' ' ' ASN . 63.2 mt -33.48 99.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 28' ' ' ILE . 5.6 pt20 29.58 53.83 0.12 Allowed 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 121.294 0.569 . . . . 0.0 111.558 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.02 145.46 8.16 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.53 131.22 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.516 -0.991 . . . . 0.0 108.908 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.7 tp -108.05 118.31 36.41 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.459 ' OG ' ' CD2' ' A' ' 24' ' ' LEU . 22.8 t -104.64 123.58 47.83 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.1 mt -105.81 129.18 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.438 -0.789 . . . . 0.0 109.433 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -120.38 139.19 53.15 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.78 -149.3 8.82 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -133.19 142.54 48.66 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.373 -1.075 . . . . 0.0 109.456 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.5 mttp 54.63 59.9 3.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.565 -0.71 . . . . 0.0 110.545 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.0 mp -91.38 74.19 6.08 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.95 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.098 -177.313 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 80.8 mt . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.625 0.726 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -84.3 -72.99 0.44 Allowed 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.571 0.701 . . . . 0.0 109.905 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.79 0.12 57.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.67 -0.644 . . . . 0.0 109.539 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.01 47.49 4.14 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -129.47 160.39 33.3 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.418 -1.048 . . . . 0.0 109.294 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.36 161.48 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.611 -0.681 . . . . 0.0 109.408 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -139.35 137.84 36.11 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.458 -0.776 . . . . 0.0 109.487 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 52.1 t -130.6 136.53 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -123.34 129.58 51.51 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.374 -0.829 . . . . 0.0 108.902 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.4 177.48 33.54 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.525 HD23 ' H ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -95.79 133.7 39.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.283 -1.128 . . . . 0.0 109.273 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.441 ' CG2' HD23 ' A' ' 60' ' ' LEU . 91.8 mt -90.54 111.7 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.148 -0.97 . . . . 0.0 109.727 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -99.31 -17.06 18.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.498 -0.751 . . . . 0.0 109.39 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.59 153.22 16.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.074 -1.016 . . . . 0.0 110.248 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.441 HD23 ' CG2' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -135.04 136.5 42.13 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.39 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.695 HG22 HD12 ' B' ' 64' ' ' LEU . 3.2 t -135.89 127.44 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.496 -0.752 . . . . 0.0 109.564 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.426 ' C ' ' CD1' ' A' ' 62' ' ' TYR . 9.2 t80 -144.06 139.86 16.39 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -64.19 79.92 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.002 1.135 . . . . 0.0 113.379 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.829 HD13 ' O ' ' A' ' 64' ' ' LEU . 1.4 tm? -103.12 82.28 2.06 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.989 -1.07 . . . . 0.0 108.7 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -135.22 14.31 3.53 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 32.5 m80 53.41 13.99 0.51 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.785 -0.572 . . . . 0.0 111.068 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.467 ' CE1' ' O ' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -139.35 155.58 47.58 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.814 -1.179 . . . . 0.0 109.492 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.467 ' O ' ' CE1' ' A' ' 67' ' ' HIS . 19.0 m80 -104.27 174.28 5.94 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -115.1 -162.89 0.84 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.446 -0.784 . . . . 0.0 110.003 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -62.24 -44.38 96.69 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.8 m80 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.265 -179.76 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ptp . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -86.56 108.85 18.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.394 -0.817 . . . . 0.0 109.645 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.493 ' O ' HD11 ' A' ' 28' ' ' ILE . 13.7 p-10 -107.46 8.39 29.43 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.366 -0.834 . . . . 0.0 110.121 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -71.44 143.41 50.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.047 -1.033 . . . . 0.0 109.315 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' GLN . . . . . 0.543 ' NE2' HD21 ' A' ' 9' ' ' LEU . 35.8 tt0 -146.45 152.76 39.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.431 -0.793 . . . . 0.0 109.598 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.598 ' N ' ' CD1' ' B' ' 6' ' ' PHE . 1.5 m-85 -124.18 145.38 49.36 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.579 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.0 tt -130.7 125.77 34.79 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.555 ' N ' HD23 ' B' ' 7' ' ' LEU . 31.1 t -107.24 137.65 44.89 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.651 -0.656 . . . . 0.0 109.264 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.717 ' O ' HG12 ' B' ' 51' ' ' VAL . 10.2 tp -149.32 155.27 40.26 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.044 -1.035 . . . . 0.0 109.652 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.7 t -149.95 157.86 43.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.131 -0.98 . . . . 0.0 109.273 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.33 12.95 57.99 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 87.0 t -67.29 135.15 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.997 -1.296 . . . . 0.0 109.28 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 33.2 m -71.87 -45.28 61.89 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.641 -0.823 . . . . 0.0 109.809 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.39 159.47 5.68 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.099 -1.001 . . . . 0.0 109.474 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 87.5 t -92.23 129.7 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.309 -0.869 . . . . 0.0 109.747 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -86.71 -26.69 24.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.421 -0.799 . . . . 0.0 109.795 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 32.7 t -171.88 160.74 5.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -0.896 . . . . 0.0 109.05 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -148.37 108.12 4.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.816 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -132.62 131.16 22.01 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.37 -24.73 9.07 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 CA-C-N 119.991 1.032 . . . . 0.0 111.829 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -93.63 -6.53 46.24 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.337 -0.852 . . . . 0.0 110.157 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -171.86 133.2 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.228 -0.92 . . . . 0.0 109.155 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 94.0 mt -128.12 131.13 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.4 -0.813 . . . . 0.0 109.469 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 17.2 mt -111.86 125.48 54.07 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 80.8 mt -122.34 118.49 28.59 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -89.55 116.5 27.75 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.576 ' O ' ' N ' ' B' ' 29' ' ' GLN . 2.9 t -123.73 149.04 46.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 109.771 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 59.3 mt 46.95 -85.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.079 0.466 . . . . 0.0 110.028 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' B' ' 27' ' ' THR . 28.1 pt20 -143.07 -23.39 0.62 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.089 -1.007 . . . . 0.0 110.786 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.6 171.56 32.04 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 54.9 t -119.92 130.22 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.848 -0.795 . . . . 0.0 108.883 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.402 HD11 HD12 ' B' ' 60' ' ' LEU . 48.6 tp -111.23 128.04 55.8 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.78 127.69 56.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 90.4 mt -105.71 126.53 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -119.49 130.63 55.32 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.7 -147.83 6.34 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -133.59 144.25 49.18 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.344 -1.091 . . . . 0.0 109.447 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 53.34 57.02 6.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.523 -0.735 . . . . 0.0 110.584 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.513 ' N ' HD12 ' B' ' 39' ' ' LEU . 9.3 mp -84.11 73.39 10.4 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.562 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.694 -178.001 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.655 0.741 . . . . 0.0 109.269 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -65.41 -35.82 82.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.635 -0.666 . . . . 0.0 109.706 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.27 -0.55 57.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.394 -0.817 . . . . 0.0 109.855 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.5 19.2 79.64 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -139.45 158.5 44.04 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.404 -1.057 . . . . 0.0 109.15 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.717 HG12 ' O ' ' B' ' 9' ' ' LEU . 14.8 p -128.17 153.91 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.372 -0.83 . . . . 0.0 109.51 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -141.13 119.46 12.18 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.22 153.85 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.334 -0.854 . . . . 0.0 108.888 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -123.66 133.21 53.94 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.456 0.646 . . . . 0.0 109.49 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.14 163.78 14.79 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.448 HD23 ' H ' ' B' ' 56' ' ' LEU . 0.1 OUTLIER -88.13 140.93 28.98 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.02 -1.282 . . . . 0.0 109.643 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.485 ' H ' HD12 ' A' ' 28' ' ' ILE . 45.5 mm -84.31 126.17 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.322 -0.861 . . . . 0.0 109.481 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -113.53 -34.71 5.47 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.45 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -167.99 146.11 4.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.158 -0.964 . . . . 0.0 110.323 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.45 HD22 ' O ' ' B' ' 59' ' ' ALA . 3.9 mm? -117.31 135.96 53.47 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.12 118.05 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.803 0.811 . . . . 0.0 108.97 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.524 ' O ' ' N ' ' B' ' 64' ' ' LEU . 55.8 t80 -138.66 100.98 8.11 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -46.13 84.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 121.473 1.449 . . . . 0.0 112.341 -177.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.695 HD12 HG22 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -74.21 78.6 1.79 Allowed 'General case' 0 C--N 1.306 -1.288 0 O-C-N 120.884 -1.135 . . . . 0.0 108.883 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -156.96 147.93 21.82 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -46.54 119.89 2.63 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.884 -1.135 . . . . 0.0 109.737 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.47 ' C ' ' H ' ' B' ' 69' ' ' HIS . 0.1 OUTLIER -67.39 -104.56 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.771 -0.58 . . . . 0.0 110.899 -178.488 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 57.1 7.51 0.44 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.146 -0.971 . . . . 0.0 108.458 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.47 ' H ' ' C ' ' B' ' 67' ' ' HIS . 9.2 t-80 -170.98 125.24 0.66 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.49 157.63 30.21 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 4.6 t60 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.803 -1.094 . . . . 0.0 108.796 179.359 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ptt? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -147.98 25.04 1.04 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.43 HD22 ' CB ' ' A' ' 56' ' ' LEU . 8.5 p-10 -102.51 -24.0 13.85 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.554 0.692 . . . . 0.0 109.306 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.538 ' NH1' ' N ' ' A' ' 55' ' ' GLY . 7.6 mmm180 -54.08 148.33 11.14 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.322 -0.861 . . . . 0.0 109.743 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' OE1' HD11 ' B' ' 9' ' ' LEU . 16.0 pt20 -155.16 159.09 39.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.529 -0.732 . . . . 0.0 110.167 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -99.62 148.94 23.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.629 -0.67 . . . . 0.0 109.366 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.505 HD23 ' N ' ' A' ' 8' ' ' SER . 7.0 tt -138.5 126.63 22.75 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.176 -0.952 . . . . 0.0 108.457 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.505 ' N ' HD23 ' A' ' 7' ' ' LEU . 20.0 m -123.77 141.67 51.81 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.436 -0.79 . . . . 0.0 109.563 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.4 tp -150.76 145.64 25.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.386 -0.821 . . . . 0.0 109.354 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 p -137.92 172.14 13.37 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.462 -0.774 . . . . 0.0 109.09 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.62 20.85 59.19 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.91 134.84 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.028 -1.278 . . . . 0.0 110.067 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.1 m -74.71 -53.6 8.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.885 . . . . 0.0 109.841 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.14 156.19 28.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.042 -1.036 . . . . 0.0 109.835 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.1 t -88.92 129.5 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.348 -0.845 . . . . 0.0 109.841 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -97.98 -36.34 10.17 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.163 -0.961 . . . . 0.0 109.316 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.7 t -170.8 148.24 2.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.887 . . . . 0.0 108.907 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -141.49 110.78 6.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.343 -0.848 . . . . 0.0 109.142 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -133.48 144.58 52.83 Favored Pre-proline 0 N--CA 1.503 2.189 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.73 -35.67 48.62 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.027 1.152 . . . . 0.0 111.565 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -63.15 -45.09 93.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.2 -0.938 . . . . 0.0 110.0 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -156.83 156.15 32.72 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.393 -0.817 . . . . 0.0 109.089 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.5 mt -120.25 131.47 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.639 -0.663 . . . . 0.0 109.966 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.3 mt -112.93 116.62 30.27 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 mt -127.03 135.54 50.95 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.389 -0.819 . . . . 0.0 109.292 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -97.48 119.26 35.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.146 -0.971 . . . . 0.0 109.216 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 29' ' ' GLN . 8.9 t -124.57 158.99 31.66 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.301 0.572 . . . . 0.0 110.348 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 27' ' ' THR . 44.8 mt 32.26 -86.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 CA-C-O 121.125 0.488 . . . . 0.0 111.261 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 27' ' ' THR . 24.9 pt20 -150.33 47.71 0.9 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.191 -0.943 . . . . 0.0 109.943 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -171.45 142.31 6.92 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.6 t -90.19 132.64 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.4 -1.059 . . . . 0.0 109.559 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.9 tp -106.95 125.09 50.55 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.6 t -113.05 124.46 52.66 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.6 mt -108.31 123.88 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -112.91 137.34 51.44 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.577 0.703 . . . . 0.0 109.558 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.92 -149.52 10.03 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -137.31 144.56 42.67 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.337 -1.096 . . . . 0.0 109.492 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp 56.1 59.01 3.94 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.726 0.774 . . . . 0.0 109.438 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.1 mp -92.23 73.86 5.39 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.572 0 C-N-CA 119.939 -1.124 . . . . 0.0 110.528 -178.355 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.8 tp . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -160.11 -74.09 0.07 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.0 108.669 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.07 -2.64 41.43 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.598 -0.689 . . . . 0.0 109.225 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.74 22.75 78.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -82.17 161.19 22.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.33 -1.1 . . . . 0.0 109.215 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.98 135.46 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.472 -0.768 . . . . 0.0 109.397 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -126.49 131.7 51.57 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.455 0.645 . . . . 0.0 109.588 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -120.58 136.25 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HB2' HH22 ' A' ' 4' ' ' ARG . 2.6 pt-20 -130.08 146.33 51.74 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.538 ' N ' ' NH1' ' A' ' 4' ' ' ARG . . . 149.1 -175.57 28.27 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.43 ' CB ' HD22 ' A' ' 3' ' ' ASN . 2.4 pp -97.06 127.42 43.01 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.058 -1.26 . . . . 0.0 109.667 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.4 mm -87.32 120.91 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.273 -0.892 . . . . 0.0 109.837 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -105.7 -12.4 15.93 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.524 -0.735 . . . . 0.0 109.592 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -174.07 156.66 2.74 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.084 -1.01 . . . . 0.0 110.259 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.9 mt -138.7 135.48 34.83 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.488 HG22 HD12 ' B' ' 64' ' ' LEU . 77.7 t -128.08 128.88 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.554 -0.716 . . . . 0.0 109.248 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.434 ' CE1' ' O ' ' A' ' 63' ' ' PRO . 29.9 t80 -145.03 140.09 15.8 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.434 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 90.0 Cg_endo -80.3 113.01 2.85 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.442 1.428 . . . . 0.0 112.129 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.866 ' H ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -106.09 3.36 28.02 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.208 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.523 ' N ' HD22 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -74.87 157.62 34.78 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.982 0.896 . . . . 0.0 110.891 -178.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.489 ' ND1' ' N ' ' A' ' 66' ' ' HIS . 2.6 p-80 -153.46 -107.76 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.416 ' CD2' ' C ' ' A' ' 67' ' ' HIS . 22.8 t-160 -166.87 115.34 0.85 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.907 -1.12 . . . . 0.0 109.796 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 69' ' ' HIS . 2.7 t-160 -148.29 102.32 3.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.135 -0.978 . . . . 0.0 108.96 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.49 ' CE1' ' O ' ' A' ' 70' ' ' HIS . 26.0 t-80 56.72 118.64 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.601 0.715 . . . . 0.0 110.138 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.49 ' O ' ' CE1' ' A' ' 69' ' ' HIS . 19.3 m170 -72.04 137.61 47.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.198 -0.939 . . . . 0.0 109.559 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.8 p80 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.325 179.662 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 29.9 tpp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -130.22 94.64 3.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.458 -0.776 . . . . 0.0 109.028 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -95.81 1.88 53.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.381 -0.825 . . . . 0.0 109.255 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -69.37 142.45 53.94 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.372 -0.83 . . . . 0.0 109.121 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -144.63 153.11 41.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.274 -0.891 . . . . 0.0 109.857 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -114.66 129.16 56.64 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.574 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.8 tt -120.63 124.63 45.73 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.386 -0.821 . . . . 0.0 109.102 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.563 ' N ' HD23 ' B' ' 7' ' ' LEU . 7.6 m -118.98 138.37 52.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.664 -0.647 . . . . 0.0 109.338 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.445 HD11 ' OE1' ' A' ' 5' ' ' GLN . 53.7 tp -146.64 140.87 26.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 0.0 109.23 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.411 ' O ' ' OG1' ' B' ' 10' ' ' THR . 1.0 OUTLIER -134.22 106.34 7.09 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.79 48.35 0.03 OUTLIER Glycine 0 N--CA 1.495 2.571 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.457 ' O ' HG13 ' B' ' 12' ' ' VAL . 14.6 p -104.49 131.54 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.542 -0.975 . . . . 0.0 109.67 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 6.3 t -71.21 -43.86 66.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.261 -0.899 . . . . 0.0 109.005 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.81 159.27 5.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.29 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 88.0 t -91.09 127.36 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.131 -0.981 . . . . 0.0 109.59 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -88.35 -23.32 23.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.253 -0.904 . . . . 0.0 109.364 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 32.9 t -172.52 159.78 4.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.322 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -146.09 104.01 3.78 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.054 -1.029 . . . . 0.0 109.73 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.74 150.76 74.34 Favored Pre-proline 0 N--CA 1.497 1.887 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.44 -9.09 22.63 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.449 1.433 . . . . 0.0 111.095 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -99.43 -16.96 18.19 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.388 -0.82 . . . . 0.0 109.437 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.41 ' OE2' ' C ' ' B' ' 23' ' ' ILE . 2.1 tm-20 -173.74 125.04 0.37 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.41 ' C ' ' OE2' ' B' ' 22' ' ' GLU . 77.9 mt -116.04 129.27 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.331 -0.855 . . . . 0.0 109.371 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 86.9 mt -105.18 125.5 51.05 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 88.2 mt -124.06 122.18 37.18 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.659 -0.651 . . . . 0.0 109.697 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -89.65 110.76 21.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.571 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.9 t -124.45 148.91 47.33 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.659 0.742 . . . . 0.0 109.842 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.402 HD13 ' N ' ' B' ' 28' ' ' ILE . 6.1 mm 51.95 -80.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.839 -0.538 . . . . 0.0 110.024 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' B' ' 27' ' ' THR . 15.3 pt20 -152.1 -21.46 0.18 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.195 -0.94 . . . . 0.0 109.825 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.99 177.87 32.96 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 47.7 t -119.93 132.42 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 38.5 tp -105.86 128.01 53.48 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.411 -0.806 . . . . 0.0 109.363 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 37.0 t -114.39 120.1 39.18 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 86.2 mt -107.19 123.39 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -114.44 140.67 48.51 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.47 0.652 . . . . 0.0 109.489 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.47 -154.46 24.69 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -130.97 149.92 52.37 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.389 -1.065 . . . . 0.0 109.321 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' B' ' 54' ' ' GLU . 26.1 mmtp 61.88 48.08 5.6 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.558 0.694 . . . . 0.0 109.382 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.536 ' N ' HD12 ' B' ' 39' ' ' LEU . 10.1 mp -91.85 72.89 5.71 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.242 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.466 HD12 ' H ' ' B' ' 50' ' ' GLN . 4.1 mm? . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -67.98 -33.37 74.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.623 -0.673 . . . . 0.0 109.519 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.75 -2.46 54.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.86 . . . . 0.0 108.862 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 50.16 71.97 0.55 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.466 ' H ' HD12 ' B' ' 46' ' ' LEU . 88.9 mt-30 -138.22 159.11 42.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.256 -1.143 . . . . 0.0 108.731 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 8.1 m -126.11 131.29 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.385 -0.822 . . . . 0.0 109.845 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -130.46 126.39 36.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 69.6 t -116.58 136.56 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' B' ' 38' ' ' LYS . 29.6 mt-10 -123.42 144.43 49.5 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.99 177.41 23.98 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.436 HD23 ' H ' ' B' ' 56' ' ' LEU . 0.1 OUTLIER -90.18 144.11 26.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.093 -1.239 . . . . 0.0 109.283 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.507 ' CG2' HD23 ' B' ' 60' ' ' LEU . 35.5 mm -93.62 112.87 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.316 -0.865 . . . . 0.0 109.72 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -101.15 -21.55 14.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.335 -0.853 . . . . 0.0 109.249 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.555 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -167.06 152.65 7.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.744 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.555 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.5 OUTLIER -134.99 133.06 39.08 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.505 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 53.3 t -134.95 127.07 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.547 -0.721 . . . . 0.0 110.0 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.571 ' O ' ' N ' ' B' ' 64' ' ' LEU . 16.0 t80 -141.46 122.49 8.8 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -43.87 84.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.214 1.276 . . . . 0.0 112.376 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.724 ' H ' HD23 ' B' ' 64' ' ' LEU . 0.9 OUTLIER -93.76 21.11 6.79 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -94.26 121.74 36.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.482 -0.761 . . . . 0.0 110.724 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -170.97 76.66 0.07 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.593 ' ND1' ' N ' ' B' ' 68' ' ' HIS . 1.1 t60 -143.11 141.74 31.31 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 0.593 ' N ' ' ND1' ' B' ' 67' ' ' HIS . 0.7 OUTLIER -99.14 110.08 22.69 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.355 -0.841 . . . . 0.0 109.606 -179.207 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.88 -38.99 87.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.443 -0.785 . . . . 0.0 109.086 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -52.68 170.91 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.379 -0.826 . . . . 0.0 110.099 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 30.3 m80 . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.203 -179.58 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.517 ' O ' ' N ' ' A' ' 3' ' ' ASN . 96.6 mtp . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.586 0.707 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.523 ' C ' ' OD1' ' A' ' 2' ' ' ASP . 1.4 p30 42.26 22.11 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.768 0.794 . . . . 0.0 110.069 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 1' ' ' MET . 31.3 p-10 -72.85 -5.04 35.5 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -82.26 122.31 27.77 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -142.14 163.57 32.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.188 -0.945 . . . . 0.0 109.625 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.457 ' N ' ' CD1' ' A' ' 6' ' ' PHE . 1.1 m-85 -111.33 134.29 53.02 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.573 HD23 ' C ' ' A' ' 7' ' ' LEU . 6.0 tt -120.28 121.91 39.7 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.573 ' N ' HD23 ' A' ' 7' ' ' LEU . 68.5 m -115.3 146.74 41.22 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.526 -0.734 . . . . 0.0 109.409 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 tp -152.83 149.65 28.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 109.288 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 t -140.76 165.81 26.47 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.368 -0.833 . . . . 0.0 109.651 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.35 20.87 53.75 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -67.68 136.81 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -1.126 . . . . 0.0 110.333 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t -73.08 -41.36 64.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.379 -0.826 . . . . 0.0 109.542 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -168.89 167.56 10.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.097 -1.002 . . . . 0.0 109.655 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.1 t -98.82 99.61 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.276 -0.89 . . . . 0.0 109.871 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -65.93 -40.68 91.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 108.886 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -168.5 153.44 6.3 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -149.33 107.08 3.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 108.621 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -132.76 152.92 80.75 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.82 5.96 0.91 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.025 1.817 . . . . 0.0 111.438 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -133.25 -2.27 3.15 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.461 -0.774 . . . . 0.0 109.5 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -171.92 130.1 0.64 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.918 . . . . 0.0 108.856 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.85 128.73 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.329 -0.857 . . . . 0.0 109.979 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.2 mt -123.25 121.25 35.42 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.8 mt -129.39 131.63 46.86 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.536 -0.728 . . . . 0.0 109.203 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -96.43 119.42 34.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.985 -1.072 . . . . 0.0 109.582 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.569 ' O ' ' N ' ' A' ' 29' ' ' GLN . 5.2 t -124.2 148.61 47.15 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.538 0.685 . . . . 0.0 110.098 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.401 ' N ' HD13 ' A' ' 28' ' ' ILE . 5.9 mm 54.81 -79.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.783 -0.573 . . . . 0.0 109.541 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 27' ' ' THR . 13.5 pt20 -154.52 -20.61 0.12 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 0.0 110.074 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.06 177.18 32.42 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.0 t -123.0 132.84 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.779 -0.836 . . . . 0.0 109.203 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.7 tp -105.12 126.51 52.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.487 -0.758 . . . . 0.0 108.971 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.3 t -113.6 123.43 49.93 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.5 mt -112.95 130.2 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.73 139.0 53.9 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.3 -153.24 16.09 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -131.25 153.6 49.35 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.503 -0.998 . . . . 0.0 109.312 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt 57.81 56.54 4.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.493 -0.754 . . . . 0.0 109.82 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.8 mp -93.0 71.91 4.68 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.713 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.114 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 49' ' ' GLY . 3.7 mm? . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 46' ' ' LEU . 38.1 ttpt 33.0 -89.63 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.369 0.604 . . . . 0.0 111.403 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . -77.82 16.33 0.71 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.159 -0.963 . . . . 0.0 109.867 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . 62.72 51.5 55.39 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -101.03 152.44 20.58 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.303 -1.116 . . . . 0.0 109.92 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.2 t -127.67 135.97 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -129.79 144.36 51.26 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.298 -0.876 . . . . 0.0 109.844 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 54' ' ' GLU . 39.2 t -135.93 160.0 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.632 -0.667 . . . . 0.0 109.79 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.454 ' N ' HG12 ' A' ' 53' ' ' VAL . 22.4 pt-20 -137.79 142.35 40.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.321 -0.862 . . . . 0.0 109.319 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.24 177.23 29.22 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.521 HD23 ' H ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -94.77 142.48 27.42 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.434 -1.039 . . . . 0.0 108.859 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.457 ' CG2' HD23 ' A' ' 60' ' ' LEU . 46.4 mm -89.4 121.38 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.292 -0.88 . . . . 0.0 109.692 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -106.58 -29.59 9.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.457 -0.777 . . . . 0.0 109.429 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.602 ' O ' HD22 ' A' ' 60' ' ' LEU . . . -163.42 147.88 10.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.006 . . . . 0.0 109.933 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.602 HD22 ' O ' ' A' ' 59' ' ' ALA . 1.1 mm? -130.36 131.18 45.22 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 54.4 t -131.99 132.95 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.612 0.72 . . . . 0.0 109.638 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.467 ' O ' ' N ' ' A' ' 64' ' ' LEU . 34.2 t80 -144.47 139.33 15.49 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.98 78.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 120.844 1.03 . . . . 0.0 111.596 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.627 ' CD2' ' H ' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -86.51 0.82 53.47 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.524 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -88.53 179.83 6.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.416 -0.803 . . . . 0.0 109.908 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.557 ' ND1' ' N ' ' A' ' 66' ' ' HIS . 0.4 OUTLIER -113.84 -137.98 0.37 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.515 -0.741 . . . . 0.0 109.791 -179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.48 109.94 21.77 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.316 -0.865 . . . . 0.0 109.869 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -164.4 -43.12 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.19 -0.944 . . . . 0.0 108.497 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.665 ' N ' ' ND1' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -123.01 -38.59 2.59 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -59.92 -42.54 94.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.356 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.031 -1.043 . . . . 0.0 108.305 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mtp . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.526 0.679 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.96 134.7 54.49 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.794 0.807 . . . . 0.0 110.047 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -172.26 -23.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.4 mmm-85 -63.12 138.65 58.62 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.22 -0.925 . . . . 0.0 108.651 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' GLN . . . . . 0.53 ' NE2' HD12 ' B' ' 57' ' ' ILE . 25.3 pt20 -146.35 161.17 40.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.252 -0.905 . . . . 0.0 109.491 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -108.95 136.03 49.15 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.586 HD23 ' N ' ' B' ' 8' ' ' SER . 5.7 tt -122.56 120.68 34.53 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.586 ' N ' HD23 ' B' ' 7' ' ' LEU . 9.2 p -111.42 140.52 45.94 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.576 -0.702 . . . . 0.0 109.303 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.3 tp -148.21 146.49 28.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.259 -0.901 . . . . 0.0 109.505 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.454 HG23 ' O ' ' B' ' 10' ' ' THR . 4.9 t -146.12 117.79 8.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.449 -0.782 . . . . 0.0 109.293 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.24 22.57 0.37 Allowed Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 79.3 t -76.82 132.14 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.084 -1.245 . . . . 0.0 109.775 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -72.83 -43.18 62.98 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.128 -0.983 . . . . 0.0 109.774 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.77 157.89 22.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.961 -1.087 . . . . 0.0 110.088 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 69.6 t -93.17 127.22 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.41 -0.806 . . . . 0.0 109.153 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -96.29 -35.56 11.2 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.97 -1.081 . . . . 0.0 109.368 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 36.4 t -173.06 150.22 1.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 108.85 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' PHE . . . . . 0.418 ' CZ ' HD13 ' B' ' 23' ' ' ILE . 5.7 t80 -143.24 113.44 7.27 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.106 -0.996 . . . . 0.0 109.147 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -126.34 152.73 74.32 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.18 -17.06 54.04 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.669 1.579 . . . . 0.0 111.446 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -114.47 8.21 16.44 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.567 -0.708 . . . . 0.0 109.447 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -171.74 133.37 0.76 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 109.252 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.418 HD13 ' CZ ' ' B' ' 18' ' ' PHE . 96.7 mt -130.65 129.31 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.194 -0.941 . . . . 0.0 109.784 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 72.6 mt -120.88 119.19 31.94 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 87.9 mt -133.46 131.96 40.51 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.476 -0.765 . . . . 0.0 109.49 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -94.28 118.39 31.52 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.016 -1.052 . . . . 0.0 109.156 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.546 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.9 t -124.39 154.25 40.68 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.421 ' C ' ' O ' ' B' ' 27' ' ' THR . 44.3 mt 37.87 -89.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.901 -0.499 . . . . 0.0 110.456 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.546 ' N ' ' O ' ' B' ' 27' ' ' THR . 15.0 pt20 -151.6 46.2 0.79 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.004 -1.06 . . . . 0.0 109.515 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.95 132.28 2.57 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 90.4 t -84.3 131.32 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -1.09 . . . . 0.0 109.262 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 48.9 tp -104.18 125.22 50.3 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 28.7 t -112.35 120.75 42.77 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 83.7 mt -107.3 130.77 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -124.27 138.86 54.35 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.23 -147.89 8.54 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -135.99 143.27 44.72 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.226 -1.161 . . . . 0.0 109.319 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 54.9 61.2 3.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.956 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.529 ' N ' HD12 ' B' ' 39' ' ' LEU . 10.5 mp -92.95 72.31 4.74 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.187 -0.946 . . . . 0.0 108.805 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.492 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.636 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' B' ' 48' ' ' ALA . 10.4 mp . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.534 ' C ' ' H ' ' B' ' 49' ' ' GLY . 37.1 ttmt 45.08 -85.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.75 -0.594 . . . . 0.0 110.353 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' B' ' 46' ' ' LEU . . . -65.23 14.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.064 -1.023 . . . . 0.0 110.212 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' B' ' 47' ' ' LYS . . . 61.71 28.17 69.51 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -87.18 158.79 19.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -1.104 . . . . 0.0 109.368 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 16.6 m -131.77 157.47 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.417 -0.802 . . . . 0.0 109.243 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -144.68 148.07 33.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.27 -0.894 . . . . 0.0 109.508 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 53.8 t -127.08 135.58 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -120.79 131.14 54.31 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.537 -0.727 . . . . 0.0 109.185 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.98 179.19 29.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.436 HD23 ' H ' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -97.95 133.78 41.96 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.404 -1.056 . . . . 0.0 109.187 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.53 HD12 ' NE2' ' B' ' 5' ' ' GLN . 90.4 mt -90.15 115.3 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.053 . . . . 0.0 109.706 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -99.49 -14.95 18.86 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.4 -0.813 . . . . 0.0 109.676 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.4 152.43 8.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.977 -1.077 . . . . 0.0 110.365 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.446 HD23 HG21 ' B' ' 57' ' ' ILE . 0.3 OUTLIER -134.93 134.73 40.92 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.35 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.404 HG22 HD12 ' A' ' 64' ' ' LEU . 67.5 t -130.03 123.61 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.455 -0.778 . . . . 0.0 109.05 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.444 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 44.2 t80 -146.02 136.85 12.44 Favored Pre-proline 0 N--CA 1.494 1.753 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.444 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 70.9 Cg_endo -74.45 113.73 3.86 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.328 1.352 . . . . 0.0 112.001 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.949 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -89.22 16.29 7.56 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.284 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 65.19 101.46 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.476 0.655 . . . . 0.0 110.497 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -81.1 -57.06 3.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 108.646 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -156.03 -132.26 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 0.424 ' C ' ' H ' ' B' ' 70' ' ' HIS . 23.3 t-80 -147.66 -179.94 7.24 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.57 -1.331 . . . . 0.0 109.65 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 7.5 m80 58.54 6.52 0.59 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.916 -1.115 . . . . 0.0 108.818 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.434 ' O ' ' ND1' ' B' ' 70' ' ' HIS . 0.5 OUTLIER -61.21 149.0 38.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.376 -0.827 . . . . 0.0 109.958 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.134 179.259 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.98 103.96 3.1 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.409 ' CA ' HD13 ' B' ' 28' ' ' ILE . 0.6 OUTLIER -148.9 12.0 0.85 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -77.91 144.46 36.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.725 -1.235 . . . . 0.0 108.233 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.576 ' NE2' HD21 ' B' ' 9' ' ' LEU . 39.7 tt0 -146.66 156.23 43.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.121 -0.987 . . . . 0.0 110.263 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -109.13 114.02 27.38 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.525 HD23 ' C ' ' A' ' 7' ' ' LEU . 7.3 tt -113.28 126.47 55.44 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.495 ' N ' HD23 ' A' ' 7' ' ' LEU . 42.0 t -132.1 140.28 48.77 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.401 HD11 HE21 ' B' ' 5' ' ' GLN . 45.0 tp -131.03 148.14 52.71 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 p -125.26 153.38 43.28 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.48 8.54 87.1 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.52 143.84 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.144 -1.209 . . . . 0.0 109.927 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.2 m -73.34 -47.51 41.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.513 -0.742 . . . . 0.0 109.982 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -172.59 172.91 4.13 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.042 -1.036 . . . . 0.0 110.483 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.7 t -101.21 103.83 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -64.1 -40.43 96.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 109.796 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.4 t -158.17 151.87 23.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.341 -0.85 . . . . 0.0 109.323 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -131.14 112.0 12.46 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.57 150.99 77.36 Favored Pre-proline 0 N--CA 1.501 2.114 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.59 -10.63 25.46 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.962 1.775 . . . . 0.0 111.615 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -129.24 11.45 5.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.598 -0.689 . . . . 0.0 109.61 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -169.3 123.2 0.8 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mm -123.2 130.14 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.188 -0.945 . . . . 0.0 109.695 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.2 mt -113.87 129.85 56.55 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.75 124.29 33.11 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.496 -0.753 . . . . 0.0 110.346 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -96.16 123.36 39.75 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' GLN . 2.6 t -125.64 154.04 42.91 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.231 0.539 . . . . 0.0 109.746 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 27' ' ' THR . 46.7 mt 29.3 -85.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-O 121.16 0.505 . . . . 0.0 111.507 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' THR . 13.1 pt20 -144.05 59.54 1.36 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.16 -0.963 . . . . 0.0 110.148 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.9 160.69 28.93 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.0 t -116.35 130.68 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.655 -0.909 . . . . 0.0 109.06 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.449 HD11 HD12 ' A' ' 60' ' ' LEU . 52.3 tp -110.04 126.34 53.88 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.537 -0.727 . . . . 0.0 109.148 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.8 t -110.34 123.13 49.27 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.432 HG12 HD11 ' A' ' 60' ' ' LEU . 96.2 mt -112.39 129.72 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -116.63 140.69 49.11 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.87 -153.98 12.89 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -133.75 146.71 50.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.535 -0.979 . . . . 0.0 109.338 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 55.83 54.98 7.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.72 -0.613 . . . . 0.0 110.159 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.0 mp -90.45 69.15 6.87 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.895 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -178.752 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.597 ' O ' ' N ' ' A' ' 48' ' ' ALA . 68.7 mt . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 120.848 0.356 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? 56.28 -73.24 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.711 -0.618 . . . . 0.0 110.307 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . -73.63 -4.56 34.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.13 -0.982 . . . . 0.0 109.535 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.1 26.19 74.16 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -92.45 161.71 14.53 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.531 -0.982 . . . . 0.0 109.98 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.87 141.19 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.64 148.41 50.38 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.468 0.652 . . . . 0.0 110.085 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 75.4 t -136.97 136.3 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.43 128.86 47.65 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.05 -1.032 . . . . 0.0 108.379 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.67 174.84 32.04 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.421 HD23 ' H ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -98.32 128.13 44.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.556 -0.967 . . . . 0.0 109.467 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.635 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.7 mp -77.5 133.43 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 0.0 109.76 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -112.82 -26.11 8.72 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.603 ' O ' HD22 ' A' ' 60' ' ' LEU . . . -166.88 154.01 9.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.417 -0.802 . . . . 0.0 110.034 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.603 HD22 ' O ' ' A' ' 59' ' ' ALA . 1.1 mm? -131.1 130.36 43.05 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.5 t -134.56 130.95 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.733 0.777 . . . . 0.0 109.788 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.652 ' O ' ' N ' ' A' ' 64' ' ' LEU . 12.6 t80 -144.7 143.24 20.62 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -49.4 76.33 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.636 0 CA-C-N 120.405 1.18 . . . . 0.0 111.915 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.652 ' N ' ' O ' ' A' ' 62' ' ' TYR . 0.8 OUTLIER -92.73 15.23 14.99 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.363 -0.836 . . . . 0.0 109.034 -179.534 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.544 ' C ' ' O ' ' A' ' 64' ' ' LEU . 90.8 mt-10 -8.42 117.48 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 121.402 0.62 . . . . 0.0 112.171 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -73.1 -71.06 0.32 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.632 -0.668 . . . . 0.0 110.236 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -72.12 -96.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.448 -0.783 . . . . 0.0 110.037 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.649 ' CG ' ' H ' ' A' ' 69' ' ' HIS . 39.9 t-80 -166.77 -172.06 2.01 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.464 -0.773 . . . . 0.0 109.264 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.649 ' H ' ' CG ' ' A' ' 68' ' ' HIS . 0.4 OUTLIER -66.49 -41.59 88.72 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.579 -0.701 . . . . 0.0 109.491 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -83.11 -64.08 1.24 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.49 -0.757 . . . . 0.0 109.567 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 118.157 -0.925 . . . . 0.0 108.879 179.739 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mtp . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.6 116.52 28.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.478 -0.764 . . . . 0.0 109.54 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' B' ' 3' ' ' ASN . 9.4 p-10 -166.53 -30.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.602 HH21 ' CD ' ' B' ' 54' ' ' GLU . 10.7 mmm180 -49.66 143.63 6.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.519 -0.738 . . . . 0.0 110.031 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' GLN . . . . . 0.401 HE21 HD11 ' A' ' 9' ' ' LEU . 5.7 pt20 -149.8 162.03 41.07 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.348 0.594 . . . . 0.0 109.476 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -118.18 141.88 48.03 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.579 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.1 tt -131.07 120.26 23.15 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.566 ' N ' HD23 ' B' ' 7' ' ' LEU . 5.5 m -110.73 146.09 36.91 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.576 HD21 ' NE2' ' A' ' 5' ' ' GLN . 5.4 tp -146.92 139.1 24.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.298 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.15 107.57 7.79 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 146.42 -5.81 1.21 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.57 142.18 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.419 -1.048 . . . . 0.0 110.066 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -72.72 -51.56 18.75 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.665 -0.647 . . . . 0.0 109.629 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.15 160.31 6.29 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.124 -0.985 . . . . 0.0 110.297 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' VAL . . . . . 0.592 HG11 ' CE2' ' B' ' 18' ' ' PHE . 20.6 t -81.39 133.07 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.654 -0.654 . . . . 0.0 109.891 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -88.79 -23.78 22.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.4 -0.813 . . . . 0.0 110.121 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 30.3 t -172.42 151.52 2.5 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.101 -0.999 . . . . 0.0 109.899 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' PHE . . . . . 0.592 ' CE2' HG11 ' B' ' 15' ' ' VAL . 4.5 m-85 -121.93 104.64 9.68 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.628 -0.67 . . . . 0.0 109.886 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.39 139.34 31.11 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.32 -17.4 35.07 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.815 1.677 . . . . 0.0 111.97 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -95.62 -10.75 28.62 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.322 -0.861 . . . . 0.0 109.472 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -174.75 130.01 0.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.66 129.49 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 62.0 mt -110.07 123.53 49.86 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.404 HD23 HG13 ' B' ' 15' ' ' VAL . 68.6 mt -119.07 131.12 55.91 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.577 -0.702 . . . . 0.0 109.704 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -83.64 104.97 14.18 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.463 ' O ' ' O ' ' B' ' 28' ' ' ILE . 12.9 t -124.87 169.95 11.55 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.73 0.776 . . . . 0.0 110.751 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' B' ' 27' ' ' THR . 8.0 mt -33.0 154.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.344 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 65.38 -60.51 0.26 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.18 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' B' ' 27' ' ' THR . . . -166.71 -168.13 28.43 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.459 -1.353 . . . . 0.0 109.795 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 15.5 t -86.88 135.37 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.405 -1.056 . . . . 0.0 110.146 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 43.0 tp -101.05 119.99 39.55 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 11.5 m -99.6 127.27 45.69 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 86.8 mt -103.95 126.84 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -118.98 144.47 46.47 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.536 0.684 . . . . 0.0 110.075 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.89 -138.05 4.74 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -138.83 139.58 38.23 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.246 -1.149 . . . . 0.0 109.766 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 46.98 73.8 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.686 -0.634 . . . . 0.0 109.834 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.558 ' N ' HD12 ' B' ' 39' ' ' LEU . 9.1 mp -91.89 71.25 5.61 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.068 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' B' ' 47' ' ' LYS . 62.0 tp . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 121.278 0.561 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.492 ' C ' ' H ' ' B' ' 49' ' ' GLY . 53.2 tttp 59.05 136.1 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.506 0.669 . . . . 0.0 110.389 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' B' ' 47' ' ' LYS . . . 63.55 -3.62 0.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.605 -0.684 . . . . 0.0 109.5 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' B' ' 47' ' ' LYS . . . 62.9 31.58 81.0 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -103.04 148.13 26.09 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.399 -1.059 . . . . 0.0 109.68 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.85 145.71 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -130.26 149.6 51.88 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.45 0.643 . . . . 0.0 109.387 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.32 135.42 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.602 ' CD ' HH21 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -116.83 125.39 51.49 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 55' ' ' GLY . . . . . 0.535 ' N ' ' OE1' ' B' ' 54' ' ' GLU . . . 154.77 176.13 26.66 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.14 132.79 46.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.679 -0.895 . . . . 0.0 109.475 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.621 ' N ' HD12 ' B' ' 57' ' ' ILE . 1.5 mp -87.12 118.81 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.191 -0.943 . . . . 0.0 108.965 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' ASP . . . . . 0.444 ' OD2' ' NE2' ' A' ' 29' ' ' GLN . 2.2 t70 -112.8 -5.64 13.88 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.621 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -169.05 156.55 7.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.419 -0.801 . . . . 0.0 110.338 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.621 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.4 OUTLIER -139.28 135.87 34.3 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 t -129.97 124.18 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.575 0.702 . . . . 0.0 109.308 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.579 ' O ' HD13 ' B' ' 64' ' ' LEU . 36.0 t80 -146.29 138.16 13.36 Favored Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.492 ' C ' ' H ' ' B' ' 65' ' ' GLU . 38.7 Cg_endo -70.13 104.66 1.41 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.295 1.33 . . . . 0.0 112.167 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.954 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -75.57 18.39 0.24 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.492 ' H ' ' C ' ' B' ' 63' ' ' PRO . 0.7 OUTLIER 63.8 138.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -128.7 127.88 42.98 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.612 -0.68 . . . . 0.0 110.268 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.575 ' N ' ' ND1' ' B' ' 67' ' ' HIS . 0.0 OUTLIER -153.59 -46.82 0.09 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -49.03 96.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.533 -0.729 . . . . 0.0 109.726 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.432 ' N ' ' O ' ' B' ' 67' ' ' HIS . 78.8 m-70 -85.95 -154.81 0.22 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.515 -0.74 . . . . 0.0 109.442 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -56.86 -44.72 82.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.414 -0.804 . . . . 0.0 109.534 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' HIS . . . . . 0.499 ' N ' ' ND1' ' B' ' 71' ' ' HIS . 1.6 p-80 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.591 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.396 0.617 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -91.61 106.47 18.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.331 -0.856 . . . . 0.0 109.885 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -173.92 -26.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -64.0 140.06 58.83 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.389 -0.819 . . . . 0.0 108.868 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -154.25 165.44 36.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 0.0 109.881 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -106.09 144.58 32.6 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.609 HD23 ' N ' ' A' ' 8' ' ' SER . 5.6 tt -132.33 121.54 23.69 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.609 ' N ' HD23 ' A' ' 7' ' ' LEU . 4.6 m -114.24 140.97 48.14 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.593 -0.692 . . . . 0.0 109.903 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.584 HD21 ' NE2' ' B' ' 5' ' ' GLN . 4.8 tp -144.79 145.92 31.88 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.8 p -137.23 173.1 12.05 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.371 -0.831 . . . . 0.0 110.102 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 73.51 24.78 74.16 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 12' ' ' VAL . 10.5 p -72.24 130.5 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.254 -1.145 . . . . 0.0 109.817 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -73.03 -43.25 62.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.09 -1.006 . . . . 0.0 109.195 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.25 153.52 4.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 109.591 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.5 t -92.28 117.02 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.848 . . . . 0.0 109.676 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -68.05 -37.44 81.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.48 -0.763 . . . . 0.0 109.508 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.7 t -169.04 169.47 9.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.825 . . . . 0.0 109.456 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.534 ' CD1' HD12 ' A' ' 23' ' ' ILE . 86.3 t80 -145.62 107.18 4.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 109.217 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.484 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -130.03 122.78 20.46 Favored Pre-proline 0 N--CA 1.5 2.035 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.795 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -45.66 -30.9 6.79 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.037 1.158 . . . . 0.0 111.618 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -92.97 -6.37 48.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.28 -0.888 . . . . 0.0 109.969 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.525 ' OE2' ' NZ ' ' A' ' 35' ' ' LYS . 34.2 tt0 -163.82 128.28 2.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 109.549 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.534 HD12 ' CD1' ' A' ' 18' ' ' PHE . 46.6 mm -120.44 130.21 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.482 -0.761 . . . . 0.0 109.57 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.3 mt -117.63 130.56 56.45 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.6 mt -133.36 134.53 43.88 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.476 -0.765 . . . . 0.0 109.851 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -108.9 113.17 25.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.602 -0.686 . . . . 0.0 109.166 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 29' ' ' GLN . 2.6 t -125.24 167.38 14.95 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.411 0.624 . . . . 0.0 110.152 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.7 mm 44.95 -87.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.805 -0.56 . . . . 0.0 110.134 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 27' ' ' THR . 27.8 pt20 -158.77 19.54 0.21 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.974 -1.078 . . . . 0.0 108.837 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.02 169.82 21.96 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.3 t -110.89 130.53 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.748 -0.854 . . . . 0.0 109.267 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.1 tp -110.8 123.15 49.52 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.0 m -110.18 120.31 42.04 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.8 mt -102.9 127.27 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.525 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 68.9 mttm -118.22 138.79 52.09 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.656 0.741 . . . . 0.0 109.318 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.98 -147.15 7.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -140.7 143.73 35.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.304 -1.115 . . . . 0.0 108.864 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.7 mttp 55.86 60.27 3.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.603 -0.685 . . . . 0.0 109.904 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.2 mp -92.59 72.21 5.05 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.493 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -178.811 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 49' ' ' GLY . 2.5 pp . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt 41.88 -103.74 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.533 0.682 . . . . 0.0 110.509 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.05 20.64 2.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.503 -0.748 . . . . 0.0 110.065 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . 87.4 32.58 13.35 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.491 ' OE1' ' N ' ' A' ' 50' ' ' GLN . 24.0 mp0 -104.55 152.93 21.81 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.28 -1.129 . . . . 0.0 109.111 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.66 158.76 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.372 -0.83 . . . . 0.0 109.667 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -141.16 149.28 41.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.296 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -124.88 133.41 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -119.07 125.46 49.36 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.36 -175.52 35.48 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.416 HD23 ' H ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -99.11 130.87 45.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.996 . . . . 0.0 109.225 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.1 mt -86.46 117.45 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.074 -1.016 . . . . 0.0 109.161 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -96.77 -23.82 16.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.456 -0.777 . . . . 0.0 109.143 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -170.1 157.49 6.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.986 . . . . 0.0 110.522 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.408 HD13 HD13 ' B' ' 32' ' ' LEU . 10.4 mt -133.01 139.22 47.12 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.2 t -132.07 115.14 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.511 -0.743 . . . . 0.0 109.628 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 62' ' ' TYR . 25.1 t80 -134.34 113.71 12.3 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.52 123.7 14.37 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 CA-C-N 120.06 1.057 . . . . 0.0 111.03 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.887 ' H ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -98.7 17.26 19.71 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.128 -0.982 . . . . 0.0 108.712 179.103 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 66' ' ' HIS . 0.4 OUTLIER 68.44 -174.45 0.19 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.515 -0.741 . . . . 0.0 110.447 178.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.509 ' O ' ' CG ' ' A' ' 67' ' ' HIS . 4.6 t-80 77.99 -145.75 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.406 -0.809 . . . . 0.0 109.752 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.509 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 45.9 p-80 41.19 94.23 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.626 0.727 . . . . 0.0 109.776 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -57.79 146.13 32.52 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.363 -0.835 . . . . 0.0 110.181 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -152.84 162.9 40.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.462 -0.774 . . . . 0.0 109.429 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -105.03 138.71 40.82 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 77.7 m80 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.815 -179.799 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 95.3 mtp . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 54.51 27.38 8.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.451 -0.781 . . . . 0.0 109.308 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -102.87 10.42 38.36 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 33.2 mmm-85 -74.08 141.35 45.7 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' GLN . . . . . 0.584 ' NE2' HD21 ' A' ' 9' ' ' LEU . 40.1 tt0 -141.36 147.11 37.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.305 -0.872 . . . . 0.0 109.375 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -117.23 131.55 56.82 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.509 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.1 tt -118.08 124.44 48.07 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.467 ' N ' HD23 ' B' ' 7' ' ' LEU . 78.3 p -115.57 134.67 54.84 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.537 0.684 . . . . 0.0 109.625 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 tp -146.43 143.66 29.16 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -131.26 156.86 44.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.436 -0.79 . . . . 0.0 109.277 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.75 53.9 3.24 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -92.51 139.21 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.088 -1.242 . . . . 0.0 109.833 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -71.7 -42.38 67.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.952 . . . . 0.0 109.136 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -171.73 166.2 6.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.149 -0.969 . . . . 0.0 110.113 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 73.3 t -93.59 99.01 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.331 -0.856 . . . . 0.0 109.13 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -65.5 -40.0 92.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -0.868 . . . . 0.0 109.419 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -169.69 145.48 3.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.13 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -134.52 108.33 8.04 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.533 -0.73 . . . . 0.0 109.672 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -133.81 148.85 70.05 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.61 -12.4 31.22 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 121.706 1.604 . . . . 0.0 111.147 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -104.67 -7.84 19.31 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.522 -0.736 . . . . 0.0 109.539 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -173.74 140.63 0.78 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.463 -0.773 . . . . 0.0 109.158 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.2 130.1 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.383 -0.823 . . . . 0.0 110.438 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.405 ' CD2' ' OG ' ' B' ' 33' ' ' SER . 13.5 mt -122.03 125.41 46.21 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 65.4 mt -132.18 131.62 42.38 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.504 -0.748 . . . . 0.0 109.135 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -88.75 118.75 28.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.895 -1.128 . . . . 0.0 108.602 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.566 ' O ' ' N ' ' B' ' 29' ' ' GLN . 2.2 t -123.8 153.66 40.66 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.709 -0.619 . . . . 0.0 109.974 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' B' ' 27' ' ' THR . 54.8 mt 34.01 -86.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.168 0.509 . . . . 0.0 110.665 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' B' ' 27' ' ' THR . 18.9 pt20 -150.61 39.41 0.72 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.046 -1.034 . . . . 0.0 109.615 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -161.22 130.38 2.33 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 69.7 t -83.42 132.96 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.438 -1.037 . . . . 0.0 109.481 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.408 HD13 HD13 ' A' ' 60' ' ' LEU . 43.5 tp -107.48 128.54 54.59 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.405 ' OG ' ' CD2' ' B' ' 24' ' ' LEU . 25.1 m -111.16 125.49 53.84 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.3 0.572 . . . . 0.0 109.582 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 93.2 mt -106.77 129.86 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -124.72 138.3 54.3 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.467 0.651 . . . . 0.0 109.453 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.57 -146.37 11.29 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -140.51 157.45 45.48 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.281 -1.129 . . . . 0.0 109.624 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.48 57.0 5.17 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.552 0.691 . . . . 0.0 109.783 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.542 ' N ' HD12 ' B' ' 39' ' ' LEU . 8.8 mp -91.7 70.62 5.75 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 C-N-CA 120.305 -0.95 . . . . 0.0 110.941 -178.544 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 81.8 mt . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -63.88 -36.44 83.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.622 -0.674 . . . . 0.0 109.351 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.78 -8.77 10.8 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.661 -0.65 . . . . 0.0 109.417 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.4 24.98 71.65 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -122.2 155.71 35.26 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.555 -0.968 . . . . 0.0 109.282 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t -126.14 134.33 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.636 -0.665 . . . . 0.0 109.255 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -128.74 148.87 50.88 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 76.3 t -122.64 134.1 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -120.79 134.97 55.27 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.602 -0.686 . . . . 0.0 109.287 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.97 171.84 18.79 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.459 HD23 ' H ' ' B' ' 56' ' ' LEU . 0.1 OUTLIER -87.07 126.13 34.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.368 -1.078 . . . . 0.0 108.768 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.0 mt -88.56 113.08 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.078 -1.014 . . . . 0.0 109.184 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -94.26 -13.82 26.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.453 -0.78 . . . . 0.0 109.559 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -172.14 155.83 3.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.026 -1.046 . . . . 0.0 110.55 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.413 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 14.2 mt -138.62 142.77 39.11 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.402 HG22 HD12 ' A' ' 64' ' ' LEU . 54.1 t -135.72 126.91 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.415 -0.803 . . . . 0.0 109.382 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' B' ' 64' ' ' LEU . 12.0 t80 -141.07 135.89 15.6 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -42.89 82.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.69 1.593 . . . . 0.0 112.722 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.633 ' C ' HD23 ' B' ' 64' ' ' LEU . 0.7 OUTLIER -63.14 -12.49 27.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.181 -0.95 . . . . 0.0 108.485 179.228 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' B' ' 67' ' ' HIS . 5.7 mt-10 -99.77 17.04 21.71 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.447 -0.783 . . . . 0.0 109.084 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 63.54 -68.1 0.09 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.55 ' N ' ' O ' ' B' ' 65' ' ' GLU . 0.0 OUTLIER -175.76 86.2 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.317 -0.865 . . . . 0.0 109.134 179.506 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -133.55 114.92 14.11 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.307 -0.871 . . . . 0.0 109.498 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.529 ' O ' ' ND1' ' B' ' 70' ' ' HIS . 34.7 p80 -80.49 129.4 34.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.71 -0.619 . . . . 0.0 109.618 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.529 ' ND1' ' O ' ' B' ' 69' ' ' HIS . 5.4 m-70 -136.24 145.31 45.5 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.349 -0.844 . . . . 0.0 109.96 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 11.7 m80 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.682 -179.845 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 122.052 0.929 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.449 ' OD2' ' CG ' ' A' ' 4' ' ' ARG . 4.2 p-10 -142.93 -146.48 0.19 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -108.22 4.47 24.77 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.705 -1.247 . . . . 0.0 109.291 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.449 ' CG ' ' OD2' ' A' ' 2' ' ' ASP . 30.4 mmm-85 -81.26 139.42 35.47 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -139.74 163.33 32.89 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.02 -1.05 . . . . 0.0 110.436 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.412 ' CD2' ' HG2' ' A' ' 54' ' ' GLU . 36.7 m-85 -108.73 127.07 53.68 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.301 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.459 HD23 ' C ' ' A' ' 7' ' ' LEU . 6.2 tt -125.71 119.88 29.17 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.416 ' N ' HD23 ' A' ' 7' ' ' LEU . 34.9 t -129.31 151.43 49.97 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.572 0.701 . . . . 0.0 109.927 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.4 tp -142.91 155.72 44.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.429 -0.794 . . . . 0.0 109.549 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.4 p -69.21 170.24 10.53 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.732 0.777 . . . . 0.0 110.804 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -40.07 117.11 0.82 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.572 HG22 ' N ' ' A' ' 13' ' ' SER . 9.1 p -83.51 165.84 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.693 -0.886 . . . . 0.0 110.417 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 12' ' ' VAL . 69.7 m -72.82 -45.43 58.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.0 109.313 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.17 145.12 1.71 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.069 -1.019 . . . . 0.0 109.831 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 80.6 t -89.88 128.24 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.195 -0.941 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -86.55 -22.42 26.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.464 -0.772 . . . . 0.0 110.033 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 t -172.26 157.16 4.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.968 -1.082 . . . . 0.0 109.837 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.484 ' C ' ' CD1' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -145.9 105.2 3.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 109.566 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -134.61 147.47 63.37 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.8 -13.68 34.91 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.372 2.048 . . . . 0.0 110.807 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -100.88 -4.63 27.4 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.407 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -178.81 143.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.6 mt -134.53 131.44 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.092 -1.005 . . . . 0.0 109.407 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.3 mt -112.08 127.97 56.06 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.4 mt -124.88 128.05 48.06 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.614 -0.679 . . . . 0.0 109.626 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -103.46 117.0 33.45 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 29' ' ' GLN . 5.5 t -124.03 150.09 45.33 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.945 0.879 . . . . 0.0 110.705 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.4 HD11 ' O ' ' B' ' 3' ' ' ASN . 61.4 mt 47.52 -83.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.359 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.4 pt20 -144.6 -23.04 0.52 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.118 -0.989 . . . . 0.0 109.691 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.6 170.15 32.11 Favored Glycine 0 N--CA 1.498 2.816 0 O-C-N 120.912 -1.118 . . . . 0.0 111.156 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.1 t -120.04 133.5 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.769 -0.842 . . . . 0.0 109.525 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.8 tp -110.12 124.5 51.64 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.4 m -110.64 124.04 51.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.546 -0.721 . . . . 0.0 109.737 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.5 mt -107.75 131.55 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -126.81 139.49 53.07 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.673 0.749 . . . . 0.0 109.456 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.92 -155.71 25.83 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -132.06 148.34 52.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.622 -0.928 . . . . 0.0 109.118 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 61.72 54.6 2.9 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.939 0.876 . . . . 0.0 109.403 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.1 mp -93.2 71.94 4.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.334 -0.854 . . . . 0.0 108.836 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.622 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 47' ' ' LYS . 55.4 tp . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.565 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 88.5 tttt -34.74 152.21 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.432 0.634 . . . . 0.0 110.984 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 47' ' ' LYS . . . 72.9 -23.76 0.2 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 47' ' ' LYS . . . 64.96 28.61 73.71 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -95.57 161.13 14.18 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.273 -1.134 . . . . 0.0 110.447 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.6 t -120.63 136.98 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.433 0.635 . . . . 0.0 109.359 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -111.86 146.7 37.25 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.4 t -134.11 136.02 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -125.05 134.75 52.41 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.126 0.965 . . . . 0.0 109.535 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.549 ' N ' ' OE1' ' A' ' 54' ' ' GLU . . . 155.37 174.41 25.22 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.401 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -95.44 139.47 31.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.607 -0.937 . . . . 0.0 109.643 -179.639 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.5 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.5 mp -93.2 111.92 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 108.768 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -98.54 -22.83 15.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.588 -0.695 . . . . 0.0 109.403 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.27 149.45 11.97 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.829 -1.169 . . . . 0.0 110.705 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.432 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 67.4 mt -133.29 135.34 44.82 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 49.2 t -135.55 123.35 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.75 0.786 . . . . 0.0 109.303 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.518 ' O ' HD13 ' A' ' 64' ' ' LEU . 22.8 t80 -137.24 142.13 36.72 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.49 111.65 2.85 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.708 1.605 . . . . 0.0 112.432 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.86 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -103.7 -15.45 15.75 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.676 ' N ' HD22 ' A' ' 64' ' ' LEU . 86.7 mt-10 -150.17 153.57 36.54 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.928 0.87 . . . . 0.0 109.979 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.522 ' O ' ' CG ' ' A' ' 67' ' ' HIS . 16.3 t60 -174.66 -35.69 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 3.4 m-70 174.68 106.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.622 0.725 . . . . 0.0 109.095 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m80 54.85 80.17 0.13 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.928 0.871 . . . . 0.0 108.818 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.564 ' N ' ' ND1' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -70.08 -83.5 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.676 -0.64 . . . . 0.0 110.279 -179.318 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.557 ' H ' ' CG ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -119.37 153.33 35.32 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 122.012 0.91 . . . . 0.0 110.076 -179.117 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 44.0 t60 . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.301 179.998 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.868 0.842 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' B' ' 3' ' ' ASN . 15.1 t70 -76.35 167.29 22.11 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.893 0.854 . . . . 0.0 110.559 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.423 ' N ' ' OD1' ' B' ' 2' ' ' ASP . 6.9 p30 -82.72 -3.54 56.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.366 -0.834 . . . . 0.0 109.514 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 34.1 mmm-85 -77.59 139.6 39.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.065 -1.022 . . . . 0.0 109.869 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' GLN . . . . . 0.422 ' NE2' ' OG1' ' A' ' 27' ' ' THR . 33.6 mt-30 -139.16 156.65 46.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.474 -0.766 . . . . 0.0 109.468 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -112.04 133.91 53.92 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.431 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.1 tt -118.25 125.03 49.3 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 96.2 p -112.71 145.47 40.44 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.829 0.823 . . . . 0.0 109.988 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.2 tp -156.88 156.33 32.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.515 -0.741 . . . . 0.0 109.358 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.9 t -150.44 158.5 44.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.5 -0.75 . . . . 0.0 110.138 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.68 15.21 73.85 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.0 p -54.75 149.53 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -1.188 . . . . 0.0 110.254 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 3.2 t -73.06 -44.01 61.16 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -172.5 166.59 5.64 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.131 -0.981 . . . . 0.0 110.37 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 88.2 t -96.67 99.75 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.543 -0.723 . . . . 0.0 109.145 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -65.28 -48.39 73.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.509 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 32.1 t -168.82 129.26 1.16 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.05 -1.031 . . . . 0.0 109.409 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -112.34 117.27 32.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.51 -0.744 . . . . 0.0 109.276 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.02 151.16 77.43 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.66 -13.41 29.79 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.31 2.006 . . . . 0.0 111.62 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -115.5 -0.38 13.1 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.431 -0.793 . . . . 0.0 109.197 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.83 138.91 1.86 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 109.078 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.56 130.91 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.332 -0.855 . . . . 0.0 110.297 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 19.0 mt -122.2 123.3 41.18 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.479 0.657 . . . . 0.0 109.567 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 94.6 mt -132.41 132.6 42.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.684 -0.635 . . . . 0.0 110.121 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -89.06 121.69 31.65 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.562 ' O ' ' N ' ' B' ' 29' ' ' GLN . 6.8 t -124.89 154.89 40.39 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.479 0.657 . . . . 0.0 110.191 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.424 ' C ' ' O ' ' B' ' 27' ' ' THR . 24.8 mm 30.77 -84.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.578 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' B' ' 27' ' ' THR . 26.2 pt20 -147.03 48.65 1.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.873 -1.142 . . . . 0.0 109.191 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.06 167.31 39.37 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 53.4 t -117.09 134.6 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.384 -1.068 . . . . 0.0 110.155 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 48.1 tp -106.07 125.91 51.57 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 18.4 t -111.67 127.55 55.8 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.579 0.704 . . . . 0.0 109.313 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 81.8 mt -106.84 131.28 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.372 0.606 . . . . 0.0 109.387 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -123.64 142.1 51.37 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.554 0.692 . . . . 0.0 109.463 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.38 -148.56 18.34 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -130.58 147.98 52.32 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.475 -1.015 . . . . 0.0 110.048 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt 61.07 52.11 4.17 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.807 0.813 . . . . 0.0 109.495 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.565 ' N ' HD12 ' B' ' 39' ' ' LEU . 7.5 mp -91.41 72.02 6.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.874 . . . . 0.0 109.287 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' GLY . . . . . 0.421 ' O ' ' OE1' ' B' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.622 ' N ' HD12 ' B' ' 46' ' ' LEU . 9.4 mp . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.79 0.805 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -64.33 -45.61 87.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 108.615 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.5 32.02 2.31 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.37 26.47 65.78 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -122.02 149.76 43.05 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.359 -1.083 . . . . 0.0 110.307 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -134.78 141.52 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -118.25 136.89 53.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.762 -0.586 . . . . 0.0 109.569 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 53.9 t -127.88 132.03 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' B' ' 54' ' ' GLU . 2.6 mp0 -116.17 145.69 42.89 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.854 0.835 . . . . 0.0 110.205 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.39 170.28 22.1 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.4 ' H ' HD23 ' B' ' 56' ' ' LEU . 0.2 OUTLIER -97.79 110.8 23.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.533 -0.98 . . . . 0.0 108.956 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.618 ' N ' HD12 ' B' ' 57' ' ' ILE . 2.1 mp -75.93 122.33 29.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.059 -1.026 . . . . 0.0 108.957 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -105.04 -22.38 13.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.541 -0.725 . . . . 0.0 109.131 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.22 150.82 16.86 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.75 -1.219 . . . . 0.0 110.659 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 17.2 mt -132.99 146.77 52.07 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.422 -0.799 . . . . 0.0 109.677 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 55.9 t -137.7 115.69 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.364 -0.835 . . . . 0.0 110.233 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.432 ' CG ' ' HB2' ' A' ' 60' ' ' LEU . 59.1 t80 -138.26 104.11 7.94 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -43.32 105.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.209 1.939 . . . . 0.0 112.428 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 1.0 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -78.09 -5.28 51.05 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.483 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' B' ' 64' ' ' LEU . 2.3 mm-40 158.63 -161.27 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -141.67 -46.5 0.37 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.558 -1.339 . . . . 0.0 108.624 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.58 ' O ' ' N ' ' B' ' 69' ' ' HIS . 4.3 m-70 -157.0 172.94 17.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.415 -0.803 . . . . 0.0 109.026 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 0.566 ' O ' ' ND1' ' B' ' 69' ' ' HIS . 4.2 m80 -43.07 88.44 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.624 0.725 . . . . 0.0 110.595 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.58 ' N ' ' O ' ' B' ' 67' ' ' HIS . 0.0 OUTLIER -156.19 31.19 0.34 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.725 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -95.99 133.55 40.07 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.839 0.828 . . . . 0.0 110.302 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.4 mmm . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -88.36 114.92 25.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.432 -0.793 . . . . 0.0 109.276 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.53 ' H ' ' ND2' ' A' ' 3' ' ' ASN . 1.6 p30 -94.59 4.89 53.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.159 -0.963 . . . . 0.0 109.377 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.5 mmm-85 -69.21 142.58 54.21 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.291 -0.88 . . . . 0.0 108.916 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -145.94 150.32 35.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.0 109.674 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.527 ' CD2' ' OE1' ' A' ' 54' ' ' GLU . 77.1 m-85 -103.12 145.25 30.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.565 -0.71 . . . . 0.0 109.3 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.46 HD23 ' C ' ' A' ' 7' ' ' LEU . 7.0 tt -140.8 124.25 16.8 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.457 ' N ' HD23 ' A' ' 7' ' ' LEU . 41.3 t -128.98 135.36 48.87 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.28 -0.887 . . . . 0.0 108.742 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.0 tp -146.48 154.34 41.46 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.077 -1.014 . . . . 0.0 109.336 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 t -144.0 164.24 31.19 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.256 -0.903 . . . . 0.0 109.383 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.68 18.53 51.43 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.9 t -66.25 137.71 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.284 -1.127 . . . . 0.0 110.236 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 m -72.19 -42.93 65.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.549 -0.719 . . . . 0.0 109.929 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.92 160.65 10.31 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.881 -1.137 . . . . 0.0 110.343 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.6 t -93.08 129.15 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.499 -0.75 . . . . 0.0 110.222 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -100.06 -35.69 9.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.436 -0.79 . . . . 0.0 108.939 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.0 t -173.02 144.3 1.24 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 0.0 109.559 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -129.81 107.83 9.7 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -133.67 148.99 70.8 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.94 -11.71 31.13 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.839 1.693 . . . . 0.0 111.792 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -108.97 -5.63 16.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.343 -0.848 . . . . 0.0 110.149 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -172.01 127.4 0.59 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.977 -1.077 . . . . 0.0 108.936 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.47 126.83 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.259 -0.901 . . . . 0.0 109.459 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.9 mt -118.79 110.76 17.62 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.1 mt -129.81 132.56 46.54 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.256 -0.903 . . . . 0.0 109.143 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -94.12 113.58 25.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.237 -0.914 . . . . 0.0 109.899 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 28' ' ' ILE . 4.4 t -124.36 147.67 48.05 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.835 0.826 . . . . 0.0 109.615 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.457 ' C ' ' O ' ' A' ' 27' ' ' THR . 37.4 mt 21.0 -96.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.238 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.411 ' CG ' ' O ' ' B' ' 57' ' ' ILE . 20.9 mm100 -46.62 -73.76 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.494 -0.754 . . . . 0.0 111.596 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.96 -143.83 3.78 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 119.573 -1.298 . . . . 0.0 111.473 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 t -89.31 134.97 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.65 -0.912 . . . . 0.0 111.39 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.0 tp -112.82 120.46 41.54 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.1 m -108.73 124.55 50.73 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.6 mt -112.45 130.41 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -117.47 143.72 45.76 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.578 -0.701 . . . . 0.0 109.65 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.94 -148.34 13.59 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -136.29 152.05 50.28 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.316 -1.108 . . . . 0.0 109.517 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 54' ' ' GLU . 53.5 mtmt 56.16 52.11 10.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.552 -0.718 . . . . 0.0 110.142 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.5 mp -92.32 72.49 5.3 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.104 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.369 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.363 0.602 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -148.73 -63.52 0.24 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.381 -0.824 . . . . 0.0 109.43 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.43 2.0 49.31 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.327 -0.858 . . . . 0.0 109.412 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.54 20.33 78.57 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -97.63 161.51 13.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.334 -1.097 . . . . 0.0 109.544 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.9 t -116.15 131.86 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -118.86 130.51 55.78 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.8 t -127.34 133.89 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.501 -0.749 . . . . 0.0 109.068 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.527 ' OE1' ' CD2' ' A' ' 6' ' ' PHE . 17.3 tp10 -122.05 137.31 54.85 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 155.0 173.37 23.69 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.487 HD23 ' H ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -96.91 140.55 31.29 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.416 -1.049 . . . . 0.0 109.599 -179.719 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.536 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.7 mp -97.24 116.48 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.372 -0.83 . . . . 0.0 108.953 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -95.12 -18.97 20.5 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -171.42 151.45 3.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 0.0 109.764 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 mt -126.7 137.29 53.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.505 -0.747 . . . . 0.0 109.11 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.3 t -133.94 127.22 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.366 -0.834 . . . . 0.0 109.088 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.565 ' O ' ' N ' ' A' ' 64' ' ' LEU . 48.0 t80 -138.22 107.96 8.06 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -45.26 81.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.739 1.626 . . . . 0.0 112.479 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.946 HD12 HG22 ' B' ' 61' ' ' VAL . 0.3 OUTLIER -79.67 80.77 6.02 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.371 -1.456 . . . . 0.0 108.958 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -144.59 91.28 2.16 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.249 -0.907 . . . . 0.0 109.504 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.532 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 59.2 t-80 -169.67 10.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.401 ' H ' ' H ' ' A' ' 66' ' ' HIS . 11.0 p-80 -141.39 168.54 19.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.479 -0.763 . . . . 0.0 109.628 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -57.93 -174.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.595 0.712 . . . . 0.0 109.658 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -145.58 2.49 0.95 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.403 ' O ' ' C ' ' A' ' 71' ' ' HIS . 1.5 t-80 -80.05 159.57 26.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.186 -0.946 . . . . 0.0 109.903 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.506 ' OXT' ' ND1' ' A' ' 71' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.553 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mmm . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 t70 61.26 35.97 18.01 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.524 HD22 ' CB ' ' B' ' 56' ' ' LEU . 6.0 p-10 -95.2 -1.72 51.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.444 -0.785 . . . . 0.0 109.2 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -72.41 134.39 45.38 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.212 -0.93 . . . . 0.0 109.393 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -148.89 163.44 37.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.239 -0.913 . . . . 0.0 109.769 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -104.31 148.74 26.03 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.446 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.1 tt -135.64 118.66 16.4 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 28.6 t -111.49 131.08 55.48 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.428 -0.795 . . . . 0.0 109.335 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 tp -148.85 153.86 38.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.96 -1.088 . . . . 0.0 110.059 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 12.7 t -154.45 -167.03 2.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.829 . . . . 0.0 109.529 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.59 19.52 62.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.4 145.26 13.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.283 -1.128 . . . . 0.0 110.15 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 24.1 m -71.97 -43.13 65.67 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.27 -0.893 . . . . 0.0 108.941 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' LYS . . . . . 0.426 ' HB2' ' HZ2' ' B' ' 14' ' ' LYS . 0.0 OUTLIER -171.17 159.6 5.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.349 -0.844 . . . . 0.0 109.501 179.44 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.15 107.33 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.162 -0.961 . . . . 0.0 109.935 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -66.14 -40.57 90.71 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.239 -0.913 . . . . 0.0 109.067 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 23.1 t -172.26 162.42 5.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.09 -1.006 . . . . 0.0 109.147 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -140.25 110.41 6.57 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.327 -0.858 . . . . 0.0 109.76 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.97 148.01 67.72 Favored Pre-proline 0 N--CA 1.495 1.779 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.67 -9.81 27.07 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.851 1.701 . . . . 0.0 111.996 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -118.19 7.52 12.14 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.547 -0.721 . . . . 0.0 109.776 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -171.05 132.45 0.84 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.932 . . . . 0.0 109.194 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 47.0 mm -121.75 125.88 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.475 -0.765 . . . . 0.0 109.279 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 74.5 mt -119.89 113.14 20.12 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -131.64 140.31 49.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.329 -0.857 . . . . 0.0 109.303 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -107.63 117.77 34.98 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.569 ' O ' ' N ' ' B' ' 29' ' ' GLN . 3.7 t -125.01 153.01 43.48 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.417 0.627 . . . . 0.0 110.041 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.406 ' N ' HD13 ' B' ' 28' ' ' ILE . 5.4 mm 53.39 -78.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.872 -0.518 . . . . 0.0 110.193 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' B' ' 27' ' ' THR . 22.0 pt20 -169.5 52.4 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -171.53 140.08 5.69 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 92.4 t -84.27 132.48 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.378 -1.072 . . . . 0.0 109.515 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.428 HD11 HD12 ' B' ' 60' ' ' LEU . 47.6 tp -111.26 123.12 49.56 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 24.0 m -109.87 119.63 39.96 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.325 -0.859 . . . . 0.0 109.076 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 95.9 mt -109.91 129.31 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -117.86 137.46 52.76 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.92 -152.72 10.4 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -134.22 145.37 49.11 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.307 -1.114 . . . . 0.0 109.608 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' B' ' 54' ' ' GLU . 72.4 mmtt 59.43 52.02 6.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.568 -0.707 . . . . 0.0 110.058 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.555 ' N ' HD12 ' B' ' 39' ' ' LEU . 10.4 mp -88.45 72.04 8.91 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.952 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -178.547 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 62.0 mt . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 121.612 0.72 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -171.07 -81.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.2 8.85 5.21 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.462 -0.774 . . . . 0.0 109.471 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.13 35.44 15.15 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -129.82 159.99 34.87 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.412 -1.052 . . . . 0.0 109.182 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.38 137.42 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -122.04 147.35 46.2 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -126.69 135.33 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' B' ' 38' ' ' LYS . 47.7 tt0 -119.2 133.03 55.99 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.86 -178.69 34.04 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.524 ' CB ' HD22 ' B' ' 3' ' ' ASN . 0.2 OUTLIER -103.03 126.43 50.2 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.451 -1.029 . . . . 0.0 109.806 -179.625 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.554 ' N ' HD12 ' B' ' 57' ' ' ILE . 1.4 mp -76.9 126.1 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.962 . . . . 0.0 109.198 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -104.95 -23.28 13.0 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.618 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -169.26 153.28 5.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.055 -1.028 . . . . 0.0 110.019 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.618 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.9 OUTLIER -131.19 134.16 46.22 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.479 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.946 HG22 HD12 ' A' ' 64' ' ' LEU . 4.1 t -135.43 124.72 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.786 -0.571 . . . . 0.0 110.033 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.463 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 17.9 t80 -144.19 140.32 16.77 Favored Pre-proline 0 N--CA 1.493 1.712 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.463 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 72.6 Cg_endo -74.46 108.48 2.7 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.538 1.492 . . . . 0.0 112.082 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.96 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -82.25 8.84 10.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.535 -0.728 . . . . 0.0 109.164 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 72.9 155.48 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.502 0.668 . . . . 0.0 110.631 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.407 ' C ' ' H ' ' B' ' 68' ' ' HIS . 90.7 m-70 -88.39 17.49 5.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.611 -0.681 . . . . 0.0 109.371 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.528 ' O ' ' CG ' ' B' ' 67' ' ' HIS . 16.1 t-80 -77.51 39.81 0.28 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.323 -0.861 . . . . 0.0 108.775 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 0.561 ' O ' ' ND1' ' B' ' 69' ' ' HIS . 1.6 p-80 -80.61 -20.72 42.59 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.171 -0.956 . . . . 0.0 109.651 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.639 ' CG ' ' H ' ' B' ' 70' ' ' HIS . 0.0 OUTLIER 18.96 -125.9 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 CA-C-O 121.266 0.555 . . . . 0.0 112.268 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.639 ' H ' ' CG ' ' B' ' 69' ' ' HIS . 0.1 OUTLIER -46.19 -73.07 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.406 -0.809 . . . . 0.0 109.722 -179.477 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 71' ' ' HIS . . . . . 0.412 ' C ' ' O ' ' B' ' 70' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.585 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.442 ' O ' ' O ' ' A' ' 2' ' ' ASP . 27.9 ttt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 1' ' ' MET . 30.6 t70 58.61 122.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.537 0.685 . . . . 0.0 110.478 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -144.17 -29.12 0.5 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.449 -0.782 . . . . 0.0 109.143 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 41.5 mmm-85 -60.48 141.29 56.65 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.327 -0.858 . . . . 0.0 108.785 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -152.19 161.93 41.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.125 -0.984 . . . . 0.0 109.917 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 6' ' ' PHE . 1.2 m-85 -117.89 139.62 50.87 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.493 HD23 ' C ' ' A' ' 7' ' ' LEU . 7.2 tt -115.8 126.06 53.52 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.393 -0.817 . . . . 0.0 108.996 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.476 ' N ' HD23 ' A' ' 7' ' ' LEU . 32.4 t -115.25 126.75 54.9 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.4 tp -144.63 151.77 39.5 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 t -143.15 166.84 23.56 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.278 -0.889 . . . . 0.0 109.631 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.4 10.95 67.33 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -69.97 145.23 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -1.219 . . . . 0.0 110.028 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 m -73.87 -51.97 14.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.361 -0.837 . . . . 0.0 109.529 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.43 ' HZ2' ' HB2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -167.37 158.69 11.88 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.067 -1.021 . . . . 0.0 109.619 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.7 t -89.27 116.01 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.268 -0.895 . . . . 0.0 109.403 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -69.19 -40.89 77.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 109.7 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.1 t -161.83 125.28 3.14 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.369 -0.832 . . . . 0.0 109.844 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -109.25 110.19 21.32 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -133.61 148.05 67.07 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.16 -20.1 50.14 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.715 1.61 . . . . 0.0 111.604 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -100.14 -5.44 27.79 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.341 -0.849 . . . . 0.0 109.671 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.403 ' OE2' ' NZ ' ' A' ' 35' ' ' LYS . 36.2 tt0 -171.32 142.91 1.77 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.208 -0.932 . . . . 0.0 109.603 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.8 mt -131.2 130.04 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.715 -0.616 . . . . 0.0 109.497 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.8 mt -117.28 125.75 51.61 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.3 mt -121.1 130.09 53.59 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.591 -0.693 . . . . 0.0 109.647 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.403 ' HG2' HG22 ' A' ' 31' ' ' VAL . 29.4 mt-10 -97.68 103.54 15.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.357 -0.839 . . . . 0.0 110.011 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 28' ' ' ILE . 6.6 t -127.18 -172.47 2.66 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.951 0.882 . . . . 0.0 110.562 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' THR . 4.2 mt -31.84 154.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.924 0.868 . . . . 0.0 111.244 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 64.49 -56.17 0.26 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.646 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -173.4 -129.48 1.16 Allowed Glycine 0 N--CA 1.487 2.059 0 C-N-CA 119.234 -1.46 . . . . 0.0 109.944 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.403 HG22 ' HG2' ' A' ' 26' ' ' GLU . 52.7 t -120.72 136.14 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.778 0.799 . . . . 0.0 110.862 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.9 tp -104.61 126.85 52.09 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -100.8 125.51 47.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.632 -0.668 . . . . 0.0 109.512 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.3 mt -111.3 128.54 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-O 121.294 0.569 . . . . 0.0 109.513 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.403 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 68.5 mttm -128.27 144.24 51.11 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.453 0.644 . . . . 0.0 109.629 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.9 -137.69 4.31 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -132.57 153.3 51.13 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.193 -1.181 . . . . 0.0 110.232 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 54' ' ' GLU . 98.9 mttt 49.72 40.64 20.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.619 -0.676 . . . . 0.0 110.135 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.3 mp -68.51 72.23 0.21 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 0.0 109.244 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.676 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.869 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 48' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.846 0.831 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.548 ' HD3' ' H ' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -91.05 -11.75 37.81 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.025 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HB3' HD12 ' A' ' 46' ' ' LEU . . . -43.8 -17.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.831 -0.543 . . . . 0.0 109.898 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 47' ' ' LYS . . . 126.55 23.79 1.47 Allowed Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -130.02 134.35 47.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.713 -0.875 . . . . 0.0 109.111 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 52' ' ' GLU . 40.6 t -131.44 161.16 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.56 -0.712 . . . . 0.0 109.231 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.483 ' N ' HG12 ' A' ' 51' ' ' VAL . 92.5 mt-10 -132.83 160.03 38.1 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.529 0.681 . . . . 0.0 109.673 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 t -128.84 157.82 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 38' ' ' LYS . 32.1 tt0 -135.37 134.56 39.89 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.6 172.14 13.18 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 pp -97.46 134.94 40.03 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.438 -1.037 . . . . 0.0 109.169 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.3 mp -84.95 113.69 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.845 -1.16 . . . . 0.0 108.664 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -98.74 -22.19 16.0 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -159.47 148.57 18.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.315 -0.866 . . . . 0.0 110.298 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.49 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 51.5 mt -133.97 146.36 50.38 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.5 t -146.53 114.83 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.059 -1.025 . . . . 0.0 109.869 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.532 ' O ' ' N ' ' A' ' 64' ' ' LEU . 13.8 t80 -130.28 142.52 45.73 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.519 ' C ' ' H ' ' A' ' 65' ' ' GLU . 84.7 Cg_exo -44.87 85.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.34 1.36 . . . . 0.0 111.916 177.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.647 ' O ' HD23 ' A' ' 64' ' ' LEU . 2.1 tt -56.7 -7.83 0.49 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.817 -1.177 . . . . 0.0 108.525 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.56 ' CB ' ' O ' ' A' ' 64' ' ' LEU . 2.1 tp10 95.27 -73.91 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.588 ' H ' HD23 ' A' ' 64' ' ' LEU . 1.8 t60 75.63 172.56 0.25 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.512 -0.742 . . . . 0.0 109.178 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.447 ' O ' ' CB ' ' A' ' 68' ' ' HIS . 0.1 OUTLIER -77.41 149.49 35.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.005 -1.059 . . . . 0.0 110.164 -178.692 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.447 ' CB ' ' O ' ' A' ' 67' ' ' HIS . 4.0 t60 74.71 176.0 0.24 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.656 -0.652 . . . . 0.0 109.511 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 70' ' ' HIS . 6.5 t-80 -129.62 16.17 5.91 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 69' ' ' HIS . 34.5 m-70 44.31 -167.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.402 -0.811 . . . . 0.0 109.959 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.502 ' CG ' ' OXT' ' A' ' 71' ' ' HIS . 10.2 p80 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.346 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 77.6 mtm . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 7.0 t70 58.15 -171.04 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.416 -0.802 . . . . 0.0 109.85 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.501 HD22 ' CB ' ' B' ' 56' ' ' LEU . 2.7 p-10 -95.57 12.87 28.07 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 43.5 mmm-85 -89.39 131.46 35.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.964 -1.085 . . . . 0.0 109.128 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -144.52 159.01 43.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.288 -0.882 . . . . 0.0 109.903 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.9 115.17 29.65 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.437 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.6 tt -113.8 126.77 55.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.407 -0.808 . . . . 0.0 109.061 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.401 ' N ' HD23 ' B' ' 7' ' ' LEU . 40.7 t -132.47 143.76 50.0 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.418 ' O ' HG12 ' B' ' 51' ' ' VAL . 52.0 tp -133.64 150.09 51.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.527 -0.733 . . . . 0.0 109.154 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.6 p -129.3 171.12 12.8 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.704 -0.623 . . . . 0.0 109.35 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.52 5.46 63.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.04 135.32 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.339 -1.095 . . . . 0.0 109.695 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.3 t -72.56 -46.12 55.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 109.55 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.03 160.78 5.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.179 -0.95 . . . . 0.0 109.55 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 90.4 t -93.6 121.27 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.189 -0.944 . . . . 0.0 109.218 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -66.7 -40.03 88.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 109.545 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 47.7 t -162.43 149.77 13.75 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.43 -0.794 . . . . 0.0 108.889 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -136.24 117.85 14.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.377 -0.827 . . . . 0.0 109.491 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -132.45 150.81 76.94 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.06 -13.81 41.19 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.502 1.468 . . . . 0.0 111.07 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -118.2 3.12 12.01 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.749 -0.594 . . . . 0.0 109.603 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -170.03 134.43 1.27 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.269 -0.894 . . . . 0.0 109.409 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.2 mt -132.24 129.54 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.279 -0.888 . . . . 0.0 109.46 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 74.8 mt -112.34 125.64 54.41 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 87.1 mt -113.21 132.44 55.5 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.53 -0.731 . . . . 0.0 110.121 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -104.66 101.12 10.77 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.567 ' O ' ' N ' ' B' ' 29' ' ' GLN . 0.0 OUTLIER -108.73 148.86 29.84 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.822 -0.549 . . . . 0.0 110.447 -178.353 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' B' ' 27' ' ' THR . 39.9 mt 34.2 -86.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 122.151 -0.343 . . . . 0.0 110.83 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.567 ' N ' ' O ' ' B' ' 27' ' ' THR . 18.5 pt20 -137.49 -16.05 1.38 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.382 -0.824 . . . . 0.0 109.738 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.32 167.85 29.21 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 54.6 t -123.1 131.51 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 43.5 tp -110.76 126.18 54.32 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 19.1 t -106.69 122.8 47.08 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 94.9 mt -105.73 129.29 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -124.13 141.39 52.09 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.628 -0.67 . . . . 0.0 109.379 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.23 -153.42 22.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -121.45 150.85 40.95 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.571 -0.958 . . . . 0.0 109.847 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' B' ' 54' ' ' GLU . 95.3 mttt 51.93 61.68 3.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -0.8 . . . . 0.0 110.124 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.406 ' N ' HD12 ' B' ' 39' ' ' LEU . 9.2 mp -93.05 71.56 4.63 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.764 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -179.11 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' B' ' 47' ' ' LYS . 53.3 tp . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.105 0.479 . . . . 0.0 110.51 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.557 ' O ' ' HB3' ' B' ' 48' ' ' ALA . 88.1 tttt -39.44 150.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.424 -0.798 . . . . 0.0 110.583 -178.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' B' ' 47' ' ' LYS . . . 71.38 -17.08 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.603 -0.686 . . . . 0.0 109.237 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' B' ' 47' ' ' LYS . . . 79.01 10.39 86.22 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -109.94 160.18 16.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.633 -0.922 . . . . 0.0 109.266 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.418 HG12 ' O ' ' B' ' 9' ' ' LEU . 2.2 p -132.18 141.71 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.569 -0.707 . . . . 0.0 109.32 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -122.1 149.78 43.1 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 10.2 t -141.45 138.22 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.163 -0.961 . . . . 0.0 109.545 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' B' ' 38' ' ' LYS . 16.0 tt0 -127.62 137.59 52.59 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.61 178.36 26.29 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.501 ' CB ' HD22 ' B' ' 3' ' ' ASN . 0.2 OUTLIER -99.82 124.46 45.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.572 -0.958 . . . . 0.0 108.929 179.312 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.586 ' N ' HD12 ' B' ' 57' ' ' ILE . 1.5 mp -82.82 119.25 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.181 -0.949 . . . . 0.0 108.895 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -95.26 -21.46 18.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.386 -0.821 . . . . 0.0 109.488 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -170.29 153.5 4.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.117 -0.989 . . . . 0.0 109.8 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.413 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 96.2 mt -134.04 136.58 44.11 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 56.7 t -132.64 124.81 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.554 -0.716 . . . . 0.0 109.459 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.49 ' CG ' ' HB2' ' A' ' 60' ' ' LEU . 19.4 t80 -133.01 139.71 35.3 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.477 ' O ' ' C ' ' B' ' 64' ' ' LEU . 71.6 Cg_exo -44.5 -65.49 0.19 Allowed 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 122.026 1.818 . . . . 0.0 115.294 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.835 ' O ' HD13 ' B' ' 64' ' ' LEU . 2.0 tm? 28.27 89.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.622 0.725 . . . . 0.0 111.002 -177.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.407 ' OE1' ' O ' ' B' ' 63' ' ' PRO . 2.9 mt-10 -140.44 141.43 35.48 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.65 ' ND1' ' N ' ' B' ' 67' ' ' HIS . 3.7 p80 -59.51 -42.76 92.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.762 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.65 ' N ' ' ND1' ' B' ' 66' ' ' HIS . 1.9 m170 -172.6 152.59 2.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -0.862 . . . . 0.0 108.723 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.22 174.44 10.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.075 -1.015 . . . . 0.0 109.824 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -81.21 14.91 2.14 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -57.71 141.96 46.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.6 -0.687 . . . . 0.0 109.527 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 t60 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.317 -179.605 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.629 0.728 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 31.9 t0 -72.58 163.79 27.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 109.919 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 6.6 p30 -88.85 11.12 18.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.181 -0.949 . . . . 0.0 109.487 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.431 ' NE ' ' OE2' ' A' ' 54' ' ' GLU . 40.1 mmm-85 -71.23 147.89 47.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 109.126 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -141.37 156.86 45.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.187 -0.945 . . . . 0.0 109.996 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.51 ' CE1' ' OE1' ' A' ' 54' ' ' GLU . 69.6 m-85 -107.21 125.74 51.51 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.468 HD23 ' C ' ' A' ' 7' ' ' LEU . 7.3 tt -117.92 124.97 49.56 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.423 ' N ' HD23 ' A' ' 7' ' ' LEU . 44.2 t -115.94 135.1 54.3 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.639 -0.663 . . . . 0.0 109.633 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.4 tp -145.4 148.95 33.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.442 -0.786 . . . . 0.0 109.565 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 p -142.76 -163.14 1.56 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.81 . . . . 0.0 109.717 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.62 17.97 7.2 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.65 141.72 16.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.165 -1.197 . . . . 0.0 109.939 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.2 m -71.43 -45.16 63.39 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.53 154.68 0.8 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.186 -0.946 . . . . 0.0 110.384 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.0 t -77.2 132.32 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.544 -0.722 . . . . 0.0 110.382 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.526 ' OE1' HG21 ' A' ' 31' ' ' VAL . 45.3 tt0 -98.5 -34.66 10.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.49 -0.756 . . . . 0.0 108.968 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 p -161.54 163.28 30.27 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.016 -1.053 . . . . 0.0 109.683 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -148.96 104.77 3.47 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -133.85 125.85 18.5 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -47.14 -22.51 2.29 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.857 1.705 . . . . 0.0 111.868 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -94.25 -9.01 37.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.578 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -174.32 143.28 0.85 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 109.315 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.1 mt -128.38 131.35 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.353 -0.842 . . . . 0.0 109.007 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.1 mt -116.69 115.71 26.18 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.2 mt -117.79 130.43 56.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.569 -0.707 . . . . 0.0 109.637 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.07 103.16 11.5 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 28' ' ' ILE . 7.0 t -124.28 -177.96 3.95 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.586 0.708 . . . . 0.0 110.132 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 27' ' ' THR . 3.8 mt -31.91 153.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.765 0.793 . . . . 0.0 110.847 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 64.05 -63.26 0.15 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.504 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -161.85 -123.18 0.65 Allowed Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.191 -1.48 . . . . 0.0 110.014 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.526 HG21 ' OE1' ' A' ' 16' ' ' GLN . 55.8 t -120.58 135.88 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.668 -0.901 . . . . 0.0 109.727 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.7 tp -100.27 125.23 46.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.603 -0.685 . . . . 0.0 109.205 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.1 m -104.47 121.57 43.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 0.0 108.94 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.9 mt -110.73 127.42 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -117.48 147.96 42.27 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.453 0.644 . . . . 0.0 110.1 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.95 -149.65 12.14 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -136.38 145.92 45.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.346 -1.09 . . . . 0.0 109.472 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 54.99 57.65 5.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.545 -0.722 . . . . 0.0 110.092 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.6 mp -89.65 71.73 7.8 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.132 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.038 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 tt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 121.653 0.74 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.592 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 87.8 tttt -169.03 129.3 1.1 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.421 -0.8 . . . . 0.0 109.386 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 47' ' ' LYS . . . 75.48 -6.11 2.04 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.785 -0.572 . . . . 0.0 109.504 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.14 52.67 2.85 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -155.14 159.48 40.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.995 -1.297 . . . . 0.0 109.056 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.2 t -126.94 134.66 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.574 -0.704 . . . . 0.0 109.261 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -118.41 153.01 34.79 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.716 -0.615 . . . . 0.0 109.624 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.7 t -124.66 135.56 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.51 ' OE1' ' CE1' ' A' ' 6' ' ' PHE . 16.4 tp10 -113.38 127.12 56.02 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.56 169.06 21.58 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -90.91 140.8 29.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.415 -1.05 . . . . 0.0 109.744 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.435 ' CG2' HD23 ' A' ' 60' ' ' LEU . 92.9 mt -93.82 115.17 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.991 -1.068 . . . . 0.0 109.714 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -98.64 -24.21 15.17 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.82 151.81 18.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.903 -1.123 . . . . 0.0 111.091 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.435 HD23 ' CG2' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -130.1 131.7 45.84 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.249 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 54.9 t -129.75 128.88 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.682 0.753 . . . . 0.0 109.588 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 64' ' ' LEU . 12.0 t80 -144.9 142.13 18.27 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -49.08 78.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.589 1.526 . . . . 0.0 111.968 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.638 HD23 ' C ' ' A' ' 64' ' ' LEU . 0.6 OUTLIER -60.93 -12.92 12.8 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.38 -0.825 . . . . 0.0 109.193 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -86.02 -167.74 1.97 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.257 -0.902 . . . . 0.0 110.251 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.627 ' CG ' ' N ' ' A' ' 67' ' ' HIS . 11.9 t-80 -141.43 -109.02 0.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.55 -0.719 . . . . 0.0 109.179 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.631 ' ND1' ' NE2' ' A' ' 69' ' ' HIS . 1.8 t-80 53.18 -163.93 0.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.402 -0.811 . . . . 0.0 110.2 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.4 81.26 1.66 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.631 ' NE2' ' ND1' ' A' ' 67' ' ' HIS . 55.8 m170 -102.01 -74.26 0.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 68.11 -14.88 0.23 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.538 ' H ' ' C ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.098 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.442 0.639 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -86.74 117.15 25.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.334 -0.853 . . . . 0.0 109.998 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -90.81 11.82 21.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.482 -0.762 . . . . 0.0 109.025 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -85.31 138.54 32.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.087 -1.008 . . . . 0.0 109.458 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -141.8 153.22 44.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 109.898 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -108.12 119.23 38.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.564 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.4 tt -108.09 121.67 45.3 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.545 ' N ' HD23 ' B' ' 7' ' ' LEU . 8.2 p -114.78 137.25 52.17 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.354 0.597 . . . . 0.0 109.995 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.8 tp -149.3 148.31 29.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.546 -0.721 . . . . 0.0 109.306 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -142.42 164.59 29.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.274 -0.891 . . . . 0.0 110.256 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.98 21.02 58.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 p -59.5 142.29 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.117 -1.225 . . . . 0.0 110.432 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 15.1 m -72.86 -39.99 66.04 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -172.26 163.91 5.83 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.12 -0.988 . . . . 0.0 110.01 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 85.7 t -96.84 99.8 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.425 -0.797 . . . . 0.0 109.555 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -65.53 -39.22 91.52 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.313 -0.867 . . . . 0.0 109.128 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 47.0 t -172.67 152.33 2.52 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.27 -0.893 . . . . 0.0 109.318 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -133.81 107.98 8.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.557 -0.714 . . . . 0.0 109.259 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.93 145.79 57.32 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.6 -19.13 42.58 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.973 1.782 . . . . 0.0 111.426 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -98.52 -7.0 29.1 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -173.38 131.98 0.47 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.368 -0.833 . . . . 0.0 109.352 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.72 128.69 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.447 -0.783 . . . . 0.0 109.28 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 62.9 mt -118.45 121.88 41.38 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 88.8 mt -132.28 130.58 41.07 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -93.62 127.86 39.51 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.211 -0.931 . . . . 0.0 109.101 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.59 ' O ' ' N ' ' B' ' 29' ' ' GLN . 5.4 t -124.39 149.05 47.13 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.373 0.606 . . . . 0.0 109.47 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.411 ' N ' HD13 ' B' ' 28' ' ' ILE . 5.9 mm 48.05 -81.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.049 0.452 . . . . 0.0 110.321 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' B' ' 27' ' ' THR . 11.4 pt20 -149.03 -21.21 0.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.052 -1.03 . . . . 0.0 109.359 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.67 165.14 25.7 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 120.987 -1.071 . . . . 0.0 110.509 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.63 130.6 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.609 -0.936 . . . . 0.0 109.488 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 50.9 tp -106.98 126.04 51.8 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 71.0 m -111.27 117.31 32.8 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 89.6 mt -100.77 128.04 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -124.68 136.82 54.23 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.51 -149.01 9.79 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -133.83 148.63 51.33 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.513 -0.992 . . . . 0.0 109.813 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 56.23 57.96 4.63 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.732 0.777 . . . . 0.0 109.747 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.505 ' N ' HD12 ' B' ' 39' ' ' LEU . 9.9 mp -91.34 72.03 6.12 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.386 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.544 ' N ' HD12 ' B' ' 46' ' ' LEU . 10.4 mp . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.182 0.515 . . . . 0.0 110.028 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -128.0 -17.61 4.35 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.08 29.74 0.57 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.134 -0.979 . . . . 0.0 109.056 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.12 22.01 78.34 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -104.57 155.75 18.56 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.302 -1.116 . . . . 0.0 109.487 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.3 t -127.78 135.1 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.504 -0.748 . . . . 0.0 109.355 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.72 159.88 40.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.658 -0.652 . . . . 0.0 109.381 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 99.3 t -127.73 138.25 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -117.96 138.47 52.15 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.17 -179.49 30.33 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.58 124.45 43.36 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.399 -1.059 . . . . 0.0 109.793 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.534 ' N ' HD12 ' B' ' 57' ' ' ILE . 1.3 mp -77.83 126.41 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.488 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -109.38 -19.14 13.38 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.647 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -166.15 152.25 9.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.927 -1.108 . . . . 0.0 110.305 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.647 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.6 OUTLIER -134.19 129.56 35.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.569 -0.707 . . . . 0.0 109.176 179.423 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.0 t -126.59 128.41 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.578 ' O ' HD13 ' B' ' 64' ' ' LEU . 45.4 t80 -144.02 101.47 4.9 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -46.62 89.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.111 1.874 . . . . 0.0 112.582 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.903 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -79.24 4.45 14.96 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.311 -0.868 . . . . 0.0 109.292 179.533 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.417 ' N ' HD22 ' B' ' 64' ' ' LEU . 3.4 mm-40 -74.92 -100.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.385 -0.822 . . . . 0.0 110.081 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -124.31 165.67 17.25 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.607 0.718 . . . . 0.0 110.548 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' B' ' 68' ' ' HIS . 8.6 p80 -79.98 -11.02 59.82 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 0.524 ' C ' ' CG ' ' B' ' 69' ' ' HIS . 11.2 m80 -54.7 -163.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.498 -0.751 . . . . 0.0 110.199 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.524 ' CG ' ' C ' ' B' ' 68' ' ' HIS . 1.3 m-70 79.88 -128.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' B' ' 71' ' ' HIS . 0.0 OUTLIER 60.37 15.89 5.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.907 -1.12 . . . . 0.0 110.528 179.497 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 71' ' ' HIS . . . . . 0.657 ' N ' ' ND1' ' B' ' 71' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 118.184 -0.912 . . . . 0.0 109.73 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.71 0.767 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -87.73 110.18 20.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.388 -0.82 . . . . 0.0 109.49 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -101.32 -3.33 29.05 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.829 0.823 . . . . 0.0 109.397 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -71.4 138.62 49.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.172 -0.955 . . . . 0.0 109.911 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -146.27 154.99 42.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.293 -0.88 . . . . 0.0 110.005 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 6' ' ' PHE . 8.1 m-85 -110.75 121.1 44.5 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.526 HD23 ' C ' ' A' ' 7' ' ' LEU . 6.9 tt -114.08 124.58 52.46 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.509 -0.744 . . . . 0.0 109.223 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.523 ' N ' HD23 ' A' ' 7' ' ' LEU . 23.8 p -125.41 149.56 48.07 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.778 0.799 . . . . 0.0 109.558 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.621 HD11 ' NE2' ' B' ' 5' ' ' GLN . 36.6 tp -147.8 144.45 28.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.45 -0.781 . . . . 0.0 109.511 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -125.99 164.38 20.94 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.714 0.768 . . . . 0.0 110.169 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.54 17.04 71.94 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.34 134.78 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -1.168 . . . . 0.0 110.438 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -72.68 -45.08 60.69 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.543 -0.723 . . . . 0.0 109.074 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.12 160.46 4.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.445 -0.785 . . . . 0.0 109.976 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.8 t -91.62 110.93 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.578 0.704 . . . . 0.0 109.873 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -68.55 -38.32 80.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.45 -0.781 . . . . 0.0 109.595 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.2 t -162.61 156.17 20.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.876 -1.14 . . . . 0.0 110.383 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -141.66 105.57 4.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.98 147.74 66.61 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.74 -18.0 42.16 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.447 2.098 . . . . 0.0 111.274 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -102.16 -9.12 20.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.43 -0.794 . . . . 0.0 109.344 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -171.83 133.68 0.76 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.212 -0.93 . . . . 0.0 109.704 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.1 mt -126.45 130.07 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.428 -0.795 . . . . 0.0 110.135 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.0 mt -116.27 125.89 52.82 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.7 mt -121.15 130.42 53.71 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.715 0.769 . . . . 0.0 109.466 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -98.01 113.69 25.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.6 -0.688 . . . . 0.0 109.556 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.549 ' O ' ' N ' ' A' ' 29' ' ' GLN . 9.0 t -124.65 157.6 35.14 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.941 0.877 . . . . 0.0 110.097 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.407 HD12 ' HB2' ' B' ' 3' ' ' ASN . 14.6 mm 38.2 -85.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.287 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.549 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.8 pp0? -142.62 -17.02 0.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.95 -1.094 . . . . 0.0 108.873 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.06 175.24 24.91 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.1 t -125.6 133.45 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.781 -0.835 . . . . 0.0 109.602 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.1 tp -102.76 128.31 49.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.621 -0.675 . . . . 0.0 109.51 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -112.85 126.79 55.83 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.823 0.82 . . . . 0.0 110.166 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.6 mt -108.98 130.25 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -124.84 140.49 52.88 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.575 0.703 . . . . 0.0 109.446 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.06 -145.75 9.42 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -134.53 144.52 48.06 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.463 -1.021 . . . . 0.0 109.362 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.8 mttp 55.48 61.22 2.95 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.834 0.826 . . . . 0.0 109.695 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.5 mp -92.56 71.64 5.05 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.912 0.863 . . . . 0.0 109.062 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.221 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 46' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.677 0.751 . . . . 0.0 109.997 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt 44.01 -85.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.379 0.609 . . . . 0.0 110.92 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . -83.95 -0.54 51.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 0.0 109.235 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 49.25 64.31 3.43 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -138.44 157.18 46.71 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.203 -1.175 . . . . 0.0 109.476 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.1 m -117.0 158.37 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.618 0.723 . . . . 0.0 109.848 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -141.52 140.11 33.4 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.9 t -125.81 134.89 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.591 -0.693 . . . . 0.0 109.423 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -117.18 125.88 51.89 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.04 174.6 30.03 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.164 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.547 HD23 ' H ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -91.35 128.76 37.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.667 -0.902 . . . . 0.0 110.092 -179.365 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.4 mp -78.74 125.96 38.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.435 -0.791 . . . . 0.0 109.126 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -112.19 -29.97 7.38 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.473 ' O ' HD22 ' A' ' 60' ' ' LEU . . . -166.38 137.84 3.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.028 -1.045 . . . . 0.0 110.812 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.473 HD22 ' O ' ' A' ' 59' ' ' ALA . 3.1 mm? -117.14 135.51 53.7 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.78 129.48 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.867 0.841 . . . . 0.0 110.075 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -145.47 137.84 13.51 Favored Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.02 108.42 2.12 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.788 1.658 . . . . 0.0 112.543 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.979 ' H ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -87.54 -7.83 57.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.245 -0.909 . . . . 0.0 109.095 179.354 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.571 ' N ' HD22 ' A' ' 64' ' ' LEU . 2.2 mt-10 -60.59 136.09 57.95 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 122.24 1.019 . . . . 0.0 110.584 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.468 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 34.5 t-80 -85.36 -6.71 59.21 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -99.48 -165.66 1.25 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.69 0.757 . . . . 0.0 109.911 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -161.34 -155.88 0.42 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.687 0.756 . . . . 0.0 109.874 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.403 ' O ' ' C ' ' A' ' 70' ' ' HIS . 1.3 t60 -55.0 97.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.498 -0.751 . . . . 0.0 110.474 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.74 ' CG ' ' H ' ' A' ' 71' ' ' HIS . 12.3 t-80 41.33 -126.71 0.54 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.791 -0.568 . . . . 0.0 109.964 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.74 ' H ' ' CG ' ' A' ' 70' ' ' HIS . 50.7 m-70 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.799 -1.188 . . . . 0.0 108.87 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.647 0.737 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' B' ' 3' ' ' ASN . 14.6 t0 -88.96 -147.02 0.16 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.35 -0.844 . . . . 0.0 110.286 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' B' ' 4' ' ' ARG . 52.8 p-10 -105.37 -23.98 12.75 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.473 -0.767 . . . . 0.0 110.537 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.543 ' N ' ' OD1' ' B' ' 3' ' ' ASN . 45.0 mmm-85 -50.46 136.78 20.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.192 -0.942 . . . . 0.0 110.682 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' GLN . . . . . 0.621 ' NE2' HD11 ' A' ' 9' ' ' LEU . 2.3 pt20 -146.37 155.81 42.87 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.335 -0.853 . . . . 0.0 109.551 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' B' ' 6' ' ' PHE . 30.3 m-85 -115.04 121.64 43.71 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.635 HD23 ' N ' ' B' ' 8' ' ' SER . 6.4 tt -118.43 122.79 43.63 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.635 ' N ' HD23 ' B' ' 7' ' ' LEU . 29.8 t -119.01 134.76 55.0 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.511 0.672 . . . . 0.0 109.825 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 48.9 tp -131.61 144.91 51.4 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.8 p -128.09 164.0 23.39 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.701 0.762 . . . . 0.0 110.26 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.33 20.06 61.19 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 p -67.39 135.71 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.187 -1.184 . . . . 0.0 110.01 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 56.2 m -72.45 -43.65 63.47 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.421 -0.8 . . . . 0.0 109.25 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.98 162.28 3.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.385 -0.822 . . . . 0.0 110.278 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.2 t -89.98 111.24 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.519 0.676 . . . . 0.0 110.066 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -67.2 -38.91 86.13 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.881 0.848 . . . . 0.0 108.791 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 30.1 t -168.89 166.37 11.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 0.0 109.655 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -145.48 104.7 3.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.37 -0.831 . . . . 0.0 109.513 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' B' ' 22' ' ' GLU . 13.7 m-20 -133.92 125.94 18.48 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.62 -26.27 16.63 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.824 1.683 . . . . 0.0 111.503 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -88.59 -5.05 58.42 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.708 0.766 . . . . 0.0 109.379 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' B' ' 19' ' ' ASP . 32.9 tt0 -176.35 132.99 0.23 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.517 -0.74 . . . . 0.0 109.399 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 93.5 mt -123.09 128.1 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.45 -0.781 . . . . 0.0 109.481 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 mt -117.84 129.07 55.44 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.361 0.601 . . . . 0.0 109.463 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 86.3 mt -131.03 131.87 44.58 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.665 0.745 . . . . 0.0 109.873 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -95.4 114.46 26.24 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.616 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.3 t -125.53 153.77 43.13 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.439 0.638 . . . . 0.0 110.114 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 14.0 mm 46.3 -78.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-O 121.558 0.694 . . . . 0.0 110.91 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.616 ' N ' ' O ' ' B' ' 27' ' ' THR . 13.3 pt20 -151.89 -22.84 0.19 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.161 -0.962 . . . . 0.0 109.118 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.94 176.17 29.29 Favored Glycine 0 N--CA 1.5 2.944 0 O-C-N 120.993 -1.067 . . . . 0.0 110.624 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 56.0 t -121.13 134.65 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.6 -0.941 . . . . 0.0 109.442 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 51.2 tp -104.88 128.27 53.03 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.473 0.654 . . . . 0.0 109.655 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 46.4 t -112.26 121.27 44.42 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 93.9 mt -106.05 130.95 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.551 0.691 . . . . 0.0 110.202 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -127.71 141.21 51.66 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.83 -141.47 4.7 Favored Glycine 0 N--CA 1.485 1.928 0 C-N-CA 119.655 -1.26 . . . . 0.0 110.235 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -129.42 135.62 48.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.708 -0.878 . . . . 0.0 109.544 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? 43.23 80.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.91 0.862 . . . . 0.0 110.08 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.477 ' N ' HD12 ' B' ' 39' ' ' LEU . 8.7 mp -95.06 71.59 3.35 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.073 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -179.156 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 122.08 0.943 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -56.71 -69.23 0.16 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.884 0.849 . . . . 0.0 109.856 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.68 34.98 1.61 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.141 -0.975 . . . . 0.0 109.121 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.82 25.61 75.45 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -82.95 160.16 22.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.349 -1.089 . . . . 0.0 109.983 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 6.2 m -124.28 133.14 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.682 0.753 . . . . 0.0 109.793 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -127.15 129.3 47.61 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.27 136.43 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.648 -0.657 . . . . 0.0 109.25 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -121.06 134.5 55.27 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.713 0.768 . . . . 0.0 109.373 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.55 -179.82 29.57 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.52 126.87 43.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.667 -0.902 . . . . 0.0 109.52 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.522 ' N ' HD12 ' B' ' 57' ' ' ILE . 1.4 mp -83.78 121.65 36.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.418 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -106.95 -19.24 13.69 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.667 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -162.14 150.03 14.5 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.647 -1.283 . . . . 0.0 110.984 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.667 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.6 OUTLIER -137.11 139.36 41.19 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.372 0.606 . . . . 0.0 109.386 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 54.7 t -141.03 131.61 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.454 -0.779 . . . . 0.0 110.198 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.505 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 11.9 t80 -145.73 140.16 15.47 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.505 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 68.4 Cg_endo -76.06 108.82 2.76 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.282 1.988 . . . . 0.0 112.336 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.86 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -100.54 34.65 2.35 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.364 -0.835 . . . . 0.0 109.157 179.699 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' B' ' 65' ' ' GLU . 0.0 OUTLIER 40.19 -165.81 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.762 0.791 . . . . 0.0 110.696 179.254 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' B' ' 65' ' ' GLU . 2.5 t-160 36.58 61.31 0.84 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.86 0.838 . . . . 0.0 110.263 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.643 ' CG ' ' N ' ' B' ' 68' ' ' HIS . 26.6 p-80 -150.61 -54.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 0.643 ' N ' ' CG ' ' B' ' 67' ' ' HIS . 5.0 t60 -165.76 126.88 1.88 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 109.956 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -84.6 162.04 19.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.519 -0.738 . . . . 0.0 109.018 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.526 ' O ' ' ND1' ' B' ' 70' ' ' HIS . 0.1 OUTLIER -124.51 139.4 53.92 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.399 -0.813 . . . . 0.0 110.004 -179.618 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.722 -179.847 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.421 ' O ' ' O ' ' A' ' 2' ' ' ASP . 78.5 mtm . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.242 0.544 . . . . 0.0 109.747 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 1' ' ' MET . 4.7 t70 44.82 -169.93 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.491 -0.756 . . . . 0.0 110.106 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -149.65 -28.71 0.25 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.212 -0.93 . . . . 0.0 109.609 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.7 mmm-85 -53.67 140.41 29.34 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.268 -0.895 . . . . 0.0 109.46 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -146.97 160.82 41.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.32 -0.862 . . . . 0.0 109.534 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -111.35 131.89 54.83 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.0 tt -118.2 139.83 50.71 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 m -121.79 146.69 46.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.509 -0.745 . . . . 0.0 109.262 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tp -156.1 149.0 24.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.113 -0.992 . . . . 0.0 109.868 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.3 163.76 34.51 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.582 -0.699 . . . . 0.0 109.562 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.14 18.96 56.77 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.14 140.22 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.171 -1.194 . . . . 0.0 109.798 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 t -73.44 -51.79 15.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.118 -0.989 . . . . 0.0 109.585 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -155.87 160.42 40.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.026 -1.046 . . . . 0.0 109.917 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.4 t -92.54 102.33 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -65.82 -39.22 90.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 109.445 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -167.74 164.36 14.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.156 -0.965 . . . . 0.0 109.513 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -147.06 108.07 4.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.186 -0.946 . . . . 0.0 108.863 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -132.26 146.97 63.89 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.91 -18.37 46.75 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 121.814 1.676 . . . . 0.0 111.367 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -100.12 -3.58 31.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.408 -0.808 . . . . 0.0 109.502 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.445 ' OE1' ' NZ ' ' A' ' 35' ' ' LYS . 29.8 tt0 -174.29 151.03 1.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.222 -0.924 . . . . 0.0 109.441 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.7 mt -133.98 129.76 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.27 -0.894 . . . . 0.0 109.733 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.0 mt -117.8 120.55 38.26 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.8 mt -134.09 133.23 40.88 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.25 -0.906 . . . . 0.0 109.413 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -102.53 118.56 37.11 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.244 -0.91 . . . . 0.0 108.974 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 29' ' ' GLN . 5.0 t -125.15 153.69 42.66 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.681 0.753 . . . . 0.0 110.143 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.0 mm 53.8 -82.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.635 -0.665 . . . . 0.0 109.879 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' THR . 20.9 pt20 -164.04 51.05 0.14 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.976 -1.078 . . . . 0.0 109.748 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -171.43 155.12 23.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.2 t -95.99 130.38 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.329 -1.101 . . . . 0.0 109.942 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.4 tp -107.2 121.71 45.06 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.9 t -107.71 118.06 35.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.3 mt -103.89 127.14 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.445 ' NZ ' ' OE1' ' A' ' 22' ' ' GLU . 68.7 mttm -121.43 129.54 53.06 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.553 0.692 . . . . 0.0 109.153 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.67 -141.42 3.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -144.53 151.67 39.45 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.989 -1.301 . . . . 0.0 110.168 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 54' ' ' GLU . 45.6 mmtm 56.65 43.53 25.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.574 -0.704 . . . . 0.0 109.726 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.7 mp -73.77 71.99 1.5 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.706 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.093 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 47' ' ' LYS . 52.9 tp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.056 0.455 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.544 ' C ' ' H ' ' A' ' 49' ' ' GLY . 65.0 tttm -37.3 148.72 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.434 0.635 . . . . 0.0 110.99 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 63.2 -9.0 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.7 -0.625 . . . . 0.0 109.793 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 47' ' ' LYS . . . 52.07 27.56 22.92 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -93.06 154.1 18.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.374 -1.074 . . . . 0.0 108.835 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.65 159.7 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.294 -0.879 . . . . 0.0 109.193 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.15 146.35 42.67 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.8 t -123.07 135.24 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 38' ' ' LYS . 19.8 pt-20 -116.38 132.09 56.77 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.31 173.34 25.61 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.412 ' O ' HD12 ' A' ' 56' ' ' LEU . 2.6 pp -96.84 124.51 40.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.252 -1.146 . . . . 0.0 109.745 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.7 mt -79.67 129.03 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.238 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -118.72 -27.63 5.81 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.59 ' O ' HD22 ' A' ' 60' ' ' LEU . . . -152.77 146.88 25.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.025 -1.047 . . . . 0.0 110.532 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -133.93 134.1 42.2 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.426 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.444 HG22 HD12 ' B' ' 64' ' ' LEU . 98.5 t -130.68 123.29 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.243 -0.91 . . . . 0.0 109.937 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.41 ' CE1' ' O ' ' A' ' 63' ' ' PRO . 46.4 t80 -146.66 138.01 13.05 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.41 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 61.6 Cg_endo -75.03 116.41 4.57 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.454 1.436 . . . . 0.0 111.442 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.972 ' H ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -88.55 39.95 0.94 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.196 -0.94 . . . . 0.0 108.473 179.736 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.499 ' O ' ' O ' ' A' ' 64' ' ' LEU . 0.8 OUTLIER 60.31 136.29 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.224 -0.923 . . . . 0.0 108.894 178.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.435 ' CG ' ' H ' ' A' ' 67' ' ' HIS . 5.8 t-80 -164.03 -170.01 2.01 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.435 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 1.7 t60 -146.91 142.01 27.15 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.937 -1.102 . . . . 0.0 109.721 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -77.36 135.85 38.39 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -94.51 126.38 39.76 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.961 -1.087 . . . . 0.0 109.796 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -88.68 176.81 6.94 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.676 -0.64 . . . . 0.0 109.541 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.098 -0.953 . . . . 0.0 109.445 179.533 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.543 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -76.32 118.04 18.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.089 -1.007 . . . . 0.0 109.631 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' B' ' 3' ' ' ASN . 7.2 p-10 -97.02 6.32 48.83 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.306 -0.871 . . . . 0.0 109.099 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -80.36 140.33 36.12 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.364 -0.835 . . . . 0.0 109.319 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -152.02 161.77 42.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 109.38 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.484 ' N ' ' CD1' ' B' ' 6' ' ' PHE . 23.6 m-85 -104.2 146.03 29.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.628 -0.67 . . . . 0.0 109.412 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.589 HD23 ' N ' ' B' ' 8' ' ' SER . 6.2 tt -132.66 122.27 24.41 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.589 ' N ' HD23 ' B' ' 7' ' ' LEU . 80.0 p -114.71 144.75 42.96 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.35 -0.844 . . . . 0.0 109.835 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.9 tp -150.67 150.72 31.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.295 -0.878 . . . . 0.0 109.323 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.6 160.76 41.76 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.476 -0.765 . . . . 0.0 109.472 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.37 14.3 60.36 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.31 135.11 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.235 -1.156 . . . . 0.0 109.689 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t -73.15 -43.41 61.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 109.857 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.56 165.03 10.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.941 -1.099 . . . . 0.0 109.798 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 71.4 t -98.31 129.68 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.22 -0.925 . . . . 0.0 109.917 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -83.57 -29.03 28.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 109.272 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 34.7 t -172.01 168.7 5.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.254 -0.904 . . . . 0.0 109.032 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -150.41 107.63 3.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.137 -0.977 . . . . 0.0 109.771 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -132.12 149.61 73.73 Favored Pre-proline 0 N--CA 1.497 1.923 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.19 -3.25 11.93 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.694 1.596 . . . . 0.0 111.606 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -122.26 -12.59 8.24 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.532 -0.73 . . . . 0.0 109.974 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -158.82 109.57 2.07 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.097 -1.002 . . . . 0.0 109.242 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 95.8 mt -111.67 128.74 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.403 ' CD2' ' OG ' ' B' ' 33' ' ' SER . 15.0 mt -111.6 125.05 53.52 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 80.0 mt -121.69 128.97 52.41 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.571 -0.706 . . . . 0.0 109.853 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -96.75 113.75 25.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.185 -0.947 . . . . 0.0 108.707 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.547 ' O ' ' N ' ' B' ' 29' ' ' GLN . 5.1 t -124.17 156.44 36.71 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.364 0.602 . . . . 0.0 110.514 -178.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.423 ' C ' ' O ' ' B' ' 27' ' ' THR . 45.4 mt 34.71 -87.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 CA-C-O 121.123 0.487 . . . . 0.0 110.639 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.547 ' N ' ' O ' ' B' ' 27' ' ' THR . 17.1 pt20 -150.73 45.19 0.85 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 0.0 109.682 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.68 136.69 4.29 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 74.7 t -91.55 132.73 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.391 -1.064 . . . . 0.0 109.751 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 53.0 tp -107.02 125.27 50.8 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.403 ' OG ' ' CD2' ' B' ' 24' ' ' LEU . 21.0 m -107.61 120.42 42.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.479 -0.763 . . . . 0.0 109.422 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 87.5 mt -106.78 127.5 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -124.78 139.89 53.43 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.581 0.705 . . . . 0.0 109.355 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.8 -139.97 5.46 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -143.63 152.72 41.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.996 -1.296 . . . . 0.0 109.52 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' B' ' 54' ' ' GLU . 68.1 mttm 56.15 51.23 12.12 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.301 0.572 . . . . 0.0 110.201 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.526 ' N ' HD12 ' B' ' 39' ' ' LEU . 9.8 mp -85.56 71.65 10.72 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -178.701 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.59 ' N ' HD12 ' B' ' 46' ' ' LEU . 8.5 mp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.444 ' H ' ' HD2' ' B' ' 47' ' ' LYS . 0.8 OUTLIER -66.55 -44.4 82.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.344 -0.848 . . . . 0.0 110.085 -179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.19 38.1 4.06 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.57 -0.706 . . . . 0.0 109.775 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 47.57 23.62 2.27 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -93.16 154.61 17.96 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.228 -1.16 . . . . 0.0 109.138 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.12 159.82 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.49 -0.756 . . . . 0.0 109.124 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' GLU . . . . . 0.429 ' CD ' ' N ' ' B' ' 52' ' ' GLU . 18.3 mp0 -138.68 153.86 48.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.347 -0.845 . . . . 0.0 109.508 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.412 HG12 ' N ' ' B' ' 54' ' ' GLU . 55.4 t -131.42 156.25 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.412 ' N ' HG12 ' B' ' 53' ' ' VAL . 31.3 tt0 -138.68 134.55 33.77 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.49 178.91 32.95 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.443 HD23 ' H ' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -96.03 139.24 32.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.338 -1.095 . . . . 0.0 109.119 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 43.3 mm -86.38 118.07 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 109.257 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -107.69 -31.77 7.93 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.447 -0.783 . . . . 0.0 109.682 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.581 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -160.76 147.21 15.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.16 -0.963 . . . . 0.0 110.265 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.581 HD22 ' O ' ' B' ' 59' ' ' ALA . 1.3 mm? -129.84 135.85 48.88 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 95.0 t -135.28 129.36 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.294 -0.879 . . . . 0.0 109.515 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' B' ' 64' ' ' LEU . 42.4 t80 -144.89 123.18 6.63 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -42.34 86.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.464 1.443 . . . . 0.0 112.224 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.682 ' H ' ' CD2' ' B' ' 64' ' ' LEU . 0.7 OUTLIER -95.17 21.56 7.72 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.467 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.562 ' N ' ' OE1' ' B' ' 65' ' ' GLU . 0.0 OUTLIER -41.1 155.88 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.617 0.723 . . . . 0.0 110.404 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' B' ' 64' ' ' LEU . 5.4 m80 -125.63 -13.48 6.48 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.358 -0.839 . . . . 0.0 109.307 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -150.82 161.2 43.13 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.112 -0.993 . . . . 0.0 109.548 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 0.65 ' ND1' ' N ' ' B' ' 69' ' ' HIS . 4.3 p80 -164.01 -38.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 0.0 109.042 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.65 ' N ' ' ND1' ' B' ' 68' ' ' HIS . 42.3 t-80 -105.76 122.77 46.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.627 -0.671 . . . . 0.0 109.669 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' B' ' 71' ' ' HIS . 1.7 t-80 -175.83 155.58 1.68 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.359 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 71' ' ' HIS . . . . . 0.584 ' N ' ' ND1' ' B' ' 70' ' ' HIS . 5.3 t60 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.268 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.61 32.43 22.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.904 . . . . 0.0 108.599 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.43 HD22 ' HB3' ' A' ' 56' ' ' LEU . 1.1 p-10 -99.51 11.33 39.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.352 -0.843 . . . . 0.0 109.142 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.3 mmm-85 -69.97 145.32 51.93 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.223 -0.923 . . . . 0.0 109.03 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -135.56 146.65 48.21 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.676 0.751 . . . . 0.0 110.005 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -110.19 114.71 28.42 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.605 HD23 ' C ' ' A' ' 7' ' ' LEU . 6.9 tt -111.27 125.08 53.45 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.424 -0.797 . . . . 0.0 108.867 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.599 ' N ' HD23 ' A' ' 7' ' ' LEU . 37.7 t -119.58 148.04 43.78 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.477 0.656 . . . . 0.0 109.555 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 tp -149.07 -179.46 7.04 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.631 0.729 . . . . 0.0 109.717 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.514 HG21 ' NE2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -175.13 158.18 2.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.344 -0.848 . . . . 0.0 109.378 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.12 20.63 57.04 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -66.48 139.88 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -1.078 . . . . 0.0 110.217 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.0 t -72.68 -43.36 63.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.429 -0.794 . . . . 0.0 109.598 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.99 159.12 9.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 0.0 109.93 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.5 t -91.61 106.61 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.472 -0.768 . . . . 0.0 109.959 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -69.09 -38.22 78.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 109.395 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -168.87 164.15 11.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.832 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -149.02 105.16 3.5 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -132.79 150.43 75.71 Favored Pre-proline 0 N--CA 1.498 1.957 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.64 -19.29 36.89 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.134 1.889 . . . . 0.0 111.231 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -100.02 -3.34 32.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.4 -0.813 . . . . 0.0 109.078 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -174.49 146.97 1.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.541 -0.724 . . . . 0.0 109.435 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.0 mt -133.04 129.81 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.335 -0.853 . . . . 0.0 109.614 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.8 mt -117.13 124.9 50.32 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.3 mt -136.64 129.36 30.61 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.56 -0.712 . . . . 0.0 109.192 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -104.7 123.05 46.94 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.526 -0.734 . . . . 0.0 109.444 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 29' ' ' GLN . 8.9 t -123.82 154.71 39.2 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.528 0.68 . . . . 0.0 109.72 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.6 mt 42.97 -84.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.999 -0.438 . . . . 0.0 110.623 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.578 ' N ' ' O ' ' A' ' 27' ' ' THR . 12.9 pt20 -154.9 57.24 0.67 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.932 -1.105 . . . . 0.0 109.85 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.71 141.65 6.15 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.187 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.4 t -86.34 132.2 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.487 -1.007 . . . . 0.0 109.518 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.9 tp -111.26 123.55 50.43 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 t -115.7 126.69 54.42 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.572 -0.705 . . . . 0.0 109.992 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.0 mt -112.59 130.74 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.36 144.67 50.74 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 121.499 0.666 . . . . 0.0 109.662 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.83 -140.1 5.52 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -135.93 143.06 44.74 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.421 -1.046 . . . . 0.0 108.885 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 54.44 62.21 2.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.523 -0.736 . . . . 0.0 110.171 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.3 mp -91.71 73.04 5.84 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.148 -0.97 . . . . 0.0 108.548 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.013 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 47' ' ' LYS . 47.6 tp . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.581 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 21.2 tptm -37.09 149.87 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.484 0.659 . . . . 0.0 110.74 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 47' ' ' LYS . . . 73.22 -14.56 0.6 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 47' ' ' LYS . . . 65.68 35.95 91.72 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.514 ' NE2' HG21 ' A' ' 10' ' ' THR . 2.0 tp60 -81.88 162.54 22.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.306 -1.114 . . . . 0.0 109.442 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -113.71 136.34 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -136.43 131.0 33.52 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.849 -0.796 . . . . 0.0 108.849 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.1 t -125.1 148.88 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.565 -0.709 . . . . 0.0 109.174 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -133.1 127.97 35.15 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.6 173.64 23.71 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.438 HD23 ' H ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -95.44 128.3 42.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.371 -1.076 . . . . 0.0 109.343 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.1 mt -81.46 121.31 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.868 . . . . 0.0 109.639 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -103.37 -23.76 13.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.545 -0.722 . . . . 0.0 109.085 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.02 151.17 13.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.167 -0.958 . . . . 0.0 109.98 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.615 HD13 ' N ' ' A' ' 61' ' ' VAL . 0.3 OUTLIER -130.95 126.98 37.48 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.546 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.615 ' N ' HD13 ' A' ' 60' ' ' LEU . 58.6 t -123.04 123.89 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.303 -0.873 . . . . 0.0 109.773 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -146.3 139.76 14.76 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.97 110.01 2.82 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.27 1.313 . . . . 0.0 111.769 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.968 ' H ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -88.15 3.64 48.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.36 -0.838 . . . . 0.0 109.17 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.499 ' N ' HD22 ' A' ' 64' ' ' LEU . 23.0 pt-20 -40.3 160.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.79 -0.569 . . . . 0.0 110.008 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -41.7 72.73 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.418 ' O ' ' O ' ' A' ' 68' ' ' HIS . 19.9 p80 168.18 20.4 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.436 ' O ' ' OE2' ' A' ' 65' ' ' GLU . 28.2 m-70 -52.85 -167.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.949 0.88 . . . . 0.0 111.784 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -83.32 -111.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.571 0.7 . . . . 0.0 110.387 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.643 ' CG ' ' N ' ' A' ' 71' ' ' HIS . 2.1 t-80 -170.7 -90.63 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.643 ' N ' ' CG ' ' A' ' 70' ' ' HIS . 59.6 m-70 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.32 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.423 ' O ' ' O ' ' B' ' 2' ' ' ASP . 67.1 mtt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' B' ' 1' ' ' MET . 8.3 t70 57.5 112.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.401 -0.812 . . . . 0.0 110.251 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -101.76 12.82 36.46 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.401 -0.812 . . . . 0.0 109.253 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -87.56 137.25 32.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.154 -0.966 . . . . 0.0 109.296 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -146.13 163.75 34.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.409 -0.807 . . . . 0.0 109.299 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -108.96 129.79 55.45 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 7.5 tt -113.41 135.44 53.87 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 12.4 t -130.99 139.8 50.05 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.726 0.774 . . . . 0.0 110.226 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' B' ' 9' ' ' LEU . 45.6 tp -151.03 146.06 25.95 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.604 -0.685 . . . . 0.0 109.319 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.4 p -130.11 177.77 7.05 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.61 -0.681 . . . . 0.0 109.414 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.1 18.55 69.23 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 79.3 t -74.55 130.86 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.14 -1.212 . . . . 0.0 109.771 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 38.9 t -73.4 -42.37 62.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.355 -0.841 . . . . 0.0 109.114 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.2 160.29 9.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.155 -0.966 . . . . 0.0 109.946 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 10.1 t -82.08 104.15 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.435 -0.79 . . . . 0.0 109.506 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -67.53 -35.81 79.8 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.164 -0.96 . . . . 0.0 109.352 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 7.5 t -165.46 153.26 11.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.922 . . . . 0.0 109.223 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -140.27 104.54 4.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.278 -0.889 . . . . 0.0 109.455 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.411 ' OD2' ' O ' ' B' ' 22' ' ' GLU . 0.4 OUTLIER -133.26 150.32 74.98 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.97 -16.69 32.46 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.846 1.697 . . . . 0.0 111.953 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -107.93 -8.54 15.91 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.353 -0.842 . . . . 0.0 109.743 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.447 ' CD ' ' HZ1' ' B' ' 35' ' ' LYS . 50.0 tt0 -167.33 126.78 1.39 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 109.435 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.2 mt -125.11 130.7 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.438 -0.789 . . . . 0.0 109.683 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 60.7 mt -112.95 128.43 56.48 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 94.7 mt -127.02 126.74 43.63 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.629 -0.67 . . . . 0.0 109.658 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -94.03 112.34 24.16 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.534 ' O ' ' N ' ' B' ' 29' ' ' GLN . 15.0 t -124.7 164.93 18.87 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.524 0.678 . . . . 0.0 110.488 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' B' ' 27' ' ' THR . 22.2 mm 33.21 -86.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.415 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' B' ' 27' ' ' THR . 27.2 pt20 -148.98 27.2 0.87 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.933 -1.104 . . . . 0.0 109.728 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.84 165.96 31.25 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 55.7 t -112.51 132.4 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.655 -0.909 . . . . 0.0 109.143 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 46.8 tp -104.52 124.33 49.1 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' B' ' 61' ' ' VAL . 5.4 p -107.52 122.59 46.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.591 -0.693 . . . . 0.0 109.48 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' ILE . . . . . 0.54 ' N ' HD12 ' B' ' 34' ' ' ILE . 4.4 mp -108.6 129.08 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.447 ' HZ1' ' CD ' ' B' ' 22' ' ' GLU . 68.5 mttm -123.27 133.3 54.18 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.565 0.698 . . . . 0.0 109.459 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.68 -147.72 8.62 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -136.61 153.76 50.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.357 -1.084 . . . . 0.0 109.767 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 67.8 mttm 55.96 57.41 5.16 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.539 0.685 . . . . 0.0 110.557 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.528 ' N ' HD12 ' B' ' 39' ' ' LEU . 9.0 mp -92.35 70.09 5.13 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.557 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.55 ' N ' HD12 ' B' ' 46' ' ' LEU . 10.3 mp . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.714 0.769 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.647 ' O ' ' HB3' ' B' ' 48' ' ' ALA . 1.3 tmtp? 60.9 117.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.378 -0.827 . . . . 0.0 110.015 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' B' ' 47' ' ' LYS . . . 79.05 -1.48 2.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.757 -0.589 . . . . 0.0 109.876 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.98 23.48 77.78 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -106.43 153.56 22.08 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.31 -1.112 . . . . 0.0 109.402 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.3 t -125.42 132.21 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-O 121.616 0.722 . . . . 0.0 109.26 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -144.11 127.67 17.03 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 t -118.17 162.55 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.655 -0.653 . . . . 0.0 109.678 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -123.46 132.93 54.08 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.89 179.71 37.62 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.439 HD23 ' H ' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -96.68 138.84 33.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.301 -1.117 . . . . 0.0 109.201 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.459 ' N ' HD12 ' B' ' 57' ' ' ILE . 1.4 mp -91.31 117.6 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.247 -0.908 . . . . 0.0 109.061 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -108.13 -25.23 11.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.514 -0.741 . . . . 0.0 109.8 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.505 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -164.59 135.59 4.22 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.74 -1.225 . . . . 0.0 111.146 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.505 HD22 ' O ' ' B' ' 59' ' ' ALA . 3.1 mm? -119.83 135.43 54.87 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.426 ' O ' ' OG ' ' B' ' 33' ' ' SER . 46.6 t -132.58 122.75 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.543 0.687 . . . . 0.0 109.823 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' B' ' 64' ' ' LEU . 28.2 t80 -144.54 128.39 8.88 Favored Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -41.21 88.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.427 1.418 . . . . 0.0 111.785 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.683 ' C ' HD23 ' B' ' 64' ' ' LEU . 0.4 OUTLIER -55.37 -21.2 14.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.783 -1.198 . . . . 0.0 108.678 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' B' ' 67' ' ' HIS . 0.7 OUTLIER -121.49 49.53 1.51 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.739 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.583 ' O ' ' CG ' ' B' ' 67' ' ' HIS . 0.0 OUTLIER -40.91 87.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.093 -178.789 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' B' ' 66' ' ' HIS . 23.5 m-70 -168.55 -1.18 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 0.5 ' O ' ' O ' ' B' ' 67' ' ' HIS . 56.8 t-80 -44.43 -101.35 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.226 -0.921 . . . . 0.0 110.619 -178.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.409 ' N ' ' CG ' ' B' ' 68' ' ' HIS . 24.4 t-80 -174.47 -80.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.008 -1.058 . . . . 0.0 109.268 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -74.19 147.45 42.54 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.424 -0.798 . . . . 0.0 109.642 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 29.7 m170 . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.623 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.566 ' H2 ' ' HG2' ' A' ' 4' ' ' ARG . 52.9 ttp . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.69 -19.01 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.28 16.64 19.94 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.568 -0.707 . . . . 0.0 109.872 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.566 ' HG2' ' H2 ' ' A' ' 1' ' ' MET . 47.3 mmm-85 -69.95 140.92 53.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 108.742 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -142.3 162.0 36.59 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.124 -0.985 . . . . 0.0 110.088 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -108.99 142.07 40.18 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.564 HD23 ' N ' ' A' ' 8' ' ' SER . 6.2 tt -142.11 124.01 15.26 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.564 ' N ' HD23 ' A' ' 7' ' ' LEU . 37.8 t -132.34 140.45 48.55 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.461 -0.774 . . . . 0.0 109.152 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.5 tp -144.65 142.54 30.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.305 -0.872 . . . . 0.0 109.008 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.5 p -130.61 112.68 13.37 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.548 -0.72 . . . . 0.0 109.468 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 143.33 31.87 0.1 Allowed Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.4 t -81.16 133.47 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -1.125 . . . . 0.0 110.238 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.1 m -72.65 -41.6 65.28 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.56 153.45 4.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.771 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 81.6 t -84.93 106.0 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.509 -0.745 . . . . 0.0 110.285 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -67.96 -42.01 81.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.96 . . . . 0.0 108.86 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.3 t -171.89 136.54 0.91 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.407 -0.808 . . . . 0.0 108.89 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.437 ' CE1' HD12 ' A' ' 23' ' ' ILE . 6.9 t80 -123.77 106.46 10.51 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.428 -0.795 . . . . 0.0 109.143 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.413 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -128.22 150.45 74.04 Favored Pre-proline 0 N--CA 1.498 1.968 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.513 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.1 -19.57 39.08 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.272 1.981 . . . . 0.0 111.364 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -97.47 -7.12 32.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.466 -0.771 . . . . 0.0 108.978 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -172.86 140.36 0.94 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.437 HD12 ' CE1' ' A' ' 18' ' ' PHE . 27.0 mm -127.12 127.51 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.323 -0.861 . . . . 0.0 109.437 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.8 mt -120.51 120.55 36.18 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.1 mt -131.31 125.61 33.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.419 -0.801 . . . . 0.0 108.849 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -92.4 120.83 33.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 29' ' ' GLN . 6.1 t -122.37 154.0 38.28 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.674 0.749 . . . . 0.0 110.271 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.3 mm 46.08 -82.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.085 0.469 . . . . 0.0 110.764 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.578 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.8 pp0? -147.71 -21.36 0.37 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.102 -0.999 . . . . 0.0 109.898 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.485 ' N ' ' CD ' ' A' ' 29' ' ' GLN . . . -97.45 173.77 28.91 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.7 t -118.95 132.67 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.753 -0.851 . . . . 0.0 109.107 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.471 HD13 HD12 ' B' ' 60' ' ' LEU . 60.3 tp -109.62 127.81 54.79 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.6 t -113.22 122.4 47.37 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.7 mt -108.12 130.14 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.403 -0.811 . . . . 0.0 109.264 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -129.16 141.17 51.25 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.488 -0.757 . . . . 0.0 109.37 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.07 -138.1 4.91 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.454 ' HB3' HD21 ' A' ' 56' ' ' LEU . 6.7 tt0 -133.03 150.03 52.16 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.492 -1.005 . . . . 0.0 110.711 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 54' ' ' GLU . 55.0 mmtt 54.08 66.36 1.25 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.492 178.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 39' ' ' LEU . 11.1 mp -98.39 71.18 2.03 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.138 0 O-C-N 121.128 -0.982 . . . . 0.0 110.793 -178.146 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 47' ' ' LYS . 91.2 mt . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.52 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 87.5 tttt 59.14 134.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.548 0.689 . . . . 0.0 110.388 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 47' ' ' LYS . . . 70.58 -14.87 0.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.605 -0.685 . . . . 0.0 109.497 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 47' ' ' LYS . . . 82.38 18.34 66.79 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -101.13 160.0 14.76 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.315 -1.109 . . . . 0.0 109.094 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.0 t -122.65 131.8 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.529 -0.732 . . . . 0.0 109.103 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -130.64 130.98 44.63 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 t -136.36 138.36 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.496 -0.753 . . . . 0.0 109.097 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.491 ' O ' ' O ' ' A' ' 38' ' ' LYS . 24.0 tt0 -118.42 145.98 44.79 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.15 166.14 15.6 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.454 HD21 ' HB3' ' A' ' 37' ' ' GLU . 2.5 pp -88.69 128.83 35.62 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.391 -1.064 . . . . 0.0 109.656 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.3 mm -80.12 135.31 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.85 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -125.26 -31.05 3.1 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.02 143.4 16.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.064 -1.023 . . . . 0.0 110.598 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.435 HD13 HD13 ' B' ' 32' ' ' LEU . 9.1 mt -129.73 143.31 50.76 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 54.3 t -139.23 118.22 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.102 -0.999 . . . . 0.0 110.165 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -139.72 108.97 7.17 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.96 109.36 0.23 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.406 1.404 . . . . 0.0 112.426 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.017 ' H ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -82.44 -8.04 59.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.323 -0.861 . . . . 0.0 109.588 179.693 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.595 ' N ' HD22 ' A' ' 64' ' ' LEU . 3.3 mt-10 66.86 137.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.644 0.735 . . . . 0.0 110.551 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.588 ' ND1' HD23 ' A' ' 64' ' ' LEU . 5.5 m80 -159.98 -31.47 0.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -42.65 89.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.808 -0.558 . . . . 0.0 110.669 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' A' ' 66' ' ' HIS . 5.9 t60 -172.76 65.54 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.456 -0.777 . . . . 0.0 109.791 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.473 ' ND1' ' C ' ' A' ' 68' ' ' HIS . 2.3 m-70 -124.92 147.58 48.78 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.423 -0.798 . . . . 0.0 109.053 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.79 106.45 9.62 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.212 1.006 . . . . 0.0 108.741 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.426 ' ND1' ' N ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.292 -1.922 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.642 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ptt? . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.9 0.857 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.19 121.69 30.88 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.552 0.692 . . . . 0.0 110.335 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -161.3 9.61 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.541 -0.724 . . . . 0.0 109.55 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.8 mmm-85 -69.25 142.71 54.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.97 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -140.15 148.29 41.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.517 -0.739 . . . . 0.0 109.577 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -103.95 119.5 39.06 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.517 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.2 tt -119.16 121.24 39.29 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.262 -0.899 . . . . 0.0 108.638 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.487 ' N ' HD23 ' B' ' 7' ' ' LEU . 70.1 m -132.53 151.37 51.94 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.509 -0.744 . . . . 0.0 109.163 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 tp -147.29 149.3 32.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.193 -0.942 . . . . 0.0 109.5 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.2 p -128.67 163.7 24.53 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.588 -0.695 . . . . 0.0 109.612 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.43 29.27 56.17 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.41 131.37 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -1.174 . . . . 0.0 109.901 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' B' ' 28' ' ' ILE . 58.2 m -73.83 -40.07 63.58 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.615 -0.678 . . . . 0.0 110.613 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -158.91 158.38 33.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.983 -1.073 . . . . 0.0 109.914 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 76.3 t -103.63 99.96 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -68.96 -49.25 59.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 110.532 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 31.8 t -170.4 146.58 2.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.924 -1.11 . . . . 0.0 110.211 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.71 110.18 17.53 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.673 -0.642 . . . . 0.0 109.882 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' B' ' 22' ' ' GLU . 0.3 OUTLIER -133.76 119.89 15.16 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.431 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -50.19 -27.14 16.7 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.476 1.45 . . . . 0.0 111.443 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -94.52 -5.4 46.13 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' B' ' 19' ' ' ASP . 40.2 tt0 -170.8 115.57 0.45 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 97.0 mt -114.45 126.33 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.203 -0.936 . . . . 0.0 109.194 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 57.9 mt -119.35 126.53 51.63 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 87.0 mt -135.58 123.76 23.04 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.256 -0.902 . . . . 0.0 108.988 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -81.73 118.32 22.76 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.128 -0.982 . . . . 0.0 108.84 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.562 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.8 t -109.54 149.19 30.0 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.472 -0.767 . . . . 0.0 110.201 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.494 ' N ' ' OG ' ' B' ' 13' ' ' SER . 58.7 mt 38.47 -87.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.037 0.446 . . . . 0.0 110.798 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' B' ' 27' ' ' THR . 24.0 pt20 -133.68 -22.52 1.89 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.38 -0.825 . . . . 0.0 110.198 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.6 173.99 30.21 Favored Glycine 0 N--CA 1.498 2.769 0 O-C-N 121.139 -0.976 . . . . 0.0 110.724 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -119.34 131.57 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.79 -0.829 . . . . 0.0 109.401 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 60' ' ' LEU . 48.7 tp -111.92 128.79 56.25 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.3 t -110.2 120.41 42.37 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 84.3 mt -99.81 125.56 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -130.53 139.06 50.48 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.502 -0.749 . . . . 0.0 109.52 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.66 -138.28 3.28 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -131.86 136.81 47.73 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.348 -1.089 . . . . 0.0 109.836 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.415 ' C ' HD12 ' B' ' 39' ' ' LEU . 52.9 mtmt 46.92 75.38 0.12 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 110.283 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.6 ' N ' HD12 ' B' ' 39' ' ' LEU . 8.5 mp -93.24 72.12 4.54 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.18 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 40.2 tp . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.552 0.692 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.486 ' NZ ' ' OE2' ' B' ' 52' ' ' GLU . 20.7 ptmt -65.48 -40.28 92.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.561 -0.712 . . . . 0.0 109.66 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -179.28 -27.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 140.02 33.83 0.15 Allowed Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -135.6 156.74 48.39 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.262 -1.14 . . . . 0.0 109.492 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 m -122.49 132.55 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-O 121.539 0.685 . . . . 0.0 109.513 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' GLU . . . . . 0.486 ' OE2' ' NZ ' ' B' ' 47' ' ' LYS . 90.2 mt-10 -126.62 131.58 51.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.9 t -125.96 137.54 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.499 -0.751 . . . . 0.0 109.721 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -117.24 131.42 56.84 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.7 174.21 28.11 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.99 127.04 40.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.066 -1.256 . . . . 0.0 109.429 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.568 ' N ' HD12 ' B' ' 57' ' ' ILE . 1.4 mp -85.63 113.4 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 108.684 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.37 -10.29 16.4 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -159.9 146.28 15.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.904 -1.123 . . . . 0.0 110.522 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.471 HD12 HD13 ' A' ' 32' ' ' LEU . 52.8 mt -141.3 138.49 33.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.469 -0.769 . . . . 0.0 108.972 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 53.4 t -133.2 128.23 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.194 -0.941 . . . . 0.0 109.89 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -145.37 137.88 13.59 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.34 109.28 2.86 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.384 1.39 . . . . 0.0 111.74 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.936 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -81.83 -11.27 59.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.479 -0.763 . . . . 0.0 108.981 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.504 ' N ' HD22 ' B' ' 64' ' ' LEU . 97.3 mt-10 55.73 51.88 11.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.802 -0.561 . . . . 0.0 111.09 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -128.59 7.48 5.76 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.315 -0.866 . . . . 0.0 109.123 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -72.93 -36.4 67.21 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 86.89 0.3 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.533 -0.729 . . . . 0.0 110.137 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -174.82 94.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -104.06 -11.41 17.38 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.166 -0.959 . . . . 0.0 108.71 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.306 -1.302 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.333 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -69.16 139.23 54.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.655 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -153.57 35.99 0.46 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.318 -0.864 . . . . 0.0 108.763 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.445 ' NE ' ' OE2' ' A' ' 54' ' ' GLU . 46.4 mmm-85 -88.39 138.43 31.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.344 -0.848 . . . . 0.0 109.13 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -145.19 161.88 38.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.181 -0.949 . . . . 0.0 109.187 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -119.8 146.4 45.72 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.505 0.669 . . . . 0.0 109.916 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.579 HD23 ' C ' ' A' ' 7' ' ' LEU . 6.4 tt -132.51 122.7 25.26 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.571 ' N ' HD23 ' A' ' 7' ' ' LEU . 33.3 t -113.8 133.04 55.63 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.49 -0.756 . . . . 0.0 109.283 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.6 tp -144.76 151.5 38.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.35 -0.844 . . . . 0.0 109.444 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.4 t -146.48 162.88 37.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.399 -0.813 . . . . 0.0 108.944 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.27 24.99 41.51 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.45 138.14 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -1.1 . . . . 0.0 109.652 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.5 m -73.57 -38.36 65.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.232 -0.918 . . . . 0.0 109.257 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -169.89 166.71 9.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.177 -0.952 . . . . 0.0 109.499 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.5 t -98.32 96.19 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.329 -0.857 . . . . 0.0 109.063 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -65.21 -39.39 92.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.146 -0.971 . . . . 0.0 109.463 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 t -168.82 152.85 5.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 109.256 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -146.89 107.73 4.16 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.247 -0.908 . . . . 0.0 109.422 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.3 158.68 75.11 Favored Pre-proline 0 N--CA 1.502 2.161 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.83 -26.07 67.67 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 121.672 1.581 . . . . 0.0 112.142 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -106.04 3.43 28.2 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.372 -0.83 . . . . 0.0 110.276 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -171.54 133.46 0.8 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.031 -1.043 . . . . 0.0 109.46 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.9 mt -130.84 126.83 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.421 -0.799 . . . . 0.0 109.184 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.2 mt -117.5 122.18 43.03 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.711 . . . . 0.0 109.271 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.9 mt -133.37 124.56 27.4 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.375 -0.828 . . . . 0.0 108.839 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -91.73 124.74 36.1 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.679 -1.263 . . . . 0.0 109.72 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 29' ' ' GLN . 6.1 t -124.5 153.33 42.2 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.462 0.649 . . . . 0.0 109.755 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.48 HD12 ' CB ' ' B' ' 3' ' ' ASN . 20.4 mm 44.74 -88.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.868 -0.52 . . . . 0.0 110.094 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.544 ' N ' ' O ' ' A' ' 27' ' ' THR . 25.7 pt20 -143.19 -17.4 0.65 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.965 -1.084 . . . . 0.0 110.213 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.29 173.67 30.32 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.2 t -121.25 131.21 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.779 -0.836 . . . . 0.0 108.909 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -107.56 126.12 52.15 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.37 -0.831 . . . . 0.0 109.554 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -116.9 124.03 48.46 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.639 -0.663 . . . . 0.0 109.417 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.2 mt -107.77 130.0 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.521 -0.737 . . . . 0.0 109.238 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -124.69 138.79 54.27 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.493 -0.754 . . . . 0.0 109.657 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.58 -146.36 9.41 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -140.61 151.87 44.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.036 -1.273 . . . . 0.0 109.802 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 54' ' ' GLU . 73.7 mmtt 58.34 55.24 5.12 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.681 -0.637 . . . . 0.0 109.939 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 39' ' ' LEU . 7.9 mp -93.75 70.6 4.12 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.38 0 C-N-CA 120.247 -0.978 . . . . 0.0 110.732 -178.898 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.576 ' N ' HD22 ' A' ' 46' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.611 0.719 . . . . 0.0 109.592 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -64.63 -50.08 68.5 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.774 0.797 . . . . 0.0 110.1 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.72 33.05 0.1 Allowed 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.925 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.96 14.47 60.73 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -107.98 159.92 16.18 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.498 -1.001 . . . . 0.0 108.718 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 m -131.43 156.1 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.265 -0.897 . . . . 0.0 109.964 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -142.8 150.37 39.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.425 -0.797 . . . . 0.0 109.107 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.7 t -126.65 134.92 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.458 -0.776 . . . . 0.0 110.109 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.473 ' OE1' ' N ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -114.57 126.08 54.51 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.473 ' N ' ' OE1' ' A' ' 54' ' ' GLU . . . 163.72 176.44 35.64 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.158 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.406 HD23 ' H ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -96.17 121.44 37.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.527 -0.984 . . . . 0.0 108.885 179.762 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.69 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.7 mp -90.43 113.3 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.018 -1.051 . . . . 0.0 108.937 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -99.94 -10.77 21.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.452 -0.78 . . . . 0.0 109.988 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.94 145.74 13.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.816 -1.178 . . . . 0.0 110.428 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 mt -135.19 134.53 40.2 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.61 -0.681 . . . . 0.0 109.297 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.8 t -129.81 126.0 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.527 -0.733 . . . . 0.0 109.571 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.558 ' O ' ' N ' ' A' ' 64' ' ' LEU . 10.8 t80 -141.0 127.61 11.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -45.68 84.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.247 1.298 . . . . 0.0 112.206 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.7 ' CD2' ' H ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -91.72 22.67 3.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.363 -0.836 . . . . 0.0 109.207 179.785 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 68.07 159.23 0.16 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.42 0.629 . . . . 0.0 110.342 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -128.36 -79.09 0.57 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.706 -0.621 . . . . 0.0 109.687 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 68' ' ' HIS . 7.1 t60 -66.4 -42.81 87.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.474 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 67' ' ' HIS . 1.4 t-80 60.36 130.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.349 -0.844 . . . . 0.0 109.651 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.49 142.01 31.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.097 -1.002 . . . . 0.0 109.578 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 53.23 177.4 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.56 -0.712 . . . . 0.0 110.549 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.562 ' ND1' ' N ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.344 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mmm . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 43.2 t0 46.66 89.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.894 . . . . 0.0 110.069 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.48 ' CB ' HD12 ' A' ' 28' ' ' ILE . 8.2 p30 -99.54 10.81 40.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.456 -0.777 . . . . 0.0 109.272 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 31.7 mmm-85 -73.0 142.14 47.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.318 -0.863 . . . . 0.0 109.425 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -147.04 156.09 42.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.272 -0.893 . . . . 0.0 109.025 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -98.79 141.37 31.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.328 -0.858 . . . . 0.0 109.393 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.549 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.1 tt -139.95 126.47 20.31 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.545 ' N ' HD23 ' B' ' 7' ' ' LEU . 69.8 m -128.53 150.96 49.95 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.442 -0.786 . . . . 0.0 109.594 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.8 tp -146.91 153.21 39.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.35 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.4 t -143.48 164.44 30.32 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.299 -0.876 . . . . 0.0 109.189 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.07 14.95 59.85 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 p -69.14 137.41 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.341 -1.094 . . . . 0.0 109.443 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 4.5 t -73.96 -52.18 13.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.213 -0.929 . . . . 0.0 108.938 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.18 150.6 13.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.253 -0.904 . . . . 0.0 109.646 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 93.0 t -82.58 131.46 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.199 -0.938 . . . . 0.0 110.058 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -95.59 -32.25 12.9 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.314 -0.866 . . . . 0.0 109.247 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 47.3 t -169.04 153.97 5.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.89 . . . . 0.0 108.981 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' PHE . . . . . 0.45 ' CZ ' HD13 ' B' ' 23' ' ' ILE . 3.0 t80 -145.65 112.49 5.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.004 -1.06 . . . . 0.0 109.408 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' B' ' 19' ' ' ASP . 0.3 OUTLIER -132.6 151.73 78.68 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.59 -18.21 48.52 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.658 1.572 . . . . 0.0 111.382 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -107.7 -3.29 19.32 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.491 -0.756 . . . . 0.0 109.581 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -169.98 127.85 0.88 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.284 -0.885 . . . . 0.0 109.227 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.45 HD13 ' CZ ' ' B' ' 18' ' ' PHE . 96.8 mt -127.74 129.65 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.241 -0.912 . . . . 0.0 109.921 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 70.0 mt -115.06 124.15 50.85 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.336 -0.853 . . . . 0.0 109.639 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 41.5 mt -126.31 131.26 51.88 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.303 -0.873 . . . . 0.0 109.138 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -90.91 119.87 31.45 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.556 ' O ' ' N ' ' B' ' 29' ' ' GLN . 3.1 t -123.53 148.36 46.36 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.669 0.747 . . . . 0.0 110.186 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 68.5 mt 39.05 -88.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.145 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' B' ' 27' ' ' THR . 29.7 pt20 -139.0 -18.17 1.03 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.392 -0.817 . . . . 0.0 109.999 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.19 144.5 17.17 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 18.6 t -94.15 129.64 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.343 -1.092 . . . . 0.0 108.848 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 37.5 tp -106.21 126.02 51.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.445 -0.784 . . . . 0.0 109.415 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 70.9 m -109.34 124.4 50.89 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 90.8 mt -106.13 129.41 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.534 -0.729 . . . . 0.0 109.178 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -125.25 141.74 51.91 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.507 -0.746 . . . . 0.0 109.414 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.04 -151.52 17.93 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -140.07 150.26 44.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.226 -1.161 . . . . 0.0 108.93 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt 60.27 51.24 5.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.553 -0.717 . . . . 0.0 109.668 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.551 ' N ' HD12 ' B' ' 39' ' ' LEU . 9.0 mp -91.24 72.99 6.23 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.386 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -178.706 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.483 HD23 ' C ' ' B' ' 46' ' ' LEU . 3.7 tt . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.325 0.584 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -93.0 -35.37 13.3 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.202 -0.936 . . . . 0.0 109.208 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -165.66 48.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 109.476 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.57 18.33 71.11 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -140.01 157.32 45.86 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.315 -1.109 . . . . 0.0 109.052 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.07 131.73 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.46 -0.775 . . . . 0.0 108.91 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -119.5 137.29 53.9 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.516 -0.74 . . . . 0.0 109.077 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.423 HG12 ' N ' ' B' ' 54' ' ' GLU . 21.4 t -128.39 160.84 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.411 -0.806 . . . . 0.0 110.086 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.423 ' N ' HG12 ' B' ' 53' ' ' VAL . 0.0 OUTLIER -136.32 146.87 47.06 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.26 176.02 23.68 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.405 HD23 ' H ' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -99.0 136.44 38.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.357 -1.084 . . . . 0.0 108.545 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 36.1 mm -93.49 111.53 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.884 -1.135 . . . . 0.0 109.186 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -100.38 -24.48 14.5 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.399 -0.813 . . . . 0.0 109.799 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.04 147.05 12.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.937 -1.102 . . . . 0.0 110.632 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 9.5 mt -132.48 141.17 48.68 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.417 HG22 HD12 ' A' ' 64' ' ' LEU . 77.9 t -133.91 118.97 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.578 -0.701 . . . . 0.0 109.154 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.433 ' O ' HD13 ' B' ' 64' ' ' LEU . 18.2 t80 -135.86 140.81 34.57 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -79.84 105.78 1.87 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.491 1.461 . . . . 0.0 112.485 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.937 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -96.18 2.45 53.08 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.928 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.514 ' N ' HD22 ' B' ' 64' ' ' LEU . 7.0 mm-40 -51.39 98.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.35 -0.843 . . . . 0.0 110.099 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -168.19 36.37 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.458 ' CG ' ' H ' ' B' ' 68' ' ' HIS . 0.7 OUTLIER -65.35 -151.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.462 0.649 . . . . 0.0 110.365 -178.837 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 0.64 ' ND1' ' N ' ' B' ' 69' ' ' HIS . 60.0 t-80 -61.03 -112.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.435 -0.791 . . . . 0.0 110.046 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.64 ' N ' ' ND1' ' B' ' 68' ' ' HIS . 2.2 m80 43.05 85.41 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.34 -0.85 . . . . 0.0 109.672 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.569 ' CG ' ' N ' ' B' ' 71' ' ' HIS . 0.0 OUTLIER -61.67 -132.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 0.0 110.102 -179.395 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 71' ' ' HIS . . . . . 0.569 ' N ' ' CG ' ' B' ' 70' ' ' HIS . 1.9 m-70 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.653 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 ttp . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.991 0.9 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -164.93 -175.0 3.54 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.587 -0.696 . . . . 0.0 110.348 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -99.59 8.18 44.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.213 -0.93 . . . . 0.0 109.861 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 41.8 mmm-85 -65.16 141.31 58.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.92 -1.112 . . . . 0.0 109.145 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -135.38 147.78 49.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.205 -0.934 . . . . 0.0 110.557 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -112.99 113.28 25.26 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.515 HD23 ' C ' ' A' ' 7' ' ' LEU . 6.5 tt -111.68 123.11 49.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 108.89 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.499 ' N ' HD23 ' A' ' 7' ' ' LEU . 30.3 t -115.22 133.72 55.78 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.48 0.657 . . . . 0.0 109.662 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 tp -141.02 139.11 34.09 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.725 0.774 . . . . 0.0 109.345 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -130.51 168.4 17.1 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.723 -0.61 . . . . 0.0 109.44 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.4 14.09 74.8 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.0 t -67.94 133.94 30.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 109.761 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.6 t -71.15 -43.25 67.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 109.189 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.68 163.82 3.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 0.0 110.026 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.3 t -88.81 111.45 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.432 -0.792 . . . . 0.0 110.086 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -67.46 -31.23 71.26 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.476 -0.765 . . . . 0.0 109.097 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.1 t -167.91 159.34 11.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.099 -1.0 . . . . 0.0 109.537 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.443 ' C ' ' CD1' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -138.77 107.09 5.79 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.342 -0.849 . . . . 0.0 109.31 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.84 145.03 54.29 Favored Pre-proline 0 N--CA 1.495 1.799 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.61 -13.69 32.76 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.444 2.096 . . . . 0.0 111.609 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -115.5 -1.74 12.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.28 -0.887 . . . . 0.0 108.967 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -169.07 111.61 0.51 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.149 -0.97 . . . . 0.0 109.157 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.5 mt -112.51 129.7 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.152 -0.967 . . . . 0.0 109.475 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.3 mt -113.41 123.54 50.32 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.531 -0.73 . . . . 0.0 109.039 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.3 mt -120.95 126.87 51.07 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.587 0.708 . . . . 0.0 109.112 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.81 118.25 31.45 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.35 -0.844 . . . . 0.0 108.974 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.579 ' O ' ' N ' ' A' ' 29' ' ' GLN . 3.4 t -116.95 154.49 30.76 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.345 0.593 . . . . 0.0 110.392 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.405 ' C ' ' O ' ' A' ' 27' ' ' THR . 27.1 mm 34.09 -85.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-O 121.451 0.643 . . . . 0.0 110.933 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 27' ' ' THR . 24.0 pt20 -138.82 -17.48 1.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.927 . . . . 0.0 108.944 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.58 167.51 25.93 Favored Glycine 0 N--CA 1.497 2.735 0 O-C-N 120.855 -1.153 . . . . 0.0 110.797 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -120.43 132.94 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.513 -0.992 . . . . 0.0 109.305 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.559 HD13 HD13 ' B' ' 60' ' ' LEU . 57.7 tp -112.23 131.92 55.21 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.7 t -115.79 129.9 56.63 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.453 0.644 . . . . 0.0 109.358 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.7 mt -112.8 132.23 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 121.315 0.578 . . . . 0.0 109.457 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -131.33 146.65 52.38 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.575 0.702 . . . . 0.0 109.488 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' OE1' ' A' ' 37' ' ' GLU . . . 168.63 -148.21 12.18 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 36' ' ' GLY . 0.7 OUTLIER -118.89 137.36 53.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.866 -0.785 . . . . 0.0 109.83 -178.722 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.421 ' C ' HD12 ' A' ' 39' ' ' LEU . 70.7 mmtt 50.94 71.3 0.44 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.018 0.913 . . . . 0.0 110.179 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.4 mp -98.75 72.55 1.98 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.982 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 -178.869 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.4 tp . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -64.64 -64.43 0.88 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.201 -0.937 . . . . 0.0 109.83 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.05 42.63 0.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.228 -0.92 . . . . 0.0 109.375 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.07 24.78 76.32 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -112.35 154.85 25.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.338 -1.096 . . . . 0.0 109.694 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.9 m -133.42 163.0 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.538 -0.726 . . . . 0.0 109.731 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -135.45 160.78 37.38 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.701 0.762 . . . . 0.0 109.688 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.08 135.17 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -122.04 125.52 46.43 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.838 0.827 . . . . 0.0 109.322 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.4 178.47 24.43 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.82 129.83 44.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -1.081 . . . . 0.0 109.297 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.48 122.52 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.282 -0.887 . . . . 0.0 109.519 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -102.22 -24.43 13.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.482 -0.761 . . . . 0.0 109.036 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.93 149.7 14.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.843 -1.161 . . . . 0.0 110.749 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.465 HD13 HD13 ' B' ' 32' ' ' LEU . 12.7 mt -131.2 144.74 51.57 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.502 HG13 HD12 ' B' ' 64' ' ' LEU . 21.8 t -141.24 122.0 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.763 0.792 . . . . 0.0 110.3 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.557 ' O ' ' N ' ' A' ' 64' ' ' LEU . 19.6 t80 -139.73 115.77 8.16 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 65' ' ' GLU . 53.2 Cg_exo -52.54 78.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.43 1.42 . . . . 0.0 111.419 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -53.3 85.01 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 122.338 1.066 . . . . 0.0 109.498 -179.153 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.579 ' N ' ' O ' ' A' ' 63' ' ' PRO . 0.2 OUTLIER 54.78 107.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.918 0.866 . . . . 0.0 110.922 179.593 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.6 ' CG ' ' N ' ' A' ' 67' ' ' HIS . 55.4 t-80 47.47 170.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.429 1.109 . . . . 0.0 112.094 177.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.6 ' N ' ' CG ' ' A' ' 66' ' ' HIS . 1.4 t60 -174.81 -166.85 0.26 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 122.122 0.963 . . . . 0.0 110.276 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 48.88 42.56 20.49 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.913 0.863 . . . . 0.0 108.711 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -72.0 146.88 47.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.055 -1.028 . . . . 0.0 110.899 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -179.26 144.02 0.22 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.708 0.766 . . . . 0.0 109.094 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.2 p80 . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.617 -179.247 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ptt? . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.641 0.734 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 55.43 24.41 6.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.466 -0.771 . . . . 0.0 109.431 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -112.01 9.95 20.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.447 -0.783 . . . . 0.0 109.098 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -69.72 144.65 52.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.107 -0.995 . . . . 0.0 109.9 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -140.71 150.06 42.97 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.785 0.802 . . . . 0.0 109.691 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -110.58 127.25 55.14 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.476 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.5 tt -122.33 122.25 38.63 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.229 -0.92 . . . . 0.0 108.876 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.453 ' N ' HD23 ' B' ' 7' ' ' LEU . 18.2 p -121.19 147.89 44.99 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.726 0.774 . . . . 0.0 109.994 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 32.0 tp -148.83 143.78 26.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.568 -0.707 . . . . 0.0 109.102 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -130.25 161.39 31.3 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.651 0.739 . . . . 0.0 109.933 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.41 20.75 61.6 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.83 134.63 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.834 -1.392 . . . . 0.0 109.78 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 34.0 m -72.92 -41.84 64.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.193 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.02 164.83 4.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.819 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 77.1 t -99.29 128.22 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.429 -0.794 . . . . 0.0 109.66 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -84.0 -29.65 26.8 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.686 0.755 . . . . 0.0 109.187 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 35.6 t -169.3 155.5 6.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.121 -0.987 . . . . 0.0 109.289 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -137.42 108.86 6.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 0.0 109.779 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' ASP . . . . . 0.42 ' OD2' ' O ' ' B' ' 22' ' ' GLU . 0.8 OUTLIER -132.91 149.12 72.01 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.293 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.5 -7.76 19.89 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.327 2.018 . . . . 0.0 111.607 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -114.47 -20.96 10.56 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.781 0.8 . . . . 0.0 109.03 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.431 ' CD ' ' NZ ' ' B' ' 35' ' ' LYS . 74.6 tt0 -153.46 115.62 4.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.142 -0.974 . . . . 0.0 109.078 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 81.3 mt -115.88 130.22 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.217 -0.927 . . . . 0.0 109.959 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 14.5 mt -112.39 126.34 55.17 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 81.1 mt -120.57 125.91 48.97 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.808 0.813 . . . . 0.0 109.148 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -95.12 110.4 22.35 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.583 ' O ' ' N ' ' B' ' 29' ' ' GLN . 0.1 OUTLIER -113.92 151.74 31.82 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.313 0.578 . . . . 0.0 110.031 -178.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' B' ' 27' ' ' THR . 55.0 mt 34.51 -85.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-O 121.161 0.505 . . . . 0.0 110.765 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.583 ' N ' ' O ' ' B' ' 27' ' ' THR . 20.5 pt20 -138.51 -14.91 1.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.127 -0.983 . . . . 0.0 109.638 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.01 165.19 20.76 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.971 -1.081 . . . . 0.0 110.807 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 53.1 t -122.32 132.93 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.253 -1.145 . . . . 0.0 109.107 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.465 HD13 HD13 ' A' ' 60' ' ' LEU . 53.9 tp -115.58 137.57 51.93 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.335 0.588 . . . . 0.0 109.926 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.11 138.15 53.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.607 -0.683 . . . . 0.0 109.167 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 5.0 mp -115.25 130.89 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.591 -0.693 . . . . 0.0 109.426 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.431 ' NZ ' ' CD ' ' B' ' 22' ' ' GLU . 68.3 mttm -128.57 140.99 51.51 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.518 0.675 . . . . 0.0 109.837 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.99 -139.27 5.46 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' B' ' 38' ' ' LYS . 0.4 OUTLIER -117.59 138.31 52.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.627 -0.925 . . . . 0.0 109.059 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 38' ' ' LYS . . . . . 0.44 ' C ' HD12 ' B' ' 39' ' ' LEU . 32.3 mtmm 36.42 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.996 0.903 . . . . 0.0 110.754 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.483 ' N ' HD12 ' B' ' 39' ' ' LEU . 9.1 mp -100.14 71.6 1.61 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.633 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.898 -178.4 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 14.3 tp . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.685 0.755 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -84.41 -82.16 0.17 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.689 0.757 . . . . 0.0 110.31 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.38 5.33 10.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -0.943 . . . . 0.0 109.255 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.02 30.95 36.46 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -81.96 148.77 28.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -1.119 . . . . 0.0 110.155 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 53.9 t -128.08 134.64 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.401 -0.812 . . . . 0.0 109.805 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -120.71 147.16 45.66 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.94 135.06 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.432 -0.793 . . . . 0.0 109.308 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.12 126.12 49.93 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.63 0.729 . . . . 0.0 109.744 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.02 171.2 23.66 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.04 111.94 23.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.29 -1.123 . . . . 0.0 108.805 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -74.24 112.18 10.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.311 -0.868 . . . . 0.0 109.564 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -101.53 -11.46 19.26 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.58 143.17 6.93 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.726 -1.234 . . . . 0.0 110.744 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.559 HD13 HD13 ' A' ' 32' ' ' LEU . 15.0 mt -127.1 144.64 50.98 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.472 HG22 HD12 ' A' ' 64' ' ' LEU . 2.3 t -135.36 128.27 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.534 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' TYR . . . . . 0.434 ' HD2' ' H ' ' B' ' 64' ' ' LEU . 73.3 t80 -140.14 137.37 17.96 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 63' ' ' PRO . . . . . 0.569 ' C ' ' H ' ' B' ' 65' ' ' GLU . 96.8 Cg_exo -36.52 -39.62 0.42 Allowed 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.414 2.076 . . . . 0.0 112.506 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 64' ' ' LEU . . . . . 0.677 HD23 ' O ' ' B' ' 64' ' ' LEU . 2.2 tt 59.98 -1.88 0.16 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.575 ' O ' HD23 ' B' ' 64' ' ' LEU . 5.3 mm-40 72.49 128.21 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.038 0.923 . . . . 0.0 110.431 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -64.04 157.77 24.34 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.876 0.846 . . . . 0.0 110.37 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' HIS . . . . . 0.403 ' C ' ' N ' ' B' ' 69' ' ' HIS . 94.5 m-70 -81.76 119.68 24.17 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -55.49 -11.07 0.76 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.098 -1.001 . . . . 0.0 109.51 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' B' ' 71' ' ' HIS . 3.5 t60 -55.17 -86.71 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.311 -0.868 . . . . 0.0 109.659 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.55 ' O ' ' CD2' ' B' ' 71' ' ' HIS . 0.5 OUTLIER 42.83 20.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.903 0.858 . . . . 0.0 109.777 -179.323 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 71' ' ' HIS . . . . . 0.55 ' CD2' ' O ' ' B' ' 70' ' ' HIS . 1.3 p80 . . . . . 0 C--N 1.294 -1.83 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.958 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 . . . . . 0 N--CA 1.496 1.848 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -73.95 143.04 45.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.311 -0.868 . . . . 0.0 109.142 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.486 ' NE2' ' OG1' ' B' ' 27' ' ' THR . 79.1 mt-30 -144.65 158.02 43.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.2 -0.938 . . . . 0.0 109.803 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -114.91 132.7 56.45 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.6 tt -121.68 130.27 53.35 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.3 p -127.04 147.43 50.15 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.527 -0.733 . . . . 0.0 109.745 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.2 tp -158.56 160.47 36.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.402 -0.811 . . . . 0.0 109.162 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t -151.52 -165.94 2.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.42 -0.8 . . . . 0.0 108.972 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.48 28.35 55.57 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.0 t -66.4 137.83 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.512 -0.993 . . . . 0.0 109.839 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.4 p -72.63 -37.0 68.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 0.0 109.261 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -170.37 163.59 8.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.0 109.451 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.1 t -98.5 96.5 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.23 -0.919 . . . . 0.0 109.3 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.23 -38.83 88.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.148 -0.97 . . . . 0.0 108.977 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 t -170.26 161.54 8.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.823 . . . . 0.0 109.294 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -146.6 105.49 3.86 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.93 151.62 78.82 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.543 -0.723 . . . . 0.0 109.186 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.87 -16.82 32.84 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.159 1.906 . . . . 0.0 111.086 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -104.97 -10.59 17.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.524 -0.735 . . . . 0.0 109.475 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -169.28 131.4 1.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.413 -0.805 . . . . 0.0 109.209 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.79 129.33 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.695 -0.628 . . . . 0.0 109.496 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 mt -120.48 118.41 30.2 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -133.39 127.93 34.49 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -91.01 123.8 34.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.923 -1.11 . . . . 0.0 109.692 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.611 ' O ' ' N ' ' A' ' 29' ' ' GLN . 1.9 t -119.39 149.24 42.16 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.7 mt 50.46 -80.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.3 pt20 -153.45 -18.19 0.14 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.967 -1.083 . . . . 0.0 110.67 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.67 168.94 26.81 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.36 131.95 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.447 -1.031 . . . . 0.0 109.598 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.0 tp -108.23 128.79 55.03 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.465 0.65 . . . . 0.0 109.445 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.5 t -111.42 126.25 54.74 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.3 mm -106.54 127.53 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.798 -0.564 . . . . 0.0 109.551 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -122.94 135.08 54.35 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.17 -156.5 19.53 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -135.84 146.44 47.49 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.417 -1.049 . . . . 0.0 108.825 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt 55.79 56.45 6.09 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.626 -0.672 . . . . 0.0 110.193 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 39' ' ' LEU . 7.6 mp -93.64 68.84 4.05 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.946 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -179.075 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.88 139.16 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.47 -0.769 . . . . 0.0 108.937 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -114.82 160.11 19.84 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -137.43 138.15 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.31 -0.869 . . . . 0.0 109.121 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -120.68 124.79 46.06 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.47 172.78 31.39 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.99 127.64 44.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.492 -1.005 . . . . 0.0 108.817 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -83.01 117.1 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.058 -1.027 . . . . 0.0 109.284 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -96.96 -12.18 23.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.327 -0.858 . . . . 0.0 109.284 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -173.86 154.27 2.35 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.177 -0.952 . . . . 0.0 110.196 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.433 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 13.6 mt -137.17 134.7 36.61 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.2 t -133.23 123.83 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.234 -0.916 . . . . 0.0 109.708 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.54 ' CE1' ' O ' ' A' ' 63' ' ' PRO . 15.3 t80 -139.72 120.72 9.51 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.54 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 31.5 Cg_exo -56.86 127.86 27.58 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 CA-C-N 120.641 1.265 . . . . 0.0 111.109 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.832 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.077 0 O-C-N 121.19 -0.944 . . . . 0.0 109.005 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.464 ' N ' ' OD1' ' B' ' 3' ' ' ASN . 13.7 p-10 . . . . . 0 N--CA 1.498 1.959 0 CA-C-O 121.321 0.581 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -68.84 141.04 55.22 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.313 -0.867 . . . . 0.0 109.436 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . 0.516 ' NE2' ' OG1' ' A' ' 27' ' ' THR . 26.5 mt-30 -146.74 158.27 43.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.183 -0.948 . . . . 0.0 109.782 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -103.81 135.63 44.99 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.504 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.2 tt -138.41 125.48 21.39 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.396 -0.815 . . . . 0.0 108.841 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . 0.474 ' N ' HD23 ' B' ' 7' ' ' LEU . 1.8 m -129.41 149.31 51.25 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.4 tp -145.96 146.52 31.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.225 -0.922 . . . . 0.0 109.302 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -132.74 171.33 14.02 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.547 -0.72 . . . . 0.0 109.192 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.75 23.21 70.33 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -77.61 137.17 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -1.158 . . . . 0.0 109.612 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 41.2 t -71.03 -44.31 66.09 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.061 -1.024 . . . . 0.0 109.882 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.68 151.81 4.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.899 -1.126 . . . . 0.0 110.36 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 70.4 t -85.55 130.35 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.458 -0.776 . . . . 0.0 109.349 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -98.54 -42.15 7.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.176 -0.953 . . . . 0.0 109.919 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -157.57 118.7 3.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.111 -0.993 . . . . 0.0 109.261 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -111.86 106.39 15.1 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.472 -0.768 . . . . 0.0 109.133 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -132.42 151.08 77.61 Favored Pre-proline 0 N--CA 1.498 1.971 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.36 -20.27 48.75 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.12 1.88 . . . . 0.0 112.18 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -110.89 6.9 21.56 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.366 -0.834 . . . . 0.0 109.408 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -170.46 137.94 1.47 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.346 -0.846 . . . . 0.0 109.172 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 91.3 mt -137.92 128.37 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.17 -0.956 . . . . 0.0 109.478 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 mt -124.21 109.83 13.91 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 86.7 mt -113.77 124.2 51.69 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -83.36 104.89 13.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.285 -0.884 . . . . 0.0 109.15 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.486 ' OG1' ' NE2' ' A' ' 5' ' ' GLN . 13.8 t -123.95 -178.92 4.21 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.397 0.618 . . . . 0.0 109.548 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' B' ' 27' ' ' THR . 8.6 mm -34.31 157.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.908 0.861 . . . . 0.0 110.629 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 64.94 -57.76 0.27 Allowed 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.961 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' B' ' 28' ' ' ILE . . . -171.36 -131.61 1.37 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.214 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -121.47 134.43 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.718 -0.872 . . . . 0.0 110.175 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 29.3 tp -100.0 126.58 46.21 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -106.34 135.33 48.03 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.541 -0.724 . . . . 0.0 109.619 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 79.7 mt -124.71 132.39 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -124.82 141.53 52.05 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.546 0.689 . . . . 0.0 109.85 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.23 -153.23 21.65 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -130.95 143.74 50.95 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.204 -1.174 . . . . 0.0 109.421 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 55.66 57.0 5.61 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.695 . . . . 0.0 109.704 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.437 HD12 ' N ' ' B' ' 39' ' ' LEU . 9.1 mp -97.5 72.29 2.35 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.432 -0.792 . . . . 0.0 109.194 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.002 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.499 1.978 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -125.91 132.83 52.05 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.99 135.21 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -124.38 133.32 53.45 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.436 -0.79 . . . . 0.0 108.967 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.51 -178.38 39.08 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.415 ' H ' HD23 ' B' ' 56' ' ' LEU . 0.2 OUTLIER -95.13 120.64 35.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.412 -1.052 . . . . 0.0 108.927 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.3 mt -91.79 110.27 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.078 -1.014 . . . . 0.0 108.762 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -97.88 -16.43 19.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.373 -0.829 . . . . 0.0 109.997 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.96 147.33 23.98 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.823 -1.173 . . . . 0.0 110.884 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.43 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 13.1 mt -139.15 132.16 29.51 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 54.2 t -130.64 127.01 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.308 -0.87 . . . . 0.0 109.318 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 14.6 t80 -138.71 141.44 30.77 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . 0.531 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 71.9 Cg_endo -76.6 112.41 3.45 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.867 1.711 . . . . 0.0 111.908 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.871 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.138 0 O-C-N 121.187 -0.946 . . . . 0.0 109.022 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 . . . . . 0 N--CA 1.497 1.903 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 43.2 mmm-85 -59.77 142.47 53.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.559 -0.713 . . . . 0.0 110.525 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.444 ' CD ' HD11 ' B' ' 9' ' ' LEU . 2.8 pt20 -154.34 162.12 41.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.477 -0.764 . . . . 0.0 109.579 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 9.7 m-85 -106.66 130.86 54.33 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.552 -0.718 . . . . 0.0 109.469 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.698 HD21 ' CD1' ' B' ' 9' ' ' LEU . 4.0 mm? -113.64 146.83 39.16 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.143 0.973 . . . . 0.0 109.267 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.0 t -139.44 143.2 37.49 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.374 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.748 HD11 ' NE2' ' B' ' 5' ' ' GLN . 17.4 tp -155.22 139.47 16.62 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.342 -0.848 . . . . 0.0 109.743 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 t -145.33 164.9 30.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.397 -0.814 . . . . 0.0 109.376 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.61 11.55 77.18 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 13' ' ' SER . 21.6 t -66.82 159.78 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.769 -0.842 . . . . 0.0 110.633 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.447 ' N ' HG12 ' A' ' 12' ' ' VAL . 22.1 p -74.68 -53.09 9.95 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.4 ' N ' ' OG ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -171.7 158.09 4.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.261 -0.9 . . . . 0.0 109.706 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 t -83.8 108.18 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.86 . . . . 0.0 110.099 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -66.89 -41.57 86.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.426 -0.796 . . . . 0.0 109.094 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.8 t -172.62 143.62 1.34 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.414 -0.804 . . . . 0.0 109.18 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -127.61 116.72 20.76 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.55 -0.719 . . . . 0.0 109.227 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.0 147.87 67.11 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.84 -16.82 46.53 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.835 1.69 . . . . 0.0 110.77 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -98.39 -7.86 27.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.621 -0.675 . . . . 0.0 109.198 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 23' ' ' ILE . 9.5 tm-20 -174.61 150.84 1.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.366 -0.833 . . . . 0.0 109.082 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.479 ' N ' ' CD ' ' A' ' 22' ' ' GLU . 96.5 mt -133.44 130.86 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.299 -0.875 . . . . 0.0 109.991 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.2 mt -115.52 128.11 55.76 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.2 mt -128.54 132.48 48.27 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.393 -0.817 . . . . 0.0 109.155 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -98.81 110.22 22.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 108.709 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.611 ' O ' ' N ' ' A' ' 29' ' ' GLN . 12.3 t -113.43 149.06 34.73 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.411 0.624 . . . . 0.0 109.97 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.446 ' N ' HD13 ' A' ' 28' ' ' ILE . 3.8 mm 43.26 -80.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.652 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' A' ' 27' ' ' THR . 9.0 mt-30 -143.58 -24.65 0.58 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.11 -0.994 . . . . 0.0 109.836 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.01 174.78 36.01 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.76 130.31 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.849 -0.795 . . . . 0.0 109.019 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.46 HD13 HD13 ' B' ' 60' ' ' LEU . 31.1 tp -103.75 126.59 50.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.582 -0.699 . . . . 0.0 109.42 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.7 t -113.35 128.11 56.35 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.5 mt -107.27 130.33 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -124.42 138.6 54.34 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.477 0.656 . . . . 0.0 109.416 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.71 -144.92 8.65 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -133.93 144.46 48.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.317 -1.108 . . . . 0.0 108.939 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 54' ' ' GLU . 71.1 mmtt 58.3 57.69 3.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 0.0 109.351 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.1 mp -95.56 72.79 3.18 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.601 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.0 t -113.79 132.23 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -125.95 141.02 52.16 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.1 t -131.0 133.67 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.508 ' OE1' ' CD2' ' A' ' 6' ' ' PHE . 27.1 tp10 -117.69 143.13 46.48 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.71 -172.7 30.4 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.93 126.95 54.42 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.632 -0.922 . . . . 0.0 109.218 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.31 118.96 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.033 -1.042 . . . . 0.0 109.552 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -98.7 -19.5 17.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.414 -0.804 . . . . 0.0 108.855 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -168.25 154.33 7.18 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.131 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.446 HD13 HD13 ' B' ' 32' ' ' LEU . 12.9 mt -133.32 139.48 46.89 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.2 t -134.58 122.41 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.526 -0.734 . . . . 0.0 109.796 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.439 ' CD1' ' C ' ' A' ' 62' ' ' TYR . 10.0 t80 -136.23 139.79 30.97 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.16 87.71 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.472 1.448 . . . . 0.0 112.245 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.708 ' CD2' ' H ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' B' ' 3' ' ' ASN . 8.9 p-10 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -79.53 139.11 37.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.586 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . 0.748 ' NE2' HD11 ' A' ' 9' ' ' LEU . 4.0 pt20 -148.14 158.43 44.07 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.138 -0.976 . . . . 0.0 109.734 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -113.94 134.35 54.88 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.483 -0.76 . . . . 0.0 109.021 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.8 mt -116.06 147.3 41.41 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 43.1 t -141.04 131.67 25.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.497 -0.752 . . . . 0.0 109.577 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.698 ' CD1' HD21 ' A' ' 7' ' ' LEU . 25.1 tp -142.82 145.25 33.02 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.501 ' O ' ' N ' ' B' ' 12' ' ' VAL . 14.1 p -68.25 165.64 18.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.208 -0.933 . . . . 0.0 110.649 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.19 92.87 0.01 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.523 HG22 ' N ' ' B' ' 13' ' ' SER . 9.3 p -48.2 168.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.51 -0.994 . . . . 0.0 110.26 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . 0.523 ' N ' HG22 ' B' ' 12' ' ' VAL . 15.7 m -72.86 -39.8 66.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.665 -0.647 . . . . 0.0 110.528 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -148.98 147.66 28.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.883 -1.136 . . . . 0.0 109.949 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 78.6 t -103.32 97.48 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -65.13 -41.83 94.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.851 . . . . 0.0 109.83 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 31.1 t -174.43 147.0 1.1 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.886 . . . . 0.0 109.07 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . 0.512 ' CE1' HD12 ' B' ' 23' ' ' ILE . 1.6 t80 -128.88 112.46 14.13 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.454 ' H ' HD13 ' B' ' 23' ' ' ILE . 4.9 m-20 -130.7 148.14 68.91 Favored Pre-proline 0 N--CA 1.498 1.93 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.6 -10.33 28.37 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.792 1.662 . . . . 0.0 111.496 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -118.38 3.86 11.86 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.768 -0.582 . . . . 0.0 109.64 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -172.07 129.76 0.61 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.261 -0.899 . . . . 0.0 109.382 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.512 HD12 ' CE1' ' B' ' 18' ' ' PHE . 50.8 mm -122.03 121.65 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.347 -0.845 . . . . 0.0 109.214 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 58.4 mt -119.21 114.53 22.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 46.3 mt -131.35 127.11 36.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.394 -0.816 . . . . 0.0 108.883 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -87.39 111.34 21.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.021 -1.049 . . . . 0.0 109.414 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.618 ' O ' ' N ' ' B' ' 29' ' ' GLN . 9.6 t -105.74 150.06 25.86 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.475 -0.766 . . . . 0.0 109.96 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 57.5 mt 38.26 -84.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 121.06 0.457 . . . . 0.0 110.485 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.618 ' N ' ' O ' ' B' ' 27' ' ' THR . 15.9 pt20 -139.4 -19.47 0.96 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.338 -0.851 . . . . 0.0 110.26 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.58 166.24 23.91 Favored Glycine 0 N--CA 1.496 2.654 0 O-C-N 121.077 -1.015 . . . . 0.0 110.665 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 69.1 t -114.97 131.31 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.725 -0.868 . . . . 0.0 108.668 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 60' ' ' LEU . 52.7 tp -109.77 127.61 54.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.613 -0.679 . . . . 0.0 109.24 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.5 t -117.23 124.2 48.48 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 74.1 mt -110.18 131.38 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.387 -0.821 . . . . 0.0 108.997 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -124.84 139.56 53.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.546 -0.721 . . . . 0.0 109.365 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.67 -144.69 8.05 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.566 ' OE1' ' N ' ' B' ' 37' ' ' GLU . 7.5 mp0 -138.65 147.44 42.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.522 -0.987 . . . . 0.0 109.204 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' B' ' 54' ' ' GLU . 68.8 mmtt 62.54 49.75 3.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.667 -0.646 . . . . 0.0 109.94 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.576 HD12 ' N ' ' B' ' 39' ' ' LEU . 10.0 mp -93.01 71.17 4.63 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.005 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -178.736 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.497 1.906 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -136.97 149.93 47.84 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.427 HG12 ' N ' ' B' ' 54' ' ' GLU . 23.8 t -130.62 159.16 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.311 -0.868 . . . . 0.0 109.623 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.427 ' N ' HG12 ' B' ' 53' ' ' VAL . 7.5 pt-20 -143.38 144.33 32.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.332 -0.855 . . . . 0.0 109.244 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.46 -175.53 31.82 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.54 113.85 27.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.442 -1.034 . . . . 0.0 109.208 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.592 HD12 ' N ' ' B' ' 57' ' ' ILE . 1.5 mp -81.14 127.07 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.156 -0.965 . . . . 0.0 109.759 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -101.78 -23.0 14.26 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.07 155.01 15.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.043 -1.036 . . . . 0.0 110.655 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.46 HD13 HD13 ' A' ' 32' ' ' LEU . 14.0 mt -130.82 142.56 50.4 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.473 HG22 HD12 ' A' ' 64' ' ' LEU . 71.3 t -134.19 119.77 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.421 -0.8 . . . . 0.0 109.177 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.591 ' O ' HD13 ' B' ' 64' ' ' LEU . 50.2 t80 -133.71 102.86 12.32 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.66 97.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.829 1.686 . . . . 0.0 112.745 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.779 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.483 -0.761 . . . . 0.0 109.22 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.478 0.656 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.3 mmm-85 -69.4 138.3 53.48 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.5 -0.75 . . . . 0.0 109.693 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -150.44 155.75 40.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.454 -0.779 . . . . 0.0 109.139 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -114.34 131.93 56.37 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.611 HD23 ' N ' ' A' ' 8' ' ' SER . 6.0 tt -120.3 123.73 43.87 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.611 ' N ' HD23 ' A' ' 7' ' ' LEU . 38.3 t -109.93 132.24 54.34 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.498 -0.751 . . . . 0.0 109.601 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.624 HD11 ' NE2' ' B' ' 5' ' ' GLN . 44.6 tp -146.92 147.29 30.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.785 . . . . 0.0 109.232 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.408 HG21 ' OE1' ' A' ' 50' ' ' GLN . 1.9 t -148.43 177.74 9.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.306 -0.871 . . . . 0.0 109.187 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.3 20.98 76.51 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 p -62.46 144.37 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.586 -0.949 . . . . 0.0 110.001 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 t -72.38 -42.7 64.93 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.543 -0.723 . . . . 0.0 109.573 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -165.12 160.65 18.95 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.983 -1.073 . . . . 0.0 110.179 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -94.85 108.89 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -81.9 -56.3 4.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -0.816 . . . . 0.0 110.024 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 t -162.18 127.16 3.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.304 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.492 ' CE1' HD12 ' A' ' 23' ' ' ILE . 1.7 t80 -109.66 117.43 33.91 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.423 ' H ' HD13 ' A' ' 23' ' ' ILE . 1.1 m-20 -131.05 148.41 70.14 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 121.309 -0.869 . . . . 0.0 109.466 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.66 -11.8 31.73 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.508 1.472 . . . . 0.0 110.515 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -105.71 -14.52 15.23 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.791 -0.568 . . . . 0.0 110.094 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -167.82 145.89 4.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.232 -0.917 . . . . 0.0 109.306 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.492 HD12 ' CE1' ' A' ' 18' ' ' PHE . 51.2 mm -121.74 125.29 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.561 -0.712 . . . . 0.0 109.079 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.4 mt -118.39 115.56 24.92 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.4 mt -133.38 133.56 42.59 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -75.7 116.33 16.3 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.312 -0.867 . . . . 0.0 109.3 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.499 ' O ' ' C ' ' A' ' 28' ' ' ILE . 13.3 t -114.51 146.96 40.06 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.499 ' C ' ' O ' ' A' ' 27' ' ' THR . 10.0 mm -1.97 -75.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 123.557 0.743 . . . . 0.0 112.932 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.469 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 99.4 mm-40 -59.35 -71.01 0.13 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.438 -0.789 . . . . 0.0 111.749 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.55 -128.24 1.9 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.2 t -116.72 131.81 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.916 0.865 . . . . 0.0 110.711 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.4 tp -100.71 129.86 46.67 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.7 m -110.21 120.69 43.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.6 mt -105.32 124.04 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -118.41 141.32 48.66 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.754 0.788 . . . . 0.0 109.35 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.444 ' HA2' ' H ' ' A' ' 58' ' ' ASP . . . -179.58 -138.56 3.36 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.401 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.78 132.35 43.71 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.48 -1.012 . . . . 0.0 108.353 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp 39.72 86.13 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.642 0.734 . . . . 0.0 110.646 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.2 mp -96.8 72.12 2.58 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.686 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.539 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.408 ' OE1' HG21 ' A' ' 10' ' ' THR . 94.1 mm-40 . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.7 t -122.22 133.08 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.539 ' N ' ' OE1' ' A' ' 52' ' ' GLU . 13.3 mp0 -131.67 146.68 52.31 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.501 0.667 . . . . 0.0 109.428 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.1 t -129.06 134.41 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -117.32 134.76 54.43 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.694 0.759 . . . . 0.0 109.243 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.83 -176.05 34.21 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -103.71 120.92 41.91 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.9 mt -83.76 116.9 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.056 -1.028 . . . . 0.0 109.772 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.444 ' H ' ' HA2' ' A' ' 36' ' ' GLY . 59.0 m-20 -96.99 -15.42 21.09 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.481 -0.762 . . . . 0.0 109.81 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.6 152.96 8.67 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.083 -1.011 . . . . 0.0 110.446 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.418 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 8.8 mt -138.63 134.97 34.41 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 49.7 t -130.86 124.91 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.496 -0.753 . . . . 0.0 109.421 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.556 ' O ' ' N ' ' A' ' 64' ' ' LEU . 33.7 t80 -133.63 111.54 12.55 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.12 78.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.413 1.409 . . . . 0.0 112.326 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.895 HD12 HG22 ' B' ' 61' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.304 -1.402 0 O-C-N 120.528 -1.358 . . . . 0.0 108.667 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' B' ' 3' ' ' ASN . 10.7 p-10 . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 121.246 0.546 . . . . 0.0 109.809 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 38.6 mmm-85 -72.18 141.22 49.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.295 -0.878 . . . . 0.0 109.166 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . 0.624 ' NE2' HD11 ' A' ' 9' ' ' LEU . 2.8 pt20 -146.61 150.78 36.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.359 -0.838 . . . . 0.0 109.477 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -98.49 144.82 27.42 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.458 HD23 ' N ' ' B' ' 8' ' ' SER . 7.0 tt -127.79 125.9 40.71 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . 0.458 ' N ' HD23 ' B' ' 7' ' ' LEU . 3.7 m -122.17 145.44 48.19 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.533 -0.73 . . . . 0.0 110.126 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.6 tp -153.17 149.29 27.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.4 t -151.15 159.06 44.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.089 -1.007 . . . . 0.0 109.885 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.49 15.07 72.13 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.6 p -62.3 153.03 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -1.079 . . . . 0.0 110.378 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 67.1 m -73.71 -54.07 8.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.15 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.41 153.34 4.3 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.2 -0.937 . . . . 0.0 109.614 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 79.8 t -86.22 130.12 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.416 -0.802 . . . . 0.0 109.886 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -92.8 -23.82 18.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.291 -0.88 . . . . 0.0 109.378 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 21.5 t -171.55 158.16 5.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.133 -0.98 . . . . 0.0 109.893 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -147.52 112.27 5.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.401 -0.812 . . . . 0.0 109.492 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.458 ' OD2' ' O ' ' B' ' 22' ' ' GLU . 1.1 m-20 -133.18 152.88 80.35 Favored Pre-proline 0 N--CA 1.5 2.067 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.58 -12.61 36.23 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.654 1.569 . . . . 0.0 111.556 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -125.88 2.48 7.37 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.574 -0.704 . . . . 0.0 109.563 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.458 ' O ' ' OD2' ' B' ' 19' ' ' ASP . 55.1 tt0 -160.85 119.63 2.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.334 -0.853 . . . . 0.0 109.256 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.6 mt -129.02 127.87 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.173 -0.955 . . . . 0.0 109.416 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 79.3 mt -108.77 134.92 50.82 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 93.7 mt -135.05 123.42 23.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.349 -0.845 . . . . 0.0 109.7 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -93.93 123.17 37.11 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.566 ' O ' ' N ' ' B' ' 29' ' ' GLN . 7.0 t -123.58 149.45 45.28 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.606 0.717 . . . . 0.0 109.886 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 16.7 mt 45.04 -85.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.922 -0.486 . . . . 0.0 110.218 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' B' ' 27' ' ' THR . 17.1 pt20 -142.88 -20.62 0.65 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.08 -1.013 . . . . 0.0 110.201 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.98 171.59 35.88 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -116.54 131.4 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.879 -0.777 . . . . 0.0 109.125 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 31.8 tp -112.76 127.17 56.08 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.42 0.629 . . . . 0.0 109.485 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 40.5 t -108.94 123.46 49.13 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 39.3 mm -99.71 128.15 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -133.06 125.64 30.08 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.83 -139.5 2.65 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -137.94 136.93 37.47 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.349 -1.089 . . . . 0.0 109.99 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 54.84 57.84 5.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.467 -0.771 . . . . 0.0 110.09 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.565 HD12 ' N ' ' B' ' 39' ' ' LEU . 8.8 mp -85.15 72.15 10.8 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.791 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -178.716 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.498 1.954 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -146.45 159.6 43.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.236 -0.915 . . . . 0.0 110.131 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.415 HG12 ' N ' ' B' ' 54' ' ' GLU . 21.4 t -134.15 159.38 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.691 -0.63 . . . . 0.0 109.513 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.415 ' N ' HG12 ' B' ' 53' ' ' VAL . 3.3 tm-20 -127.81 142.11 51.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.435 -0.79 . . . . 0.0 109.139 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.27 -177.76 31.49 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.66 128.81 52.82 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 30.6 mm -78.61 125.34 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.073 -1.017 . . . . 0.0 109.656 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -110.09 -9.85 14.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.658 -0.652 . . . . 0.0 109.478 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -174.24 149.29 1.38 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.096 -1.002 . . . . 0.0 110.095 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.416 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 13.0 mt -138.34 137.5 37.42 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.895 HG22 HD12 ' A' ' 64' ' ' LEU . 9.4 t -134.42 122.74 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.491 -0.755 . . . . 0.0 109.982 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.418 ' CG ' ' HB2' ' A' ' 60' ' ' LEU . 26.9 t80 -140.33 106.08 6.6 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -50.59 113.05 0.89 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.302 1.334 . . . . 0.0 112.336 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.979 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.098 0 O-C-N 121.187 -0.946 . . . . 0.0 108.922 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.414 ' ND2' ' HG ' ' A' ' 56' ' ' LEU . 18.1 p-10 . . . . . 0 N--CA 1.501 2.081 0 CA-C-O 121.434 0.635 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -71.18 146.67 48.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 109.649 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.58 ' NE2' HD11 ' B' ' 9' ' ' LEU . 2.8 pt20 -150.2 160.12 43.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.37 -0.831 . . . . 0.0 109.174 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -100.08 141.56 32.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.377 -0.827 . . . . 0.0 109.053 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 8' ' ' SER . 6.6 tt -133.76 123.85 25.61 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.516 ' N ' HD23 ' A' ' 7' ' ' LEU . 40.4 t -131.88 139.62 48.84 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.736 -0.603 . . . . 0.0 109.556 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.506 HD11 ' NE2' ' B' ' 5' ' ' GLN . 41.8 tp -133.3 147.62 51.9 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p -130.71 159.12 38.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.526 -0.734 . . . . 0.0 109.544 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.95 21.05 69.04 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.35 137.05 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -1.154 . . . . 0.0 109.898 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.5 m -73.12 -44.35 60.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.206 -0.934 . . . . 0.0 109.796 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.56 163.2 5.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.163 -0.961 . . . . 0.0 109.564 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.0 t -93.99 127.71 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.282 -0.886 . . . . 0.0 109.433 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -85.19 -30.92 23.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.046 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.8 t -174.01 167.26 4.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.516 -0.74 . . . . 0.0 109.293 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -149.77 106.54 3.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.344 -0.847 . . . . 0.0 108.856 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.62 126.02 19.81 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -47.24 -24.21 3.58 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.361 1.374 . . . . 0.0 112.228 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -90.7 -8.15 50.67 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.985 -1.072 . . . . 0.0 109.98 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -176.65 141.58 0.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.472 -0.767 . . . . 0.0 109.081 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mt -130.76 130.58 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.105 -0.997 . . . . 0.0 109.085 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.1 mt -114.35 125.0 53.36 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.8 mt -124.33 131.35 53.51 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.566 -0.709 . . . . 0.0 109.624 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -95.28 122.59 38.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.401 -0.812 . . . . 0.0 109.162 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 29' ' ' GLN . 2.9 t -124.18 148.67 47.08 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.44 0.638 . . . . 0.0 110.348 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' A' ' 27' ' ' THR . 60.0 mt 38.09 -90.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.971 -0.455 . . . . 0.0 110.5 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.525 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.1 pt20 -136.47 -15.79 1.62 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.227 -0.921 . . . . 0.0 109.786 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.21 153.82 20.06 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.1 t -111.13 131.05 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.553 -0.969 . . . . 0.0 108.39 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.8 tp -107.34 124.07 49.27 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.693 -0.629 . . . . 0.0 109.633 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.1 m -107.49 120.36 41.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.1 mt -104.73 127.11 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.52 127.64 52.37 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.96 -148.61 5.38 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -142.79 139.23 30.91 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.4 ' C ' HD12 ' A' ' 39' ' ' LEU . 33.1 mtmm 57.25 63.3 1.92 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.524 -0.735 . . . . 0.0 110.315 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.0 mp -94.73 72.06 3.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.268 -0.895 . . . . 0.0 109.023 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.367 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.533 -179.087 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 . . . . . 0 N--CA 1.5 2.047 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.58 135.47 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.509 -0.744 . . . . 0.0 109.422 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -126.93 137.9 53.2 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.5 t -137.48 141.08 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -0.799 . . . . 0.0 108.951 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -114.96 125.21 53.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.497 -0.752 . . . . 0.0 109.033 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.49 166.17 27.12 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.703 HD22 ' C ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -86.77 151.42 23.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.52 -0.988 . . . . 0.0 110.772 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.411 HD12 ' OE1' ' A' ' 5' ' ' GLN . 87.9 mt -103.46 119.28 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.832 -1.167 . . . . 0.0 109.168 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -112.5 -11.94 13.55 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.405 -0.81 . . . . 0.0 108.995 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.78 149.03 6.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.105 -0.997 . . . . 0.0 110.086 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.5 mt -138.08 141.46 40.26 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.525 HG22 HD12 ' B' ' 64' ' ' LEU . 65.3 t -134.62 123.4 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.419 -0.801 . . . . 0.0 109.792 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.548 ' O ' ' N ' ' A' ' 64' ' ' LEU . 13.1 t80 -145.69 136.66 12.48 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -44.67 88.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.288 0 CA-C-N 120.22 1.114 . . . . 0.0 111.492 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.592 ' C ' HD23 ' A' ' 64' ' ' LEU . 1.7 tt . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.245 -0.909 . . . . 0.0 109.33 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 . . . . . 0 N--CA 1.5 2.025 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.3 mmm-85 -77.25 141.84 39.8 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.407 -0.808 . . . . 0.0 109.12 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . 0.506 ' NE2' HD11 ' A' ' 9' ' ' LEU . 2.9 pt20 -147.63 161.3 41.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.213 -0.93 . . . . 0.0 109.591 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -116.52 130.77 56.93 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.538 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.4 tt -123.12 121.81 36.91 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . 0.524 ' N ' HD23 ' B' ' 7' ' ' LEU . 97.8 p -114.0 145.76 41.1 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.7 -0.625 . . . . 0.0 109.695 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.58 HD11 ' NE2' ' A' ' 5' ' ' GLN . 34.1 tp -148.09 144.2 27.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.357 -0.839 . . . . 0.0 109.259 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 46.0 p -130.93 170.07 14.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.616 -0.677 . . . . 0.0 109.577 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.02 11.04 77.3 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 83.4 t -72.24 133.75 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -1.166 . . . . 0.0 109.684 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.8 t -72.28 -45.37 60.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.313 -0.867 . . . . 0.0 109.605 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.21 163.06 8.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.077 -1.014 . . . . 0.0 109.658 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 98.1 t -84.67 110.55 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.869 . . . . 0.0 109.979 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -66.35 -41.05 90.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 0.0 109.16 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 5.5 p -160.19 163.96 33.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.338 -0.851 . . . . 0.0 108.963 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -151.21 110.68 3.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.006 -1.058 . . . . 0.0 110.073 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.25 150.0 74.76 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.01 -16.5 49.66 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.612 1.541 . . . . 0.0 111.479 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -111.67 -1.97 15.53 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.557 -0.714 . . . . 0.0 109.517 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.554 ' OE2' HD21 ' B' ' 24' ' ' LEU . 2.7 tm-20 -170.86 130.63 0.81 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.169 -0.957 . . . . 0.0 109.286 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -129.73 132.07 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.231 -0.918 . . . . 0.0 109.847 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.554 HD21 ' OE2' ' B' ' 22' ' ' GLU . 89.5 mt -111.4 125.57 54.01 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 76.4 mt -121.73 124.83 45.16 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.667 -0.646 . . . . 0.0 109.357 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -93.32 113.52 25.72 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.576 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.7 t -124.95 154.04 41.79 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.447 0.641 . . . . 0.0 110.028 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 18.5 mm 42.22 -86.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.883 -0.51 . . . . 0.0 110.339 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' B' ' 27' ' ' THR . 18.7 pt20 -143.51 -17.0 0.63 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.018 -1.051 . . . . 0.0 110.232 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.94 178.05 30.6 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.84 134.35 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 54.8 tp -105.42 127.28 52.9 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.368 -0.833 . . . . 0.0 109.463 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.7 m -116.55 120.69 39.52 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.716 . . . . 0.0 109.645 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 92.1 mt -109.85 129.91 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -127.92 143.22 51.1 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.627 -0.67 . . . . 0.0 109.423 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.61 -142.53 7.58 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.523 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.419 ' HB3' HD11 ' B' ' 56' ' ' LEU . 27.2 tp10 -123.0 143.72 49.74 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.627 -0.925 . . . . 0.0 109.069 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' B' ' 54' ' ' GLU . 49.5 mtmt 51.77 63.32 2.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.341 -0.849 . . . . 0.0 111.184 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.517 HD12 ' N ' ' B' ' 39' ' ' LEU . 8.7 mp -94.88 70.7 3.41 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.979 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.347 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -120.07 143.24 48.23 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.422 -0.799 . . . . 0.0 108.941 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.7 t -124.17 135.59 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.629 -0.669 . . . . 0.0 109.513 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' B' ' 38' ' ' LYS . 44.0 tt0 -125.94 135.05 51.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.62 -177.1 27.09 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.461 ' H ' HD23 ' B' ' 56' ' ' LEU . 0.2 OUTLIER -99.67 127.2 45.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.347 -1.09 . . . . 0.0 108.556 179.388 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.509 HD12 ' N ' ' B' ' 57' ' ' ILE . 1.3 mp -79.8 128.06 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.925 . . . . 0.0 109.752 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -108.93 -39.54 5.29 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.569 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -148.29 149.66 32.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 110.094 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.569 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.8 OUTLIER -131.69 131.21 42.9 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.473 HG13 HD12 ' A' ' 64' ' ' LEU . 47.4 t -129.09 128.77 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' B' ' 62' ' ' TYR . 19.8 t80 -143.53 140.06 17.07 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.57 85.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 120.986 1.124 . . . . 0.0 112.051 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.651 ' H ' ' CD2' ' B' ' 64' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -88.84 132.1 34.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.104 -0.997 . . . . 0.0 108.87 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -147.75 161.07 41.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.994 -1.066 . . . . 0.0 109.346 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -108.52 131.17 55.09 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.565 ' C ' HD23 ' A' ' 7' ' ' LEU . 6.3 tt -117.82 121.77 41.63 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.548 ' N ' HD23 ' A' ' 7' ' ' LEU . 46.8 t -116.04 132.34 56.68 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.538 -0.726 . . . . 0.0 109.657 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.539 HD21 ' NE2' ' B' ' 5' ' ' GLN . 5.5 tp -147.31 153.72 40.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.361 -0.837 . . . . 0.0 109.317 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.463 ' OG1' ' N ' ' A' ' 11' ' ' GLY . 6.1 t -149.85 -164.54 2.05 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.36 -0.838 . . . . 0.0 109.847 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.463 ' N ' ' OG1' ' A' ' 10' ' ' THR . . . 65.24 19.38 66.2 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.5 t -70.25 141.66 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.677 -0.896 . . . . 0.0 110.617 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.3 m -71.78 -43.5 65.6 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.91 160.36 3.55 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.234 -0.916 . . . . 0.0 109.918 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.2 t -88.66 129.96 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.4 -0.812 . . . . 0.0 109.852 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -97.34 -35.1 10.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.386 -0.821 . . . . 0.0 109.23 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.8 t -169.67 145.61 3.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.566 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -137.61 113.94 10.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.513 -0.742 . . . . 0.0 109.132 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -133.24 153.56 80.73 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.03 -20.08 44.82 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.295 1.997 . . . . 0.0 111.605 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -102.07 -4.56 25.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.539 -0.726 . . . . 0.0 109.318 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -172.87 142.04 1.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.444 -0.785 . . . . 0.0 109.045 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.8 mt -132.48 130.24 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.427 -0.796 . . . . 0.0 109.725 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.5 mt -118.06 121.44 40.59 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.6 mt -124.37 125.09 43.73 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -81.76 114.75 20.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.347 -0.846 . . . . 0.0 109.924 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 28' ' ' ILE . 14.5 t -124.68 -179.52 4.54 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.659 0.742 . . . . 0.0 110.215 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.492 ' O ' ' O ' ' A' ' 27' ' ' THR . 1.3 mt -36.51 161.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 121.736 0.779 . . . . 0.0 110.414 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.414 ' OE1' ' OD1' ' B' ' 58' ' ' ASP . 78.6 mm-40 65.12 -61.9 0.22 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.139 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -165.94 -127.26 0.88 Allowed Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.093 -1.527 . . . . 0.0 109.962 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.6 t -122.37 135.18 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.593 -0.945 . . . . 0.0 110.338 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.451 HD11 HD12 ' A' ' 60' ' ' LEU . 42.8 tp -105.55 125.41 50.96 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.8 m -103.61 123.0 46.16 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -107.75 125.02 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -116.57 140.83 48.95 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.47 -151.38 9.43 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.415 ' HB3' HD11 ' A' ' 56' ' ' LEU . 14.1 tp10 -143.32 146.39 33.51 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.337 -1.096 . . . . 0.0 109.024 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 54' ' ' GLU . 67.5 mttm 58.33 55.22 5.14 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.486 0.66 . . . . 0.0 109.68 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.7 mp -92.9 72.64 4.81 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.849 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -179.125 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.015 0.435 . . . . 0.0 109.859 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.4 t -115.05 131.97 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -131.16 136.56 48.42 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.76 135.01 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 38' ' ' LYS . 5.1 tm-20 -116.89 126.55 53.16 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.0 -174.61 41.62 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.211 -1.471 . . . . 0.0 110.032 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.415 HD11 ' HB3' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -106.42 118.21 36.06 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.809 -0.818 . . . . 0.0 109.387 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.53 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.4 mp -74.05 128.08 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.337 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -105.73 -21.9 13.07 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.629 ' O ' HD22 ' A' ' 60' ' ' LEU . . . -166.89 158.28 12.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.991 -1.068 . . . . 0.0 110.834 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.629 HD22 ' O ' ' A' ' 59' ' ' ALA . 0.7 OUTLIER -135.64 135.34 40.1 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.461 HG22 HD12 ' B' ' 64' ' ' LEU . 58.8 t -133.96 119.94 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.436 -0.79 . . . . 0.0 109.63 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 64' ' ' LEU . 29.2 t80 -133.46 140.06 35.85 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.77 68.4 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.602 1.535 . . . . 0.0 111.924 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.608 HD12 HG22 ' B' ' 61' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.734 -0.604 . . . . 0.0 109.689 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 47.2 mmm-85 -88.66 137.77 32.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.657 -1.277 . . . . 0.0 109.451 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . 0.539 ' NE2' HD21 ' A' ' 9' ' ' LEU . 46.5 tt0 -139.05 149.92 45.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.295 -0.878 . . . . 0.0 109.502 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -109.46 129.55 55.55 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.508 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.9 tt -122.69 122.49 38.88 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . 0.46 ' N ' HD23 ' B' ' 7' ' ' LEU . 41.6 t -123.14 137.26 54.95 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.6 tp -145.25 151.59 38.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.221 -0.924 . . . . 0.0 109.835 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -140.49 159.74 41.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.708 -0.62 . . . . 0.0 109.629 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.47 24.19 26.86 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.439 HG22 ' H ' ' B' ' 14' ' ' LYS . 6.2 p -62.62 141.37 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.166 -1.197 . . . . 0.0 110.034 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 10.0 m -92.28 -21.35 20.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.411 -0.806 . . . . 0.0 109.26 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.439 ' H ' HG22 ' B' ' 12' ' ' VAL . 9.8 tttt -171.8 154.2 3.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.555 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 75.5 t -102.67 99.16 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -67.36 -40.55 85.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 109.07 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 25.8 t -170.76 167.97 7.49 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.408 -0.808 . . . . 0.0 109.523 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -149.7 105.2 3.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.532 -0.73 . . . . 0.0 109.123 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -132.77 147.82 67.04 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.59 -14.59 39.9 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 121.7 1.6 . . . . 0.0 111.735 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -104.05 -8.01 19.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.548 -0.72 . . . . 0.0 109.534 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -173.18 113.19 0.23 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.371 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 97.3 mt -109.35 127.14 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.235 -0.916 . . . . 0.0 109.221 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 68.4 mt -117.69 123.43 46.06 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 88.5 mt -131.22 129.49 41.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.465 -0.772 . . . . 0.0 109.391 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.2 111.47 17.65 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.604 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.487 ' O ' ' O ' ' B' ' 28' ' ' ILE . 12.9 t -124.39 -176.94 3.64 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.571 0.7 . . . . 0.0 110.29 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' B' ' 27' ' ' THR . 1.9 mt -32.62 157.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.886 0.85 . . . . 0.0 110.951 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.471 HE21 HG22 ' B' ' 28' ' ' ILE . 81.2 mm-40 64.6 -62.45 0.18 Allowed 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.939 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' B' ' 28' ' ' ILE . . . -166.34 -120.09 0.5 Allowed Glycine 0 N--CA 1.486 1.968 0 C-N-CA 119.225 -1.464 . . . . 0.0 110.202 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 53.1 t -119.4 135.03 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.676 -0.897 . . . . 0.0 110.539 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 59.0 tp -109.33 123.38 49.22 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.4 t -107.4 123.66 48.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.792 -0.567 . . . . 0.0 109.989 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 94.6 mt -108.52 122.37 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -117.6 142.44 47.2 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.599 -0.688 . . . . 0.0 109.457 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . 0.433 ' HA2' ' H ' ' B' ' 58' ' ' ASP . . . 174.61 -146.74 8.71 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -139.1 142.06 38.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.365 -1.08 . . . . 0.0 109.489 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 88.9 mttt 56.21 57.1 5.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.668 -0.645 . . . . 0.0 109.798 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.511 HD12 ' N ' ' B' ' 39' ' ' LEU . 8.6 mp -92.99 71.53 4.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.345 -0.847 . . . . 0.0 108.912 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . 0.41 ' O ' ' OE1' ' B' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -126.35 127.96 46.32 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.92 140.68 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.46 -0.775 . . . . 0.0 109.91 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.41 ' OE1' ' O ' ' B' ' 40' ' ' GLY . 5.3 mp0 -114.99 139.58 49.73 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.92 170.66 26.97 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.16 131.33 38.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.242 -1.152 . . . . 0.0 109.469 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 44.2 mm -87.66 113.98 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.099 -1.001 . . . . 0.0 108.862 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . 0.433 ' H ' ' HA2' ' B' ' 36' ' ' GLY . 18.2 t0 -97.68 -7.0 31.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.593 -0.692 . . . . 0.0 109.222 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -177.19 154.85 1.09 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.048 -1.032 . . . . 0.0 110.823 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.4 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 11.8 mt -139.93 138.46 35.61 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.608 HG22 HD12 ' A' ' 64' ' ' LEU . 61.3 t -134.14 129.8 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.507 -0.746 . . . . 0.0 109.216 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.666 ' O ' ' N ' ' B' ' 64' ' ' LEU . 65.1 t80 -143.2 123.0 7.71 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -48.44 71.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 121.983 1.788 . . . . 0.0 111.91 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.666 ' N ' ' O ' ' B' ' 62' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.298 -1.642 0 CA-C-O 121.886 0.851 . . . . 0.0 109.975 -179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 121.307 0.575 . . . . 0.0 109.705 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.6 mmm-85 -81.61 148.0 29.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.241 -0.912 . . . . 0.0 110.121 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -155.83 160.13 39.96 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.46 -0.775 . . . . 0.0 109.264 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -108.92 138.37 45.36 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.536 HD23 ' N ' ' A' ' 8' ' ' SER . 6.7 tt -126.82 124.72 40.3 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.536 ' N ' HD23 ' A' ' 7' ' ' LEU . 44.2 t -127.81 149.12 50.41 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.543 HD21 ' NE2' ' B' ' 5' ' ' GLN . 9.0 tp -142.5 146.25 34.53 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.344 -0.848 . . . . 0.0 109.402 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -124.73 167.77 14.11 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.641 -0.662 . . . . 0.0 109.534 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.37 14.96 69.8 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.3 p -68.93 136.76 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -1.12 . . . . 0.0 109.685 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.5 m -73.18 -46.5 50.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.307 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.96 163.1 4.0 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.346 -0.846 . . . . 0.0 109.882 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.2 t -95.18 117.55 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.412 -0.805 . . . . 0.0 109.823 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -68.84 -35.9 77.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.373 -0.83 . . . . 0.0 109.184 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -167.31 161.61 14.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.294 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -151.29 111.47 4.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.394 -0.816 . . . . 0.0 108.97 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -126.9 156.63 73.7 Favored Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.436 -0.79 . . . . 0.0 108.888 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.19 -29.78 84.81 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.776 1.651 . . . . 0.0 112.514 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -117.17 17.71 14.72 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.469 -0.769 . . . . 0.0 110.589 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -171.24 132.36 0.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 0.0 109.168 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.17 129.94 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.366 -0.834 . . . . 0.0 109.54 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.459 ' CD2' ' OG ' ' A' ' 33' ' ' SER . 64.4 mt -112.93 126.86 55.94 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.1 mt -121.53 132.43 54.7 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.666 -0.647 . . . . 0.0 109.763 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -101.68 113.94 27.54 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 28' ' ' ILE . 9.9 t -124.61 -162.84 1.12 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.396 0.617 . . . . 0.0 110.037 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.493 HD11 ' O ' ' B' ' 3' ' ' ASN . 63.2 mt -33.48 99.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 28' ' ' ILE . 5.6 pt20 29.58 53.83 0.12 Allowed 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 121.294 0.569 . . . . 0.0 111.558 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.02 145.46 8.16 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.53 131.22 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.516 -0.991 . . . . 0.0 108.908 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.7 tp -108.05 118.31 36.41 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.459 ' OG ' ' CD2' ' A' ' 24' ' ' LEU . 22.8 t -104.64 123.58 47.83 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.1 mt -105.81 129.18 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.438 -0.789 . . . . 0.0 109.433 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -120.38 139.19 53.15 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.78 -149.3 8.82 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -133.19 142.54 48.66 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.373 -1.075 . . . . 0.0 109.456 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.5 mttp 54.63 59.9 3.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.565 -0.71 . . . . 0.0 110.545 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.0 mp -91.38 74.19 6.08 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.95 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.098 -177.313 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 . . . . . 0 N--CA 1.5 2.061 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.36 161.48 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.611 -0.681 . . . . 0.0 109.408 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -139.35 137.84 36.11 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.458 -0.776 . . . . 0.0 109.487 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 52.1 t -130.6 136.53 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -123.34 129.58 51.51 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.374 -0.829 . . . . 0.0 108.902 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.4 177.48 33.54 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.525 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -95.79 133.7 39.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.283 -1.128 . . . . 0.0 109.273 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.441 ' CG2' HD23 ' A' ' 60' ' ' LEU . 91.8 mt -90.54 111.7 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.148 -0.97 . . . . 0.0 109.727 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -99.31 -17.06 18.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.498 -0.751 . . . . 0.0 109.39 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.59 153.22 16.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.074 -1.016 . . . . 0.0 110.248 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.441 HD23 ' CG2' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -135.04 136.5 42.13 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.695 HG22 HD12 ' B' ' 64' ' ' LEU . 3.2 t -135.89 127.44 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.496 -0.752 . . . . 0.0 109.564 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.426 ' C ' ' CD1' ' A' ' 62' ' ' TYR . 9.2 t80 -144.06 139.86 16.39 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -64.19 79.92 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.002 1.135 . . . . 0.0 113.379 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.829 ' O ' HD13 ' A' ' 64' ' ' LEU . 1.4 tm? . . . . . 0 C--N 1.304 -1.375 0 O-C-N 120.989 -1.07 . . . . 0.0 108.7 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.493 ' O ' HD11 ' A' ' 28' ' ' ILE . 13.7 p-10 . . . . . 0 N--CA 1.501 2.091 0 CA-C-O 120.847 0.356 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -71.44 143.41 50.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.047 -1.033 . . . . 0.0 109.315 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . 0.543 ' NE2' HD21 ' A' ' 9' ' ' LEU . 35.8 tt0 -146.45 152.76 39.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.431 -0.793 . . . . 0.0 109.598 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' B' ' 6' ' ' PHE . 1.5 m-85 -124.18 145.38 49.36 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.579 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.0 tt -130.7 125.77 34.79 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . 0.555 ' N ' HD23 ' B' ' 7' ' ' LEU . 31.1 t -107.24 137.65 44.89 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.651 -0.656 . . . . 0.0 109.264 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.717 ' O ' HG12 ' B' ' 51' ' ' VAL . 10.2 tp -149.32 155.27 40.26 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.044 -1.035 . . . . 0.0 109.652 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.7 t -149.95 157.86 43.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.131 -0.98 . . . . 0.0 109.273 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.33 12.95 57.99 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 87.0 t -67.29 135.15 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.997 -1.296 . . . . 0.0 109.28 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 33.2 m -71.87 -45.28 61.89 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.641 -0.823 . . . . 0.0 109.809 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.39 159.47 5.68 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.099 -1.001 . . . . 0.0 109.474 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 87.5 t -92.23 129.7 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.309 -0.869 . . . . 0.0 109.747 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -86.71 -26.69 24.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.421 -0.799 . . . . 0.0 109.795 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 32.7 t -171.88 160.74 5.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -0.896 . . . . 0.0 109.05 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -148.37 108.12 4.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.816 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -132.62 131.16 22.01 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.37 -24.73 9.07 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 CA-C-N 119.991 1.032 . . . . 0.0 111.829 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -93.63 -6.53 46.24 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.337 -0.852 . . . . 0.0 110.157 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -171.86 133.2 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.228 -0.92 . . . . 0.0 109.155 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 94.0 mt -128.12 131.13 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.4 -0.813 . . . . 0.0 109.469 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 17.2 mt -111.86 125.48 54.07 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 80.8 mt -122.34 118.49 28.59 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -89.55 116.5 27.75 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.576 ' O ' ' N ' ' B' ' 29' ' ' GLN . 2.9 t -123.73 149.04 46.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 109.771 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 59.3 mt 46.95 -85.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.079 0.466 . . . . 0.0 110.028 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' B' ' 27' ' ' THR . 28.1 pt20 -143.07 -23.39 0.62 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.089 -1.007 . . . . 0.0 110.786 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.6 171.56 32.04 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 54.9 t -119.92 130.22 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.848 -0.795 . . . . 0.0 108.883 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.402 HD11 HD12 ' B' ' 60' ' ' LEU . 48.6 tp -111.23 128.04 55.8 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.78 127.69 56.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 90.4 mt -105.71 126.53 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -119.49 130.63 55.32 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.7 -147.83 6.34 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -133.59 144.25 49.18 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.344 -1.091 . . . . 0.0 109.447 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 53.34 57.02 6.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.523 -0.735 . . . . 0.0 110.584 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.513 HD12 ' N ' ' B' ' 39' ' ' LEU . 9.3 mp -84.11 73.39 10.4 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.562 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.694 -178.001 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.717 HG12 ' O ' ' B' ' 9' ' ' LEU . 14.8 p . . . . . 0 N--CA 1.5 2.052 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -141.13 119.46 12.18 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.22 153.85 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.334 -0.854 . . . . 0.0 108.888 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -123.66 133.21 53.94 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.456 0.646 . . . . 0.0 109.49 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.14 163.78 14.79 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.448 ' H ' HD23 ' B' ' 56' ' ' LEU . 0.1 OUTLIER -88.13 140.93 28.98 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.02 -1.282 . . . . 0.0 109.643 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.485 ' H ' HD12 ' A' ' 28' ' ' ILE . 45.5 mm -84.31 126.17 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.322 -0.861 . . . . 0.0 109.481 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -113.53 -34.71 5.47 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.45 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -167.99 146.11 4.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.158 -0.964 . . . . 0.0 110.323 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.45 HD22 ' O ' ' B' ' 59' ' ' ALA . 3.9 mm? -117.31 135.96 53.47 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.12 118.05 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.803 0.811 . . . . 0.0 108.97 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.524 ' O ' ' N ' ' B' ' 64' ' ' LEU . 55.8 t80 -138.66 100.98 8.11 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -46.13 84.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 121.473 1.449 . . . . 0.0 112.341 -177.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.695 HD12 HG22 ' A' ' 61' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.306 -1.288 0 O-C-N 120.884 -1.135 . . . . 0.0 108.883 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.43 HD22 ' CB ' ' A' ' 56' ' ' LEU . 8.5 p-10 . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 121.554 0.692 . . . . 0.0 109.306 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.538 ' NH1' ' N ' ' A' ' 55' ' ' GLY . 7.6 mmm180 -54.08 148.33 11.14 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.322 -0.861 . . . . 0.0 109.743 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.588 ' NE2' HD11 ' B' ' 9' ' ' LEU . 1.8 pt20 -155.16 159.09 39.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.529 -0.732 . . . . 0.0 110.167 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -99.62 148.94 23.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.629 -0.67 . . . . 0.0 109.366 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.505 HD23 ' N ' ' A' ' 8' ' ' SER . 7.0 tt -138.5 126.63 22.75 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.176 -0.952 . . . . 0.0 108.457 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.505 ' N ' HD23 ' A' ' 7' ' ' LEU . 20.0 m -123.77 141.67 51.81 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.436 -0.79 . . . . 0.0 109.563 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.4 tp -150.76 145.64 25.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.386 -0.821 . . . . 0.0 109.354 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 p -137.92 172.14 13.37 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.462 -0.774 . . . . 0.0 109.09 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.62 20.85 59.19 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.91 134.84 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.028 -1.278 . . . . 0.0 110.067 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.1 m -74.71 -53.6 8.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.885 . . . . 0.0 109.841 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.14 156.19 28.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.042 -1.036 . . . . 0.0 109.835 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.1 t -88.92 129.5 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.348 -0.845 . . . . 0.0 109.841 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -97.98 -36.34 10.17 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.163 -0.961 . . . . 0.0 109.316 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.7 t -170.8 148.24 2.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.887 . . . . 0.0 108.907 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -141.49 110.78 6.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.343 -0.848 . . . . 0.0 109.142 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -133.48 144.58 52.83 Favored Pre-proline 0 N--CA 1.503 2.189 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.73 -35.67 48.62 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.027 1.152 . . . . 0.0 111.565 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -63.15 -45.09 93.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.2 -0.938 . . . . 0.0 110.0 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -156.83 156.15 32.72 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.393 -0.817 . . . . 0.0 109.089 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.5 mt -120.25 131.47 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.639 -0.663 . . . . 0.0 109.966 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.3 mt -112.93 116.62 30.27 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 mt -127.03 135.54 50.95 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.389 -0.819 . . . . 0.0 109.292 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -97.48 119.26 35.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.146 -0.971 . . . . 0.0 109.216 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.563 ' OG1' ' NE2' ' B' ' 5' ' ' GLN . 8.9 t -124.57 158.99 31.66 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.301 0.572 . . . . 0.0 110.348 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 27' ' ' THR . 44.8 mt 32.26 -86.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 CA-C-O 121.125 0.488 . . . . 0.0 111.261 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 27' ' ' THR . 24.9 pt20 -150.33 47.71 0.9 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.191 -0.943 . . . . 0.0 109.943 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -171.45 142.31 6.92 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.6 t -90.19 132.64 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.4 -1.059 . . . . 0.0 109.559 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.9 tp -106.95 125.09 50.55 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.6 t -113.05 124.46 52.66 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.6 mt -108.31 123.88 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -112.91 137.34 51.44 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.577 0.703 . . . . 0.0 109.558 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.92 -149.52 10.03 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -137.31 144.56 42.67 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.337 -1.096 . . . . 0.0 109.492 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp 56.1 59.01 3.94 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.726 0.774 . . . . 0.0 109.438 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.1 mp -92.23 73.86 5.39 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.572 0 C-N-CA 119.939 -1.124 . . . . 0.0 110.528 -178.355 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.98 135.46 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.472 -0.768 . . . . 0.0 109.397 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -126.49 131.7 51.57 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.455 0.645 . . . . 0.0 109.588 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -120.58 136.25 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HB2' HH22 ' A' ' 4' ' ' ARG . 2.6 pt-20 -130.08 146.33 51.74 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.538 ' N ' ' NH1' ' A' ' 4' ' ' ARG . . . 149.1 -175.57 28.27 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.43 ' CB ' HD22 ' A' ' 3' ' ' ASN . 2.4 pp -97.06 127.42 43.01 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.058 -1.26 . . . . 0.0 109.667 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.4 mm -87.32 120.91 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.273 -0.892 . . . . 0.0 109.837 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -105.7 -12.4 15.93 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.524 -0.735 . . . . 0.0 109.592 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -174.07 156.66 2.74 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.084 -1.01 . . . . 0.0 110.259 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.9 mt -138.7 135.48 34.83 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.488 HG22 HD12 ' B' ' 64' ' ' LEU . 77.7 t -128.08 128.88 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.554 -0.716 . . . . 0.0 109.248 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.434 ' CE1' ' O ' ' A' ' 63' ' ' PRO . 29.9 t80 -145.03 140.09 15.8 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.434 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 90.0 Cg_endo -80.3 113.01 2.85 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.442 1.428 . . . . 0.0 112.129 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.866 HD13 ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.131 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.535 0.683 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -69.37 142.45 53.94 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.372 -0.83 . . . . 0.0 109.121 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . 0.563 ' NE2' ' OG1' ' A' ' 27' ' ' THR . 76.1 mt-30 -144.63 153.11 41.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.274 -0.891 . . . . 0.0 109.857 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -114.66 129.16 56.64 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.574 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.8 tt -120.63 124.63 45.73 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.386 -0.821 . . . . 0.0 109.102 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . 0.563 ' N ' HD23 ' B' ' 7' ' ' LEU . 7.6 m -118.98 138.37 52.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.664 -0.647 . . . . 0.0 109.338 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.588 HD11 ' NE2' ' A' ' 5' ' ' GLN . 53.7 tp -146.64 140.87 26.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 0.0 109.23 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.411 ' O ' ' OG1' ' B' ' 10' ' ' THR . 1.0 OUTLIER -134.22 106.34 7.09 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.79 48.35 0.03 OUTLIER Glycine 0 N--CA 1.495 2.571 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.457 ' O ' HG13 ' B' ' 12' ' ' VAL . 14.6 p -104.49 131.54 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.542 -0.975 . . . . 0.0 109.67 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 6.3 t -71.21 -43.86 66.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.261 -0.899 . . . . 0.0 109.005 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.81 159.27 5.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.29 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 88.0 t -91.09 127.36 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.131 -0.981 . . . . 0.0 109.59 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -88.35 -23.32 23.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.253 -0.904 . . . . 0.0 109.364 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 32.9 t -172.52 159.78 4.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.322 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -146.09 104.01 3.78 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.054 -1.029 . . . . 0.0 109.73 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.74 150.76 74.34 Favored Pre-proline 0 N--CA 1.497 1.887 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.44 -9.09 22.63 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.449 1.433 . . . . 0.0 111.095 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -99.43 -16.96 18.19 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.388 -0.82 . . . . 0.0 109.437 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.41 ' OE2' ' C ' ' B' ' 23' ' ' ILE . 2.1 tm-20 -173.74 125.04 0.37 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.41 ' C ' ' OE2' ' B' ' 22' ' ' GLU . 77.9 mt -116.04 129.27 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.331 -0.855 . . . . 0.0 109.371 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 86.9 mt -105.18 125.5 51.05 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 88.2 mt -124.06 122.18 37.18 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.659 -0.651 . . . . 0.0 109.697 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -89.65 110.76 21.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.571 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.9 t -124.45 148.91 47.33 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.659 0.742 . . . . 0.0 109.842 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.402 HD13 ' N ' ' B' ' 28' ' ' ILE . 6.1 mm 51.95 -80.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.839 -0.538 . . . . 0.0 110.024 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' B' ' 27' ' ' THR . 15.3 pt20 -152.1 -21.46 0.18 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.195 -0.94 . . . . 0.0 109.825 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.99 177.87 32.96 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 47.7 t -119.93 132.42 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 38.5 tp -105.86 128.01 53.48 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.411 -0.806 . . . . 0.0 109.363 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 37.0 t -114.39 120.1 39.18 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 86.2 mt -107.19 123.39 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -114.44 140.67 48.51 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.47 0.652 . . . . 0.0 109.489 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.47 -154.46 24.69 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -130.97 149.92 52.37 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.389 -1.065 . . . . 0.0 109.321 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' B' ' 54' ' ' GLU . 26.1 mmtp 61.88 48.08 5.6 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.558 0.694 . . . . 0.0 109.382 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.536 HD12 ' N ' ' B' ' 39' ' ' LEU . 10.1 mp -91.85 72.89 5.71 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.242 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 121.613 0.72 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -130.46 126.39 36.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 69.6 t -116.58 136.56 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' B' ' 38' ' ' LYS . 29.6 mt-10 -123.42 144.43 49.5 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.99 177.41 23.98 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.436 ' H ' HD23 ' B' ' 56' ' ' LEU . 0.1 OUTLIER -90.18 144.11 26.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.093 -1.239 . . . . 0.0 109.283 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.507 ' CG2' HD23 ' B' ' 60' ' ' LEU . 35.5 mm -93.62 112.87 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.316 -0.865 . . . . 0.0 109.72 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -101.15 -21.55 14.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.335 -0.853 . . . . 0.0 109.249 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.555 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -167.06 152.65 7.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.744 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.555 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.5 OUTLIER -134.99 133.06 39.08 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 53.3 t -134.95 127.07 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.547 -0.721 . . . . 0.0 110.0 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.571 ' O ' ' N ' ' B' ' 64' ' ' LEU . 16.0 t80 -141.46 122.49 8.8 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -43.87 84.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.214 1.276 . . . . 0.0 112.376 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.724 ' H ' HD23 ' B' ' 64' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -82.26 122.31 27.77 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -142.14 163.57 32.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.188 -0.945 . . . . 0.0 109.625 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 1.1 m-85 -111.33 134.29 53.02 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.573 ' C ' HD23 ' A' ' 7' ' ' LEU . 6.0 tt -120.28 121.91 39.7 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.573 ' N ' HD23 ' A' ' 7' ' ' LEU . 68.5 m -115.3 146.74 41.22 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.526 -0.734 . . . . 0.0 109.409 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 tp -152.83 149.65 28.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 109.288 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 t -140.76 165.81 26.47 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.368 -0.833 . . . . 0.0 109.651 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.35 20.87 53.75 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -67.68 136.81 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -1.126 . . . . 0.0 110.333 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t -73.08 -41.36 64.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.379 -0.826 . . . . 0.0 109.542 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -168.89 167.56 10.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.097 -1.002 . . . . 0.0 109.655 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.1 t -98.82 99.61 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.276 -0.89 . . . . 0.0 109.871 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -65.93 -40.68 91.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 108.886 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -168.5 153.44 6.3 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -149.33 107.08 3.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 108.621 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -132.76 152.92 80.75 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.82 5.96 0.91 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.025 1.817 . . . . 0.0 111.438 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -133.25 -2.27 3.15 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.461 -0.774 . . . . 0.0 109.5 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -171.92 130.1 0.64 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.918 . . . . 0.0 108.856 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.85 128.73 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.329 -0.857 . . . . 0.0 109.979 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.2 mt -123.25 121.25 35.42 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.8 mt -129.39 131.63 46.86 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.536 -0.728 . . . . 0.0 109.203 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -96.43 119.42 34.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.985 -1.072 . . . . 0.0 109.582 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.569 ' O ' ' N ' ' A' ' 29' ' ' GLN . 5.2 t -124.2 148.61 47.15 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.538 0.685 . . . . 0.0 110.098 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.401 ' N ' HD13 ' A' ' 28' ' ' ILE . 5.9 mm 54.81 -79.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.783 -0.573 . . . . 0.0 109.541 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 27' ' ' THR . 13.5 pt20 -154.52 -20.61 0.12 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 0.0 110.074 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.06 177.18 32.42 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.0 t -123.0 132.84 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.779 -0.836 . . . . 0.0 109.203 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.7 tp -105.12 126.51 52.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.487 -0.758 . . . . 0.0 108.971 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.3 t -113.6 123.43 49.93 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.5 mt -112.95 130.2 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.73 139.0 53.9 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.3 -153.24 16.09 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -131.25 153.6 49.35 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.503 -0.998 . . . . 0.0 109.312 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt 57.81 56.54 4.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.493 -0.754 . . . . 0.0 109.82 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.8 mp -93.0 71.91 4.68 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.713 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.114 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 . . . . . 0 N--CA 1.499 1.989 0 CA-C-O 121.206 0.526 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.2 t -127.67 135.97 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -129.79 144.36 51.26 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.298 -0.876 . . . . 0.0 109.844 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 54' ' ' GLU . 39.2 t -135.93 160.0 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.632 -0.667 . . . . 0.0 109.79 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.454 ' N ' HG12 ' A' ' 53' ' ' VAL . 22.4 pt-20 -137.79 142.35 40.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.321 -0.862 . . . . 0.0 109.319 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.24 177.23 29.22 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.521 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -94.77 142.48 27.42 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.434 -1.039 . . . . 0.0 108.859 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.457 ' CG2' HD23 ' A' ' 60' ' ' LEU . 46.4 mm -89.4 121.38 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.292 -0.88 . . . . 0.0 109.692 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -106.58 -29.59 9.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.457 -0.777 . . . . 0.0 109.429 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.602 ' O ' HD22 ' A' ' 60' ' ' LEU . . . -163.42 147.88 10.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.006 . . . . 0.0 109.933 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.602 HD22 ' O ' ' A' ' 59' ' ' ALA . 1.1 mm? -130.36 131.18 45.22 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 54.4 t -131.99 132.95 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.612 0.72 . . . . 0.0 109.638 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.467 ' O ' ' N ' ' A' ' 64' ' ' LEU . 34.2 t80 -144.47 139.33 15.49 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.98 78.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 120.844 1.03 . . . . 0.0 111.596 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.627 ' CD2' ' H ' ' A' ' 64' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.4 mmm-85 -63.12 138.65 58.62 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.22 -0.925 . . . . 0.0 108.651 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -146.35 161.17 40.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.252 -0.905 . . . . 0.0 109.491 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -108.95 136.03 49.15 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.586 HD23 ' N ' ' B' ' 8' ' ' SER . 5.7 tt -122.56 120.68 34.53 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . 0.586 ' N ' HD23 ' B' ' 7' ' ' LEU . 9.2 p -111.42 140.52 45.94 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.576 -0.702 . . . . 0.0 109.303 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.3 tp -148.21 146.49 28.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.259 -0.901 . . . . 0.0 109.505 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.454 HG23 ' O ' ' B' ' 10' ' ' THR . 4.9 t -146.12 117.79 8.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.449 -0.782 . . . . 0.0 109.293 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.24 22.57 0.37 Allowed Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 79.3 t -76.82 132.14 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.084 -1.245 . . . . 0.0 109.775 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -72.83 -43.18 62.98 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.128 -0.983 . . . . 0.0 109.774 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.77 157.89 22.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.961 -1.087 . . . . 0.0 110.088 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 69.6 t -93.17 127.22 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.41 -0.806 . . . . 0.0 109.153 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -96.29 -35.56 11.2 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.97 -1.081 . . . . 0.0 109.368 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 36.4 t -173.06 150.22 1.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 108.85 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . 0.418 ' CZ ' HD13 ' B' ' 23' ' ' ILE . 5.7 t80 -143.24 113.44 7.27 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.106 -0.996 . . . . 0.0 109.147 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -126.34 152.73 74.32 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.18 -17.06 54.04 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.669 1.579 . . . . 0.0 111.446 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -114.47 8.21 16.44 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.567 -0.708 . . . . 0.0 109.447 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -171.74 133.37 0.76 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 109.252 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.418 HD13 ' CZ ' ' B' ' 18' ' ' PHE . 96.7 mt -130.65 129.31 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.194 -0.941 . . . . 0.0 109.784 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 72.6 mt -120.88 119.19 31.94 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 87.9 mt -133.46 131.96 40.51 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.476 -0.765 . . . . 0.0 109.49 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -94.28 118.39 31.52 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.016 -1.052 . . . . 0.0 109.156 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.546 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.9 t -124.39 154.25 40.68 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.421 ' C ' ' O ' ' B' ' 27' ' ' THR . 44.3 mt 37.87 -89.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.901 -0.499 . . . . 0.0 110.456 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.546 ' N ' ' O ' ' B' ' 27' ' ' THR . 15.0 pt20 -151.6 46.2 0.79 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.004 -1.06 . . . . 0.0 109.515 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.95 132.28 2.57 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 90.4 t -84.3 131.32 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -1.09 . . . . 0.0 109.262 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 48.9 tp -104.18 125.22 50.3 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 28.7 t -112.35 120.75 42.77 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 83.7 mt -107.3 130.77 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -124.27 138.86 54.35 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.23 -147.89 8.54 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -135.99 143.27 44.72 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.226 -1.161 . . . . 0.0 109.319 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 54.9 61.2 3.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.956 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.529 HD12 ' N ' ' B' ' 39' ' ' LEU . 10.5 mp -92.95 72.31 4.74 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.187 -0.946 . . . . 0.0 108.805 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.492 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.636 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -144.68 148.07 33.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.27 -0.894 . . . . 0.0 109.508 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 53.8 t -127.08 135.58 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -120.79 131.14 54.31 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.537 -0.727 . . . . 0.0 109.185 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.98 179.19 29.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.436 ' H ' HD23 ' B' ' 56' ' ' LEU . 0.3 OUTLIER -97.95 133.78 41.96 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.404 -1.056 . . . . 0.0 109.187 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.446 HG21 HD23 ' B' ' 60' ' ' LEU . 90.4 mt -90.15 115.3 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.053 . . . . 0.0 109.706 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -99.49 -14.95 18.86 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.4 -0.813 . . . . 0.0 109.676 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.4 152.43 8.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.977 -1.077 . . . . 0.0 110.365 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.446 HD23 HG21 ' B' ' 57' ' ' ILE . 0.3 OUTLIER -134.93 134.73 40.92 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.35 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.404 HG22 HD12 ' A' ' 64' ' ' LEU . 67.5 t -130.03 123.61 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.455 -0.778 . . . . 0.0 109.05 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.444 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 44.2 t80 -146.02 136.85 12.44 Favored Pre-proline 0 N--CA 1.494 1.753 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . 0.444 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 70.9 Cg_endo -74.45 113.73 3.86 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.328 1.352 . . . . 0.0 112.001 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.949 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.51 HD22 ' CB ' ' A' ' 56' ' ' LEU . 1.3 p-10 . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -77.91 144.46 36.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.725 -1.235 . . . . 0.0 108.233 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.576 ' NE2' HD21 ' B' ' 9' ' ' LEU . 39.7 tt0 -146.66 156.23 43.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.121 -0.987 . . . . 0.0 110.263 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -109.13 114.02 27.38 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.525 ' C ' HD23 ' A' ' 7' ' ' LEU . 7.3 tt -113.28 126.47 55.44 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.495 ' N ' HD23 ' A' ' 7' ' ' LEU . 42.0 t -132.1 140.28 48.77 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.401 HD11 HE21 ' B' ' 5' ' ' GLN . 45.0 tp -131.03 148.14 52.71 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 p -125.26 153.38 43.28 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.48 8.54 87.1 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.52 143.84 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.144 -1.209 . . . . 0.0 109.927 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.2 m -73.34 -47.51 41.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.513 -0.742 . . . . 0.0 109.982 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -172.59 172.91 4.13 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.042 -1.036 . . . . 0.0 110.483 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.7 t -101.21 103.83 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -64.1 -40.43 96.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 109.796 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.4 t -158.17 151.87 23.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.341 -0.85 . . . . 0.0 109.323 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -131.14 112.0 12.46 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.57 150.99 77.36 Favored Pre-proline 0 N--CA 1.501 2.114 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.59 -10.63 25.46 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.962 1.775 . . . . 0.0 111.615 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -129.24 11.45 5.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.598 -0.689 . . . . 0.0 109.61 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -169.3 123.2 0.8 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mm -123.2 130.14 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.188 -0.945 . . . . 0.0 109.695 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.2 mt -113.87 129.85 56.55 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.75 124.29 33.11 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.496 -0.753 . . . . 0.0 110.346 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -96.16 123.36 39.75 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' GLN . 2.6 t -125.64 154.04 42.91 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.231 0.539 . . . . 0.0 109.746 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 27' ' ' THR . 46.7 mt 29.3 -85.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-O 121.16 0.505 . . . . 0.0 111.507 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' THR . 13.1 pt20 -144.05 59.54 1.36 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.16 -0.963 . . . . 0.0 110.148 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.9 160.69 28.93 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.0 t -116.35 130.68 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.655 -0.909 . . . . 0.0 109.06 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.449 HD11 HD12 ' A' ' 60' ' ' LEU . 52.3 tp -110.04 126.34 53.88 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.537 -0.727 . . . . 0.0 109.148 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.8 t -110.34 123.13 49.27 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.432 HG12 HD11 ' A' ' 60' ' ' LEU . 96.2 mt -112.39 129.72 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -116.63 140.69 49.11 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.87 -153.98 12.89 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -133.75 146.71 50.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.535 -0.979 . . . . 0.0 109.338 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 55.83 54.98 7.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.72 -0.613 . . . . 0.0 110.159 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.0 mp -90.45 69.15 6.87 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.895 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -178.752 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 121.223 0.535 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.87 141.19 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.64 148.41 50.38 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.468 0.652 . . . . 0.0 110.085 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 75.4 t -136.97 136.3 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.43 128.86 47.65 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.05 -1.032 . . . . 0.0 108.379 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.67 174.84 32.04 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.51 ' CB ' HD22 ' A' ' 3' ' ' ASN . 0.2 OUTLIER -98.32 128.13 44.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.556 -0.967 . . . . 0.0 109.467 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.635 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.7 mp -77.5 133.43 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 0.0 109.76 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -112.82 -26.11 8.72 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.603 ' O ' HD22 ' A' ' 60' ' ' LEU . . . -166.88 154.01 9.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.417 -0.802 . . . . 0.0 110.034 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.603 HD22 ' O ' ' A' ' 59' ' ' ALA . 1.1 mm? -131.1 130.36 43.05 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.5 t -134.56 130.95 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.733 0.777 . . . . 0.0 109.788 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.652 ' O ' ' N ' ' A' ' 64' ' ' LEU . 12.6 t80 -144.7 143.24 20.62 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -49.4 76.33 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.636 0 CA-C-N 120.405 1.18 . . . . 0.0 111.915 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.652 ' N ' ' O ' ' A' ' 62' ' ' TYR . 0.8 OUTLIER . . . . . 0 C--N 1.297 -1.703 0 O-C-N 121.363 -0.836 . . . . 0.0 109.034 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' B' ' 3' ' ' ASN . 9.4 p-10 . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.602 HH21 ' CD ' ' B' ' 54' ' ' GLU . 10.7 mmm180 -49.66 143.63 6.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.519 -0.738 . . . . 0.0 110.031 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . 0.401 HE21 HD11 ' A' ' 9' ' ' LEU . 5.7 pt20 -149.8 162.03 41.07 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.348 0.594 . . . . 0.0 109.476 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -118.18 141.88 48.03 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.579 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.1 tt -131.07 120.26 23.15 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . 0.566 ' N ' HD23 ' B' ' 7' ' ' LEU . 5.5 m -110.73 146.09 36.91 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.576 HD21 ' NE2' ' A' ' 5' ' ' GLN . 5.4 tp -146.92 139.1 24.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.298 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.15 107.57 7.79 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 146.42 -5.81 1.21 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.57 142.18 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.419 -1.048 . . . . 0.0 110.066 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -72.72 -51.56 18.75 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.665 -0.647 . . . . 0.0 109.629 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.15 160.31 6.29 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.124 -0.985 . . . . 0.0 110.297 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . 0.592 HG11 ' CE2' ' B' ' 18' ' ' PHE . 20.6 t -81.39 133.07 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.654 -0.654 . . . . 0.0 109.891 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -88.79 -23.78 22.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.4 -0.813 . . . . 0.0 110.121 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 30.3 t -172.42 151.52 2.5 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.101 -0.999 . . . . 0.0 109.899 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . 0.592 ' CE2' HG11 ' B' ' 15' ' ' VAL . 4.5 m-85 -121.93 104.64 9.68 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.628 -0.67 . . . . 0.0 109.886 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.39 139.34 31.11 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.32 -17.4 35.07 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.815 1.677 . . . . 0.0 111.97 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -95.62 -10.75 28.62 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.322 -0.861 . . . . 0.0 109.472 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -174.75 130.01 0.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.66 129.49 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 62.0 mt -110.07 123.53 49.86 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . 0.404 HD23 HG13 ' B' ' 15' ' ' VAL . 68.6 mt -119.07 131.12 55.91 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.577 -0.702 . . . . 0.0 109.704 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -83.64 104.97 14.18 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.463 ' O ' ' O ' ' B' ' 28' ' ' ILE . 12.9 t -124.87 169.95 11.55 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.73 0.776 . . . . 0.0 110.751 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' B' ' 27' ' ' THR . 8.0 mt -33.0 154.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.344 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 65.38 -60.51 0.26 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.18 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' B' ' 27' ' ' THR . . . -166.71 -168.13 28.43 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.459 -1.353 . . . . 0.0 109.795 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 15.5 t -86.88 135.37 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.405 -1.056 . . . . 0.0 110.146 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 43.0 tp -101.05 119.99 39.55 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 11.5 m -99.6 127.27 45.69 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 86.8 mt -103.95 126.84 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -118.98 144.47 46.47 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.536 0.684 . . . . 0.0 110.075 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.89 -138.05 4.74 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -138.83 139.58 38.23 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.246 -1.149 . . . . 0.0 109.766 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 46.98 73.8 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.686 -0.634 . . . . 0.0 109.834 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.558 HD12 ' N ' ' B' ' 39' ' ' LEU . 9.1 mp -91.89 71.25 5.61 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.068 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.497 1.906 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -130.26 149.6 51.88 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.45 0.643 . . . . 0.0 109.387 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.32 135.42 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.602 ' CD ' HH21 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -116.83 125.39 51.49 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . 0.535 ' N ' ' OE1' ' B' ' 54' ' ' GLU . . . 154.77 176.13 26.66 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.14 132.79 46.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.679 -0.895 . . . . 0.0 109.475 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.621 HD12 ' N ' ' B' ' 57' ' ' ILE . 1.5 mp -87.12 118.81 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.191 -0.943 . . . . 0.0 108.965 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . 0.444 ' OD2' ' NE2' ' A' ' 29' ' ' GLN . 2.2 t70 -112.8 -5.64 13.88 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.621 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -169.05 156.55 7.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.419 -0.801 . . . . 0.0 110.338 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.621 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.4 OUTLIER -139.28 135.87 34.3 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 t -129.97 124.18 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.575 0.702 . . . . 0.0 109.308 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.579 ' O ' HD13 ' B' ' 64' ' ' LEU . 36.0 t80 -146.29 138.16 13.36 Favored Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -70.13 104.66 1.41 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.295 1.33 . . . . 0.0 112.167 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.954 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -64.0 140.06 58.83 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.389 -0.819 . . . . 0.0 108.868 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -154.25 165.44 36.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 0.0 109.881 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -106.09 144.58 32.6 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.609 HD23 ' N ' ' A' ' 8' ' ' SER . 5.6 tt -132.33 121.54 23.69 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.609 ' N ' HD23 ' A' ' 7' ' ' LEU . 4.6 m -114.24 140.97 48.14 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.593 -0.692 . . . . 0.0 109.903 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.584 HD21 ' NE2' ' B' ' 5' ' ' GLN . 4.8 tp -144.79 145.92 31.88 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.8 p -137.23 173.1 12.05 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.371 -0.831 . . . . 0.0 110.102 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 73.51 24.78 74.16 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 12' ' ' VAL . 10.5 p -72.24 130.5 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.254 -1.145 . . . . 0.0 109.817 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -73.03 -43.25 62.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.09 -1.006 . . . . 0.0 109.195 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.25 153.52 4.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 109.591 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.5 t -92.28 117.02 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.848 . . . . 0.0 109.676 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -68.05 -37.44 81.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.48 -0.763 . . . . 0.0 109.508 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.7 t -169.04 169.47 9.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.825 . . . . 0.0 109.456 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.534 ' CD1' HD12 ' A' ' 23' ' ' ILE . 86.3 t80 -145.62 107.18 4.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 109.217 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.484 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -130.03 122.78 20.46 Favored Pre-proline 0 N--CA 1.5 2.035 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -45.66 -30.9 6.79 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.037 1.158 . . . . 0.0 111.618 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -92.97 -6.37 48.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.28 -0.888 . . . . 0.0 109.969 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.525 ' OE2' ' NZ ' ' A' ' 35' ' ' LYS . 34.2 tt0 -163.82 128.28 2.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 109.549 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.534 HD12 ' CD1' ' A' ' 18' ' ' PHE . 46.6 mm -120.44 130.21 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.482 -0.761 . . . . 0.0 109.57 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.3 mt -117.63 130.56 56.45 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.6 mt -133.36 134.53 43.88 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.476 -0.765 . . . . 0.0 109.851 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -108.9 113.17 25.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.602 -0.686 . . . . 0.0 109.166 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 29' ' ' GLN . 2.6 t -125.24 167.38 14.95 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.411 0.624 . . . . 0.0 110.152 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.7 mm 44.95 -87.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.805 -0.56 . . . . 0.0 110.134 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 27' ' ' THR . 27.8 pt20 -158.77 19.54 0.21 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.974 -1.078 . . . . 0.0 108.837 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.02 169.82 21.96 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.3 t -110.89 130.53 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.748 -0.854 . . . . 0.0 109.267 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.1 tp -110.8 123.15 49.52 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.0 m -110.18 120.31 42.04 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.8 mt -102.9 127.27 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.525 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 68.9 mttm -118.22 138.79 52.09 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.656 0.741 . . . . 0.0 109.318 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.98 -147.15 7.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -140.7 143.73 35.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.304 -1.115 . . . . 0.0 108.864 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.7 mttp 55.86 60.27 3.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.603 -0.685 . . . . 0.0 109.904 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.2 mp -92.59 72.21 5.05 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.493 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -178.811 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.491 ' OE1' ' N ' ' A' ' 50' ' ' GLN . 24.0 mp0 . . . . . 0 N--CA 1.498 1.958 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.66 158.76 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.372 -0.83 . . . . 0.0 109.667 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -141.16 149.28 41.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.296 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -124.88 133.41 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -119.07 125.46 49.36 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.36 -175.52 35.48 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -99.11 130.87 45.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.996 . . . . 0.0 109.225 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.1 mt -86.46 117.45 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.074 -1.016 . . . . 0.0 109.161 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -96.77 -23.82 16.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.456 -0.777 . . . . 0.0 109.143 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -170.1 157.49 6.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.986 . . . . 0.0 110.522 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.408 HD13 HD13 ' B' ' 32' ' ' LEU . 10.4 mt -133.01 139.22 47.12 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.2 t -132.07 115.14 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.511 -0.743 . . . . 0.0 109.628 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 62' ' ' TYR . 25.1 t80 -134.34 113.71 12.3 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.52 123.7 14.37 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 CA-C-N 120.06 1.057 . . . . 0.0 111.03 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.887 HD13 ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.062 0 O-C-N 121.128 -0.982 . . . . 0.0 108.712 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 N--CA 1.495 1.818 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 33.2 mmm-85 -74.08 141.35 45.7 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . 0.584 ' NE2' HD21 ' A' ' 9' ' ' LEU . 40.1 tt0 -141.36 147.11 37.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.305 -0.872 . . . . 0.0 109.375 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -117.23 131.55 56.82 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.509 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.1 tt -118.08 124.44 48.07 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . 0.467 ' N ' HD23 ' B' ' 7' ' ' LEU . 78.3 p -115.57 134.67 54.84 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.537 0.684 . . . . 0.0 109.625 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 tp -146.43 143.66 29.16 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -131.26 156.86 44.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.436 -0.79 . . . . 0.0 109.277 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.75 53.9 3.24 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -92.51 139.21 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.088 -1.242 . . . . 0.0 109.833 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -71.7 -42.38 67.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.952 . . . . 0.0 109.136 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -171.73 166.2 6.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.149 -0.969 . . . . 0.0 110.113 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 73.3 t -93.59 99.01 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.331 -0.856 . . . . 0.0 109.13 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -65.5 -40.0 92.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -0.868 . . . . 0.0 109.419 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -169.69 145.48 3.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.13 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -134.52 108.33 8.04 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.533 -0.73 . . . . 0.0 109.672 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -133.81 148.85 70.05 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.61 -12.4 31.22 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 121.706 1.604 . . . . 0.0 111.147 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -104.67 -7.84 19.31 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.522 -0.736 . . . . 0.0 109.539 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -173.74 140.63 0.78 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.463 -0.773 . . . . 0.0 109.158 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.2 130.1 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.383 -0.823 . . . . 0.0 110.438 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.405 ' CD2' ' OG ' ' B' ' 33' ' ' SER . 13.5 mt -122.03 125.41 46.21 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 65.4 mt -132.18 131.62 42.38 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.504 -0.748 . . . . 0.0 109.135 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -88.75 118.75 28.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.895 -1.128 . . . . 0.0 108.602 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.566 ' O ' ' N ' ' B' ' 29' ' ' GLN . 2.2 t -123.8 153.66 40.66 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.709 -0.619 . . . . 0.0 109.974 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' B' ' 27' ' ' THR . 54.8 mt 34.01 -86.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.168 0.509 . . . . 0.0 110.665 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' B' ' 27' ' ' THR . 18.9 pt20 -150.61 39.41 0.72 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.046 -1.034 . . . . 0.0 109.615 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -161.22 130.38 2.33 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 69.7 t -83.42 132.96 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.438 -1.037 . . . . 0.0 109.481 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.408 HD13 HD13 ' A' ' 60' ' ' LEU . 43.5 tp -107.48 128.54 54.59 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.405 ' OG ' ' CD2' ' B' ' 24' ' ' LEU . 25.1 m -111.16 125.49 53.84 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.3 0.572 . . . . 0.0 109.582 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 93.2 mt -106.77 129.86 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -124.72 138.3 54.3 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.467 0.651 . . . . 0.0 109.453 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.57 -146.37 11.29 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -140.51 157.45 45.48 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.281 -1.129 . . . . 0.0 109.624 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.48 57.0 5.17 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.552 0.691 . . . . 0.0 109.783 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.542 HD12 ' N ' ' B' ' 39' ' ' LEU . 8.8 mp -91.7 70.62 5.75 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 C-N-CA 120.305 -0.95 . . . . 0.0 110.941 -178.544 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t . . . . . 0 N--CA 1.499 1.991 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -128.74 148.87 50.88 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 76.3 t -122.64 134.1 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -120.79 134.97 55.27 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.602 -0.686 . . . . 0.0 109.287 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.97 171.84 18.79 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.459 ' H ' HD23 ' B' ' 56' ' ' LEU . 0.1 OUTLIER -87.07 126.13 34.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.368 -1.078 . . . . 0.0 108.768 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.0 mt -88.56 113.08 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.078 -1.014 . . . . 0.0 109.184 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -94.26 -13.82 26.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.453 -0.78 . . . . 0.0 109.559 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -172.14 155.83 3.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.026 -1.046 . . . . 0.0 110.55 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.413 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 14.2 mt -138.62 142.77 39.11 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.402 HG22 HD12 ' A' ' 64' ' ' LEU . 54.1 t -135.72 126.91 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.415 -0.803 . . . . 0.0 109.382 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' B' ' 64' ' ' LEU . 12.0 t80 -141.07 135.89 15.6 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -42.89 82.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.69 1.593 . . . . 0.0 112.722 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.633 ' C ' HD23 ' B' ' 64' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.3 -1.545 0 O-C-N 121.181 -0.95 . . . . 0.0 108.485 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 N--CA 1.502 2.132 0 CA-C-O 121.772 0.796 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 30.4 mmm-85 -81.26 139.42 35.47 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -139.74 163.33 32.89 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.02 -1.05 . . . . 0.0 110.436 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.412 ' CD2' ' HG2' ' A' ' 54' ' ' GLU . 36.7 m-85 -108.73 127.07 53.68 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.301 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.459 ' C ' HD23 ' A' ' 7' ' ' LEU . 6.2 tt -125.71 119.88 29.17 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.416 ' N ' HD23 ' A' ' 7' ' ' LEU . 34.9 t -129.31 151.43 49.97 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.572 0.701 . . . . 0.0 109.927 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.4 tp -142.91 155.72 44.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.429 -0.794 . . . . 0.0 109.549 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.4 p -69.21 170.24 10.53 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.732 0.777 . . . . 0.0 110.804 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -40.07 117.11 0.82 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.572 HG22 ' N ' ' A' ' 13' ' ' SER . 9.1 p -83.51 165.84 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.693 -0.886 . . . . 0.0 110.417 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 12' ' ' VAL . 69.7 m -72.82 -45.43 58.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.0 109.313 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.17 145.12 1.71 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.069 -1.019 . . . . 0.0 109.831 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 80.6 t -89.88 128.24 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.195 -0.941 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -86.55 -22.42 26.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.464 -0.772 . . . . 0.0 110.033 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 t -172.26 157.16 4.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.968 -1.082 . . . . 0.0 109.837 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.484 ' CD1' ' C ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -145.9 105.2 3.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 109.566 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -134.61 147.47 63.37 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.8 -13.68 34.91 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.372 2.048 . . . . 0.0 110.807 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -100.88 -4.63 27.4 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.407 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -178.81 143.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.6 mt -134.53 131.44 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.092 -1.005 . . . . 0.0 109.407 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.3 mt -112.08 127.97 56.06 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.4 mt -124.88 128.05 48.06 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.614 -0.679 . . . . 0.0 109.626 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -103.46 117.0 33.45 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 29' ' ' GLN . 5.5 t -124.03 150.09 45.33 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.945 0.879 . . . . 0.0 110.705 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.4 HD11 ' O ' ' B' ' 3' ' ' ASN . 61.4 mt 47.52 -83.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.359 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.4 pt20 -144.6 -23.04 0.52 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.118 -0.989 . . . . 0.0 109.691 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.6 170.15 32.11 Favored Glycine 0 N--CA 1.498 2.816 0 O-C-N 120.912 -1.118 . . . . 0.0 111.156 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.1 t -120.04 133.5 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.769 -0.842 . . . . 0.0 109.525 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.8 tp -110.12 124.5 51.64 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.4 m -110.64 124.04 51.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.546 -0.721 . . . . 0.0 109.737 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.5 mt -107.75 131.55 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -126.81 139.49 53.07 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.673 0.749 . . . . 0.0 109.456 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.92 -155.71 25.83 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -132.06 148.34 52.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.622 -0.928 . . . . 0.0 109.118 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 61.72 54.6 2.9 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.939 0.876 . . . . 0.0 109.403 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.1 mp -93.2 71.94 4.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.334 -0.854 . . . . 0.0 108.836 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.622 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.643 0.735 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.6 t -120.63 136.98 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.433 0.635 . . . . 0.0 109.359 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -111.86 146.7 37.25 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.4 t -134.11 136.02 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -125.05 134.75 52.41 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.126 0.965 . . . . 0.0 109.535 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.549 ' N ' ' OE1' ' A' ' 54' ' ' GLU . . . 155.37 174.41 25.22 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.401 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -95.44 139.47 31.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.607 -0.937 . . . . 0.0 109.643 -179.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.5 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.5 mp -93.2 111.92 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 108.768 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -98.54 -22.83 15.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.588 -0.695 . . . . 0.0 109.403 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.27 149.45 11.97 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.829 -1.169 . . . . 0.0 110.705 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.432 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 67.4 mt -133.29 135.34 44.82 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 49.2 t -135.55 123.35 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.75 0.786 . . . . 0.0 109.303 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.518 ' O ' HD13 ' A' ' 64' ' ' LEU . 22.8 t80 -137.24 142.13 36.72 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.49 111.65 2.85 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.708 1.605 . . . . 0.0 112.432 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.86 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.4 ' O ' HD11 ' A' ' 28' ' ' ILE . 2.6 p-10 . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 121.497 0.665 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 34.1 mmm-85 -77.59 139.6 39.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.065 -1.022 . . . . 0.0 109.869 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -139.16 156.65 46.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.474 -0.766 . . . . 0.0 109.468 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -112.04 133.91 53.92 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.431 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.1 tt -118.25 125.03 49.3 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 96.2 p -112.71 145.47 40.44 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.829 0.823 . . . . 0.0 109.988 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.2 tp -156.88 156.33 32.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.515 -0.741 . . . . 0.0 109.358 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.9 t -150.44 158.5 44.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.5 -0.75 . . . . 0.0 110.138 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.68 15.21 73.85 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.0 p -54.75 149.53 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -1.188 . . . . 0.0 110.254 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 3.2 t -73.06 -44.01 61.16 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -172.5 166.59 5.64 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.131 -0.981 . . . . 0.0 110.37 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 88.2 t -96.67 99.75 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.543 -0.723 . . . . 0.0 109.145 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -65.28 -48.39 73.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.509 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 32.1 t -168.82 129.26 1.16 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.05 -1.031 . . . . 0.0 109.409 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -112.34 117.27 32.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.51 -0.744 . . . . 0.0 109.276 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.02 151.16 77.43 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.66 -13.41 29.79 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.31 2.006 . . . . 0.0 111.62 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -115.5 -0.38 13.1 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.431 -0.793 . . . . 0.0 109.197 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.83 138.91 1.86 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 109.078 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.56 130.91 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.332 -0.855 . . . . 0.0 110.297 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 19.0 mt -122.2 123.3 41.18 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.479 0.657 . . . . 0.0 109.567 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 94.6 mt -132.41 132.6 42.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.684 -0.635 . . . . 0.0 110.121 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -89.06 121.69 31.65 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.562 ' O ' ' N ' ' B' ' 29' ' ' GLN . 6.8 t -124.89 154.89 40.39 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.479 0.657 . . . . 0.0 110.191 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.424 ' C ' ' O ' ' B' ' 27' ' ' THR . 24.8 mm 30.77 -84.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.578 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' B' ' 27' ' ' THR . 26.2 pt20 -147.03 48.65 1.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.873 -1.142 . . . . 0.0 109.191 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.06 167.31 39.37 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 53.4 t -117.09 134.6 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.384 -1.068 . . . . 0.0 110.155 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 48.1 tp -106.07 125.91 51.57 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 18.4 t -111.67 127.55 55.8 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.579 0.704 . . . . 0.0 109.313 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 81.8 mt -106.84 131.28 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.372 0.606 . . . . 0.0 109.387 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -123.64 142.1 51.37 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.554 0.692 . . . . 0.0 109.463 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.38 -148.56 18.34 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -130.58 147.98 52.32 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.475 -1.015 . . . . 0.0 110.048 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt 61.07 52.11 4.17 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.807 0.813 . . . . 0.0 109.495 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.565 HD12 ' N ' ' B' ' 39' ' ' LEU . 7.5 mp -91.41 72.02 6.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.874 . . . . 0.0 109.287 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . 0.421 ' O ' ' OE1' ' B' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -118.25 136.89 53.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.762 -0.586 . . . . 0.0 109.569 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 53.9 t -127.88 132.03 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' B' ' 54' ' ' GLU . 2.6 mp0 -116.17 145.69 42.89 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.854 0.835 . . . . 0.0 110.205 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.39 170.28 22.1 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.4 ' H ' HD23 ' B' ' 56' ' ' LEU . 0.2 OUTLIER -97.79 110.8 23.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.533 -0.98 . . . . 0.0 108.956 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.618 HD12 ' N ' ' B' ' 57' ' ' ILE . 2.1 mp -75.93 122.33 29.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.059 -1.026 . . . . 0.0 108.957 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -105.04 -22.38 13.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.541 -0.725 . . . . 0.0 109.131 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.22 150.82 16.86 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.75 -1.219 . . . . 0.0 110.659 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 17.2 mt -132.99 146.77 52.07 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.422 -0.799 . . . . 0.0 109.677 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 55.9 t -137.7 115.69 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.364 -0.835 . . . . 0.0 110.233 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.432 ' CG ' ' HB2' ' A' ' 60' ' ' LEU . 59.1 t80 -138.26 104.11 7.94 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -43.32 105.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.209 1.939 . . . . 0.0 112.428 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 1.0 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.503 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.588 HD22 ' HB3' ' A' ' 56' ' ' LEU . 2.8 p-10 . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.5 mmm-85 -69.21 142.58 54.21 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.291 -0.88 . . . . 0.0 108.916 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.549 ' NE2' HD21 ' B' ' 9' ' ' LEU . 50.1 tt0 -145.94 150.32 35.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.0 109.674 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.527 ' CD2' ' OE1' ' A' ' 54' ' ' GLU . 77.1 m-85 -103.12 145.25 30.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.565 -0.71 . . . . 0.0 109.3 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 7' ' ' LEU . 7.0 tt -140.8 124.25 16.8 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.457 ' N ' HD23 ' A' ' 7' ' ' LEU . 41.3 t -128.98 135.36 48.87 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.28 -0.887 . . . . 0.0 108.742 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.0 tp -146.48 154.34 41.46 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.077 -1.014 . . . . 0.0 109.336 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 t -144.0 164.24 31.19 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.256 -0.903 . . . . 0.0 109.383 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.68 18.53 51.43 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.9 t -66.25 137.71 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.284 -1.127 . . . . 0.0 110.236 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 m -72.19 -42.93 65.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.549 -0.719 . . . . 0.0 109.929 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.92 160.65 10.31 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.881 -1.137 . . . . 0.0 110.343 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.6 t -93.08 129.15 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.499 -0.75 . . . . 0.0 110.222 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -100.06 -35.69 9.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.436 -0.79 . . . . 0.0 108.939 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.0 t -173.02 144.3 1.24 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 0.0 109.559 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -129.81 107.83 9.7 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -133.67 148.99 70.8 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.94 -11.71 31.13 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.839 1.693 . . . . 0.0 111.792 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -108.97 -5.63 16.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.343 -0.848 . . . . 0.0 110.149 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -172.01 127.4 0.59 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.977 -1.077 . . . . 0.0 108.936 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.47 126.83 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.259 -0.901 . . . . 0.0 109.459 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.9 mt -118.79 110.76 17.62 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.1 mt -129.81 132.56 46.54 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.256 -0.903 . . . . 0.0 109.143 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -94.12 113.58 25.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.237 -0.914 . . . . 0.0 109.899 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 28' ' ' ILE . 4.4 t -124.36 147.67 48.05 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.835 0.826 . . . . 0.0 109.615 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.457 ' C ' ' O ' ' A' ' 27' ' ' THR . 37.4 mt 21.0 -96.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.238 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.411 ' CG ' ' O ' ' B' ' 57' ' ' ILE . 77.0 mm-40 -46.62 -73.76 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.494 -0.754 . . . . 0.0 111.596 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.96 -143.83 3.78 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 119.573 -1.298 . . . . 0.0 111.473 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 t -89.31 134.97 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.65 -0.912 . . . . 0.0 111.39 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.0 tp -112.82 120.46 41.54 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.1 m -108.73 124.55 50.73 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.6 mt -112.45 130.41 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -117.47 143.72 45.76 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.578 -0.701 . . . . 0.0 109.65 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.94 -148.34 13.59 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -136.29 152.05 50.28 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.316 -1.108 . . . . 0.0 109.517 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 54' ' ' GLU . 53.5 mtmt 56.16 52.11 10.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.552 -0.718 . . . . 0.0 110.142 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.5 mp -92.32 72.49 5.3 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.104 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.369 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.9 t -116.15 131.86 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -118.86 130.51 55.78 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.8 t -127.34 133.89 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.501 -0.749 . . . . 0.0 109.068 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.527 ' OE1' ' CD2' ' A' ' 6' ' ' PHE . 17.3 tp10 -122.05 137.31 54.85 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 155.0 173.37 23.69 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.588 ' HB3' HD22 ' A' ' 3' ' ' ASN . 0.2 OUTLIER -96.91 140.55 31.29 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.416 -1.049 . . . . 0.0 109.599 -179.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.536 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.7 mp -97.24 116.48 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.372 -0.83 . . . . 0.0 108.953 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -95.12 -18.97 20.5 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -171.42 151.45 3.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 0.0 109.764 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 mt -126.7 137.29 53.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.505 -0.747 . . . . 0.0 109.11 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.3 t -133.94 127.22 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.366 -0.834 . . . . 0.0 109.088 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.565 ' O ' ' N ' ' A' ' 64' ' ' LEU . 48.0 t80 -138.22 107.96 8.06 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -45.26 81.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.739 1.626 . . . . 0.0 112.479 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.946 HD12 HG22 ' B' ' 61' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 O-C-N 120.371 -1.456 . . . . 0.0 108.958 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.524 HD22 ' CB ' ' B' ' 56' ' ' LEU . 6.0 p-10 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -72.41 134.39 45.38 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.212 -0.93 . . . . 0.0 109.393 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -148.89 163.44 37.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.239 -0.913 . . . . 0.0 109.769 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -104.31 148.74 26.03 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.446 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.1 tt -135.64 118.66 16.4 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 28.6 t -111.49 131.08 55.48 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.428 -0.795 . . . . 0.0 109.335 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.549 HD21 ' NE2' ' A' ' 5' ' ' GLN . 3.1 tp -148.85 153.86 38.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.96 -1.088 . . . . 0.0 110.059 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 12.7 t -154.45 -167.03 2.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.829 . . . . 0.0 109.529 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.59 19.52 62.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.4 145.26 13.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.283 -1.128 . . . . 0.0 110.15 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 24.1 m -71.97 -43.13 65.67 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.27 -0.893 . . . . 0.0 108.941 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . 0.426 ' HB2' ' HZ2' ' B' ' 14' ' ' LYS . 0.0 OUTLIER -171.17 159.6 5.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.349 -0.844 . . . . 0.0 109.501 179.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.15 107.33 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.162 -0.961 . . . . 0.0 109.935 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -66.14 -40.57 90.71 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.239 -0.913 . . . . 0.0 109.067 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 23.1 t -172.26 162.42 5.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.09 -1.006 . . . . 0.0 109.147 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -140.25 110.41 6.57 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.327 -0.858 . . . . 0.0 109.76 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.97 148.01 67.72 Favored Pre-proline 0 N--CA 1.495 1.779 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.67 -9.81 27.07 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.851 1.701 . . . . 0.0 111.996 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -118.19 7.52 12.14 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.547 -0.721 . . . . 0.0 109.776 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -171.05 132.45 0.84 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.932 . . . . 0.0 109.194 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 47.0 mm -121.75 125.88 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.475 -0.765 . . . . 0.0 109.279 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 74.5 mt -119.89 113.14 20.12 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -131.64 140.31 49.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.329 -0.857 . . . . 0.0 109.303 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -107.63 117.77 34.98 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.569 ' O ' ' N ' ' B' ' 29' ' ' GLN . 3.7 t -125.01 153.01 43.48 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.417 0.627 . . . . 0.0 110.041 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.406 HD13 ' N ' ' B' ' 28' ' ' ILE . 5.4 mm 53.39 -78.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.872 -0.518 . . . . 0.0 110.193 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' B' ' 27' ' ' THR . 22.0 pt20 -169.5 52.4 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -171.53 140.08 5.69 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 92.4 t -84.27 132.48 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.378 -1.072 . . . . 0.0 109.515 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.428 HD11 HD12 ' B' ' 60' ' ' LEU . 47.6 tp -111.26 123.12 49.56 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 24.0 m -109.87 119.63 39.96 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.325 -0.859 . . . . 0.0 109.076 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 95.9 mt -109.91 129.31 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -117.86 137.46 52.76 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.92 -152.72 10.4 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -134.22 145.37 49.11 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.307 -1.114 . . . . 0.0 109.608 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' B' ' 54' ' ' GLU . 72.4 mmtt 59.43 52.02 6.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.568 -0.707 . . . . 0.0 110.058 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.555 HD12 ' N ' ' B' ' 39' ' ' LEU . 10.4 mp -88.45 72.04 8.91 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.952 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -178.547 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -122.04 147.35 46.2 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -126.69 135.33 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' B' ' 38' ' ' LYS . 47.7 tt0 -119.2 133.03 55.99 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.86 -178.69 34.04 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.524 ' CB ' HD22 ' B' ' 3' ' ' ASN . 0.2 OUTLIER -103.03 126.43 50.2 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.451 -1.029 . . . . 0.0 109.806 -179.625 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.554 HD12 ' N ' ' B' ' 57' ' ' ILE . 1.4 mp -76.9 126.1 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.962 . . . . 0.0 109.198 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -104.95 -23.28 13.0 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.618 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -169.26 153.28 5.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.055 -1.028 . . . . 0.0 110.019 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.618 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.9 OUTLIER -131.19 134.16 46.22 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.946 HG22 HD12 ' A' ' 64' ' ' LEU . 4.1 t -135.43 124.72 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.786 -0.571 . . . . 0.0 110.033 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.463 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 17.9 t80 -144.19 140.32 16.77 Favored Pre-proline 0 N--CA 1.493 1.712 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . 0.463 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 72.6 Cg_endo -74.46 108.48 2.7 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.538 1.492 . . . . 0.0 112.082 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.96 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.535 -0.728 . . . . 0.0 109.164 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 41.5 mmm-85 -60.48 141.29 56.65 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.327 -0.858 . . . . 0.0 108.785 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -152.19 161.93 41.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.125 -0.984 . . . . 0.0 109.917 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 1.2 m-85 -117.89 139.62 50.87 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.493 ' C ' HD23 ' A' ' 7' ' ' LEU . 7.2 tt -115.8 126.06 53.52 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.393 -0.817 . . . . 0.0 108.996 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.476 ' N ' HD23 ' A' ' 7' ' ' LEU . 32.4 t -115.25 126.75 54.9 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.4 tp -144.63 151.77 39.5 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 t -143.15 166.84 23.56 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.278 -0.889 . . . . 0.0 109.631 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.4 10.95 67.33 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -69.97 145.23 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -1.219 . . . . 0.0 110.028 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 m -73.87 -51.97 14.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.361 -0.837 . . . . 0.0 109.529 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.43 ' HB2' ' HZ2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -167.37 158.69 11.88 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.067 -1.021 . . . . 0.0 109.619 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.7 t -89.27 116.01 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.268 -0.895 . . . . 0.0 109.403 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -69.19 -40.89 77.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 109.7 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.1 t -161.83 125.28 3.14 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.369 -0.832 . . . . 0.0 109.844 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -109.25 110.19 21.32 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -133.61 148.05 67.07 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.16 -20.1 50.14 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.715 1.61 . . . . 0.0 111.604 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -100.14 -5.44 27.79 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.341 -0.849 . . . . 0.0 109.671 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.403 ' OE2' ' NZ ' ' A' ' 35' ' ' LYS . 36.2 tt0 -171.32 142.91 1.77 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.208 -0.932 . . . . 0.0 109.603 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.8 mt -131.2 130.04 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.715 -0.616 . . . . 0.0 109.497 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.8 mt -117.28 125.75 51.61 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.3 mt -121.1 130.09 53.59 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.591 -0.693 . . . . 0.0 109.647 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.403 ' HG2' HG22 ' A' ' 31' ' ' VAL . 29.4 mt-10 -97.68 103.54 15.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.357 -0.839 . . . . 0.0 110.011 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 28' ' ' ILE . 6.6 t -127.18 -172.47 2.66 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.951 0.882 . . . . 0.0 110.562 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' THR . 4.2 mt -31.84 154.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.924 0.868 . . . . 0.0 111.244 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 64.49 -56.17 0.26 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.646 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -173.4 -129.48 1.16 Allowed Glycine 0 N--CA 1.487 2.059 0 C-N-CA 119.234 -1.46 . . . . 0.0 109.944 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.403 HG22 ' HG2' ' A' ' 26' ' ' GLU . 52.7 t -120.72 136.14 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.778 0.799 . . . . 0.0 110.862 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.9 tp -104.61 126.85 52.09 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -100.8 125.51 47.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.632 -0.668 . . . . 0.0 109.512 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.3 mt -111.3 128.54 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-O 121.294 0.569 . . . . 0.0 109.513 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.403 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 68.5 mttm -128.27 144.24 51.11 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.453 0.644 . . . . 0.0 109.629 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.9 -137.69 4.31 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -132.57 153.3 51.13 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.193 -1.181 . . . . 0.0 110.232 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 54' ' ' GLU . 98.9 mttt 49.72 40.64 20.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.619 -0.676 . . . . 0.0 110.135 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.3 mp -68.51 72.23 0.21 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 0.0 109.244 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.676 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.869 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 52' ' ' GLU . 40.6 t -131.44 161.16 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.56 -0.712 . . . . 0.0 109.231 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.483 ' N ' HG12 ' A' ' 51' ' ' VAL . 92.5 mt-10 -132.83 160.03 38.1 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.529 0.681 . . . . 0.0 109.673 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 t -128.84 157.82 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 38' ' ' LYS . 32.1 tt0 -135.37 134.56 39.89 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.6 172.14 13.18 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 pp -97.46 134.94 40.03 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.438 -1.037 . . . . 0.0 109.169 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.3 mp -84.95 113.69 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.845 -1.16 . . . . 0.0 108.664 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -98.74 -22.19 16.0 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -159.47 148.57 18.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.315 -0.866 . . . . 0.0 110.298 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.49 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 51.5 mt -133.97 146.36 50.38 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.5 t -146.53 114.83 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.059 -1.025 . . . . 0.0 109.869 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.532 ' O ' ' N ' ' A' ' 64' ' ' LEU . 13.8 t80 -130.28 142.52 45.73 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -44.87 85.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.34 1.36 . . . . 0.0 111.916 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.647 ' O ' HD23 ' A' ' 64' ' ' LEU . 2.1 tt . . . . . 0 N--CA 1.492 1.653 0 O-C-N 120.817 -1.177 . . . . 0.0 108.525 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.501 HD22 ' CB ' ' B' ' 56' ' ' LEU . 2.7 p-10 . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 43.5 mmm-85 -89.39 131.46 35.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.964 -1.085 . . . . 0.0 109.128 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -144.52 159.01 43.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.288 -0.882 . . . . 0.0 109.903 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.9 115.17 29.65 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.437 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.6 tt -113.8 126.77 55.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.407 -0.808 . . . . 0.0 109.061 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . 0.401 ' N ' HD23 ' B' ' 7' ' ' LEU . 40.7 t -132.47 143.76 50.0 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.418 ' O ' HG12 ' B' ' 51' ' ' VAL . 52.0 tp -133.64 150.09 51.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.527 -0.733 . . . . 0.0 109.154 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.6 p -129.3 171.12 12.8 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.704 -0.623 . . . . 0.0 109.35 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.52 5.46 63.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.04 135.32 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.339 -1.095 . . . . 0.0 109.695 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.3 t -72.56 -46.12 55.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 109.55 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.03 160.78 5.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.179 -0.95 . . . . 0.0 109.55 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 90.4 t -93.6 121.27 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.189 -0.944 . . . . 0.0 109.218 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -66.7 -40.03 88.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 109.545 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 47.7 t -162.43 149.77 13.75 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.43 -0.794 . . . . 0.0 108.889 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -136.24 117.85 14.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.377 -0.827 . . . . 0.0 109.491 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -132.45 150.81 76.94 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.06 -13.81 41.19 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.502 1.468 . . . . 0.0 111.07 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -118.2 3.12 12.01 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.749 -0.594 . . . . 0.0 109.603 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -170.03 134.43 1.27 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.269 -0.894 . . . . 0.0 109.409 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.2 mt -132.24 129.54 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.279 -0.888 . . . . 0.0 109.46 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 74.8 mt -112.34 125.64 54.41 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 87.1 mt -113.21 132.44 55.5 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.53 -0.731 . . . . 0.0 110.121 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -104.66 101.12 10.77 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.567 ' O ' ' N ' ' B' ' 29' ' ' GLN . 0.0 OUTLIER -108.73 148.86 29.84 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.822 -0.549 . . . . 0.0 110.447 -178.353 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' B' ' 27' ' ' THR . 39.9 mt 34.2 -86.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 122.151 -0.343 . . . . 0.0 110.83 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.567 ' N ' ' O ' ' B' ' 27' ' ' THR . 18.5 pt20 -137.49 -16.05 1.38 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.382 -0.824 . . . . 0.0 109.738 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.32 167.85 29.21 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 54.6 t -123.1 131.51 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 43.5 tp -110.76 126.18 54.32 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 19.1 t -106.69 122.8 47.08 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 94.9 mt -105.73 129.29 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -124.13 141.39 52.09 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.628 -0.67 . . . . 0.0 109.379 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.23 -153.42 22.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -121.45 150.85 40.95 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.571 -0.958 . . . . 0.0 109.847 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' B' ' 54' ' ' GLU . 95.3 mttt 51.93 61.68 3.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -0.8 . . . . 0.0 110.124 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.406 ' N ' HD12 ' B' ' 39' ' ' LEU . 9.2 mp -93.05 71.56 4.63 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.764 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -179.11 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.418 HG12 ' O ' ' B' ' 9' ' ' LEU . 2.2 p . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 121.563 0.696 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -122.1 149.78 43.1 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 10.2 t -141.45 138.22 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.163 -0.961 . . . . 0.0 109.545 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' B' ' 38' ' ' LYS . 16.0 tt0 -127.62 137.59 52.59 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.61 178.36 26.29 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.501 ' CB ' HD22 ' B' ' 3' ' ' ASN . 0.2 OUTLIER -99.82 124.46 45.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.572 -0.958 . . . . 0.0 108.929 179.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.586 HD12 ' N ' ' B' ' 57' ' ' ILE . 1.5 mp -82.82 119.25 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.181 -0.949 . . . . 0.0 108.895 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -95.26 -21.46 18.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.386 -0.821 . . . . 0.0 109.488 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -170.29 153.5 4.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.117 -0.989 . . . . 0.0 109.8 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.413 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 96.2 mt -134.04 136.58 44.11 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 56.7 t -132.64 124.81 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.554 -0.716 . . . . 0.0 109.459 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.49 ' CG ' ' HB2' ' A' ' 60' ' ' LEU . 19.4 t80 -133.01 139.71 35.3 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . 0.477 ' O ' ' C ' ' B' ' 64' ' ' LEU . 71.6 Cg_exo -44.5 -65.49 0.19 Allowed 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 122.026 1.818 . . . . 0.0 115.294 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.835 HD13 ' O ' ' B' ' 64' ' ' LEU . 2.0 tm? . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.622 0.725 . . . . 0.0 111.002 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.451 HD22 ' HB3' ' A' ' 56' ' ' LEU . 1.9 p-10 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.343 0.592 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.431 ' NE ' ' OE2' ' A' ' 54' ' ' GLU . 40.1 mmm-85 -71.23 147.89 47.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 109.126 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -141.37 156.86 45.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.187 -0.945 . . . . 0.0 109.996 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.51 ' CE1' ' OE1' ' A' ' 54' ' ' GLU . 69.6 m-85 -107.21 125.74 51.51 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 7' ' ' LEU . 7.3 tt -117.92 124.97 49.56 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.423 ' N ' HD23 ' A' ' 7' ' ' LEU . 44.2 t -115.94 135.1 54.3 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.639 -0.663 . . . . 0.0 109.633 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.4 tp -145.4 148.95 33.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.442 -0.786 . . . . 0.0 109.565 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 p -142.76 -163.14 1.56 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.81 . . . . 0.0 109.717 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.62 17.97 7.2 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.65 141.72 16.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.165 -1.197 . . . . 0.0 109.939 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.2 m -71.43 -45.16 63.39 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.53 154.68 0.8 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.186 -0.946 . . . . 0.0 110.384 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.0 t -77.2 132.32 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.544 -0.722 . . . . 0.0 110.382 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.526 ' OE1' HG21 ' A' ' 31' ' ' VAL . 45.3 tt0 -98.5 -34.66 10.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.49 -0.756 . . . . 0.0 108.968 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 p -161.54 163.28 30.27 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.016 -1.053 . . . . 0.0 109.683 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -148.96 104.77 3.47 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -133.85 125.85 18.5 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -47.14 -22.51 2.29 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.857 1.705 . . . . 0.0 111.868 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -94.25 -9.01 37.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.578 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -174.32 143.28 0.85 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 109.315 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.1 mt -128.38 131.35 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.353 -0.842 . . . . 0.0 109.007 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.1 mt -116.69 115.71 26.18 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.2 mt -117.79 130.43 56.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.569 -0.707 . . . . 0.0 109.637 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.07 103.16 11.5 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 28' ' ' ILE . 7.0 t -124.28 -177.96 3.95 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.586 0.708 . . . . 0.0 110.132 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 27' ' ' THR . 3.8 mt -31.91 153.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.765 0.793 . . . . 0.0 110.847 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 64.05 -63.26 0.15 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.504 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -161.85 -123.18 0.65 Allowed Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.191 -1.48 . . . . 0.0 110.014 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.526 HG21 ' OE1' ' A' ' 16' ' ' GLN . 55.8 t -120.58 135.88 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.668 -0.901 . . . . 0.0 109.727 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.7 tp -100.27 125.23 46.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.603 -0.685 . . . . 0.0 109.205 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.1 m -104.47 121.57 43.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 0.0 108.94 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.9 mt -110.73 127.42 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -117.48 147.96 42.27 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.453 0.644 . . . . 0.0 110.1 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.95 -149.65 12.14 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -136.38 145.92 45.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.346 -1.09 . . . . 0.0 109.472 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 54.99 57.65 5.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.545 -0.722 . . . . 0.0 110.092 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.6 mp -89.65 71.73 7.8 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.132 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.038 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.2 t -126.94 134.66 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.574 -0.704 . . . . 0.0 109.261 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -118.41 153.01 34.79 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.716 -0.615 . . . . 0.0 109.624 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.7 t -124.66 135.56 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.51 ' OE1' ' CE1' ' A' ' 6' ' ' PHE . 16.4 tp10 -113.38 127.12 56.02 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.56 169.06 21.58 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -90.91 140.8 29.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.415 -1.05 . . . . 0.0 109.744 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.435 ' CG2' HD23 ' A' ' 60' ' ' LEU . 92.9 mt -93.82 115.17 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.991 -1.068 . . . . 0.0 109.714 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -98.64 -24.21 15.17 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.82 151.81 18.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.903 -1.123 . . . . 0.0 111.091 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.435 HD23 ' CG2' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -130.1 131.7 45.84 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.249 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 54.9 t -129.75 128.88 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.682 0.753 . . . . 0.0 109.588 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 64' ' ' LEU . 12.0 t80 -144.9 142.13 18.27 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -49.08 78.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.589 1.526 . . . . 0.0 111.968 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.638 ' C ' HD23 ' A' ' 64' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.302 -1.472 0 O-C-N 121.38 -0.825 . . . . 0.0 109.193 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -85.31 138.54 32.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.087 -1.008 . . . . 0.0 109.458 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -141.8 153.22 44.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 109.898 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -108.12 119.23 38.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.564 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.4 tt -108.09 121.67 45.3 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . 0.545 ' N ' HD23 ' B' ' 7' ' ' LEU . 8.2 p -114.78 137.25 52.17 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.354 0.597 . . . . 0.0 109.995 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.8 tp -149.3 148.31 29.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.546 -0.721 . . . . 0.0 109.306 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -142.42 164.59 29.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.274 -0.891 . . . . 0.0 110.256 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.98 21.02 58.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 p -59.5 142.29 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.117 -1.225 . . . . 0.0 110.432 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 15.1 m -72.86 -39.99 66.04 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -172.26 163.91 5.83 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.12 -0.988 . . . . 0.0 110.01 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 85.7 t -96.84 99.8 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.425 -0.797 . . . . 0.0 109.555 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -65.53 -39.22 91.52 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.313 -0.867 . . . . 0.0 109.128 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 47.0 t -172.67 152.33 2.52 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.27 -0.893 . . . . 0.0 109.318 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -133.81 107.98 8.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.557 -0.714 . . . . 0.0 109.259 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.93 145.79 57.32 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.6 -19.13 42.58 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.973 1.782 . . . . 0.0 111.426 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -98.52 -7.0 29.1 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -173.38 131.98 0.47 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.368 -0.833 . . . . 0.0 109.352 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.72 128.69 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.447 -0.783 . . . . 0.0 109.28 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 62.9 mt -118.45 121.88 41.38 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 88.8 mt -132.28 130.58 41.07 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -93.62 127.86 39.51 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.211 -0.931 . . . . 0.0 109.101 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.59 ' O ' ' N ' ' B' ' 29' ' ' GLN . 5.4 t -124.39 149.05 47.13 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.373 0.606 . . . . 0.0 109.47 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.411 ' N ' HD13 ' B' ' 28' ' ' ILE . 5.9 mm 48.05 -81.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.049 0.452 . . . . 0.0 110.321 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' B' ' 27' ' ' THR . 11.4 pt20 -149.03 -21.21 0.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.052 -1.03 . . . . 0.0 109.359 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.67 165.14 25.7 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 120.987 -1.071 . . . . 0.0 110.509 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.63 130.6 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.609 -0.936 . . . . 0.0 109.488 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 50.9 tp -106.98 126.04 51.8 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 71.0 m -111.27 117.31 32.8 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 89.6 mt -100.77 128.04 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -124.68 136.82 54.23 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.51 -149.01 9.79 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -133.83 148.63 51.33 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.513 -0.992 . . . . 0.0 109.813 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 56.23 57.96 4.63 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.732 0.777 . . . . 0.0 109.747 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.505 HD12 ' N ' ' B' ' 39' ' ' LEU . 9.9 mp -91.34 72.03 6.12 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.386 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.72 159.88 40.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.658 -0.652 . . . . 0.0 109.381 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 99.3 t -127.73 138.25 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -117.96 138.47 52.15 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.17 -179.49 30.33 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.58 124.45 43.36 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.399 -1.059 . . . . 0.0 109.793 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.534 HD12 ' N ' ' B' ' 57' ' ' ILE . 1.3 mp -77.83 126.41 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.488 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -109.38 -19.14 13.38 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.647 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -166.15 152.25 9.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.927 -1.108 . . . . 0.0 110.305 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.647 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.6 OUTLIER -134.19 129.56 35.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.569 -0.707 . . . . 0.0 109.176 179.423 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.0 t -126.59 128.41 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.578 ' O ' HD13 ' B' ' 64' ' ' LEU . 45.4 t80 -144.02 101.47 4.9 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -46.62 89.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.111 1.874 . . . . 0.0 112.582 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.903 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.4 0 O-C-N 121.311 -0.868 . . . . 0.0 109.292 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 15.5 p-10 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.829 0.823 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -71.4 138.62 49.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.172 -0.955 . . . . 0.0 109.911 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -146.27 154.99 42.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.293 -0.88 . . . . 0.0 110.005 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 8.1 m-85 -110.75 121.1 44.5 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.526 ' C ' HD23 ' A' ' 7' ' ' LEU . 6.9 tt -114.08 124.58 52.46 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.509 -0.744 . . . . 0.0 109.223 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.523 ' N ' HD23 ' A' ' 7' ' ' LEU . 23.8 p -125.41 149.56 48.07 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.778 0.799 . . . . 0.0 109.558 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.621 HD11 ' NE2' ' B' ' 5' ' ' GLN . 36.6 tp -147.8 144.45 28.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.45 -0.781 . . . . 0.0 109.511 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -125.99 164.38 20.94 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.714 0.768 . . . . 0.0 110.169 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.54 17.04 71.94 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.34 134.78 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -1.168 . . . . 0.0 110.438 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -72.68 -45.08 60.69 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.543 -0.723 . . . . 0.0 109.074 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.12 160.46 4.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.445 -0.785 . . . . 0.0 109.976 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.8 t -91.62 110.93 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.578 0.704 . . . . 0.0 109.873 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -68.55 -38.32 80.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.45 -0.781 . . . . 0.0 109.595 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.2 t -162.61 156.17 20.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.876 -1.14 . . . . 0.0 110.383 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -141.66 105.57 4.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.98 147.74 66.61 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.74 -18.0 42.16 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.447 2.098 . . . . 0.0 111.274 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -102.16 -9.12 20.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.43 -0.794 . . . . 0.0 109.344 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -171.83 133.68 0.76 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.212 -0.93 . . . . 0.0 109.704 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.1 mt -126.45 130.07 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.428 -0.795 . . . . 0.0 110.135 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.0 mt -116.27 125.89 52.82 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.7 mt -121.15 130.42 53.71 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.715 0.769 . . . . 0.0 109.466 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -98.01 113.69 25.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.6 -0.688 . . . . 0.0 109.556 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.549 ' O ' ' N ' ' A' ' 29' ' ' GLN . 9.0 t -124.65 157.6 35.14 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.941 0.877 . . . . 0.0 110.097 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.407 HD12 ' HB2' ' B' ' 3' ' ' ASN . 14.6 mm 38.2 -85.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.287 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.549 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.8 pp0? -142.62 -17.02 0.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.95 -1.094 . . . . 0.0 108.873 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.06 175.24 24.91 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.1 t -125.6 133.45 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.781 -0.835 . . . . 0.0 109.602 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.1 tp -102.76 128.31 49.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.621 -0.675 . . . . 0.0 109.51 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -112.85 126.79 55.83 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.823 0.82 . . . . 0.0 110.166 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.6 mt -108.98 130.25 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -124.84 140.49 52.88 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.575 0.703 . . . . 0.0 109.446 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.06 -145.75 9.42 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -134.53 144.52 48.06 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.463 -1.021 . . . . 0.0 109.362 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.8 mttp 55.48 61.22 2.95 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.834 0.826 . . . . 0.0 109.695 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.5 mp -92.56 71.64 5.05 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.912 0.863 . . . . 0.0 109.062 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.221 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.1 m -117.0 158.37 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.618 0.723 . . . . 0.0 109.848 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -141.52 140.11 33.4 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.9 t -125.81 134.89 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.591 -0.693 . . . . 0.0 109.423 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -117.18 125.88 51.89 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.04 174.6 30.03 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.164 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.547 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -91.35 128.76 37.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.667 -0.902 . . . . 0.0 110.092 -179.365 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.4 mp -78.74 125.96 38.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.435 -0.791 . . . . 0.0 109.126 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -112.19 -29.97 7.38 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.473 ' O ' HD22 ' A' ' 60' ' ' LEU . . . -166.38 137.84 3.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.028 -1.045 . . . . 0.0 110.812 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.473 HD22 ' O ' ' A' ' 59' ' ' ALA . 3.1 mm? -117.14 135.51 53.7 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.78 129.48 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.867 0.841 . . . . 0.0 110.075 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -145.47 137.84 13.51 Favored Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.02 108.42 2.12 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.788 1.658 . . . . 0.0 112.543 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.979 HD13 ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.245 -0.909 . . . . 0.0 109.095 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' B' ' 4' ' ' ARG . 52.8 p-10 . . . . . 0 N--CA 1.5 2.037 0 CA-C-O 121.549 0.69 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.543 ' N ' ' OD1' ' B' ' 3' ' ' ASN . 45.0 mmm-85 -50.46 136.78 20.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.192 -0.942 . . . . 0.0 110.682 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . 0.621 ' NE2' HD11 ' A' ' 9' ' ' LEU . 2.3 pt20 -146.37 155.81 42.87 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.335 -0.853 . . . . 0.0 109.551 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' B' ' 6' ' ' PHE . 30.3 m-85 -115.04 121.64 43.71 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.635 HD23 ' N ' ' B' ' 8' ' ' SER . 6.4 tt -118.43 122.79 43.63 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . 0.635 ' N ' HD23 ' B' ' 7' ' ' LEU . 29.8 t -119.01 134.76 55.0 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.511 0.672 . . . . 0.0 109.825 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 48.9 tp -131.61 144.91 51.4 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.8 p -128.09 164.0 23.39 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.701 0.762 . . . . 0.0 110.26 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.33 20.06 61.19 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 p -67.39 135.71 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.187 -1.184 . . . . 0.0 110.01 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 56.2 m -72.45 -43.65 63.47 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.421 -0.8 . . . . 0.0 109.25 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.98 162.28 3.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.385 -0.822 . . . . 0.0 110.278 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.2 t -89.98 111.24 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.519 0.676 . . . . 0.0 110.066 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -67.2 -38.91 86.13 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.881 0.848 . . . . 0.0 108.791 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 30.1 t -168.89 166.37 11.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 0.0 109.655 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -145.48 104.7 3.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.37 -0.831 . . . . 0.0 109.513 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' B' ' 22' ' ' GLU . 13.7 m-20 -133.92 125.94 18.48 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.62 -26.27 16.63 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.824 1.683 . . . . 0.0 111.503 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -88.59 -5.05 58.42 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.708 0.766 . . . . 0.0 109.379 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' B' ' 19' ' ' ASP . 32.9 tt0 -176.35 132.99 0.23 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.517 -0.74 . . . . 0.0 109.399 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 93.5 mt -123.09 128.1 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.45 -0.781 . . . . 0.0 109.481 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 mt -117.84 129.07 55.44 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.361 0.601 . . . . 0.0 109.463 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 86.3 mt -131.03 131.87 44.58 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.665 0.745 . . . . 0.0 109.873 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -95.4 114.46 26.24 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.616 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.3 t -125.53 153.77 43.13 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.439 0.638 . . . . 0.0 110.114 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 14.0 mm 46.3 -78.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-O 121.558 0.694 . . . . 0.0 110.91 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.616 ' N ' ' O ' ' B' ' 27' ' ' THR . 13.3 pt20 -151.89 -22.84 0.19 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.161 -0.962 . . . . 0.0 109.118 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.94 176.17 29.29 Favored Glycine 0 N--CA 1.5 2.944 0 O-C-N 120.993 -1.067 . . . . 0.0 110.624 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 56.0 t -121.13 134.65 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.6 -0.941 . . . . 0.0 109.442 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 51.2 tp -104.88 128.27 53.03 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.473 0.654 . . . . 0.0 109.655 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 46.4 t -112.26 121.27 44.42 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 93.9 mt -106.05 130.95 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.551 0.691 . . . . 0.0 110.202 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -127.71 141.21 51.66 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.83 -141.47 4.7 Favored Glycine 0 N--CA 1.485 1.928 0 C-N-CA 119.655 -1.26 . . . . 0.0 110.235 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -129.42 135.62 48.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.708 -0.878 . . . . 0.0 109.544 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? 43.23 80.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.91 0.862 . . . . 0.0 110.08 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.477 HD12 ' N ' ' B' ' 39' ' ' LEU . 8.7 mp -95.06 71.59 3.35 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.073 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -179.156 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 121.682 0.753 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -127.15 129.3 47.61 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.27 136.43 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.648 -0.657 . . . . 0.0 109.25 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -121.06 134.5 55.27 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.713 0.768 . . . . 0.0 109.373 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.55 -179.82 29.57 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.52 126.87 43.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.667 -0.902 . . . . 0.0 109.52 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.522 HD12 ' N ' ' B' ' 57' ' ' ILE . 1.4 mp -83.78 121.65 36.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.418 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -106.95 -19.24 13.69 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.667 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -162.14 150.03 14.5 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.647 -1.283 . . . . 0.0 110.984 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.667 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.6 OUTLIER -137.11 139.36 41.19 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.372 0.606 . . . . 0.0 109.386 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 54.7 t -141.03 131.61 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.454 -0.779 . . . . 0.0 110.198 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.505 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 11.9 t80 -145.73 140.16 15.47 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . 0.505 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 68.4 Cg_endo -76.06 108.82 2.76 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.282 1.988 . . . . 0.0 112.336 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.86 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.961 0 O-C-N 121.364 -0.835 . . . . 0.0 109.157 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 121.305 0.574 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.7 mmm-85 -53.67 140.41 29.34 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.268 -0.895 . . . . 0.0 109.46 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -146.97 160.82 41.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.32 -0.862 . . . . 0.0 109.534 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -111.35 131.89 54.83 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.0 tt -118.2 139.83 50.71 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 m -121.79 146.69 46.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.509 -0.745 . . . . 0.0 109.262 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tp -156.1 149.0 24.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.113 -0.992 . . . . 0.0 109.868 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.3 163.76 34.51 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.582 -0.699 . . . . 0.0 109.562 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.14 18.96 56.77 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.14 140.22 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.171 -1.194 . . . . 0.0 109.798 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 t -73.44 -51.79 15.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.118 -0.989 . . . . 0.0 109.585 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -155.87 160.42 40.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.026 -1.046 . . . . 0.0 109.917 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.4 t -92.54 102.33 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -65.82 -39.22 90.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 109.445 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -167.74 164.36 14.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.156 -0.965 . . . . 0.0 109.513 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -147.06 108.07 4.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.186 -0.946 . . . . 0.0 108.863 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -132.26 146.97 63.89 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.91 -18.37 46.75 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 121.814 1.676 . . . . 0.0 111.367 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -100.12 -3.58 31.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.408 -0.808 . . . . 0.0 109.502 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.445 ' OE1' ' NZ ' ' A' ' 35' ' ' LYS . 29.8 tt0 -174.29 151.03 1.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.222 -0.924 . . . . 0.0 109.441 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.7 mt -133.98 129.76 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.27 -0.894 . . . . 0.0 109.733 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.0 mt -117.8 120.55 38.26 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.8 mt -134.09 133.23 40.88 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.25 -0.906 . . . . 0.0 109.413 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -102.53 118.56 37.11 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.244 -0.91 . . . . 0.0 108.974 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 29' ' ' GLN . 5.0 t -125.15 153.69 42.66 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.681 0.753 . . . . 0.0 110.143 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.0 mm 53.8 -82.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.635 -0.665 . . . . 0.0 109.879 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' THR . 20.9 pt20 -164.04 51.05 0.14 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.976 -1.078 . . . . 0.0 109.748 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -171.43 155.12 23.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.2 t -95.99 130.38 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.329 -1.101 . . . . 0.0 109.942 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.4 tp -107.2 121.71 45.06 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.9 t -107.71 118.06 35.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.3 mt -103.89 127.14 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.445 ' NZ ' ' OE1' ' A' ' 22' ' ' GLU . 68.7 mttm -121.43 129.54 53.06 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.553 0.692 . . . . 0.0 109.153 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.67 -141.42 3.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -144.53 151.67 39.45 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.989 -1.301 . . . . 0.0 110.168 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 54' ' ' GLU . 45.6 mmtm 56.65 43.53 25.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.574 -0.704 . . . . 0.0 109.726 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.7 mp -73.77 71.99 1.5 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.706 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.093 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.65 159.7 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.294 -0.879 . . . . 0.0 109.193 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.15 146.35 42.67 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.8 t -123.07 135.24 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 38' ' ' LYS . 19.8 pt-20 -116.38 132.09 56.77 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.31 173.34 25.61 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.412 ' O ' HD12 ' A' ' 56' ' ' LEU . 2.6 pp -96.84 124.51 40.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.252 -1.146 . . . . 0.0 109.745 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.7 mt -79.67 129.03 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.238 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -118.72 -27.63 5.81 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.59 ' O ' HD22 ' A' ' 60' ' ' LEU . . . -152.77 146.88 25.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.025 -1.047 . . . . 0.0 110.532 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -133.93 134.1 42.2 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.426 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.444 HG22 HD12 ' B' ' 64' ' ' LEU . 98.5 t -130.68 123.29 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.243 -0.91 . . . . 0.0 109.937 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.41 ' CE1' ' O ' ' A' ' 63' ' ' PRO . 46.4 t80 -146.66 138.01 13.05 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.41 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 61.6 Cg_endo -75.03 116.41 4.57 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.454 1.436 . . . . 0.0 111.442 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.972 HD13 ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.196 -0.94 . . . . 0.0 108.473 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.515 ' N ' ' OD1' ' B' ' 3' ' ' ASN . 7.2 p-10 . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -80.36 140.33 36.12 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.364 -0.835 . . . . 0.0 109.319 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -152.02 161.77 42.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 109.38 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' B' ' 6' ' ' PHE . 23.6 m-85 -104.2 146.03 29.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.628 -0.67 . . . . 0.0 109.412 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.589 HD23 ' N ' ' B' ' 8' ' ' SER . 6.2 tt -132.66 122.27 24.41 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . 0.589 ' N ' HD23 ' B' ' 7' ' ' LEU . 80.0 p -114.71 144.75 42.96 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.35 -0.844 . . . . 0.0 109.835 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.9 tp -150.67 150.72 31.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.295 -0.878 . . . . 0.0 109.323 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.6 160.76 41.76 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.476 -0.765 . . . . 0.0 109.472 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.37 14.3 60.36 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.31 135.11 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.235 -1.156 . . . . 0.0 109.689 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t -73.15 -43.41 61.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 109.857 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.56 165.03 10.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.941 -1.099 . . . . 0.0 109.798 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 71.4 t -98.31 129.68 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.22 -0.925 . . . . 0.0 109.917 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -83.57 -29.03 28.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 109.272 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 34.7 t -172.01 168.7 5.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.254 -0.904 . . . . 0.0 109.032 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -150.41 107.63 3.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.137 -0.977 . . . . 0.0 109.771 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -132.12 149.61 73.73 Favored Pre-proline 0 N--CA 1.497 1.923 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.19 -3.25 11.93 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.694 1.596 . . . . 0.0 111.606 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -122.26 -12.59 8.24 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.532 -0.73 . . . . 0.0 109.974 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -158.82 109.57 2.07 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.097 -1.002 . . . . 0.0 109.242 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 95.8 mt -111.67 128.74 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.403 ' CD2' ' OG ' ' B' ' 33' ' ' SER . 15.0 mt -111.6 125.05 53.52 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 80.0 mt -121.69 128.97 52.41 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.571 -0.706 . . . . 0.0 109.853 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -96.75 113.75 25.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.185 -0.947 . . . . 0.0 108.707 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.547 ' O ' ' N ' ' B' ' 29' ' ' GLN . 5.1 t -124.17 156.44 36.71 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.364 0.602 . . . . 0.0 110.514 -178.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.423 ' C ' ' O ' ' B' ' 27' ' ' THR . 45.4 mt 34.71 -87.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 CA-C-O 121.123 0.487 . . . . 0.0 110.639 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.547 ' N ' ' O ' ' B' ' 27' ' ' THR . 17.1 pt20 -150.73 45.19 0.85 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 0.0 109.682 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.68 136.69 4.29 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 74.7 t -91.55 132.73 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.391 -1.064 . . . . 0.0 109.751 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 53.0 tp -107.02 125.27 50.8 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.403 ' OG ' ' CD2' ' B' ' 24' ' ' LEU . 21.0 m -107.61 120.42 42.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.479 -0.763 . . . . 0.0 109.422 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 87.5 mt -106.78 127.5 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -124.78 139.89 53.43 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.581 0.705 . . . . 0.0 109.355 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.8 -139.97 5.46 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -143.63 152.72 41.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.996 -1.296 . . . . 0.0 109.52 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' B' ' 54' ' ' GLU . 68.1 mttm 56.15 51.23 12.12 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.301 0.572 . . . . 0.0 110.201 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.526 HD12 ' N ' ' B' ' 39' ' ' LEU . 9.8 mp -85.56 71.65 10.72 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -178.701 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.498 1.968 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . 0.429 ' CD ' ' N ' ' B' ' 52' ' ' GLU . 18.3 mp0 -138.68 153.86 48.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.347 -0.845 . . . . 0.0 109.508 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.412 HG12 ' N ' ' B' ' 54' ' ' GLU . 55.4 t -131.42 156.25 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.412 ' N ' HG12 ' B' ' 53' ' ' VAL . 31.3 tt0 -138.68 134.55 33.77 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.49 178.91 32.95 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.443 ' H ' HD23 ' B' ' 56' ' ' LEU . 0.2 OUTLIER -96.03 139.24 32.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.338 -1.095 . . . . 0.0 109.119 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 43.3 mm -86.38 118.07 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 109.257 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -107.69 -31.77 7.93 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.447 -0.783 . . . . 0.0 109.682 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.581 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -160.76 147.21 15.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.16 -0.963 . . . . 0.0 110.265 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.581 HD22 ' O ' ' B' ' 59' ' ' ALA . 1.3 mm? -129.84 135.85 48.88 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 95.0 t -135.28 129.36 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.294 -0.879 . . . . 0.0 109.515 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' B' ' 64' ' ' LEU . 42.4 t80 -144.89 123.18 6.63 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -42.34 86.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.464 1.443 . . . . 0.0 112.224 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.682 ' H ' ' CD2' ' B' ' 64' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.43 HD22 ' HB3' ' A' ' 56' ' ' LEU . 1.1 p-10 . . . . . 0 N--CA 1.493 1.725 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.3 mmm-85 -69.97 145.32 51.93 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.223 -0.923 . . . . 0.0 109.03 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.543 ' NE2' ' OG1' ' B' ' 27' ' ' THR . 83.2 mt-30 -135.56 146.65 48.21 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.676 0.751 . . . . 0.0 110.005 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -110.19 114.71 28.42 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.605 ' C ' HD23 ' A' ' 7' ' ' LEU . 6.9 tt -111.27 125.08 53.45 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.424 -0.797 . . . . 0.0 108.867 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.599 ' N ' HD23 ' A' ' 7' ' ' LEU . 37.7 t -119.58 148.04 43.78 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.477 0.656 . . . . 0.0 109.555 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 tp -149.07 -179.46 7.04 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.631 0.729 . . . . 0.0 109.717 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.514 HG21 ' NE2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -175.13 158.18 2.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.344 -0.848 . . . . 0.0 109.378 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.12 20.63 57.04 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -66.48 139.88 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -1.078 . . . . 0.0 110.217 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.0 t -72.68 -43.36 63.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.429 -0.794 . . . . 0.0 109.598 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.99 159.12 9.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 0.0 109.93 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.5 t -91.61 106.61 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.472 -0.768 . . . . 0.0 109.959 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -69.09 -38.22 78.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 109.395 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -168.87 164.15 11.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.832 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -149.02 105.16 3.5 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -132.79 150.43 75.71 Favored Pre-proline 0 N--CA 1.498 1.957 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.64 -19.29 36.89 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.134 1.889 . . . . 0.0 111.231 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -100.02 -3.34 32.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.4 -0.813 . . . . 0.0 109.078 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -174.49 146.97 1.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.541 -0.724 . . . . 0.0 109.435 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.0 mt -133.04 129.81 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.335 -0.853 . . . . 0.0 109.614 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.8 mt -117.13 124.9 50.32 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.3 mt -136.64 129.36 30.61 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.56 -0.712 . . . . 0.0 109.192 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -104.7 123.05 46.94 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.526 -0.734 . . . . 0.0 109.444 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 29' ' ' GLN . 8.9 t -123.82 154.71 39.2 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.528 0.68 . . . . 0.0 109.72 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.6 mt 42.97 -84.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.999 -0.438 . . . . 0.0 110.623 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.578 ' N ' ' O ' ' A' ' 27' ' ' THR . 12.9 pt20 -154.9 57.24 0.67 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.932 -1.105 . . . . 0.0 109.85 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.71 141.65 6.15 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.187 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.4 t -86.34 132.2 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.487 -1.007 . . . . 0.0 109.518 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.9 tp -111.26 123.55 50.43 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 t -115.7 126.69 54.42 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.572 -0.705 . . . . 0.0 109.992 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.0 mt -112.59 130.74 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.36 144.67 50.74 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 121.499 0.666 . . . . 0.0 109.662 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.83 -140.1 5.52 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -135.93 143.06 44.74 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.421 -1.046 . . . . 0.0 108.885 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 54.44 62.21 2.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.523 -0.736 . . . . 0.0 110.171 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.3 mp -91.71 73.04 5.84 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.148 -0.97 . . . . 0.0 108.548 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.013 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.514 ' NE2' HG21 ' A' ' 10' ' ' THR . 2.0 tp60 . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 121.475 0.655 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -113.71 136.34 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -136.43 131.0 33.52 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.849 -0.796 . . . . 0.0 108.849 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.1 t -125.1 148.88 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.565 -0.709 . . . . 0.0 109.174 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -133.1 127.97 35.15 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.6 173.64 23.71 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.438 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -95.44 128.3 42.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.371 -1.076 . . . . 0.0 109.343 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.1 mt -81.46 121.31 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.868 . . . . 0.0 109.639 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -103.37 -23.76 13.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.545 -0.722 . . . . 0.0 109.085 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.02 151.17 13.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.167 -0.958 . . . . 0.0 109.98 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.615 HD13 ' N ' ' A' ' 61' ' ' VAL . 0.3 OUTLIER -130.95 126.98 37.48 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.546 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.615 ' N ' HD13 ' A' ' 60' ' ' LEU . 58.6 t -123.04 123.89 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.303 -0.873 . . . . 0.0 109.773 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -146.3 139.76 14.76 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.97 110.01 2.82 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.27 1.313 . . . . 0.0 111.769 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.968 HD13 ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.36 -0.838 . . . . 0.0 109.17 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -87.56 137.25 32.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.154 -0.966 . . . . 0.0 109.296 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -146.13 163.75 34.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.409 -0.807 . . . . 0.0 109.299 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -108.96 129.79 55.45 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 7.5 tt -113.41 135.44 53.87 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 12.4 t -130.99 139.8 50.05 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.726 0.774 . . . . 0.0 110.226 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' B' ' 9' ' ' LEU . 45.6 tp -151.03 146.06 25.95 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.604 -0.685 . . . . 0.0 109.319 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.4 p -130.11 177.77 7.05 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.61 -0.681 . . . . 0.0 109.414 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.1 18.55 69.23 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 79.3 t -74.55 130.86 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.14 -1.212 . . . . 0.0 109.771 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 38.9 t -73.4 -42.37 62.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.355 -0.841 . . . . 0.0 109.114 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.2 160.29 9.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.155 -0.966 . . . . 0.0 109.946 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 10.1 t -82.08 104.15 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.435 -0.79 . . . . 0.0 109.506 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -67.53 -35.81 79.8 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.164 -0.96 . . . . 0.0 109.352 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 7.5 t -165.46 153.26 11.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.922 . . . . 0.0 109.223 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -140.27 104.54 4.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.278 -0.889 . . . . 0.0 109.455 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.411 ' OD2' ' O ' ' B' ' 22' ' ' GLU . 0.4 OUTLIER -133.26 150.32 74.98 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.97 -16.69 32.46 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.846 1.697 . . . . 0.0 111.953 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -107.93 -8.54 15.91 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.353 -0.842 . . . . 0.0 109.743 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.447 ' CD ' ' HZ1' ' B' ' 35' ' ' LYS . 50.0 tt0 -167.33 126.78 1.39 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 109.435 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.2 mt -125.11 130.7 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.438 -0.789 . . . . 0.0 109.683 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 60.7 mt -112.95 128.43 56.48 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 94.7 mt -127.02 126.74 43.63 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.629 -0.67 . . . . 0.0 109.658 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -94.03 112.34 24.16 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.543 ' OG1' ' NE2' ' A' ' 5' ' ' GLN . 15.0 t -124.7 164.93 18.87 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.524 0.678 . . . . 0.0 110.488 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' B' ' 27' ' ' THR . 22.2 mm 33.21 -86.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.415 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' B' ' 27' ' ' THR . 27.2 pt20 -148.98 27.2 0.87 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.933 -1.104 . . . . 0.0 109.728 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.84 165.96 31.25 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 55.7 t -112.51 132.4 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.655 -0.909 . . . . 0.0 109.143 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 46.8 tp -104.52 124.33 49.1 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' B' ' 61' ' ' VAL . 5.4 p -107.52 122.59 46.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.591 -0.693 . . . . 0.0 109.48 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . 0.54 HD12 ' N ' ' B' ' 34' ' ' ILE . 4.4 mp -108.6 129.08 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' LYS . . . . . 0.447 ' HZ1' ' CD ' ' B' ' 22' ' ' GLU . 68.5 mttm -123.27 133.3 54.18 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.565 0.698 . . . . 0.0 109.459 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.68 -147.72 8.62 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -136.61 153.76 50.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.357 -1.084 . . . . 0.0 109.767 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 67.8 mttm 55.96 57.41 5.16 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.539 0.685 . . . . 0.0 110.557 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.528 HD12 ' N ' ' B' ' 39' ' ' LEU . 9.0 mp -92.35 70.09 5.13 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.557 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.3 t . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 121.616 0.722 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -144.11 127.67 17.03 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 t -118.17 162.55 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.655 -0.653 . . . . 0.0 109.678 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -123.46 132.93 54.08 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.89 179.71 37.62 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.439 ' H ' HD23 ' B' ' 56' ' ' LEU . 0.2 OUTLIER -96.68 138.84 33.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.301 -1.117 . . . . 0.0 109.201 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.459 HD12 ' N ' ' B' ' 57' ' ' ILE . 1.4 mp -91.31 117.6 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.247 -0.908 . . . . 0.0 109.061 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -108.13 -25.23 11.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.514 -0.741 . . . . 0.0 109.8 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . 0.505 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -164.59 135.59 4.22 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.74 -1.225 . . . . 0.0 111.146 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.505 HD22 ' O ' ' B' ' 59' ' ' ALA . 3.1 mm? -119.83 135.43 54.87 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.426 ' O ' ' OG ' ' B' ' 33' ' ' SER . 46.6 t -132.58 122.75 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.543 0.687 . . . . 0.0 109.823 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' B' ' 64' ' ' LEU . 28.2 t80 -144.54 128.39 8.88 Favored Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -41.21 88.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.427 1.418 . . . . 0.0 111.785 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.683 ' C ' HD23 ' B' ' 64' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 120.783 -1.198 . . . . 0.0 108.678 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.405 HD22 ' HB2' ' A' ' 56' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 121.092 0.472 . . . . 0.0 109.872 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -69.95 140.92 53.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 108.742 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -142.3 162.0 36.59 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.124 -0.985 . . . . 0.0 110.088 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -108.99 142.07 40.18 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.564 HD23 ' N ' ' A' ' 8' ' ' SER . 6.2 tt -142.11 124.01 15.26 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.564 ' N ' HD23 ' A' ' 7' ' ' LEU . 37.8 t -132.34 140.45 48.55 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.461 -0.774 . . . . 0.0 109.152 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.5 tp -144.65 142.54 30.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.305 -0.872 . . . . 0.0 109.008 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.5 p -130.61 112.68 13.37 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.548 -0.72 . . . . 0.0 109.468 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 143.33 31.87 0.1 Allowed Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.4 t -81.16 133.47 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -1.125 . . . . 0.0 110.238 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.1 m -72.65 -41.6 65.28 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.56 153.45 4.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.771 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 81.6 t -84.93 106.0 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.509 -0.745 . . . . 0.0 110.285 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -67.96 -42.01 81.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.96 . . . . 0.0 108.86 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.3 t -171.89 136.54 0.91 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.407 -0.808 . . . . 0.0 108.89 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.437 ' CE1' HD12 ' A' ' 23' ' ' ILE . 6.9 t80 -123.77 106.46 10.51 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.428 -0.795 . . . . 0.0 109.143 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.413 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -128.22 150.45 74.04 Favored Pre-proline 0 N--CA 1.498 1.968 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.513 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.1 -19.57 39.08 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.272 1.981 . . . . 0.0 111.364 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -97.47 -7.12 32.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.466 -0.771 . . . . 0.0 108.978 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -172.86 140.36 0.94 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.437 HD12 ' CE1' ' A' ' 18' ' ' PHE . 27.0 mm -127.12 127.51 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.323 -0.861 . . . . 0.0 109.437 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.8 mt -120.51 120.55 36.18 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.1 mt -131.31 125.61 33.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.419 -0.801 . . . . 0.0 108.849 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -92.4 120.83 33.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 29' ' ' GLN . 6.1 t -122.37 154.0 38.28 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.674 0.749 . . . . 0.0 110.271 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.3 mm 46.08 -82.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.085 0.469 . . . . 0.0 110.764 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.578 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.8 pp0? -147.71 -21.36 0.37 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.102 -0.999 . . . . 0.0 109.898 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.485 ' N ' ' CD ' ' A' ' 29' ' ' GLN . . . -97.45 173.77 28.91 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.7 t -118.95 132.67 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.753 -0.851 . . . . 0.0 109.107 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.471 HD13 HD12 ' B' ' 60' ' ' LEU . 60.3 tp -109.62 127.81 54.79 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.6 t -113.22 122.4 47.37 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.7 mt -108.12 130.14 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.403 -0.811 . . . . 0.0 109.264 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -129.16 141.17 51.25 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.488 -0.757 . . . . 0.0 109.37 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.07 -138.1 4.91 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.454 ' HB3' HD21 ' A' ' 56' ' ' LEU . 6.7 tt0 -133.03 150.03 52.16 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.492 -1.005 . . . . 0.0 110.711 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 54' ' ' GLU . 55.0 mmtt 54.08 66.36 1.25 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.492 178.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 39' ' ' LEU . 11.1 mp -98.39 71.18 2.03 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.138 0 O-C-N 121.128 -0.982 . . . . 0.0 110.793 -178.146 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 . . . . . 0 N--CA 1.495 1.821 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.0 t -122.65 131.8 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.529 -0.732 . . . . 0.0 109.103 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -130.64 130.98 44.63 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 t -136.36 138.36 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.496 -0.753 . . . . 0.0 109.097 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.491 ' O ' ' O ' ' A' ' 38' ' ' LYS . 24.0 tt0 -118.42 145.98 44.79 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.15 166.14 15.6 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.454 HD21 ' HB3' ' A' ' 37' ' ' GLU . 2.5 pp -88.69 128.83 35.62 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.391 -1.064 . . . . 0.0 109.656 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.3 mm -80.12 135.31 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.85 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -125.26 -31.05 3.1 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.02 143.4 16.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.064 -1.023 . . . . 0.0 110.598 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.435 HD13 HD13 ' B' ' 32' ' ' LEU . 9.1 mt -129.73 143.31 50.76 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 54.3 t -139.23 118.22 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.102 -0.999 . . . . 0.0 110.165 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -139.72 108.97 7.17 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.96 109.36 0.23 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.406 1.404 . . . . 0.0 112.426 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.017 HD13 ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.323 -0.861 . . . . 0.0 109.588 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.8 mmm-85 -69.25 142.71 54.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.97 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . 0.498 ' NE2' ' OG1' ' A' ' 27' ' ' THR . 86.3 mt-30 -140.15 148.29 41.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.517 -0.739 . . . . 0.0 109.577 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -103.95 119.5 39.06 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.517 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.2 tt -119.16 121.24 39.29 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.262 -0.899 . . . . 0.0 108.638 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . 0.487 ' N ' HD23 ' B' ' 7' ' ' LEU . 70.1 m -132.53 151.37 51.94 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.509 -0.744 . . . . 0.0 109.163 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 tp -147.29 149.3 32.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.193 -0.942 . . . . 0.0 109.5 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.2 p -128.67 163.7 24.53 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.588 -0.695 . . . . 0.0 109.612 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.43 29.27 56.17 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.41 131.37 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -1.174 . . . . 0.0 109.901 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' B' ' 28' ' ' ILE . 58.2 m -73.83 -40.07 63.58 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.615 -0.678 . . . . 0.0 110.613 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -158.91 158.38 33.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.983 -1.073 . . . . 0.0 109.914 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 76.3 t -103.63 99.96 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -68.96 -49.25 59.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 110.532 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 31.8 t -170.4 146.58 2.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.924 -1.11 . . . . 0.0 110.211 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.71 110.18 17.53 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.673 -0.642 . . . . 0.0 109.882 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' B' ' 22' ' ' GLU . 0.3 OUTLIER -133.76 119.89 15.16 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.431 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -50.19 -27.14 16.7 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.476 1.45 . . . . 0.0 111.443 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -94.52 -5.4 46.13 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' B' ' 19' ' ' ASP . 40.2 tt0 -170.8 115.57 0.45 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 97.0 mt -114.45 126.33 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.203 -0.936 . . . . 0.0 109.194 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 57.9 mt -119.35 126.53 51.63 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 87.0 mt -135.58 123.76 23.04 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.256 -0.902 . . . . 0.0 108.988 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -81.73 118.32 22.76 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.128 -0.982 . . . . 0.0 108.84 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.562 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.8 t -109.54 149.19 30.0 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.472 -0.767 . . . . 0.0 110.201 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.494 ' N ' ' OG ' ' B' ' 13' ' ' SER . 58.7 mt 38.47 -87.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.037 0.446 . . . . 0.0 110.798 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' B' ' 27' ' ' THR . 24.0 pt20 -133.68 -22.52 1.89 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.38 -0.825 . . . . 0.0 110.198 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.6 173.99 30.21 Favored Glycine 0 N--CA 1.498 2.769 0 O-C-N 121.139 -0.976 . . . . 0.0 110.724 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -119.34 131.57 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.79 -0.829 . . . . 0.0 109.401 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 60' ' ' LEU . 48.7 tp -111.92 128.79 56.25 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.3 t -110.2 120.41 42.37 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 84.3 mt -99.81 125.56 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -130.53 139.06 50.48 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.502 -0.749 . . . . 0.0 109.52 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.66 -138.28 3.28 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -131.86 136.81 47.73 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.348 -1.089 . . . . 0.0 109.836 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.415 ' C ' HD12 ' B' ' 39' ' ' LEU . 52.9 mtmt 46.92 75.38 0.12 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 110.283 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.6 HD12 ' N ' ' B' ' 39' ' ' LEU . 8.5 mp -93.24 72.12 4.54 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.18 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 121.539 0.685 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -126.62 131.58 51.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.9 t -125.96 137.54 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.499 -0.751 . . . . 0.0 109.721 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -117.24 131.42 56.84 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.7 174.21 28.11 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.99 127.04 40.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.066 -1.256 . . . . 0.0 109.429 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.568 HD12 ' N ' ' B' ' 57' ' ' ILE . 1.4 mp -85.63 113.4 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 108.684 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.37 -10.29 16.4 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -159.9 146.28 15.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.904 -1.123 . . . . 0.0 110.522 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.471 HD12 HD13 ' A' ' 32' ' ' LEU . 52.8 mt -141.3 138.49 33.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.469 -0.769 . . . . 0.0 108.972 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 53.4 t -133.2 128.23 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.194 -0.941 . . . . 0.0 109.89 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -145.37 137.88 13.59 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.34 109.28 2.86 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.384 1.39 . . . . 0.0 111.74 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.936 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.479 -0.763 . . . . 0.0 108.981 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.445 ' NE ' ' OE2' ' A' ' 54' ' ' GLU . 46.4 mmm-85 -88.39 138.43 31.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.344 -0.848 . . . . 0.0 109.13 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -145.19 161.88 38.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.181 -0.949 . . . . 0.0 109.187 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -119.8 146.4 45.72 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.505 0.669 . . . . 0.0 109.916 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.579 ' C ' HD23 ' A' ' 7' ' ' LEU . 6.4 tt -132.51 122.7 25.26 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.571 ' N ' HD23 ' A' ' 7' ' ' LEU . 33.3 t -113.8 133.04 55.63 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.49 -0.756 . . . . 0.0 109.283 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.6 tp -144.76 151.5 38.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.35 -0.844 . . . . 0.0 109.444 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.4 t -146.48 162.88 37.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.399 -0.813 . . . . 0.0 108.944 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.27 24.99 41.51 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.45 138.14 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -1.1 . . . . 0.0 109.652 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.5 m -73.57 -38.36 65.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.232 -0.918 . . . . 0.0 109.257 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -169.89 166.71 9.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.177 -0.952 . . . . 0.0 109.499 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.5 t -98.32 96.19 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.329 -0.857 . . . . 0.0 109.063 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -65.21 -39.39 92.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.146 -0.971 . . . . 0.0 109.463 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 t -168.82 152.85 5.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 109.256 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -146.89 107.73 4.16 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.247 -0.908 . . . . 0.0 109.422 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.3 158.68 75.11 Favored Pre-proline 0 N--CA 1.502 2.161 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.83 -26.07 67.67 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 121.672 1.581 . . . . 0.0 112.142 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -106.04 3.43 28.2 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.372 -0.83 . . . . 0.0 110.276 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -171.54 133.46 0.8 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.031 -1.043 . . . . 0.0 109.46 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.9 mt -130.84 126.83 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.421 -0.799 . . . . 0.0 109.184 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.2 mt -117.5 122.18 43.03 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.711 . . . . 0.0 109.271 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.9 mt -133.37 124.56 27.4 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.375 -0.828 . . . . 0.0 108.839 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -91.73 124.74 36.1 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.679 -1.263 . . . . 0.0 109.72 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 29' ' ' GLN . 6.1 t -124.5 153.33 42.2 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.462 0.649 . . . . 0.0 109.755 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.48 HD12 ' CB ' ' B' ' 3' ' ' ASN . 20.4 mm 44.74 -88.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.868 -0.52 . . . . 0.0 110.094 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.544 ' N ' ' O ' ' A' ' 27' ' ' THR . 25.7 pt20 -143.19 -17.4 0.65 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.965 -1.084 . . . . 0.0 110.213 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.29 173.67 30.32 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.2 t -121.25 131.21 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.779 -0.836 . . . . 0.0 108.909 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -107.56 126.12 52.15 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.37 -0.831 . . . . 0.0 109.554 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -116.9 124.03 48.46 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.639 -0.663 . . . . 0.0 109.417 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.2 mt -107.77 130.0 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.521 -0.737 . . . . 0.0 109.238 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -124.69 138.79 54.27 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.493 -0.754 . . . . 0.0 109.657 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.58 -146.36 9.41 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -140.61 151.87 44.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.036 -1.273 . . . . 0.0 109.802 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 54' ' ' GLU . 73.7 mmtt 58.34 55.24 5.12 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.681 -0.637 . . . . 0.0 109.939 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 39' ' ' LEU . 7.9 mp -93.75 70.6 4.12 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.38 0 C-N-CA 120.247 -0.978 . . . . 0.0 110.732 -178.898 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 m -131.43 156.1 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.265 -0.897 . . . . 0.0 109.964 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -142.8 150.37 39.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.425 -0.797 . . . . 0.0 109.107 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.7 t -126.65 134.92 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.458 -0.776 . . . . 0.0 110.109 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.473 ' OE1' ' N ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -114.57 126.08 54.51 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.473 ' N ' ' OE1' ' A' ' 54' ' ' GLU . . . 163.72 176.44 35.64 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.158 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.406 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -96.17 121.44 37.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.527 -0.984 . . . . 0.0 108.885 179.762 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.69 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.7 mp -90.43 113.3 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.018 -1.051 . . . . 0.0 108.937 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -99.94 -10.77 21.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.452 -0.78 . . . . 0.0 109.988 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.94 145.74 13.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.816 -1.178 . . . . 0.0 110.428 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 mt -135.19 134.53 40.2 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.61 -0.681 . . . . 0.0 109.297 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.8 t -129.81 126.0 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.527 -0.733 . . . . 0.0 109.571 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.558 ' O ' ' N ' ' A' ' 64' ' ' LEU . 10.8 t80 -141.0 127.61 11.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -45.68 84.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.247 1.298 . . . . 0.0 112.206 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.7 ' CD2' ' H ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 O-C-N 121.363 -0.836 . . . . 0.0 109.207 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . 0.48 ' CB ' HD12 ' A' ' 28' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 31.7 mmm-85 -73.0 142.14 47.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.318 -0.863 . . . . 0.0 109.425 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -147.04 156.09 42.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.272 -0.893 . . . . 0.0 109.025 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -98.79 141.37 31.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.328 -0.858 . . . . 0.0 109.393 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.549 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.1 tt -139.95 126.47 20.31 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . 0.545 ' N ' HD23 ' B' ' 7' ' ' LEU . 69.8 m -128.53 150.96 49.95 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.442 -0.786 . . . . 0.0 109.594 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.8 tp -146.91 153.21 39.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.35 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.4 t -143.48 164.44 30.32 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.299 -0.876 . . . . 0.0 109.189 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.07 14.95 59.85 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 p -69.14 137.41 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.341 -1.094 . . . . 0.0 109.443 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 4.5 t -73.96 -52.18 13.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.213 -0.929 . . . . 0.0 108.938 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.18 150.6 13.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.253 -0.904 . . . . 0.0 109.646 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 93.0 t -82.58 131.46 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.199 -0.938 . . . . 0.0 110.058 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -95.59 -32.25 12.9 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.314 -0.866 . . . . 0.0 109.247 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 47.3 t -169.04 153.97 5.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.89 . . . . 0.0 108.981 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . 0.45 ' CZ ' HD13 ' B' ' 23' ' ' ILE . 3.0 t80 -145.65 112.49 5.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.004 -1.06 . . . . 0.0 109.408 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' B' ' 19' ' ' ASP . 0.3 OUTLIER -132.6 151.73 78.68 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.59 -18.21 48.52 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.658 1.572 . . . . 0.0 111.382 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -107.7 -3.29 19.32 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.491 -0.756 . . . . 0.0 109.581 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -169.98 127.85 0.88 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.284 -0.885 . . . . 0.0 109.227 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.45 HD13 ' CZ ' ' B' ' 18' ' ' PHE . 96.8 mt -127.74 129.65 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.241 -0.912 . . . . 0.0 109.921 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 70.0 mt -115.06 124.15 50.85 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.336 -0.853 . . . . 0.0 109.639 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 41.5 mt -126.31 131.26 51.88 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.303 -0.873 . . . . 0.0 109.138 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -90.91 119.87 31.45 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.556 ' O ' ' N ' ' B' ' 29' ' ' GLN . 3.1 t -123.53 148.36 46.36 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.669 0.747 . . . . 0.0 110.186 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 68.5 mt 39.05 -88.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.145 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' B' ' 27' ' ' THR . 29.7 pt20 -139.0 -18.17 1.03 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.392 -0.817 . . . . 0.0 109.999 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.19 144.5 17.17 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 18.6 t -94.15 129.64 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.343 -1.092 . . . . 0.0 108.848 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 37.5 tp -106.21 126.02 51.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.445 -0.784 . . . . 0.0 109.415 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 70.9 m -109.34 124.4 50.89 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 90.8 mt -106.13 129.41 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.534 -0.729 . . . . 0.0 109.178 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -125.25 141.74 51.91 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.507 -0.746 . . . . 0.0 109.414 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.04 -151.52 17.93 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -140.07 150.26 44.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.226 -1.161 . . . . 0.0 108.93 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt 60.27 51.24 5.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.553 -0.717 . . . . 0.0 109.668 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.551 HD12 ' N ' ' B' ' 39' ' ' LEU . 9.0 mp -91.24 72.99 6.23 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.386 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -178.706 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.2 t . . . . . 0 N--CA 1.499 2.016 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -119.5 137.29 53.9 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.516 -0.74 . . . . 0.0 109.077 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.423 HG12 ' N ' ' B' ' 54' ' ' GLU . 21.4 t -128.39 160.84 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.411 -0.806 . . . . 0.0 110.086 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.423 ' N ' HG12 ' B' ' 53' ' ' VAL . 0.0 OUTLIER -136.32 146.87 47.06 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.26 176.02 23.68 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.405 HD23 ' H ' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -99.0 136.44 38.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.357 -1.084 . . . . 0.0 108.545 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 36.1 mm -93.49 111.53 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.884 -1.135 . . . . 0.0 109.186 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -100.38 -24.48 14.5 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.399 -0.813 . . . . 0.0 109.799 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.04 147.05 12.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.937 -1.102 . . . . 0.0 110.632 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 9.5 mt -132.48 141.17 48.68 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.417 HG22 HD12 ' A' ' 64' ' ' LEU . 77.9 t -133.91 118.97 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.578 -0.701 . . . . 0.0 109.154 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.433 ' O ' HD13 ' B' ' 64' ' ' LEU . 18.2 t80 -135.86 140.81 34.57 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -79.84 105.78 1.87 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.491 1.461 . . . . 0.0 112.485 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.937 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.925 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.592 0.71 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 41.8 mmm-85 -65.16 141.31 58.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.92 -1.112 . . . . 0.0 109.145 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.541 ' NE2' ' OG1' ' B' ' 27' ' ' THR . 85.3 mt-30 -135.38 147.78 49.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.205 -0.934 . . . . 0.0 110.557 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -112.99 113.28 25.26 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.515 ' C ' HD23 ' A' ' 7' ' ' LEU . 6.5 tt -111.68 123.11 49.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 108.89 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.499 ' N ' HD23 ' A' ' 7' ' ' LEU . 30.3 t -115.22 133.72 55.78 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.48 0.657 . . . . 0.0 109.662 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 tp -141.02 139.11 34.09 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.725 0.774 . . . . 0.0 109.345 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -130.51 168.4 17.1 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.723 -0.61 . . . . 0.0 109.44 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.4 14.09 74.8 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.0 t -67.94 133.94 30.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 109.761 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.6 t -71.15 -43.25 67.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 109.189 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.68 163.82 3.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 0.0 110.026 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.3 t -88.81 111.45 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.432 -0.792 . . . . 0.0 110.086 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -67.46 -31.23 71.26 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.476 -0.765 . . . . 0.0 109.097 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.1 t -167.91 159.34 11.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.099 -1.0 . . . . 0.0 109.537 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.443 ' CD1' ' C ' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -138.77 107.09 5.79 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.342 -0.849 . . . . 0.0 109.31 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.84 145.03 54.29 Favored Pre-proline 0 N--CA 1.495 1.799 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.61 -13.69 32.76 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.444 2.096 . . . . 0.0 111.609 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -115.5 -1.74 12.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.28 -0.887 . . . . 0.0 108.967 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -169.07 111.61 0.51 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.149 -0.97 . . . . 0.0 109.157 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.5 mt -112.51 129.7 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.152 -0.967 . . . . 0.0 109.475 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.3 mt -113.41 123.54 50.32 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.531 -0.73 . . . . 0.0 109.039 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.3 mt -120.95 126.87 51.07 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.587 0.708 . . . . 0.0 109.112 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.81 118.25 31.45 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.35 -0.844 . . . . 0.0 108.974 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.579 ' O ' ' N ' ' A' ' 29' ' ' GLN . 3.4 t -116.95 154.49 30.76 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.345 0.593 . . . . 0.0 110.392 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.405 ' C ' ' O ' ' A' ' 27' ' ' THR . 27.1 mm 34.09 -85.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-O 121.451 0.643 . . . . 0.0 110.933 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 27' ' ' THR . 24.0 pt20 -138.82 -17.48 1.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.927 . . . . 0.0 108.944 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.58 167.51 25.93 Favored Glycine 0 N--CA 1.497 2.735 0 O-C-N 120.855 -1.153 . . . . 0.0 110.797 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -120.43 132.94 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.513 -0.992 . . . . 0.0 109.305 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.559 HD13 HD13 ' B' ' 60' ' ' LEU . 57.7 tp -112.23 131.92 55.21 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.7 t -115.79 129.9 56.63 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.453 0.644 . . . . 0.0 109.358 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.7 mt -112.8 132.23 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 121.315 0.578 . . . . 0.0 109.457 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -131.33 146.65 52.38 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.575 0.702 . . . . 0.0 109.488 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' OE1' ' A' ' 37' ' ' GLU . . . 168.63 -148.21 12.18 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 36' ' ' GLY . 0.7 OUTLIER -118.89 137.36 53.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.866 -0.785 . . . . 0.0 109.83 -178.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.421 ' C ' HD12 ' A' ' 39' ' ' LEU . 70.7 mmtt 50.94 71.3 0.44 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.018 0.913 . . . . 0.0 110.179 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.4 mp -98.75 72.55 1.98 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.982 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 -178.869 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 121.513 0.673 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.9 m -133.42 163.0 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.538 -0.726 . . . . 0.0 109.731 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -135.45 160.78 37.38 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.701 0.762 . . . . 0.0 109.688 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.08 135.17 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -122.04 125.52 46.43 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.838 0.827 . . . . 0.0 109.322 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.4 178.47 24.43 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.82 129.83 44.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -1.081 . . . . 0.0 109.297 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.48 122.52 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.282 -0.887 . . . . 0.0 109.519 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -102.22 -24.43 13.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.482 -0.761 . . . . 0.0 109.036 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.93 149.7 14.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.843 -1.161 . . . . 0.0 110.749 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.465 HD13 HD13 ' B' ' 32' ' ' LEU . 12.7 mt -131.2 144.74 51.57 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.502 HG13 HD12 ' B' ' 64' ' ' LEU . 21.8 t -141.24 122.0 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.763 0.792 . . . . 0.0 110.3 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.557 ' O ' ' N ' ' A' ' 64' ' ' LEU . 19.6 t80 -139.73 115.77 8.16 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.54 78.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.43 1.42 . . . . 0.0 111.419 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 62' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.505 0 CA-C-O 122.338 1.066 . . . . 0.0 109.498 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 121.65 0.738 . . . . 0.0 109.098 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -69.72 144.65 52.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.107 -0.995 . . . . 0.0 109.9 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . 0.529 ' NE2' ' OG1' ' A' ' 27' ' ' THR . 75.5 mt-30 -140.71 150.06 42.97 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.785 0.802 . . . . 0.0 109.691 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -110.58 127.25 55.14 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.476 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.5 tt -122.33 122.25 38.63 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.229 -0.92 . . . . 0.0 108.876 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . 0.453 ' N ' HD23 ' B' ' 7' ' ' LEU . 18.2 p -121.19 147.89 44.99 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.726 0.774 . . . . 0.0 109.994 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 32.0 tp -148.83 143.78 26.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.568 -0.707 . . . . 0.0 109.102 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -130.25 161.39 31.3 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.651 0.739 . . . . 0.0 109.933 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.41 20.75 61.6 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.83 134.63 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.834 -1.392 . . . . 0.0 109.78 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 34.0 m -72.92 -41.84 64.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.193 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.02 164.83 4.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.819 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 77.1 t -99.29 128.22 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.429 -0.794 . . . . 0.0 109.66 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -84.0 -29.65 26.8 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.686 0.755 . . . . 0.0 109.187 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 35.6 t -169.3 155.5 6.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.121 -0.987 . . . . 0.0 109.289 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -137.42 108.86 6.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 0.0 109.779 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' ASP . . . . . 0.42 ' OD2' ' O ' ' B' ' 22' ' ' GLU . 0.8 OUTLIER -132.91 149.12 72.01 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.293 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.5 -7.76 19.89 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.327 2.018 . . . . 0.0 111.607 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -114.47 -20.96 10.56 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.781 0.8 . . . . 0.0 109.03 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.431 ' CD ' ' NZ ' ' B' ' 35' ' ' LYS . 74.6 tt0 -153.46 115.62 4.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.142 -0.974 . . . . 0.0 109.078 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 81.3 mt -115.88 130.22 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.217 -0.927 . . . . 0.0 109.959 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 14.5 mt -112.39 126.34 55.17 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 81.1 mt -120.57 125.91 48.97 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.808 0.813 . . . . 0.0 109.148 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -95.12 110.4 22.35 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.583 ' O ' ' N ' ' B' ' 29' ' ' GLN . 0.1 OUTLIER -113.92 151.74 31.82 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.313 0.578 . . . . 0.0 110.031 -178.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' B' ' 27' ' ' THR . 55.0 mt 34.51 -85.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-O 121.161 0.505 . . . . 0.0 110.765 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.583 ' N ' ' O ' ' B' ' 27' ' ' THR . 20.5 pt20 -138.51 -14.91 1.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.127 -0.983 . . . . 0.0 109.638 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.01 165.19 20.76 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.971 -1.081 . . . . 0.0 110.807 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 53.1 t -122.32 132.93 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.253 -1.145 . . . . 0.0 109.107 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.465 HD13 HD13 ' A' ' 60' ' ' LEU . 53.9 tp -115.58 137.57 51.93 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.335 0.588 . . . . 0.0 109.926 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.11 138.15 53.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.607 -0.683 . . . . 0.0 109.167 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 5.0 mp -115.25 130.89 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.591 -0.693 . . . . 0.0 109.426 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' LYS . . . . . 0.431 ' NZ ' ' CD ' ' B' ' 22' ' ' GLU . 68.3 mttm -128.57 140.99 51.51 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.518 0.675 . . . . 0.0 109.837 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.99 -139.27 5.46 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' B' ' 38' ' ' LYS . 0.4 OUTLIER -117.59 138.31 52.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.627 -0.925 . . . . 0.0 109.059 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' LYS . . . . . 0.44 ' C ' HD12 ' B' ' 39' ' ' LEU . 32.3 mtmm 36.42 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.996 0.903 . . . . 0.0 110.754 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.483 HD12 ' N ' ' B' ' 39' ' ' LEU . 9.1 mp -100.14 71.6 1.61 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.633 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.898 -178.4 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 121.691 0.757 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -120.71 147.16 45.66 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.94 135.06 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.432 -0.793 . . . . 0.0 109.308 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.12 126.12 49.93 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.63 0.729 . . . . 0.0 109.744 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.02 171.2 23.66 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.04 111.94 23.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.29 -1.123 . . . . 0.0 108.805 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -74.24 112.18 10.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.311 -0.868 . . . . 0.0 109.564 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -101.53 -11.46 19.26 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.58 143.17 6.93 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.726 -1.234 . . . . 0.0 110.744 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.559 HD13 HD13 ' A' ' 32' ' ' LEU . 15.0 mt -127.1 144.64 50.98 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.472 HG22 HD12 ' A' ' 64' ' ' LEU . 2.3 t -135.36 128.27 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.534 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' TYR . . . . . 0.434 ' HD2' ' H ' ' B' ' 64' ' ' LEU . 73.3 t80 -140.14 137.37 17.96 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -36.52 -39.62 0.42 Allowed 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.414 2.076 . . . . 0.0 112.506 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' LEU . . . . . 0.677 HD23 ' O ' ' B' ' 64' ' ' LEU . 2.2 tt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.9 mtp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.344 0.592 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -86.35 109.5 19.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.883 . . . . 0.0 109.587 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -104.95 5.86 33.1 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -73.95 143.04 45.85 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.311 -0.868 . . . . 0.0 109.142 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.486 ' NE2' ' OG1' ' B' ' 27' ' ' THR . 79.1 mt-30 -144.65 158.02 43.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.2 -0.938 . . . . 0.0 109.803 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -114.91 132.7 56.45 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.6 tt -121.68 130.27 53.35 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.3 p -127.04 147.43 50.15 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.527 -0.733 . . . . 0.0 109.745 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.2 tp -158.56 160.47 36.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.402 -0.811 . . . . 0.0 109.162 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t -151.52 -165.94 2.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.42 -0.8 . . . . 0.0 108.972 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.48 28.35 55.57 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.0 t -66.4 137.83 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.512 -0.993 . . . . 0.0 109.839 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.4 p -72.63 -37.0 68.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 0.0 109.261 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -170.37 163.59 8.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.0 109.451 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.1 t -98.5 96.5 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.23 -0.919 . . . . 0.0 109.3 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -66.23 -38.83 88.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.148 -0.97 . . . . 0.0 108.977 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.6 t -170.26 161.54 8.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.823 . . . . 0.0 109.294 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -146.6 105.49 3.86 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.93 151.62 78.82 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.543 -0.723 . . . . 0.0 109.186 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.87 -16.82 32.84 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.159 1.906 . . . . 0.0 111.086 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -104.97 -10.59 17.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.524 -0.735 . . . . 0.0 109.475 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -169.28 131.4 1.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.413 -0.805 . . . . 0.0 109.209 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.79 129.33 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.695 -0.628 . . . . 0.0 109.496 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.3 mt -120.48 118.41 30.2 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -133.39 127.93 34.49 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -91.01 123.8 34.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.923 -1.11 . . . . 0.0 109.692 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.611 ' O ' ' N ' ' A' ' 29' ' ' GLN . 1.9 t -119.39 149.24 42.16 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.7 mt 50.46 -80.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.3 pt20 -153.45 -18.19 0.14 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.967 -1.083 . . . . 0.0 110.67 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.67 168.94 26.81 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.36 131.95 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.447 -1.031 . . . . 0.0 109.598 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.0 tp -108.23 128.79 55.03 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.465 0.65 . . . . 0.0 109.445 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.5 t -111.42 126.25 54.74 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.3 mm -106.54 127.53 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.798 -0.564 . . . . 0.0 109.551 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -122.94 135.08 54.35 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.17 -156.5 19.53 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -135.84 146.44 47.49 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.417 -1.049 . . . . 0.0 108.825 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt 55.79 56.45 6.09 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.626 -0.672 . . . . 0.0 110.193 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 39' ' ' LEU . 7.6 mp -93.64 68.84 4.05 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.946 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -179.075 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 47' ' ' LYS . 42.0 tp . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.566 ' C ' ' H ' ' A' ' 49' ' ' GLY . 52.7 mmtt 55.93 152.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.201 1.0 . . . . 0.0 111.311 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 57.52 -4.04 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.741 -0.599 . . . . 0.0 110.159 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 47' ' ' LYS . . . 63.85 24.39 68.26 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -111.98 153.09 27.31 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.563 -0.963 . . . . 0.0 109.174 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 p -126.88 139.16 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.47 -0.769 . . . . 0.0 108.937 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -114.82 160.11 19.84 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -137.43 138.15 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.31 -0.869 . . . . 0.0 109.121 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -120.68 124.79 46.06 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.47 172.78 31.39 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.99 127.64 44.06 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.492 -1.005 . . . . 0.0 108.817 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.4 mt -83.01 117.1 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.058 -1.027 . . . . 0.0 109.284 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -96.96 -12.18 23.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.327 -0.858 . . . . 0.0 109.284 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -173.86 154.27 2.35 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.177 -0.952 . . . . 0.0 110.196 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.433 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 13.6 mt -137.17 134.7 36.61 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.2 t -133.23 123.83 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.234 -0.916 . . . . 0.0 109.708 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.54 ' CE1' ' O ' ' A' ' 63' ' ' PRO . 15.3 t80 -139.72 120.72 9.51 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.54 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 31.5 Cg_exo -56.86 127.86 27.58 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 CA-C-N 120.641 1.265 . . . . 0.0 111.109 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.832 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -103.59 49.76 0.82 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.19 -0.944 . . . . 0.0 109.005 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -51.11 84.5 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.162 -0.961 . . . . 0.0 110.374 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.611 ' N ' ' O ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER -175.98 -30.39 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.403 ' CD2' ' O ' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -70.39 134.0 47.43 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.618 -0.676 . . . . 0.0 109.849 -179.415 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 69' ' ' HIS . 0.1 OUTLIER -127.57 -39.72 1.82 Allowed 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 68' ' ' HIS . 2.2 t-80 57.38 151.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.665 0.745 . . . . 0.0 110.432 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -76.58 -68.39 0.6 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -0.929 . . . . 0.0 109.844 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.6 t60 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 117.939 -1.029 . . . . 0.0 109.522 -179.32 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' B' ' 3' ' ' ASN . 21.6 t70 60.11 -176.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.501 -0.749 . . . . 0.0 110.176 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.462 ' N ' ' OD1' ' B' ' 3' ' ' ASN . 13.7 p-10 -126.57 -18.55 4.79 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.643 -0.661 . . . . 0.0 109.476 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -68.84 141.04 55.22 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.313 -0.867 . . . . 0.0 109.436 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . 0.516 ' NE2' ' OG1' ' A' ' 27' ' ' THR . 26.5 mt-30 -146.74 158.27 43.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.183 -0.948 . . . . 0.0 109.782 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -103.81 135.63 44.99 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.504 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.2 tt -138.41 125.48 21.39 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.396 -0.815 . . . . 0.0 108.841 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.474 ' N ' HD23 ' B' ' 7' ' ' LEU . 1.8 m -129.41 149.31 51.25 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 16.4 tp -145.96 146.52 31.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.225 -0.922 . . . . 0.0 109.302 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -132.74 171.33 14.02 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.547 -0.72 . . . . 0.0 109.192 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.75 23.21 70.33 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -77.61 137.17 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -1.158 . . . . 0.0 109.612 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 41.2 t -71.03 -44.31 66.09 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.061 -1.024 . . . . 0.0 109.882 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.68 151.81 4.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.899 -1.126 . . . . 0.0 110.36 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 70.4 t -85.55 130.35 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.458 -0.776 . . . . 0.0 109.349 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -98.54 -42.15 7.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.176 -0.953 . . . . 0.0 109.919 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -157.57 118.7 3.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.111 -0.993 . . . . 0.0 109.261 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -111.86 106.39 15.1 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.472 -0.768 . . . . 0.0 109.133 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -132.42 151.08 77.61 Favored Pre-proline 0 N--CA 1.498 1.971 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.36 -20.27 48.75 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.12 1.88 . . . . 0.0 112.18 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -110.89 6.9 21.56 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.366 -0.834 . . . . 0.0 109.408 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -170.46 137.94 1.47 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.346 -0.846 . . . . 0.0 109.172 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 91.3 mt -137.92 128.37 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.17 -0.956 . . . . 0.0 109.478 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 mt -124.21 109.83 13.91 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 86.7 mt -113.77 124.2 51.69 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -83.36 104.89 13.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.285 -0.884 . . . . 0.0 109.15 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.486 ' OG1' ' NE2' ' A' ' 5' ' ' GLN . 13.8 t -123.95 -178.92 4.21 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.397 0.618 . . . . 0.0 109.548 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' B' ' 27' ' ' THR . 8.6 mm -34.31 157.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.908 0.861 . . . . 0.0 110.629 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 64.94 -57.76 0.27 Allowed 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.961 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' B' ' 28' ' ' ILE . . . -171.36 -131.61 1.37 Allowed Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.214 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -121.47 134.43 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.718 -0.872 . . . . 0.0 110.175 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 29.3 tp -100.0 126.58 46.21 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -106.34 135.33 48.03 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.541 -0.724 . . . . 0.0 109.619 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 79.7 mt -124.71 132.39 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -124.82 141.53 52.05 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.546 0.689 . . . . 0.0 109.85 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.23 -153.23 21.65 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -130.95 143.74 50.95 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.204 -1.174 . . . . 0.0 109.421 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 55.66 57.0 5.61 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.589 -0.695 . . . . 0.0 109.704 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.437 HD12 ' N ' ' B' ' 39' ' ' LEU . 9.1 mp -97.5 72.29 2.35 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.432 -0.792 . . . . 0.0 109.194 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.002 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.588 HD23 ' N ' ' B' ' 47' ' ' LYS . 2.5 tt . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.612 ' C ' ' H ' ' B' ' 49' ' ' GLY . 18.0 ptpt -108.59 -161.92 0.79 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.346 -0.846 . . . . 0.0 109.261 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' B' ' 47' ' ' LYS . . . 63.73 -20.83 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.442 -0.786 . . . . 0.0 109.838 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . 0.612 ' H ' ' C ' ' B' ' 47' ' ' LYS . . . 78.0 25.5 62.0 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -101.9 160.04 14.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.472 -1.016 . . . . 0.0 109.393 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -122.03 132.99 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.491 -0.756 . . . . 0.0 109.149 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -125.91 132.83 52.05 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.2 t -129.99 135.21 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -124.38 133.32 53.45 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.436 -0.79 . . . . 0.0 108.967 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.51 -178.38 39.08 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.415 ' H ' HD23 ' B' ' 56' ' ' LEU . 0.2 OUTLIER -95.13 120.64 35.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.412 -1.052 . . . . 0.0 108.927 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.3 mt -91.79 110.27 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.078 -1.014 . . . . 0.0 108.762 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -97.88 -16.43 19.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.373 -0.829 . . . . 0.0 109.997 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.96 147.33 23.98 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.823 -1.173 . . . . 0.0 110.884 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.43 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 13.1 mt -139.15 132.16 29.51 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 54.2 t -130.64 127.01 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.308 -0.87 . . . . 0.0 109.318 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 14.6 t80 -138.71 141.44 30.77 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.531 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 71.9 Cg_endo -76.6 112.41 3.45 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.867 1.711 . . . . 0.0 111.908 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.871 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -98.98 48.46 0.96 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.187 -0.946 . . . . 0.0 109.022 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' B' ' 67' ' ' HIS . 5.7 mm-40 -76.34 -95.97 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 109.784 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.639 ' ND1' ' N ' ' B' ' 66' ' ' HIS . 0.1 OUTLIER 61.48 -70.57 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.477 -0.765 . . . . 0.0 109.884 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.538 ' N ' ' O ' ' B' ' 65' ' ' GLU . 2.5 m-70 -118.53 158.15 25.94 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.452 ' ND1' ' N ' ' B' ' 68' ' ' HIS . 8.0 m80 -77.01 136.96 38.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.166 -0.959 . . . . 0.0 110.111 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -154.88 95.46 1.76 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -140.57 149.81 42.86 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.38 -0.825 . . . . 0.0 109.968 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 117.952 -1.023 . . . . 0.0 108.943 179.511 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ptp . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -93.57 106.52 18.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.066 -1.021 . . . . 0.0 108.399 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -152.16 -19.1 0.18 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.515 -0.741 . . . . 0.0 109.533 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 43.2 mmm-85 -59.77 142.47 53.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.559 -0.713 . . . . 0.0 110.525 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.444 ' CD ' HD11 ' B' ' 9' ' ' LEU . 2.8 pt20 -154.34 162.12 41.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.477 -0.764 . . . . 0.0 109.579 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 9.7 m-85 -106.66 130.86 54.33 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.552 -0.718 . . . . 0.0 109.469 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.698 HD21 ' CD1' ' B' ' 9' ' ' LEU . 4.0 mm? -113.64 146.83 39.16 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.143 0.973 . . . . 0.0 109.267 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.0 t -139.44 143.2 37.49 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.374 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.748 HD11 ' NE2' ' B' ' 5' ' ' GLN . 17.4 tp -155.22 139.47 16.62 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.342 -0.848 . . . . 0.0 109.743 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 t -145.33 164.9 30.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.397 -0.814 . . . . 0.0 109.376 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.61 11.55 77.18 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 13' ' ' SER . 21.6 t -66.82 159.78 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.769 -0.842 . . . . 0.0 110.633 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.447 ' N ' HG12 ' A' ' 12' ' ' VAL . 22.1 p -74.68 -53.09 9.95 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.4 ' N ' ' OG ' ' A' ' 13' ' ' SER . 0.0 OUTLIER -171.7 158.09 4.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.261 -0.9 . . . . 0.0 109.706 179.215 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 t -83.8 108.18 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.86 . . . . 0.0 110.099 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -66.89 -41.57 86.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.426 -0.796 . . . . 0.0 109.094 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.8 t -172.62 143.62 1.34 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.414 -0.804 . . . . 0.0 109.18 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -127.61 116.72 20.76 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.55 -0.719 . . . . 0.0 109.227 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.0 147.87 67.11 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.84 -16.82 46.53 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.835 1.69 . . . . 0.0 110.77 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.4 mtmm -98.39 -7.86 27.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.621 -0.675 . . . . 0.0 109.198 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 23' ' ' ILE . 9.5 tm-20 -174.61 150.84 1.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.366 -0.833 . . . . 0.0 109.082 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.479 ' N ' ' CD ' ' A' ' 22' ' ' GLU . 96.5 mt -133.44 130.86 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.299 -0.875 . . . . 0.0 109.991 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.2 mt -115.52 128.11 55.76 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 97.2 mt -128.54 132.48 48.27 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.393 -0.817 . . . . 0.0 109.155 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -98.81 110.22 22.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 108.709 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.611 ' O ' ' N ' ' A' ' 29' ' ' GLN . 12.3 t -113.43 149.06 34.73 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.411 0.624 . . . . 0.0 109.97 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.446 ' N ' HD13 ' A' ' 28' ' ' ILE . 3.8 mm 43.26 -80.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.652 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.611 ' N ' ' O ' ' A' ' 27' ' ' THR . 9.0 mt-30 -143.58 -24.65 0.58 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.11 -0.994 . . . . 0.0 109.836 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.01 174.78 36.01 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.2 t -118.76 130.31 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.849 -0.795 . . . . 0.0 109.019 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.46 HD13 HD13 ' B' ' 60' ' ' LEU . 31.1 tp -103.75 126.59 50.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.582 -0.699 . . . . 0.0 109.42 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.7 t -113.35 128.11 56.35 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.5 mt -107.27 130.33 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -124.42 138.6 54.34 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.477 0.656 . . . . 0.0 109.416 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.71 -144.92 8.65 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -133.93 144.46 48.84 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.317 -1.108 . . . . 0.0 108.939 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' A' ' 54' ' ' GLU . 71.1 mmtt 58.3 57.69 3.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 0.0 109.351 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.1 mp -95.56 72.79 3.18 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.601 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 46' ' ' LEU . 10.2 mp . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 120.655 0.264 . . . . 0.0 110.775 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.0 tttt 59.91 -70.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.243 0.544 . . . . 0.0 109.862 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . -72.21 0.95 8.48 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.454 -0.778 . . . . 0.0 109.446 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.82 28.94 74.09 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -134.11 161.05 35.94 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.441 -1.035 . . . . 0.0 109.338 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.0 t -113.79 132.23 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -125.95 141.02 52.16 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.1 t -131.0 133.67 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.508 ' OE1' ' CD2' ' A' ' 6' ' ' PHE . 27.1 tp10 -117.69 143.13 46.48 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.71 -172.7 30.4 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.93 126.95 54.42 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.632 -0.922 . . . . 0.0 109.218 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.31 118.96 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.033 -1.042 . . . . 0.0 109.552 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -98.7 -19.5 17.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.414 -0.804 . . . . 0.0 108.855 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -168.25 154.33 7.18 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.131 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.446 HD13 HD13 ' B' ' 32' ' ' LEU . 12.9 mt -133.32 139.48 46.89 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.2 t -134.58 122.41 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.526 -0.734 . . . . 0.0 109.796 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.439 ' CD1' ' C ' ' A' ' 62' ' ' TYR . 10.0 t80 -136.23 139.79 30.97 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.16 87.71 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.472 1.448 . . . . 0.0 112.245 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.708 ' CD2' ' H ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER -99.18 7.82 45.42 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 64' ' ' LEU . 3.0 pp20? -37.33 154.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.576 0.703 . . . . 0.0 110.771 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.655 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 0.3 OUTLIER -158.09 75.47 0.75 Allowed 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 179.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.571 ' C ' ' O ' ' A' ' 66' ' ' HIS . 5.7 m-70 -18.39 -92.14 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.671 -0.643 . . . . 0.0 110.88 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.496 ' ND1' ' N ' ' A' ' 69' ' ' HIS . 16.2 p80 -176.46 -156.15 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.496 ' N ' ' ND1' ' A' ' 68' ' ' HIS . 1.7 t60 73.7 162.69 0.26 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.505 0.669 . . . . 0.0 110.296 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -157.07 -3.28 0.11 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.511 0.672 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' B' ' 2' ' ' ASP . 0.0 OUTLIER -166.92 -171.31 1.77 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.738 -179.321 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' B' ' 3' ' ' ASN . 8.9 p-10 -86.36 -1.05 57.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.462 -0.774 . . . . 0.0 110.088 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -79.53 139.11 37.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.586 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . 0.748 ' NE2' HD11 ' A' ' 9' ' ' LEU . 4.0 pt20 -148.14 158.43 44.07 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.138 -0.976 . . . . 0.0 109.734 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -113.94 134.35 54.88 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.483 -0.76 . . . . 0.0 109.021 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 6.8 mt -116.06 147.3 41.41 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 43.1 t -141.04 131.67 25.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.497 -0.752 . . . . 0.0 109.577 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.698 ' CD1' HD21 ' A' ' 7' ' ' LEU . 25.1 tp -142.82 145.25 33.02 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.501 ' O ' ' N ' ' B' ' 12' ' ' VAL . 14.1 p -68.25 165.64 18.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.208 -0.933 . . . . 0.0 110.649 -178.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -45.19 92.87 0.01 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.523 HG22 ' N ' ' B' ' 13' ' ' SER . 9.3 p -48.2 168.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.51 -0.994 . . . . 0.0 110.26 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . 0.523 ' N ' HG22 ' B' ' 12' ' ' VAL . 15.7 m -72.86 -39.8 66.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.665 -0.647 . . . . 0.0 110.528 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -148.98 147.66 28.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.883 -1.136 . . . . 0.0 109.949 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 78.6 t -103.32 97.48 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -65.13 -41.83 94.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.851 . . . . 0.0 109.83 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 31.1 t -174.43 147.0 1.1 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.886 . . . . 0.0 109.07 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . 0.512 ' CE1' HD12 ' B' ' 23' ' ' ILE . 1.6 t80 -128.88 112.46 14.13 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.454 ' H ' HD13 ' B' ' 23' ' ' ILE . 4.9 m-20 -130.7 148.14 68.91 Favored Pre-proline 0 N--CA 1.498 1.93 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.6 -10.33 28.37 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.792 1.662 . . . . 0.0 111.496 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -118.38 3.86 11.86 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.768 -0.582 . . . . 0.0 109.64 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -172.07 129.76 0.61 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.261 -0.899 . . . . 0.0 109.382 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.512 HD12 ' CE1' ' B' ' 18' ' ' PHE . 50.8 mm -122.03 121.65 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.347 -0.845 . . . . 0.0 109.214 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 58.4 mt -119.21 114.53 22.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 46.3 mt -131.35 127.11 36.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.394 -0.816 . . . . 0.0 108.883 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -87.39 111.34 21.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.021 -1.049 . . . . 0.0 109.414 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.618 ' O ' ' N ' ' B' ' 29' ' ' GLN . 9.6 t -105.74 150.06 25.86 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.475 -0.766 . . . . 0.0 109.96 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 57.5 mt 38.26 -84.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 121.06 0.457 . . . . 0.0 110.485 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.618 ' N ' ' O ' ' B' ' 27' ' ' THR . 15.9 pt20 -139.4 -19.47 0.96 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.338 -0.851 . . . . 0.0 110.26 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.58 166.24 23.91 Favored Glycine 0 N--CA 1.496 2.654 0 O-C-N 121.077 -1.015 . . . . 0.0 110.665 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 69.1 t -114.97 131.31 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.725 -0.868 . . . . 0.0 108.668 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.446 HD13 HD13 ' A' ' 60' ' ' LEU . 52.7 tp -109.77 127.61 54.75 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.613 -0.679 . . . . 0.0 109.24 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.5 t -117.23 124.2 48.48 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 74.1 mt -110.18 131.38 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.387 -0.821 . . . . 0.0 108.997 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -124.84 139.56 53.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.546 -0.721 . . . . 0.0 109.365 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.67 -144.69 8.05 Favored Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.566 ' OE1' ' N ' ' B' ' 37' ' ' GLU . 7.5 mp0 -138.65 147.44 42.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.522 -0.987 . . . . 0.0 109.204 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' B' ' 54' ' ' GLU . 68.8 mmtt 62.54 49.75 3.87 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.667 -0.646 . . . . 0.0 109.94 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.576 HD12 ' N ' ' B' ' 39' ' ' LEU . 10.0 mp -93.01 71.17 4.63 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.005 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -178.736 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.557 HD12 ' N ' ' B' ' 46' ' ' LEU . 10.8 mp . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.573 0.701 . . . . 0.0 109.647 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -92.47 -80.39 0.37 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.411 -0.805 . . . . 0.0 109.459 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.05 6.38 25.62 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.83 15.78 69.51 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -90.63 160.31 15.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.439 -1.036 . . . . 0.0 109.683 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.18 144.02 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.405 -0.809 . . . . 0.0 109.252 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -136.97 149.93 47.84 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.427 HG12 ' N ' ' B' ' 54' ' ' GLU . 23.8 t -130.62 159.16 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.311 -0.868 . . . . 0.0 109.623 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.427 ' N ' HG12 ' B' ' 53' ' ' VAL . 7.5 pt-20 -143.38 144.33 32.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.332 -0.855 . . . . 0.0 109.244 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.46 -175.53 31.82 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.54 113.85 27.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.442 -1.034 . . . . 0.0 109.208 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.592 HD12 ' N ' ' B' ' 57' ' ' ILE . 1.5 mp -81.14 127.07 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.156 -0.965 . . . . 0.0 109.759 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -101.78 -23.0 14.26 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.07 155.01 15.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.043 -1.036 . . . . 0.0 110.655 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.46 HD13 HD13 ' A' ' 32' ' ' LEU . 14.0 mt -130.82 142.56 50.4 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.473 HG22 HD12 ' A' ' 64' ' ' LEU . 71.3 t -134.19 119.77 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.421 -0.8 . . . . 0.0 109.177 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.591 ' O ' HD13 ' B' ' 64' ' ' LEU . 50.2 t80 -133.71 102.86 12.32 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.66 97.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.829 1.686 . . . . 0.0 112.745 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.779 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -88.23 11.78 15.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.483 -0.761 . . . . 0.0 109.22 179.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' B' ' 64' ' ' LEU . 1.6 pm0 44.22 178.68 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 122.25 1.024 . . . . 0.0 112.082 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -174.84 73.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 109.138 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -68.24 -60.01 2.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.263 -0.898 . . . . 0.0 109.189 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.55 -178.76 6.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 110.483 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.537 ' O ' ' N ' ' B' ' 71' ' ' HIS . 0.1 OUTLIER -176.39 -120.89 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.083 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.461 ' H ' ' HB3' ' B' ' 69' ' ' HIS . 1.0 OUTLIER -45.66 -16.3 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.508 -1.37 . . . . 0.0 109.873 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' B' ' 69' ' ' HIS . 27.4 t60 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 118.113 -0.946 . . . . 0.0 109.874 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.4 mmm . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.458 0.647 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.2 t70 63.34 114.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.459 -0.776 . . . . 0.0 109.921 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -100.88 -14.2 18.05 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.445 -0.784 . . . . 0.0 109.594 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.3 mmm-85 -69.4 138.3 53.48 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.5 -0.75 . . . . 0.0 109.693 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -150.44 155.75 40.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.454 -0.779 . . . . 0.0 109.139 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -114.34 131.93 56.37 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.611 HD23 ' N ' ' A' ' 8' ' ' SER . 6.0 tt -120.3 123.73 43.87 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.611 ' N ' HD23 ' A' ' 7' ' ' LEU . 38.3 t -109.93 132.24 54.34 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.498 -0.751 . . . . 0.0 109.601 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.624 HD11 ' NE2' ' B' ' 5' ' ' GLN . 44.6 tp -146.92 147.29 30.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.785 . . . . 0.0 109.232 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.408 HG21 ' OE1' ' A' ' 50' ' ' GLN . 1.9 t -148.43 177.74 9.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.306 -0.871 . . . . 0.0 109.187 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.3 20.98 76.51 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.5 p -62.46 144.37 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.586 -0.949 . . . . 0.0 110.001 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.3 t -72.38 -42.7 64.93 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.543 -0.723 . . . . 0.0 109.573 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -165.12 160.65 18.95 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.983 -1.073 . . . . 0.0 110.179 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -94.85 108.89 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -81.9 -56.3 4.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -0.816 . . . . 0.0 110.024 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 t -162.18 127.16 3.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.304 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.492 ' CE1' HD12 ' A' ' 23' ' ' ILE . 1.7 t80 -109.66 117.43 33.91 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.423 ' H ' HD13 ' A' ' 23' ' ' ILE . 1.1 m-20 -131.05 148.41 70.14 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 121.309 -0.869 . . . . 0.0 109.466 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.66 -11.8 31.73 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.508 1.472 . . . . 0.0 110.515 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -105.71 -14.52 15.23 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.791 -0.568 . . . . 0.0 110.094 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -167.82 145.89 4.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.232 -0.917 . . . . 0.0 109.306 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.492 HD12 ' CE1' ' A' ' 18' ' ' PHE . 51.2 mm -121.74 125.29 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.561 -0.712 . . . . 0.0 109.079 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.4 mt -118.39 115.56 24.92 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.4 mt -133.38 133.56 42.59 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -75.7 116.33 16.3 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.312 -0.867 . . . . 0.0 109.3 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.499 ' O ' ' C ' ' A' ' 28' ' ' ILE . 13.3 t -114.51 146.96 40.06 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.499 ' C ' ' O ' ' A' ' 27' ' ' THR . 10.0 mm -1.97 -75.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 C-N-CA 123.557 0.743 . . . . 0.0 112.932 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.469 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 99.4 mm-40 -59.35 -71.01 0.13 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.438 -0.789 . . . . 0.0 111.749 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.55 -128.24 1.9 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.2 t -116.72 131.81 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 CA-C-O 121.916 0.865 . . . . 0.0 110.711 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.4 tp -100.71 129.86 46.67 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.7 m -110.21 120.69 43.24 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.6 mt -105.32 124.04 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -118.41 141.32 48.66 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.754 0.788 . . . . 0.0 109.35 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.444 ' HA2' ' H ' ' A' ' 58' ' ' ASP . . . -179.58 -138.56 3.36 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.401 ' O ' ' OE1' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.78 132.35 43.71 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.48 -1.012 . . . . 0.0 108.353 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp 39.72 86.13 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.642 0.734 . . . . 0.0 110.646 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.2 mp -96.8 72.12 2.58 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.686 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.539 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 46' ' ' LEU . 9.5 mp . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.506 0.67 . . . . 0.0 109.584 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -63.35 -51.12 67.23 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.495 -0.753 . . . . 0.0 109.542 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.06 49.31 0.78 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.457 -0.777 . . . . 0.0 109.872 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.99 20.31 79.92 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.408 ' OE1' HG21 ' A' ' 10' ' ' THR . 94.1 mm-40 -104.23 159.68 15.5 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.294 -1.121 . . . . 0.0 109.032 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.7 t -122.22 133.08 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.539 ' N ' ' OE1' ' A' ' 52' ' ' GLU . 13.3 mp0 -131.67 146.68 52.31 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.501 0.667 . . . . 0.0 109.428 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.1 t -129.06 134.41 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -117.32 134.76 54.43 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.694 0.759 . . . . 0.0 109.243 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.83 -176.05 34.21 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -103.71 120.92 41.91 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.9 mt -83.76 116.9 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.056 -1.028 . . . . 0.0 109.772 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.444 ' H ' ' HA2' ' A' ' 36' ' ' GLY . 59.0 m-20 -96.99 -15.42 21.09 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.481 -0.762 . . . . 0.0 109.81 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.6 152.96 8.67 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.083 -1.011 . . . . 0.0 110.446 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.418 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 8.8 mt -138.63 134.97 34.41 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 49.7 t -130.86 124.91 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.496 -0.753 . . . . 0.0 109.421 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.556 ' O ' ' N ' ' A' ' 64' ' ' LEU . 33.7 t80 -133.63 111.54 12.55 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.12 78.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.413 1.409 . . . . 0.0 112.326 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.895 HD12 HG22 ' B' ' 61' ' ' VAL . 0.4 OUTLIER -75.08 84.14 2.31 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.528 -1.358 . . . . 0.0 108.667 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -163.47 126.63 2.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.562 -0.711 . . . . 0.0 109.555 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.627 ' CE1' ' ND1' ' A' ' 67' ' ' HIS . 14.9 p-80 -88.23 11.04 17.53 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.627 ' ND1' ' CE1' ' A' ' 66' ' ' HIS . 27.8 p-80 -152.44 165.07 36.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.582 -0.699 . . . . 0.0 109.659 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -153.97 41.36 0.51 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -167.48 -177.92 3.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.393 -0.817 . . . . 0.0 109.68 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.467 ' O ' ' OXT' ' A' ' 71' ' ' HIS . 1.4 p-80 -153.86 -55.49 0.11 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.193 -0.942 . . . . 0.0 109.29 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.467 ' OXT' ' O ' ' A' ' 70' ' ' HIS . 71.3 m-70 . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 117.903 -1.046 . . . . 0.0 109.838 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 78.8 mtm . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.444 0.64 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 13.7 t0 62.88 33.44 15.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.471 -0.768 . . . . 0.0 109.529 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' B' ' 3' ' ' ASN . 10.7 p-10 -90.2 -5.73 56.08 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.378 -0.826 . . . . 0.0 109.809 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 38.6 mmm-85 -72.18 141.22 49.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.295 -0.878 . . . . 0.0 109.166 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . 0.624 ' NE2' HD11 ' A' ' 9' ' ' LEU . 2.8 pt20 -146.61 150.78 36.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.359 -0.838 . . . . 0.0 109.477 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -98.49 144.82 27.42 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.458 HD23 ' N ' ' B' ' 8' ' ' SER . 7.0 tt -127.79 125.9 40.71 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.458 ' N ' HD23 ' B' ' 7' ' ' LEU . 3.7 m -122.17 145.44 48.19 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.533 -0.73 . . . . 0.0 110.126 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.6 tp -153.17 149.29 27.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.4 t -151.15 159.06 44.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.089 -1.007 . . . . 0.0 109.885 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.49 15.07 72.13 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.6 p -62.3 153.03 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -1.079 . . . . 0.0 110.378 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 67.1 m -73.71 -54.07 8.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.15 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.41 153.34 4.3 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.2 -0.937 . . . . 0.0 109.614 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 79.8 t -86.22 130.12 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.416 -0.802 . . . . 0.0 109.886 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -92.8 -23.82 18.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.291 -0.88 . . . . 0.0 109.378 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 21.5 t -171.55 158.16 5.03 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.133 -0.98 . . . . 0.0 109.893 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -147.52 112.27 5.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.401 -0.812 . . . . 0.0 109.492 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.458 ' OD2' ' O ' ' B' ' 22' ' ' GLU . 1.1 m-20 -133.18 152.88 80.35 Favored Pre-proline 0 N--CA 1.5 2.067 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.58 -12.61 36.23 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.654 1.569 . . . . 0.0 111.556 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -125.88 2.48 7.37 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.574 -0.704 . . . . 0.0 109.563 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.458 ' O ' ' OD2' ' B' ' 19' ' ' ASP . 55.1 tt0 -160.85 119.63 2.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.334 -0.853 . . . . 0.0 109.256 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.6 mt -129.02 127.87 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.173 -0.955 . . . . 0.0 109.416 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 79.3 mt -108.77 134.92 50.82 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 93.7 mt -135.05 123.42 23.21 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.349 -0.845 . . . . 0.0 109.7 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -93.93 123.17 37.11 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.566 ' O ' ' N ' ' B' ' 29' ' ' GLN . 7.0 t -123.58 149.45 45.28 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.606 0.717 . . . . 0.0 109.886 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 16.7 mt 45.04 -85.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.922 -0.486 . . . . 0.0 110.218 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' B' ' 27' ' ' THR . 17.1 pt20 -142.88 -20.62 0.65 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.08 -1.013 . . . . 0.0 110.201 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.98 171.59 35.88 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -116.54 131.4 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.879 -0.777 . . . . 0.0 109.125 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 31.8 tp -112.76 127.17 56.08 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.42 0.629 . . . . 0.0 109.485 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 40.5 t -108.94 123.46 49.13 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 39.3 mm -99.71 128.15 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -133.06 125.64 30.08 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.83 -139.5 2.65 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -137.94 136.93 37.47 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.349 -1.089 . . . . 0.0 109.99 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 54.84 57.84 5.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.467 -0.771 . . . . 0.0 110.09 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.565 HD12 ' N ' ' B' ' 39' ' ' LEU . 8.8 mp -85.15 72.15 10.8 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.791 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -178.716 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 66.3 mt . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.696 0.76 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -82.6 133.67 35.18 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.313 0.578 . . . . 0.0 109.479 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . 51.3 16.42 0.4 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.32 -0.862 . . . . 0.0 110.261 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.24 25.23 37.47 Favored Glycine 0 N--CA 1.496 2.651 0 O-C-N 120.823 -1.173 . . . . 0.0 110.185 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -137.24 159.71 41.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.257 -1.143 . . . . 0.0 109.089 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 5.8 p -127.86 136.88 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -146.45 159.6 43.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.236 -0.915 . . . . 0.0 110.131 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.415 HG12 ' N ' ' B' ' 54' ' ' GLU . 21.4 t -134.15 159.38 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.691 -0.63 . . . . 0.0 109.513 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.415 ' N ' HG12 ' B' ' 53' ' ' VAL . 3.3 tm-20 -127.81 142.11 51.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.435 -0.79 . . . . 0.0 109.139 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.27 -177.76 31.49 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.66 128.81 52.82 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 30.6 mm -78.61 125.34 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.073 -1.017 . . . . 0.0 109.656 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -110.09 -9.85 14.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.658 -0.652 . . . . 0.0 109.478 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -174.24 149.29 1.38 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.096 -1.002 . . . . 0.0 110.095 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.416 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 13.0 mt -138.34 137.5 37.42 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.895 HG22 HD12 ' A' ' 64' ' ' LEU . 9.4 t -134.42 122.74 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.491 -0.755 . . . . 0.0 109.982 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.418 ' CG ' ' HB2' ' A' ' 60' ' ' LEU . 26.9 t80 -140.33 106.08 6.6 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -50.59 113.05 0.89 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.302 1.334 . . . . 0.0 112.336 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.979 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -93.61 5.79 50.44 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.187 -0.946 . . . . 0.0 108.922 179.066 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.476 ' N ' HD22 ' B' ' 64' ' ' LEU . 0.7 OUTLIER -87.05 123.9 32.63 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.547 -0.721 . . . . 0.0 110.119 -179.134 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -88.25 -70.02 0.66 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.411 -0.805 . . . . 0.0 109.655 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.467 ' C ' ' H ' ' B' ' 69' ' ' HIS . 54.1 m80 -110.57 120.34 42.11 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' B' ' 70' ' ' HIS . 28.8 m80 -71.99 14.55 0.21 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.55 -0.719 . . . . 0.0 110.006 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.467 ' H ' ' C ' ' B' ' 67' ' ' HIS . 75.5 m80 59.04 -68.76 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.281 0.562 . . . . 0.0 110.397 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.644 ' ND1' ' N ' ' B' ' 70' ' ' HIS . 0.1 OUTLIER -57.04 -165.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.253 -0.905 . . . . 0.0 110.52 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.037 -179.624 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.2 mtp . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.929 0.871 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 54.5 p-10 -146.61 -157.01 0.76 Allowed 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.778 -0.576 . . . . 0.0 109.499 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.414 ' ND2' ' HG ' ' A' ' 56' ' ' LEU . 18.1 p-10 -107.66 1.84 23.42 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.305 -0.872 . . . . 0.0 109.934 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -71.18 146.67 48.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 109.649 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.58 ' NE2' HD11 ' B' ' 9' ' ' LEU . 2.8 pt20 -150.2 160.12 43.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.37 -0.831 . . . . 0.0 109.174 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -100.08 141.56 32.75 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.377 -0.827 . . . . 0.0 109.053 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 8' ' ' SER . 6.6 tt -133.76 123.85 25.61 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.516 ' N ' HD23 ' A' ' 7' ' ' LEU . 40.4 t -131.88 139.62 48.84 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.736 -0.603 . . . . 0.0 109.556 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.506 HD11 ' NE2' ' B' ' 5' ' ' GLN . 41.8 tp -133.3 147.62 51.9 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p -130.71 159.12 38.2 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.526 -0.734 . . . . 0.0 109.544 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.95 21.05 69.04 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.35 137.05 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.238 -1.154 . . . . 0.0 109.898 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.5 m -73.12 -44.35 60.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.206 -0.934 . . . . 0.0 109.796 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.56 163.2 5.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.163 -0.961 . . . . 0.0 109.564 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.0 t -93.99 127.71 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.282 -0.886 . . . . 0.0 109.433 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -85.19 -30.92 23.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.046 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.8 t -174.01 167.26 4.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.516 -0.74 . . . . 0.0 109.293 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -149.77 106.54 3.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.344 -0.847 . . . . 0.0 108.856 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.62 126.02 19.81 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -47.24 -24.21 3.58 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.361 1.374 . . . . 0.0 112.228 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -90.7 -8.15 50.67 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.985 -1.072 . . . . 0.0 109.98 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -176.65 141.58 0.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.472 -0.767 . . . . 0.0 109.081 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mt -130.76 130.58 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.105 -0.997 . . . . 0.0 109.085 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.1 mt -114.35 125.0 53.36 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.8 mt -124.33 131.35 53.51 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.566 -0.709 . . . . 0.0 109.624 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -95.28 122.59 38.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.401 -0.812 . . . . 0.0 109.162 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 29' ' ' GLN . 2.9 t -124.18 148.67 47.08 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.44 0.638 . . . . 0.0 110.348 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' A' ' 27' ' ' THR . 60.0 mt 38.09 -90.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.971 -0.455 . . . . 0.0 110.5 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.525 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.1 pt20 -136.47 -15.79 1.62 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.227 -0.921 . . . . 0.0 109.786 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.21 153.82 20.06 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.1 t -111.13 131.05 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.553 -0.969 . . . . 0.0 108.39 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.8 tp -107.34 124.07 49.27 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.693 -0.629 . . . . 0.0 109.633 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.1 m -107.49 120.36 41.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.1 mt -104.73 127.11 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.52 127.64 52.37 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.96 -148.61 5.38 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -142.79 139.23 30.91 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.4 ' C ' HD12 ' A' ' 39' ' ' LEU . 33.1 mtmm 57.25 63.3 1.92 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.524 -0.735 . . . . 0.0 110.315 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.0 mp -94.73 72.06 3.57 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.268 -0.895 . . . . 0.0 109.023 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.367 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.533 -179.087 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 47.8 tp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.216 0.532 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.534 ' C ' ' H ' ' A' ' 49' ' ' GLY . 63.2 pttt -172.39 -175.45 1.38 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.324 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 47' ' ' LYS . . . 65.78 -15.51 0.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.415 -0.803 . . . . 0.0 110.204 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' A' ' 47' ' ' LYS . . . 82.49 20.4 62.16 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 48' ' ' ALA . 20.9 mp0 -122.49 151.63 41.13 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.397 -1.061 . . . . 0.0 108.974 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.58 135.47 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.509 -0.744 . . . . 0.0 109.422 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -126.93 137.9 53.2 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.5 t -137.48 141.08 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -0.799 . . . . 0.0 108.951 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -114.96 125.21 53.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.497 -0.752 . . . . 0.0 109.033 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 168.49 166.17 27.12 Favored Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.703 HD22 ' C ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -86.77 151.42 23.39 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.52 -0.988 . . . . 0.0 110.772 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.411 HD12 ' OE1' ' A' ' 5' ' ' GLN . 87.9 mt -103.46 119.28 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.832 -1.167 . . . . 0.0 109.168 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -112.5 -11.94 13.55 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.405 -0.81 . . . . 0.0 108.995 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.78 149.03 6.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.105 -0.997 . . . . 0.0 110.086 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.5 mt -138.08 141.46 40.26 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.525 HG22 HD12 ' B' ' 64' ' ' LEU . 65.3 t -134.62 123.4 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.419 -0.801 . . . . 0.0 109.792 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.548 ' O ' ' N ' ' A' ' 64' ' ' LEU . 13.1 t80 -145.69 136.66 12.48 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -44.67 88.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.288 0 CA-C-N 120.22 1.114 . . . . 0.0 111.492 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.592 ' C ' HD23 ' A' ' 64' ' ' LEU . 1.7 tt -58.88 -14.01 7.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.245 -0.909 . . . . 0.0 109.33 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.567 ' HB2' HD23 ' A' ' 64' ' ' LEU . 21.1 tt0 -159.91 -118.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.111 -0.993 . . . . 0.0 108.854 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -109.34 146.42 34.41 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.395 -0.815 . . . . 0.0 109.615 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.584 ' ND1' ' C ' ' A' ' 67' ' ' HIS . 0.0 OUTLIER -75.93 141.33 42.3 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.447 ' O ' ' C ' ' A' ' 69' ' ' HIS . 48.1 m170 -116.95 139.93 50.07 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 177.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.683 ' ND1' ' N ' ' A' ' 69' ' ' HIS . 0.1 OUTLIER -38.91 111.01 0.15 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.491 ' O ' ' CD2' ' A' ' 70' ' ' HIS . 0.1 OUTLIER -42.04 144.61 0.43 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.563 -0.711 . . . . 0.0 110.777 -177.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.386 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.28 0.562 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -148.51 99.98 3.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.259 -0.901 . . . . 0.0 110.088 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -106.52 4.83 28.61 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.458 -0.776 . . . . 0.0 109.335 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.3 mmm-85 -77.25 141.84 39.8 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.407 -0.808 . . . . 0.0 109.12 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . 0.506 ' NE2' HD11 ' A' ' 9' ' ' LEU . 2.9 pt20 -147.63 161.3 41.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.213 -0.93 . . . . 0.0 109.591 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -116.52 130.77 56.93 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.538 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.4 tt -123.12 121.81 36.91 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.524 ' N ' HD23 ' B' ' 7' ' ' LEU . 97.8 p -114.0 145.76 41.1 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.7 -0.625 . . . . 0.0 109.695 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.58 HD11 ' NE2' ' A' ' 5' ' ' GLN . 34.1 tp -148.09 144.2 27.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.357 -0.839 . . . . 0.0 109.259 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 46.0 p -130.93 170.07 14.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.616 -0.677 . . . . 0.0 109.577 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.02 11.04 77.3 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 83.4 t -72.24 133.75 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.218 -1.166 . . . . 0.0 109.684 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.8 t -72.28 -45.37 60.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.313 -0.867 . . . . 0.0 109.605 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.21 163.06 8.93 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.077 -1.014 . . . . 0.0 109.658 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 98.1 t -84.67 110.55 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.869 . . . . 0.0 109.979 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -66.35 -41.05 90.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 0.0 109.16 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 5.5 p -160.19 163.96 33.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.338 -0.851 . . . . 0.0 108.963 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -151.21 110.68 3.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.006 -1.058 . . . . 0.0 110.073 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -132.25 150.0 74.76 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.01 -16.5 49.66 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.612 1.541 . . . . 0.0 111.479 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -111.67 -1.97 15.53 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.557 -0.714 . . . . 0.0 109.517 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.554 ' OE2' HD21 ' B' ' 24' ' ' LEU . 2.7 tm-20 -170.86 130.63 0.81 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.169 -0.957 . . . . 0.0 109.286 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -129.73 132.07 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.231 -0.918 . . . . 0.0 109.847 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.554 HD21 ' OE2' ' B' ' 22' ' ' GLU . 89.5 mt -111.4 125.57 54.01 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 76.4 mt -121.73 124.83 45.16 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.667 -0.646 . . . . 0.0 109.357 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -93.32 113.52 25.72 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.576 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.7 t -124.95 154.04 41.79 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.447 0.641 . . . . 0.0 110.028 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 18.5 mm 42.22 -86.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.883 -0.51 . . . . 0.0 110.339 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' B' ' 27' ' ' THR . 18.7 pt20 -143.51 -17.0 0.63 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.018 -1.051 . . . . 0.0 110.232 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.94 178.05 30.6 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 45.5 t -121.84 134.35 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 54.8 tp -105.42 127.28 52.9 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.368 -0.833 . . . . 0.0 109.463 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.7 m -116.55 120.69 39.52 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.716 . . . . 0.0 109.645 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 92.1 mt -109.85 129.91 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -127.92 143.22 51.1 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.627 -0.67 . . . . 0.0 109.423 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.61 -142.53 7.58 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.523 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.419 ' HB3' HD11 ' B' ' 56' ' ' LEU . 27.2 tp10 -123.0 143.72 49.74 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.627 -0.925 . . . . 0.0 109.069 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' B' ' 54' ' ' GLU . 49.5 mtmt 51.77 63.32 2.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.341 -0.849 . . . . 0.0 111.184 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.517 HD12 ' N ' ' B' ' 39' ' ' LEU . 8.7 mp -94.88 70.7 3.41 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.979 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.347 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.494 HD12 ' N ' ' B' ' 46' ' ' LEU . 11.3 mp . . . . . 0 N--CA 1.507 2.376 0 CA-C-O 121.91 0.862 . . . . 0.0 109.899 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -148.69 -43.6 0.15 Allowed 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.433 -1.417 . . . . 0.0 108.318 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.54 1.94 35.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.638 -0.664 . . . . 0.0 109.573 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.63 21.43 72.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -87.92 160.05 18.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.423 -1.045 . . . . 0.0 109.563 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 16.3 m -125.86 133.25 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.606 -0.684 . . . . 0.0 109.292 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -120.07 143.24 48.23 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.422 -0.799 . . . . 0.0 108.941 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.7 t -124.17 135.59 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.629 -0.669 . . . . 0.0 109.513 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' B' ' 38' ' ' LYS . 44.0 tt0 -125.94 135.05 51.42 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.62 -177.1 27.09 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.461 ' H ' HD23 ' B' ' 56' ' ' LEU . 0.2 OUTLIER -99.67 127.2 45.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.347 -1.09 . . . . 0.0 108.556 179.388 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.509 HD12 ' N ' ' B' ' 57' ' ' ILE . 1.3 mp -79.8 128.06 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.925 . . . . 0.0 109.752 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -108.93 -39.54 5.29 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.569 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -148.29 149.66 32.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.378 -0.826 . . . . 0.0 110.094 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.569 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.8 OUTLIER -131.69 131.21 42.9 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.473 HG13 HD12 ' A' ' 64' ' ' LEU . 47.4 t -129.09 128.77 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' B' ' 62' ' ' TYR . 19.8 t80 -143.53 140.06 17.07 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.57 85.64 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 120.986 1.124 . . . . 0.0 112.051 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.651 ' H ' ' CD2' ' B' ' 64' ' ' LEU . 0.9 OUTLIER -95.29 5.01 52.86 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.92 -18.96 2.31 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.458 -0.776 . . . . 0.0 109.64 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.467 ' C ' ' ND1' ' B' ' 67' ' ' HIS . 14.8 m-70 56.55 174.78 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.89 0.852 . . . . 0.0 110.173 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.467 ' ND1' ' C ' ' B' ' 66' ' ' HIS . 0.0 OUTLIER 52.33 169.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.03 0.919 . . . . 0.0 110.438 179.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -172.91 155.95 3.24 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -86.31 21.76 1.98 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.602 ' ND1' ' N ' ' B' ' 71' ' ' HIS . 0.2 OUTLIER -68.4 133.14 48.22 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 121.831 0.824 . . . . 0.0 109.196 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.602 ' N ' ' ND1' ' B' ' 70' ' ' HIS . 24.5 t-80 . . . . . 0 C--N 1.295 -1.795 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.291 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.388 0.614 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.7 t0 58.79 33.28 22.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.329 -0.857 . . . . 0.0 108.861 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -100.87 13.24 35.7 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.509 -0.744 . . . . 0.0 109.182 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -88.84 132.1 34.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.104 -0.997 . . . . 0.0 108.87 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -147.75 161.07 41.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.994 -1.066 . . . . 0.0 109.346 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -108.52 131.17 55.09 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.565 ' C ' HD23 ' A' ' 7' ' ' LEU . 6.3 tt -117.82 121.77 41.63 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.548 ' N ' HD23 ' A' ' 7' ' ' LEU . 46.8 t -116.04 132.34 56.68 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.538 -0.726 . . . . 0.0 109.657 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.539 HD21 ' NE2' ' B' ' 5' ' ' GLN . 5.5 tp -147.31 153.72 40.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.361 -0.837 . . . . 0.0 109.317 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.463 ' OG1' ' N ' ' A' ' 11' ' ' GLY . 6.1 t -149.85 -164.54 2.05 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.36 -0.838 . . . . 0.0 109.847 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.463 ' N ' ' OG1' ' A' ' 10' ' ' THR . . . 65.24 19.38 66.2 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.5 t -70.25 141.66 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.677 -0.896 . . . . 0.0 110.617 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.3 m -71.78 -43.5 65.6 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.91 160.36 3.55 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.234 -0.916 . . . . 0.0 109.918 179.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.2 t -88.66 129.96 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.4 -0.812 . . . . 0.0 109.852 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -97.34 -35.1 10.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.386 -0.821 . . . . 0.0 109.23 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.8 t -169.67 145.61 3.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.566 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -137.61 113.94 10.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.513 -0.742 . . . . 0.0 109.132 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -133.24 153.56 80.73 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.03 -20.08 44.82 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.295 1.997 . . . . 0.0 111.605 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -102.07 -4.56 25.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.539 -0.726 . . . . 0.0 109.318 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -172.87 142.04 1.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.444 -0.785 . . . . 0.0 109.045 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.8 mt -132.48 130.24 59.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.427 -0.796 . . . . 0.0 109.725 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.5 mt -118.06 121.44 40.59 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.6 mt -124.37 125.09 43.73 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -81.76 114.75 20.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.347 -0.846 . . . . 0.0 109.924 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 28' ' ' ILE . 14.5 t -124.68 -179.52 4.54 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.659 0.742 . . . . 0.0 110.215 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.492 ' O ' ' O ' ' A' ' 27' ' ' THR . 1.3 mt -36.51 161.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 CA-C-O 121.736 0.779 . . . . 0.0 110.414 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.414 ' OE1' ' OD1' ' B' ' 58' ' ' ASP . 78.6 mm-40 65.12 -61.9 0.22 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.139 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -165.94 -127.26 0.88 Allowed Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.093 -1.527 . . . . 0.0 109.962 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.6 t -122.37 135.18 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.593 -0.945 . . . . 0.0 110.338 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.451 HD11 HD12 ' A' ' 60' ' ' LEU . 42.8 tp -105.55 125.41 50.96 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.8 m -103.61 123.0 46.16 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -107.75 125.02 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -116.57 140.83 48.95 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -178.47 -151.38 9.43 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 109.104 -1.599 . . . . 0.0 109.104 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.415 ' HB3' HD11 ' A' ' 56' ' ' LEU . 14.1 tp10 -143.32 146.39 33.51 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.337 -1.096 . . . . 0.0 109.024 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 54' ' ' GLU . 67.5 mttm 58.33 55.22 5.14 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.486 0.66 . . . . 0.0 109.68 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.7 mp -92.9 72.64 4.81 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.849 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -179.125 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.6 tp . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.578 0.704 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -144.4 -83.94 0.15 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.735 -0.603 . . . . 0.0 109.399 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.53 -5.39 58.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 0.0 109.415 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.44 18.97 79.96 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -91.6 162.15 14.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.17 -1.194 . . . . 0.0 109.859 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.4 t -115.05 131.97 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -131.16 136.56 48.42 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.8 t -126.76 135.01 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 38' ' ' LYS . 5.1 tm-20 -116.89 126.55 53.16 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.0 -174.61 41.62 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.211 -1.471 . . . . 0.0 110.032 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.415 HD11 ' HB3' ' A' ' 37' ' ' GLU . 0.1 OUTLIER -106.42 118.21 36.06 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.809 -0.818 . . . . 0.0 109.387 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.53 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.4 mp -74.05 128.08 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.337 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -105.73 -21.9 13.07 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.629 ' O ' HD22 ' A' ' 60' ' ' LEU . . . -166.89 158.28 12.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.991 -1.068 . . . . 0.0 110.834 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.629 HD22 ' O ' ' A' ' 59' ' ' ALA . 0.7 OUTLIER -135.64 135.34 40.1 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.461 HG22 HD12 ' B' ' 64' ' ' LEU . 58.8 t -133.96 119.94 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.436 -0.79 . . . . 0.0 109.63 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 64' ' ' LEU . 29.2 t80 -133.46 140.06 35.85 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.77 68.4 0.26 Allowed 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.602 1.535 . . . . 0.0 111.924 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.608 HD12 HG22 ' B' ' 61' ' ' VAL . 0.2 OUTLIER -71.54 55.08 0.24 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.734 -0.604 . . . . 0.0 109.689 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 64' ' ' LEU . 8.1 pt-20 -39.56 -23.53 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.997 -1.065 . . . . 0.0 109.974 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.573 ' N ' ' O ' ' A' ' 64' ' ' LEU . 2.0 t-80 51.16 11.41 0.1 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.691 -0.631 . . . . 0.0 109.616 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.51 ' ND1' ' OXT' ' A' ' 71' ' ' HIS . 12.2 t-80 -140.11 119.57 13.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.425 -0.797 . . . . 0.0 109.766 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.466 ' H ' ' CD2' ' A' ' 68' ' ' HIS . 0.4 OUTLIER -74.58 144.75 43.82 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.651 0.739 . . . . 0.0 110.151 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.699 ' CD2' ' H ' ' A' ' 70' ' ' HIS . 9.1 t-160 60.79 173.17 0.1 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.39 0.614 . . . . 0.0 110.677 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.699 ' H ' ' CD2' ' A' ' 69' ' ' HIS . 15.2 m80 44.4 -115.06 0.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.51 ' OXT' ' ND1' ' A' ' 67' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 117.873 -1.061 . . . . 0.0 109.196 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.6 ttm . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.315 0.579 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 21.6 t0 56.02 69.0 0.78 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.355 -0.84 . . . . 0.0 109.635 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -104.27 17.52 23.95 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 47.2 mmm-85 -88.66 137.77 32.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.657 -1.277 . . . . 0.0 109.451 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . 0.539 ' NE2' HD21 ' A' ' 9' ' ' LEU . 46.5 tt0 -139.05 149.92 45.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.295 -0.878 . . . . 0.0 109.502 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -109.46 129.55 55.55 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.508 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.9 tt -122.69 122.49 38.88 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.46 ' N ' HD23 ' B' ' 7' ' ' LEU . 41.6 t -123.14 137.26 54.95 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.6 tp -145.25 151.59 38.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.221 -0.924 . . . . 0.0 109.835 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -140.49 159.74 41.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.708 -0.62 . . . . 0.0 109.629 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.47 24.19 26.86 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.439 HG22 ' H ' ' B' ' 14' ' ' LYS . 6.2 p -62.62 141.37 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.166 -1.197 . . . . 0.0 110.034 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 10.0 m -92.28 -21.35 20.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.411 -0.806 . . . . 0.0 109.26 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.439 ' H ' HG22 ' B' ' 12' ' ' VAL . 9.8 tttt -171.8 154.2 3.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.555 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 75.5 t -102.67 99.16 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -67.36 -40.55 85.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 109.07 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 25.8 t -170.76 167.97 7.49 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.408 -0.808 . . . . 0.0 109.523 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -149.7 105.2 3.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.532 -0.73 . . . . 0.0 109.123 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -132.77 147.82 67.04 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.59 -14.59 39.9 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 121.7 1.6 . . . . 0.0 111.735 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -104.05 -8.01 19.85 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.548 -0.72 . . . . 0.0 109.534 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -173.18 113.19 0.23 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.354 -0.841 . . . . 0.0 109.371 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 97.3 mt -109.35 127.14 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.235 -0.916 . . . . 0.0 109.221 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 68.4 mt -117.69 123.43 46.06 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 88.5 mt -131.22 129.49 41.72 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.465 -0.772 . . . . 0.0 109.391 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.2 111.47 17.65 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.604 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.487 ' O ' ' O ' ' B' ' 28' ' ' ILE . 12.9 t -124.39 -176.94 3.64 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.571 0.7 . . . . 0.0 110.29 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' B' ' 27' ' ' THR . 1.9 mt -32.62 157.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.886 0.85 . . . . 0.0 110.951 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.471 HE21 HG22 ' B' ' 28' ' ' ILE . 81.2 mm-40 64.6 -62.45 0.18 Allowed 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.939 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' B' ' 28' ' ' ILE . . . -166.34 -120.09 0.5 Allowed Glycine 0 N--CA 1.486 1.968 0 C-N-CA 119.225 -1.464 . . . . 0.0 110.202 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 53.1 t -119.4 135.03 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.676 -0.897 . . . . 0.0 110.539 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 59.0 tp -109.33 123.38 49.22 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 29.4 t -107.4 123.66 48.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.792 -0.567 . . . . 0.0 109.989 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 94.6 mt -108.52 122.37 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -117.6 142.44 47.2 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.599 -0.688 . . . . 0.0 109.457 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . 0.433 ' HA2' ' H ' ' B' ' 58' ' ' ASP . . . 174.61 -146.74 8.71 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -139.1 142.06 38.11 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.365 -1.08 . . . . 0.0 109.489 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 88.9 mttt 56.21 57.1 5.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.668 -0.645 . . . . 0.0 109.798 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.511 HD12 ' N ' ' B' ' 39' ' ' LEU . 8.6 mp -92.99 71.53 4.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.345 -0.847 . . . . 0.0 108.912 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . 0.41 ' O ' ' OE1' ' B' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 121.567 0.698 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -63.98 -46.74 83.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.607 -0.683 . . . . 0.0 109.463 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -169.71 47.77 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.384 -0.822 . . . . 0.0 108.816 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.91 17.62 62.91 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -125.15 154.58 41.28 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.316 -1.108 . . . . 0.0 109.399 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 m -124.07 133.12 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.652 -0.655 . . . . 0.0 109.381 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -126.35 127.96 46.32 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -127.92 140.68 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.46 -0.775 . . . . 0.0 109.91 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.41 ' OE1' ' O ' ' B' ' 40' ' ' GLY . 5.3 mp0 -114.99 139.58 49.73 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.92 170.66 26.97 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.16 131.33 38.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.242 -1.152 . . . . 0.0 109.469 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 44.2 mm -87.66 113.98 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.099 -1.001 . . . . 0.0 108.862 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . 0.433 ' H ' ' HA2' ' B' ' 36' ' ' GLY . 18.2 t0 -97.68 -7.0 31.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.593 -0.692 . . . . 0.0 109.222 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -177.19 154.85 1.09 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.048 -1.032 . . . . 0.0 110.823 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.4 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 11.8 mt -139.93 138.46 35.61 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.608 HG22 HD12 ' A' ' 64' ' ' LEU . 61.3 t -134.14 129.8 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.507 -0.746 . . . . 0.0 109.216 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.666 ' O ' ' N ' ' B' ' 64' ' ' LEU . 65.1 t80 -143.2 123.0 7.71 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' B' ' 65' ' ' GLU . 71.0 Cg_exo -48.44 71.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 121.983 1.788 . . . . 0.0 111.91 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.666 ' N ' ' O ' ' B' ' 62' ' ' TYR . 0.3 OUTLIER -71.53 40.89 0.07 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.886 0.851 . . . . 0.0 109.975 -179.128 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.452 ' H ' ' C ' ' B' ' 63' ' ' PRO . 13.7 mt-10 -86.58 116.57 24.79 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.265 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.547 ' O ' ' N ' ' B' ' 68' ' ' HIS . 65.1 t60 -95.07 170.06 9.68 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.503 ' O ' ' O ' ' B' ' 68' ' ' HIS . 5.3 t60 64.92 -45.0 0.34 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.547 ' N ' ' O ' ' B' ' 66' ' ' HIS . 0.1 OUTLIER 54.76 117.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.545 -0.722 . . . . 0.0 109.421 178.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.46 ' C ' ' O ' ' B' ' 68' ' ' HIS . 6.1 t-160 -33.54 91.7 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.289 0.566 . . . . 0.0 111.344 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' B' ' 68' ' ' HIS . 17.3 t-160 -89.69 -5.27 57.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.318 -0.864 . . . . 0.0 109.1 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.194 -0.941 . . . . 0.0 109.269 -179.707 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.345 0.593 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.32 113.05 24.28 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.377 -0.827 . . . . 0.0 109.556 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -93.35 1.14 57.05 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.368 -0.832 . . . . 0.0 109.705 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.6 mmm-85 -81.61 148.0 29.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.241 -0.912 . . . . 0.0 110.121 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -155.83 160.13 39.96 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.46 -0.775 . . . . 0.0 109.264 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -108.92 138.37 45.36 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.536 HD23 ' N ' ' A' ' 8' ' ' SER . 6.7 tt -126.82 124.72 40.3 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.536 ' N ' HD23 ' A' ' 7' ' ' LEU . 44.2 t -127.81 149.12 50.41 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.543 HD21 ' NE2' ' B' ' 5' ' ' GLN . 9.0 tp -142.5 146.25 34.53 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.344 -0.848 . . . . 0.0 109.402 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -124.73 167.77 14.11 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.641 -0.662 . . . . 0.0 109.534 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.37 14.96 69.8 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.3 p -68.93 136.76 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.296 -1.12 . . . . 0.0 109.685 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.5 m -73.18 -46.5 50.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.0 109.307 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.96 163.1 4.0 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.346 -0.846 . . . . 0.0 109.882 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.2 t -95.18 117.55 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.412 -0.805 . . . . 0.0 109.823 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -68.84 -35.9 77.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.373 -0.83 . . . . 0.0 109.184 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -167.31 161.61 14.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.294 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -151.29 111.47 4.12 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.394 -0.816 . . . . 0.0 108.97 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -126.9 156.63 73.7 Favored Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.436 -0.79 . . . . 0.0 108.888 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.19 -29.78 84.81 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.776 1.651 . . . . 0.0 112.514 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -117.17 17.71 14.72 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.469 -0.769 . . . . 0.0 110.589 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -171.24 132.36 0.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.323 -0.861 . . . . 0.0 109.168 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.17 129.94 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.366 -0.834 . . . . 0.0 109.54 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.459 ' CD2' ' OG ' ' A' ' 33' ' ' SER . 64.4 mt -112.93 126.86 55.94 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.1 mt -121.53 132.43 54.7 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.666 -0.647 . . . . 0.0 109.763 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -101.68 113.94 27.54 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 28' ' ' ILE . 9.9 t -124.61 -162.84 1.12 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.396 0.617 . . . . 0.0 110.037 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.493 HD11 ' O ' ' B' ' 3' ' ' ASN . 63.2 mt -33.48 99.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.462 ' C ' ' O ' ' A' ' 28' ' ' ILE . 5.6 pt20 29.58 53.83 0.12 Allowed 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 121.294 0.569 . . . . 0.0 111.558 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.02 145.46 8.16 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.4 t -109.53 131.22 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.516 -0.991 . . . . 0.0 108.908 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.7 tp -108.05 118.31 36.41 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.459 ' OG ' ' CD2' ' A' ' 24' ' ' LEU . 22.8 t -104.64 123.58 47.83 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.1 mt -105.81 129.18 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.438 -0.789 . . . . 0.0 109.433 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -120.38 139.19 53.15 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.78 -149.3 8.82 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -133.19 142.54 48.66 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.373 -1.075 . . . . 0.0 109.456 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.5 mttp 54.63 59.9 3.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.565 -0.71 . . . . 0.0 110.545 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.0 mp -91.38 74.19 6.08 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.95 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.098 -177.313 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 80.8 mt . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.625 0.726 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -84.3 -72.99 0.44 Allowed 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.571 0.701 . . . . 0.0 109.905 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.79 0.12 57.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.67 -0.644 . . . . 0.0 109.539 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.01 47.49 4.14 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -129.47 160.39 33.3 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.418 -1.048 . . . . 0.0 109.294 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.7 m -117.36 161.48 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.611 -0.681 . . . . 0.0 109.408 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -139.35 137.84 36.11 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.458 -0.776 . . . . 0.0 109.487 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 52.1 t -130.6 136.53 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -123.34 129.58 51.51 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.374 -0.829 . . . . 0.0 108.902 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.4 177.48 33.54 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.525 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -95.79 133.7 39.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.283 -1.128 . . . . 0.0 109.273 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.441 ' CG2' HD23 ' A' ' 60' ' ' LEU . 91.8 mt -90.54 111.7 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.148 -0.97 . . . . 0.0 109.727 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -99.31 -17.06 18.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.498 -0.751 . . . . 0.0 109.39 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.59 153.22 16.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.074 -1.016 . . . . 0.0 110.248 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.441 HD23 ' CG2' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -135.04 136.5 42.13 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.695 HG22 HD12 ' B' ' 64' ' ' LEU . 3.2 t -135.89 127.44 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.496 -0.752 . . . . 0.0 109.564 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.426 ' C ' ' CD1' ' A' ' 62' ' ' TYR . 9.2 t80 -144.06 139.86 16.39 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -64.19 79.92 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.002 1.135 . . . . 0.0 113.379 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.829 ' O ' HD13 ' A' ' 64' ' ' LEU . 1.4 tm? -103.12 82.28 2.06 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.989 -1.07 . . . . 0.0 108.7 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -135.22 14.31 3.53 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 32.5 m80 53.41 13.99 0.51 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.785 -0.572 . . . . 0.0 111.068 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.467 ' CE1' ' O ' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -139.35 155.58 47.58 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.814 -1.179 . . . . 0.0 109.492 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.467 ' O ' ' CE1' ' A' ' 67' ' ' HIS . 19.0 m80 -104.27 174.28 5.94 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.2 m80 -115.1 -162.89 0.84 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.446 -0.784 . . . . 0.0 110.003 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -62.24 -44.38 96.69 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.8 m80 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.265 -179.76 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ptp . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -86.56 108.85 18.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.394 -0.817 . . . . 0.0 109.645 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.493 ' O ' HD11 ' A' ' 28' ' ' ILE . 13.7 p-10 -107.46 8.39 29.43 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.366 -0.834 . . . . 0.0 110.121 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -71.44 143.41 50.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.047 -1.033 . . . . 0.0 109.315 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . 0.543 ' NE2' HD21 ' A' ' 9' ' ' LEU . 35.8 tt0 -146.45 152.76 39.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.431 -0.793 . . . . 0.0 109.598 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.598 ' CD1' ' N ' ' B' ' 6' ' ' PHE . 1.5 m-85 -124.18 145.38 49.36 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.579 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.0 tt -130.7 125.77 34.79 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.555 ' N ' HD23 ' B' ' 7' ' ' LEU . 31.1 t -107.24 137.65 44.89 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.651 -0.656 . . . . 0.0 109.264 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.717 ' O ' HG12 ' B' ' 51' ' ' VAL . 10.2 tp -149.32 155.27 40.26 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.044 -1.035 . . . . 0.0 109.652 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.7 t -149.95 157.86 43.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.131 -0.98 . . . . 0.0 109.273 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.33 12.95 57.99 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 87.0 t -67.29 135.15 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.997 -1.296 . . . . 0.0 109.28 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 33.2 m -71.87 -45.28 61.89 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.641 -0.823 . . . . 0.0 109.809 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.39 159.47 5.68 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.099 -1.001 . . . . 0.0 109.474 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 87.5 t -92.23 129.7 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.309 -0.869 . . . . 0.0 109.747 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -86.71 -26.69 24.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.421 -0.799 . . . . 0.0 109.795 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 32.7 t -171.88 160.74 5.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -0.896 . . . . 0.0 109.05 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -148.37 108.12 4.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.816 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -132.62 131.16 22.01 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.37 -24.73 9.07 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 CA-C-N 119.991 1.032 . . . . 0.0 111.829 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -93.63 -6.53 46.24 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.337 -0.852 . . . . 0.0 110.157 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -171.86 133.2 0.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.228 -0.92 . . . . 0.0 109.155 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 94.0 mt -128.12 131.13 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.4 -0.813 . . . . 0.0 109.469 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 17.2 mt -111.86 125.48 54.07 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 80.8 mt -122.34 118.49 28.59 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -89.55 116.5 27.75 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.576 ' O ' ' N ' ' B' ' 29' ' ' GLN . 2.9 t -123.73 149.04 46.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.585 -0.697 . . . . 0.0 109.771 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 59.3 mt 46.95 -85.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.079 0.466 . . . . 0.0 110.028 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' B' ' 27' ' ' THR . 28.1 pt20 -143.07 -23.39 0.62 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.089 -1.007 . . . . 0.0 110.786 -179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.6 171.56 32.04 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 54.9 t -119.92 130.22 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.848 -0.795 . . . . 0.0 108.883 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.402 HD11 HD12 ' B' ' 60' ' ' LEU . 48.6 tp -111.23 128.04 55.8 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.78 127.69 56.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 90.4 mt -105.71 126.53 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -119.49 130.63 55.32 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -174.7 -147.83 6.34 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -133.59 144.25 49.18 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.344 -1.091 . . . . 0.0 109.447 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 53.34 57.02 6.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.523 -0.735 . . . . 0.0 110.584 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.513 HD12 ' N ' ' B' ' 39' ' ' LEU . 9.3 mp -84.11 73.39 10.4 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.562 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.694 -178.001 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.655 0.741 . . . . 0.0 109.269 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -65.41 -35.82 82.1 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.635 -0.666 . . . . 0.0 109.706 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.27 -0.55 57.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.394 -0.817 . . . . 0.0 109.855 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.5 19.2 79.64 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -139.45 158.5 44.04 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.404 -1.057 . . . . 0.0 109.15 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.717 HG12 ' O ' ' B' ' 9' ' ' LEU . 14.8 p -128.17 153.91 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.372 -0.83 . . . . 0.0 109.51 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -141.13 119.46 12.18 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 47.2 t -106.22 153.85 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.334 -0.854 . . . . 0.0 108.888 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -123.66 133.21 53.94 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.456 0.646 . . . . 0.0 109.49 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.14 163.78 14.79 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.448 ' H ' HD23 ' B' ' 56' ' ' LEU . 0.1 OUTLIER -88.13 140.93 28.98 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.02 -1.282 . . . . 0.0 109.643 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.485 ' H ' HD12 ' A' ' 28' ' ' ILE . 45.5 mm -84.31 126.17 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.322 -0.861 . . . . 0.0 109.481 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -113.53 -34.71 5.47 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.45 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -167.99 146.11 4.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.158 -0.964 . . . . 0.0 110.323 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.45 HD22 ' O ' ' B' ' 59' ' ' ALA . 3.9 mm? -117.31 135.96 53.47 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 41.4 t -129.12 118.05 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.803 0.811 . . . . 0.0 108.97 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.524 ' O ' ' N ' ' B' ' 64' ' ' LEU . 55.8 t80 -138.66 100.98 8.11 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -46.13 84.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 121.473 1.449 . . . . 0.0 112.341 -177.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.695 HD12 HG22 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -74.21 78.6 1.79 Allowed 'General case' 0 C--N 1.306 -1.288 0 O-C-N 120.884 -1.135 . . . . 0.0 108.883 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -156.96 147.93 21.82 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -46.54 119.89 2.63 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.884 -1.135 . . . . 0.0 109.737 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.47 ' C ' ' H ' ' B' ' 69' ' ' HIS . 0.1 OUTLIER -67.39 -104.56 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.771 -0.58 . . . . 0.0 110.899 -178.488 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 57.1 7.51 0.44 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.146 -0.971 . . . . 0.0 108.458 -178.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.47 ' H ' ' C ' ' B' ' 67' ' ' HIS . 9.2 t-80 -170.98 125.24 0.66 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' B' ' 70' ' ' HIS . 0.0 OUTLIER -121.49 157.63 30.21 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -178.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 4.6 t60 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.803 -1.094 . . . . 0.0 108.796 179.359 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ptt? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -147.98 25.04 1.04 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.43 HD22 ' CB ' ' A' ' 56' ' ' LEU . 8.5 p-10 -102.51 -24.0 13.85 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.554 0.692 . . . . 0.0 109.306 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.538 ' NH1' ' N ' ' A' ' 55' ' ' GLY . 7.6 mmm180 -54.08 148.33 11.14 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.322 -0.861 . . . . 0.0 109.743 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.588 ' NE2' HD11 ' B' ' 9' ' ' LEU . 1.8 pt20 -155.16 159.09 39.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.529 -0.732 . . . . 0.0 110.167 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -99.62 148.94 23.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.629 -0.67 . . . . 0.0 109.366 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.505 HD23 ' N ' ' A' ' 8' ' ' SER . 7.0 tt -138.5 126.63 22.75 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.176 -0.952 . . . . 0.0 108.457 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.505 ' N ' HD23 ' A' ' 7' ' ' LEU . 20.0 m -123.77 141.67 51.81 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.436 -0.79 . . . . 0.0 109.563 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.4 tp -150.76 145.64 25.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.386 -0.821 . . . . 0.0 109.354 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 p -137.92 172.14 13.37 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.462 -0.774 . . . . 0.0 109.09 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.62 20.85 59.19 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.91 134.84 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.028 -1.278 . . . . 0.0 110.067 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.1 m -74.71 -53.6 8.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.885 . . . . 0.0 109.841 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.14 156.19 28.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.042 -1.036 . . . . 0.0 109.835 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.1 t -88.92 129.5 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.348 -0.845 . . . . 0.0 109.841 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -97.98 -36.34 10.17 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.163 -0.961 . . . . 0.0 109.316 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.7 t -170.8 148.24 2.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.887 . . . . 0.0 108.907 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -141.49 110.78 6.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.343 -0.848 . . . . 0.0 109.142 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -133.48 144.58 52.83 Favored Pre-proline 0 N--CA 1.503 2.189 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.73 -35.67 48.62 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.027 1.152 . . . . 0.0 111.565 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -63.15 -45.09 93.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.2 -0.938 . . . . 0.0 110.0 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -156.83 156.15 32.72 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.393 -0.817 . . . . 0.0 109.089 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.5 mt -120.25 131.47 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.639 -0.663 . . . . 0.0 109.966 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.3 mt -112.93 116.62 30.27 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 mt -127.03 135.54 50.95 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.389 -0.819 . . . . 0.0 109.292 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -97.48 119.26 35.71 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.146 -0.971 . . . . 0.0 109.216 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.563 ' OG1' ' NE2' ' B' ' 5' ' ' GLN . 8.9 t -124.57 158.99 31.66 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.301 0.572 . . . . 0.0 110.348 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 27' ' ' THR . 44.8 mt 32.26 -86.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 CA-C-O 121.125 0.488 . . . . 0.0 111.261 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.551 ' N ' ' O ' ' A' ' 27' ' ' THR . 24.9 pt20 -150.33 47.71 0.9 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.191 -0.943 . . . . 0.0 109.943 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -171.45 142.31 6.92 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.6 t -90.19 132.64 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.4 -1.059 . . . . 0.0 109.559 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.9 tp -106.95 125.09 50.55 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.6 t -113.05 124.46 52.66 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.6 mt -108.31 123.88 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -112.91 137.34 51.44 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.577 0.703 . . . . 0.0 109.558 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.92 -149.52 10.03 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -137.31 144.56 42.67 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.337 -1.096 . . . . 0.0 109.492 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp 56.1 59.01 3.94 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.726 0.774 . . . . 0.0 109.438 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.1 mp -92.23 73.86 5.39 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.572 0 C-N-CA 119.939 -1.124 . . . . 0.0 110.528 -178.355 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.8 tp . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -160.11 -74.09 0.07 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.0 108.669 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.07 -2.64 41.43 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.598 -0.689 . . . . 0.0 109.225 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.74 22.75 78.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -82.17 161.19 22.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.33 -1.1 . . . . 0.0 109.215 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.98 135.46 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.472 -0.768 . . . . 0.0 109.397 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -126.49 131.7 51.57 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.455 0.645 . . . . 0.0 109.588 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -120.58 136.25 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.425 ' HB2' HH22 ' A' ' 4' ' ' ARG . 2.6 pt-20 -130.08 146.33 51.74 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.538 ' N ' ' NH1' ' A' ' 4' ' ' ARG . . . 149.1 -175.57 28.27 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.43 ' CB ' HD22 ' A' ' 3' ' ' ASN . 2.4 pp -97.06 127.42 43.01 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.058 -1.26 . . . . 0.0 109.667 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.4 mm -87.32 120.91 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.273 -0.892 . . . . 0.0 109.837 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -105.7 -12.4 15.93 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.524 -0.735 . . . . 0.0 109.592 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -174.07 156.66 2.74 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.084 -1.01 . . . . 0.0 110.259 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.9 mt -138.7 135.48 34.83 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.488 HG22 HD12 ' B' ' 64' ' ' LEU . 77.7 t -128.08 128.88 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.554 -0.716 . . . . 0.0 109.248 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.434 ' CE1' ' O ' ' A' ' 63' ' ' PRO . 29.9 t80 -145.03 140.09 15.8 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.434 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 90.0 Cg_endo -80.3 113.01 2.85 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.442 1.428 . . . . 0.0 112.129 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.866 HD13 ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -106.09 3.36 28.02 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.208 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.523 ' N ' HD22 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -74.87 157.62 34.78 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.982 0.896 . . . . 0.0 110.891 -178.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.489 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 2.6 p-80 -153.46 -107.76 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.586 ' CE1' ' CE1' ' A' ' 70' ' ' HIS . 1.7 t60 -166.87 115.34 0.85 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.907 -1.12 . . . . 0.0 109.796 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 69' ' ' HIS . 2.7 t-160 -148.29 102.32 3.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.135 -0.978 . . . . 0.0 108.96 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.49 ' CE1' ' O ' ' A' ' 70' ' ' HIS . 26.0 t-80 56.72 118.64 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.601 0.715 . . . . 0.0 110.138 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.586 ' CE1' ' CE1' ' A' ' 67' ' ' HIS . 4.8 m-70 -72.04 137.61 47.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.198 -0.939 . . . . 0.0 109.559 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.8 p80 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.325 179.662 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 29.9 tpp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -130.22 94.64 3.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.458 -0.776 . . . . 0.0 109.028 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -95.81 1.88 53.45 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.381 -0.825 . . . . 0.0 109.255 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -69.37 142.45 53.94 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.372 -0.83 . . . . 0.0 109.121 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . 0.563 ' NE2' ' OG1' ' A' ' 27' ' ' THR . 76.1 mt-30 -144.63 153.11 41.42 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.274 -0.891 . . . . 0.0 109.857 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -114.66 129.16 56.64 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.574 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.8 tt -120.63 124.63 45.73 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.386 -0.821 . . . . 0.0 109.102 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.563 ' N ' HD23 ' B' ' 7' ' ' LEU . 7.6 m -118.98 138.37 52.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.664 -0.647 . . . . 0.0 109.338 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.588 HD11 ' NE2' ' A' ' 5' ' ' GLN . 53.7 tp -146.64 140.87 26.34 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 0.0 109.23 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.411 ' O ' ' OG1' ' B' ' 10' ' ' THR . 1.0 OUTLIER -134.22 106.34 7.09 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.79 48.35 0.03 OUTLIER Glycine 0 N--CA 1.495 2.571 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.457 ' O ' HG13 ' B' ' 12' ' ' VAL . 14.6 p -104.49 131.54 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.542 -0.975 . . . . 0.0 109.67 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 6.3 t -71.21 -43.86 66.53 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.261 -0.899 . . . . 0.0 109.005 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.81 159.27 5.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.29 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 88.0 t -91.09 127.36 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.131 -0.981 . . . . 0.0 109.59 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -88.35 -23.32 23.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.253 -0.904 . . . . 0.0 109.364 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 32.9 t -172.52 159.78 4.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.322 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -146.09 104.01 3.78 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.054 -1.029 . . . . 0.0 109.73 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.74 150.76 74.34 Favored Pre-proline 0 N--CA 1.497 1.887 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.44 -9.09 22.63 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.449 1.433 . . . . 0.0 111.095 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -99.43 -16.96 18.19 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.388 -0.82 . . . . 0.0 109.437 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.41 ' OE2' ' C ' ' B' ' 23' ' ' ILE . 2.1 tm-20 -173.74 125.04 0.37 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.41 ' C ' ' OE2' ' B' ' 22' ' ' GLU . 77.9 mt -116.04 129.27 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.331 -0.855 . . . . 0.0 109.371 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 86.9 mt -105.18 125.5 51.05 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 88.2 mt -124.06 122.18 37.18 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.659 -0.651 . . . . 0.0 109.697 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -89.65 110.76 21.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.571 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.9 t -124.45 148.91 47.33 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.659 0.742 . . . . 0.0 109.842 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.402 HD13 ' N ' ' B' ' 28' ' ' ILE . 6.1 mm 51.95 -80.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.839 -0.538 . . . . 0.0 110.024 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' B' ' 27' ' ' THR . 15.3 pt20 -152.1 -21.46 0.18 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.195 -0.94 . . . . 0.0 109.825 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.99 177.87 32.96 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 47.7 t -119.93 132.42 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 38.5 tp -105.86 128.01 53.48 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.411 -0.806 . . . . 0.0 109.363 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 37.0 t -114.39 120.1 39.18 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 86.2 mt -107.19 123.39 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -114.44 140.67 48.51 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.47 0.652 . . . . 0.0 109.489 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.47 -154.46 24.69 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -130.97 149.92 52.37 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.389 -1.065 . . . . 0.0 109.321 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.432 ' O ' ' O ' ' B' ' 54' ' ' GLU . 26.1 mmtp 61.88 48.08 5.6 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.558 0.694 . . . . 0.0 109.382 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.536 HD12 ' N ' ' B' ' 39' ' ' LEU . 10.1 mp -91.85 72.89 5.71 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.242 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.466 HD12 ' H ' ' B' ' 50' ' ' GLN . 4.1 mm? . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -67.98 -33.37 74.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.623 -0.673 . . . . 0.0 109.519 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.75 -2.46 54.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.86 . . . . 0.0 108.862 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 50.16 71.97 0.55 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.466 ' H ' HD12 ' B' ' 46' ' ' LEU . 88.9 mt-30 -138.22 159.11 42.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.256 -1.143 . . . . 0.0 108.731 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 8.1 m -126.11 131.29 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.385 -0.822 . . . . 0.0 109.845 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -130.46 126.39 36.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 69.6 t -116.58 136.56 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' B' ' 38' ' ' LYS . 29.6 mt-10 -123.42 144.43 49.5 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.99 177.41 23.98 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.436 ' H ' HD23 ' B' ' 56' ' ' LEU . 0.1 OUTLIER -90.18 144.11 26.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.093 -1.239 . . . . 0.0 109.283 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.507 ' CG2' HD23 ' B' ' 60' ' ' LEU . 35.5 mm -93.62 112.87 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.316 -0.865 . . . . 0.0 109.72 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -101.15 -21.55 14.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.335 -0.853 . . . . 0.0 109.249 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.555 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -167.06 152.65 7.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -0.914 . . . . 0.0 109.744 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.555 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.5 OUTLIER -134.99 133.06 39.08 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 53.3 t -134.95 127.07 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.547 -0.721 . . . . 0.0 110.0 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.571 ' O ' ' N ' ' B' ' 64' ' ' LEU . 16.0 t80 -141.46 122.49 8.8 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -43.87 84.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.214 1.276 . . . . 0.0 112.376 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.724 ' H ' HD23 ' B' ' 64' ' ' LEU . 0.9 OUTLIER -93.76 21.11 6.79 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -94.26 121.74 36.09 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.482 -0.761 . . . . 0.0 110.724 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -170.97 76.66 0.07 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.593 ' ND1' ' N ' ' B' ' 68' ' ' HIS . 1.1 t60 -143.11 141.74 31.31 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.593 ' N ' ' ND1' ' B' ' 67' ' ' HIS . 0.7 OUTLIER -99.14 110.08 22.69 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.355 -0.841 . . . . 0.0 109.606 -179.207 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.88 -38.99 87.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.443 -0.785 . . . . 0.0 109.086 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.562 ' CE1' ' CD2' ' B' ' 71' ' ' HIS . 3.0 t60 -52.68 170.91 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.379 -0.826 . . . . 0.0 110.099 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.562 ' CD2' ' CE1' ' B' ' 70' ' ' HIS . 78.7 m-70 . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.203 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.517 ' O ' ' N ' ' A' ' 3' ' ' ASN . 96.6 mtp . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.586 0.707 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.523 ' C ' ' OD1' ' A' ' 2' ' ' ASP . 1.4 p30 42.26 22.11 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.768 0.794 . . . . 0.0 110.069 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 1' ' ' MET . 31.3 p-10 -72.85 -5.04 35.5 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 46.7 mmm-85 -82.26 122.31 27.77 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -142.14 163.57 32.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.188 -0.945 . . . . 0.0 109.625 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 1.1 m-85 -111.33 134.29 53.02 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.573 ' C ' HD23 ' A' ' 7' ' ' LEU . 6.0 tt -120.28 121.91 39.7 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.573 ' N ' HD23 ' A' ' 7' ' ' LEU . 68.5 m -115.3 146.74 41.22 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.526 -0.734 . . . . 0.0 109.409 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 tp -152.83 149.65 28.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 109.288 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 t -140.76 165.81 26.47 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.368 -0.833 . . . . 0.0 109.651 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.35 20.87 53.75 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.5 p -67.68 136.81 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -1.126 . . . . 0.0 110.333 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 t -73.08 -41.36 64.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.379 -0.826 . . . . 0.0 109.542 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -168.89 167.56 10.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.097 -1.002 . . . . 0.0 109.655 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 92.1 t -98.82 99.61 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.276 -0.89 . . . . 0.0 109.871 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -65.93 -40.68 91.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 108.886 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -168.5 153.44 6.3 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -149.33 107.08 3.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 108.621 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -132.76 152.92 80.75 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.82 5.96 0.91 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.025 1.817 . . . . 0.0 111.438 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -133.25 -2.27 3.15 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.461 -0.774 . . . . 0.0 109.5 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -171.92 130.1 0.64 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.918 . . . . 0.0 108.856 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -130.85 128.73 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.329 -0.857 . . . . 0.0 109.979 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.2 mt -123.25 121.25 35.42 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.8 mt -129.39 131.63 46.86 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.536 -0.728 . . . . 0.0 109.203 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -96.43 119.42 34.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.985 -1.072 . . . . 0.0 109.582 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.569 ' O ' ' N ' ' A' ' 29' ' ' GLN . 5.2 t -124.2 148.61 47.15 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.538 0.685 . . . . 0.0 110.098 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.401 ' N ' HD13 ' A' ' 28' ' ' ILE . 5.9 mm 54.81 -79.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.783 -0.573 . . . . 0.0 109.541 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 27' ' ' THR . 13.5 pt20 -154.52 -20.61 0.12 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 0.0 110.074 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.06 177.18 32.42 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.0 t -123.0 132.84 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.779 -0.836 . . . . 0.0 109.203 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.7 tp -105.12 126.51 52.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.487 -0.758 . . . . 0.0 108.971 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.3 t -113.6 123.43 49.93 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.5 mt -112.95 130.2 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -125.73 139.0 53.9 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.3 -153.24 16.09 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -131.25 153.6 49.35 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.503 -0.998 . . . . 0.0 109.312 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt 57.81 56.54 4.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.493 -0.754 . . . . 0.0 109.82 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.8 mp -93.0 71.91 4.68 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.713 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -179.114 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 49' ' ' GLY . 3.7 mm? . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 46' ' ' LEU . 38.1 ttpt 33.0 -89.63 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.369 0.604 . . . . 0.0 111.403 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . -77.82 16.33 0.71 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.159 -0.963 . . . . 0.0 109.867 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . 62.72 51.5 55.39 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -101.03 152.44 20.58 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.303 -1.116 . . . . 0.0 109.92 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.2 t -127.67 135.97 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -129.79 144.36 51.26 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.298 -0.876 . . . . 0.0 109.844 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 54' ' ' GLU . 39.2 t -135.93 160.0 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.632 -0.667 . . . . 0.0 109.79 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.454 ' N ' HG12 ' A' ' 53' ' ' VAL . 22.4 pt-20 -137.79 142.35 40.86 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.321 -0.862 . . . . 0.0 109.319 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.24 177.23 29.22 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.521 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -94.77 142.48 27.42 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.434 -1.039 . . . . 0.0 108.859 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.457 ' CG2' HD23 ' A' ' 60' ' ' LEU . 46.4 mm -89.4 121.38 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.292 -0.88 . . . . 0.0 109.692 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -106.58 -29.59 9.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.457 -0.777 . . . . 0.0 109.429 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.602 ' O ' HD22 ' A' ' 60' ' ' LEU . . . -163.42 147.88 10.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.006 . . . . 0.0 109.933 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.602 HD22 ' O ' ' A' ' 59' ' ' ALA . 1.1 mm? -130.36 131.18 45.22 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 54.4 t -131.99 132.95 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 121.612 0.72 . . . . 0.0 109.638 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.467 ' O ' ' N ' ' A' ' 64' ' ' LEU . 34.2 t80 -144.47 139.33 15.49 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.98 78.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 120.844 1.03 . . . . 0.0 111.596 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.627 ' CD2' ' H ' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -86.51 0.82 53.47 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.524 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -88.53 179.83 6.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.416 -0.803 . . . . 0.0 109.908 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.557 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 0.4 OUTLIER -113.84 -137.98 0.37 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.515 -0.741 . . . . 0.0 109.791 -179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.48 109.94 21.77 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.316 -0.865 . . . . 0.0 109.869 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -164.4 -43.12 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.19 -0.944 . . . . 0.0 108.497 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.665 ' ND1' ' N ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -123.01 -38.59 2.59 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -59.92 -42.54 94.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.356 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.031 -1.043 . . . . 0.0 108.305 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mtp . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.526 0.679 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.96 134.7 54.49 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.794 0.807 . . . . 0.0 110.047 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -172.26 -23.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.4 mmm-85 -63.12 138.65 58.62 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.22 -0.925 . . . . 0.0 108.651 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -146.35 161.17 40.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.252 -0.905 . . . . 0.0 109.491 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -108.95 136.03 49.15 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.586 HD23 ' N ' ' B' ' 8' ' ' SER . 5.7 tt -122.56 120.68 34.53 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.586 ' N ' HD23 ' B' ' 7' ' ' LEU . 9.2 p -111.42 140.52 45.94 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.576 -0.702 . . . . 0.0 109.303 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 6.3 tp -148.21 146.49 28.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.259 -0.901 . . . . 0.0 109.505 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.454 HG23 ' O ' ' B' ' 10' ' ' THR . 4.9 t -146.12 117.79 8.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.449 -0.782 . . . . 0.0 109.293 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.24 22.57 0.37 Allowed Glycine 0 N--CA 1.498 2.8 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 79.3 t -76.82 132.14 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.084 -1.245 . . . . 0.0 109.775 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -72.83 -43.18 62.98 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.128 -0.983 . . . . 0.0 109.774 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.77 157.89 22.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.961 -1.087 . . . . 0.0 110.088 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 69.6 t -93.17 127.22 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.41 -0.806 . . . . 0.0 109.153 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -96.29 -35.56 11.2 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.97 -1.081 . . . . 0.0 109.368 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 36.4 t -173.06 150.22 1.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 108.85 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . 0.418 ' CZ ' HD13 ' B' ' 23' ' ' ILE . 5.7 t80 -143.24 113.44 7.27 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.106 -0.996 . . . . 0.0 109.147 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -126.34 152.73 74.32 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.18 -17.06 54.04 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.669 1.579 . . . . 0.0 111.446 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -114.47 8.21 16.44 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.567 -0.708 . . . . 0.0 109.447 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -171.74 133.37 0.76 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.246 -0.909 . . . . 0.0 109.252 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.418 HD13 ' CZ ' ' B' ' 18' ' ' PHE . 96.7 mt -130.65 129.31 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 121.194 -0.941 . . . . 0.0 109.784 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 72.6 mt -120.88 119.19 31.94 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 87.9 mt -133.46 131.96 40.51 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.476 -0.765 . . . . 0.0 109.49 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -94.28 118.39 31.52 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.016 -1.052 . . . . 0.0 109.156 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.546 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.9 t -124.39 154.25 40.68 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.421 ' C ' ' O ' ' B' ' 27' ' ' THR . 44.3 mt 37.87 -89.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.901 -0.499 . . . . 0.0 110.456 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.546 ' N ' ' O ' ' B' ' 27' ' ' THR . 15.0 pt20 -151.6 46.2 0.79 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.004 -1.06 . . . . 0.0 109.515 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.95 132.28 2.57 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 90.4 t -84.3 131.32 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -1.09 . . . . 0.0 109.262 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 48.9 tp -104.18 125.22 50.3 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 28.7 t -112.35 120.75 42.77 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 83.7 mt -107.3 130.77 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -124.27 138.86 54.35 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.23 -147.89 8.54 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -135.99 143.27 44.72 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.226 -1.161 . . . . 0.0 109.319 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 54.9 61.2 3.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.591 -0.693 . . . . 0.0 109.956 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.529 HD12 ' N ' ' B' ' 39' ' ' LEU . 10.5 mp -92.95 72.31 4.74 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.187 -0.946 . . . . 0.0 108.805 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.492 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.636 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' B' ' 48' ' ' ALA . 10.4 mp . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.534 ' C ' ' H ' ' B' ' 49' ' ' GLY . 37.1 ttmt 45.08 -85.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.75 -0.594 . . . . 0.0 110.353 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' B' ' 46' ' ' LEU . . . -65.23 14.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.064 -1.023 . . . . 0.0 110.212 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' B' ' 47' ' ' LYS . . . 61.71 28.17 69.51 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -87.18 158.79 19.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -1.104 . . . . 0.0 109.368 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 16.6 m -131.77 157.47 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.417 -0.802 . . . . 0.0 109.243 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -144.68 148.07 33.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.27 -0.894 . . . . 0.0 109.508 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 53.8 t -127.08 135.58 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -120.79 131.14 54.31 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.537 -0.727 . . . . 0.0 109.185 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.98 179.19 29.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.436 ' H ' HD23 ' B' ' 56' ' ' LEU . 0.3 OUTLIER -97.95 133.78 41.96 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.404 -1.056 . . . . 0.0 109.187 179.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.446 HG21 HD23 ' B' ' 60' ' ' LEU . 90.4 mt -90.15 115.3 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.053 . . . . 0.0 109.706 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -99.49 -14.95 18.86 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.4 -0.813 . . . . 0.0 109.676 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.4 152.43 8.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.977 -1.077 . . . . 0.0 110.365 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.446 HD23 HG21 ' B' ' 57' ' ' ILE . 0.3 OUTLIER -134.93 134.73 40.92 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.35 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.404 HG22 HD12 ' A' ' 64' ' ' LEU . 67.5 t -130.03 123.61 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.455 -0.778 . . . . 0.0 109.05 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.444 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 44.2 t80 -146.02 136.85 12.44 Favored Pre-proline 0 N--CA 1.494 1.753 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.444 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 70.9 Cg_endo -74.45 113.73 3.86 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.328 1.352 . . . . 0.0 112.001 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.949 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -89.22 16.29 7.56 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 65.19 101.46 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.476 0.655 . . . . 0.0 110.497 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -81.1 -57.06 3.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 108.646 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -156.03 -132.26 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.699 ' CD2' ' H ' ' B' ' 69' ' ' HIS . 6.3 t60 -147.66 -179.94 7.24 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.57 -1.331 . . . . 0.0 109.65 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.699 ' H ' ' CD2' ' B' ' 68' ' ' HIS . 7.5 m80 58.54 6.52 0.59 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.916 -1.115 . . . . 0.0 108.818 -178.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.434 ' O ' ' ND1' ' B' ' 70' ' ' HIS . 0.5 OUTLIER -61.21 149.0 38.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.376 -0.827 . . . . 0.0 109.958 -179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.134 179.259 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.98 103.96 3.1 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.51 HD22 ' CB ' ' A' ' 56' ' ' LEU . 1.3 p-10 -148.9 12.0 0.85 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -77.91 144.46 36.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.725 -1.235 . . . . 0.0 108.233 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.576 ' NE2' HD21 ' B' ' 9' ' ' LEU . 39.7 tt0 -146.66 156.23 43.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.121 -0.987 . . . . 0.0 110.263 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -109.13 114.02 27.38 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.525 ' C ' HD23 ' A' ' 7' ' ' LEU . 7.3 tt -113.28 126.47 55.44 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.495 ' N ' HD23 ' A' ' 7' ' ' LEU . 42.0 t -132.1 140.28 48.77 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.401 HD11 HE21 ' B' ' 5' ' ' GLN . 45.0 tp -131.03 148.14 52.71 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 p -125.26 153.38 43.28 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.48 8.54 87.1 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.52 143.84 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.144 -1.209 . . . . 0.0 109.927 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.2 m -73.34 -47.51 41.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.513 -0.742 . . . . 0.0 109.982 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -172.59 172.91 4.13 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.042 -1.036 . . . . 0.0 110.483 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.7 t -101.21 103.83 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -64.1 -40.43 96.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.235 -0.916 . . . . 0.0 109.796 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.4 t -158.17 151.87 23.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.341 -0.85 . . . . 0.0 109.323 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -131.14 112.0 12.46 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.57 150.99 77.36 Favored Pre-proline 0 N--CA 1.501 2.114 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.59 -10.63 25.46 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.962 1.775 . . . . 0.0 111.615 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -129.24 11.45 5.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.598 -0.689 . . . . 0.0 109.61 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -169.3 123.2 0.8 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mm -123.2 130.14 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.188 -0.945 . . . . 0.0 109.695 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.2 mt -113.87 129.85 56.55 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.75 124.29 33.11 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.496 -0.753 . . . . 0.0 110.346 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -96.16 123.36 39.75 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 29' ' ' GLN . 2.6 t -125.64 154.04 42.91 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.231 0.539 . . . . 0.0 109.746 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 27' ' ' THR . 46.7 mt 29.3 -85.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-O 121.16 0.505 . . . . 0.0 111.507 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.537 ' N ' ' O ' ' A' ' 27' ' ' THR . 13.1 pt20 -144.05 59.54 1.36 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.16 -0.963 . . . . 0.0 110.148 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.9 160.69 28.93 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.0 t -116.35 130.68 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.655 -0.909 . . . . 0.0 109.06 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.449 HD11 HD12 ' A' ' 60' ' ' LEU . 52.3 tp -110.04 126.34 53.88 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.537 -0.727 . . . . 0.0 109.148 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.8 t -110.34 123.13 49.27 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.432 HG12 HD11 ' A' ' 60' ' ' LEU . 96.2 mt -112.39 129.72 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -116.63 140.69 49.11 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.87 -153.98 12.89 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -133.75 146.71 50.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.535 -0.979 . . . . 0.0 109.338 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 55.83 54.98 7.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.72 -0.613 . . . . 0.0 110.159 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.0 mp -90.45 69.15 6.87 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.895 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -178.752 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.597 ' O ' ' N ' ' A' ' 48' ' ' ALA . 68.7 mt . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 120.848 0.356 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? 56.28 -73.24 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.711 -0.618 . . . . 0.0 110.307 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . -73.63 -4.56 34.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.13 -0.982 . . . . 0.0 109.535 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.1 26.19 74.16 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -92.45 161.71 14.53 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.531 -0.982 . . . . 0.0 109.98 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.87 141.19 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.64 148.41 50.38 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.468 0.652 . . . . 0.0 110.085 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 75.4 t -136.97 136.3 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -126.43 128.86 47.65 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.05 -1.032 . . . . 0.0 108.379 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 161.67 174.84 32.04 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.51 ' CB ' HD22 ' A' ' 3' ' ' ASN . 0.2 OUTLIER -98.32 128.13 44.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.556 -0.967 . . . . 0.0 109.467 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.635 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.7 mp -77.5 133.43 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 0.0 109.76 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -112.82 -26.11 8.72 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.603 ' O ' HD22 ' A' ' 60' ' ' LEU . . . -166.88 154.01 9.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.417 -0.802 . . . . 0.0 110.034 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.603 HD22 ' O ' ' A' ' 59' ' ' ALA . 1.1 mm? -131.1 130.36 43.05 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.5 t -134.56 130.95 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.733 0.777 . . . . 0.0 109.788 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.652 ' O ' ' N ' ' A' ' 64' ' ' LEU . 12.6 t80 -144.7 143.24 20.62 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -49.4 76.33 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.636 0 CA-C-N 120.405 1.18 . . . . 0.0 111.915 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.652 ' N ' ' O ' ' A' ' 62' ' ' TYR . 0.8 OUTLIER -92.73 15.23 14.99 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.363 -0.836 . . . . 0.0 109.034 -179.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.544 ' C ' ' O ' ' A' ' 64' ' ' LEU . 90.8 mt-10 -8.42 117.48 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.453 0 CA-C-O 121.402 0.62 . . . . 0.0 112.171 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -73.1 -71.06 0.32 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.632 -0.668 . . . . 0.0 110.236 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -72.12 -96.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.448 -0.783 . . . . 0.0 110.037 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.708 ' CD2' ' H ' ' A' ' 69' ' ' HIS . 69.8 t60 -166.77 -172.06 2.01 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.464 -0.773 . . . . 0.0 109.264 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.708 ' H ' ' CD2' ' A' ' 68' ' ' HIS . 0.4 OUTLIER -66.49 -41.59 88.72 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.579 -0.701 . . . . 0.0 109.491 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -83.11 -64.08 1.24 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.49 -0.757 . . . . 0.0 109.567 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 118.157 -0.925 . . . . 0.0 108.879 179.739 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mtp . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.6 116.52 28.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.478 -0.764 . . . . 0.0 109.54 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' B' ' 3' ' ' ASN . 9.4 p-10 -166.53 -30.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.602 HH21 ' CD ' ' B' ' 54' ' ' GLU . 10.7 mmm180 -49.66 143.63 6.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.519 -0.738 . . . . 0.0 110.031 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . 0.401 HE21 HD11 ' A' ' 9' ' ' LEU . 5.7 pt20 -149.8 162.03 41.07 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.348 0.594 . . . . 0.0 109.476 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -118.18 141.88 48.03 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.579 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.1 tt -131.07 120.26 23.15 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.566 ' N ' HD23 ' B' ' 7' ' ' LEU . 5.5 m -110.73 146.09 36.91 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.576 HD21 ' NE2' ' A' ' 5' ' ' GLN . 5.4 tp -146.92 139.1 24.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.298 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.15 107.57 7.79 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 146.42 -5.81 1.21 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.57 142.18 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.419 -1.048 . . . . 0.0 110.066 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -72.72 -51.56 18.75 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.665 -0.647 . . . . 0.0 109.629 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.15 160.31 6.29 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.124 -0.985 . . . . 0.0 110.297 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . 0.592 HG11 ' CE2' ' B' ' 18' ' ' PHE . 20.6 t -81.39 133.07 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.654 -0.654 . . . . 0.0 109.891 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -88.79 -23.78 22.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.4 -0.813 . . . . 0.0 110.121 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 30.3 t -172.42 151.52 2.5 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.101 -0.999 . . . . 0.0 109.899 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . 0.592 ' CE2' HG11 ' B' ' 15' ' ' VAL . 4.5 m-85 -121.93 104.64 9.68 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.628 -0.67 . . . . 0.0 109.886 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.39 139.34 31.11 Favored Pre-proline 0 N--CA 1.498 1.962 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.32 -17.4 35.07 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.815 1.677 . . . . 0.0 111.97 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -95.62 -10.75 28.62 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.322 -0.861 . . . . 0.0 109.472 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -174.75 130.01 0.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.66 129.49 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 62.0 mt -110.07 123.53 49.86 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.404 HD23 HG13 ' B' ' 15' ' ' VAL . 68.6 mt -119.07 131.12 55.91 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.577 -0.702 . . . . 0.0 109.704 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -83.64 104.97 14.18 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.463 ' O ' ' O ' ' B' ' 28' ' ' ILE . 12.9 t -124.87 169.95 11.55 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.73 0.776 . . . . 0.0 110.751 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' B' ' 27' ' ' THR . 8.0 mt -33.0 154.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.344 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 65.38 -60.51 0.26 Allowed 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.18 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' B' ' 27' ' ' THR . . . -166.71 -168.13 28.43 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.459 -1.353 . . . . 0.0 109.795 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 15.5 t -86.88 135.37 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.405 -1.056 . . . . 0.0 110.146 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 43.0 tp -101.05 119.99 39.55 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 11.5 m -99.6 127.27 45.69 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 86.8 mt -103.95 126.84 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -118.98 144.47 46.47 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.536 0.684 . . . . 0.0 110.075 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.89 -138.05 4.74 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -138.83 139.58 38.23 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.246 -1.149 . . . . 0.0 109.766 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 46.98 73.8 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.686 -0.634 . . . . 0.0 109.834 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.558 HD12 ' N ' ' B' ' 39' ' ' LEU . 9.1 mp -91.89 71.25 5.61 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.068 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' B' ' 47' ' ' LYS . 62.0 tp . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 121.278 0.561 . . . . 0.0 110.431 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.492 ' C ' ' H ' ' B' ' 49' ' ' GLY . 53.2 tttp 59.05 136.1 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.506 0.669 . . . . 0.0 110.389 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' B' ' 47' ' ' LYS . . . 63.55 -3.62 0.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.605 -0.684 . . . . 0.0 109.5 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' B' ' 47' ' ' LYS . . . 62.9 31.58 81.0 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -103.04 148.13 26.09 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.399 -1.059 . . . . 0.0 109.68 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.85 145.71 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -130.26 149.6 51.88 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.45 0.643 . . . . 0.0 109.387 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.9 t -123.32 135.42 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.602 ' CD ' HH21 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -116.83 125.39 51.49 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . 0.535 ' N ' ' OE1' ' B' ' 54' ' ' GLU . . . 154.77 176.13 26.66 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.14 132.79 46.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.679 -0.895 . . . . 0.0 109.475 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.621 HD12 ' N ' ' B' ' 57' ' ' ILE . 1.5 mp -87.12 118.81 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.191 -0.943 . . . . 0.0 108.965 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . 0.444 ' OD2' ' NE2' ' A' ' 29' ' ' GLN . 2.2 t70 -112.8 -5.64 13.88 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.621 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -169.05 156.55 7.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.419 -0.801 . . . . 0.0 110.338 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.621 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.4 OUTLIER -139.28 135.87 34.3 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 t -129.97 124.18 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.575 0.702 . . . . 0.0 109.308 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.579 ' O ' HD13 ' B' ' 64' ' ' LEU . 36.0 t80 -146.29 138.16 13.36 Favored Pre-proline 0 N--CA 1.493 1.678 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.492 ' C ' ' H ' ' B' ' 65' ' ' GLU . 38.7 Cg_endo -70.13 104.66 1.41 Allowed 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.295 1.33 . . . . 0.0 112.167 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.954 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -75.57 18.39 0.24 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.492 ' H ' ' C ' ' B' ' 63' ' ' PRO . 0.7 OUTLIER 63.8 138.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -128.7 127.88 42.98 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.612 -0.68 . . . . 0.0 110.268 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' B' ' 67' ' ' HIS . 0.0 OUTLIER -153.59 -46.82 0.09 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -49.03 96.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.533 -0.729 . . . . 0.0 109.726 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.432 ' N ' ' O ' ' B' ' 67' ' ' HIS . 78.8 m-70 -85.95 -154.81 0.22 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.515 -0.74 . . . . 0.0 109.442 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -56.86 -44.72 82.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.414 -0.804 . . . . 0.0 109.534 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.499 ' N ' ' ND1' ' B' ' 71' ' ' HIS . 1.6 p-80 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.591 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.396 0.617 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -91.61 106.47 18.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.331 -0.856 . . . . 0.0 109.885 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -173.92 -26.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 51.0 mmm-85 -64.0 140.06 58.83 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.389 -0.819 . . . . 0.0 108.868 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -154.25 165.44 36.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 0.0 109.881 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -106.09 144.58 32.6 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.609 HD23 ' N ' ' A' ' 8' ' ' SER . 5.6 tt -132.33 121.54 23.69 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.609 ' N ' HD23 ' A' ' 7' ' ' LEU . 4.6 m -114.24 140.97 48.14 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.593 -0.692 . . . . 0.0 109.903 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.584 HD21 ' NE2' ' B' ' 5' ' ' GLN . 4.8 tp -144.79 145.92 31.88 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.8 p -137.23 173.1 12.05 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.371 -0.831 . . . . 0.0 110.102 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 73.51 24.78 74.16 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 12' ' ' VAL . 10.5 p -72.24 130.5 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.254 -1.145 . . . . 0.0 109.817 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -73.03 -43.25 62.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.09 -1.006 . . . . 0.0 109.195 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.25 153.52 4.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 109.591 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.5 t -92.28 117.02 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.848 . . . . 0.0 109.676 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -68.05 -37.44 81.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.48 -0.763 . . . . 0.0 109.508 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.7 t -169.04 169.47 9.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.825 . . . . 0.0 109.456 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.534 ' CD1' HD12 ' A' ' 23' ' ' ILE . 86.3 t80 -145.62 107.18 4.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 0.0 109.217 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.484 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -130.03 122.78 20.46 Favored Pre-proline 0 N--CA 1.5 2.035 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -45.66 -30.9 6.79 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.037 1.158 . . . . 0.0 111.618 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -92.97 -6.37 48.6 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.28 -0.888 . . . . 0.0 109.969 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.525 ' OE2' ' NZ ' ' A' ' 35' ' ' LYS . 34.2 tt0 -163.82 128.28 2.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.249 -0.907 . . . . 0.0 109.549 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.534 HD12 ' CD1' ' A' ' 18' ' ' PHE . 46.6 mm -120.44 130.21 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.482 -0.761 . . . . 0.0 109.57 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.3 mt -117.63 130.56 56.45 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.6 mt -133.36 134.53 43.88 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.476 -0.765 . . . . 0.0 109.851 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -108.9 113.17 25.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.602 -0.686 . . . . 0.0 109.166 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 29' ' ' GLN . 2.6 t -125.24 167.38 14.95 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.411 0.624 . . . . 0.0 110.152 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.7 mm 44.95 -87.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.805 -0.56 . . . . 0.0 110.134 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.553 ' N ' ' O ' ' A' ' 27' ' ' THR . 27.8 pt20 -158.77 19.54 0.21 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.974 -1.078 . . . . 0.0 108.837 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.02 169.82 21.96 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.3 t -110.89 130.53 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.748 -0.854 . . . . 0.0 109.267 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.1 tp -110.8 123.15 49.52 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.0 m -110.18 120.31 42.04 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.8 mt -102.9 127.27 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.525 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 68.9 mttm -118.22 138.79 52.09 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.656 0.741 . . . . 0.0 109.318 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 177.98 -147.15 7.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -140.7 143.73 35.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.304 -1.115 . . . . 0.0 108.864 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.7 mttp 55.86 60.27 3.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.603 -0.685 . . . . 0.0 109.904 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.2 mp -92.59 72.21 5.05 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.493 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -178.811 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 49' ' ' GLY . 2.5 pp . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.7 mtpt 41.88 -103.74 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.533 0.682 . . . . 0.0 110.509 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.05 20.64 2.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.503 -0.748 . . . . 0.0 110.065 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . 87.4 32.58 13.35 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.491 ' OE1' ' N ' ' A' ' 50' ' ' GLN . 24.0 mp0 -104.55 152.93 21.81 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.28 -1.129 . . . . 0.0 109.111 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.66 158.76 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.372 -0.83 . . . . 0.0 109.667 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -141.16 149.28 41.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.296 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -124.88 133.41 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 62.4 tt0 -119.07 125.46 49.36 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.36 -175.52 35.48 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -99.11 130.87 45.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.996 . . . . 0.0 109.225 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.1 mt -86.46 117.45 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.074 -1.016 . . . . 0.0 109.161 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -96.77 -23.82 16.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.456 -0.777 . . . . 0.0 109.143 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -170.1 157.49 6.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.986 . . . . 0.0 110.522 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.408 HD13 HD13 ' B' ' 32' ' ' LEU . 10.4 mt -133.01 139.22 47.12 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.2 t -132.07 115.14 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.511 -0.743 . . . . 0.0 109.628 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 62' ' ' TYR . 25.1 t80 -134.34 113.71 12.3 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.52 123.7 14.37 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 CA-C-N 120.06 1.057 . . . . 0.0 111.03 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.887 HD13 ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -98.7 17.26 19.71 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.128 -0.982 . . . . 0.0 108.712 179.103 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 66' ' ' HIS . 0.4 OUTLIER 68.44 -174.45 0.19 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.515 -0.741 . . . . 0.0 110.447 178.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.509 ' O ' ' CG ' ' A' ' 67' ' ' HIS . 1.8 t60 77.99 -145.75 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.406 -0.809 . . . . 0.0 109.752 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.509 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 45.9 p-80 41.19 94.23 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.626 0.727 . . . . 0.0 109.776 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -57.79 146.13 32.52 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.363 -0.835 . . . . 0.0 110.181 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -152.84 162.9 40.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.462 -0.774 . . . . 0.0 109.429 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -105.03 138.71 40.82 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 77.7 m80 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.815 -179.799 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 95.3 mtp . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 54.51 27.38 8.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.451 -0.781 . . . . 0.0 109.308 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -102.87 10.42 38.36 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 33.2 mmm-85 -74.08 141.35 45.7 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . 0.584 ' NE2' HD21 ' A' ' 9' ' ' LEU . 40.1 tt0 -141.36 147.11 37.53 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.305 -0.872 . . . . 0.0 109.375 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -117.23 131.55 56.82 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.509 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.1 tt -118.08 124.44 48.07 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.467 ' N ' HD23 ' B' ' 7' ' ' LEU . 78.3 p -115.57 134.67 54.84 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.537 0.684 . . . . 0.0 109.625 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 tp -146.43 143.66 29.16 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -131.26 156.86 44.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.436 -0.79 . . . . 0.0 109.277 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.75 53.9 3.24 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -92.51 139.21 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.088 -1.242 . . . . 0.0 109.833 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -71.7 -42.38 67.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.952 . . . . 0.0 109.136 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -171.73 166.2 6.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.149 -0.969 . . . . 0.0 110.113 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 73.3 t -93.59 99.01 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.331 -0.856 . . . . 0.0 109.13 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -65.5 -40.0 92.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -0.868 . . . . 0.0 109.419 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -169.69 145.48 3.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.13 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -134.52 108.33 8.04 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.533 -0.73 . . . . 0.0 109.672 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -133.81 148.85 70.05 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.61 -12.4 31.22 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 121.706 1.604 . . . . 0.0 111.147 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -104.67 -7.84 19.31 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.522 -0.736 . . . . 0.0 109.539 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -173.74 140.63 0.78 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.463 -0.773 . . . . 0.0 109.158 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.6 mt -132.2 130.1 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.383 -0.823 . . . . 0.0 110.438 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.405 ' CD2' ' OG ' ' B' ' 33' ' ' SER . 13.5 mt -122.03 125.41 46.21 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 65.4 mt -132.18 131.62 42.38 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.504 -0.748 . . . . 0.0 109.135 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -88.75 118.75 28.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.895 -1.128 . . . . 0.0 108.602 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.566 ' O ' ' N ' ' B' ' 29' ' ' GLN . 2.2 t -123.8 153.66 40.66 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.709 -0.619 . . . . 0.0 109.974 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' B' ' 27' ' ' THR . 54.8 mt 34.01 -86.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-O 121.168 0.509 . . . . 0.0 110.665 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' B' ' 27' ' ' THR . 18.9 pt20 -150.61 39.41 0.72 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.046 -1.034 . . . . 0.0 109.615 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -161.22 130.38 2.33 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 69.7 t -83.42 132.96 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.438 -1.037 . . . . 0.0 109.481 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.408 HD13 HD13 ' A' ' 60' ' ' LEU . 43.5 tp -107.48 128.54 54.59 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.405 ' OG ' ' CD2' ' B' ' 24' ' ' LEU . 25.1 m -111.16 125.49 53.84 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.3 0.572 . . . . 0.0 109.582 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 93.2 mt -106.77 129.86 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -124.72 138.3 54.3 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.467 0.651 . . . . 0.0 109.453 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 164.57 -146.37 11.29 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -140.51 157.45 45.48 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.281 -1.129 . . . . 0.0 109.624 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 98.8 mttt 56.48 57.0 5.17 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.552 0.691 . . . . 0.0 109.783 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.542 HD12 ' N ' ' B' ' 39' ' ' LEU . 8.8 mp -91.7 70.62 5.75 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 C-N-CA 120.305 -0.95 . . . . 0.0 110.941 -178.544 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 81.8 mt . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -63.88 -36.44 83.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.622 -0.674 . . . . 0.0 109.351 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.78 -8.77 10.8 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.661 -0.65 . . . . 0.0 109.417 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.4 24.98 71.65 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -122.2 155.71 35.26 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.555 -0.968 . . . . 0.0 109.282 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.8 t -126.14 134.33 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.636 -0.665 . . . . 0.0 109.255 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -128.74 148.87 50.88 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 76.3 t -122.64 134.1 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -120.79 134.97 55.27 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.602 -0.686 . . . . 0.0 109.287 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.97 171.84 18.79 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.459 ' H ' HD23 ' B' ' 56' ' ' LEU . 0.1 OUTLIER -87.07 126.13 34.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.368 -1.078 . . . . 0.0 108.768 179.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 89.0 mt -88.56 113.08 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.078 -1.014 . . . . 0.0 109.184 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -94.26 -13.82 26.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.453 -0.78 . . . . 0.0 109.559 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -172.14 155.83 3.78 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.026 -1.046 . . . . 0.0 110.55 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.413 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 14.2 mt -138.62 142.77 39.11 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.402 HG22 HD12 ' A' ' 64' ' ' LEU . 54.1 t -135.72 126.91 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.415 -0.803 . . . . 0.0 109.382 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' B' ' 64' ' ' LEU . 12.0 t80 -141.07 135.89 15.6 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -42.89 82.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.69 1.593 . . . . 0.0 112.722 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.633 ' C ' HD23 ' B' ' 64' ' ' LEU . 0.7 OUTLIER -63.14 -12.49 27.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.181 -0.95 . . . . 0.0 108.485 179.228 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' B' ' 67' ' ' HIS . 5.7 mt-10 -99.77 17.04 21.71 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.447 -0.783 . . . . 0.0 109.084 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 63.54 -68.1 0.09 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.55 ' N ' ' O ' ' B' ' 65' ' ' GLU . 0.3 OUTLIER -175.76 86.2 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.317 -0.865 . . . . 0.0 109.134 179.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -133.55 114.92 14.11 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.307 -0.871 . . . . 0.0 109.498 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.529 ' O ' ' ND1' ' B' ' 70' ' ' HIS . 34.7 p80 -80.49 129.4 34.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.71 -0.619 . . . . 0.0 109.618 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.529 ' ND1' ' O ' ' B' ' 69' ' ' HIS . 5.4 m-70 -136.24 145.31 45.5 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.349 -0.844 . . . . 0.0 109.96 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 11.7 m80 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.682 -179.845 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 122.052 0.929 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.449 ' OD2' ' CG ' ' A' ' 4' ' ' ARG . 4.2 p-10 -142.93 -146.48 0.19 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -108.22 4.47 24.77 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.705 -1.247 . . . . 0.0 109.291 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.449 ' CG ' ' OD2' ' A' ' 2' ' ' ASP . 30.4 mmm-85 -81.26 139.42 35.47 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -139.74 163.33 32.89 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.02 -1.05 . . . . 0.0 110.436 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.412 ' CD2' ' HG2' ' A' ' 54' ' ' GLU . 36.7 m-85 -108.73 127.07 53.68 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.301 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.459 ' C ' HD23 ' A' ' 7' ' ' LEU . 6.2 tt -125.71 119.88 29.17 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.416 ' N ' HD23 ' A' ' 7' ' ' LEU . 34.9 t -129.31 151.43 49.97 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.572 0.701 . . . . 0.0 109.927 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.4 tp -142.91 155.72 44.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.429 -0.794 . . . . 0.0 109.549 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.4 p -69.21 170.24 10.53 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.732 0.777 . . . . 0.0 110.804 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -40.07 117.11 0.82 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.572 HG22 ' N ' ' A' ' 13' ' ' SER . 9.1 p -83.51 165.84 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.693 -0.886 . . . . 0.0 110.417 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 12' ' ' VAL . 69.7 m -72.82 -45.43 58.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.0 109.313 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.17 145.12 1.71 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.069 -1.019 . . . . 0.0 109.831 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 80.6 t -89.88 128.24 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.195 -0.941 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -86.55 -22.42 26.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.464 -0.772 . . . . 0.0 110.033 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.7 t -172.26 157.16 4.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.968 -1.082 . . . . 0.0 109.837 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.484 ' CD1' ' C ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -145.9 105.2 3.93 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 109.566 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -134.61 147.47 63.37 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.8 -13.68 34.91 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.372 2.048 . . . . 0.0 110.807 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -100.88 -4.63 27.4 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.407 ' C ' ' OE1' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -178.81 143.78 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.6 mt -134.53 131.44 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.092 -1.005 . . . . 0.0 109.407 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 68.3 mt -112.08 127.97 56.06 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.4 mt -124.88 128.05 48.06 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.614 -0.679 . . . . 0.0 109.626 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -103.46 117.0 33.45 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 29' ' ' GLN . 5.5 t -124.03 150.09 45.33 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.945 0.879 . . . . 0.0 110.705 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.4 HD11 ' O ' ' B' ' 3' ' ' ASN . 61.4 mt 47.52 -83.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.359 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 27' ' ' THR . 28.4 pt20 -144.6 -23.04 0.52 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.118 -0.989 . . . . 0.0 109.691 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.6 170.15 32.11 Favored Glycine 0 N--CA 1.498 2.816 0 O-C-N 120.912 -1.118 . . . . 0.0 111.156 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.1 t -120.04 133.5 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.769 -0.842 . . . . 0.0 109.525 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.8 tp -110.12 124.5 51.64 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.4 m -110.64 124.04 51.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.546 -0.721 . . . . 0.0 109.737 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.5 mt -107.75 131.55 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -126.81 139.49 53.07 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.673 0.749 . . . . 0.0 109.456 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.92 -155.71 25.83 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -132.06 148.34 52.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.622 -0.928 . . . . 0.0 109.118 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 61.72 54.6 2.9 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.939 0.876 . . . . 0.0 109.403 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.1 mp -93.2 71.94 4.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.334 -0.854 . . . . 0.0 108.836 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.622 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 47' ' ' LYS . 55.4 tp . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.565 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 88.5 tttt -34.74 152.21 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.432 0.634 . . . . 0.0 110.984 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 47' ' ' LYS . . . 72.9 -23.76 0.2 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 47' ' ' LYS . . . 64.96 28.61 73.71 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -95.57 161.13 14.18 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.273 -1.134 . . . . 0.0 110.447 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.6 t -120.63 136.98 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.433 0.635 . . . . 0.0 109.359 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -111.86 146.7 37.25 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.4 t -134.11 136.02 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -125.05 134.75 52.41 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.126 0.965 . . . . 0.0 109.535 -179.776 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.549 ' N ' ' OE1' ' A' ' 54' ' ' GLU . . . 155.37 174.41 25.22 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.401 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -95.44 139.47 31.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.607 -0.937 . . . . 0.0 109.643 -179.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.5 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.5 mp -93.2 111.92 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 108.768 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -98.54 -22.83 15.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.588 -0.695 . . . . 0.0 109.403 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.27 149.45 11.97 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.829 -1.169 . . . . 0.0 110.705 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.432 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 67.4 mt -133.29 135.34 44.82 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 49.2 t -135.55 123.35 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 121.75 0.786 . . . . 0.0 109.303 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.518 ' O ' HD13 ' A' ' 64' ' ' LEU . 22.8 t80 -137.24 142.13 36.72 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.49 111.65 2.85 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.708 1.605 . . . . 0.0 112.432 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.86 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -103.7 -15.45 15.75 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.676 ' N ' HD22 ' A' ' 64' ' ' LEU . 86.7 mt-10 -150.17 153.57 36.54 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.928 0.87 . . . . 0.0 109.979 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.522 ' O ' ' CG ' ' A' ' 67' ' ' HIS . 16.3 t60 -174.66 -35.69 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 3.4 m-70 174.68 106.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.622 0.725 . . . . 0.0 109.095 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m80 54.85 80.17 0.13 Allowed 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.928 0.871 . . . . 0.0 108.818 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.564 ' ND1' ' N ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -70.08 -83.5 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.676 -0.64 . . . . 0.0 110.279 -179.318 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.673 ' H ' ' CD2' ' A' ' 70' ' ' HIS . 0.0 OUTLIER -119.37 153.33 35.32 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 122.012 0.91 . . . . 0.0 110.076 -179.117 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 44.0 t60 . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.301 179.998 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.868 0.842 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' B' ' 3' ' ' ASN . 15.1 t70 -76.35 167.29 22.11 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.893 0.854 . . . . 0.0 110.559 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.423 ' N ' ' OD1' ' B' ' 2' ' ' ASP . 2.6 p-10 -82.72 -3.54 56.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.366 -0.834 . . . . 0.0 109.514 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 34.1 mmm-85 -77.59 139.6 39.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.065 -1.022 . . . . 0.0 109.869 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -139.16 156.65 46.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.474 -0.766 . . . . 0.0 109.468 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -112.04 133.91 53.92 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.431 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.1 tt -118.25 125.03 49.3 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 96.2 p -112.71 145.47 40.44 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.829 0.823 . . . . 0.0 109.988 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.2 tp -156.88 156.33 32.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.515 -0.741 . . . . 0.0 109.358 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.9 t -150.44 158.5 44.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.5 -0.75 . . . . 0.0 110.138 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.68 15.21 73.85 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.0 p -54.75 149.53 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -1.188 . . . . 0.0 110.254 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 3.2 t -73.06 -44.01 61.16 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -172.5 166.59 5.64 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.131 -0.981 . . . . 0.0 110.37 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 88.2 t -96.67 99.75 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.543 -0.723 . . . . 0.0 109.145 178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -65.28 -48.39 73.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.509 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 32.1 t -168.82 129.26 1.16 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.05 -1.031 . . . . 0.0 109.409 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -112.34 117.27 32.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.51 -0.744 . . . . 0.0 109.276 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.02 151.16 77.43 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.66 -13.41 29.79 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.31 2.006 . . . . 0.0 111.62 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -115.5 -0.38 13.1 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.431 -0.793 . . . . 0.0 109.197 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -169.83 138.91 1.86 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 109.078 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.56 130.91 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.332 -0.855 . . . . 0.0 110.297 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 19.0 mt -122.2 123.3 41.18 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.479 0.657 . . . . 0.0 109.567 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 94.6 mt -132.41 132.6 42.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.684 -0.635 . . . . 0.0 110.121 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -89.06 121.69 31.65 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.562 ' O ' ' N ' ' B' ' 29' ' ' GLN . 6.8 t -124.89 154.89 40.39 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.479 0.657 . . . . 0.0 110.191 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.424 ' C ' ' O ' ' B' ' 27' ' ' THR . 24.8 mm 30.77 -84.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.578 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' B' ' 27' ' ' THR . 26.2 pt20 -147.03 48.65 1.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.873 -1.142 . . . . 0.0 109.191 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.06 167.31 39.37 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 53.4 t -117.09 134.6 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.384 -1.068 . . . . 0.0 110.155 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 48.1 tp -106.07 125.91 51.57 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 18.4 t -111.67 127.55 55.8 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.579 0.704 . . . . 0.0 109.313 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 81.8 mt -106.84 131.28 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.372 0.606 . . . . 0.0 109.387 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -123.64 142.1 51.37 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.554 0.692 . . . . 0.0 109.463 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 157.38 -148.56 18.34 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -130.58 147.98 52.32 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.475 -1.015 . . . . 0.0 110.048 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt 61.07 52.11 4.17 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.807 0.813 . . . . 0.0 109.495 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.565 HD12 ' N ' ' B' ' 39' ' ' LEU . 7.5 mp -91.41 72.02 6.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.301 -0.874 . . . . 0.0 109.287 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . 0.421 ' O ' ' OE1' ' B' ' 54' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.622 HD12 ' N ' ' B' ' 46' ' ' LEU . 9.4 mp . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.79 0.805 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -64.33 -45.61 87.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 108.615 178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -138.5 32.02 2.31 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.37 26.47 65.78 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -122.02 149.76 43.05 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.359 -1.083 . . . . 0.0 110.307 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 9.8 p -134.78 141.52 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -118.25 136.89 53.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.762 -0.586 . . . . 0.0 109.569 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 53.9 t -127.88 132.03 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' B' ' 54' ' ' GLU . 2.6 mp0 -116.17 145.69 42.89 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.854 0.835 . . . . 0.0 110.205 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.39 170.28 22.1 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.4 ' H ' HD23 ' B' ' 56' ' ' LEU . 0.2 OUTLIER -97.79 110.8 23.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.533 -0.98 . . . . 0.0 108.956 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.618 HD12 ' N ' ' B' ' 57' ' ' ILE . 2.1 mp -75.93 122.33 29.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.059 -1.026 . . . . 0.0 108.957 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -105.04 -22.38 13.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.541 -0.725 . . . . 0.0 109.131 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.22 150.82 16.86 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.75 -1.219 . . . . 0.0 110.659 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 17.2 mt -132.99 146.77 52.07 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.422 -0.799 . . . . 0.0 109.677 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 55.9 t -137.7 115.69 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.364 -0.835 . . . . 0.0 110.233 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.432 ' CG ' ' HB2' ' A' ' 60' ' ' LEU . 59.1 t80 -138.26 104.11 7.94 Favored Pre-proline 0 N--CA 1.491 1.603 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -43.32 105.79 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.209 1.939 . . . . 0.0 112.428 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 1.0 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -78.09 -5.28 51.05 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 179.483 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' B' ' 64' ' ' LEU . 2.3 mm-40 158.63 -161.27 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -141.67 -46.5 0.37 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.558 -1.339 . . . . 0.0 108.624 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.58 ' O ' ' N ' ' B' ' 69' ' ' HIS . 4.3 m-70 -157.0 172.94 17.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.415 -0.803 . . . . 0.0 109.026 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.566 ' O ' ' ND1' ' B' ' 69' ' ' HIS . 4.2 m80 -43.07 88.44 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.624 0.725 . . . . 0.0 110.595 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.58 ' N ' ' O ' ' B' ' 67' ' ' HIS . 0.0 OUTLIER -156.19 31.19 0.34 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.725 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -95.99 133.55 40.07 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.839 0.828 . . . . 0.0 110.302 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.456 ' C ' ' CD2' ' B' ' 71' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.4 mmm . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -88.36 114.92 25.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.432 -0.793 . . . . 0.0 109.276 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.588 HD22 ' HB3' ' A' ' 56' ' ' LEU . 2.8 p-10 -94.59 4.89 53.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.159 -0.963 . . . . 0.0 109.377 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.5 mmm-85 -69.21 142.58 54.21 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.291 -0.88 . . . . 0.0 108.916 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.549 ' NE2' HD21 ' B' ' 9' ' ' LEU . 50.1 tt0 -145.94 150.32 35.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.0 109.674 -179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.527 ' CD2' ' OE1' ' A' ' 54' ' ' GLU . 77.1 m-85 -103.12 145.25 30.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.565 -0.71 . . . . 0.0 109.3 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 7' ' ' LEU . 7.0 tt -140.8 124.25 16.8 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.457 ' N ' HD23 ' A' ' 7' ' ' LEU . 41.3 t -128.98 135.36 48.87 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.28 -0.887 . . . . 0.0 108.742 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.0 tp -146.48 154.34 41.46 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.077 -1.014 . . . . 0.0 109.336 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 t -144.0 164.24 31.19 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.256 -0.903 . . . . 0.0 109.383 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.68 18.53 51.43 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.9 t -66.25 137.71 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.284 -1.127 . . . . 0.0 110.236 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 m -72.19 -42.93 65.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.549 -0.719 . . . . 0.0 109.929 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.92 160.65 10.31 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.881 -1.137 . . . . 0.0 110.343 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 70.6 t -93.08 129.15 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.499 -0.75 . . . . 0.0 110.222 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -100.06 -35.69 9.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.436 -0.79 . . . . 0.0 108.939 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.0 t -173.02 144.3 1.24 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 0.0 109.559 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -129.81 107.83 9.7 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -133.67 148.99 70.8 Favored Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.94 -11.71 31.13 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.839 1.693 . . . . 0.0 111.792 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -108.97 -5.63 16.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.343 -0.848 . . . . 0.0 110.149 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -172.01 127.4 0.59 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.977 -1.077 . . . . 0.0 108.936 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.47 126.83 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.259 -0.901 . . . . 0.0 109.459 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.9 mt -118.79 110.76 17.62 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.1 mt -129.81 132.56 46.54 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.256 -0.903 . . . . 0.0 109.143 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -94.12 113.58 25.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.237 -0.914 . . . . 0.0 109.899 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 28' ' ' ILE . 4.4 t -124.36 147.67 48.05 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.835 0.826 . . . . 0.0 109.615 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.457 ' C ' ' O ' ' A' ' 27' ' ' THR . 37.4 mt 21.0 -96.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.238 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.411 ' CG ' ' O ' ' B' ' 57' ' ' ILE . 77.0 mm-40 -46.62 -73.76 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.494 -0.754 . . . . 0.0 111.596 -178.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.96 -143.83 3.78 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 119.573 -1.298 . . . . 0.0 111.473 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 t -89.31 134.97 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.65 -0.912 . . . . 0.0 111.39 -178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.0 tp -112.82 120.46 41.54 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.1 m -108.73 124.55 50.73 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.6 mt -112.45 130.41 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -117.47 143.72 45.76 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.578 -0.701 . . . . 0.0 109.65 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 165.94 -148.34 13.59 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -136.29 152.05 50.28 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.316 -1.108 . . . . 0.0 109.517 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 54' ' ' GLU . 53.5 mtmt 56.16 52.11 10.81 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.552 -0.718 . . . . 0.0 110.142 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.5 mp -92.32 72.49 5.3 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.104 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.369 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.363 0.602 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -148.73 -63.52 0.24 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.381 -0.824 . . . . 0.0 109.43 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.43 2.0 49.31 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.327 -0.858 . . . . 0.0 109.412 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.54 20.33 78.57 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -97.63 161.51 13.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.334 -1.097 . . . . 0.0 109.544 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.9 t -116.15 131.86 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -118.86 130.51 55.78 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.8 t -127.34 133.89 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.501 -0.749 . . . . 0.0 109.068 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.527 ' OE1' ' CD2' ' A' ' 6' ' ' PHE . 17.3 tp10 -122.05 137.31 54.85 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 155.0 173.37 23.69 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.588 ' HB3' HD22 ' A' ' 3' ' ' ASN . 0.2 OUTLIER -96.91 140.55 31.29 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.416 -1.049 . . . . 0.0 109.599 -179.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.536 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.7 mp -97.24 116.48 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.372 -0.83 . . . . 0.0 108.953 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -95.12 -18.97 20.5 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -171.42 151.45 3.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 0.0 109.764 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.8 mt -126.7 137.29 53.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.505 -0.747 . . . . 0.0 109.11 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.3 t -133.94 127.22 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.366 -0.834 . . . . 0.0 109.088 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.565 ' O ' ' N ' ' A' ' 64' ' ' LEU . 48.0 t80 -138.22 107.96 8.06 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -45.26 81.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.739 1.626 . . . . 0.0 112.479 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.946 HD12 HG22 ' B' ' 61' ' ' VAL . 0.3 OUTLIER -79.67 80.77 6.02 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.371 -1.456 . . . . 0.0 108.958 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -144.59 91.28 2.16 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.249 -0.907 . . . . 0.0 109.504 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.532 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 59.2 t-80 -169.67 10.04 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.401 ' H ' ' H ' ' A' ' 66' ' ' HIS . 11.0 p-80 -141.39 168.54 19.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.479 -0.763 . . . . 0.0 109.628 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -57.93 -174.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.595 0.712 . . . . 0.0 109.658 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -145.58 2.49 0.95 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.403 ' O ' ' C ' ' A' ' 71' ' ' HIS . 1.5 t-80 -80.05 159.57 26.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.186 -0.946 . . . . 0.0 109.903 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.506 ' OXT' ' ND1' ' A' ' 71' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.553 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 85.9 mmm . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 t70 61.26 35.97 18.01 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.524 HD22 ' CB ' ' B' ' 56' ' ' LEU . 6.0 p-10 -95.2 -1.72 51.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.444 -0.785 . . . . 0.0 109.2 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.1 mmm-85 -72.41 134.39 45.38 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.212 -0.93 . . . . 0.0 109.393 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -148.89 163.44 37.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.239 -0.913 . . . . 0.0 109.769 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -104.31 148.74 26.03 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.446 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.1 tt -135.64 118.66 16.4 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 28.6 t -111.49 131.08 55.48 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.428 -0.795 . . . . 0.0 109.335 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.549 HD21 ' NE2' ' A' ' 5' ' ' GLN . 3.1 tp -148.85 153.86 38.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.96 -1.088 . . . . 0.0 110.059 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 12.7 t -154.45 -167.03 2.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.829 . . . . 0.0 109.529 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.59 19.52 62.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.4 145.26 13.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.283 -1.128 . . . . 0.0 110.15 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 24.1 m -71.97 -43.13 65.67 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.27 -0.893 . . . . 0.0 108.941 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . 0.426 ' HB2' ' HZ2' ' B' ' 14' ' ' LYS . 0.0 OUTLIER -171.17 159.6 5.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.349 -0.844 . . . . 0.0 109.501 179.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.15 107.33 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.162 -0.961 . . . . 0.0 109.935 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -66.14 -40.57 90.71 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.239 -0.913 . . . . 0.0 109.067 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 23.1 t -172.26 162.42 5.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.09 -1.006 . . . . 0.0 109.147 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -140.25 110.41 6.57 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.327 -0.858 . . . . 0.0 109.76 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -132.97 148.01 67.72 Favored Pre-proline 0 N--CA 1.495 1.779 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.67 -9.81 27.07 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.851 1.701 . . . . 0.0 111.996 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -118.19 7.52 12.14 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.547 -0.721 . . . . 0.0 109.776 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -171.05 132.45 0.84 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.932 . . . . 0.0 109.194 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 47.0 mm -121.75 125.88 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.475 -0.765 . . . . 0.0 109.279 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 74.5 mt -119.89 113.14 20.12 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -131.64 140.31 49.33 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.329 -0.857 . . . . 0.0 109.303 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -107.63 117.77 34.98 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.569 ' O ' ' N ' ' B' ' 29' ' ' GLN . 3.7 t -125.01 153.01 43.48 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.417 0.627 . . . . 0.0 110.041 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.406 HD13 ' N ' ' B' ' 28' ' ' ILE . 5.4 mm 53.39 -78.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.872 -0.518 . . . . 0.0 110.193 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' B' ' 27' ' ' THR . 22.0 pt20 -169.5 52.4 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -171.53 140.08 5.69 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 92.4 t -84.27 132.48 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.378 -1.072 . . . . 0.0 109.515 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.428 HD11 HD12 ' B' ' 60' ' ' LEU . 47.6 tp -111.26 123.12 49.56 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 24.0 m -109.87 119.63 39.96 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.325 -0.859 . . . . 0.0 109.076 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 95.9 mt -109.91 129.31 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -117.86 137.46 52.76 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -177.92 -152.72 10.4 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -134.22 145.37 49.11 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.307 -1.114 . . . . 0.0 109.608 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' B' ' 54' ' ' GLU . 72.4 mmtt 59.43 52.02 6.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.568 -0.707 . . . . 0.0 110.058 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.555 HD12 ' N ' ' B' ' 39' ' ' LEU . 10.4 mp -88.45 72.04 8.91 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.952 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -178.547 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 62.0 mt . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 121.612 0.72 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -171.07 -81.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.2 8.85 5.21 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.462 -0.774 . . . . 0.0 109.471 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.13 35.44 15.15 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.029 -1.229 . . . . 0.0 110.029 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -129.82 159.99 34.87 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.412 -1.052 . . . . 0.0 109.182 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.38 137.42 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -122.04 147.35 46.2 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -126.69 135.33 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' B' ' 38' ' ' LYS . 47.7 tt0 -119.2 133.03 55.99 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.86 -178.69 34.04 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.524 ' CB ' HD22 ' B' ' 3' ' ' ASN . 0.2 OUTLIER -103.03 126.43 50.2 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.451 -1.029 . . . . 0.0 109.806 -179.625 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.554 HD12 ' N ' ' B' ' 57' ' ' ILE . 1.4 mp -76.9 126.1 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.962 . . . . 0.0 109.198 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -104.95 -23.28 13.0 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.618 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -169.26 153.28 5.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.055 -1.028 . . . . 0.0 110.019 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.618 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.9 OUTLIER -131.19 134.16 46.22 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.946 HG22 HD12 ' A' ' 64' ' ' LEU . 4.1 t -135.43 124.72 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.786 -0.571 . . . . 0.0 110.033 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.463 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 17.9 t80 -144.19 140.32 16.77 Favored Pre-proline 0 N--CA 1.493 1.712 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.463 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 72.6 Cg_endo -74.46 108.48 2.7 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.538 1.492 . . . . 0.0 112.082 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.96 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -82.25 8.84 10.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.535 -0.728 . . . . 0.0 109.164 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 72.9 155.48 0.16 Allowed 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.502 0.668 . . . . 0.0 110.631 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.407 ' C ' ' H ' ' B' ' 68' ' ' HIS . 90.7 m-70 -88.39 17.49 5.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.611 -0.681 . . . . 0.0 109.371 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.528 ' CG ' ' O ' ' B' ' 67' ' ' HIS . 16.1 t-80 -77.51 39.81 0.28 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.323 -0.861 . . . . 0.0 108.775 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.561 ' O ' ' ND1' ' B' ' 69' ' ' HIS . 0.3 OUTLIER -80.61 -20.72 42.59 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.171 -0.956 . . . . 0.0 109.651 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.639 ' CG ' ' H ' ' B' ' 70' ' ' HIS . 0.0 OUTLIER 18.96 -125.9 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 CA-C-O 121.266 0.555 . . . . 0.0 112.268 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.639 ' H ' ' CG ' ' B' ' 69' ' ' HIS . 0.1 OUTLIER -46.19 -73.07 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.406 -0.809 . . . . 0.0 109.722 -179.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.412 ' C ' ' O ' ' B' ' 70' ' ' HIS . 8.7 t-160 . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.585 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.442 ' O ' ' O ' ' A' ' 2' ' ' ASP . 27.9 ttt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 1' ' ' MET . 30.6 t70 58.61 122.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.537 0.685 . . . . 0.0 110.478 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -144.17 -29.12 0.5 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.449 -0.782 . . . . 0.0 109.143 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 41.5 mmm-85 -60.48 141.29 56.65 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.327 -0.858 . . . . 0.0 108.785 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -152.19 161.93 41.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.125 -0.984 . . . . 0.0 109.917 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 1.2 m-85 -117.89 139.62 50.87 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.493 ' C ' HD23 ' A' ' 7' ' ' LEU . 7.2 tt -115.8 126.06 53.52 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.393 -0.817 . . . . 0.0 108.996 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.476 ' N ' HD23 ' A' ' 7' ' ' LEU . 32.4 t -115.25 126.75 54.9 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.4 tp -144.63 151.77 39.5 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 t -143.15 166.84 23.56 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.278 -0.889 . . . . 0.0 109.631 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.4 10.95 67.33 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -69.97 145.23 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -1.219 . . . . 0.0 110.028 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.1 m -73.87 -51.97 14.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.361 -0.837 . . . . 0.0 109.529 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.43 ' HB2' ' HZ2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -167.37 158.69 11.88 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.067 -1.021 . . . . 0.0 109.619 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.7 t -89.27 116.01 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.268 -0.895 . . . . 0.0 109.403 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -69.19 -40.89 77.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.22 -0.925 . . . . 0.0 109.7 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.1 t -161.83 125.28 3.14 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.369 -0.832 . . . . 0.0 109.844 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -109.25 110.19 21.32 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -133.61 148.05 67.07 Favored Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.16 -20.1 50.14 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.715 1.61 . . . . 0.0 111.604 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -100.14 -5.44 27.79 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.341 -0.849 . . . . 0.0 109.671 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.403 ' OE2' ' NZ ' ' A' ' 35' ' ' LYS . 36.2 tt0 -171.32 142.91 1.77 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.208 -0.932 . . . . 0.0 109.603 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.8 mt -131.2 130.04 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.715 -0.616 . . . . 0.0 109.497 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.8 mt -117.28 125.75 51.61 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.3 mt -121.1 130.09 53.59 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.591 -0.693 . . . . 0.0 109.647 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.403 ' HG2' HG22 ' A' ' 31' ' ' VAL . 29.4 mt-10 -97.68 103.54 15.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.357 -0.839 . . . . 0.0 110.011 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 28' ' ' ILE . 6.6 t -127.18 -172.47 2.66 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.951 0.882 . . . . 0.0 110.562 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 27' ' ' THR . 4.2 mt -31.84 154.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.924 0.868 . . . . 0.0 111.244 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 64.49 -56.17 0.26 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.646 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -173.4 -129.48 1.16 Allowed Glycine 0 N--CA 1.487 2.059 0 C-N-CA 119.234 -1.46 . . . . 0.0 109.944 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.403 HG22 ' HG2' ' A' ' 26' ' ' GLU . 52.7 t -120.72 136.14 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 121.778 0.799 . . . . 0.0 110.862 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.9 tp -104.61 126.85 52.09 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -100.8 125.51 47.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.632 -0.668 . . . . 0.0 109.512 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.3 mt -111.3 128.54 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-O 121.294 0.569 . . . . 0.0 109.513 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.403 ' NZ ' ' OE2' ' A' ' 22' ' ' GLU . 68.5 mttm -128.27 144.24 51.11 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.453 0.644 . . . . 0.0 109.629 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.9 -137.69 4.31 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -132.57 153.3 51.13 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.193 -1.181 . . . . 0.0 110.232 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 54' ' ' GLU . 98.9 mttt 49.72 40.64 20.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.619 -0.676 . . . . 0.0 110.135 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.3 mp -68.51 72.23 0.21 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 0.0 109.244 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.676 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.869 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 48' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.846 0.831 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.548 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -91.05 -11.75 37.81 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.025 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HB3' HD12 ' A' ' 46' ' ' LEU . . . -43.8 -17.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.831 -0.543 . . . . 0.0 109.898 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 47' ' ' LYS . . . 126.55 23.79 1.47 Allowed Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.42 ' NE2' HD11 ' A' ' 46' ' ' LEU . 12.5 mt-30 -130.02 134.35 47.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.713 -0.875 . . . . 0.0 109.111 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 52' ' ' GLU . 40.6 t -131.44 161.16 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.56 -0.712 . . . . 0.0 109.231 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.483 ' N ' HG12 ' A' ' 51' ' ' VAL . 92.5 mt-10 -132.83 160.03 38.1 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.529 0.681 . . . . 0.0 109.673 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 t -128.84 157.82 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 38' ' ' LYS . 32.1 tt0 -135.37 134.56 39.89 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.6 172.14 13.18 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 pp -97.46 134.94 40.03 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.438 -1.037 . . . . 0.0 109.169 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.3 mp -84.95 113.69 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.845 -1.16 . . . . 0.0 108.664 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -98.74 -22.19 16.0 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -159.47 148.57 18.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.315 -0.866 . . . . 0.0 110.298 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.49 ' HB2' ' CG ' ' B' ' 62' ' ' TYR . 51.5 mt -133.97 146.36 50.38 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.5 t -146.53 114.83 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.059 -1.025 . . . . 0.0 109.869 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.532 ' O ' ' N ' ' A' ' 64' ' ' LEU . 13.8 t80 -130.28 142.52 45.73 Favored Pre-proline 0 N--CA 1.496 1.866 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.519 ' C ' ' H ' ' A' ' 65' ' ' GLU . 84.7 Cg_exo -44.87 85.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.34 1.36 . . . . 0.0 111.916 177.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.647 ' O ' HD23 ' A' ' 64' ' ' LEU . 2.1 tt -56.7 -7.83 0.49 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.817 -1.177 . . . . 0.0 108.525 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.56 ' CB ' ' O ' ' A' ' 64' ' ' LEU . 2.1 tp10 95.27 -73.91 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.588 ' H ' HD23 ' A' ' 64' ' ' LEU . 1.8 t60 75.63 172.56 0.25 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.512 -0.742 . . . . 0.0 109.178 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.447 ' O ' ' CB ' ' A' ' 68' ' ' HIS . 0.1 OUTLIER -77.41 149.49 35.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.005 -1.059 . . . . 0.0 110.164 -178.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.447 ' CB ' ' O ' ' A' ' 67' ' ' HIS . 4.0 t60 74.71 176.0 0.24 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.656 -0.652 . . . . 0.0 109.511 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 70' ' ' HIS . 6.5 t-80 -129.62 16.17 5.91 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 69' ' ' HIS . 34.5 m-70 44.31 -167.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.402 -0.811 . . . . 0.0 109.959 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.502 ' OXT' ' CG ' ' A' ' 71' ' ' HIS . 10.2 p80 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.346 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 77.6 mtm . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 7.0 t70 58.15 -171.04 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.416 -0.802 . . . . 0.0 109.85 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.501 HD22 ' CB ' ' B' ' 56' ' ' LEU . 2.7 p-10 -95.57 12.87 28.07 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 43.5 mmm-85 -89.39 131.46 35.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.964 -1.085 . . . . 0.0 109.128 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -144.52 159.01 43.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.288 -0.882 . . . . 0.0 109.903 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.9 115.17 29.65 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.437 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.6 tt -113.8 126.77 55.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.407 -0.808 . . . . 0.0 109.061 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.401 ' N ' HD23 ' B' ' 7' ' ' LEU . 40.7 t -132.47 143.76 50.0 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.418 ' O ' HG12 ' B' ' 51' ' ' VAL . 52.0 tp -133.64 150.09 51.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.527 -0.733 . . . . 0.0 109.154 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.6 p -129.3 171.12 12.8 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.704 -0.623 . . . . 0.0 109.35 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.52 5.46 63.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.04 135.32 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.339 -1.095 . . . . 0.0 109.695 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.3 t -72.56 -46.12 55.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 109.55 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.03 160.78 5.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.179 -0.95 . . . . 0.0 109.55 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 90.4 t -93.6 121.27 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.189 -0.944 . . . . 0.0 109.218 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -66.7 -40.03 88.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.337 -0.852 . . . . 0.0 109.545 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 47.7 t -162.43 149.77 13.75 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.43 -0.794 . . . . 0.0 108.889 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -136.24 117.85 14.92 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.377 -0.827 . . . . 0.0 109.491 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -132.45 150.81 76.94 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.06 -13.81 41.19 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.502 1.468 . . . . 0.0 111.07 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -118.2 3.12 12.01 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.749 -0.594 . . . . 0.0 109.603 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -170.03 134.43 1.27 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.269 -0.894 . . . . 0.0 109.409 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.2 mt -132.24 129.54 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.279 -0.888 . . . . 0.0 109.46 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 74.8 mt -112.34 125.64 54.41 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 87.1 mt -113.21 132.44 55.5 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.53 -0.731 . . . . 0.0 110.121 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -104.66 101.12 10.77 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.567 ' O ' ' N ' ' B' ' 29' ' ' GLN . 0.0 OUTLIER -108.73 148.86 29.84 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.822 -0.549 . . . . 0.0 110.447 -178.353 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' B' ' 27' ' ' THR . 39.9 mt 34.2 -86.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 122.151 -0.343 . . . . 0.0 110.83 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.567 ' N ' ' O ' ' B' ' 27' ' ' THR . 18.5 pt20 -137.49 -16.05 1.38 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.382 -0.824 . . . . 0.0 109.738 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.32 167.85 29.21 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 54.6 t -123.1 131.51 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 43.5 tp -110.76 126.18 54.32 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 19.1 t -106.69 122.8 47.08 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 94.9 mt -105.73 129.29 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -124.13 141.39 52.09 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.628 -0.67 . . . . 0.0 109.379 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.23 -153.42 22.95 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -121.45 150.85 40.95 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.571 -0.958 . . . . 0.0 109.847 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' B' ' 54' ' ' GLU . 95.3 mttt 51.93 61.68 3.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -0.8 . . . . 0.0 110.124 179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.406 ' N ' HD12 ' B' ' 39' ' ' LEU . 9.2 mp -93.05 71.56 4.63 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.764 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -179.11 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' B' ' 47' ' ' LYS . 53.3 tp . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.105 0.479 . . . . 0.0 110.51 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.557 ' O ' ' HB3' ' B' ' 48' ' ' ALA . 88.1 tttt -39.44 150.26 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.424 -0.798 . . . . 0.0 110.583 -178.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' B' ' 47' ' ' LYS . . . 71.38 -17.08 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.603 -0.686 . . . . 0.0 109.237 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' B' ' 47' ' ' LYS . . . 79.01 10.39 86.22 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -109.94 160.18 16.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.633 -0.922 . . . . 0.0 109.266 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.418 HG12 ' O ' ' B' ' 9' ' ' LEU . 2.2 p -132.18 141.71 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.569 -0.707 . . . . 0.0 109.32 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -122.1 149.78 43.1 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 10.2 t -141.45 138.22 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.163 -0.961 . . . . 0.0 109.545 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' B' ' 38' ' ' LYS . 16.0 tt0 -127.62 137.59 52.59 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.61 178.36 26.29 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.501 ' CB ' HD22 ' B' ' 3' ' ' ASN . 0.2 OUTLIER -99.82 124.46 45.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.572 -0.958 . . . . 0.0 108.929 179.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.586 HD12 ' N ' ' B' ' 57' ' ' ILE . 1.5 mp -82.82 119.25 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.181 -0.949 . . . . 0.0 108.895 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -95.26 -21.46 18.43 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.386 -0.821 . . . . 0.0 109.488 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -170.29 153.5 4.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.117 -0.989 . . . . 0.0 109.8 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.413 ' HB2' ' CG ' ' A' ' 62' ' ' TYR . 96.2 mt -134.04 136.58 44.11 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 56.7 t -132.64 124.81 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.554 -0.716 . . . . 0.0 109.459 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.49 ' CG ' ' HB2' ' A' ' 60' ' ' LEU . 19.4 t80 -133.01 139.71 35.3 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.477 ' O ' ' C ' ' B' ' 64' ' ' LEU . 71.6 Cg_exo -44.5 -65.49 0.19 Allowed 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 122.026 1.818 . . . . 0.0 115.294 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.835 HD13 ' O ' ' B' ' 64' ' ' LEU . 2.0 tm? 28.27 89.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.622 0.725 . . . . 0.0 111.002 -177.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.407 ' OE1' ' O ' ' B' ' 63' ' ' PRO . 2.9 mt-10 -140.44 141.43 35.48 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.65 ' ND1' ' N ' ' B' ' 67' ' ' HIS . 3.7 p80 -59.51 -42.76 92.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.762 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.65 ' N ' ' ND1' ' B' ' 66' ' ' HIS . 1.9 m170 -172.6 152.59 2.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -0.862 . . . . 0.0 108.723 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.22 174.44 10.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.075 -1.015 . . . . 0.0 109.824 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -81.21 14.91 2.14 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -57.71 141.96 46.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.6 -0.687 . . . . 0.0 109.527 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 2.0 t60 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.317 -179.605 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.629 0.728 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 31.9 t0 -72.58 163.79 27.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.343 -0.848 . . . . 0.0 109.919 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.508 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 1.9 p-10 -88.85 11.12 18.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.181 -0.949 . . . . 0.0 109.487 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.431 ' NE ' ' OE2' ' A' ' 54' ' ' GLU . 40.1 mmm-85 -71.23 147.89 47.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 109.126 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -141.37 156.86 45.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.187 -0.945 . . . . 0.0 109.996 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.51 ' CE1' ' OE1' ' A' ' 54' ' ' GLU . 69.6 m-85 -107.21 125.74 51.51 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 7' ' ' LEU . 7.3 tt -117.92 124.97 49.56 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.423 ' N ' HD23 ' A' ' 7' ' ' LEU . 44.2 t -115.94 135.1 54.3 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.639 -0.663 . . . . 0.0 109.633 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.4 tp -145.4 148.95 33.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.442 -0.786 . . . . 0.0 109.565 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.4 p -142.76 -163.14 1.56 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.403 -0.81 . . . . 0.0 109.717 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.62 17.97 7.2 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.65 141.72 16.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.165 -1.197 . . . . 0.0 109.939 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.2 m -71.43 -45.16 63.39 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.53 154.68 0.8 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.186 -0.946 . . . . 0.0 110.384 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.0 t -77.2 132.32 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.544 -0.722 . . . . 0.0 110.382 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.526 ' OE1' HG21 ' A' ' 31' ' ' VAL . 45.3 tt0 -98.5 -34.66 10.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.49 -0.756 . . . . 0.0 108.968 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 p -161.54 163.28 30.27 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.016 -1.053 . . . . 0.0 109.683 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -148.96 104.77 3.47 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -133.85 125.85 18.5 Favored Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -47.14 -22.51 2.29 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.857 1.705 . . . . 0.0 111.868 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -94.25 -9.01 37.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.578 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 -174.32 143.28 0.85 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.379 -0.826 . . . . 0.0 109.315 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.1 mt -128.38 131.35 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.353 -0.842 . . . . 0.0 109.007 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.1 mt -116.69 115.71 26.18 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.2 mt -117.79 130.43 56.29 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.569 -0.707 . . . . 0.0 109.637 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.07 103.16 11.5 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 28' ' ' ILE . 7.0 t -124.28 -177.96 3.95 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.586 0.708 . . . . 0.0 110.132 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 27' ' ' THR . 3.8 mt -31.91 153.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.765 0.793 . . . . 0.0 110.847 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 64.05 -63.26 0.15 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.504 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -161.85 -123.18 0.65 Allowed Glycine 0 N--CA 1.488 2.111 0 C-N-CA 119.191 -1.48 . . . . 0.0 110.014 -178.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.526 HG21 ' OE1' ' A' ' 16' ' ' GLN . 55.8 t -120.58 135.88 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.668 -0.901 . . . . 0.0 109.727 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.7 tp -100.27 125.23 46.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.603 -0.685 . . . . 0.0 109.205 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.1 m -104.47 121.57 43.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.393 -0.817 . . . . 0.0 108.94 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 89.9 mt -110.73 127.42 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -117.48 147.96 42.27 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.453 0.644 . . . . 0.0 110.1 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.95 -149.65 12.14 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -136.38 145.92 45.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.346 -1.09 . . . . 0.0 109.472 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 54.99 57.65 5.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.545 -0.722 . . . . 0.0 110.092 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.6 mp -89.65 71.73 7.8 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.132 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.038 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.0 tt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 121.653 0.74 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.592 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 87.8 tttt -169.03 129.3 1.1 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.421 -0.8 . . . . 0.0 109.386 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 47' ' ' LYS . . . 75.48 -6.11 2.04 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.785 -0.572 . . . . 0.0 109.504 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.14 52.67 2.85 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -155.14 159.48 40.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.995 -1.297 . . . . 0.0 109.056 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.2 t -126.94 134.66 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.574 -0.704 . . . . 0.0 109.261 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -118.41 153.01 34.79 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.716 -0.615 . . . . 0.0 109.624 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.7 t -124.66 135.56 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.51 ' OE1' ' CE1' ' A' ' 6' ' ' PHE . 16.4 tp10 -113.38 127.12 56.02 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.56 169.06 21.58 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -90.91 140.8 29.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.415 -1.05 . . . . 0.0 109.744 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.435 ' CG2' HD23 ' A' ' 60' ' ' LEU . 92.9 mt -93.82 115.17 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.991 -1.068 . . . . 0.0 109.714 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -98.64 -24.21 15.17 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.82 151.81 18.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.903 -1.123 . . . . 0.0 111.091 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.435 HD23 ' CG2' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -130.1 131.7 45.84 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.249 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 54.9 t -129.75 128.88 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.682 0.753 . . . . 0.0 109.588 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 64' ' ' LEU . 12.0 t80 -144.9 142.13 18.27 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -49.08 78.01 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.589 1.526 . . . . 0.0 111.968 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.638 ' C ' HD23 ' A' ' 64' ' ' LEU . 0.6 OUTLIER -60.93 -12.92 12.8 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.38 -0.825 . . . . 0.0 109.193 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -86.02 -167.74 1.97 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.257 -0.902 . . . . 0.0 110.251 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.627 ' CG ' ' N ' ' A' ' 67' ' ' HIS . 11.9 t-80 -141.43 -109.02 0.14 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.55 -0.719 . . . . 0.0 109.179 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.631 ' ND1' ' NE2' ' A' ' 69' ' ' HIS . 1.8 t-80 53.18 -163.93 0.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.402 -0.811 . . . . 0.0 110.2 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.4 81.26 1.66 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.631 ' NE2' ' ND1' ' A' ' 67' ' ' HIS . 55.8 m170 -102.01 -74.26 0.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 68.11 -14.88 0.23 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.538 ' H ' ' C ' ' A' ' 69' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.098 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.442 0.639 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -86.74 117.15 25.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.334 -0.853 . . . . 0.0 109.998 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -90.81 11.82 21.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.482 -0.762 . . . . 0.0 109.025 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 47.5 mmm-85 -85.31 138.54 32.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.087 -1.008 . . . . 0.0 109.458 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -141.8 153.22 44.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 0.0 109.898 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -108.12 119.23 38.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.564 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.4 tt -108.09 121.67 45.3 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.545 ' N ' HD23 ' B' ' 7' ' ' LEU . 8.2 p -114.78 137.25 52.17 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.354 0.597 . . . . 0.0 109.995 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.8 tp -149.3 148.31 29.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.546 -0.721 . . . . 0.0 109.306 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -142.42 164.59 29.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.274 -0.891 . . . . 0.0 110.256 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.98 21.02 58.3 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 p -59.5 142.29 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.117 -1.225 . . . . 0.0 110.432 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 15.1 m -72.86 -39.99 66.04 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -172.26 163.91 5.83 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.12 -0.988 . . . . 0.0 110.01 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 85.7 t -96.84 99.8 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.425 -0.797 . . . . 0.0 109.555 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -65.53 -39.22 91.52 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.313 -0.867 . . . . 0.0 109.128 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 47.0 t -172.67 152.33 2.52 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.27 -0.893 . . . . 0.0 109.318 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -133.81 107.98 8.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.557 -0.714 . . . . 0.0 109.259 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.93 145.79 57.32 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.6 -19.13 42.58 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.973 1.782 . . . . 0.0 111.426 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -98.52 -7.0 29.1 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -173.38 131.98 0.47 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.368 -0.833 . . . . 0.0 109.352 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.72 128.69 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.447 -0.783 . . . . 0.0 109.28 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 62.9 mt -118.45 121.88 41.38 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 88.8 mt -132.28 130.58 41.07 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -93.62 127.86 39.51 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.211 -0.931 . . . . 0.0 109.101 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.59 ' O ' ' N ' ' B' ' 29' ' ' GLN . 5.4 t -124.39 149.05 47.13 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.373 0.606 . . . . 0.0 109.47 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.411 ' N ' HD13 ' B' ' 28' ' ' ILE . 5.9 mm 48.05 -81.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.049 0.452 . . . . 0.0 110.321 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' B' ' 27' ' ' THR . 11.4 pt20 -149.03 -21.21 0.3 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.052 -1.03 . . . . 0.0 109.359 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.67 165.14 25.7 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 120.987 -1.071 . . . . 0.0 110.509 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.63 130.6 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.609 -0.936 . . . . 0.0 109.488 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 50.9 tp -106.98 126.04 51.8 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 71.0 m -111.27 117.31 32.8 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 89.6 mt -100.77 128.04 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -124.68 136.82 54.23 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 175.51 -149.01 9.79 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -133.83 148.63 51.33 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.513 -0.992 . . . . 0.0 109.813 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 56.23 57.96 4.63 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.732 0.777 . . . . 0.0 109.747 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.505 HD12 ' N ' ' B' ' 39' ' ' LEU . 9.9 mp -91.34 72.03 6.12 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.386 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.544 HD12 ' N ' ' B' ' 46' ' ' LEU . 10.4 mp . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.182 0.515 . . . . 0.0 110.028 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -128.0 -17.61 4.35 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.08 29.74 0.57 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.134 -0.979 . . . . 0.0 109.056 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.12 22.01 78.34 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -104.57 155.75 18.56 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.302 -1.116 . . . . 0.0 109.487 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.3 t -127.78 135.1 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.504 -0.748 . . . . 0.0 109.355 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.72 159.88 40.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.658 -0.652 . . . . 0.0 109.381 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 99.3 t -127.73 138.25 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -117.96 138.47 52.15 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.17 -179.49 30.33 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.58 124.45 43.36 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.399 -1.059 . . . . 0.0 109.793 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.534 HD12 ' N ' ' B' ' 57' ' ' ILE . 1.3 mp -77.83 126.41 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.41 -0.806 . . . . 0.0 109.488 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -109.38 -19.14 13.38 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.647 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -166.15 152.25 9.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.927 -1.108 . . . . 0.0 110.305 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.647 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.6 OUTLIER -134.19 129.56 35.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.569 -0.707 . . . . 0.0 109.176 179.423 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 61.0 t -126.59 128.41 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.578 ' O ' HD13 ' B' ' 64' ' ' LEU . 45.4 t80 -144.02 101.47 4.9 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -46.62 89.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.111 1.874 . . . . 0.0 112.582 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.903 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -79.24 4.45 14.96 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.311 -0.868 . . . . 0.0 109.292 179.533 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.417 ' N ' HD22 ' B' ' 64' ' ' LEU . 3.4 mm-40 -74.92 -100.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.385 -0.822 . . . . 0.0 110.081 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -124.31 165.67 17.25 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.607 0.718 . . . . 0.0 110.548 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' B' ' 68' ' ' HIS . 8.6 p80 -79.98 -11.02 59.82 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.524 ' C ' ' CG ' ' B' ' 69' ' ' HIS . 11.2 m80 -54.7 -163.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.498 -0.751 . . . . 0.0 110.199 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.524 ' CG ' ' C ' ' B' ' 68' ' ' HIS . 0.7 OUTLIER 79.88 -128.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' B' ' 71' ' ' HIS . 0.0 OUTLIER 60.37 15.89 5.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.907 -1.12 . . . . 0.0 110.528 179.497 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.657 ' N ' ' ND1' ' B' ' 71' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 118.184 -0.912 . . . . 0.0 109.73 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.71 0.767 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -87.73 110.18 20.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.388 -0.82 . . . . 0.0 109.49 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -101.32 -3.33 29.05 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.829 0.823 . . . . 0.0 109.397 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 48.0 mmm-85 -71.4 138.62 49.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.172 -0.955 . . . . 0.0 109.911 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -146.27 154.99 42.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.293 -0.88 . . . . 0.0 110.005 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 8.1 m-85 -110.75 121.1 44.5 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.526 ' C ' HD23 ' A' ' 7' ' ' LEU . 6.9 tt -114.08 124.58 52.46 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.509 -0.744 . . . . 0.0 109.223 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.523 ' N ' HD23 ' A' ' 7' ' ' LEU . 23.8 p -125.41 149.56 48.07 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.778 0.799 . . . . 0.0 109.558 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.621 HD11 ' NE2' ' B' ' 5' ' ' GLN . 36.6 tp -147.8 144.45 28.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.45 -0.781 . . . . 0.0 109.511 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -125.99 164.38 20.94 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.714 0.768 . . . . 0.0 110.169 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.54 17.04 71.94 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.34 134.78 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -1.168 . . . . 0.0 110.438 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 t -72.68 -45.08 60.69 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.543 -0.723 . . . . 0.0 109.074 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.12 160.46 4.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.445 -0.785 . . . . 0.0 109.976 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.8 t -91.62 110.93 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.578 0.704 . . . . 0.0 109.873 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -68.55 -38.32 80.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.45 -0.781 . . . . 0.0 109.595 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.2 t -162.61 156.17 20.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.876 -1.14 . . . . 0.0 110.383 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -141.66 105.57 4.75 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.98 147.74 66.61 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.74 -18.0 42.16 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.447 2.098 . . . . 0.0 111.274 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -102.16 -9.12 20.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.43 -0.794 . . . . 0.0 109.344 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -171.83 133.68 0.76 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.212 -0.93 . . . . 0.0 109.704 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.1 mt -126.45 130.07 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.428 -0.795 . . . . 0.0 110.135 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.0 mt -116.27 125.89 52.82 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.7 mt -121.15 130.42 53.71 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.715 0.769 . . . . 0.0 109.466 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -98.01 113.69 25.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.6 -0.688 . . . . 0.0 109.556 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.549 ' O ' ' N ' ' A' ' 29' ' ' GLN . 9.0 t -124.65 157.6 35.14 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.941 0.877 . . . . 0.0 110.097 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.407 HD12 ' HB2' ' B' ' 3' ' ' ASN . 14.6 mm 38.2 -85.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.287 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.549 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.8 pp0? -142.62 -17.02 0.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.95 -1.094 . . . . 0.0 108.873 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.06 175.24 24.91 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.1 t -125.6 133.45 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.781 -0.835 . . . . 0.0 109.602 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 49.1 tp -102.76 128.31 49.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.621 -0.675 . . . . 0.0 109.51 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -112.85 126.79 55.83 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.823 0.82 . . . . 0.0 110.166 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.6 mt -108.98 130.25 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -124.84 140.49 52.88 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.575 0.703 . . . . 0.0 109.446 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 170.06 -145.75 9.42 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -134.53 144.52 48.06 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.463 -1.021 . . . . 0.0 109.362 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.8 mttp 55.48 61.22 2.95 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.834 0.826 . . . . 0.0 109.695 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.5 mp -92.56 71.64 5.05 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.912 0.863 . . . . 0.0 109.062 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.221 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.624 ' N ' HD23 ' A' ' 46' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.677 0.751 . . . . 0.0 109.997 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt 44.01 -85.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.379 0.609 . . . . 0.0 110.92 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 46' ' ' LEU . . . -83.95 -0.54 51.87 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 0.0 109.235 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 49.25 64.31 3.43 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -138.44 157.18 46.71 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.203 -1.175 . . . . 0.0 109.476 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.1 m -117.0 158.37 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 CA-C-O 121.618 0.723 . . . . 0.0 109.848 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -141.52 140.11 33.4 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 64.9 t -125.81 134.89 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.591 -0.693 . . . . 0.0 109.423 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -117.18 125.88 51.89 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.04 174.6 30.03 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.164 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.547 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -91.35 128.76 37.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.667 -0.902 . . . . 0.0 110.092 -179.365 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.495 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.4 mp -78.74 125.96 38.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.435 -0.791 . . . . 0.0 109.126 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -112.19 -29.97 7.38 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.473 ' O ' HD22 ' A' ' 60' ' ' LEU . . . -166.38 137.84 3.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.028 -1.045 . . . . 0.0 110.812 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.473 HD22 ' O ' ' A' ' 59' ' ' ALA . 3.1 mm? -117.14 135.51 53.7 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.78 129.48 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.867 0.841 . . . . 0.0 110.075 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -145.47 137.84 13.51 Favored Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.02 108.42 2.12 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.788 1.658 . . . . 0.0 112.543 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.979 HD13 ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -87.54 -7.83 57.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.245 -0.909 . . . . 0.0 109.095 179.354 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.571 ' N ' HD22 ' A' ' 64' ' ' LEU . 2.2 mt-10 -60.59 136.09 57.95 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 122.24 1.019 . . . . 0.0 110.584 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.468 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 34.5 t-80 -85.36 -6.71 59.21 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -99.48 -165.66 1.25 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.69 0.757 . . . . 0.0 109.911 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -161.34 -155.88 0.42 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.687 0.756 . . . . 0.0 109.874 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.403 ' O ' ' C ' ' A' ' 70' ' ' HIS . 1.3 t60 -55.0 97.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.498 -0.751 . . . . 0.0 110.474 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.74 ' CG ' ' H ' ' A' ' 71' ' ' HIS . 30.9 t60 41.33 -126.71 0.54 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.791 -0.568 . . . . 0.0 109.964 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.74 ' H ' ' CG ' ' A' ' 70' ' ' HIS . 50.7 m-70 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.799 -1.188 . . . . 0.0 108.87 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.647 0.737 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' B' ' 3' ' ' ASN . 14.6 t0 -88.96 -147.02 0.16 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.35 -0.844 . . . . 0.0 110.286 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' B' ' 4' ' ' ARG . 52.8 p-10 -105.37 -23.98 12.75 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.473 -0.767 . . . . 0.0 110.537 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.543 ' N ' ' OD1' ' B' ' 3' ' ' ASN . 45.0 mmm-85 -50.46 136.78 20.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.192 -0.942 . . . . 0.0 110.682 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . 0.621 ' NE2' HD11 ' A' ' 9' ' ' LEU . 2.3 pt20 -146.37 155.81 42.87 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.335 -0.853 . . . . 0.0 109.551 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' B' ' 6' ' ' PHE . 30.3 m-85 -115.04 121.64 43.71 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.635 HD23 ' N ' ' B' ' 8' ' ' SER . 6.4 tt -118.43 122.79 43.63 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.635 ' N ' HD23 ' B' ' 7' ' ' LEU . 29.8 t -119.01 134.76 55.0 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.511 0.672 . . . . 0.0 109.825 -179.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 48.9 tp -131.61 144.91 51.4 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.8 p -128.09 164.0 23.39 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.701 0.762 . . . . 0.0 110.26 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.33 20.06 61.19 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 p -67.39 135.71 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.187 -1.184 . . . . 0.0 110.01 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 56.2 m -72.45 -43.65 63.47 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.421 -0.8 . . . . 0.0 109.25 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.98 162.28 3.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.385 -0.822 . . . . 0.0 110.278 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.2 t -89.98 111.24 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.519 0.676 . . . . 0.0 110.066 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -67.2 -38.91 86.13 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.881 0.848 . . . . 0.0 108.791 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 30.1 t -168.89 166.37 11.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 0.0 109.655 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -145.48 104.7 3.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.37 -0.831 . . . . 0.0 109.513 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' B' ' 22' ' ' GLU . 13.7 m-20 -133.92 125.94 18.48 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.62 -26.27 16.63 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.824 1.683 . . . . 0.0 111.503 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -88.59 -5.05 58.42 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.708 0.766 . . . . 0.0 109.379 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' B' ' 19' ' ' ASP . 32.9 tt0 -176.35 132.99 0.23 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.517 -0.74 . . . . 0.0 109.399 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 93.5 mt -123.09 128.1 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.45 -0.781 . . . . 0.0 109.481 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 15.8 mt -117.84 129.07 55.44 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.361 0.601 . . . . 0.0 109.463 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 86.3 mt -131.03 131.87 44.58 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.665 0.745 . . . . 0.0 109.873 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -95.4 114.46 26.24 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.616 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.3 t -125.53 153.77 43.13 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.439 0.638 . . . . 0.0 110.114 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 14.0 mm 46.3 -78.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-O 121.558 0.694 . . . . 0.0 110.91 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.616 ' N ' ' O ' ' B' ' 27' ' ' THR . 13.3 pt20 -151.89 -22.84 0.19 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.161 -0.962 . . . . 0.0 109.118 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.94 176.17 29.29 Favored Glycine 0 N--CA 1.5 2.944 0 O-C-N 120.993 -1.067 . . . . 0.0 110.624 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 56.0 t -121.13 134.65 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.6 -0.941 . . . . 0.0 109.442 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 51.2 tp -104.88 128.27 53.03 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.473 0.654 . . . . 0.0 109.655 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 46.4 t -112.26 121.27 44.42 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 93.9 mt -106.05 130.95 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.551 0.691 . . . . 0.0 110.202 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -127.71 141.21 51.66 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.83 -141.47 4.7 Favored Glycine 0 N--CA 1.485 1.928 0 C-N-CA 119.655 -1.26 . . . . 0.0 110.235 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -129.42 135.62 48.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.708 -0.878 . . . . 0.0 109.544 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? 43.23 80.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.91 0.862 . . . . 0.0 110.08 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.477 HD12 ' N ' ' B' ' 39' ' ' LEU . 8.7 mp -95.06 71.59 3.35 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.073 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -179.156 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 122.08 0.943 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -56.71 -69.23 0.16 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.884 0.849 . . . . 0.0 109.856 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -141.68 34.98 1.61 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.141 -0.975 . . . . 0.0 109.121 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.82 25.61 75.45 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -82.95 160.16 22.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.349 -1.089 . . . . 0.0 109.983 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 6.2 m -124.28 133.14 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.682 0.753 . . . . 0.0 109.793 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -127.15 129.3 47.61 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.27 136.43 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.648 -0.657 . . . . 0.0 109.25 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -121.06 134.5 55.27 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.713 0.768 . . . . 0.0 109.373 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.55 -179.82 29.57 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.52 126.87 43.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.667 -0.902 . . . . 0.0 109.52 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.522 HD12 ' N ' ' B' ' 57' ' ' ILE . 1.4 mp -83.78 121.65 36.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.418 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -106.95 -19.24 13.69 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.667 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -162.14 150.03 14.5 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.647 -1.283 . . . . 0.0 110.984 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.667 HD22 ' O ' ' B' ' 59' ' ' ALA . 0.6 OUTLIER -137.11 139.36 41.19 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.372 0.606 . . . . 0.0 109.386 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 54.7 t -141.03 131.61 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.454 -0.779 . . . . 0.0 110.198 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.505 ' CE1' ' O ' ' B' ' 63' ' ' PRO . 11.9 t80 -145.73 140.16 15.47 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.505 ' O ' ' CE1' ' B' ' 62' ' ' TYR . 68.4 Cg_endo -76.06 108.82 2.76 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.282 1.988 . . . . 0.0 112.336 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.86 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -100.54 34.65 2.35 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.364 -0.835 . . . . 0.0 109.157 179.699 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' B' ' 65' ' ' GLU . 0.0 OUTLIER 40.19 -165.81 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.762 0.791 . . . . 0.0 110.696 179.254 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' B' ' 65' ' ' GLU . 2.5 t-160 36.58 61.31 0.84 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.86 0.838 . . . . 0.0 110.263 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.671 ' CD2' ' H ' ' B' ' 68' ' ' HIS . 6.0 p80 -150.61 -54.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.671 ' H ' ' CD2' ' B' ' 67' ' ' HIS . 5.0 t60 -165.76 126.88 1.88 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 109.956 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -84.6 162.04 19.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.519 -0.738 . . . . 0.0 109.018 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.526 ' O ' ' ND1' ' B' ' 70' ' ' HIS . 0.1 OUTLIER -124.51 139.4 53.92 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.399 -0.813 . . . . 0.0 110.004 -179.618 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.722 -179.847 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.421 ' O ' ' O ' ' A' ' 2' ' ' ASP . 78.5 mtm . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.242 0.544 . . . . 0.0 109.747 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 1' ' ' MET . 4.7 t70 44.82 -169.93 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.491 -0.756 . . . . 0.0 110.106 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -149.65 -28.71 0.25 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.212 -0.93 . . . . 0.0 109.609 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.7 mmm-85 -53.67 140.41 29.34 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.268 -0.895 . . . . 0.0 109.46 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -146.97 160.82 41.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.32 -0.862 . . . . 0.0 109.534 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -111.35 131.89 54.83 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.0 tt -118.2 139.83 50.71 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.0 m -121.79 146.69 46.81 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.509 -0.745 . . . . 0.0 109.262 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tp -156.1 149.0 24.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.113 -0.992 . . . . 0.0 109.868 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -146.3 163.76 34.51 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.582 -0.699 . . . . 0.0 109.562 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.14 18.96 56.77 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.14 140.22 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.171 -1.194 . . . . 0.0 109.798 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 t -73.44 -51.79 15.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.118 -0.989 . . . . 0.0 109.585 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt -155.87 160.42 40.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.026 -1.046 . . . . 0.0 109.917 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 89.4 t -92.54 102.33 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -65.82 -39.22 90.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 109.445 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -167.74 164.36 14.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.156 -0.965 . . . . 0.0 109.513 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -147.06 108.07 4.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.186 -0.946 . . . . 0.0 108.863 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -132.26 146.97 63.89 Favored Pre-proline 0 N--CA 1.497 1.916 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.91 -18.37 46.75 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 121.814 1.676 . . . . 0.0 111.367 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -100.12 -3.58 31.52 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.408 -0.808 . . . . 0.0 109.502 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.445 ' OE1' ' NZ ' ' A' ' 35' ' ' LYS . 29.8 tt0 -174.29 151.03 1.56 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.222 -0.924 . . . . 0.0 109.441 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.7 mt -133.98 129.76 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.27 -0.894 . . . . 0.0 109.733 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.0 mt -117.8 120.55 38.26 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.8 mt -134.09 133.23 40.88 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.25 -0.906 . . . . 0.0 109.413 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -102.53 118.56 37.11 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.244 -0.91 . . . . 0.0 108.974 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 29' ' ' GLN . 5.0 t -125.15 153.69 42.66 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.681 0.753 . . . . 0.0 110.143 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.0 mm 53.8 -82.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.635 -0.665 . . . . 0.0 109.879 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' THR . 20.9 pt20 -164.04 51.05 0.14 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.976 -1.078 . . . . 0.0 109.748 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -171.43 155.12 23.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.2 t -95.99 130.38 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.329 -1.101 . . . . 0.0 109.942 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.4 tp -107.2 121.71 45.06 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.9 t -107.71 118.06 35.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.3 mt -103.89 127.14 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.445 ' NZ ' ' OE1' ' A' ' 22' ' ' GLU . 68.7 mttm -121.43 129.54 53.06 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.553 0.692 . . . . 0.0 109.153 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -173.67 -141.42 3.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.609 -1.797 . . . . 0.0 108.609 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -144.53 151.67 39.45 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.989 -1.301 . . . . 0.0 110.168 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 54' ' ' GLU . 45.6 mmtm 56.65 43.53 25.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.574 -0.704 . . . . 0.0 109.726 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 39' ' ' LEU . 9.7 mp -73.77 71.99 1.5 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.706 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.093 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 47' ' ' LYS . 52.9 tp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.056 0.455 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.544 ' C ' ' H ' ' A' ' 49' ' ' GLY . 65.0 tttm -37.3 148.72 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.434 0.635 . . . . 0.0 110.99 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 63.2 -9.0 0.12 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.7 -0.625 . . . . 0.0 109.793 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 47' ' ' LYS . . . 52.07 27.56 22.92 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -93.06 154.1 18.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.374 -1.074 . . . . 0.0 108.835 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -134.65 159.7 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.294 -0.879 . . . . 0.0 109.193 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.15 146.35 42.67 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.8 t -123.07 135.24 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 38' ' ' LYS . 19.8 pt-20 -116.38 132.09 56.77 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.31 173.34 25.61 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.351 -1.499 . . . . 0.0 109.351 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.412 ' O ' HD12 ' A' ' 56' ' ' LEU . 2.6 pp -96.84 124.51 40.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.252 -1.146 . . . . 0.0 109.745 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.7 mt -79.67 129.03 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.238 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -118.72 -27.63 5.81 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.59 ' O ' HD22 ' A' ' 60' ' ' LEU . . . -152.77 146.88 25.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.025 -1.047 . . . . 0.0 110.532 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -133.93 134.1 42.2 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.426 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.444 HG22 HD12 ' B' ' 64' ' ' LEU . 98.5 t -130.68 123.29 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.243 -0.91 . . . . 0.0 109.937 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.41 ' CE1' ' O ' ' A' ' 63' ' ' PRO . 46.4 t80 -146.66 138.01 13.05 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.41 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 61.6 Cg_endo -75.03 116.41 4.57 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.454 1.436 . . . . 0.0 111.442 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.972 HD13 ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -88.55 39.95 0.94 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.196 -0.94 . . . . 0.0 108.473 179.736 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.499 ' O ' ' O ' ' A' ' 64' ' ' LEU . 0.8 OUTLIER 60.31 136.29 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.224 -0.923 . . . . 0.0 108.894 178.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.435 ' CG ' ' H ' ' A' ' 67' ' ' HIS . 5.8 t-80 -164.03 -170.01 2.01 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.435 ' H ' ' CG ' ' A' ' 66' ' ' HIS . 1.7 t60 -146.91 142.01 27.15 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.937 -1.102 . . . . 0.0 109.721 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -77.36 135.85 38.39 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -94.51 126.38 39.76 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.961 -1.087 . . . . 0.0 109.796 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -88.68 176.81 6.94 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.676 -0.64 . . . . 0.0 109.541 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.098 -0.953 . . . . 0.0 109.445 179.533 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.543 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -76.32 118.04 18.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.089 -1.007 . . . . 0.0 109.631 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' B' ' 3' ' ' ASN . 7.2 p-10 -97.02 6.32 48.83 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.306 -0.871 . . . . 0.0 109.099 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 39.6 mmm-85 -80.36 140.33 36.12 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.364 -0.835 . . . . 0.0 109.319 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -152.02 161.77 42.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 109.38 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' B' ' 6' ' ' PHE . 23.6 m-85 -104.2 146.03 29.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.628 -0.67 . . . . 0.0 109.412 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.589 HD23 ' N ' ' B' ' 8' ' ' SER . 6.2 tt -132.66 122.27 24.41 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.589 ' N ' HD23 ' B' ' 7' ' ' LEU . 80.0 p -114.71 144.75 42.96 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.35 -0.844 . . . . 0.0 109.835 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 4.9 tp -150.67 150.72 31.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.295 -0.878 . . . . 0.0 109.323 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.6 160.76 41.76 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.476 -0.765 . . . . 0.0 109.472 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.37 14.3 60.36 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.31 135.11 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.235 -1.156 . . . . 0.0 109.689 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t -73.15 -43.41 61.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 109.857 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.56 165.03 10.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.941 -1.099 . . . . 0.0 109.798 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 71.4 t -98.31 129.68 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.22 -0.925 . . . . 0.0 109.917 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -83.57 -29.03 28.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 109.272 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 34.7 t -172.01 168.7 5.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.254 -0.904 . . . . 0.0 109.032 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -150.41 107.63 3.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.137 -0.977 . . . . 0.0 109.771 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -132.12 149.61 73.73 Favored Pre-proline 0 N--CA 1.497 1.923 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.19 -3.25 11.93 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.694 1.596 . . . . 0.0 111.606 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -122.26 -12.59 8.24 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.532 -0.73 . . . . 0.0 109.974 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -158.82 109.57 2.07 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.097 -1.002 . . . . 0.0 109.242 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 95.8 mt -111.67 128.74 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.403 ' CD2' ' OG ' ' B' ' 33' ' ' SER . 15.0 mt -111.6 125.05 53.52 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 80.0 mt -121.69 128.97 52.41 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.571 -0.706 . . . . 0.0 109.853 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -96.75 113.75 25.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.185 -0.947 . . . . 0.0 108.707 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.547 ' O ' ' N ' ' B' ' 29' ' ' GLN . 5.1 t -124.17 156.44 36.71 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.364 0.602 . . . . 0.0 110.514 -178.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.423 ' C ' ' O ' ' B' ' 27' ' ' THR . 45.4 mt 34.71 -87.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 CA-C-O 121.123 0.487 . . . . 0.0 110.639 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.547 ' N ' ' O ' ' B' ' 27' ' ' THR . 17.1 pt20 -150.73 45.19 0.85 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 0.0 109.682 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.68 136.69 4.29 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 74.7 t -91.55 132.73 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.391 -1.064 . . . . 0.0 109.751 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 53.0 tp -107.02 125.27 50.8 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.403 ' OG ' ' CD2' ' B' ' 24' ' ' LEU . 21.0 m -107.61 120.42 42.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.479 -0.763 . . . . 0.0 109.422 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 87.5 mt -106.78 127.5 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -124.78 139.89 53.43 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.581 0.705 . . . . 0.0 109.355 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.8 -139.97 5.46 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -143.63 152.72 41.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.996 -1.296 . . . . 0.0 109.52 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' B' ' 54' ' ' GLU . 68.1 mttm 56.15 51.23 12.12 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.301 0.572 . . . . 0.0 110.201 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.526 HD12 ' N ' ' B' ' 39' ' ' LEU . 9.8 mp -85.56 71.65 10.72 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -178.701 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.59 HD12 ' N ' ' B' ' 46' ' ' LEU . 8.5 mp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.444 ' HD2' ' H ' ' B' ' 47' ' ' LYS . 0.8 OUTLIER -66.55 -44.4 82.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.344 -0.848 . . . . 0.0 110.085 -179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -120.19 38.1 4.06 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.57 -0.706 . . . . 0.0 109.775 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 47.57 23.62 2.27 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -93.16 154.61 17.96 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.228 -1.16 . . . . 0.0 109.138 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.12 159.82 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.49 -0.756 . . . . 0.0 109.124 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . 0.429 ' CD ' ' N ' ' B' ' 52' ' ' GLU . 18.3 mp0 -138.68 153.86 48.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.347 -0.845 . . . . 0.0 109.508 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.412 HG12 ' N ' ' B' ' 54' ' ' GLU . 55.4 t -131.42 156.25 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.412 ' N ' HG12 ' B' ' 53' ' ' VAL . 31.3 tt0 -138.68 134.55 33.77 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.49 178.91 32.95 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.443 ' H ' HD23 ' B' ' 56' ' ' LEU . 0.2 OUTLIER -96.03 139.24 32.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.338 -1.095 . . . . 0.0 109.119 -179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 43.3 mm -86.38 118.07 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 109.257 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -107.69 -31.77 7.93 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.447 -0.783 . . . . 0.0 109.682 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.581 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -160.76 147.21 15.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.16 -0.963 . . . . 0.0 110.265 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.581 HD22 ' O ' ' B' ' 59' ' ' ALA . 1.3 mm? -129.84 135.85 48.88 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 95.0 t -135.28 129.36 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.294 -0.879 . . . . 0.0 109.515 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.555 ' O ' ' N ' ' B' ' 64' ' ' LEU . 42.4 t80 -144.89 123.18 6.63 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -42.34 86.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.464 1.443 . . . . 0.0 112.224 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.682 ' H ' ' CD2' ' B' ' 64' ' ' LEU . 0.7 OUTLIER -95.17 21.56 7.72 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.467 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.562 ' N ' ' OE1' ' B' ' 65' ' ' GLU . 0.0 OUTLIER -41.1 155.88 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.617 0.723 . . . . 0.0 110.404 -179.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' B' ' 64' ' ' LEU . 5.4 m80 -125.63 -13.48 6.48 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.358 -0.839 . . . . 0.0 109.307 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -150.82 161.2 43.13 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.112 -0.993 . . . . 0.0 109.548 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.65 ' ND1' ' N ' ' B' ' 69' ' ' HIS . 4.3 p80 -164.01 -38.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 0.0 109.042 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.65 ' N ' ' ND1' ' B' ' 68' ' ' HIS . 42.3 t-80 -105.76 122.77 46.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.627 -0.671 . . . . 0.0 109.669 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' B' ' 71' ' ' HIS . 1.7 t-80 -175.83 155.58 1.68 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.359 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.584 ' N ' ' ND1' ' B' ' 70' ' ' HIS . 5.3 t60 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.268 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.61 32.43 22.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.253 -0.904 . . . . 0.0 108.599 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.43 HD22 ' HB3' ' A' ' 56' ' ' LEU . 1.1 p-10 -99.51 11.33 39.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.352 -0.843 . . . . 0.0 109.142 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.3 mmm-85 -69.97 145.32 51.93 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.223 -0.923 . . . . 0.0 109.03 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.543 ' NE2' ' OG1' ' B' ' 27' ' ' THR . 83.2 mt-30 -135.56 146.65 48.21 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.676 0.751 . . . . 0.0 110.005 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -110.19 114.71 28.42 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.605 ' C ' HD23 ' A' ' 7' ' ' LEU . 6.9 tt -111.27 125.08 53.45 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.424 -0.797 . . . . 0.0 108.867 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.599 ' N ' HD23 ' A' ' 7' ' ' LEU . 37.7 t -119.58 148.04 43.78 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.477 0.656 . . . . 0.0 109.555 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.9 tp -149.07 -179.46 7.04 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.631 0.729 . . . . 0.0 109.717 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.514 HG21 ' NE2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -175.13 158.18 2.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.344 -0.848 . . . . 0.0 109.378 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.12 20.63 57.04 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -66.48 139.88 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.368 -1.078 . . . . 0.0 110.217 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.0 t -72.68 -43.36 63.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.429 -0.794 . . . . 0.0 109.598 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.99 159.12 9.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 0.0 109.93 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.5 t -91.61 106.61 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.472 -0.768 . . . . 0.0 109.959 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -69.09 -38.22 78.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 109.395 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -168.87 164.15 11.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.832 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -149.02 105.16 3.5 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -132.79 150.43 75.71 Favored Pre-proline 0 N--CA 1.498 1.957 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.64 -19.29 36.89 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.134 1.889 . . . . 0.0 111.231 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -100.02 -3.34 32.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.4 -0.813 . . . . 0.0 109.078 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -174.49 146.97 1.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.541 -0.724 . . . . 0.0 109.435 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 97.0 mt -133.04 129.81 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.335 -0.853 . . . . 0.0 109.614 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.8 mt -117.13 124.9 50.32 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.3 mt -136.64 129.36 30.61 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.56 -0.712 . . . . 0.0 109.192 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -104.7 123.05 46.94 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.526 -0.734 . . . . 0.0 109.444 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 29' ' ' GLN . 8.9 t -123.82 154.71 39.2 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.528 0.68 . . . . 0.0 109.72 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.6 mt 42.97 -84.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.999 -0.438 . . . . 0.0 110.623 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.578 ' N ' ' O ' ' A' ' 27' ' ' THR . 12.9 pt20 -154.9 57.24 0.67 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.932 -1.105 . . . . 0.0 109.85 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.71 141.65 6.15 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.187 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.4 t -86.34 132.2 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.487 -1.007 . . . . 0.0 109.518 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.9 tp -111.26 123.55 50.43 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 t -115.7 126.69 54.42 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.572 -0.705 . . . . 0.0 109.992 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.0 mt -112.59 130.74 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -126.36 144.67 50.74 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-O 121.499 0.666 . . . . 0.0 109.662 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 172.83 -140.1 5.52 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -135.93 143.06 44.74 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.421 -1.046 . . . . 0.0 108.885 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.6 mttt 54.44 62.21 2.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.523 -0.736 . . . . 0.0 110.171 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.3 mp -91.71 73.04 5.84 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.148 -0.97 . . . . 0.0 108.548 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.422 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.013 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 47' ' ' LYS . 47.6 tp . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.581 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 21.2 tptm -37.09 149.87 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.484 0.659 . . . . 0.0 110.74 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 47' ' ' LYS . . . 73.22 -14.56 0.6 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 47' ' ' LYS . . . 65.68 35.95 91.72 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.514 ' NE2' HG21 ' A' ' 10' ' ' THR . 2.0 tp60 -81.88 162.54 22.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.306 -1.114 . . . . 0.0 109.442 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.0 t -113.71 136.34 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -136.43 131.0 33.52 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.849 -0.796 . . . . 0.0 108.849 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.1 t -125.1 148.88 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.565 -0.709 . . . . 0.0 109.174 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -133.1 127.97 35.15 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.6 173.64 23.71 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.438 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -95.44 128.3 42.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.371 -1.076 . . . . 0.0 109.343 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 54.1 mt -81.46 121.31 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.868 . . . . 0.0 109.639 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -103.37 -23.76 13.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.545 -0.722 . . . . 0.0 109.085 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -163.02 151.17 13.83 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.167 -0.958 . . . . 0.0 109.98 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.615 HD13 ' N ' ' A' ' 61' ' ' VAL . 0.3 OUTLIER -130.95 126.98 37.48 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.546 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.615 ' N ' HD13 ' A' ' 60' ' ' LEU . 58.6 t -123.04 123.89 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.303 -0.873 . . . . 0.0 109.773 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -146.3 139.76 14.76 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.97 110.01 2.82 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.27 1.313 . . . . 0.0 111.769 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.968 HD13 ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -88.15 3.64 48.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.36 -0.838 . . . . 0.0 109.17 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.499 ' N ' HD22 ' A' ' 64' ' ' LEU . 23.0 pt-20 -40.3 160.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.79 -0.569 . . . . 0.0 110.008 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -55.31 -41.7 72.73 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.418 ' O ' ' O ' ' A' ' 68' ' ' HIS . 7.2 p-80 168.18 20.4 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.436 ' O ' ' OE2' ' A' ' 65' ' ' GLU . 28.2 m-70 -52.85 -167.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.949 0.88 . . . . 0.0 111.784 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.463 ' CD2' ' N ' ' A' ' 70' ' ' HIS . 50.1 t60 -83.32 -111.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.571 0.7 . . . . 0.0 110.387 -178.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.643 ' CG ' ' N ' ' A' ' 71' ' ' HIS . 2.1 t-80 -170.7 -90.63 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.643 ' N ' ' CG ' ' A' ' 70' ' ' HIS . 25.0 m80 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.32 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.423 ' O ' ' O ' ' B' ' 2' ' ' ASP . 67.1 mtt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' B' ' 1' ' ' MET . 8.3 t70 57.5 112.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.401 -0.812 . . . . 0.0 110.251 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -101.76 12.82 36.46 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.401 -0.812 . . . . 0.0 109.253 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 48.5 mmm-85 -87.56 137.25 32.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.154 -0.966 . . . . 0.0 109.296 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -146.13 163.75 34.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.409 -0.807 . . . . 0.0 109.299 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -108.96 129.79 55.45 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 7.5 tt -113.41 135.44 53.87 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 12.4 t -130.99 139.8 50.05 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.726 0.774 . . . . 0.0 110.226 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' B' ' 9' ' ' LEU . 45.6 tp -151.03 146.06 25.95 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.604 -0.685 . . . . 0.0 109.319 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.4 p -130.11 177.77 7.05 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.61 -0.681 . . . . 0.0 109.414 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.1 18.55 69.23 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 79.3 t -74.55 130.86 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.14 -1.212 . . . . 0.0 109.771 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 38.9 t -73.4 -42.37 62.18 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.355 -0.841 . . . . 0.0 109.114 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.2 160.29 9.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.155 -0.966 . . . . 0.0 109.946 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 10.1 t -82.08 104.15 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.435 -0.79 . . . . 0.0 109.506 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -67.53 -35.81 79.8 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.164 -0.96 . . . . 0.0 109.352 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 7.5 t -165.46 153.26 11.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.922 . . . . 0.0 109.223 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -140.27 104.54 4.82 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.278 -0.889 . . . . 0.0 109.455 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.411 ' OD2' ' O ' ' B' ' 22' ' ' GLU . 0.4 OUTLIER -133.26 150.32 74.98 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.97 -16.69 32.46 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.846 1.697 . . . . 0.0 111.953 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -107.93 -8.54 15.91 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.353 -0.842 . . . . 0.0 109.743 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.447 ' CD ' ' HZ1' ' B' ' 35' ' ' LYS . 50.0 tt0 -167.33 126.78 1.39 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 109.435 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 96.2 mt -125.11 130.7 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.438 -0.789 . . . . 0.0 109.683 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 60.7 mt -112.95 128.43 56.48 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 94.7 mt -127.02 126.74 43.63 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.629 -0.67 . . . . 0.0 109.658 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -94.03 112.34 24.16 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.543 ' OG1' ' NE2' ' A' ' 5' ' ' GLN . 15.0 t -124.7 164.93 18.87 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.524 0.678 . . . . 0.0 110.488 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' B' ' 27' ' ' THR . 22.2 mm 33.21 -86.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.415 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' B' ' 27' ' ' THR . 27.2 pt20 -148.98 27.2 0.87 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.933 -1.104 . . . . 0.0 109.728 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.84 165.96 31.25 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 55.7 t -112.51 132.4 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.655 -0.909 . . . . 0.0 109.143 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 46.8 tp -104.52 124.33 49.1 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' B' ' 61' ' ' VAL . 5.4 p -107.52 122.59 46.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.591 -0.693 . . . . 0.0 109.48 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . 0.54 HD12 ' N ' ' B' ' 34' ' ' ILE . 4.4 mp -108.6 129.08 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.447 ' HZ1' ' CD ' ' B' ' 22' ' ' GLU . 68.5 mttm -123.27 133.3 54.18 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.565 0.698 . . . . 0.0 109.459 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 176.68 -147.72 8.62 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -136.61 153.76 50.86 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.357 -1.084 . . . . 0.0 109.767 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 67.8 mttm 55.96 57.41 5.16 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.539 0.685 . . . . 0.0 110.557 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.528 HD12 ' N ' ' B' ' 39' ' ' LEU . 9.0 mp -92.35 70.09 5.13 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.448 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.557 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.55 HD12 ' N ' ' B' ' 46' ' ' LEU . 10.3 mp . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.714 0.769 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.647 ' O ' ' HB3' ' B' ' 48' ' ' ALA . 1.3 tmtp? 60.9 117.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.378 -0.827 . . . . 0.0 110.015 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' B' ' 47' ' ' LYS . . . 79.05 -1.48 2.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.757 -0.589 . . . . 0.0 109.876 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.98 23.48 77.78 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -106.43 153.56 22.08 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.31 -1.112 . . . . 0.0 109.402 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 54.3 t -125.42 132.21 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 CA-C-O 121.616 0.722 . . . . 0.0 109.26 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -144.11 127.67 17.03 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 3.8 t -118.17 162.55 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.655 -0.653 . . . . 0.0 109.678 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -123.46 132.93 54.08 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.89 179.71 37.62 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.439 ' H ' HD23 ' B' ' 56' ' ' LEU . 0.2 OUTLIER -96.68 138.84 33.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.301 -1.117 . . . . 0.0 109.201 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.459 HD12 ' N ' ' B' ' 57' ' ' ILE . 1.4 mp -91.31 117.6 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.247 -0.908 . . . . 0.0 109.061 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -108.13 -25.23 11.21 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.514 -0.741 . . . . 0.0 109.8 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.505 ' O ' HD22 ' B' ' 60' ' ' LEU . . . -164.59 135.59 4.22 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.74 -1.225 . . . . 0.0 111.146 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.505 HD22 ' O ' ' B' ' 59' ' ' ALA . 3.1 mm? -119.83 135.43 54.87 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.426 ' O ' ' OG ' ' B' ' 33' ' ' SER . 46.6 t -132.58 122.75 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.543 0.687 . . . . 0.0 109.823 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' B' ' 64' ' ' LEU . 28.2 t80 -144.54 128.39 8.88 Favored Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -41.21 88.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.427 1.418 . . . . 0.0 111.785 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.683 ' C ' HD23 ' B' ' 64' ' ' LEU . 0.4 OUTLIER -55.37 -21.2 14.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.783 -1.198 . . . . 0.0 108.678 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' B' ' 67' ' ' HIS . 0.7 OUTLIER -121.49 49.53 1.51 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.583 ' O ' ' CG ' ' B' ' 67' ' ' HIS . 0.0 OUTLIER -40.91 87.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.093 -178.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' B' ' 66' ' ' HIS . 23.5 m-70 -168.55 -1.18 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.5 ' O ' ' O ' ' B' ' 67' ' ' HIS . 77.1 t60 -44.43 -101.35 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.226 -0.921 . . . . 0.0 110.619 -178.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.454 ' N ' ' CD2' ' B' ' 68' ' ' HIS . 24.4 t-80 -174.47 -80.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.008 -1.058 . . . . 0.0 109.268 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -74.19 147.45 42.54 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.424 -0.798 . . . . 0.0 109.642 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . . . . . . . . . 29.7 m170 . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.623 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.566 ' H2 ' ' HG2' ' A' ' 4' ' ' ARG . 52.9 ttp . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.69 -19.01 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.405 HD22 ' HB2' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -112.28 16.64 19.94 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.568 -0.707 . . . . 0.0 109.872 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.566 ' HG2' ' H2 ' ' A' ' 1' ' ' MET . 47.3 mmm-85 -69.95 140.92 53.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.118 -0.989 . . . . 0.0 108.742 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -142.3 162.0 36.59 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.124 -0.985 . . . . 0.0 110.088 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -108.99 142.07 40.18 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.564 HD23 ' N ' ' A' ' 8' ' ' SER . 6.2 tt -142.11 124.01 15.26 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.564 ' N ' HD23 ' A' ' 7' ' ' LEU . 37.8 t -132.34 140.45 48.55 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.461 -0.774 . . . . 0.0 109.152 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.5 tp -144.65 142.54 30.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.305 -0.872 . . . . 0.0 109.008 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.5 p -130.61 112.68 13.37 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.548 -0.72 . . . . 0.0 109.468 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 143.33 31.87 0.1 Allowed Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.4 t -81.16 133.47 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -1.125 . . . . 0.0 110.238 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.1 m -72.65 -41.6 65.28 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.56 153.45 4.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.771 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 81.6 t -84.93 106.0 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.509 -0.745 . . . . 0.0 110.285 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -67.96 -42.01 81.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.96 . . . . 0.0 108.86 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.3 t -171.89 136.54 0.91 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.407 -0.808 . . . . 0.0 108.89 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.437 ' CE1' HD12 ' A' ' 23' ' ' ILE . 6.9 t80 -123.77 106.46 10.51 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.428 -0.795 . . . . 0.0 109.143 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.413 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -128.22 150.45 74.04 Favored Pre-proline 0 N--CA 1.498 1.968 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.513 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.1 -19.57 39.08 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.272 1.981 . . . . 0.0 111.364 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -97.47 -7.12 32.27 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.466 -0.771 . . . . 0.0 108.978 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -172.86 140.36 0.94 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.437 HD12 ' CE1' ' A' ' 18' ' ' PHE . 27.0 mm -127.12 127.51 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.323 -0.861 . . . . 0.0 109.437 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.8 mt -120.51 120.55 36.18 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.1 mt -131.31 125.61 33.21 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.419 -0.801 . . . . 0.0 108.849 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -92.4 120.83 33.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 29' ' ' GLN . 6.1 t -122.37 154.0 38.28 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.674 0.749 . . . . 0.0 110.271 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.3 mm 46.08 -82.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.085 0.469 . . . . 0.0 110.764 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.578 ' N ' ' O ' ' A' ' 27' ' ' THR . 2.8 pp0? -147.71 -21.36 0.37 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.102 -0.999 . . . . 0.0 109.898 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.485 ' N ' ' CD ' ' A' ' 29' ' ' GLN . . . -97.45 173.77 28.91 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.7 t -118.95 132.67 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.753 -0.851 . . . . 0.0 109.107 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.471 HD13 HD12 ' B' ' 60' ' ' LEU . 60.3 tp -109.62 127.81 54.79 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.6 t -113.22 122.4 47.37 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.7 mt -108.12 130.14 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.403 -0.811 . . . . 0.0 109.264 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -129.16 141.17 51.25 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.488 -0.757 . . . . 0.0 109.37 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.07 -138.1 4.91 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.454 ' HB3' HD21 ' A' ' 56' ' ' LEU . 6.7 tt0 -133.03 150.03 52.16 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.492 -1.005 . . . . 0.0 110.711 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 54' ' ' GLU . 55.0 mmtt 54.08 66.36 1.25 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.492 178.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 39' ' ' LEU . 11.1 mp -98.39 71.18 2.03 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 3.138 0 O-C-N 121.128 -0.982 . . . . 0.0 110.793 -178.146 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' A' ' 47' ' ' LYS . 91.2 mt . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.52 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 87.5 tttt 59.14 134.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.548 0.689 . . . . 0.0 110.388 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 47' ' ' LYS . . . 70.58 -14.87 0.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.605 -0.685 . . . . 0.0 109.497 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 47' ' ' LYS . . . 82.38 18.34 66.79 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -101.13 160.0 14.76 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.315 -1.109 . . . . 0.0 109.094 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.0 t -122.65 131.8 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.529 -0.732 . . . . 0.0 109.103 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -130.64 130.98 44.63 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 t -136.36 138.36 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.496 -0.753 . . . . 0.0 109.097 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.491 ' O ' ' O ' ' A' ' 38' ' ' LYS . 24.0 tt0 -118.42 145.98 44.79 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.15 166.14 15.6 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.454 HD21 ' HB3' ' A' ' 37' ' ' GLU . 2.5 pp -88.69 128.83 35.62 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.391 -1.064 . . . . 0.0 109.656 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.3 mm -80.12 135.31 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.902 . . . . 0.0 109.85 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -125.26 -31.05 3.1 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.02 143.4 16.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.064 -1.023 . . . . 0.0 110.598 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.435 HD13 HD13 ' B' ' 32' ' ' LEU . 9.1 mt -129.73 143.31 50.76 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 54.3 t -139.23 118.22 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.102 -0.999 . . . . 0.0 110.165 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -139.72 108.97 7.17 Favored Pre-proline 0 N--CA 1.492 1.669 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.96 109.36 0.23 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.406 1.404 . . . . 0.0 112.426 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.017 HD13 ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -82.44 -8.04 59.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.323 -0.861 . . . . 0.0 109.588 179.693 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.595 ' N ' HD22 ' A' ' 64' ' ' LEU . 3.3 mt-10 66.86 137.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.644 0.735 . . . . 0.0 110.551 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.588 ' ND1' HD23 ' A' ' 64' ' ' LEU . 5.5 m80 -159.98 -31.47 0.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -42.65 89.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.808 -0.558 . . . . 0.0 110.669 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' A' ' 66' ' ' HIS . 5.9 t60 -172.76 65.54 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.456 -0.777 . . . . 0.0 109.791 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.473 ' ND1' ' C ' ' A' ' 68' ' ' HIS . 2.3 m-70 -124.92 147.58 48.78 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.423 -0.798 . . . . 0.0 109.053 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.79 106.45 9.62 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.212 1.006 . . . . 0.0 108.741 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.687 ' H ' ' CD2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.292 -1.922 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.642 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ptt? . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.9 0.857 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.19 121.69 30.88 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.552 0.692 . . . . 0.0 110.335 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -161.3 9.61 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.541 -0.724 . . . . 0.0 109.55 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 45.8 mmm-85 -69.25 142.71 54.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.97 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . 0.498 ' NE2' ' OG1' ' A' ' 27' ' ' THR . 86.3 mt-30 -140.15 148.29 41.42 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.517 -0.739 . . . . 0.0 109.577 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -103.95 119.5 39.06 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.517 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.2 tt -119.16 121.24 39.29 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.262 -0.899 . . . . 0.0 108.638 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.487 ' N ' HD23 ' B' ' 7' ' ' LEU . 70.1 m -132.53 151.37 51.94 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.509 -0.744 . . . . 0.0 109.163 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 tp -147.29 149.3 32.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.193 -0.942 . . . . 0.0 109.5 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.2 p -128.67 163.7 24.53 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.588 -0.695 . . . . 0.0 109.612 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.43 29.27 56.17 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 84.0 t -66.41 131.37 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -1.174 . . . . 0.0 109.901 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' B' ' 28' ' ' ILE . 58.2 m -73.83 -40.07 63.58 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.615 -0.678 . . . . 0.0 110.613 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -158.91 158.38 33.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.983 -1.073 . . . . 0.0 109.914 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 76.3 t -103.63 99.96 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -68.96 -49.25 59.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 0.0 110.532 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 31.8 t -170.4 146.58 2.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.924 -1.11 . . . . 0.0 110.211 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -117.71 110.18 17.53 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.673 -0.642 . . . . 0.0 109.882 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' B' ' 22' ' ' GLU . 0.3 OUTLIER -133.76 119.89 15.16 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.431 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -50.19 -27.14 16.7 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.476 1.45 . . . . 0.0 111.443 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -94.52 -5.4 46.13 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' B' ' 19' ' ' ASP . 40.2 tt0 -170.8 115.57 0.45 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 97.0 mt -114.45 126.33 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.203 -0.936 . . . . 0.0 109.194 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 57.9 mt -119.35 126.53 51.63 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 87.0 mt -135.58 123.76 23.04 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.256 -0.902 . . . . 0.0 108.988 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -81.73 118.32 22.76 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.128 -0.982 . . . . 0.0 108.84 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.562 ' O ' ' N ' ' B' ' 29' ' ' GLN . 4.8 t -109.54 149.19 30.0 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.472 -0.767 . . . . 0.0 110.201 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.494 ' N ' ' OG ' ' B' ' 13' ' ' SER . 58.7 mt 38.47 -87.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.037 0.446 . . . . 0.0 110.798 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' B' ' 27' ' ' THR . 24.0 pt20 -133.68 -22.52 1.89 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.38 -0.825 . . . . 0.0 110.198 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.6 173.99 30.21 Favored Glycine 0 N--CA 1.498 2.769 0 O-C-N 121.139 -0.976 . . . . 0.0 110.724 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -119.34 131.57 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.79 -0.829 . . . . 0.0 109.401 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 60' ' ' LEU . 48.7 tp -111.92 128.79 56.25 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 30.3 t -110.2 120.41 42.37 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 84.3 mt -99.81 125.56 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -130.53 139.06 50.48 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.502 -0.749 . . . . 0.0 109.52 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -179.66 -138.28 3.28 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -131.86 136.81 47.73 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.348 -1.089 . . . . 0.0 109.836 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.415 ' C ' HD12 ' B' ' 39' ' ' LEU . 52.9 mtmt 46.92 75.38 0.12 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 110.283 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.6 HD12 ' N ' ' B' ' 39' ' ' LEU . 8.5 mp -93.24 72.12 4.54 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.18 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 40.2 tp . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.552 0.692 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.486 ' NZ ' ' OE2' ' B' ' 52' ' ' GLU . 20.7 ptmt -65.48 -40.28 92.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.561 -0.712 . . . . 0.0 109.66 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -179.28 -27.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 140.02 33.83 0.15 Allowed Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -135.6 156.74 48.39 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.262 -1.14 . . . . 0.0 109.492 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 m -122.49 132.55 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-O 121.539 0.685 . . . . 0.0 109.513 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . 0.486 ' OE2' ' NZ ' ' B' ' 47' ' ' LYS . 90.2 mt-10 -126.62 131.58 51.44 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.9 t -125.96 137.54 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.499 -0.751 . . . . 0.0 109.721 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -117.24 131.42 56.84 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.7 174.21 28.11 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.99 127.04 40.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.066 -1.256 . . . . 0.0 109.429 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.568 HD12 ' N ' ' B' ' 57' ' ' ILE . 1.4 mp -85.63 113.4 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.897 . . . . 0.0 108.684 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.37 -10.29 16.4 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -159.9 146.28 15.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.904 -1.123 . . . . 0.0 110.522 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.471 HD12 HD13 ' A' ' 32' ' ' LEU . 52.8 mt -141.3 138.49 33.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.469 -0.769 . . . . 0.0 108.972 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 53.4 t -133.2 128.23 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.194 -0.941 . . . . 0.0 109.89 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -145.37 137.88 13.59 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.34 109.28 2.86 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.384 1.39 . . . . 0.0 111.74 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.936 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -81.83 -11.27 59.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.479 -0.763 . . . . 0.0 108.981 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.504 ' N ' HD22 ' B' ' 64' ' ' LEU . 97.3 mt-10 55.73 51.88 11.76 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.802 -0.561 . . . . 0.0 111.09 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -128.59 7.48 5.76 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.315 -0.866 . . . . 0.0 109.123 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -72.93 -36.4 67.21 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 86.89 0.3 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.533 -0.729 . . . . 0.0 110.137 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -174.82 94.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -104.06 -11.41 17.38 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.166 -0.959 . . . . 0.0 108.71 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' B' ' 71' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.306 -1.302 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.333 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -69.16 139.23 54.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.655 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -153.57 35.99 0.46 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.318 -0.864 . . . . 0.0 108.763 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.445 ' NE ' ' OE2' ' A' ' 54' ' ' GLU . 46.4 mmm-85 -88.39 138.43 31.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.344 -0.848 . . . . 0.0 109.13 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -145.19 161.88 38.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.181 -0.949 . . . . 0.0 109.187 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -119.8 146.4 45.72 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.505 0.669 . . . . 0.0 109.916 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.579 ' C ' HD23 ' A' ' 7' ' ' LEU . 6.4 tt -132.51 122.7 25.26 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.571 ' N ' HD23 ' A' ' 7' ' ' LEU . 33.3 t -113.8 133.04 55.63 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.49 -0.756 . . . . 0.0 109.283 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.6 tp -144.76 151.5 38.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.35 -0.844 . . . . 0.0 109.444 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.4 t -146.48 162.88 37.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.399 -0.813 . . . . 0.0 108.944 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.27 24.99 41.51 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.45 138.14 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -1.1 . . . . 0.0 109.652 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.5 m -73.57 -38.36 65.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.232 -0.918 . . . . 0.0 109.257 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -169.89 166.71 9.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.177 -0.952 . . . . 0.0 109.499 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.5 t -98.32 96.19 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.329 -0.857 . . . . 0.0 109.063 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -65.21 -39.39 92.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.146 -0.971 . . . . 0.0 109.463 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 t -168.82 152.85 5.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 109.256 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -146.89 107.73 4.16 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.247 -0.908 . . . . 0.0 109.422 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.3 158.68 75.11 Favored Pre-proline 0 N--CA 1.502 2.161 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.83 -26.07 67.67 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 121.672 1.581 . . . . 0.0 112.142 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -106.04 3.43 28.2 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.372 -0.83 . . . . 0.0 110.276 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -171.54 133.46 0.8 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.031 -1.043 . . . . 0.0 109.46 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.9 mt -130.84 126.83 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.421 -0.799 . . . . 0.0 109.184 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.2 mt -117.5 122.18 43.03 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.711 . . . . 0.0 109.271 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.9 mt -133.37 124.56 27.4 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.375 -0.828 . . . . 0.0 108.839 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -91.73 124.74 36.1 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.679 -1.263 . . . . 0.0 109.72 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.544 ' O ' ' N ' ' A' ' 29' ' ' GLN . 6.1 t -124.5 153.33 42.2 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 121.462 0.649 . . . . 0.0 109.755 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.48 HD12 ' CB ' ' B' ' 3' ' ' ASN . 20.4 mm 44.74 -88.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.868 -0.52 . . . . 0.0 110.094 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.544 ' N ' ' O ' ' A' ' 27' ' ' THR . 25.7 pt20 -143.19 -17.4 0.65 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.965 -1.084 . . . . 0.0 110.213 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.29 173.67 30.32 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.2 t -121.25 131.21 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.779 -0.836 . . . . 0.0 108.909 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -107.56 126.12 52.15 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.37 -0.831 . . . . 0.0 109.554 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -116.9 124.03 48.46 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.639 -0.663 . . . . 0.0 109.417 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 92.2 mt -107.77 130.0 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.521 -0.737 . . . . 0.0 109.238 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -124.69 138.79 54.27 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.493 -0.754 . . . . 0.0 109.657 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 171.58 -146.36 9.41 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -140.61 151.87 44.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.036 -1.273 . . . . 0.0 109.802 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' O ' ' O ' ' A' ' 54' ' ' GLU . 73.7 mmtt 58.34 55.24 5.12 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.681 -0.637 . . . . 0.0 109.939 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 39' ' ' LEU . 7.9 mp -93.75 70.6 4.12 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.38 0 C-N-CA 120.247 -0.978 . . . . 0.0 110.732 -178.898 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.576 HD22 ' N ' ' A' ' 46' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.611 0.719 . . . . 0.0 109.592 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -64.63 -50.08 68.5 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.774 0.797 . . . . 0.0 110.1 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.72 33.05 0.1 Allowed 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.925 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.96 14.47 60.73 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -107.98 159.92 16.18 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.498 -1.001 . . . . 0.0 108.718 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.0 m -131.43 156.1 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.265 -0.897 . . . . 0.0 109.964 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -142.8 150.37 39.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.425 -0.797 . . . . 0.0 109.107 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.7 t -126.65 134.92 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.458 -0.776 . . . . 0.0 110.109 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.473 ' OE1' ' N ' ' A' ' 55' ' ' GLY . 0.0 OUTLIER -114.57 126.08 54.51 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.473 ' N ' ' OE1' ' A' ' 54' ' ' GLU . . . 163.72 176.44 35.64 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.726 -1.226 . . . . 0.0 110.158 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.406 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -96.17 121.44 37.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.527 -0.984 . . . . 0.0 108.885 179.762 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.69 ' N ' HD12 ' A' ' 57' ' ' ILE . 1.7 mp -90.43 113.3 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.018 -1.051 . . . . 0.0 108.937 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -99.94 -10.77 21.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.452 -0.78 . . . . 0.0 109.988 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.94 145.74 13.98 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.816 -1.178 . . . . 0.0 110.428 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.0 mt -135.19 134.53 40.2 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.61 -0.681 . . . . 0.0 109.297 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.8 t -129.81 126.0 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.527 -0.733 . . . . 0.0 109.571 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.558 ' O ' ' N ' ' A' ' 64' ' ' LEU . 10.8 t80 -141.0 127.61 11.66 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -45.68 84.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.247 1.298 . . . . 0.0 112.206 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.7 ' CD2' ' H ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -91.72 22.67 3.99 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.363 -0.836 . . . . 0.0 109.207 179.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 68.07 159.23 0.16 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.42 0.629 . . . . 0.0 110.342 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -128.36 -79.09 0.57 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.706 -0.621 . . . . 0.0 109.687 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 68' ' ' HIS . 7.1 t60 -66.4 -42.81 87.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 109.474 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 67' ' ' HIS . 1.4 t-80 60.36 130.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.349 -0.844 . . . . 0.0 109.651 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.49 142.01 31.53 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.097 -1.002 . . . . 0.0 109.578 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 53.23 177.4 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.56 -0.712 . . . . 0.0 110.549 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.562 ' ND1' ' N ' ' A' ' 71' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.344 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mmm . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 43.2 t0 46.66 89.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.894 . . . . 0.0 110.069 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.48 ' CB ' HD12 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -99.54 10.81 40.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.456 -0.777 . . . . 0.0 109.272 179.54 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 31.7 mmm-85 -73.0 142.14 47.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.318 -0.863 . . . . 0.0 109.425 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -147.04 156.09 42.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.272 -0.893 . . . . 0.0 109.025 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -98.79 141.37 31.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.328 -0.858 . . . . 0.0 109.393 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.549 HD23 ' C ' ' B' ' 7' ' ' LEU . 7.1 tt -139.95 126.47 20.31 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.545 ' N ' HD23 ' B' ' 7' ' ' LEU . 69.8 m -128.53 150.96 49.95 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.442 -0.786 . . . . 0.0 109.594 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 10.8 tp -146.91 153.21 39.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.35 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.4 t -143.48 164.44 30.32 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.299 -0.876 . . . . 0.0 109.189 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.07 14.95 59.85 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 p -69.14 137.41 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.341 -1.094 . . . . 0.0 109.443 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 4.5 t -73.96 -52.18 13.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.213 -0.929 . . . . 0.0 108.938 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.18 150.6 13.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.253 -0.904 . . . . 0.0 109.646 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 93.0 t -82.58 131.46 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.199 -0.938 . . . . 0.0 110.058 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -95.59 -32.25 12.9 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.314 -0.866 . . . . 0.0 109.247 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 47.3 t -169.04 153.97 5.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.89 . . . . 0.0 108.981 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . 0.45 ' CZ ' HD13 ' B' ' 23' ' ' ILE . 3.0 t80 -145.65 112.49 5.99 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.004 -1.06 . . . . 0.0 109.408 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' B' ' 19' ' ' ASP . 0.3 OUTLIER -132.6 151.73 78.68 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.473 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.59 -18.21 48.52 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.658 1.572 . . . . 0.0 111.382 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -107.7 -3.29 19.32 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.491 -0.756 . . . . 0.0 109.581 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -169.98 127.85 0.88 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.284 -0.885 . . . . 0.0 109.227 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.45 HD13 ' CZ ' ' B' ' 18' ' ' PHE . 96.8 mt -127.74 129.65 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.241 -0.912 . . . . 0.0 109.921 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 70.0 mt -115.06 124.15 50.85 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.336 -0.853 . . . . 0.0 109.639 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 41.5 mt -126.31 131.26 51.88 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.303 -0.873 . . . . 0.0 109.138 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -90.91 119.87 31.45 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.556 ' O ' ' N ' ' B' ' 29' ' ' GLN . 3.1 t -123.53 148.36 46.36 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.669 0.747 . . . . 0.0 110.186 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . . . . . . . . . 68.5 mt 39.05 -88.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.145 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.556 ' N ' ' O ' ' B' ' 27' ' ' THR . 29.7 pt20 -139.0 -18.17 1.03 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.392 -0.817 . . . . 0.0 109.999 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.19 144.5 17.17 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 18.6 t -94.15 129.64 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.343 -1.092 . . . . 0.0 108.848 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 37.5 tp -106.21 126.02 51.71 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.445 -0.784 . . . . 0.0 109.415 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 70.9 m -109.34 124.4 50.89 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 90.8 mt -106.13 129.41 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.534 -0.729 . . . . 0.0 109.178 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -125.25 141.74 51.91 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.507 -0.746 . . . . 0.0 109.414 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.04 -151.52 17.93 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -140.07 150.26 44.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.226 -1.161 . . . . 0.0 108.93 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt 60.27 51.24 5.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.553 -0.717 . . . . 0.0 109.668 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.551 HD12 ' N ' ' B' ' 39' ' ' LEU . 9.0 mp -91.24 72.99 6.23 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.386 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -178.706 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.483 ' C ' HD23 ' B' ' 46' ' ' LEU . 3.7 tt . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.325 0.584 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -93.0 -35.37 13.3 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.202 -0.936 . . . . 0.0 109.208 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -165.66 48.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 109.476 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.57 18.33 71.11 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -140.01 157.32 45.86 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.315 -1.109 . . . . 0.0 109.052 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.07 131.73 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.46 -0.775 . . . . 0.0 108.91 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -119.5 137.29 53.9 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.516 -0.74 . . . . 0.0 109.077 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.423 HG12 ' N ' ' B' ' 54' ' ' GLU . 21.4 t -128.39 160.84 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.411 -0.806 . . . . 0.0 110.086 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.423 ' N ' HG12 ' B' ' 53' ' ' VAL . 0.0 OUTLIER -136.32 146.87 47.06 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.26 176.02 23.68 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.405 HD23 ' H ' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -99.0 136.44 38.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.357 -1.084 . . . . 0.0 108.545 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 36.1 mm -93.49 111.53 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.884 -1.135 . . . . 0.0 109.186 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -100.38 -24.48 14.5 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.399 -0.813 . . . . 0.0 109.799 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.04 147.05 12.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.937 -1.102 . . . . 0.0 110.632 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 9.5 mt -132.48 141.17 48.68 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.417 HG22 HD12 ' A' ' 64' ' ' LEU . 77.9 t -133.91 118.97 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.578 -0.701 . . . . 0.0 109.154 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.433 ' O ' HD13 ' B' ' 64' ' ' LEU . 18.2 t80 -135.86 140.81 34.57 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -79.84 105.78 1.87 Allowed 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 121.491 1.461 . . . . 0.0 112.485 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.937 HD13 ' H ' ' B' ' 64' ' ' LEU . 0.0 OUTLIER -96.18 2.45 53.08 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.514 ' N ' HD22 ' B' ' 64' ' ' LEU . 7.0 mm-40 -51.39 98.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.35 -0.843 . . . . 0.0 110.099 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -168.19 36.37 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.458 ' CG ' ' H ' ' B' ' 68' ' ' HIS . 0.7 OUTLIER -65.35 -151.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.462 0.649 . . . . 0.0 110.365 -178.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.64 ' ND1' ' N ' ' B' ' 69' ' ' HIS . 60.0 t-80 -61.03 -112.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.435 -0.791 . . . . 0.0 110.046 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.64 ' N ' ' ND1' ' B' ' 68' ' ' HIS . 2.2 m80 43.05 85.41 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.34 -0.85 . . . . 0.0 109.672 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.569 ' CG ' ' N ' ' B' ' 71' ' ' HIS . 0.6 OUTLIER -61.67 -132.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 0.0 110.102 -179.395 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.569 ' N ' ' CG ' ' B' ' 70' ' ' HIS . 1.9 m-70 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.653 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 ttp . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.991 0.9 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.8 p30 -164.93 -175.0 3.54 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.587 -0.696 . . . . 0.0 110.348 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -99.59 8.18 44.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.213 -0.93 . . . . 0.0 109.861 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 41.8 mmm-85 -65.16 141.31 58.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.92 -1.112 . . . . 0.0 109.145 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.541 ' NE2' ' OG1' ' B' ' 27' ' ' THR . 85.3 mt-30 -135.38 147.78 49.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.205 -0.934 . . . . 0.0 110.557 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -112.99 113.28 25.26 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.515 ' C ' HD23 ' A' ' 7' ' ' LEU . 6.5 tt -111.68 123.11 49.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 108.89 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.499 ' N ' HD23 ' A' ' 7' ' ' LEU . 30.3 t -115.22 133.72 55.78 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.48 0.657 . . . . 0.0 109.662 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.9 tp -141.02 139.11 34.09 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.725 0.774 . . . . 0.0 109.345 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -130.51 168.4 17.1 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.723 -0.61 . . . . 0.0 109.44 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 83.4 14.09 74.8 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.0 t -67.94 133.94 30.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.172 -1.193 . . . . 0.0 109.761 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.6 t -71.15 -43.25 67.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 109.189 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.68 163.82 3.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 0.0 110.026 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.3 t -88.81 111.45 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.432 -0.792 . . . . 0.0 110.086 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -67.46 -31.23 71.26 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.476 -0.765 . . . . 0.0 109.097 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.1 t -167.91 159.34 11.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.099 -1.0 . . . . 0.0 109.537 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.443 ' CD1' ' C ' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -138.77 107.09 5.79 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.342 -0.849 . . . . 0.0 109.31 -179.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.84 145.03 54.29 Favored Pre-proline 0 N--CA 1.495 1.799 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.61 -13.69 32.76 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.444 2.096 . . . . 0.0 111.609 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -115.5 -1.74 12.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.28 -0.887 . . . . 0.0 108.967 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -169.07 111.61 0.51 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.149 -0.97 . . . . 0.0 109.157 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.5 mt -112.51 129.7 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.152 -0.967 . . . . 0.0 109.475 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.3 mt -113.41 123.54 50.32 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.531 -0.73 . . . . 0.0 109.039 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.3 mt -120.95 126.87 51.07 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.587 0.708 . . . . 0.0 109.112 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.81 118.25 31.45 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.35 -0.844 . . . . 0.0 108.974 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.579 ' O ' ' N ' ' A' ' 29' ' ' GLN . 3.4 t -116.95 154.49 30.76 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.345 0.593 . . . . 0.0 110.392 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.405 ' C ' ' O ' ' A' ' 27' ' ' THR . 27.1 mm 34.09 -85.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-O 121.451 0.643 . . . . 0.0 110.933 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 27' ' ' THR . 24.0 pt20 -138.82 -17.48 1.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.927 . . . . 0.0 108.944 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.58 167.51 25.93 Favored Glycine 0 N--CA 1.497 2.735 0 O-C-N 120.855 -1.153 . . . . 0.0 110.797 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -120.43 132.94 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.513 -0.992 . . . . 0.0 109.305 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.559 HD13 HD13 ' B' ' 60' ' ' LEU . 57.7 tp -112.23 131.92 55.21 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.7 t -115.79 129.9 56.63 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.453 0.644 . . . . 0.0 109.358 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 93.7 mt -112.8 132.23 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 121.315 0.578 . . . . 0.0 109.457 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -131.33 146.65 52.38 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.575 0.702 . . . . 0.0 109.488 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.421 ' O ' ' OE1' ' A' ' 37' ' ' GLU . . . 168.63 -148.21 12.18 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' A' ' 36' ' ' GLY . 0.7 OUTLIER -118.89 137.36 53.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.866 -0.785 . . . . 0.0 109.83 -178.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.421 ' C ' HD12 ' A' ' 39' ' ' LEU . 70.7 mmtt 50.94 71.3 0.44 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.018 0.913 . . . . 0.0 110.179 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.4 mp -98.75 72.55 1.98 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.982 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 -178.869 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.4 tp . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -64.64 -64.43 0.88 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.201 -0.937 . . . . 0.0 109.83 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.05 42.63 0.77 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.228 -0.92 . . . . 0.0 109.375 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.07 24.78 76.32 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -112.35 154.85 25.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.338 -1.096 . . . . 0.0 109.694 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.9 m -133.42 163.0 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.538 -0.726 . . . . 0.0 109.731 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -135.45 160.78 37.38 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.701 0.762 . . . . 0.0 109.688 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.08 135.17 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -122.04 125.52 46.43 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.838 0.827 . . . . 0.0 109.322 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.4 178.47 24.43 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.82 129.83 44.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.362 -1.081 . . . . 0.0 109.297 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -85.48 122.52 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.282 -0.887 . . . . 0.0 109.519 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -102.22 -24.43 13.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.482 -0.761 . . . . 0.0 109.036 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.93 149.7 14.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.843 -1.161 . . . . 0.0 110.749 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.465 HD13 HD13 ' B' ' 32' ' ' LEU . 12.7 mt -131.2 144.74 51.57 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.502 HG13 HD12 ' B' ' 64' ' ' LEU . 21.8 t -141.24 122.0 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.763 0.792 . . . . 0.0 110.3 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.557 ' O ' ' N ' ' A' ' 64' ' ' LEU . 19.6 t80 -139.73 115.77 8.16 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 65' ' ' GLU . 53.2 Cg_exo -52.54 78.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.43 1.42 . . . . 0.0 111.419 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -53.3 85.01 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 122.338 1.066 . . . . 0.0 109.498 -179.153 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.579 ' N ' ' O ' ' A' ' 63' ' ' PRO . 0.2 OUTLIER 54.78 107.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.918 0.866 . . . . 0.0 110.922 179.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.6 ' CG ' ' N ' ' A' ' 67' ' ' HIS . 55.4 t-80 47.47 170.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.429 1.109 . . . . 0.0 112.094 177.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.6 ' N ' ' CG ' ' A' ' 66' ' ' HIS . 1.4 t60 -174.81 -166.85 0.26 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 122.122 0.963 . . . . 0.0 110.276 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 48.88 42.56 20.49 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.913 0.863 . . . . 0.0 108.711 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.407 ' O ' ' CD2' ' A' ' 69' ' ' HIS . 6.1 p-80 -72.0 146.88 47.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.055 -1.028 . . . . 0.0 110.899 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -179.26 144.02 0.22 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.708 0.766 . . . . 0.0 109.094 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.2 p80 . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.617 -179.247 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 9.8 ptt? . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.641 0.734 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 55.43 24.41 6.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.466 -0.771 . . . . 0.0 109.431 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -112.01 9.95 20.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.447 -0.783 . . . . 0.0 109.098 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -69.72 144.65 52.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.107 -0.995 . . . . 0.0 109.9 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . 0.529 ' NE2' ' OG1' ' A' ' 27' ' ' THR . 75.5 mt-30 -140.71 150.06 42.97 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.785 0.802 . . . . 0.0 109.691 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -110.58 127.25 55.14 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.476 HD23 ' C ' ' B' ' 7' ' ' LEU . 6.5 tt -122.33 122.25 38.63 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.229 -0.92 . . . . 0.0 108.876 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.453 ' N ' HD23 ' B' ' 7' ' ' LEU . 18.2 p -121.19 147.89 44.99 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.726 0.774 . . . . 0.0 109.994 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . . . . . . . . . 32.0 tp -148.83 143.78 26.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.568 -0.707 . . . . 0.0 109.102 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -130.25 161.39 31.3 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.651 0.739 . . . . 0.0 109.933 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.41 20.75 61.6 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.83 134.63 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.834 -1.392 . . . . 0.0 109.78 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 34.0 m -72.92 -41.84 64.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.193 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.02 164.83 4.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 109.819 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 77.1 t -99.29 128.22 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.429 -0.794 . . . . 0.0 109.66 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -84.0 -29.65 26.8 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.686 0.755 . . . . 0.0 109.187 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 35.6 t -169.3 155.5 6.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.121 -0.987 . . . . 0.0 109.289 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -137.42 108.86 6.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 0.0 109.779 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . 0.42 ' OD2' ' O ' ' B' ' 22' ' ' GLU . 0.8 OUTLIER -132.91 149.12 72.01 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.293 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.5 -7.76 19.89 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.327 2.018 . . . . 0.0 111.607 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -114.47 -20.96 10.56 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.781 0.8 . . . . 0.0 109.03 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.431 ' CD ' ' NZ ' ' B' ' 35' ' ' LYS . 74.6 tt0 -153.46 115.62 4.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.142 -0.974 . . . . 0.0 109.078 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 81.3 mt -115.88 130.22 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.217 -0.927 . . . . 0.0 109.959 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 14.5 mt -112.39 126.34 55.17 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 81.1 mt -120.57 125.91 48.97 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.808 0.813 . . . . 0.0 109.148 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -95.12 110.4 22.35 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.583 ' O ' ' N ' ' B' ' 29' ' ' GLN . 0.1 OUTLIER -113.92 151.74 31.82 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.313 0.578 . . . . 0.0 110.031 -178.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' B' ' 27' ' ' THR . 55.0 mt 34.51 -85.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 CA-C-O 121.161 0.505 . . . . 0.0 110.765 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.583 ' N ' ' O ' ' B' ' 27' ' ' THR . 20.5 pt20 -138.51 -14.91 1.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.127 -0.983 . . . . 0.0 109.638 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.01 165.19 20.76 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.971 -1.081 . . . . 0.0 110.807 -179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 53.1 t -122.32 132.93 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.253 -1.145 . . . . 0.0 109.107 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.465 HD13 HD13 ' A' ' 60' ' ' LEU . 53.9 tp -115.58 137.57 51.93 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.335 0.588 . . . . 0.0 109.926 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.11 138.15 53.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.607 -0.683 . . . . 0.0 109.167 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 5.0 mp -115.25 130.89 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.591 -0.693 . . . . 0.0 109.426 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.431 ' NZ ' ' CD ' ' B' ' 22' ' ' GLU . 68.3 mttm -128.57 140.99 51.51 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.518 0.675 . . . . 0.0 109.837 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.99 -139.27 5.46 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' B' ' 38' ' ' LYS . 0.4 OUTLIER -117.59 138.31 52.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.627 -0.925 . . . . 0.0 109.059 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . 0.44 ' C ' HD12 ' B' ' 39' ' ' LEU . 32.3 mtmm 36.42 93.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.996 0.903 . . . . 0.0 110.754 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.483 HD12 ' N ' ' B' ' 39' ' ' LEU . 9.1 mp -100.14 71.6 1.61 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.633 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.898 -178.4 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 14.3 tp . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.685 0.755 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -84.41 -82.16 0.17 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.689 0.757 . . . . 0.0 110.31 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.38 5.33 10.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.191 -0.943 . . . . 0.0 109.255 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.02 30.95 36.46 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -81.96 148.77 28.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -1.119 . . . . 0.0 110.155 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 53.9 t -128.08 134.64 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.401 -0.812 . . . . 0.0 109.805 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -120.71 147.16 45.66 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 54.4 t -126.94 135.06 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.432 -0.793 . . . . 0.0 109.308 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -120.12 126.12 49.93 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.63 0.729 . . . . 0.0 109.744 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' GLY . . . . . . . . . . . . . . . 158.02 171.2 23.66 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.04 111.94 23.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.29 -1.123 . . . . 0.0 108.805 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -74.24 112.18 10.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.311 -0.868 . . . . 0.0 109.564 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -101.53 -11.46 19.26 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.58 143.17 6.93 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.726 -1.234 . . . . 0.0 110.744 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.559 HD13 HD13 ' A' ' 32' ' ' LEU . 15.0 mt -127.1 144.64 50.98 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.472 HG22 HD12 ' A' ' 64' ' ' LEU . 2.3 t -135.36 128.27 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.534 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' TYR . . . . . 0.434 ' HD2' ' H ' ' B' ' 64' ' ' LEU . 73.3 t80 -140.14 137.37 17.96 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . 0.569 ' C ' ' H ' ' B' ' 65' ' ' GLU . 96.8 Cg_exo -36.52 -39.62 0.42 Allowed 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.414 2.076 . . . . 0.0 112.506 -178.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' LEU . . . . . 0.677 HD23 ' O ' ' B' ' 64' ' ' LEU . 2.2 tt 59.98 -1.88 0.16 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.575 ' O ' HD23 ' B' ' 64' ' ' LEU . 5.3 mm-40 72.49 128.21 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.038 0.923 . . . . 0.0 110.431 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -64.04 157.77 24.34 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.876 0.846 . . . . 0.0 110.37 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' HIS . . . . . 0.403 ' C ' ' N ' ' B' ' 69' ' ' HIS . 94.5 m-70 -81.76 119.68 24.17 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -55.49 -11.07 0.76 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.098 -1.001 . . . . 0.0 109.51 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.593 ' CD2' ' H ' ' B' ' 71' ' ' HIS . 10.9 t-160 -55.17 -86.71 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.311 -0.868 . . . . 0.0 109.659 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.55 ' O ' ' CD2' ' B' ' 71' ' ' HIS . 0.5 OUTLIER 42.83 20.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.903 0.858 . . . . 0.0 109.777 -179.323 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' HIS . . . . . 0.593 ' H ' ' CD2' ' B' ' 69' ' ' HIS . 1.3 p80 . . . . . 0 C--N 1.294 -1.83 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.958 -179.714 . . . . . . . . 1 1 . 1 stop_ save_